Citrus Sinensis ID: 018052
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | 2.2.26 [Sep-21-2011] | |||||||
| Q9MAM1 | 447 | CBL-interacting serine/th | yes | no | 0.991 | 0.800 | 0.799 | 1e-176 | |
| Q10SC8 | 456 | CBL-interacting protein k | yes | no | 0.983 | 0.778 | 0.766 | 1e-165 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.988 | 0.740 | 0.709 | 1e-157 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.980 | 0.786 | 0.707 | 1e-155 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.991 | 0.817 | 0.688 | 1e-150 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.988 | 0.809 | 0.682 | 1e-149 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.975 | 0.783 | 0.680 | 1e-147 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.980 | 0.806 | 0.685 | 1e-147 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.991 | 0.788 | 0.658 | 1e-147 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.991 | 0.804 | 0.641 | 1e-137 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 287/359 (79%), Positives = 329/359 (91%), Gaps = 1/359 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 86 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 146 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK++IKRIL+PNP TR++I
Sbjct: 206 CGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAKRVIKRILEPNPITRISI 265
Query: 181 SQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 239
+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS
Sbjct: 266 AELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISS 325
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK
Sbjct: 326 SSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDK 385
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 386 SGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1495), Expect = e-165, Method: Compositional matrix adjust.
Identities = 273/356 (76%), Positives = 312/356 (87%), Gaps = 1/356 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASK+KIY+VLE++DGGELFDKI GRL EDEARRYF QLINAVDYCHSRGV+HRDLKP
Sbjct: 94 MASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLINAVDYCHSRGVYHRDLKP 153
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS+G LK+SDFGLSA + Q +EDGLLHTACGTPNYVAPEVL DKGYDG A+DVWS
Sbjct: 154 ENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAPEVLADKGYDGMAADVWS 213
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CG+ILFVLMAG+LPFD+ NLM LY+ IC+A SCP WFSSGAKK IKRILDPNP TR+TI
Sbjct: 214 CGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAKKFIKRILDPNPCTRITI 273
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
+Q+LED+WFKK YKPP F++ E+V+LDDVDA F+ S+ENLV EK+EKP SMNAF LISR+
Sbjct: 274 AQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCSEENLVAEKREKPESMNAFALISRS 333
Query: 241 KSFSLENLFEKQ-TGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ F+L NLFEK+ G+VKRET FTSQ P EIMSKIEEA PLGFNVRK NYKMKL+GDK
Sbjct: 334 QGFNLGNLFEKEMMGMVKRETSFTSQCTPQEIMSKIEEACGPLGFNVRKQNYKMKLKGDK 393
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 355
TGRKG LSVATEVFEVAP+LH+VE+RKTGGDTLEFH FY FSS LKD+VW++E +
Sbjct: 394 TGRKGYLSVATEVFEVAPSLHMVELRKTGGDTLEFHNFYNNFSSELKDIVWKSESD 449
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1432), Expect = e-157, Method: Compositional matrix adjust.
Identities = 259/365 (70%), Positives = 319/365 (87%), Gaps = 8/365 (2%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIY VLEF+ GGELFDKI+ +GRLKEDEAR+YFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 98 MASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLKP 157
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+ QQVREDGLLHT CGTPNYVAPEV+N+KGYDG +D+WS
Sbjct: 158 ENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWS 217
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPF++SNL +LY+KI +A+F+CP WFS+ AKKLIKRILDPNP TR+T
Sbjct: 218 CGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRITF 277
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE--NLVTEKKEK----PVSMNAF 234
++++E+EWFKKGYK P F+ +V+LDDVDAIF+DS E NLV E++E+ PV+MNAF
Sbjct: 278 AEVIENEWFKKGYKAPKFE-NADVSLDDVDAIFDDSGESKNLVVERREEGLKTPVTMNAF 336
Query: 235 ELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMK 294
ELIS ++ +L +LFEKQ GLVKR+TRFTS+ NEI++KIE AA P+GF+V+ NYKMK
Sbjct: 337 ELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMK 396
Query: 295 LQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQA-E 353
L G+K+GRKGQL+VATEVF+VAP+L++VE+RK+GGDTLEFHKFYK ++GLKD+VW+ +
Sbjct: 397 LTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGLKDIVWKTID 456
Query: 354 ENKEE 358
E KEE
Sbjct: 457 EEKEE 461
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 547 bits (1410), Expect = e-155, Method: Compositional matrix adjust.
Identities = 254/359 (70%), Positives = 312/359 (86%), Gaps = 5/359 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIV+E + GGELFDKIA GRLKED+AR+YFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 MASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+SQQVREDGLLHT CGTPNYVAPEV+N+KGYDG +D+WS
Sbjct: 140 ENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPF++SNLM+LY+KI +ADFSCPSWFS+ AKKLIK+ILDPNP TR+TI
Sbjct: 200 CGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKILDPNPSTRITI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDS--KENLVTEKK-EKPVSMNAFELI 237
++++ +EWFKKGY+PP F+ +VNLDD+++IFN+S + LV E++ E+P MNAFELI
Sbjct: 260 AELINNEWFKKGYQPPRFET-ADVNLDDINSIFNESGDQTQLVVERREERPSVMNAFELI 318
Query: 238 SRTKSFSLENLFEKQT-GLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQ 296
S ++ +L LFEKQ+ G VKRETRF S+ P NEI+SKIE AA P+GFNV+K NYK+KLQ
Sbjct: 319 STSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPMGFNVQKRNYKLKLQ 378
Query: 297 GDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 355
G+ GRKGQL++ATEVFEV P+L++VE+RK+ GDTLEFHKFY S+GLKDV+W+ E +
Sbjct: 379 GENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHNISNGLKDVMWKPESS 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 530 bits (1365), Expect = e-150, Method: Compositional matrix adjust.
Identities = 247/359 (68%), Positives = 303/359 (84%), Gaps = 1/359 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
M SKTKIYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 MGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL D+GYDG +D+WS
Sbjct: 140 ENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQGYDGAMADLWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF++SNLM LY+KI A+F+ P W S AK+L+ RILDPNP TR+TI
Sbjct: 200 CGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRILDPNPMTRVTI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
++LEDEWFKKGYK P FD++ + LDDV A+FNDS+E+ VTEKKE+P ++NAFELIS +
Sbjct: 260 PEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEEPEALNAFELISMS 319
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
+L NLF+ + KRETRFTS+ PP EI+ KIEEAAKPLGF+V+K NYK++L+ K
Sbjct: 320 AGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKPLGFDVQKKNYKLRLEKVKA 378
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEEL 359
GRKG L+VATE+ +VAP+LH+VEVRK GDTLEFHKFYK S LKDVVW++++ + +L
Sbjct: 379 GRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNLSRTLKDVVWKSDDLQNQL 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 528 bits (1361), Expect = e-149, Method: Compositional matrix adjust.
Identities = 245/359 (68%), Positives = 304/359 (84%), Gaps = 2/359 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDYCHSRGV+HRDLKP
Sbjct: 81 MASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRGVYHRDLKP 140
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLND+GYDG +D+WS
Sbjct: 141 ENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATADMWS 200
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGV+L+VL+AG+LPFD+SNLM LY+KI +F+CP W S GA KLI RILDPNP TR+T
Sbjct: 201 CGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTRVTP 260
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK-EKPVSMNAFELISR 239
++ EDEWFKK YKPP F++ ++ N+DD+DA+F DS+E+LVTEK+ E+P ++NAFE+IS
Sbjct: 261 QEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQPAAINAFEIISM 320
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
++ +LENLF+ + KRETR T + NEI+ KIEEAAKPLGF+V+K NYKM+L+ K
Sbjct: 321 SRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVK 379
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
GRKG L+VATE+F+VAP+LH+V+V K+ GDTLEFHKFYKK S+ L+ VVW E K+E
Sbjct: 380 AGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSLEQVVWTNNEVKKE 438
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1345), Expect = e-147, Method: Compositional matrix adjust.
Identities = 241/354 (68%), Positives = 301/354 (85%), Gaps = 2/354 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
M SK +I+IVLE++ GGELF+ IA +GRLKE+EAR+YFQQLINAVDYCHSRGV+HRDLK
Sbjct: 87 MGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINAVDYCHSRGVYHRDLKL 146
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+++QV+ DGLLHT CGTPNYVAPEV+ D+GYDG A+D+WS
Sbjct: 147 ENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPEVIEDRGYDGAAADIWS 206
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+VL+AGFLPF++ N++ALY+KI A F+CPSWFS+GAKKLI RILDPNP TR+TI
Sbjct: 207 CGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKKLITRILDPNPTTRITI 266
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE-KPVSMNAFELISR 239
SQ+LED WFKKGYKPP FD++ E + DDVDA F DS++ V E+ E +P SMNAFELIS
Sbjct: 267 SQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEETEDQPTSMNAFELISL 326
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
++ +L+NLFE + KRETRFTSQ PP EI++KIEEAAKPLGF+++K NYKM+++ K
Sbjct: 327 NQALNLDNLFEAKKEY-KRETRFTSQCPPKEIITKIEEAAKPLGFDIQKKNYKMRMENLK 385
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAE 353
GRKG L+VATEVF+VAP+LH+VE++K GDTLEF KFY+ S+ LKDVVW+ +
Sbjct: 386 AGRKGNLNVATEVFQVAPSLHVVELKKAKGDTLEFQKFYRTLSTQLKDVVWKCD 439
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 521 bits (1343), Expect = e-147, Method: Compositional matrix adjust.
Identities = 244/356 (68%), Positives = 298/356 (83%), Gaps = 2/356 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 LASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APEVLND+GYDG +D+WS
Sbjct: 140 ENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATADLWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF++SNLM LY+KI ++ CP W S GAK LI RILDPNP TR+TI
Sbjct: 200 CGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKK-EKPVSMNAFELISR 239
++L D WFKK YKP F+++EE NLDDVDA+F DS+E+ VTEKK E+P SMNAFELIS
Sbjct: 260 PEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFELISM 319
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+++ L NLFE++ G KRETRF ++ N+++ KIEEA+KPLGF+++K NYKM+L+
Sbjct: 320 SRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVT 378
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 355
GRKG L VATE+F+V+P+LH++EVRKT GDTLEFHKFYKK S+ L DVVW++ E+
Sbjct: 379 AGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSLNDVVWKSGES 434
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1341), Expect = e-147, Method: Compositional matrix adjust.
Identities = 247/375 (65%), Positives = 303/375 (80%), Gaps = 17/375 (4%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
M SKT IYIVLE++ GGELFD I HGR++EDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 MGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDSYG LK+SDFGLSA+SQQ+++DGLLHT CGTPNYVAPEVL D+GYDG +D+WS
Sbjct: 140 ENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQGYDGAMADLWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF++SNLM LY+KI A+F+ P W S AK+L+ RILDPNP TR+TI
Sbjct: 200 CGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRILDPNPMTRITI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
++LEDEWFKKGYK P FD++ + LDDVDA+FNDS+E+ VTEKKE+P ++NAFELIS +
Sbjct: 260 PEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKKEEPEALNAFELISMS 319
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNY--------- 291
+L NLF+ + KRETRFTS+ PP EI+ KIEEAAKPLGF+V+K NY
Sbjct: 320 AGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKPLGFDVQKKNYKICSPCLTT 378
Query: 292 -------KMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSG 344
K++L+ K GRKG L+VATE+ +VAP+LH+VEVRK GDTLEFHKFYK S
Sbjct: 379 ICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNLSRT 438
Query: 345 LKDVVWQAEENKEEL 359
LKDVVW++++ + +L
Sbjct: 439 LKDVVWKSDDLQNQL 453
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-137, Method: Compositional matrix adjust.
Identities = 231/360 (64%), Positives = 288/360 (80%), Gaps = 2/360 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
M SKT+I+IVLE++ GGEL D IA GRLKEDEAR+YFQQLINAVDYCHSRGV+HRDLK
Sbjct: 86 MGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLKL 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G +K+SDFGLSAIS+QV+ DGLLHT CGTPNYVAPEV+ DKGYDG +D+WS
Sbjct: 146 ENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEVIEDKGYDGALADLWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF++ N+++LY KI A F+CPSWFS+ AK+LI RILDPNP TR+T
Sbjct: 206 CGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRLIARILDPNPATRITT 265
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK-KEKPVSMNAFELISR 239
SQ+L+D+WFKKGY+ P FD + DV F DS+E V E +E+P MNAFELIS
Sbjct: 266 SQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSEEKHVKEAMEEQPTLMNAFELISL 325
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
K +L+N FE KRETRFTSQ PP EI+++IEEAA LGFN++K NY+M+++ K
Sbjct: 326 NKGLNLDNFFESDKKY-KRETRFTSQCPPKEIINRIEEAANLLGFNIQKRNYRMRMENIK 384
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEEL 359
GRKG L++ATEVF+VAP+LH+VE++K GDTLEF KFY+ S+ LKDVVW+ E+ E++
Sbjct: 385 EGRKGHLNIATEVFQVAPSLHVVELKKAKGDTLEFQKFYQTLSTQLKDVVWELEDAAEDM 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| 296088995 | 440 | unnamed protein product [Vitis vinifera] | 1.0 | 0.820 | 0.836 | 0.0 | |
| 224064356 | 441 | predicted protein [Populus trichocarpa] | 0.997 | 0.816 | 0.822 | 1e-179 | |
| 224993580 | 441 | CBL-interacting protein kinase 12 [Popul | 0.997 | 0.816 | 0.816 | 1e-178 | |
| 224128033 | 442 | predicted protein [Populus trichocarpa] | 1.0 | 0.816 | 0.811 | 1e-178 | |
| 15223317 | 447 | CBL-interacting serine/threonine-protein | 0.991 | 0.800 | 0.799 | 1e-175 | |
| 14423524 | 447 | similar to wpk4 protein kinase [Arabidop | 0.991 | 0.800 | 0.799 | 1e-175 | |
| 30677898 | 449 | CBL-interacting serine/threonine-protein | 0.991 | 0.797 | 0.795 | 1e-173 | |
| 297843000 | 452 | T25K16.13 [Arabidopsis lyrata subsp. lyr | 0.991 | 0.792 | 0.793 | 1e-173 | |
| 30677901 | 451 | CBL-interacting serine/threonine-protein | 0.991 | 0.793 | 0.790 | 1e-173 | |
| 449520201 | 441 | PREDICTED: CBL-interacting serine/threon | 0.991 | 0.811 | 0.798 | 1e-172 |
| >gi|296088995|emb|CBI38698.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 302/361 (83%), Positives = 338/361 (93%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIV+EF+DGGELFD+IAK+GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 MASKTKIYIVVEFVDGGELFDRIAKNGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDSYGVLKISDFGLSA+SQQVREDGL HTACGTPNYVAPEVLN+KGYDG ++D+WS
Sbjct: 140 ENLLLDSYGVLKISDFGLSALSQQVREDGLFHTACGTPNYVAPEVLNNKGYDGASADIWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPFDE +LMALY+KIC+ADFSCPSW S GAKKLI RILDPNP TR+TI
Sbjct: 200 CGVILFVLLAGYLPFDEVSLMALYKKICKADFSCPSWLSPGAKKLINRILDPNPVTRITI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
++LED WFKKGY+P F +EE+VN+DDVDA FN+S+ENLVTE+KEKPVSMNAFELISR+
Sbjct: 260 PEILEDGWFKKGYQPTCFQQEEDVNVDDVDAAFNNSEENLVTERKEKPVSMNAFELISRS 319
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
+SF+LENLF KQ GLVKRET FTSQRP +EIMSKIEE AKPLGFNVRK NYKMKLQGDKT
Sbjct: 320 QSFNLENLFGKQAGLVKRETSFTSQRPAHEIMSKIEETAKPLGFNVRKQNYKMKLQGDKT 379
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 360
GRKG LSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKD+VW++E N EELR
Sbjct: 380 GRKGHLSVATEVFEVAPSLHMVELRKTGGDTLEFHKFYKSFSSGLKDIVWKSEANTEELR 439
Query: 361 A 361
+
Sbjct: 440 S 440
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224064356|ref|XP_002301435.1| predicted protein [Populus trichocarpa] gi|116265942|gb|ABJ91219.1| CBL-interacting protein kinase 12 [Populus trichocarpa] gi|222843161|gb|EEE80708.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 296/360 (82%), Positives = 332/360 (92%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIV+EF+DGGELFDKIAKHGRLKEDEARRYFQQLI AVDYCHSRGVFHRDLKP
Sbjct: 82 MASKTKIYIVIEFVDGGELFDKIAKHGRLKEDEARRYFQQLIKAVDYCHSRGVFHRDLKP 141
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS GVLK+SDFGLSA+SQQ+R DGLLHTACGTPNYVAPEVL D+GYDG ASDVWS
Sbjct: 142 ENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHTACGTPNYVAPEVLRDQGYDGTASDVWS 201
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+VLMAGFLPF ES+L+ LYRKICRADF+ PSWFSSGAKKLIKRILDP P TR+T+
Sbjct: 202 CGVILYVLMAGFLPFSESSLVVLYRKICRADFTFPSWFSSGAKKLIKRILDPKPLTRITV 261
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
S++LEDEWFKKGYKPP F++EE+VN+DDVDA+FNDSKE+LVTE+K KPVS+NAFELIS+T
Sbjct: 262 SEILEDEWFKKGYKPPQFEQEEDVNIDDVDAVFNDSKEHLVTERKVKPVSINAFELISKT 321
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
+ FSL+NLF KQ G+VKRET S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK+
Sbjct: 322 QGFSLDNLFGKQAGVVKRETHIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKS 381
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 360
GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFHKFYK FSSGLKDVVW++++ E LR
Sbjct: 382 GRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHKFYKSFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224993580|gb|ACN76469.1| CBL-interacting protein kinase 12 [Populus euphratica] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1626), Expect = e-178, Method: Compositional matrix adjust.
Identities = 294/360 (81%), Positives = 330/360 (91%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MAS+TKIYIV+EF++GGELFDKIAKHGRLKEDEARRYFQQLI A DYCHSRGVFHRDLKP
Sbjct: 82 MASRTKIYIVIEFVEGGELFDKIAKHGRLKEDEARRYFQQLIKAADYCHSRGVFHRDLKP 141
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS GVLK+SDFGLSA+SQQ+R DGLLH ACGTPNYVAPEVL D+GYDG ASDVWS
Sbjct: 142 ENLLLDSRGVLKVSDFGLSALSQQLRGDGLLHAACGTPNYVAPEVLRDQGYDGTASDVWS 201
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+VLMAGFLPF ES+L+ LYRKICRADF+ PSWFSSGAKKLIKRILDP P TR+T+
Sbjct: 202 CGVILYVLMAGFLPFSESSLVVLYRKICRADFTFPSWFSSGAKKLIKRILDPQPLTRITV 261
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
S++LEDEWFKKGYKPP F++EE+VN+DDVDA+FNDSKE+LVTE+K KPVSMNAFELISRT
Sbjct: 262 SEILEDEWFKKGYKPPQFEQEEDVNIDDVDAVFNDSKEHLVTERKVKPVSMNAFELISRT 321
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
+ FSL+NLF KQ G+VKRET S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK+
Sbjct: 322 QGFSLDNLFGKQAGVVKRETHIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKS 381
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 360
GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFHKFYK FSSGLKDVVW++++ E LR
Sbjct: 382 GRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHKFYKSFSSGLKDVVWKSDQTIEGLR 441
|
Source: Populus euphratica Species: Populus euphratica Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128033|ref|XP_002320224.1| predicted protein [Populus trichocarpa] gi|116265944|gb|ABJ91220.1| CBL-interacting protein kinase 13 [Populus trichocarpa] gi|222860997|gb|EEE98539.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 293/361 (81%), Positives = 331/361 (91%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIV+EF+DGGELFDKIAKHGRL+EDEARRYFQQLINAVDYCHSRGVFHRDLKP
Sbjct: 82 MASKTKIYIVIEFVDGGELFDKIAKHGRLREDEARRYFQQLINAVDYCHSRGVFHRDLKP 141
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS+GVLK+SDFGLSA+SQQ++ DGLLHTACGTPNYVAPEVL DKGYDG ASDVWS
Sbjct: 142 ENLLLDSHGVLKVSDFGLSALSQQLQGDGLLHTACGTPNYVAPEVLKDKGYDGTASDVWS 201
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+VLMAG+LPFDE++LMALY KIC ADF+ PSWFSSGAKKLIKRILDP P TR+T+
Sbjct: 202 CGVILYVLMAGYLPFDETSLMALYLKICSADFTFPSWFSSGAKKLIKRILDPEPLTRITV 261
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
++++EDEWFKKGY+PP F++EE VN+DDVDA+FND KE+LVTEKK+KP SMNAFELIS+T
Sbjct: 262 AEIIEDEWFKKGYRPPQFEQEEHVNVDDVDAVFNDLKEHLVTEKKKKPASMNAFELISKT 321
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
+ FSLENLF KQ G VKRETR S P NEIMS+IEEAAKPLGFNV K NYKMKL+GDK
Sbjct: 322 QGFSLENLFGKQAGFVKRETRIASHSPANEIMSRIEEAAKPLGFNVDKRNYKMKLKGDKG 381
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEELR 360
GRKGQLSVATEVFEVAP+LH+VE+RK GGDTLEFH FYK FSSGLKDVVW++++ E LR
Sbjct: 382 GRKGQLSVATEVFEVAPSLHMVELRKIGGDTLEFHNFYKSFSSGLKDVVWKSDQTIEGLR 441
Query: 361 A 361
+
Sbjct: 442 S 442
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223317|ref|NP_171622.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|259016207|sp|Q9MAM1.2|CIPK9_ARATH RecName: Full=CBL-interacting serine/threonine-protein kinase 9; AltName: Full=SNF1-related kinase 3.12; AltName: Full=SOS2-like protein kinase PKS6 gi|332189123|gb|AEE27244.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1596), Expect = e-175, Method: Compositional matrix adjust.
Identities = 287/359 (79%), Positives = 329/359 (91%), Gaps = 1/359 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 86 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 146 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK++IKRIL+PNP TR++I
Sbjct: 206 CGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAKRVIKRILEPNPITRISI 265
Query: 181 SQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 239
+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS
Sbjct: 266 AELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISS 325
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK
Sbjct: 326 SSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDK 385
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 386 SGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14423524|gb|AAK62444.1|AF386999_1 similar to wpk4 protein kinase [Arabidopsis thaliana] gi|20259788|gb|AAM13241.1| similar to wpk4 protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1596), Expect = e-175, Method: Compositional matrix adjust.
Identities = 287/359 (79%), Positives = 329/359 (91%), Gaps = 1/359 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 86 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 146 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK++IKRIL+PNP TR++I
Sbjct: 206 CGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAKRVIKRILEPNPITRISI 265
Query: 181 SQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 239
+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS
Sbjct: 266 AELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISS 325
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK
Sbjct: 326 SSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDK 385
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + EE
Sbjct: 386 SGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAEE 444
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30677898|ref|NP_849570.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|13249117|gb|AAK16684.1|AF295664_1 CBL-interacting protein kinase 9 [Arabidopsis thaliana] gi|332189122|gb|AEE27243.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1583), Expect = e-173, Method: Compositional matrix adjust.
Identities = 287/361 (79%), Positives = 329/361 (91%), Gaps = 3/361 (0%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 86 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 146 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYR--KICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
CGVILFVLMAG+LPFDE NLM LY+ +IC+A+FSCP WFS GAK++IKRIL+PNP TR+
Sbjct: 206 CGVILFVLMAGYLPFDEPNLMTLYKRVRICKAEFSCPPWFSQGAKRVIKRILEPNPITRI 265
Query: 179 TISQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELI 237
+I+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELI
Sbjct: 266 SIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELI 325
Query: 238 SRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQG 297
S + FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++G
Sbjct: 326 SSSSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKG 385
Query: 298 DKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKE 357
DK+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKDVVW + E
Sbjct: 386 DKSGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKFYKNFSSGLKDVVWNTDAAAE 445
Query: 358 E 358
E
Sbjct: 446 E 446
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843000|ref|XP_002889381.1| T25K16.13 [Arabidopsis lyrata subsp. lyrata] gi|297335223|gb|EFH65640.1| T25K16.13 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1582), Expect = e-173, Method: Compositional matrix adjust.
Identities = 288/363 (79%), Positives = 329/363 (90%), Gaps = 5/363 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 87 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 146
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 147 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 206
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK++IKRIL+PNP TR++I
Sbjct: 207 CGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSLGAKRVIKRILEPNPITRISI 266
Query: 181 SQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 239
+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS
Sbjct: 267 AELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISS 326
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK
Sbjct: 327 SSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDK 386
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHK----FYKKFSSGLKDVVWQAEEN 355
+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHK FYK FSSGLKDVVW E
Sbjct: 387 SGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKVFDPFYKTFSSGLKDVVWNTEAA 446
Query: 356 KEE 358
EE
Sbjct: 447 AEE 449
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30677901|ref|NP_849571.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] gi|13448037|gb|AAK26845.1|AF339147_1 SOS2-like protein kinase PKS6 [Arabidopsis thaliana] gi|332189124|gb|AEE27245.1| CBL-interacting serine/threonine-protein kinase 9 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1580), Expect = e-173, Method: Compositional matrix adjust.
Identities = 287/363 (79%), Positives = 329/363 (90%), Gaps = 5/363 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIYIVLE ++GGELFDKIA+ GRLKEDEARRYFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 86 MASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD+ GVLK+SDFGLSA S+QVREDGLLHTACGTPNYVAPEVL+DKGYDG A+DVWS
Sbjct: 146 ENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVAPEVLSDKGYDGAAADVWS 205
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPFDE NLM LY++IC+A+FSCP WFS GAK++IKRIL+PNP TR++I
Sbjct: 206 CGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGAKRVIKRILEPNPITRISI 265
Query: 181 SQMLEDEWFKKGYKPPHFDK-EEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR 239
+++LEDEWFKKGYKPP FD+ +E++ +DDVDA F++SKE LVTEKKEKPVSMNAFELIS
Sbjct: 266 AELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLVTEKKEKPVSMNAFELISS 325
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+ FSLENLFEKQ LVK+ETRFTSQR +EIMSK+EE AKPLGFNVRK NYK+K++GDK
Sbjct: 326 SSEFSLENLFEKQAQLVKKETRFTSQRSASEIMSKMEETAKPLGFNVRKDNYKIKMKGDK 385
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHK----FYKKFSSGLKDVVWQAEEN 355
+GRKGQLSVATEVFEVAP+LH+VE+RKTGGDTLEFHK FYK FSSGLKDVVW +
Sbjct: 386 SGRKGQLSVATEVFEVAPSLHVVELRKTGGDTLEFHKVCDSFYKNFSSGLKDVVWNTDAA 445
Query: 356 KEE 358
EE
Sbjct: 446 AEE 448
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520201|ref|XP_004167122.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 9-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 286/358 (79%), Positives = 321/358 (89%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASK+KIYIVLE+ DGGELFDKIA GRLKEDEAR+YF QLINAVDYCHSRGV+HRDLKP
Sbjct: 82 MASKSKIYIVLEYADGGELFDKIAAKGRLKEDEARKYFHQLINAVDYCHSRGVYHRDLKP 141
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS+ VLK+SDFGLSA SQQVR DGLLHTACGTPNYVAPEVLNDKGYDG +SD+WS
Sbjct: 142 ENLLLDSHDVLKVSDFGLSAFSQQVRGDGLLHTACGTPNYVAPEVLNDKGYDGSSSDLWS 201
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAGFLPFDE NLM LYRKI +ADF+ PSWFSSGAK L++RILDP+P TR++I
Sbjct: 202 CGVILFVLMAGFLPFDEPNLMCLYRKISKADFAFPSWFSSGAKNLVRRILDPDPTTRISI 261
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISRT 240
+++ ED WFKK Y P HF+ EE++ LDDVDA F+ SKE+LVTE+KEKPVSMNAFELISR+
Sbjct: 262 AEIQEDPWFKKDYTPAHFEVEEDITLDDVDAAFSSSKEHLVTERKEKPVSMNAFELISRS 321
Query: 241 KSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKT 300
FSLENLFEKQ + KRETRFTSQ P NEIMSKIEE AKP+GFNVRK +YKMKLQGDKT
Sbjct: 322 PGFSLENLFEKQKTVAKRETRFTSQSPANEIMSKIEETAKPMGFNVRKRDYKMKLQGDKT 381
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
GRKG LS+ATEVFEVAP+LH+VE+RKTGGDTLEFHKFYK FSSGLKD+VW+ +EN E
Sbjct: 382 GRKGHLSIATEVFEVAPSLHMVELRKTGGDTLEFHKFYKSFSSGLKDIVWRTDENTVE 439
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.988 | 0.740 | 0.709 | 9.9e-142 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.988 | 0.791 | 0.682 | 3.2e-136 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.980 | 0.806 | 0.685 | 5.4e-134 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.988 | 0.800 | 0.547 | 2.5e-106 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.966 | 0.784 | 0.539 | 2e-102 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.955 | 0.785 | 0.519 | 1.7e-98 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.941 | 0.770 | 0.516 | 9.7e-96 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.983 | 0.778 | 0.508 | 4.8e-94 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.623 | 0.465 | 0.575 | 3.8e-93 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.958 | 0.777 | 0.519 | 2.4e-92 |
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1386 (493.0 bits), Expect = 9.9e-142, P = 9.9e-142
Identities = 259/365 (70%), Positives = 319/365 (87%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIY VLEF+ GGELFDKI+ +GRLKEDEAR+YFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 98 MASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHSRGVYHRDLKP 157
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+ QQVREDGLLHT CGTPNYVAPEV+N+KGYDG +D+WS
Sbjct: 158 ENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKGYDGAKADLWS 217
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAG+LPF++SNL +LY+KI +A+F+CP WFS+ AKKLIKRILDPNP TR+T
Sbjct: 218 CGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRILDPNPATRITF 277
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE--NLVTEKKEK----PVSMNAF 234
++++E+EWFKKGYK P F+ + V+LDDVDAIF+DS E NLV E++E+ PV+MNAF
Sbjct: 278 AEVIENEWFKKGYKAPKFENAD-VSLDDVDAIFDDSGESKNLVVERREEGLKTPVTMNAF 336
Query: 235 ELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMK 294
ELIS ++ +L +LFEKQ GLVKR+TRFTS+ NEI++KIE AA P+GF+V+ NYKMK
Sbjct: 337 ELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGFDVKTNNYKMK 396
Query: 295 LQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQA-E 353
L G+K+GRKGQL+VATEVF+VAP+L++VE+RK+GGDTLEFHKFYK ++GLKD+VW+ +
Sbjct: 397 LTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTGLKDIVWKTID 456
Query: 354 ENKEE 358
E KEE
Sbjct: 457 EEKEE 461
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 3.2e-136, P = 3.2e-136
Identities = 245/359 (68%), Positives = 304/359 (84%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKI+I+LE++ GGELFDKI GR+KEDEARRYFQQLI+AVDYCHSRGV+HRDLKP
Sbjct: 91 MASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRGVYHRDLKP 150
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDSYG LKISDFGLSA+SQQVR+DGLLHT+CGTPNYVAPEVLND+GYDG +D+WS
Sbjct: 151 ENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRGYDGATADMWS 210
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGV+L+VL+AG+LPFD+SNLM LY+KI +F+CP W S GA KLI RILDPNP TR+T
Sbjct: 211 CGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITRILDPNPMTRVTP 270
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK-PVSMNAFELISR 239
++ EDEWFKK YKPP F++ ++ N+DD+DA+F DS+E+LVTEK+E+ P ++NAFE+IS
Sbjct: 271 QEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQPAAINAFEIISM 330
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
++ +LENLF+ + KRETR T + NEI+ KIEEAAKPLGF+V+K NYKM+L+ K
Sbjct: 331 SRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGFDVQKKNYKMRLENVK 389
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKEE 358
GRKG L+VATE+F+VAP+LH+V+V K+ GDTLEFHKFYKK S+ L+ VVW E K+E
Sbjct: 390 AGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNSLEQVVWTNNEVKKE 448
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 5.4e-134, P = 5.4e-134
Identities = 244/356 (68%), Positives = 298/356 (83%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ASKTKIYIVLEF GGELFDKI GRLKE+ AR+YFQQLINAVDYCHSRGV+HRDLKP
Sbjct: 80 LASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCHSRGVYHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+S+QVR DGLLHTACGTPNY APEVLND+GYDG +D+WS
Sbjct: 140 ENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQGYDGATADLWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF++SNLM LY+KI ++ CP W S GAK LI RILDPNP TR+TI
Sbjct: 200 CGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRILDPNPMTRITI 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK-PVSMNAFELISR 239
++L D WFKK YKP F+++EE NLDDVDA+F DS+E+ VTEKKE+ P SMNAFELIS
Sbjct: 260 PEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQPTSMNAFELISM 319
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDK 299
+++ L NLFE++ G KRETRF ++ N+++ KIEEA+KPLGF+++K NYKM+L+
Sbjct: 320 SRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKPLGFDIQKKNYKMRLENVT 378
Query: 300 TGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN 355
GRKG L VATE+F+V+P+LH++EVRKT GDTLEFHKFYKK S+ L DVVW++ E+
Sbjct: 379 AGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKLSTSLNDVVWKSGES 434
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
Identities = 200/365 (54%), Positives = 272/365 (74%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+AS +KIYIVLEF+ GGELFD+I GRL+E E+R+YFQQL++AV +CH +GV+HRDLKP
Sbjct: 78 LASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCHCKGVYHRDLKP 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ G LK+SDFGLSA+ Q+ E LL T CGTPNYVAPEVL+ +GYDG A+D+WS
Sbjct: 138 ENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQGYDGSAADIWS 195
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFV++AG+LPF E++L LYRKI A+FSCP WFS+ K LI RILDPNP TR+ I
Sbjct: 196 CGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRILDPNPKTRIQI 255
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK----PVSMNAFEL 236
+ +D WF+ Y P +EEEVNLDD+ A+F+ + + V E E+ P+ MNAFE+
Sbjct: 256 QGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERNDEGPLMMNAFEM 315
Query: 237 ISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQ 296
I+ ++ +L LF+++ VKR+TRF S+R P+EI++ IE A +GF N+K +L+
Sbjct: 316 ITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLE 375
Query: 297 GDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEEN- 355
G + + GQL+V E++EVAP+L +V+VRK G+TLE+HKFYKK S L++++W+A E
Sbjct: 376 GLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGI 435
Query: 356 -KEEL 359
K E+
Sbjct: 436 PKSEI 440
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 191/354 (53%), Positives = 258/354 (72%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+AS+TKIYI+LE+I GGELFDKI ++GRL E EAR+YF QLI+ VDYCHS+GV+HRDLKP
Sbjct: 76 LASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKGVYHRDLKP 135
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLDS G LKISDFGLSA+ +Q +L T CGTPNYVAPEVL+ KGY+G +D+WS
Sbjct: 136 ENLLLDSQGNLKISDFGLSALPEQGVT--ILKTTCGTPNYVAPEVLSHKGYNGAVADIWS 193
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+VLMAG+LPFDE +L LY KI +A+FSCPS+F+ GAK LI RILDPNP+TR+TI
Sbjct: 194 CGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRILDPNPETRITI 253
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK---PVSMNAFELI 237
+++ +DEWF K Y P E VNLDDV A F+D +E + + P+++NAF+LI
Sbjct: 254 AEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTGPLTLNAFDLI 313
Query: 238 SRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQG 297
++ +L LF++ +K +TRF S +P N ++S +E ++ +GF NYKM+++G
Sbjct: 314 ILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKTHIRNYKMRVEG 373
Query: 298 DKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQ 351
+ SV EVF+VAP++ +V+++ GD E+ KFYK F S L D++W+
Sbjct: 374 LSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLDDIIWK 427
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 186/358 (51%), Positives = 258/358 (72%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASKTKIY +E++ GGELFDK++K G+LKE+ AR+YFQQLI A+DYCHSRGV+HRDLKP
Sbjct: 79 MASKTKIYFAMEYVKGGELFDKVSK-GKLKENIARKYFQQLIGAIDYCHSRGVYHRDLKP 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD G LKISDFGLSA+ + ++DGLLHT CGTP YVAPEV+ KGYDG +DVWS
Sbjct: 138 ENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYDGAKADVWS 197
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGV+L+VL+AGFLPF E NL+ +YRKI + +F CP+WF KKL+ RILDPNP++R+ I
Sbjct: 198 CGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDPNPNSRIKI 257
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELISR- 239
+++E+ WF+KG+K K E + +D++ +D KP+S NAF+LIS
Sbjct: 258 EKIMENSWFQKGFKKIETPKSPESH--QIDSLISDVHAAFSV----KPMSYNAFDLISSL 311
Query: 240 TKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEE-AAKPLGFNVRKGNYKMKLQGD 298
++ F L LFEK+ + E++FT+++ EI+SK EE A FN+ K + +K++
Sbjct: 312 SQGFDLSGLFEKEE---RSESKFTTKKDAKEIVSKFEEIATSSERFNLTKSDVGVKMEDK 368
Query: 299 KTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFY-KKFSSGLKDVVWQAEEN 355
+ GRKG L++ E+FEV + H+VE +K+GGDT+E+ +F ++ LKD+VW+ + N
Sbjct: 369 REGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKDIVWKWQGN 426
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 952 (340.2 bits), Expect = 9.7e-96, P = 9.7e-96
Identities = 184/356 (51%), Positives = 256/356 (71%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MASK+KIY +E + GGELF K+AK GRL+ED AR YFQQLI+AVD+CHSRGV+HRDLKP
Sbjct: 91 MASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 149
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD G LK++DFGLSA ++ +++DGLLHT CGTP YVAPEV+ KGYDG +D+WS
Sbjct: 150 ENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGYDGAKADLWS 209
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVL+AG+LPF + NL+ +YRKI R DF CP W SS A++L+ ++LDPNP+TR+TI
Sbjct: 210 CGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLDPNPNTRITI 269
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN---LVTEKKEKPVSMNAFELI 237
++++ WFKK + + V A ++E+ LV + KE+ ++NAF +I
Sbjct: 270 EKVMDSPWFKK--------QATRSRNEPVAATITTTEEDVDFLVHKSKEETETLNAFHII 321
Query: 238 SRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLG--FNVRKGNYKMKL 295
+ ++ F L LFE++ KRE RF + RP + ++S +EEAA+ +G F+VRK ++++
Sbjct: 322 ALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAAR-VGNKFDVRKSESRVRI 380
Query: 296 QGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK-FSSGLKDVVW 350
+G + GRKG+L+V E+F VAP+ +VEV+K GDTLE++ F LKD+ W
Sbjct: 381 EGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPALKDIFW 436
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 187/368 (50%), Positives = 257/368 (69%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MA+K++IY V+E+ GGELF+K+AK G+LKED A +YF QLI+AVD+CHSRGV+HRD+KP
Sbjct: 79 MATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKYFYQLISAVDFCHSRGVYHRDIKP 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD LK+SDFGLSA++ R+DGLLHT CGTP YVAPEV+N KGY+G +D+WS
Sbjct: 138 ENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYEGTKADIWS 197
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGV+LFVL+AG+LPF ++NLM +YRKI +ADF CPSWF+ K+L+ ++LDPN +TR+TI
Sbjct: 198 CGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDPNHETRITI 257
Query: 181 SQMLEDEWFKKGY--KPPHFDKEEEVNLDDVDAIFN--DSKENLVTEKKEKP--VSMNAF 234
+++ E WF+KG K +K E+ + + S +N E E P ++NAF
Sbjct: 258 AKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQNENGENHEPPRLATLNAF 317
Query: 235 ELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKM 293
++I+ + F L LF KRE+RF SQ+P +EI+SK+ E AK L +RK G
Sbjct: 318 DIIALSTGFGLAGLFGDVYD--KRESRFASQKPASEIISKLVEVAKCLKLKIRKQGAGLF 375
Query: 294 KLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK-FSSGLKDVVW-- 350
KL+ K G+ G L++ E+F+V PT H+VEV+K GDT+E+ K ++ L D+VW
Sbjct: 376 KLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLVEEDLRPALADIVWVW 435
Query: 351 QAEENKEE 358
Q E+ KEE
Sbjct: 436 QGEKEKEE 443
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 707 (253.9 bits), Expect = 3.8e-93, Sum P(2) = 3.8e-93
Identities = 134/233 (57%), Positives = 176/233 (75%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MA+K+KIY V+E++ GGELF+K+AK GRLKE+ AR+YFQQLI+AV +CH RGV+HRDLKP
Sbjct: 95 MATKSKIYFVMEYVKGGELFNKVAK-GRLKEEMARKYFQQLISAVSFCHFRGVYHRDLKP 153
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD G LK+SDFGLSA+S Q+R+DGL HT CGTP YVAPEVL KGYDG D+WS
Sbjct: 154 ENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKGYDGAKVDIWS 213
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVILFVLMAGFLPF + N+MA+Y+KI R DF CP WF +L+ R+L+ P+ R T+
Sbjct: 214 CGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRMLETKPERRFTM 273
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNL------DDVDAIFNDS-KENLVTEKKE 226
++E WFKKG+K F E++ L D++++I + S + + V+E ++
Sbjct: 274 PDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRSSTVSEPED 326
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 920 (328.9 bits), Expect = 2.4e-92, P = 2.4e-92
Identities = 185/356 (51%), Positives = 245/356 (68%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
MA+KTKI+ V+EF+ GGELF KI+K G+L ED ARRYFQQLI+AVDYCHSRGV HRDLKP
Sbjct: 80 MATKTKIFFVMEFVKGGELFCKISK-GKLHEDAARRYFQQLISAVDYCHSRGVSHRDLKP 138
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD G LKISDFGLSA+ +Q+ +DGLLHT CGTP YVAPEVL KGYDG +D+WS
Sbjct: 139 ENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLKKKGYDGAKADIWS 198
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGV+L+VL+AG LPF + NLM +YRKI RADF P WFS A++LI ++L +PD R++I
Sbjct: 199 CGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEARRLISKLLVVDPDRRISI 258
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVS---MNAFELI 237
++ W +K + PP K +E + +E+ E + +P+S NAFE I
Sbjct: 259 PAIMRTPWLRKNFTPPLAFKIDEPICSQSSKNNEEEEEDGDCENQTEPISPKFFNAFEFI 318
Query: 238 SRTKS-FSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG-NYKMKL 295
S S F L +LFE + K ++ FTS+ E+M KIE K + V++ ++K+K+
Sbjct: 319 SSMSSGFDLSSLFESKR---KVQSVFTSRSSATEVMEKIETVTKEMNMKVKRTKDFKVKM 375
Query: 296 QGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKK-FSSGLKDVVW 350
+G GRKG+LS+ EVFEVAP + +VE K+ GDTLE+ + Y++ L D+VW
Sbjct: 376 EGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYDRLYEEEVRPALNDIVW 431
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9MAM1 | CIPK9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7994 | 0.9916 | 0.8008 | yes | no |
| Q10SC8 | CIPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7668 | 0.9833 | 0.7785 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 361 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-71 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-62 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-56 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-49 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 1e-47 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-47 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-43 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-40 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-39 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-38 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-38 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-36 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-34 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-34 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-33 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-33 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-32 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-30 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-30 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-29 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-29 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-29 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-29 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-29 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-27 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-25 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-25 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-24 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 5e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-23 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-23 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-14 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 7e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.002 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.003 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.003 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.004 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-80
Identities = 85/191 (44%), Positives = 126/191 (65%), Gaps = 8/191 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+Y+V+E+ +GG+LFD + K GRL EDEAR Y +Q+++A++Y HS+G+ HRDLKPEN
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPEN 127
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +K++DFGL+ Q+ L T GTP Y+APEVL KGY +A D+WS G
Sbjct: 128 ILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYG-KAVDIWSLG 183
Query: 123 VILFVLMAGFLPF-DESNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNPDTRM 178
VIL+ L+ G PF + L+ L++KI + P S AK LI+++L +P+ R+
Sbjct: 184 VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL 243
Query: 179 TISQMLEDEWF 189
T + L+ +F
Sbjct: 244 TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 1e-71
Identities = 82/196 (41%), Positives = 118/196 (60%), Gaps = 9/196 (4%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K +Y+V+E+ +GG+LFD +++ G L EDEA++ Q++ ++Y HS G+ HRDLKP
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD GV+KI+DFGL+ + ++ L T GTP Y+APEVL G DVWS
Sbjct: 127 ENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184
Query: 121 CGVILFVLMAGFLPFDES---NLMALYRKI--CRADFSCPSW--FSSGAKKLIKRILDPN 173
GVIL+ L+ G PF + + L R+I +F P W S AK LIK+ L+ +
Sbjct: 185 LGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKD 244
Query: 174 PDTRMTISQMLEDEWF 189
P R T ++L+ WF
Sbjct: 245 PSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 9e-62
Identities = 75/177 (42%), Positives = 111/177 (62%), Gaps = 3/177 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ K+Y+VLE+ GGELF ++K GR E+ AR Y +++ A++Y HS G+ +RDLKPEN
Sbjct: 64 TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD+ G +K++DFGL+ E +T CGTP Y+APEVL KGY G+A D WS G
Sbjct: 124 ILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLG 180
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
V+L+ ++ G PF + +Y KI + P + S A+ LI +L +P R+
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 2e-56
Identities = 75/172 (43%), Positives = 110/172 (63%), Gaps = 6/172 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V+E++ GGELF + K GR E AR Y Q++ A++Y HS + +RDLKPENLLL
Sbjct: 75 NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
DS G +KI+DFG + R G +T CGTP Y+APE++ KGY G+A D W+ G+++
Sbjct: 135 DSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILI 188
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 177
+ ++AG+ PF + N + +Y KI PS+FS AK LI+ +L + R
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 4e-54
Identities = 70/187 (37%), Positives = 111/187 (59%), Gaps = 8/187 (4%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
K K+ IV+E+ DGG+L KI K + E++ +F QL A+ Y HSR + HRD+K
Sbjct: 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
P+N+ L S G++K+ DFG+S + + L T GTP Y++PE+ +K Y+ SD+W
Sbjct: 131 PQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYN-YKSDIW 187
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRM 178
S G +L+ L PF+ NL+ L KI + + PS +SS + L+ +L +P+ R
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERP 247
Query: 179 TISQMLE 185
+I+Q+L+
Sbjct: 248 SIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 69/182 (37%), Positives = 100/182 (54%), Gaps = 35/182 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V+E+ +GG L D + ++ G+L EDE R Q++ ++Y HS G+ HRDLKPEN+LL
Sbjct: 66 LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL 125
Query: 66 DS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
DS G +K++DFGLS + + LL T GTP Y+APEVL KGY SD+WS GVI
Sbjct: 126 DSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184
L+ L K LI+++L +P+ R + ++L
Sbjct: 184 LYEL-------------------------------PELKDLIRKMLQKDPEKRPSAKEIL 212
Query: 185 ED 186
E
Sbjct: 213 EH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 1e-49
Identities = 63/187 (33%), Positives = 101/187 (54%), Gaps = 6/187 (3%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+ I LE++ GG L + K G+L E R+Y +Q++ + Y HS G+ HRD+K N+L+D
Sbjct: 76 LNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S GV+K++DFG + + + GTP ++APEV+ + Y GRA+D+WS G +
Sbjct: 136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVI 194
Query: 127 VLMAGFLPFDE-SNLMALYRKICRADFSC---PSWFSSGAKKLIKRILDPNPDTRMTISQ 182
+ G P+ E N MA KI + P S AK +++ L +P R T +
Sbjct: 195 EMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
Query: 183 MLEDEWF 189
+L+ +
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-49
Identities = 70/199 (35%), Positives = 110/199 (55%), Gaps = 12/199 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K +Y+V+E++ GG+L + G L ED AR Y +++ A++Y HS G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLL------HTACGTPNYVAPEVLNDKGYDGRAS 116
+L+DS G LK++DFGLS + R+ L GTP+Y+APEV+ +G+ +
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF--SSGAKKLIKRILDPNP 174
D WS G IL+ + G PF +++ I P S A LI ++L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 175 DTRM---TISQMLEDEWFK 190
+ R+ +I ++ +FK
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-47
Identities = 65/117 (55%), Positives = 84/117 (71%), Gaps = 2/117 (1%)
Query: 232 NAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN- 290
NAF+LIS + L LFE++ VKRETRFTS++P EI+ K+EEAAK LGF VRK
Sbjct: 1 NAFDLISLSSGLDLSGLFEEE-DEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 291 YKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKD 347
+KL+G K GRKG+L+V+ EVFEV P+L +VEV+K+ GDTLE+HKF+K L
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 74/192 (38%), Positives = 113/192 (58%), Gaps = 13/192 (6%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
IY+++E+ GGEL+ + G E AR Y ++ A +Y H+RG+ +RDLKPENLLLD
Sbjct: 68 IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD 127
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S G +K+ DFG + + ++ T CGTP YVAPE++ +KGYD + D WS G++L+
Sbjct: 128 SNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLY 183
Query: 127 VLMAGFLPFDESNL--MALYRKICRAD--FSCPSWFSSGAKKLIKRILDPNPDTRM---- 178
L+ G PF E + M +Y I + + P++ AK LIK++L NP+ R+
Sbjct: 184 ELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLK 243
Query: 179 -TISQMLEDEWF 189
I + + +WF
Sbjct: 244 GGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-44
Identities = 71/175 (40%), Positives = 109/175 (62%), Gaps = 6/175 (3%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ ++Y +LEF+ GGELF + K GR D A+ Y +L+ A +Y HS+ + +RDLKPENL
Sbjct: 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LLD+ G +K++DFG +++V + T CGTP Y+APEV+ KG+ G+A D W+ GV
Sbjct: 150 LLDNKGHVKVTDFGF---AKKVPDR--TFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGV 203
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+L+ +AG+ PF + +Y KI P+WF A+ L+K +L + R+
Sbjct: 204 LLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 69/194 (35%), Positives = 103/194 (53%), Gaps = 13/194 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRG-----V 53
S +YIV+E+ +GG+L I K ++E+ R QL+ A+ CH+R V
Sbjct: 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV 131
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRDLKP N+ LD+ +K+ DFGL+ I + T GTP Y++PE LN YD
Sbjct: 132 LHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMSPEQLNHMSYD- 188
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDP 172
SD+WS G +++ L A PF N + L KI F P +SS ++IK +L+
Sbjct: 189 EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNV 248
Query: 173 NPDTRMTISQMLED 186
+PD R + ++L+
Sbjct: 249 DPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 68/202 (33%), Positives = 113/202 (55%), Gaps = 19/202 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +Y VLE+ GEL I K+G L E R Y +++ A++Y HS+G+ HRDLKPEN
Sbjct: 73 DEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132
Query: 63 LLLDSYGVLKISDFGLSAI------SQQVREDGLLH------------TACGTPNYVAPE 104
+LLD +KI+DFG + + + + D + GT YV+PE
Sbjct: 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192
Query: 105 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKK 164
+LN+K G++SD+W+ G I++ ++ G PF SN ++KI + ++S P F AK
Sbjct: 193 LLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKD 251
Query: 165 LIKRILDPNPDTRMTISQMLED 186
LI+++L +P R+ +++ ++
Sbjct: 252 LIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 65/173 (37%), Positives = 107/173 (61%), Gaps = 3/173 (1%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+Y++LE++ GGELF + + G ED A Y ++ A+++ H +G+ +RDLKPEN+LL
Sbjct: 74 KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
D+ G +K++DFGL + + E + HT CGT Y+APE+L G+ G+A D WS G ++
Sbjct: 134 DAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALM 190
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ ++ G PF N KI + + P + + A+ L+K++L NP +R+
Sbjct: 191 YDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 67/181 (37%), Positives = 102/181 (56%), Gaps = 13/181 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
SK +Y+V+E+++GG+ I G L ED A++Y +++ V+ H RG+ HRD+KPEN
Sbjct: 68 SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPEN 127
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSC 121
LL+D G LK++DFGLS +GL + GTP+Y+APE + G D + SD WS
Sbjct: 128 LLIDQTGHLKLTDFGLS-------RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWSL 179
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDTR 177
G ++F + G+ PF A++ I + P + S A LI R+L +P R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
Query: 178 M 178
+
Sbjct: 240 L 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-39
Identities = 84/233 (36%), Positives = 124/233 (53%), Gaps = 29/233 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S K+Y+VL FI+GGELF + + GR AR Y +L+ A++ H V +RDLKPEN
Sbjct: 64 SPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G + + DFGL ++ +++D +T CGTP Y+APE+L GY +A D W+ G
Sbjct: 124 ILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLG 180
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+L+ ++ G PF + N+ +YRKI + P F AK L+ +L +P R+ +
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240
Query: 183 MLE---------DEWFK---KGYKPP------------HFDKE--EEVNLDDV 209
E W K KG +PP +FD+E E +D V
Sbjct: 241 AQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSV 293
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 60/167 (35%), Positives = 101/167 (60%), Gaps = 6/167 (3%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ +Y+++E++ GGELF + GR Y +++ A++Y HS+ + +RDLKPEN+
Sbjct: 73 QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LLD G +K++DFG ++++R+ T CGTP Y+APEV+ KG+ +A D W+ G+
Sbjct: 133 LLDKEGHIKLTDFGF---AKKLRDR--TWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGI 186
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 170
+++ ++ G+ PF + N +Y KI P AK LIK++L
Sbjct: 187 LIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 65/176 (36%), Positives = 108/176 (61%), Gaps = 3/176 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K +++ V+E+++GG+L I + GR E AR Y +++ + + H RG+ +RDLK +N
Sbjct: 67 TKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G +KI+DFG+ + + T CGTP+Y+APE+L+ + Y G A D W+ G
Sbjct: 127 VLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
V+L+ ++AG PF+ + L++ I + P W S AK ++K L NP+ R+
Sbjct: 184 VLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 68/169 (40%), Positives = 99/169 (58%), Gaps = 3/169 (1%)
Query: 10 VLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 69
V+E+ +GGELF +++ ED AR Y ++++A+ Y HS V +RDLK ENL+LD G
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132
Query: 70 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129
+KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D W GV+++ +M
Sbjct: 133 HIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMM 189
Query: 130 AGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G LPF + L+ I + P S AK L+ +L +P R+
Sbjct: 190 CGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLL 65
I IVLE++DGG L D + K G++ E +Q++ +DY H+ R + HRD+KP NLL+
Sbjct: 74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI 133
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+S G +KI+DFG+S + + +T GT Y++PE + + A+D+WS G+ L
Sbjct: 134 NSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTL 190
Query: 126 FVLMAGFLPF---DESNLMALYRKICRADFSCPSW----FSSGAKKLIKRILDPNPDTRM 178
G PF + + L + IC D PS FS + I L +P R
Sbjct: 191 LECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRDFISACLQKDPKKRP 248
Query: 179 TISQMLEDEWFKK 191
+ +++L+ + KK
Sbjct: 249 SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 69/190 (36%), Positives = 105/190 (55%), Gaps = 10/190 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K +++IV+EF GG L D + + + L E + ++L+ ++Y HS G+ HRD+K N
Sbjct: 69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN 128
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL S G +K+ DFGLSA Q+ + +T GTP ++APEV+N K YD +A D+WS G
Sbjct: 129 ILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKA-DIWSLG 184
Query: 123 VILFVLMA-GFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRM 178
I + +A G P+ E M KI P +S K +K+ L NP+ R
Sbjct: 185 -ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
Query: 179 TISQMLEDEW 188
T Q+L+ +
Sbjct: 244 TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 77/264 (29%), Positives = 117/264 (44%), Gaps = 53/264 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E++ GG+L + + + E+ AR Y +L+ A+D H G HRD+KP+N+L+D
Sbjct: 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 67 SYGVLKISDFGLSA---------------ISQQVREDGLLH------------TACGTPN 99
+ G +K++DFGL + R++ L+ + GTP+
Sbjct: 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD 195
Query: 100 YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPS- 156
Y+APEVL Y G D WS GVIL+ ++ GF PF L Y KI + P
Sbjct: 196 YIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPD 254
Query: 157 -WFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK-------GYKPP----------- 196
S A LI R+L P+ R+ ++ +FK KPP
Sbjct: 255 PPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDT 313
Query: 197 -HFDKEEEVNLDDVDAIFNDSKEN 219
+FD E+ N K N
Sbjct: 314 SNFDDFEDDKDLSDYLSQNSKKLN 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 65/176 (36%), Positives = 110/176 (62%), Gaps = 9/176 (5%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+Y++L+F+ GG+LF +++K E++ + Y +L A+D+ HS G+ +RDLKPEN+LL
Sbjct: 72 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 131
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
D G +K++DFGLS + + + ++ CGT Y+APEV+N +G+ +++D WS GV++
Sbjct: 132 DEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLM 188
Query: 126 FVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
F ++ G LPF D M + I +A P + S A+ L++ + NP R+
Sbjct: 189 FEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 69/176 (39%), Positives = 106/176 (60%), Gaps = 3/176 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+E+++GGELF +++ ED R Y ++++A+DY HS + +RDLK EN
Sbjct: 66 TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLEN 125
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D W G
Sbjct: 126 LMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLG 182
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
V+++ +M G LPF + L+ I D P S+ AK L+ +L +P+ R+
Sbjct: 183 VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 10/184 (5%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K+ IV+E+ G+L I+K + + E E R F QL+ + H + + HRDLK
Sbjct: 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+LL + ++KI D G+S + ++ + T GTP+Y+APEV + Y SD+WS
Sbjct: 133 NILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSL 187
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTI 180
G +L+ + PF+ ++ L K+ R + P +S + I+ +L P R
Sbjct: 188 GCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNC 247
Query: 181 SQML 184
++L
Sbjct: 248 DKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-36
Identities = 64/182 (35%), Positives = 109/182 (59%), Gaps = 8/182 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ TK++++L++++GGELF + + E E R Y +++ A+D+ H G+ +RD+K EN
Sbjct: 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLEN 135
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVWS 120
+LLDS G + ++DFGLS E+ ++ CGT Y+APEV+ G+D +A D WS
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHD-KAVDWWS 193
Query: 121 CGVILFVLMAGFLPF---DESNLMA-LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
GV+ F L+ G PF E N + + R+I ++ P S+ A+ I+++L+ +P
Sbjct: 194 LGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKK 253
Query: 177 RM 178
R+
Sbjct: 254 RL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-36
Identities = 67/176 (38%), Positives = 104/176 (59%), Gaps = 3/176 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V +RD+K EN
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 125
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D W G
Sbjct: 126 LMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLG 182
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
V+++ +M G LPF + L+ I + P S AK L+ +L +P R+
Sbjct: 183 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 14/194 (7%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEA--RRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K+YI +E+ GG L + + +HGR+ DE R Y QL+ + Y HS G+ HRD+KP N+
Sbjct: 73 KVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI 130
Query: 64 LLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVL---NDKGYDGRASDV 118
LD GV+K+ DFG + + + + GTP Y+APEV+ KG+ GRA+D+
Sbjct: 131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH-GRAADI 189
Query: 119 WSCGVILFVLMAGFLPFDE-SNLMALYRKIC---RADFSCPSWFSSGAKKLIKRILDPNP 174
WS G ++ + G P+ E N + + + S K + R L+ +P
Sbjct: 190 WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP 249
Query: 175 DTRMTISQMLEDEW 188
R T S++L+ +
Sbjct: 250 KKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (334), Expect = 1e-35
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 24/299 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ +Y+V+E++DGG L D + K GR L E EA Q+++A++Y HS+G+ HRD+K
Sbjct: 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK 128
Query: 60 PENLLLDSYG-VLKISDFGLSAI----SQQVREDGLLHTACGTPNYVAPEVLNDK--GYD 112
PEN+LLD G V+K+ DFGL+ + L T+ GTP Y+APEVL Y
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYA 188
Query: 113 GRASDVWSCGVILFVLMAGFLPFD----ESNLMALYRKICRADF---------SCPSWFS 159
+SD+WS G+ L+ L+ G PF+ S + I S P S
Sbjct: 189 SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248
Query: 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 219
A L+K++L +P R++ S L + K D + + DD + +
Sbjct: 249 KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH-LKLKESDLSDLLKPDDSAPLRLSLPPS 307
Query: 220 LVTEKKEKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEA 278
L + + S + L + + S + +
Sbjct: 308 LEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKI 366
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 4/188 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +YI+LE+ + G L I K G E Y Q++ + Y H +GV HRD+K N
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+L GV+K++DFG++ + GTP ++APEV+ G ASD+WS G
Sbjct: 130 ILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEMSGAS-TASDIWSLG 186
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+ L+ G P+ + N MA +I + D P S K + + +P+ R T
Sbjct: 187 CTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAK 246
Query: 182 QMLEDEWF 189
Q+L+ W
Sbjct: 247 QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 65/176 (36%), Positives = 105/176 (59%), Gaps = 5/176 (2%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ +Y+V +++ GGELF + K GR ED A+ Y +L+ A+++ H + +RDLKPEN+L
Sbjct: 69 SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL 128
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGV 123
LD+ G + + DFGLS + ++ +T CGT Y+APEV L++KGY + D WS GV
Sbjct: 129 LDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGV 185
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCP-SWFSSGAKKLIKRILDPNPDTRM 178
++F + G+ PF + +YR I P + S ++ +K +L+ NP R+
Sbjct: 186 LVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 60/173 (34%), Positives = 100/173 (57%), Gaps = 3/173 (1%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+++ V+EF++GG+L I K R E AR Y ++ +A+ + H +G+ +RDLK +N+LL
Sbjct: 70 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
D G K++DFG+ + + T CGTP+Y+APE+L + Y G + D W+ GV+L
Sbjct: 130 DHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLL 186
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ ++ G PF+ N L+ I + P+W S A ++K + NP R+
Sbjct: 187 YEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 73/243 (30%), Positives = 114/243 (46%), Gaps = 29/243 (11%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+Y+ +E++ GG+ + G L ED AR Y ++ AVD H G HRDLKPEN
Sbjct: 73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132
Query: 64 LLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
L+D+ G +K++DFGLS ++ ++ G+P+Y+APEVL KGYD D WS
Sbjct: 133 LIDASGHIKLTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSL 184
Query: 122 GVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW------FSSGAKKLIKRILDPN 173
G +L+ + GF PF S + + + P + S A LI ++++
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDP 244
Query: 174 PDTRMTISQMLEDEWFKK-------GYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 226
++ + +FK+ KPP + E ++D + D EN K
Sbjct: 245 SRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPELE----SEIDTGYFDDFENEDDMAKY 300
Query: 227 KPV 229
K V
Sbjct: 301 KDV 303
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 69/174 (39%), Positives = 104/174 (59%), Gaps = 4/174 (2%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLL 64
++ V+E+ +GGELF +++ ED AR Y ++++A+DY HS + V +RDLK ENL+
Sbjct: 69 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
LD G +KI+DFGL + +++ + T CGTP Y+APEVL D Y GRA D W GV+
Sbjct: 129 LDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVV 185
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
++ +M G LPF + L+ I + P S AK L+ +L +P R+
Sbjct: 186 MYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 56/177 (31%), Positives = 100/177 (56%), Gaps = 7/177 (3%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+Y+V++ + GG+L +++ + E++ + + +++ A++Y HS+G+ HRD+KP+N+L
Sbjct: 73 ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
LD G + I+DF ++ V D L + GTP Y+APEVL +GY A D WS GV
Sbjct: 133 LDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVT 188
Query: 125 LFVLMAGFLPFDESNLMA---LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ + G P+ + + K AD P+ +S+ A I ++L+ +P R+
Sbjct: 189 AYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 64/187 (34%), Positives = 107/187 (57%), Gaps = 5/187 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K +++ V+E+++GG+L +I + + E +R Y ++ A+ + H GV +RDLK +N
Sbjct: 67 TKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD+ G K++DFG+ + + T CGTP+Y+APE+L + Y G + D W+ G
Sbjct: 127 ILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM--TI 180
V+++ +MAG PF+ N L+ I D P W S A ++K + NP+ R+
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVA 243
Query: 181 SQMLEDE 187
SQ ED
Sbjct: 244 SQGGEDA 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 60/182 (32%), Positives = 99/182 (54%), Gaps = 4/182 (2%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ I +E++ GG + D++ +G L E R+Y +Q++ V+Y HS + HRD+K N+L
Sbjct: 78 TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR 137
Query: 66 DSYGVLKISDFGLSAISQQVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
DS G +K+ DFG S Q + G + + GTP +++PEV++ +GY GR +DVWS G
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCT 196
Query: 125 LFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
+ ++ P+ E MA KI + PS S A+ ++R N R + +
Sbjct: 197 VVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256
Query: 183 ML 184
+L
Sbjct: 257 LL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 73/241 (30%), Positives = 123/241 (51%), Gaps = 14/241 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+E+++GG+L I GR E AR Y ++I + + H +G+ +RDLK +N
Sbjct: 67 TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +KI+DFG+ + + +G T CGTP+Y+APE+L + Y+ + D WS G
Sbjct: 127 VLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+L+ ++ G PF + L+ I P W S AK + ++ + +P R+ +
Sbjct: 184 VLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDG 243
Query: 183 MLEDEWFKKGYK---------PPHFDKEEEVNLD--DVDAIFNDSKENLVTEKKEKPVSM 231
+ F +G PP F + + D + D F + K L K+ SM
Sbjct: 244 DIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASM 303
Query: 232 N 232
+
Sbjct: 304 D 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 61/176 (34%), Positives = 95/176 (53%), Gaps = 3/176 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +RDLKPEN
Sbjct: 67 TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPEN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G + ++DFGL + + T CGTP Y+APEVL + YD R D W G
Sbjct: 127 ILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+L+ ++ G PF + +Y I S A+ L++ +L + R+
Sbjct: 184 AVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 64/182 (35%), Positives = 104/182 (57%), Gaps = 8/182 (4%)
Query: 9 IVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
IV+E+ GG L + I K L ED +F Q++ A+ + H++ + HRDLK +N+LLD
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 67 SYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+ V+KI DFG IS+ + +T GTP Y++PE+ K Y+ + SD+W+ G +L
Sbjct: 136 KHKMVVKIGDFG---ISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK-SDIWALGCVL 191
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQML 184
+ L + F+ +NL AL KI F+ S +S ++LI +L+ +P R +SQ++
Sbjct: 192 YELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
Query: 185 ED 186
Sbjct: 252 AQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-32
Identities = 72/221 (32%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+Y VL++++GGELF + + E AR Y ++ +A+ Y HS + +RDLKPEN+LL
Sbjct: 70 KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL 129
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
DS G + ++DFGL + V + T CGTP Y+APEVL + YD R D W G +L
Sbjct: 130 DSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVL 186
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TISQML 184
+ ++ G PF ++ +Y I P + A L+ +L + R+ + L
Sbjct: 187 YEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFL 246
Query: 185 E------------DEWFKKGYKPP------------HFDKE 201
E D+ + K PP HFD E
Sbjct: 247 EIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPE 287
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 66/186 (35%), Positives = 108/186 (58%), Gaps = 13/186 (6%)
Query: 9 IVLEFIDGGEL---FDKIAKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IVLE D G+L K RL E +YF QL +A+++ HS+ + HRD+KP N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138
Query: 65 LDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
+ + GV+K+ D GL S + H+ GTP Y++PE +++ GY+ + SD+WS G
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPERIHENGYNFK-SDIWSLGC 194
Query: 124 ILFVLMAGFLPF--DESNLMALYRKICRADFS-CPS-WFSSGAKKLIKRILDPNPDTRMT 179
+L+ + A PF D+ NL +L +KI + D+ P+ +S + L+ R ++P+P+ R
Sbjct: 195 LLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPD 254
Query: 180 ISQMLE 185
IS +L+
Sbjct: 255 ISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 63/180 (35%), Positives = 108/180 (60%), Gaps = 5/180 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ K++++L+++ GGE+F + + EDE R Y ++I A+++ H G+ +RD+K EN
Sbjct: 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLEN 135
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G + ++DFGLS E ++ CGT Y+APE++ KG G+A D WS G
Sbjct: 136 ILLDSEGHVVLTDFGLSK-EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 123 VILFVLMAGFLPFD---ESNLMA-LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+++F L+ G PF E N + + R+I + D PS+ A+ L+ ++L +P R+
Sbjct: 195 ILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 59/173 (34%), Positives = 104/173 (60%), Gaps = 3/173 (1%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++Y V+E+++GG+L I + G+ KE A Y ++ + + HS+G+ +RDLK +N++L
Sbjct: 75 RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
D+ G +KI+DFG+ + + T CGTP+Y+APE++ + Y G++ D W+ GV+L
Sbjct: 135 DAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLL 191
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ ++AG PFD + L++ I + S P S A + K +L +P R+
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 57/189 (30%), Positives = 104/189 (55%), Gaps = 7/189 (3%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+++V+E++DGG L D I ++ R+ E + ++++ ++Y HS+ V HRD+K +N+LL
Sbjct: 90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G +K++DFG +A Q +E ++ GTP ++APEV+ K Y + D+WS G++
Sbjct: 150 SKDGSVKLADFGFAA--QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMC 206
Query: 126 FVLMAGFLP-FDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
+ G P E L AL+ + P +S K + + L +P+ R + +
Sbjct: 207 IEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266
Query: 183 MLEDEWFKK 191
+L+ + KK
Sbjct: 267 LLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 63/176 (35%), Positives = 99/176 (56%), Gaps = 3/176 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+Y VL++I+GGELF + + E AR Y ++ +A+ Y HS + +RDLKPEN
Sbjct: 67 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G + ++DFGL + + +G T CGTP Y+APEVL+ + YD R D W G
Sbjct: 127 ILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+L+ ++ G PF N +Y I ++ A+ L++ +L + R+
Sbjct: 184 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 12/195 (6%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K++I++EF DGG L + + R L E + R +Q++ A+++ HS V HRDLK N
Sbjct: 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASD 117
+LL G +K++DFG+SA ++ T GTP ++APEV+ D YD +A D
Sbjct: 134 ILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA-D 190
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNP 174
+WS G+ L L P E N M + KI +++ PS +SS +K L +P
Sbjct: 191 IWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDP 250
Query: 175 DTRMTISQMLEDEWF 189
D R T +++L+ +
Sbjct: 251 DDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 72/243 (29%), Positives = 126/243 (51%), Gaps = 28/243 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++++ V+EF+ GG+L + + +L E+ AR Y ++ A+++ H RG+ +RDLK +N
Sbjct: 67 TESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD+ G +K++D+G+ + +R T CGTPNY+APE+L + Y G + D W+ G
Sbjct: 127 VLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALG 183
Query: 123 VILFVLMAGFLPFD---------ESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 173
V++F +MAG PFD ++ L++ I P S A ++K L+ +
Sbjct: 184 VLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKD 243
Query: 174 PDTRM------TISQMLEDEWFK---------KGYKPP-HFDKEEEVNLDDVDAIFNDSK 217
P R+ + +F+ K PP + E + +LD+ D F D
Sbjct: 244 PKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEP 303
Query: 218 ENL 220
L
Sbjct: 304 VQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 74/217 (34%), Positives = 131/217 (60%), Gaps = 19/217 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ TK++++L++I+GGELF +++ R KE E + Y +++ A+++ H G+ +RD+K EN
Sbjct: 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLEN 135
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGL--LHTACGTPNYVAPEVL--NDKGYDGRASDV 118
+LLDS G + ++DFGL S++ ED + ++ CGT Y+AP+++ D G+D +A D
Sbjct: 136 ILLDSNGHVVLTDFGL---SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD-KAVDW 191
Query: 119 WSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNP 174
WS GV+++ L+ G PF ++++ + R+I +++ P S+ AK +I+R+L +P
Sbjct: 192 WSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDP 251
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDA 211
R+ DE K P F K +N DD+ A
Sbjct: 252 KKRLGCGPSDADEIKKH----PFFQK---INWDDLAA 281
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 62/182 (34%), Positives = 100/182 (54%), Gaps = 5/182 (2%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+YI LE + GG L + K+G E R Y +Q++ ++Y H R HRD+K N+L+
Sbjct: 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
D+ GV+K++DFG+ ++QV E + G+P ++APEV+ +G G A+D+WS G +
Sbjct: 136 DTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192
Query: 126 FVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
+ G P+ + +A KI R+ P S AK I + L +P R T +++
Sbjct: 193 LEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252
Query: 184 LE 185
LE
Sbjct: 253 LE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K + +V+E+++GG+ + G L D AR YF + + A++Y H+ G+ HRDLKP+N
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLH-------------TACGTPNYVAPEVLNDK 109
LL+ S G +K++DFGLS I L CGTP Y+APEV+ +
Sbjct: 132 LLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191
Query: 110 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLI 166
GY G+ D W+ G+IL+ + G +PF L+ ++ D P + A+ LI
Sbjct: 192 GY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLI 250
Query: 167 KRILDPNPDTRMTISQMLE 185
R+L NP R+ E
Sbjct: 251 SRLLRQNPLERLGTGGAFE 269
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 42/212 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+++E++ GG++ + K E+E R Y + I A+D H G HRD+KP+NLLLD
Sbjct: 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135
Query: 67 SYGVLKISDFGL-------------------------SAISQQVREDGLLHT-------- 93
+ G +K+SDFGL IS+ + T
Sbjct: 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRAL 195
Query: 94 ---ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI--C 148
GTP+Y+APEV GY + D WS GVI++ ++ G+ PF N YRKI
Sbjct: 196 AYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW 254
Query: 149 RADFSCPS--WFSSGAKKLIKRILDPNPDTRM 178
+ P S AK LIKR+ + R+
Sbjct: 255 KETLQFPDEVPLSPEAKDLIKRLC-CEAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 63/184 (34%), Positives = 98/184 (53%), Gaps = 6/184 (3%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K K+ IV+E+ + G+L + L ED+ R+F Q++ + + HS+ + HRD+K
Sbjct: 71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSL 130
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
NL LD+Y +KI D G++ + +T GTP Y++PE+ DK Y+ + SDVW+
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPYNEK-SDVWAL 187
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTI 180
GV+L+ G PFD +N AL KI R F +S +LI + L + R
Sbjct: 188 GVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDT 247
Query: 181 SQML 184
Q+L
Sbjct: 248 FQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 60/182 (32%), Positives = 102/182 (56%), Gaps = 6/182 (3%)
Query: 7 IYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ I +E+ +GG L+DKI K +E+ Y Q+++AV Y H G+ HRD+K N+
Sbjct: 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIF 133
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L G++K+ DFG+S I E + T GTP Y++PE+ Y+ + SD+W+ G +
Sbjct: 134 LTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPELCQGVKYNFK-SDIWALGCV 190
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
L+ L+ FD +N + L KI + +++ S +SS L+ +L +P+ R T ++
Sbjct: 191 LYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
Query: 184 LE 185
L+
Sbjct: 251 LD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 59/164 (35%), Positives = 97/164 (59%), Gaps = 6/164 (3%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+VLEF+ GGE F + ++ R D Y Q++ +Y S + +RDLKPENLLLD
Sbjct: 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
G +K++DFG + + D +T CGTP Y+APE+L + G+ G+A+D W+ G+ ++
Sbjct: 166 KDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIY 219
Query: 127 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 170
++ G PF + + +Y+KI P + + K L+K++L
Sbjct: 220 EILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 65/178 (36%), Positives = 101/178 (56%), Gaps = 13/178 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E++ GG+L + ++ + + E AR Y +++ A+D HS G HRD+KP+N+LLD
Sbjct: 118 LYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 67 SYGVLKISDFGLSAISQQVREDGLLH--TACGTPNYVAPEVLNDKGYD---GRASDVWSC 121
G LK++DFG ++ +G++ TA GTP+Y++PEVL +G D GR D WS
Sbjct: 177 KSGHLKLADFG---TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 122 GVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPS--WFSSGAKKLIKRILDPNPD 175
GV L+ ++ G PF +L+ Y KI + + P S AK LI L
Sbjct: 234 GVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREV 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 62/185 (33%), Positives = 109/185 (58%), Gaps = 12/185 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG+ +RDLK +N
Sbjct: 67 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y G + D W+ G
Sbjct: 127 VLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALG 183
Query: 123 VILFVLMAGFLPF---------DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 173
V++F +MAG PF D++ L++ I P S A ++K L+ +
Sbjct: 184 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD 243
Query: 174 PDTRM 178
P R+
Sbjct: 244 PKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 17/224 (7%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+Y VL+F++GGELF + + E AR Y ++ +A+ Y HS + +RDLKPEN+LL
Sbjct: 70 KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
DS G + ++DFGL + + + T CGTP Y+APEV+ + YD D W G +L
Sbjct: 130 DSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVL 186
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM----TIS 181
+ ++ G PF ++ +Y I S A +++ +L+ + R+
Sbjct: 187 YEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246
Query: 182 QMLEDEWFK--------KGYKPPHFDK--EEEVNLDDVDAIFND 215
++ E +F+ + PP F+ E ++ + DA+F +
Sbjct: 247 EIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-29
Identities = 59/173 (34%), Positives = 105/173 (60%), Gaps = 3/173 (1%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++Y V+E+++GG+L I + G+ KE +A Y ++ + + H RG+ +RDLK +N++L
Sbjct: 75 RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
DS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D W+ GV+L
Sbjct: 135 DSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLL 191
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ ++AG PFD + L++ I + S P S A + K ++ +P R+
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 51/226 (22%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ K+Y+V E+ D +L + K L + + QL+ + YCHS + HRDLKP+
Sbjct: 69 TERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQ 127
Query: 62 NLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN-----YVAPEVL-NDKGYDGR 114
N+L++ GVLK++DFGL+ A +R T Y APE+L K Y
Sbjct: 128 NILINRDGVLKLADFGLARAFGIPLRTY--------THEVVTLWYRAPEILLGSKHYST- 178
Query: 115 ASDVWSCGVILFVLMAGFLPF-DESNLMALYR--KIC-----------------RADFSC 154
A D+WS G I ++ G F +S + L++ +I + F
Sbjct: 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF-- 236
Query: 155 PSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
P + L+ ++L NP R++ + L+ +F
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 59/183 (32%), Positives = 108/183 (59%), Gaps = 10/183 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +++++V+E+++GG+L + + +L E+ AR Y ++ A+++ H RG+ +RDLK +N
Sbjct: 67 TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD+ G +K++D+G+ + + T CGTPNY+APE+L + Y G + D W+ G
Sbjct: 127 VLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALG 183
Query: 123 VILFVLMAGFLPF-------DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPD 175
V++F +MAG PF D + L++ I P + S A ++K L+ +P
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPK 243
Query: 176 TRM 178
R+
Sbjct: 244 ERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 58/173 (33%), Positives = 106/173 (61%), Gaps = 3/173 (1%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++Y V+E+++GG+L +I + GR KE A Y ++ + + HS+G+ +RDLK +N++L
Sbjct: 75 RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
DS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D W+ GV+L
Sbjct: 135 DSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLL 191
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
+ ++AG PF+ + L++ I + + P S A + K ++ +P R+
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 59/146 (40%), Positives = 94/146 (64%), Gaps = 9/146 (6%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E++ GG+L + ++ + + E A+ Y +++ A+D HS G+ HRD+KP+N+LLD
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176
Query: 67 SYGVLKISDFGLSAISQQVREDGLLH--TACGTPNYVAPEVLNDK---GYDGRASDVWSC 121
+G LK++DFG ++ E G++ TA GTP+Y++PEVL + GY GR D WS
Sbjct: 177 KHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 122 GVILFVLMAGFLPFDESNLMALYRKI 147
GV LF ++ G PF +L+ Y KI
Sbjct: 234 GVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 4e-28
Identities = 62/184 (33%), Positives = 106/184 (57%), Gaps = 7/184 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAK-HGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+++IV+E+ DGG+L +I + G L ED+ +F Q+ + + H R + HRD+K +N+
Sbjct: 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132
Query: 64 LLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L G V K+ DFG++ E L +T GTP Y++PE+ ++ Y+ + +D+WS G
Sbjct: 133 FLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLG 189
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSSGAKKLIKRILDPNPDTRMTIS 181
+L+ L PF+ +NL L KIC+ F+ S FS + LI ++ +P R +I+
Sbjct: 190 CVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSIT 249
Query: 182 QMLE 185
+L+
Sbjct: 250 SILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 58/182 (31%), Positives = 104/182 (57%), Gaps = 6/182 (3%)
Query: 7 IYIVLEFIDGGELFDKI-AKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV+++ +GG+L+ KI A+ G L ED+ +F Q+ A+ + H R + HRD+K +N+
Sbjct: 74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L G +K+ DFG++ + E L T GTP Y++PE+ ++ Y+ + SD+W+ G +
Sbjct: 134 LTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNK-SDIWALGCV 190
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
L+ + F+ N+ L KI R + S +S + L+ ++ NP R +++ +
Sbjct: 191 LYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
Query: 184 LE 185
LE
Sbjct: 251 LE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 8/194 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
S K+ +++E+ GG+L +I + H +E E F Q++ A+D HSR + HRDL
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195
Query: 59 KPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 117
K N+ L G++K+ DFG S S V D + + CGTP Y+APE+ K Y +A D
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYSKKA-D 253
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDT 176
+WS GVIL+ L+ PF + + +++ + P SSG K L+ +L NP
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPAL 313
Query: 177 RMTISQMLEDEWFK 190
R T Q+L E+ K
Sbjct: 314 RPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 32/208 (15%)
Query: 2 ASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++T + +V+++ GGELF + L E+ AR Y +++ A++Y H G+ +RDLK
Sbjct: 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLK 130
Query: 60 PENLLLDSYGVLKISDFGLS--------AISQQVR------------------EDGLLHT 93
PEN+LL G + +SDF LS +S+ +R E
Sbjct: 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190
Query: 94 AC-GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF 152
+ GT Y+APEV++ G+ A D W+ G++L+ ++ G PF SN + I + +
Sbjct: 191 SFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV 249
Query: 153 SCPS--WFSSGAKKLIKRILDPNPDTRM 178
+ P SS A+ LI+++L +P R+
Sbjct: 250 TFPGSPPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 48/229 (20%)
Query: 1 MASKTK--IYIVLEFIDGGELFD--KIAKHGRLK--EDEARRYFQQLINAVDYCHSRGVF 54
+ SK K IY+V E++D D + +K E + + Y +QL+ + Y HS G+
Sbjct: 67 VTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 55 HRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDG 113
HRD+K N+L+++ GVLK++DFGL A R T Y PE+L Y G
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPPELLLGATRY-G 180
Query: 114 RASDVWSCGVILFVLMAGFLPF---DESNLMALYRKIC---------------------- 148
D+WS G IL L G F E + ++C
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 149 --------RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
R F A L+ ++L +P R++ Q L+ E+F
Sbjct: 241 KKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 61/193 (31%), Positives = 110/193 (56%), Gaps = 15/193 (7%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+EF++GG L D I H R+ E++ ++ A+ + H++GV HRD+K +++LL
Sbjct: 90 ELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148
Query: 66 DSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
S G +K+SDFG A +S++V R L+ GTP ++APEV++ Y D+WS G+
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEV-DIWSLGI 203
Query: 124 ILFVLMAGFLP-FDESNLMALYRKICRAD----FSCPSWFSSGAKKLIKRILDPNPDTRM 178
++ ++ G P F+E L A+ ++I R + S + + R+L +P R
Sbjct: 204 MVIEMVDGEPPYFNEPPLQAM-KRI-RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA 261
Query: 179 TISQMLEDEWFKK 191
T +++L + K
Sbjct: 262 TAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 58/146 (39%), Positives = 93/146 (63%), Gaps = 9/146 (6%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E++ GG+L + ++ + + E AR Y +++ A+D HS G HRD+KP+N+LLD
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 67 SYGVLKISDFGLSAISQQVREDGLLH--TACGTPNYVAPEVLNDK---GYDGRASDVWSC 121
G LK++DFG ++ ++G++ TA GTP+Y++PEVL + GY GR D WS
Sbjct: 177 KSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 122 GVILFVLMAGFLPFDESNLMALYRKI 147
GV L+ ++ G PF +L+ Y KI
Sbjct: 234 GVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 3/189 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+EF++GG+L I GR A Y +++ + + HS+G+ +RDLK +N
Sbjct: 67 TKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
++LD G +KI+DFG+ + V D T CGTP+Y+APE+L Y + D WS G
Sbjct: 127 VMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+L+ ++ G PF + L+ I P W + +K +++++ + +P R+ +
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVG 243
Query: 183 MLEDEWFKK 191
+ F K
Sbjct: 244 NIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 66/197 (33%), Positives = 108/197 (54%), Gaps = 16/197 (8%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
K++I++EF GG + + + R L E + + +Q++ A+ Y HS + HRDLK N+L
Sbjct: 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVL 142
Query: 65 LDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEV-----LNDKGYDGRASD 117
L G +K++DFG+SA + + R D + GTP ++APEV + D YD +A D
Sbjct: 143 LTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKDTPYDYKA-D 197
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNP 174
+WS G+ L + P E N M + KI +++ S PS +S + +K LD +P
Sbjct: 198 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHP 257
Query: 175 DTRMTISQMLEDEWFKK 191
+TR + +Q+LE +
Sbjct: 258 ETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++++V+ ++ GG L D I K G L E ++++ ++Y HS G HRD+K
Sbjct: 71 GDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK 129
Query: 60 PENLLLDSYGVLKISDFGLSA-ISQQV-REDGLLHTACGTPNYVAPEVLN-DKGYDGRAS 116
N+LL G +KI+DFG+SA ++ R + T GTP ++APEV+ GYD +A
Sbjct: 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA- 188
Query: 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC------PSWFSSGAKKLIKRIL 170
D+WS G+ L G P+ + M + + D +S +K+I L
Sbjct: 189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCL 248
Query: 171 DPNPDTRMTISQMLEDEWF 189
+P R T ++L+ ++F
Sbjct: 249 QKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 66/184 (35%), Positives = 107/184 (58%), Gaps = 11/184 (5%)
Query: 6 KIYIVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ IVLE D G+L I K RL E +YF QL +A+++ HSR V HRD+KP
Sbjct: 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+ + + GV+K+ D GL + H+ GTP Y++PE +++ GY+ + SD+WS
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSL 192
Query: 122 GVILFVLMAGFLPF--DESNLMALYRKICRADF-SCPS-WFSSGAKKLIKRILDPNPDTR 177
G +L+ + A PF D+ NL +L +KI + D+ PS +S ++L+ ++P+P+ R
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
Query: 178 MTIS 181
I+
Sbjct: 253 PDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 67/185 (36%), Positives = 105/185 (56%), Gaps = 11/185 (5%)
Query: 9 IVLEFIDGGELFDKI---AKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IVLE D G+L I K RL E +YF QL +AV++ HSR V HRD+KP N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVF 138
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ + GV+K+ D GL + H+ GTP Y++PE +++ GY+ + SD+WS G +
Sbjct: 139 ITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCL 195
Query: 125 LFVLMAGFLPF--DESNLMALYRKICRADF-SCPS-WFSSGAKKLIKRILDPNPDTRMTI 180
L+ + A PF D+ NL +L +KI + D+ P+ +S ++L+ + P+PD R I
Sbjct: 196 LYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
Query: 181 SQMLE 185
+ +
Sbjct: 256 GYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 59/179 (32%), Positives = 103/179 (57%), Gaps = 5/179 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+E+++GG+L I + A Y ++I + + HS+G+ +RDLK +N
Sbjct: 67 TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD+ G +KI+DFG+ + + D T CGTP+Y+APE+L + Y + D WS G
Sbjct: 127 ILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFG 183
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTI 180
V+L+ ++ G PF + L++ I R D C P W + AK ++ ++ P+ R+ +
Sbjct: 184 VLLYEMLIGQSPFHGHDEEELFQSI-RMDNPCYPRWLTREAKDILVKLFVREPERRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 14/181 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ + V+E+ GG+L I E A Y ++ + Y H + +RDLK +N
Sbjct: 73 TEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLH-----TACGTPNYVAPEVLNDKGYDGRASD 117
LLLD+ G +KI+DFGL ++G+ T CGTP ++APEVL + Y RA D
Sbjct: 132 LLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVD 183
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 177
W GV+++ ++ G PF + ++ I + P + S A +++R+L NP+ R
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243
Query: 178 M 178
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 68/245 (27%), Positives = 101/245 (41%), Gaps = 64/245 (26%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
K+ I +V EF++ +K+ K L + + Y + ++Y HS + HRDLK
Sbjct: 72 GHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLK 129
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVLND 108
P NLL+ S GVLK++DFGL+ + G+PN Y APE+L
Sbjct: 130 PNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRADFSCPS---W------ 157
+ G D+WS G I L+ FLP +S++ L KI A P+ W
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEA-LGTPTEENWPGVTSL 233
Query: 158 -----FSSGAKK---------------LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197
F L++R+L NP+ R+T Q LE +F P
Sbjct: 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN--DPAP 291
Query: 198 FDKEE 202
+
Sbjct: 292 TPPSQ 296
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 64/191 (33%), Positives = 96/191 (50%), Gaps = 20/191 (10%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+I ++LEF+DGG L + D AR Q+++ + Y H R + HRD+KP NLL+
Sbjct: 146 EIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLI 201
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV----LNDKGYDGRASDVWSC 121
+S +KI+DFG+S I Q + +++ GT Y++PE LN YDG A D+WS
Sbjct: 202 NSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259
Query: 122 GVILFVLMAGFLPF------DESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNP 174
GV + G PF D ++LM IC + P+ S + I L P
Sbjct: 260 GVSILEFYLGRFPFGVGRQGDWASLMC---AICMSQPPEAPATASREFRHFISCCLQREP 316
Query: 175 DTRMTISQMLE 185
R + Q+L+
Sbjct: 317 AKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 62/181 (34%), Positives = 99/181 (54%), Gaps = 6/181 (3%)
Query: 7 IYIVLEFIDGGELFDKIA-KHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV+E+ DGG+L KI + G+L ED ++F Q+ V + H + V HRD+K +N+
Sbjct: 73 LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIF 132
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L G +K+ DFG + + T GTP YV PE+ + Y+ + SD+WS G I
Sbjct: 133 LTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCI 189
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
L+ L PF ++ L K+C+ + PS +S + LIK++ NP +R + + +
Sbjct: 190 LYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
Query: 184 L 184
L
Sbjct: 250 L 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
I I +EF+ GG + + + G L E +Y +Q+++ V Y H+ V HRD+K N++L
Sbjct: 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM 136
Query: 67 SYGVLKISDFG----LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
G++K+ DFG L+ + +L + GTP ++APEV+N+ GY GR SD+WS G
Sbjct: 137 PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIG 195
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNPDTRMT 179
+F + G P + +A I P FS+ A + L + R +
Sbjct: 196 CTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255
Query: 180 ISQMLE 185
Q+L
Sbjct: 256 ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 9/190 (4%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
+ +E++ GG + ++K+G KE Y +QL+ + Y H + HRD+K NLL+DS
Sbjct: 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
Query: 69 G-VLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G L+I+DFG +A ++ GT ++APEVL + Y GR+ DVWS G ++
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVI 198
Query: 126 FVLMAGFLPFDE---SNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMTI 180
+ P++ SN +AL KI A S P S G + + R L+ P+ R
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPS 258
Query: 181 SQMLEDEWFK 190
++L+ F+
Sbjct: 259 RELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 42/173 (24%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K +Y V+++I GG++ + + G +ED AR Y +L A++ H G HRD+KP+N+
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 64 LLDSYGVLKISDFGLSA------------ISQQVREDG---------------------- 89
L+D G +K++DFGL R+D
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 90 -------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G PF
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 67/184 (36%), Positives = 108/184 (58%), Gaps = 16/184 (8%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V+++ GG+L ++K RL ED AR Y +++ A+D H G HRD+KP+N+LL
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL----NDKGYDGRASDVW 119
D G ++++DFG S + ++ DG + + A GTP+Y++PE+L + KG G D W
Sbjct: 136 DKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW---FSSGAKKLIKRILDPNP 174
S GV ++ ++ G PF +L+ Y KI + F P S AK LI+R++ P
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-P 251
Query: 175 DTRM 178
+TR+
Sbjct: 252 ETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-25
Identities = 53/146 (36%), Positives = 85/146 (58%), Gaps = 2/146 (1%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+ I +E++ GG + D++ +G L E+ RRY +Q++ V Y HS + HRD+K N
Sbjct: 77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
+L DS G +K+ DFG S Q + G + + GTP +++PEV++ +GY GR +DVWS
Sbjct: 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSV 195
Query: 122 GVILFVLMAGFLPFDESNLMALYRKI 147
+ ++ P+ E MA KI
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 59/185 (31%), Positives = 101/185 (54%), Gaps = 9/185 (4%)
Query: 9 IVLEFIDGGELFDKIA--KHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
I+ E+ +G +L K+ KH L E++ +F QL+ V Y H R + HRDLK +N+
Sbjct: 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIF 138
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L + +LKI DFG+S + + L T GTP Y++PE L +GYD + SD+WS G I
Sbjct: 139 LKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCI 194
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
L+ + F+ N +++ +I S P +S +++ +L+ +P R + +++
Sbjct: 195 LYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
Query: 184 LEDEW 188
L + +
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-25
Identities = 62/176 (35%), Positives = 102/176 (57%), Gaps = 15/176 (8%)
Query: 7 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V+++ GG+L ++K RL ED AR Y +++ A+D H HRD+KP+N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL----NDKGYDGRASDVW 119
D G ++++DFG ++ EDG + + A GTP+Y++PE+L + KG G D W
Sbjct: 136 DMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW---FSSGAKKLIKRIL 170
S GV ++ ++ G PF +L+ Y KI + F P+ S AK LI+R++
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 4/165 (2%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
I +E++ GG + D++ +G L E R+Y +Q++ + Y HS + HRD+K N+L DS
Sbjct: 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA 142
Query: 69 GVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 127
G +K+ DFG S Q + G + + GTP +++PEV++ +GY GR +DVWS G +
Sbjct: 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVE 201
Query: 128 LMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKRIL 170
++ P+ E MA KI + PS S A+ + I
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 4/165 (2%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
I +E + GG + D++ +G L E+ R+Y +Q++ V Y HS + HRD+K N+L DS
Sbjct: 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV 142
Query: 69 GVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 127
G +K+ DFG S Q + G + + GTP +++PEV++ +GY GR +D+WS G +
Sbjct: 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVE 201
Query: 128 LMAGFLPFDESNLMALYRKICR--ADFSCPSWFSSGAKKLIKRIL 170
++ P+ E MA KI + P S + +KRI
Sbjct: 202 MLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 4 KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K +Y+V EF+D +L + L E + Y QL+ + +CHS G+ HRDLKPE
Sbjct: 70 KGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPE 127
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVL-NDKGYDGRASDVW 119
NLL+++ GVLK++DFGL ++ +T T Y APE+L DKGY D+W
Sbjct: 128 NLLINTEGVLKLADFGL---ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY-STPVDIW 183
Query: 120 SCGVILFVLMAG--FLPFDESNLMALYRKICRA-------------------DFSCPSW- 157
S G I L++ P S + L+ KI R FS P
Sbjct: 184 SVGCIFAELLSRRPLFPGK-SEIDQLF-KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241
Query: 158 ----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
S A L+ ++L +P R+T Q L +F
Sbjct: 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-24
Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ + I LE++ GG + + +GR +E R + +Q++ + Y HS+G+ HRDLK +N
Sbjct: 79 TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADN 138
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWS 120
LL+D+ G+ KISDFG+S S + ++ + G+ ++APEV++ +GY + D+WS
Sbjct: 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV-DIWS 197
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCP------SWFSSGAKKLIKRILDPNP 174
G ++ + AG P+ + +A K+ + P S A + NP
Sbjct: 198 LGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINP 257
Query: 175 DTRMTISQMLEDEW 188
D R T ++L+ +
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 54/150 (36%), Positives = 81/150 (54%), Gaps = 7/150 (4%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K +Y+V+E+ GG+L + ++ + ED A+ Y +L+ A+ H G HRD+KPEN
Sbjct: 73 KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN 132
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS-----D 117
+L+D G +K++DFG SA + GTP+Y+APEVL DG+ + D
Sbjct: 133 VLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKI 147
WS GVI + ++ G PF E Y I
Sbjct: 192 WWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 17/238 (7%)
Query: 7 IYIVLEFIDGGELFDKI---AKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
I +VL++ + G+L +I AK R +E EA F Q++ AV + HS+ + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL S G++K+ DFG S + D + T CGTP YVAPE+ K Y +A D++S G
Sbjct: 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKA-DMFSLG 232
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTIS 181
V+L+ L+ PFD N+ + K + P S ++++ +L +P R + S
Sbjct: 233 VLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292
Query: 182 QMLED---EWFKKGYKP-----PHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSM 231
++L + F G P F D + +K+ L E++ M
Sbjct: 293 KLLNMPICKLFISGLLEIVQTQPGFSGPLR---DTISRQIQQTKQLLQVERRRIVRQM 347
|
Length = 496 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 5e-24
Identities = 31/58 (53%), Positives = 43/58 (74%)
Query: 231 MNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 288
+NAF+LIS + L LFE++ K+ETRFTS++P +EI+SK+EE AK LGF V+K
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 58/186 (31%), Positives = 98/186 (52%), Gaps = 13/186 (6%)
Query: 6 KIYIVLEFIDG---GELFDKIA-KHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKP 60
++YIV++ I+G GE F+ + K R E+ F Q++ A+ Y H + + HRDL P
Sbjct: 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTP 142
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N++L + I+DFGL ++Q + + L + GT Y PE++ ++ Y G +DVW+
Sbjct: 143 NNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWA 198
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---SWFSSGAKKLIKRILDPNPDTR 177
G IL+ + PF +N+++L KI A + P +S +I L P+ + R
Sbjct: 199 FGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEAR 257
Query: 178 MTISQM 183
I Q+
Sbjct: 258 PDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 34/177 (19%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K +Y+++EF+ GG++ + K L E+ + Y + + A+D H G HRD+KP+NL
Sbjct: 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132
Query: 64 LLDSYGVLKISDFGL---------------------------------SAISQQVREDGL 90
LLD+ G +K+SDFGL A + + L
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 91 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 147
++ GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF YRK+
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-24
Identities = 60/182 (32%), Positives = 96/182 (52%), Gaps = 10/182 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKP 60
+K + +V+ ++GG+L I G EAR F Q+I +++ H R + +RDLKP
Sbjct: 64 TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD +G ++ISD GL+ +++ + GTP Y+APEVL + YD D ++
Sbjct: 124 ENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV-DWFA 179
Query: 121 CGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
G L+ ++AG PF + L R+ P FS AK L + +L +P+
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239
Query: 177 RM 178
R+
Sbjct: 240 RL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-24
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 7/191 (3%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
T ++IV+E+ G + D + + L E+E Q + ++Y HS HRD+K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY+ +A D+WS
Sbjct: 129 NILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-DIWSL 185
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICR---ADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G+ + G P+ + + M I S P +S +K+ L +P+ R
Sbjct: 186 GITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
Query: 179 TISQMLEDEWF 189
+ Q+L+ +
Sbjct: 246 SAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 8e-24
Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 12/192 (6%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+K++I++E+ GG D + K G+L E ++++ ++Y H G HRD+K N+L
Sbjct: 72 SKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL 130
Query: 65 LDSYGVLKISDFGLSAISQQVREDGL-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L G +K++DFG+S Q+ +T GTP ++APEV+ GYD +A D+WS G+
Sbjct: 131 LSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA-DIWSLGI 186
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMT 179
L G P + + M + I + + PS FS K + L+ +P R +
Sbjct: 187 TAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFSKPFKDFVSLCLNKDPKERPS 244
Query: 180 ISQMLEDEWFKK 191
++L+ ++ KK
Sbjct: 245 AKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 51/221 (23%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+++EF+ GG+L + K+ ED R Y + + A++ H G HRD+KP+N+L+D
Sbjct: 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID 135
Query: 67 SYGVLKISDFGLS---------AISQQVREDG---------------------------- 89
G +K+SDFGLS A Q++ +
Sbjct: 136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIA 195
Query: 90 --------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM 141
+ ++ GTP+Y+APE+ +GY G+ D WS G I+F + G+ PF N
Sbjct: 196 TWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSH 254
Query: 142 ALYRKIC--RADFSCPS--WFSSGAKKLIKRILDPNPDTRM 178
YRKI R P S A+ LI+R++ N + R+
Sbjct: 255 ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 58/191 (30%), Positives = 104/191 (54%), Gaps = 14/191 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ I LE++ GG + + +G +E R + +Q++ ++Y H+RG+ HRD+K N
Sbjct: 77 DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN 136
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--PN------YVAPEVLNDKGYDGR 114
+L+D+ G +KISDFG IS+++ E L T P+ ++APEV+ Y R
Sbjct: 137 ILVDNKGGIKISDFG---ISKKL-EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-R 191
Query: 115 ASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPN 173
+D+WS G ++ ++ G PF D + L A+++ A PS SS A +++ + +
Sbjct: 192 KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEID 251
Query: 174 PDTRMTISQML 184
+ R T +++L
Sbjct: 252 HNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 61/176 (34%), Positives = 100/176 (56%), Gaps = 15/176 (8%)
Query: 7 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V+++ GG+L ++K RL ED AR Y +++ A+ H HRD+KP+N+LL
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVL----NDKGYDGRASDVW 119
D G ++++DFG ++ +DG + + A GTP+Y++PE+L + G G D W
Sbjct: 136 DMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSWF---SSGAKKLIKRIL 170
S GV ++ ++ G PF +L+ Y KI + F PS S AK LI+R++
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLK 59
+ I I +E++DGG L DKI K GR+ E + ++ + Y H + HRD+K
Sbjct: 70 NNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
P N+L++S G +K+ DFG+S Q V + L T GT +Y+APE + Y + SD+W
Sbjct: 129 PSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK-SDIW 183
Query: 120 SCGVILFVLMAGFLPFDESNLMA-----LYRKICRADFSCP-----SWFSSGAKKLIKRI 169
S G+ L L G P+ N L + I P FS + +
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQDFVNLC 240
Query: 170 LDPNPDTRMTISQMLEDEWFKK 191
L +P R + ++LE + KK
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 44/128 (34%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ +V+E++ +L + + R L E + + Y + L+ V Y H+ G+ HRDLKP NL
Sbjct: 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L+ + GVLKI+DFGL+ + E L T Y APE+L D+W+ G
Sbjct: 131 LISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189
Query: 124 ILFVLMAG 131
I L+ G
Sbjct: 190 IFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 2e-23
Identities = 56/177 (31%), Positives = 87/177 (49%), Gaps = 34/177 (19%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K +Y+++EF+ GG++ + K L E+E + Y + + A+D H G HRD+KP+NL
Sbjct: 73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132
Query: 64 LLDSYGVLKISDFGL---------------------------------SAISQQVREDGL 90
LLDS G +K+SDFGL A + + L
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 91 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI 147
+ GTP+Y+APEV GY+ + D WS GVI++ ++ G+ PF Y+K+
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 51/131 (38%), Positives = 72/131 (54%), Gaps = 5/131 (3%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K ++Y+V E+++ L A G L D R Y QL+ A+ YCHS + HRD+KPEN
Sbjct: 71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPEN 130
Query: 63 LLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWS 120
+L+ GVLK+ DFG + A+ + L T Y APE+L D Y G+ DVW+
Sbjct: 131 ILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELLVGDTNY-GKPVDVWA 187
Query: 121 CGVILFVLMAG 131
G I+ L+ G
Sbjct: 188 IGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 65/193 (33%), Positives = 106/193 (54%), Gaps = 16/193 (8%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++I++EF GG + + + R L E + R +Q + A++Y H + HRDLK N
Sbjct: 74 ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGN 133
Query: 63 LLLDSYGVLKISDFGLSAISQQV--REDGLLHTACGTPNYVAPEVL-----NDKGYDGRA 115
+L G +K++DFG+SA + + R D + GTP ++APEV+ D+ YD +A
Sbjct: 134 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 116 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDP 172
DVWS G+ L + P E N M + KI +++ + PS +SS K +K+ L+
Sbjct: 190 -DVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEK 248
Query: 173 NPDTRMTISQMLE 185
N D R T +Q+L+
Sbjct: 249 NVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +RDLKP N+LL
Sbjct: 71 KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGV 123
D +G ++ISD GL+ + + H + GT Y+APEVL KG YD A D +S G
Sbjct: 131 DEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQ-KGVAYDSSA-DWFSLGC 184
Query: 124 ILFVLMAGFLPFDE---SNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
+LF L+ G PF + + + R P FS + L++ +L + + R+
Sbjct: 185 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 244
Query: 181 -----SQMLEDEWFK---------KGYKPP 196
++ E +F+ + Y PP
Sbjct: 245 LGRGAQEVKEHPFFRSLDWQMVFLQKYPPP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
K+ +L+ ++GG+L +++HG E E R Y ++I +++ H+R V +RDLKP N+LL
Sbjct: 71 KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-KGYDGRASDVWSCGVI 124
D +G ++ISD GL+ + + H + GT Y+APEVL YD A D +S G +
Sbjct: 131 DEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA-DWFSLGCM 185
Query: 125 LFVLMAGFLPFDE---SNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI- 180
LF L+ G PF + + + R + P FS K L++ +L + R+
Sbjct: 186 LFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCL 245
Query: 181 ---SQMLEDEWFKKGYKPPH-FDKEEEVNLDD 208
+Q +++ F KG + ++ L
Sbjct: 246 GRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 58/228 (25%)
Query: 6 KIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
KIY+V+E+++ +L + + E + QL++ V + H + HRDLK NLL
Sbjct: 80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVLNDKGYDG 113
L++ G+LKI DFGL+ RE G+P Y APE+L
Sbjct: 139 LNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWYRAPELLLGAKEYS 185
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-----DFSCPSWFS-SGAKK--- 164
A D+WS G I L+ F + + KI + + P + GAKK
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTF 245
Query: 165 -----------------------LIKRILDPNPDTRMTISQMLEDEWF 189
L+ R+L +P R++ L+ +F
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 5e-22
Identities = 53/142 (37%), Positives = 90/142 (63%), Gaps = 7/142 (4%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+EF++GG L D I H R+ E++ ++ A+ Y H++GV HRD+K +++LL
Sbjct: 93 ELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151
Query: 66 DSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
S G +K+SDFG A +S++V + L GTP ++APEV++ Y G D+WS G++
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVDIWSLGIM 207
Query: 125 LFVLMAGFLP-FDESNLMALYR 145
+ ++ G P F+E L A+ R
Sbjct: 208 VIEMIDGEPPYFNEPPLQAMRR 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 12/191 (6%)
Query: 7 IYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYFQQLINAVDYCHSRGVFHRDLKPENL 63
I +E + GG L + +K G LK++E Y +Q++ + Y H + HRD+K +N+
Sbjct: 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNV 139
Query: 64 LLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWS 120
L+++Y GV+KISDFG S + + T GT Y+APEV++ +GY G +D+WS
Sbjct: 140 LVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPADIWS 196
Query: 121 CGVILFVLMAGFLPFDE--SNLMALYR-KICRADFSCPSWFSSGAKKLIKRILDPNPDTR 177
G + + G PF E A+++ + + P S+ AK I R +P+PD R
Sbjct: 197 LGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256
Query: 178 MTISQMLEDEW 188
+ +L+D +
Sbjct: 257 ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 58/177 (32%), Positives = 82/177 (46%), Gaps = 46/177 (25%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K +Y V+++I GG++ + + G ED AR Y +L AV+ H G HRD+KP+N+
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132
Query: 64 LLDSYGVLKISDFGLSA------------ISQQVREDG---------------------- 89
L+D G +K++DFGL VR+D
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 90 -----------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
L H+ GTPNY+APEVL GY + D WS GVIL+ ++ G PF
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 52/131 (39%), Positives = 67/131 (51%), Gaps = 8/131 (6%)
Query: 3 SKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
S+ K+Y+V EF+D + D G L + Y QL+ + YCHS V HRDLKP
Sbjct: 69 SENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKP 127
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+NLL+D G LK++DFGL+ A VR H T Y APE+L D+W
Sbjct: 128 QNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQYSTPVDIW 184
Query: 120 SCGVILFVLMA 130
S G I F M
Sbjct: 185 SIGCI-FAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 58/177 (32%), Positives = 84/177 (47%), Gaps = 46/177 (25%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K +Y V+++I GG++ + + E AR Y +L A++ H G HRD+KP+N+
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI 132
Query: 64 LLDSYGVLKISDFGL---------SAISQQ---VREDG---------------------- 89
L+D G +K++DFGL S Q+ +R+D
Sbjct: 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192
Query: 90 -----------LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
L H+ GTPNY+APEVL KGY + D WS GVILF ++ G PF
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 55/197 (27%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+++I++E+ +GG + + K G + E ++++ A+ Y H GV HRD+K N+L
Sbjct: 75 PRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANIL 133
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-KGYDGRASDVWSCGV 123
+ + G +K+ DFG++A+ Q T GTP ++APEV+ + K YD +A D+WS G+
Sbjct: 134 VTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKA-DIWSLGI 190
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMT 179
++ + G P+ + + I ++ P + +S ++ + LD P R++
Sbjct: 191 TIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS 248
Query: 180 ISQMLEDEWFKKGYKPP 196
++L+ +W K K P
Sbjct: 249 AEELLKSKWIKAHSKTP 265
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 6/181 (3%)
Query: 7 IYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV+ F +GG+L+ K+ K L E++ +F Q+ A+ Y H + + HRDLK +N+
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L ++K+ D G++ + + + + T GTP Y++PE+ ++K Y+ + SDVW+ G
Sbjct: 135 LTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCC 191
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
++ + F+ ++ +L +I P +S +LI +L P+ R ++ +
Sbjct: 192 VYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
Query: 184 L 184
L
Sbjct: 252 L 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
K ++Y+V EF+D L D L E R+Y Q++ +++CHS + HRD+KPEN+
Sbjct: 72 KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131
Query: 64 LLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVW 119
L+ GV+K+ DFG + A +V D + T Y APE+L D Y GRA D+W
Sbjct: 132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLVGDTKY-GRAVDIW 185
Query: 120 SCGVILFVLMAG--FLPFDESNLMALYRKI-CRADFS----------------------- 153
+ G ++ ++ G P D S++ LY I C +
Sbjct: 186 AVGCLVTEMLTGEPLFPGD-SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244
Query: 154 -------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
P S L K+ L +PD R + SQ+L E+F
Sbjct: 245 IEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 8e-21
Identities = 55/188 (29%), Positives = 100/188 (53%), Gaps = 7/188 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+E++ GG L D + + E + ++ + A+++ HS V HRD+K +N+LL
Sbjct: 90 ELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G +K++DFG A Q E T GTP ++APEV+ K Y G D+WS G++
Sbjct: 149 GMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMA 205
Query: 126 FVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ G P+ +E+ L ALY + P S+ + + R L+ + + R + +
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265
Query: 183 MLEDEWFK 190
+L+ + K
Sbjct: 266 LLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 8e-21
Identities = 57/188 (30%), Positives = 101/188 (53%), Gaps = 7/188 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+E++ GG L D + + + E + ++ + A+D+ HS V HRD+K +N+LL
Sbjct: 90 ELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G +K++DFG A Q E T GTP ++APEV+ K Y G D+WS G++
Sbjct: 149 GMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMA 205
Query: 126 FVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ G P+ +E+ L ALY + P S+ + + R L+ + D R + +
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKE 265
Query: 183 MLEDEWFK 190
+L+ + K
Sbjct: 266 LLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 6 KIYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++++V+E GG +L + K G RLKE+ ++ + + Y H V HRD+K +
Sbjct: 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ 142
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRAS 116
N+LL +K+ DFG+SA Q G +T GTP ++APEV+ D YD R S
Sbjct: 143 NILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-S 199
Query: 117 DVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDP 172
DVWS G+ L G P D + AL+ KI R P +S I L
Sbjct: 200 DVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNPPPTLKSPENWSKKFNDFISECLIK 258
Query: 173 NPDTRMTISQMLEDEW 188
N + R + ++LE +
Sbjct: 259 NYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 4 KTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++Y V E+++G L+ K K E R Q++ + + H G FHRDLKPE
Sbjct: 70 NDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPE 128
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
NLL+ V+KI+DFGL ++++R T Y APE+L D+W+
Sbjct: 129 NLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185
Query: 122 GVILFVLMAGFLP-FDESNLMALYRKIC-------------------RADFSCPSWF--- 158
G I+ L P F S+ + KIC + F P +
Sbjct: 186 GCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS 244
Query: 159 --------SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
S A LIK +L +P R T SQ L+ +F
Sbjct: 245 LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 60/194 (30%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+EF++GG L D I H R+ E++ ++ A+ H++GV HRD+K +++LL
Sbjct: 91 ELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149
Query: 66 DSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
G +K+SDFG A +S++V L GTP ++APE+++ Y G D+WS G++
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVDIWSLGIM 205
Query: 125 LFVLMAGFLP-FDESNL--MALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+ ++ G P F+E L M + R S K + R+L +P R T +
Sbjct: 206 VIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 265
Query: 182 QMLEDEWFKKGYKP 195
++L+ + K P
Sbjct: 266 ELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 68/208 (32%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRD 57
S + I I +E+ +GG L D I K GR+ E + + ++ + Y HSR + HRD
Sbjct: 72 SSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRD 130
Query: 58 LKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 115
+KP N+LL G +K+ DFG+S ++ T GT Y+APE + K Y
Sbjct: 131 IKPSNILLTRKGQVKLCDFGVSGELVNSLAG------TFTGTSFYMAPERIQGKPYSIT- 183
Query: 116 SDVWSCGVILFVLMAGFLPF---DESNLMA--LYRKICRADF----SCPS----WFSSGA 162
SDVWS G+ L + PF E L L I P W S
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW-SEEF 242
Query: 163 KKLIKRILDPNPDTRMTISQMLEDEWFK 190
K IK+ L+ +P R T MLE W K
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 62/252 (24%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHRDLKPENLLL 65
+YIV E ++ K+ K + D+ +YF Q++ + Y HS V HRDLKP N+L+
Sbjct: 79 VYIVTELMETD--LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136
Query: 66 DSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV------APEV-LNDKGYDGRASD 117
+S LKI DFGL+ + E G L T YV APE+ L+ Y +A D
Sbjct: 137 NSNCDLKICDFGLARGVDPDEDEKGFL-----TE-YVVTRWYRAPELLLSSSRYT-KAID 189
Query: 118 VWSCGVILFVLMAG--FLP----FDESNL-MALYRKICRADFSCPSWFSSGAKK------ 164
+WS G I L+ P D+ NL + + D + S A+
Sbjct: 190 IWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT--SEKARNYLKSLP 247
Query: 165 --------------------LIKRILDPNPDTRMTISQMLEDEWFKKGYKP--------- 195
L++++L +P R+T + L + + + P
Sbjct: 248 KKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307
Query: 196 PHFDKEEEVNLD 207
FD ++ L
Sbjct: 308 FDFDFFDDDELT 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
TK++I++E++ GG D + + G E + ++++ +DY HS HRD+K N+L
Sbjct: 75 TKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVL 133
Query: 65 LDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D+WS G
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYDSKA-DIWSLG 188
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNPDTRMT 179
+ L G P + + M + I + + P+ FS K+ I L+ +P R T
Sbjct: 189 ITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSFRPT 246
Query: 180 ISQMLEDEWFKKGYKPPHFDKE 201
++L+ ++ K K + E
Sbjct: 247 AKELLKHKFIVKNAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-20
Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
TK++I++E++ GG D + + G L E + ++++ +DY HS HRD+K N+L
Sbjct: 75 TKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL 133
Query: 65 LDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L +G +K++DFG++ Q++ + + GTP ++APEV+ YD +A D+WS G
Sbjct: 134 LSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYDSKA-DIWSLG 188
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+ L G P E + M + I + + + +S K+ ++ L+ P R T
Sbjct: 189 ITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 248
Query: 182 QMLEDEWFKKGYKPPHFDKE 201
++L+ ++ + K + E
Sbjct: 249 ELLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 4 KTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ K+ +V E +D K K G L + + +QL+ VD+ HS + HRDLKP+
Sbjct: 78 ELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136
Query: 62 NLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS--DV 118
N+L+ S G +KI+DFGL+ I S ++ L + T Y APEVL Y A+ D+
Sbjct: 137 NILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSY---ATPVDM 189
Query: 119 WSCGVI---LFVLMAGFLPFDESNLMAL--------------------------YRKICR 149
WS G I LF F E++ + Y
Sbjct: 190 WSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF 249
Query: 150 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
F P G L+K++L NP R++ + L+ +F
Sbjct: 250 KSF-VPEICEEGL-DLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 7 IYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPEN 62
+Y+ +E++D G +L+ + ED RR ++ + + + HRD+KP N
Sbjct: 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA-----SD 117
+L++ G +K+ DFG+S L T G +Y+APE + G + SD
Sbjct: 134 VLVNGNGQVKLCDFGVSG----NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 118 VWSCGVILFVLMAGFLPFDE---SNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPN 173
VWS G+ + + G P+ +N+ A I D + PS +S A+ + + L+
Sbjct: 190 VWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKI 249
Query: 174 PDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
P+ R T +Q+LE W K YK D E V
Sbjct: 250 PNRRPTYAQLLEHPWLVK-YKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 39/213 (18%)
Query: 9 IVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+V E +D L++ I R L E + Y QL+ ++D+ H G+FHRD+KPEN+L+
Sbjct: 77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135
Query: 68 YGVLKISDFG-LSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+LK++DFG I + +T T Y APE L GY G D+W+ G +
Sbjct: 136 D-ILKLADFGSCRGIYSK-----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 126 FVLMAGFLPFDESN------------------LMALYRKICRADFSCPSWFSSGAKK--- 164
F +++ F F +N ++ +RK +++ PS +G +K
Sbjct: 190 FEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLP 249
Query: 165 --------LIKRILDPNPDTRMTISQMLEDEWF 189
L+K++L +PD R+T Q L +F
Sbjct: 250 NASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 40/255 (15%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
IY+V E+++ +L I + L++ R QL+ A+ Y HS V HRDLKP N+LL+
Sbjct: 84 IYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN 141
Query: 67 SYGVLKISDFGLS-AISQ--QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
S +K++DFGL+ ++S+ + E+ +L T Y APE+L + D+WS G
Sbjct: 142 SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGC 201
Query: 124 ILFVLMAGFLPFDESNLMALYRKIC--------------RADFSCPSWFSSGAKK----- 164
IL ++ G F ++ + KI ++ F+ S ++
Sbjct: 202 ILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261
Query: 165 ------------LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAI 212
L+K++L NP+ R+T + LE + + + P +E V +
Sbjct: 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP----SDEPVLPYPITIP 317
Query: 213 FNDSKENLVTEKKEK 227
+D+ + V E + K
Sbjct: 318 LDDNVKLSVAEYRNK 332
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-20
Identities = 55/182 (30%), Positives = 96/182 (52%), Gaps = 10/182 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+K + +VL ++GG+L I G +E+ A Y +++ ++ H +RDLKP
Sbjct: 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP 130
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD YG ++ISD GL+ ++ E + GT Y+APEVLN++ Y + D W
Sbjct: 131 ENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWG 186
Query: 121 CGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
G +++ ++ G PF ++ + R++ + + FS AK + K +L +P
Sbjct: 187 LGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQ 246
Query: 177 RM 178
R+
Sbjct: 247 RL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 1e-19
Identities = 56/188 (29%), Positives = 102/188 (54%), Gaps = 7/188 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+E++ GG L D + + + E + ++ + A+++ HS V HRD+K +N+LL
Sbjct: 91 ELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G +K++DFG A Q E T GTP ++APEV+ K Y G D+WS G++
Sbjct: 150 GMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMA 206
Query: 126 FVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ G P+ +E+ L ALY + P S+ + + R LD + + R + +
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 183 MLEDEWFK 190
+L+ ++ K
Sbjct: 267 LLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 61/187 (32%), Positives = 103/187 (55%), Gaps = 15/187 (8%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++++EF+ GG L D I RL E++ + ++ A+ Y HS+GV HRD+K +++LL
Sbjct: 92 ELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150
Query: 66 DSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
G +K+SDFG A IS+ V + L GTP ++APEV++ Y G D+WS G++
Sbjct: 151 TLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GTEVDIWSLGIM 206
Query: 125 LFVLMAGFLP-FDESNLMALYRKICRADFSCP-----SWFSSGAKKLIKRILDPNPDTRM 178
+ ++ G P F +S + A+ R D P S + ++R+L P R
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKR---LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA 263
Query: 179 TISQMLE 185
T ++L+
Sbjct: 264 TAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 74/250 (29%), Positives = 114/250 (45%), Gaps = 42/250 (16%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+YIV E ++ +L+ K+ K L D + + Q++ + Y HS V HRDLKP NLLL+
Sbjct: 83 VYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140
Query: 67 SYGVLKISDFGLSAIS-QQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVI 124
+ LKI DFGL+ I+ + G L T Y APE+ LN KGY +A D+WS G I
Sbjct: 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYT-KAIDIWSVGCI 199
Query: 125 LFVLMAGFLPF------DESNL---------MALYRKIC--RA-DF--SCP-----SW-- 157
L +++ F + NL I RA ++ S P W
Sbjct: 200 LAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNK 259
Query: 158 ----FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP---PHFDKEEEVNLDDVD 210
A L+ ++L NP R+T+ + L + ++ + P P ++ + + D
Sbjct: 260 LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFD 319
Query: 211 AIFNDSKENL 220
+ KE L
Sbjct: 320 DL---PKEKL 326
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
TK++I++E++ GG D + K G L+E ++++ +DY HS HRD+K N+L
Sbjct: 75 TKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVL 133
Query: 65 LDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L G +K++DFG++ Q++ + T GTP ++APEV+ YD +A D+WS G
Sbjct: 134 LSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYDFKA-DIWSLG 188
Query: 123 VILFVLMAGFLPFDESNLMALYRKICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+ L G P + + M + I + + + +S K+ ++ L+ +P R T
Sbjct: 189 ITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAK 248
Query: 182 QMLEDEWFKKGYKPPHF 198
++L+ ++ + K F
Sbjct: 249 ELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-19
Identities = 56/186 (30%), Positives = 101/186 (54%), Gaps = 15/186 (8%)
Query: 3 SKTKIYIVLEFIDGGEL----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+KT + +V+ ++GG+L ++ ++ E A Y Q+I+ +++ H R + +RDL
Sbjct: 64 TKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123
Query: 59 KPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 116
KPEN+LLD+ G ++ISD GL+ Q + G GTP ++APE+L + YD +
Sbjct: 124 KPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYD-FSV 178
Query: 117 DVWSCGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 172
D ++ GV L+ ++A PF ++ L ++I + P FS +K + +L
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238
Query: 173 NPDTRM 178
+P+ R+
Sbjct: 239 DPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 22/199 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ K++IV+E+ GG L D I + R L E + ++ + + Y H G HRD+K
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKG 129
Query: 61 ENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRAS 116
N+LL G +K++DFG+SA ++ + + + GTP ++APEV + GYDG+
Sbjct: 130 ANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVAAVERKGGYDGKC- 185
Query: 117 DVWSCGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPS------WFSSGAKKLIKR 168
D+W+ G I + +A P FD + AL+ I +++F P W S IK+
Sbjct: 186 DIWALG-ITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEKW-SPVFHDFIKK 242
Query: 169 ILDPNPDTRMTISQMLEDE 187
L +P R T +++L+
Sbjct: 243 CLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 8e-19
Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 10/182 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKP 60
+K + +VL ++GG+L I G DE R F ++ ++ H + +RDLKP
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD YG ++ISD GL+ ++ E + GT Y+APEV+ ++ Y + D W
Sbjct: 131 ENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWG 186
Query: 121 CGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
G +++ ++ G PF ++ + R++ FS A+ + +++L +P
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGF 246
Query: 177 RM 178
R+
Sbjct: 247 RL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 1e-18
Identities = 54/188 (28%), Positives = 100/188 (53%), Gaps = 7/188 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++++V+E++ GG L D + + + E + ++ + A+++ H+ V HRD+K +N+LL
Sbjct: 90 ELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
G +K++DFG A Q E T GTP ++APEV+ K Y G D+WS G++
Sbjct: 149 GMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMA 205
Query: 126 FVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ G P+ +E+ L ALY + P S + + R L+ + + R + +
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKE 265
Query: 183 MLEDEWFK 190
+L+ + K
Sbjct: 266 LLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 49/128 (38%), Positives = 71/128 (55%), Gaps = 7/128 (5%)
Query: 6 KIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
++Y++ EF+ D + D + K + + + Y Q++ + +CHSR V HRDLKP+NL
Sbjct: 73 RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNL 132
Query: 64 LLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L+D+ GV+K++DFGL+ A VR H T Y APEVL D+WS G
Sbjct: 133 LIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIG 189
Query: 123 VILFVLMA 130
I F MA
Sbjct: 190 TI-FAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 2e-18
Identities = 59/190 (31%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+YIV E++ GG+L D + KHG L + + Q+ ++Y S+ HRDL N L+
Sbjct: 76 LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVWSCG 122
V+KISDFGL S+ + ED G ++APE L D + SDVWS G
Sbjct: 136 TENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT-SKSDVWSFG 191
Query: 123 VILFVLMA-GFLPFDE---SNLMALYRKICR--ADFSCPSWFSSGAKKLIKRILDPNPDT 176
V+L+ + G P+ ++ L R +CP +L+ + +P+
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL----YELMLQCWAYDPED 247
Query: 177 RMTISQMLED 186
R T S+++ED
Sbjct: 248 RPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 49/130 (37%), Positives = 70/130 (53%), Gaps = 8/130 (6%)
Query: 3 SKTKIYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ K+Y+V EF+ D + D G + + Y QL+ + +CHS V HRDLKP
Sbjct: 70 TENKLYLVFEFLHQDLKKFMDASPLSG-IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+NLL+++ G +K++DFGL+ A VR H T Y APE+L Y A D+W
Sbjct: 129 QNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTAVDIW 185
Query: 120 SCGVILFVLM 129
S G I F M
Sbjct: 186 SLGCI-FAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 34/164 (20%)
Query: 6 KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS-------RGVF 54
K+YI++EF D G+L I K G+++E +QL++A+ YCH+ V
Sbjct: 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147
Query: 55 HRDLKPENLLLDS-----------------YGVLKISDFGLSAISQQVREDGLLHTACGT 97
HRDLKP+N+ L + + KI DFGLS + + + + H+ GT
Sbjct: 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS---KNIGIESMAHSCVGT 204
Query: 98 PNYVAPEVL--NDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 139
P Y +PE+L K YD + SD+W+ G I++ L +G PF ++N
Sbjct: 205 PYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 7 IYIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ IV+E++ GG+L + + + L + + Q+ ++Y S+ HRDL N L
Sbjct: 76 LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKGYDGRASDVWSCG 122
+ V+KISDFGL S+ + +D G P ++APE L + + SDVWS G
Sbjct: 136 VGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF-TSKSDVWSFG 191
Query: 123 VILF-VLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTI 180
V+L+ + G P+ + + + + P KL+ + +P+ R T
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTF 251
Query: 181 SQMLE 185
S+++E
Sbjct: 252 SELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLI-------NAVDYCHSRGV 53
+ +Y+VLE+++GG+L D + K + + + L+ ++Y S+
Sbjct: 67 EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF 126
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKG 110
HRDL N L+ V+KISDFGL S+ V +D G + APE L D
Sbjct: 127 VHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 111 YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIK 167
+ SDVWS GV+L+ + G P+ + + + R + P + +L+
Sbjct: 184 FT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYELML 241
Query: 168 RILDPNPDTRMTISQMLE 185
+P+ R T S+++E
Sbjct: 242 SCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 49/128 (38%), Positives = 67/128 (52%), Gaps = 11/128 (8%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR-----LKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
K +Y+V E++D +L + +GR L + + QL+ V +CH GV HRDL
Sbjct: 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDL 136
Query: 59 KPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 116
KP+NLL+D G+LKI+D GL A S V+ H T Y APEVL +
Sbjct: 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV-TLWYRAPEVLLGSTHYSTPV 193
Query: 117 DVWSCGVI 124
D+WS G I
Sbjct: 194 DIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 57/187 (30%), Positives = 93/187 (49%), Gaps = 20/187 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKP 60
+K + +VL ++GG+L I G +E R F ++ ++ H + +RDLKP
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD +G ++ISD GL+ V E + GT Y+APEV+ ++ Y + D W+
Sbjct: 131 ENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWA 186
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADF---------SCPSWFSSGAKKLIKRILD 171
G +L+ ++AG PF + +KI R + FS A+ L K +L
Sbjct: 187 LGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 172 PNPDTRM 178
+P R+
Sbjct: 242 KDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 4/137 (2%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+YIV E+++ + + G L E+ AR + QL+ + Y HS V HRDLKP N+ ++
Sbjct: 91 VYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 67 SYG-VLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ VLKI DFGL+ I G L T Y +P +L +A D+W+ G I
Sbjct: 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208
Query: 125 LFVLMAGFLPFDESNLM 141
++ G F ++ +
Sbjct: 209 FAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 9/184 (4%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+YIV+E+++GG+L + K+ +L + + Q+ ++Y S+ HRDL N L+
Sbjct: 76 LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKGYDGRASDVWSCGV 123
V+KISDFGL S+ + +D G P ++APE L + + SDVWS GV
Sbjct: 136 GENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF-TSKSDVWSFGV 191
Query: 124 ILF-VLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+L+ + G P+ + + + P L+ + +P+ R T S
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 182 QMLE 185
+++E
Sbjct: 252 ELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 55/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKP 60
+K + +VL ++GG+L I G DE R F +L ++ + +RDLKP
Sbjct: 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP 130
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD G ++ISD GL+ Q+ E + GT Y+APEV+N++ Y + D W
Sbjct: 131 ENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKY-TFSPDWWG 186
Query: 121 CGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
G +++ ++ G PF + + R++ FS AK + + +L NP
Sbjct: 187 LGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKE 246
Query: 177 RM 178
R+
Sbjct: 247 RL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 67/237 (28%), Positives = 96/237 (40%), Gaps = 56/237 (23%)
Query: 7 IYIVLEFI--DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
I++V+E+ D L D + E + + QL+ + Y H + HRDLK NLL
Sbjct: 83 IFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----YVAPEVL-NDKGYDGRASDV 118
L G LKI+DFGL+ R G L TP Y APE+L Y A D+
Sbjct: 141 LTDKGCLKIADFGLA------RTYG-LPAKPMTPKVVTLWYRAPELLLGCTTYT-TAIDM 192
Query: 119 WSCGVILFVLMAG--FLP----FDESNLMA------------------LYRKI------- 147
W+ G IL L+A LP ++ +L+ L K
Sbjct: 193 WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPY 252
Query: 148 --CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEE 202
+ F W S +L+ +L +P R T + LE +FK+ KP + E
Sbjct: 253 NNLKHKF---PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE--KPLPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 12/177 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S+ +++VL+ +GG+L+ I+K + E+ +R+ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 63 LLLDSYGVLKISDFG-LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
+LLD G ++++ F S + + + + C APEV + A D WS
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV-GGISEETEACDWWSL 168
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G ILF L+ G E + + + P W S A+ L++++L NP R+
Sbjct: 169 GAILFELLTG-KTLVECHPSGINT---HTTLNIPEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
++ V E++ G L + +A G L E R Q+++A+ H++G+ HRDLKP+N+++
Sbjct: 54 LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 67 SYGV---LKISDFGLSAISQQVREDGLL-----HTACGTPNYVAPEVLNDKGYDGRASDV 118
GV K+ DFG+ + VR+ + GTP Y APE L + SD+
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP-NSDL 172
Query: 119 WSCGVILF------VLMAGFLPFDESNLMALYRKICRADFSCPSWFSS---GAKKLIKRI 169
++ G+I ++ G S LY+++ D S P W + G ++++
Sbjct: 173 YAWGLIFLECLTGQRVVQG-----ASVAEILYQQLSPVDVSLPPWIAGHPLGQ--VLRKA 225
Query: 170 LDPNPDTRMTISQML 184
L+ +P R + L
Sbjct: 226 LNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 49/226 (21%)
Query: 3 SKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ K+ +V E++D + D G L + + + QL+ + +CH V HRDLKP
Sbjct: 69 TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGL--------SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 112
+NLL++ G LK++DFGL + S +V T Y AP+VL
Sbjct: 129 QNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----------TLWYRAPDVLLGSRTY 178
Query: 113 GRASDVWSCGVILFVLMAGFLPF----DESNLMALYR-----------------KICRAD 151
+ D+WS G I+ ++ G F +E L+ ++R +
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238
Query: 152 FSCPSW--------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
P L+ R+L NP+ R++ L+ WF
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 65/257 (25%), Positives = 110/257 (42%), Gaps = 52/257 (20%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+Y+V + G +L + I K +L +D + Q++ + Y HS G+ HRDLKP N+
Sbjct: 93 QDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 150
Query: 65 LDSYGVLKISDFGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
++ LKI DFGL+ R D + T Y APE++ + + + D+WS G
Sbjct: 151 VNEDCELKILDFGLA------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 204
Query: 124 ILFVLMAGFLPFDESNLMALYRKIC------------------------------RADFS 153
I+ L+ G F S+ + ++I + DF
Sbjct: 205 IMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFK 264
Query: 154 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAI 212
S + A L++++L +PD R+T ++ L + + D E+E V
Sbjct: 265 EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA-----EYHDPEDE----PVAPP 315
Query: 213 FNDSKENL---VTEKKE 226
++ S E+ V E KE
Sbjct: 316 YDQSFESRDLTVDEWKE 332
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 24/183 (13%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+++++I G+LFD + K G+L E E ++ +QL+ A++ H + H D+K EN+L D
Sbjct: 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144
Query: 68 YGV-LKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ + D+GL I + + GT +Y +PE + YD + D W+ GV+
Sbjct: 145 AKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPEKIKGHNYD-VSFDWWAVGVL 195
Query: 125 LFVLMAGFLPFDESN--------LMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
+ L+ G PF E L+ +K S A ++ +L N +
Sbjct: 196 TYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 177 RMT 179
R+T
Sbjct: 252 RLT 254
|
Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 18/191 (9%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ +I I EF+DGG L + ++ E R ++ + Y S + HRD+KP N+
Sbjct: 71 ENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L+++ G +K+ DFG+S +Q V + + T GT Y+APE ++ + Y G SDVWS G+
Sbjct: 127 LVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGI 181
Query: 124 ILFVLMAGFLPF-----DESNLMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNP 174
L G P+ ++ +LM L C D P FS I + + P
Sbjct: 182 SFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQP 241
Query: 175 DTRMTISQMLE 185
R +++
Sbjct: 242 KERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 15/192 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ K++I +EF GG L D G L E + ++ + + Y HS+G HRD+K N+
Sbjct: 78 RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI 137
Query: 64 LLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV--LNDKGYDGRASDVWS 120
LL G +K++DFG+SA I+ + + + GTP ++APEV + KG + D+W+
Sbjct: 138 LLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAVERKGGYNQLCDIWA 194
Query: 121 CGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPSW-----FSSGAKKLIKRILDPN 173
G I + +A P FD + AL+ + +++F P +S+ +K L N
Sbjct: 195 VG-ITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKN 252
Query: 174 PDTRMTISQMLE 185
P R T ++L+
Sbjct: 253 PKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 10/128 (7%)
Query: 4 KTKIYIVLEFID---GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K Y+V EF + G L +K K E ++ + L+N + Y H + HRD+K
Sbjct: 91 KGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA 147
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTA-CGTPNYVAPEV-LNDKGYDGRASD 117
N+L+ G+LK++DFGL+ A S +T T Y PE+ L ++ Y G D
Sbjct: 148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY-GPPID 206
Query: 118 VWSCGVIL 125
+W G I+
Sbjct: 207 MWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 30/80 (37%), Positives = 54/80 (67%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S +Y+V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLKP+N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 63 LLLDSYGVLKISDFGLSAIS 82
+L+ + G +K++DFGLS ++
Sbjct: 135 MLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K K+++V E+ D + +++ K+ R + E ++ Q + AV++CH HRD+KPEN
Sbjct: 72 KRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPEN 130
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWSC 121
+L+ G +K+ DFG + I T Y APE+L D Y G DVW+
Sbjct: 131 ILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDTQY-GPPVDVWAI 187
Query: 122 GVILFVLMAGFLPF--DESNLMALY--RKIC-------RADFSCPSWF------------ 158
G + L+ G P +S++ LY RK + FS +F
Sbjct: 188 GCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246
Query: 159 ---------SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189
SS A +K L +P R++ ++LE +F
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 27/189 (14%)
Query: 42 INAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPN 99
+ A+ Y + GV HRD+KP N+LLD+ G +K+ DFG+S + V D T + G
Sbjct: 124 VKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAA 179
Query: 100 YVAPEVL-----NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFS 153
Y+APE + N K YD RA DVWS G+ L L G P+ + KI + +
Sbjct: 180 YMAPERIDPPDPNPK-YDIRA-DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 154 CPSW---FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD 210
FS + L + R ++L+ + + ++ E DV
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR------RYETAE----VDVA 287
Query: 211 AIFNDSKEN 219
F D
Sbjct: 288 GWFQDVMAE 296
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 51/147 (34%), Positives = 79/147 (53%), Gaps = 11/147 (7%)
Query: 6 KIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
++++V+EF G + D K K LKED ++++ + + H+ V HRD+K +N+
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDV 118
LL +K+ DFG+SA Q R G +T GTP ++APEV+ D YD R SD+
Sbjct: 153 LLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDI 209
Query: 119 WSCGVILFVLMAGFLPF-DESNLMALY 144
WS G+ + G P D + AL+
Sbjct: 210 WSLGITAIEMAEGAPPLCDMHPMRALF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 48/124 (38%), Positives = 65/124 (52%), Gaps = 5/124 (4%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+YIV E +D +L I L +D + + QL+ + Y HS V HRDLKP NLLL+
Sbjct: 84 VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 142
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVIL 125
+ LKI DFGL+ + + + + T Y APE+ LN Y A DVWS G I
Sbjct: 143 ANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYRAPELLLNCSEY-TTAIDVWSVGCIF 199
Query: 126 FVLM 129
L+
Sbjct: 200 AELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 17/193 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S+ K++I +E+ GG L D G L E + ++ + + Y HS+G HRD+K N
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGAN 136
Query: 63 LLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVL---NDKGYDGRASDV 118
+LL G +K++DFG++A I+ + + + GTP ++APEV + GY+ + D+
Sbjct: 137 ILLTDNGDVKLADFGVAAKITATIAKR---KSFIGTPYWMAPEVAAVEKNGGYN-QLCDI 192
Query: 119 WSCGVILFVLMAGFLP--FDESNLMALYRKICRADFSCPSW-----FSSGAKKLIKRILD 171
W+ G I + +A P FD + AL+ + +++F P +SS +K L
Sbjct: 193 WAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKWSSTFHNFVKISLT 250
Query: 172 PNPDTRMTISQML 184
NP R T ++L
Sbjct: 251 KNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 4 KTKIYIVLEFIDG---GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K Y+V E++D G L + ED + + +QL+ ++YCH + HRD+K
Sbjct: 88 KGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKC 144
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVLNDKGYDGRASDVW 119
N+LL++ G +K++DFGL+ + E+ +T T Y PE+L + G A DVW
Sbjct: 145 SNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVW 202
Query: 120 SCGVILFVLMAGFLPFDESNLMA---------------------------------LYRK 146
SCG IL L F + +A YR+
Sbjct: 203 SCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRR 262
Query: 147 ICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188
R +F S+ + A L+ +L +P R T + L W
Sbjct: 263 RLREEF---SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 69/227 (30%), Positives = 99/227 (43%), Gaps = 49/227 (21%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR------YFQQLINAVDYCHSRGVFHR 56
S+ ++Y+V E++D D + KH D A+ Y Q++ + YCHS V HR
Sbjct: 72 SEKRLYLVFEYLD----LD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR 126
Query: 57 DLKPENLLLD-SYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 114
DLKP+NLL+D LK++DFGL+ A VR H T Y APE+L +
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPEILLGSRHYST 183
Query: 115 ASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICR----------------ADF--SC 154
D+WS G I F M P +S + L+ KI R D+ +
Sbjct: 184 PVDIWSVGCI-FAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTSLPDYKSAF 241
Query: 155 PSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
P W L+ ++L +P R+T LE E+FK
Sbjct: 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 17/129 (13%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+++E++ G L D + +H R + + R + Q+ +DY S+ HRDL N+L++
Sbjct: 85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE 143
Query: 67 SYGVLKISDFGLSAISQQ------VREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVW 119
S ++KISDFGL+ + + V+E G P + APE L + ASDVW
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGES------PIFWYAPECLRTSKFS-SASDVW 196
Query: 120 SCGVILFVL 128
S GV L+ L
Sbjct: 197 SFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 19/194 (9%)
Query: 6 KIYIVLEFIDGGELFDKIA---KHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++++VLE +GG + D + K G R++E + + + + H HRD+K
Sbjct: 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153
Query: 62 NLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGR 114
N+LL + G +K+ DFG+SA S ++R + T+ GTP ++APEV+ D YD R
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWMAPEVIACEQQLDSTYDAR 209
Query: 115 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---ADFSCPSWFSSGAKKLIKRILD 171
DVWS G+ L G P + + M KI R P +S+ I++ L
Sbjct: 210 C-DVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLT 268
Query: 172 PNPDTRMTISQMLE 185
+ + R T+S +L+
Sbjct: 269 KDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 45/129 (34%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF-QQLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+ E ++ +I + G+ D + F Q++ + Y HS V HRDLKP NLL+
Sbjct: 81 LYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138
Query: 66 DSYGVLKISDFGLS-AISQ-QVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCG 122
++ LKI DFGL+ S+ G + T Y APE+ L+ + Y +A DVWS G
Sbjct: 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYT-KAIDVWSVG 197
Query: 123 VILFVLMAG 131
IL L+
Sbjct: 198 CILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 46/133 (34%), Positives = 67/133 (50%), Gaps = 2/133 (1%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
IY+V E + +L I L D + + Q++ + Y HS G+ HRD+KP NLL++
Sbjct: 79 IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 137
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S VLKI DFGL A ++ E + T Y APE+L + A D+WS G I
Sbjct: 138 SNCVLKICDFGL-ARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 127 VLMAGFLPFDESN 139
L+ + F +
Sbjct: 197 ELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 40/121 (33%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V++ + +L I L E+ R + QL+ + Y HS V HRDLKP NLL++
Sbjct: 83 VYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN 141
Query: 67 SYGVLKISDFGL--SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
L+I DFG+ S + T Y APE+L A D+WS G I
Sbjct: 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201
Query: 125 L 125
Sbjct: 202 F 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-15
Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 6/135 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHSRGVFHRDLKP 60
SKT + +V+ ++GG+L I G + R Y Q+ + + HS + +RD+KP
Sbjct: 64 SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKP 123
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD G ++SD GL+ ++++ + GT Y+APE+L ++ Y D ++
Sbjct: 124 ENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVDWFA 179
Query: 121 CGVILFVLMAGFLPF 135
G ++ ++AG PF
Sbjct: 180 MGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 46/130 (35%), Positives = 70/130 (53%), Gaps = 6/130 (4%)
Query: 4 KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ K+Y+V E+++ EL +++ + ++ R Y QLI A+ +CH + HRD+KPE
Sbjct: 72 RGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPE 129
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
NLL+ VLK+ DFG A + + T Y +PE+L Y G+A D+WS
Sbjct: 130 NLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSV 187
Query: 122 GVILFVLMAG 131
G IL L G
Sbjct: 188 GCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 6 KIYIVLEFIDGG---ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++++VLE +GG EL + G RL E + + + H+ + HRD+K
Sbjct: 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGN 157
Query: 62 NLLLDSYGVLKISDFGLSA--ISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGR 114
N+LL + G +K+ DFG+SA S ++R + T+ GTP ++APEV+ D YD R
Sbjct: 158 NILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFWMAPEVIACEQQYDYSYDAR 213
Query: 115 ASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICR---ADFSCPSWFSSGAKKLIKRIL 170
DVWS G+ L G P FD + L+ KI R P + I + L
Sbjct: 214 C-DVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRNPPPTLLHPEKWCRSFNHFISQCL 271
Query: 171 DPNPDTRMTISQMLEDEWFK 190
+ + R +++ +LE + K
Sbjct: 272 IKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 47/128 (36%), Positives = 65/128 (50%), Gaps = 10/128 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K IYIV+E + GG+ + G RLK E + + ++Y S+ HRDL N
Sbjct: 65 KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN 124
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYDGRASDV 118
L+ VLKISDFG+S + EDG+ + G + APE LN Y SDV
Sbjct: 125 CLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SDV 179
Query: 119 WSCGVILF 126
WS G++L+
Sbjct: 180 WSFGILLW 187
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 7 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLL 64
I + +EF+D G L D+I K G + + + ++ + Y ++ + HRD+KP N+L
Sbjct: 78 ICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136
Query: 65 LDSYGVLKISDFGLS-----AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
++S G +K+ DFG+S +I+ T GT Y++PE + Y + SDVW
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIAD---------TFVGTSTYMSPERIQGGKYTVK-SDVW 186
Query: 120 SCGVILFVLMAGFLPFDESN------------LMALYRKICRADFSCPS-WFSSGAKKLI 166
S G+ + L G PF SN L L + + PS F + +
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFV 246
Query: 167 KRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
L +P R T Q+ F + + + D
Sbjct: 247 DACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 29 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 88
L+E E + + Y HS HRD+K N+LL G +K++DFG +++
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168
Query: 89 GLLHTACGTPNYVAPEVL--NDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALY 144
++ GTP ++APEV+ D+G YDG+ DVWS G+ L P N M ALY
Sbjct: 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGITCIELAERKPPLFNMNAMSALY 224
Query: 145 RKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
I + D S W S + + L P R + ++L+ + + +PP
Sbjct: 225 H-IAQNDSPTLSSNDW-SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE-RPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 7 IYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+YIV EF++ G L + + + G+L +D Q + ++Y HRDL N L+
Sbjct: 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVWSCG 122
S GV+K+SDFG+ ++ V +D ++ G + PEV N Y + SDVWS G
Sbjct: 134 SSTGVVKVSDFGM---TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSK-SDVWSFG 188
Query: 123 VILF-VLMAGFLPFDESNLMALYRKICRAD 151
V+++ V G +PF++ + + I R
Sbjct: 189 VLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 13/187 (6%)
Query: 7 IYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
IYIV+E + GG+ + K LK + ++ + Y S+ HRDL N L+
Sbjct: 67 IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----YVAPEVLNDKGYDGRASDVWSC 121
VLKISDFG+S +ED ++++ G + APE LN Y SDVWS
Sbjct: 127 GENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE-SDVWSY 180
Query: 122 GVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
G++L+ + G P+ ++ + SCP K+++R D P+ R
Sbjct: 181 GILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240
Query: 180 ISQMLED 186
S++ ++
Sbjct: 241 FSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 46/131 (35%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K IYIV+E + GG L + K RL + + ++Y S+ HRDL
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG----TP-NYVAPEVLNDKGYDGRA 115
N L+ VLKISDFG+S E+G ++T P + APE LN Y
Sbjct: 122 RNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS-E 175
Query: 116 SDVWSCGVILF 126
SDVWS G++L+
Sbjct: 176 SDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-14
Identities = 26/94 (27%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 256 VKRETRFTSQRPPNEIMSKIEEAAKPLGFN--VRKGNYKMKLQG--DKTGRKGQLSVATE 311
K E S+ P+EI I + + G N R N+ + + D E
Sbjct: 2 KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61
Query: 312 VFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 345
V+EV P L +V+ +K G T F K K L
Sbjct: 62 VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 49/147 (33%), Positives = 78/147 (53%), Gaps = 11/147 (7%)
Query: 6 KIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
++++V+EF G + D I K LKE+ ++++ + + H V HRD+K +N+
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDV 118
LL +K+ DFG+SA Q R G +T GTP ++APEV+ D YD + SD+
Sbjct: 143 LLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDL 199
Query: 119 WSCGVILFVLMAGFLPF-DESNLMALY 144
WS G+ + G P D + AL+
Sbjct: 200 WSLGITAIEMAEGAPPLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 25/154 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---------V 53
S +I I +E +DGG L D++ K EA+R ++++ V RG +
Sbjct: 74 SDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 114 RASDVWSCGVILFVLMAGFLPF---DESNLMALY 144
+ SD+WS G+ L L G P D L A++
Sbjct: 182 Q-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 46/255 (18%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
Y+V+ F+ G K+ KH +L ED + Q++ + Y H+ G+ HRDLKP NL
Sbjct: 93 HDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLA 150
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
++ LKI DFGL+ + D + T Y APEV+ + + + D+WS G I
Sbjct: 151 VNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205
Query: 125 LFVLMAGFLPF------------------------------DESNLMALYRKICRADF-S 153
+ ++ G F D N + + + DF S
Sbjct: 206 MAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS 265
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV-----NLDD 208
+ A +++++L + ++R+T ++ L +F++ + P + E E + D+
Sbjct: 266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP---EDETEAPPYDDSFDE 322
Query: 209 VDAIFNDSKENLVTE 223
VD + K TE
Sbjct: 323 VDQSLEEWKRLTFTE 337
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---------V 53
S +I I +E +DGG L D++ K +A R + ++ + RG +
Sbjct: 70 SDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLTYLREKHKI 121
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRD+KP N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYTV 177
Query: 114 RASDVWSCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKLIKRIL 170
+ SD+WS G+ L + G P D L A+ F P +
Sbjct: 178 Q-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAM--------FGRPVSEGEAKESHRPVSG 228
Query: 171 DPNPDTR-MTISQMLE 185
P R M I ++L+
Sbjct: 229 HPPDSPRPMAIFELLD 244
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 44/128 (34%), Positives = 65/128 (50%), Gaps = 9/128 (7%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IY V E + G ++ L++ + + Q++ + Y HS GV HRDLKP N+L
Sbjct: 83 EDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGV 123
++ LKI DFGL+ I Q + G + T Y APE+ L + YD D+WS G
Sbjct: 141 INENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIMLTWQKYD-VEVDIWSAGC 194
Query: 124 ILFVLMAG 131
I ++ G
Sbjct: 195 IFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 45/133 (33%), Positives = 73/133 (54%), Gaps = 6/133 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPE 61
S +I I +E +DGG L + K GR+ E + +I + Y + + HRD+KP
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+L++S G +K+ DFG+S Q + D + ++ GT +Y++PE L Y + SD+WS
Sbjct: 134 NILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSM 188
Query: 122 GVILFVLMAGFLP 134
G+ L + G P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 45/127 (35%), Positives = 67/127 (52%), Gaps = 10/127 (7%)
Query: 3 SKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
S K+ +V E+ D + FD + +G + + + + QL+ + +CHS V HRDLKP
Sbjct: 70 SDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP 127
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDV 118
+NLL++ G LK++DFGL+ A VR T Y P+VL K Y + D+
Sbjct: 128 QNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGAKLYS-TSIDM 183
Query: 119 WSCGVIL 125
WS G I
Sbjct: 184 WSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 46/184 (25%)
Query: 36 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED------- 88
F ++ ++Y HS+GV HRDLKP+N+LL +G + I D+G AI +++ E+
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA-AIFKKLEEEDLLDIDV 175
Query: 89 ---GLLHTA-------CGTPNYVAPEVLNDKGYDGRAS-DVWSCGVILF-VLMAGF---- 132
+ +++ GTP+Y+APE L G S D+++ GVIL+ +L F
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRR 233
Query: 133 -----LPFDESNL----MALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
+ + + L +A YR+I P + S ++ + L +P R + Q
Sbjct: 234 KKGRKISYRDVILSPIEVAPYREI-------PPFLS----QIAMKALAVDPAERYSSVQE 282
Query: 184 LEDE 187
L+ +
Sbjct: 283 LKQD 286
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 44/125 (35%), Positives = 67/125 (53%), Gaps = 9/125 (7%)
Query: 4 KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+TK+ +V E +D DK+ G L + + +Q + +D+ H+ + HRDLKPE
Sbjct: 79 ETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137
Query: 62 NLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+L+ S G +K++DFGL+ I S Q+ ++ T Y APEVL Y D+WS
Sbjct: 138 NILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRAPEVLLQSTY-ATPVDMWS 192
Query: 121 CGVIL 125
G I
Sbjct: 193 VGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 49/139 (35%), Positives = 76/139 (54%), Gaps = 14/139 (10%)
Query: 7 IYIVLEFIDGG--ELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPEN 62
++I +E +D + + K+ G + ED + ++ A++Y HS+ V HRD+KP N
Sbjct: 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPE----VLNDKGYDGRASD 117
+L++ G +K+ DFG+S V D + T G Y+APE LN KGYD + SD
Sbjct: 135 VLINRNGQVKLCDFGISG--YLV--DSVAKTIDAGCKPYMAPERINPELNQKGYDVK-SD 189
Query: 118 VWSCGVILFVLMAGFLPFD 136
VWS G+ + L G P+D
Sbjct: 190 VWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 49/206 (23%)
Query: 28 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI----SQ 83
+L E + + Y QL+ ++Y H + HRD+K N+L+D+ G+LKI+DFGL+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 84 QVREDGLLHTACGTPN-----YVAPE-VLNDKGYDGRASDVWSCGVIL------------ 125
+ G T T Y PE +L ++ Y A D+W G +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQG 229
Query: 126 ----------FVLMAGFLPFDESNLMALYRKI--CRADFSCPSW----------FSSGAK 163
F L P +E+ +R + C S ++
Sbjct: 230 KSDIDQLHLIFKLCGT--PTEET--WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL 285
Query: 164 KLIKRILDPNPDTRMTISQMLEDEWF 189
L+ ++L +P R+T S LE +F
Sbjct: 286 DLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 10/122 (8%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV E++ G L D + GR + + + + ++Y + HRDL N+L
Sbjct: 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGV 123
+ V K+SDFGL+ + Q ++ G L P + APE L +K + + SDVWS G+
Sbjct: 135 VSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEALREKKFSTK-SDVWSFGI 187
Query: 124 IL 125
+L
Sbjct: 188 LL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 3/122 (2%)
Query: 9 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+V+E++ G L D + KH RL + Y Q+ ++Y S+ HRDL N+L++S
Sbjct: 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVLNDKGYDGRASDVWSCGVILF 126
+KI DFGL+ + Q +E + +P + APE L + + ASDVWS GV+L+
Sbjct: 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
Query: 127 VL 128
L
Sbjct: 203 EL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 31/78 (39%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+K + +V E++D +L + G L R + QL+ + YCH R V HRDLKP+
Sbjct: 74 TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQ 132
Query: 62 NLLLDSYGVLKISDFGLS 79
NLL+ G LK++DFGL+
Sbjct: 133 NLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 9/137 (6%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEAR--RYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV+E + G L + + GR + ++ + ++Y S+ + HRDL N+L
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ GV K+SDFGL+ + ++ L + APE L K + + SDVWS GV+
Sbjct: 133 VSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSK-SDVWSYGVL 186
Query: 125 LF-VLMAGFLPFDESNL 140
L+ V G P+ + +L
Sbjct: 187 LWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 46/128 (35%), Positives = 72/128 (56%), Gaps = 15/128 (11%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
+++E++ G L D + KH +L + + QQ+ + Y HS+ HRDL N+LLD+
Sbjct: 85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143
Query: 69 GVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNY-VAPEVLNDKGYDGRASDVWSC 121
++KI DFGL+ A+ + +VREDG +P + A E L + + ASDVWS
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVECLKENKF-SYASDVWSF 196
Query: 122 GVILFVLM 129
GV L+ L+
Sbjct: 197 GVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 46/125 (36%), Positives = 68/125 (54%), Gaps = 9/125 (7%)
Query: 4 KTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+TK+ +V E +D DK+ + G + + + QL+ +D+ HS V HRDLKP+
Sbjct: 81 ETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 139
Query: 62 NLLLDSYGVLKISDFGLSAI-SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+L+ S G +K++DFGL+ I S Q+ L + T Y APEVL Y D+WS
Sbjct: 140 NILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSY-ATPVDLWS 194
Query: 121 CGVIL 125
G I
Sbjct: 195 VGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 9/135 (6%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K +YIV E++ G L D + GR L D ++ + A++Y + HRDL
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR 131
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+L+ V K+SDFGL+ + ++ G L + APE L +K + + SDVWS
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTK-SDVWSF 185
Query: 122 GVILFVLMA-GFLPF 135
G++L+ + + G +P+
Sbjct: 186 GILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 42 INAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPN 99
+ A++Y + HRD+KP N+LLD G +K+ DFG IS Q+ D + T G
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQL-VDSIAKTRDAGCRP 172
Query: 100 YVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESN 139
Y+APE ++ GYD R SDVWS G+ L+ + G P+ + N
Sbjct: 173 YMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 42/126 (33%), Positives = 68/126 (53%), Gaps = 5/126 (3%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
I +++EF+ G L + + ++ ++ + +Y Q+ +DY SR HRDL N+L+
Sbjct: 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-VAPEVL-NDKGYDGRASDVWSCGV 123
+S +KI DFGL+ + +E + +P + APE L K Y ASDVWS GV
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY--IASDVWSFGV 200
Query: 124 ILFVLM 129
L+ L+
Sbjct: 201 TLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 41/143 (28%), Positives = 75/143 (52%), Gaps = 7/143 (4%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
++Y+V + G + I K +L ++ + QL+ + Y HS G+ HRDLKP N+
Sbjct: 93 NEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVA 150
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
++ L+I DFGL ++Q ++ + A T Y APE++ + + + D+WS G I
Sbjct: 151 VNEDCELRILDFGL---ARQADDEMTGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCI 205
Query: 125 LFVLMAGFLPFDESNLMALYRKI 147
+ L+ G F ++ + ++I
Sbjct: 206 MAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 49/235 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E +D L I H L + Q++ + + HS G+ HRDLKP N+++
Sbjct: 101 VYLVMELMDA-NLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S LKI DFGL ++ + ++ T Y APEV+ GY D+WS G I+
Sbjct: 158 SDCTLKILDFGL---ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMG 213
Query: 127 VLMAGFLPFDESNLMALYRKICR------ADFSC-------------------------P 155
L+ G + F ++ + + K+ A+F P
Sbjct: 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP 273
Query: 156 SWF-----------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
W +S A+ L+ ++L +PD R+++ + L + Y P +
Sbjct: 274 DWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 3/103 (2%)
Query: 33 EARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH 92
+ R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG + ++ RE +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDY 326
Query: 93 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLP 134
GT +PE+L GY +D+WSCG+IL +++ F P
Sbjct: 327 GWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCP 368
|
Length = 501 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
I+IV E++ G L + + + G+L + + A++Y S G HRDL N L+
Sbjct: 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV 133
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVLNDKGYDGRASDVWSC 121
V+K+SDFGL ++ V +D +T+ + PEV + + + SDVWS
Sbjct: 134 GEDNVVKVSDFGL---ARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSRFSSK-SDVWSF 187
Query: 122 GVILF-VLMAGFLPFD 136
GV+++ V G +P++
Sbjct: 188 GVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 10/138 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
IYIV E++ G L + + +HG R + + + + + Y S+ HRDL N L+
Sbjct: 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVWSCG 122
D G +K+SDFGL S+ V +D ++ G+ + PEVL + + SDVW+ G
Sbjct: 134 DDQGCVKVSDFGL---SRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSK-SDVWAFG 188
Query: 123 VILF-VLMAGFLPFDESN 139
V+++ V G +P++ N
Sbjct: 189 VLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 41/229 (17%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
I +V++ + +L + + RL E + + Q++N ++ H HRDL P N+ ++
Sbjct: 95 INLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN 153
Query: 67 SYGVLKISDFGLS---AISQQVREDGLLHTACGTPN---------YVAPEVLNDKGYDGR 114
S G+ KI+DFGL+ T Y APE+L
Sbjct: 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHF 213
Query: 115 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKI---------------------CRADFS 153
A D+WS G I L+ G F N + +I
Sbjct: 214 AVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR 273
Query: 154 CPSWFSSGAK-------KLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195
P + L++ +L NP R++ + L+ E+FK P
Sbjct: 274 KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 16/177 (9%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V + G + I K +L +D + Q++ + Y HS + HRDLKP NL ++
Sbjct: 97 VYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 154
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
LKI DFGL+ D + T Y APE++ + + + D+WS G I+
Sbjct: 155 EDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 127 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183
L+ G F ++ + + I R + + +L+K+I + R I +
Sbjct: 210 ELLTGRTLFPGTDHIDQLKLILRLVGTPGA-------ELLKKI--SSESARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 44/204 (21%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-------AVDYCHSRGVFHRDLKPE 61
I+ E+++ G L DK L+E++ + QL+ + Y HRDL
Sbjct: 82 IITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAAR 135
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVLNDKGYDGRASDVW 119
N+L++S V K+SDFGLS + + T G P + APE + + + ASDVW
Sbjct: 136 NILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVW 192
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILD----PNP- 174
S G++++ +M+ + E P W S + +IK + D P P
Sbjct: 193 SFGIVMWEVMS----YGER----------------PYWDMSN-QDVIKAVEDGYRLPPPM 231
Query: 175 DTRMTISQMLEDEWFKKGYKPPHF 198
D + Q++ D W K + P F
Sbjct: 232 DCPSALYQLMLDCWQKDRNERPTF 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 27 GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 86
L D+A +Q++ + Y H++ + HRD+K EN+ ++ + I D G A V
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG--AAQFPVV 209
Query: 87 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA 130
L A GT APEVL Y+ +A D+WS G++LF ++A
Sbjct: 210 APAFLGLA-GTVETNAPEVLARDKYNSKA-DIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 39 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 98
+QL++A+DY H G+ HRD+K EN+L++ + + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 99 NYVAPEVLNDKGYDGRASDVWSCGVILF 126
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
IY+V E ++ +L I + L + + + QL+ A+ Y H+ VFHRDLKP+N+L +
Sbjct: 79 IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN 137
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGR---ASDVWSCG 122
+ LKI DFGL+ ++ + T T Y APE+ + + A D+WS G
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG--SFFSKYTPAIDIWSIG 195
Query: 123 VILFVLMAG 131
I ++ G
Sbjct: 196 CIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 44/137 (32%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+K + +V E++ +L + KH G L + + + QL+ + Y H R + HRDLKP+
Sbjct: 74 TKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQ 132
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG---TPNYVAPEVLNDKGYDGRASDV 118
NLL+ G LK++DFGL A ++ V HT T Y P+VL D+
Sbjct: 133 NLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 119 WSCGVILFVLMAGFLPF 135
W G I ++ G F
Sbjct: 188 WGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 10/133 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+K + V E++ +L + +H G L R + QL+ + Y H + + HRDLKP+
Sbjct: 74 TKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQ 132
Query: 62 NLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
NLL+ G LK++DFGL+ +I Q ++ T Y P+VL A D+
Sbjct: 133 NLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSSALDI 187
Query: 119 WSCGVILFVLMAG 131
W G I ++ G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 13/122 (10%)
Query: 7 IYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYF-QQLINAVDYCHSRGVFHRDLKPENL 63
+Y+V+E +D ++ H R+ Y Q++ + + HS G+ HRDLKP N+
Sbjct: 96 VYLVMELMDANLCQVIQMDLDHERMS------YLLYQMLCGIKHLHSAGIIHRDLKPSNI 149
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
++ S LKI DFGL+ + ++ T Y APEV+ GY D+WS G
Sbjct: 150 VVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGC 205
Query: 124 IL 125
I+
Sbjct: 206 IM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 8 YIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
++V+E+ G D + H + L+E E + + Y HS + HRD+K N+LL
Sbjct: 97 WLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 155
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKG-YDGRASDVWSCGV 123
G +K++DFG ++ S ++ GTP ++APEV+ D+G YDG+ DVWS G+
Sbjct: 156 EPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 208
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
L P N M+ I + D W + + + L P R
Sbjct: 209 TCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKIPQERPAS 267
Query: 181 SQMLEDEWFKKGYKPP 196
+++L ++ ++ +P
Sbjct: 268 AELLRHDFVRRD-RPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHTACG 96
QL+ + YCH R + HRDLKP+NLL++ G LK++DFGL+ ++ + + ++
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165
Query: 97 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 131
T Y P+VL D+W G IL+ + G
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHT 93
+ Q++ + YCH R V HRDLKP+NLL++ G LK++DFGL+ ++ + + ++
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-- 166
Query: 94 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 131
T Y P+VL D+W G I F + +G
Sbjct: 167 ---TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV+E +D + + +++ D R + Q++ + + HS G+ HRDLKP N++
Sbjct: 104 VYIVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ S LKI DFGL ++ ++ T Y APEV+ GY D+WS G I
Sbjct: 159 VKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCI 214
Query: 125 LFVLMAGFLPFDESNLMALYRKI 147
+ ++ G + F ++ + + K+
Sbjct: 215 MGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 23/147 (15%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARR--------YFQQLINAVDYCHSRG 52
+ +K IYI+ EF+ G L D LK DE + + Q+ + + R
Sbjct: 69 VVTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 53 VFHRDLKPENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLNDK 109
HRDL+ N+L+ + V KI+DFGL+ + ++ +G A + APE +N
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----AKFPIKWTAPEAINFG 178
Query: 110 GYDGRASDVWSCGVILF-VLMAGFLPF 135
+ + SDVWS G++L ++ G +P+
Sbjct: 179 SFTIK-SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 61/206 (29%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAISQQ-----VREDGL 90
Q++N V Y HS V HRDLKP N+L+ GV+KI D GL+ + D +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 91 LHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVI---LFVLMAGF----------LPFD 136
+ T Y APE+ L + Y +A D+W+ G I L L F PF
Sbjct: 176 VVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230
Query: 137 ESNLMAL--------------------YRKICRADFSCPSWFSSGAK------------- 163
L + Y + + + +S AK
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 164 KLIKRILDPNPDTRMTISQMLEDEWF 189
L++++L+ +P R+T + LE +F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS---AISQQVREDGLLHT 93
+ QL+ ++YCH R V HRDLKP+NLL++ G LK++DFGL+ +I + + ++
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-- 166
Query: 94 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 131
T Y P++L D+W G I + + G
Sbjct: 167 ---TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 46/142 (32%), Positives = 73/142 (51%), Gaps = 13/142 (9%)
Query: 8 YIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
++V+E+ G D + H + L+E E + + Y HS + HRD+K N+LL
Sbjct: 101 WLVMEYCLGSA-SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 159
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDGRASDVWSCGV 123
G +K++DFG ++I+ ++ GTP ++APEV +++ YDG+ DVWS G+
Sbjct: 160 EPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 212
Query: 124 ILFVLMAGFLPFDESNLM-ALY 144
L P N M ALY
Sbjct: 213 TCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 10/138 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ I +V EF++ G L D + A+ G+ ++ + + Y S V HRDL N
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVW 119
L+ V+K+SDFG++ D ++ GT + +PEV + Y + SDVW
Sbjct: 131 CLVGENQVVKVSDFGMTRFVL----DDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-SDVW 185
Query: 120 SCGVILF-VLMAGFLPFD 136
S GV+++ V G P++
Sbjct: 186 SFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 3/126 (2%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ IV E+++ G L + KH G+ + + + + + Y G HRDL N+L+
Sbjct: 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV 139
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGVI 124
+S V K+SDFGLS + + E P + APE + + + ASDVWS G++
Sbjct: 140 NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIV 198
Query: 125 LFVLMA 130
++ +M+
Sbjct: 199 MWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 13/142 (9%)
Query: 8 YIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
++V+E+ G D + H + L+E E + + Y HS + HRD+K N+LL
Sbjct: 91 WLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDGRASDVWSCGV 123
G++K+ DFG ++I + GTP ++APEV +++ YDG+ DVWS G+
Sbjct: 150 EPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGI 202
Query: 124 ILFVLMAGFLPFDESNLM-ALY 144
L P N M ALY
Sbjct: 203 TCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 11/121 (9%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYF--QQLINAVDYCHSRGVFHRDLKPENLL 64
+Y+V+E +D + + +++ D R + Q++ + + HS G+ HRDLKP N++
Sbjct: 97 VYLVMELMDA-----NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ S LKI DFGL ++ ++ T Y APEV+ GY D+WS G I
Sbjct: 152 VKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCI 207
Query: 125 L 125
+
Sbjct: 208 M 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 46/137 (33%), Positives = 63/137 (45%), Gaps = 28/137 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARR-YFQQLI-------NAVDYCHSRGVFHRDL 58
IYIV E++ G L D LK E ++ QL+ + Y SR HRDL
Sbjct: 76 IYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGR- 114
N+L+ V KI+DFGL+ ++ ED G + APE N Y GR
Sbjct: 130 AARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIKWTAPEAAN---Y-GRF 181
Query: 115 --ASDVWSCGVILFVLM 129
SDVWS G++L ++
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 39/110 (35%), Positives = 57/110 (51%), Gaps = 6/110 (5%)
Query: 22 KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81
KI H L ED+ + Q++ + Y HS G+ HRDLKP NL ++ LKI DFGL+
Sbjct: 108 KIMGH-PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165
Query: 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 131
D + T Y APEV+ + + + D+WS G I+ ++ G
Sbjct: 166 ----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 19/193 (9%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQQLINAVDYCHSRGVFHRD 57
+ +V E G L D RL++D Y Q+ N + Y S+ HRD
Sbjct: 69 PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRD 122
Query: 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRAS 116
L N+LL S +KI DFGL Q + ++ P + APE L + + AS
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS-HAS 181
Query: 117 DVWSCGVILF-VLMAGFLPFDESNLMALYRKICRAD--FSCPSWFSSGAKKLIKRILDPN 173
DVW GV L+ + G P+ + + +KI + P ++ + N
Sbjct: 182 DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHN 241
Query: 174 PDTRMTISQMLED 186
P R T + + E
Sbjct: 242 PADRPTFAALREF 254
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++IV+E GEL + + L Y QL A+ Y S+ HRD+ N+L+
Sbjct: 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVWSCG 122
S +K+ DFGLS + ED + A ++APE +N + + ASDVW G
Sbjct: 141 SSPDCVKLGDFGLS----RYLEDESYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFG 195
Query: 123 VILF-VLMAGFLPF 135
V ++ +LM G PF
Sbjct: 196 VCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ--QLINAVDYCHSRGVFHRDLKPENLLL 65
YI+ EF+ G L D + + R + + + Q+ +A++Y + HRDL N L+
Sbjct: 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137
Query: 66 DSYGVLKISDFGLSAISQQVREDGLL-HTACGTP-NYVAPEVLNDKGYDGRASDVWSCGV 123
++K++DFGLS + + D H P + APE L + + SDVW+ GV
Sbjct: 138 GENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGV 193
Query: 124 ILF-VLMAGFLPFDESNLMALYRKI 147
+L+ + G P+ +L +Y +
Sbjct: 194 LLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 38/169 (22%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 96
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 226
Query: 97 TPNYV------------APEVLNDKGYDGRASDVWSCGVIL---FVLMAGFLP---FDES 138
P+YV APE + DK Y + SDVWS GV+L F L A P DE
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
Query: 139 NLMALYR--KICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
L ++ +++ P +S ++ NP+ R T S+++E
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYS-----IMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 7 IYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQ-QLINAVDYCHSRGVFHRDLKPENLL 64
+YI+ E ++ G L + G++ + Q+ + Y + HRDL N+L
Sbjct: 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGV 123
+ V K++DFGL+ + ++ED L + P + APE + + + SDVWS G+
Sbjct: 137 VGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGTFSTK-SDVWSFGI 192
Query: 124 ILFVLMA-GFLPFDESN-------LMALYRKICRADFSCP 155
+L+ + G +P+ N + A YR C A CP
Sbjct: 193 LLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA--KCP 230
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 11/135 (8%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IYI+ E++ G L D K + G++ + + Q+ + Y + HRDL+ N+L
Sbjct: 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRASDVWSC 121
+ + KI+DFGL+ +V ED G + APE +N + + SDVWS
Sbjct: 136 VSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSF 190
Query: 122 GVILF-VLMAGFLPF 135
G++L+ ++ G +P+
Sbjct: 191 GILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 15/154 (9%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--T 97
Q+ ++Y SR HRDL N+L+ V+KI+DFGL+ + D T+ G
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYKKTSNGRLP 199
Query: 98 PNYVAPEVLNDKGYDGRASDVWSCGVIL---FVLMAG---FLPFDESNLMALYRKICRAD 151
++APE L D+ Y SDVWS G+++ F L +P +E L L R+ R D
Sbjct: 200 VKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLLREGHRMD 256
Query: 152 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
PS + L++ P R T Q++E
Sbjct: 257 --KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 3 SKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ IYI+ E+++ G L D K + +L ++ Q+ + + + HRDL+
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRA 130
Query: 61 ENLLLDSYGVLKISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 117
N+L+ KI+DFGL+ + ++ +G A + APE +N G SD
Sbjct: 131 ANILVSETLCCKIADFGLARLIEDNEYTAREG----AKFPIKWTAPEAIN-YGTFTIKSD 185
Query: 118 VWSCGVILF-VLMAGFLPFDE-------SNLMALYRKICRADFSCPSWFSSGAKKLIKRI 169
VWS G++L ++ G +P+ NL YR +CP L++
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD--NCPEELYE----LMRLC 239
Query: 170 LDPNPDTRMT---ISQMLED 186
P+ R T + +LED
Sbjct: 240 WKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 37/204 (18%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI-------NAVDYCHSRGVFHRDLK 59
+ I+ EF++ G L D L++++ + QL+ + Y HRDL
Sbjct: 80 VMIITEFMENGAL-DSF-----LRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA 133
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP---NYVAPEVLNDKGYDGRAS 116
N+L++S V K+SDFGLS + D ++ G + APE + + + AS
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS-AS 192
Query: 117 DVWSCGVILFVLMA-GFLPF-DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNP 174
DVWS G++++ +M+ G P+ D SN + D+ P P
Sbjct: 193 DVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP----------------PPM 234
Query: 175 DTRMTISQMLEDEWFKKGYKPPHF 198
D + Q++ D W K P F
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKF 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--T 97
Q+ ++Y S+ HRDL N+L+ V+KI+DFGL+ + D T G
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYYKKTTNGRLP 205
Query: 98 PNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLMALYRKICRADFS 153
++APE L D+ Y + SDVWS GV+L+ + G P+ L L ++ R D
Sbjct: 206 VKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK- 263
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186
PS ++ +++ P R T Q++ED
Sbjct: 264 -PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 58/196 (29%), Positives = 84/196 (42%), Gaps = 15/196 (7%)
Query: 1 MASKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+ S+ IYIV EF+ G L D K LK + Q+ + + Y HRDL
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR---A 115
+ N+L+ V KI+DFGL+ + + E A + APE GR
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----ALYGRFTIK 183
Query: 116 SDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPN 173
SDVWS G++L L+ G +P+ + ++ R CP +L+K +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243
Query: 174 PDTRMT---ISQMLED 186
PD R T I LED
Sbjct: 244 PDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 25/136 (18%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEAR--------RYFQ---QLINAVDYCHSRGVFHR 56
+V+E + G+L + R + + ++ Q ++ + + Y ++ HR
Sbjct: 85 LVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHR 143
Query: 57 DLKPENLLLDSYGVLKISDFGLSA-ISQQ--VREDG--LLHTACGTP-NYVAPEVLNDKG 110
DL N ++ +KI DFG++ I + R+ G LL P ++APE L D G
Sbjct: 144 DLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL------PVRWMAPESLKD-G 196
Query: 111 YDGRASDVWSCGVILF 126
SDVWS GV+L+
Sbjct: 197 VFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 39 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP 98
+ ++ A+ Y H + HRD+K EN+ ++ G + + DFG + + + A GT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTI 247
Query: 99 NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG 131
APE+L Y G A D+WS G++LF +
Sbjct: 248 ATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 35/134 (26%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
++ ++ + + G L D + H + + Q+ + Y + + HRDL N+L
Sbjct: 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVL 141
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGV 123
+ + +KI+DFGL+ + V E P ++A E + + Y + SDVWS GV
Sbjct: 142 VKTPQHVKITDFGLAKL-LDVDEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGV 199
Query: 124 ILFVLMA-GFLPFD 136
++ LM G P++
Sbjct: 200 TVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IYIV E + G L + + LK + Q+ + + Y ++ HRDL N+L
Sbjct: 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135
Query: 65 LDSYGVLKISDFGLSAISQQVREDGL-LHTACGTP-NYVAPEVLNDKGYDGRASDVWSCG 122
+ + K++DFGL+ + ++ED P + APE + + SDVWS G
Sbjct: 136 VGENNICKVADFGLARV---IKEDIYEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFG 191
Query: 123 VILFVLMA-GFLPF-DESNLMAL------YRKICRADFSCPSWFSSGAKKLIKRILD--- 171
++L ++ G +P+ +N L YR C CP K+L +LD
Sbjct: 192 ILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP--GCP-------KELYDIMLDCWK 242
Query: 172 PNPDTRMTISQM---LED 186
+PD R T + LED
Sbjct: 243 EDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+++Y+V + G D + H G L E + ++NA+DY HS+G HR +K
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 60 PENLLLDSYGVLKISDF--GLSAISQQVRE---DGLLHTACGTPNYVAPEVL--NDKGYD 112
++LL G + +S +S I R+ ++ +++PEVL N +GY+
Sbjct: 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYN 188
Query: 113 GRASDVWSCGVILFVLMAGFLPFDESNLMALY 144
+ SD++S G+ L G +PF + +
Sbjct: 189 EK-SDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 36/102 (35%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 96
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 227
Query: 97 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 126
P+YV APE + DK Y + SDVWS GV+L+
Sbjct: 228 -PDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 8/122 (6%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
+V+E + G L + K+ + E Q+ + Y HRDL N+LL +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ 131
Query: 69 GVLKISDFGLSAISQQVREDGLLHTACGTP----NYVAPEVLNDKGYDGRASDVWSCGVI 124
KISDFGL S+ + D + A + APE +N + + SDVWS GV+
Sbjct: 132 HYAKISDFGL---SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVL 187
Query: 125 LF 126
++
Sbjct: 188 MW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-------AVDYCHSRGVFHRDLKPE 61
I+ E+++ G L DK L++ + QL+ + Y HRDL
Sbjct: 83 IITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWS 120
N+L++S K+SDFGLS + + E + P + APE + + + ASDVWS
Sbjct: 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS-ASDVWS 195
Query: 121 CGVILFVLMA-GFLPF-DESN 139
G++++ +M+ G P+ D SN
Sbjct: 196 FGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 15/196 (7%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAK-HGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+ S+ IYIV E++ G L D + GR LK Q+ + Y HRDL
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR---A 115
+ N+L+ V KI+DFGL+ + + E A + APE GR
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEA----ALYGRFTIK 183
Query: 116 SDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPN 173
SDVWS G++L L+ G +P+ N + ++ R CP +L+ + +
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKD 243
Query: 174 PDTRMT---ISQMLED 186
P+ R T + LED
Sbjct: 244 PEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--T 97
Q+ ++Y S+ HRDL N+L+ V+KI+DFGL+ + D T G
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI--DYYKKTTNGRLP 199
Query: 98 PNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLMALYRKICRADFS 153
++APE L D+ Y SDVWS GV+L+ + G P+ L L ++ R D
Sbjct: 200 VKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-- 256
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186
P+ + +++ P R T Q++ED
Sbjct: 257 KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 40/122 (32%), Positives = 56/122 (45%), Gaps = 10/122 (8%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
+V+E G L + K + + + Q+ + Y S+ HRDL N+LL +
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR 131
Query: 69 GVLKISDFGLS----AISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGV 123
KISDFG+S A S R TA P + APE +N + + SDVWS GV
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECINYGKFSSK-SDVWSYGV 186
Query: 124 IL 125
L
Sbjct: 187 TL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 10/103 (9%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ + Y H RGV H+D+ N ++D +KI+D +A+S+ + H N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDY-HCLGDNEN 180
Query: 100 ----YVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 137
++A E L +K Y ASDVWS GV+L+ LM G P+ E
Sbjct: 181 RPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--T 97
Q+ ++Y S+ HRDL N+L+ V+KI+DFGL+ + D T G
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--DYYKKTTNGRLP 202
Query: 98 PNYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDE---SNLMALYRKICRADFS 153
++APE L D+ Y SDVWS GV+++ + G P+ L L ++ R D
Sbjct: 203 VKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-- 259
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186
P+ ++ +++ P R T Q++ED
Sbjct: 260 KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 1/118 (0%)
Query: 18 ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77
+LF + + G L ++A ++L+ A+ Y H RG+ HRD+K EN+ LD + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230
Query: 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
+ + + GT +PE+L Y + +D+WS G++LF + +
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--------DGLL 91
Q+ +++ S+ HRDL N+L+ V+KI+DFGL ++ + +G L
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL---ARDIHHIDYYRKTTNGRL 196
Query: 92 HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129
++APE L D+ Y SDVWS GV+L+ +
Sbjct: 197 PV-----KWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTP 98
Q+ ++Y S+ HRDL N +LD +K++DFGL+ I + HT P
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 99 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-------FDESNLMALYRKICRA 150
++A E L + + + SDVWS GV+L+ LM P FD + + R++ +
Sbjct: 166 VKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP 224
Query: 151 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186
++ CP ++ P P+ R T S+++
Sbjct: 225 EY-CPDPLYE----VMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 25/102 (24%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 96
Y Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 232
Query: 97 TPNYV------------APEVLNDKGYDGRASDVWSCGVILF 126
P+YV APE + D+ Y + SDVWS GV+L+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 14/146 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ ++++V F+ G D I H + E Q ++ A+DY H G HR +K
Sbjct: 70 ADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKA 129
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAPEVL--NDKGY 111
++L+ G + +S GL + + L P Y ++PEVL N +GY
Sbjct: 130 SHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY 187
Query: 112 DGRASDVWSCGVILFVLMAGFLPFDE 137
D + SD++S G+ L G +PF +
Sbjct: 188 DAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEA---------RRYFQQLIN-------AVDYCHS 50
+Y+ +E+ G L D + K L+ D A QQL++ +DY
Sbjct: 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDK 109
+ HRDL N+L+ V KI+DFGLS Q+V + T P ++A E LN
Sbjct: 143 KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY---VKKTMGRLPVRWMAIESLNYS 198
Query: 110 GYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 147
Y SDVWS GV+L+ ++ G P+ LY K+
Sbjct: 199 VYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 42/141 (29%), Positives = 67/141 (47%), Gaps = 11/141 (7%)
Query: 1 MASKTKIYIVLEFIDGGELFDKI-AKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+ S+ IYIV E++ G L D + + G+ L+ + Q+ + + Y HRDL
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR---A 115
+ N+L+ V K++DFGL+ + + E A + APE GR
Sbjct: 129 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEA----ALYGRFTIK 183
Query: 116 SDVWSCGVILFVLMA-GFLPF 135
SDVWS G++L L G +P+
Sbjct: 184 SDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 23/159 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYFQQLINAVDYCHS 50
+Y+ +E+ G L D + K L+ D A + + +DY
Sbjct: 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDK 109
+ HRDL N+L+ V KI+DFGLS + +E + T P ++A E LN
Sbjct: 131 KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLPVRWMAIESLNYS 186
Query: 110 GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 147
Y SDVWS GV+L+ +++ G P+ LY K+
Sbjct: 187 VYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 33/140 (23%)
Query: 19 LFDKIAKHGRLKEDEARRYFQQLI----NAVDYCHSR-GVFHRDLKPENLLLDSYGV--- 70
L D I KHG R+ Q+I A+DY H+ + H DLKPEN+L+++
Sbjct: 218 LLDWIMKHGPFSH----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273
Query: 71 -------------LKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRAS 116
++I D G + R TA T +Y +PEV+ G+ ++
Sbjct: 274 PVTNRALPPDPCRVRICDLGGCCDERHSR------TAIVSTRHYRSPEVVLGLGW-MYST 326
Query: 117 DVWSCGVILFVLMAGFLPFD 136
D+WS G I++ L G L +D
Sbjct: 327 DMWSMGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEA----------------RRYFQQLINAVDYCHS 50
+YI +E+ G L D + K L+ D A ++ + + Y
Sbjct: 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDK 109
+ HRDL N+L+ KI+DFGLS + E + T P ++A E LN
Sbjct: 138 KQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVKKTMGRLPVRWMAIESLNYS 193
Query: 110 GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 147
Y + SDVWS GV+L+ +++ G P+ LY K+
Sbjct: 194 VYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 20/192 (10%)
Query: 8 YIVLEFIDGGEL--FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV--------FHRD 57
Y++LE+ D G+L F + K K +Q + A+ + G+ HRD
Sbjct: 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIALGMDHLSNARFVHRD 142
Query: 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 117
L N L+ S +K+S LS E L A ++APE + + + + SD
Sbjct: 143 LAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SD 200
Query: 118 VWSCGVILF-VLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 172
VWS GV+++ V G LPF DE L L + + P S KL+ R
Sbjct: 201 VWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAV 258
Query: 173 NPDTRMTISQML 184
NP R + S+++
Sbjct: 259 NPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP 98
Q+ + Y + HRDL N+L+ +KISDFGLS ED + + G P
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RDVYEEDSYVKRSKGRIP 192
Query: 99 -NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFD---ESNLMALYRKICRADFS 153
++A E L D Y + SDVWS GV+L+ ++ G P+ L L + R +
Sbjct: 193 VKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER- 250
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186
P S L+ PD R T + + ++
Sbjct: 251 -PENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 42/187 (22%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
M SK Y V ++ G + K + + +Q++ A+D HS G+ HRD+KP
Sbjct: 226 MQSKEFPYNVEPYLLGK--VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283
Query: 61 ENLLLD-SYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVAPE---------- 104
+N++ G KI D G +A I+ +E L P Y APE
Sbjct: 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL------DPRYAAPEQYIMSTQTPS 337
Query: 105 ------------VLNDKGYDGRASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRA 150
VL R D++S G+I F+ MA P +SNL+ R++ R
Sbjct: 338 APSAPVATALSPVLWQLNLPDRF-DIYSAGLI-FLQMA--FPNLRSDSNLIQFNRQLKRN 393
Query: 151 DFSCPSW 157
D+ +W
Sbjct: 394 DYDLVAW 400
|
Length = 566 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 39/113 (34%), Positives = 61/113 (53%), Gaps = 5/113 (4%)
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTAC 95
Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG SA + + + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYIC- 232
Query: 96 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKI 147
+ Y APE++ D+WS G I+ ++ G+ F +S++ L R I
Sbjct: 233 -SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 28 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-S 82
+L + Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129
++ L T Y APE+L + +A D+W+ G I L+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDFGLSAI-SQQVREDGLLHTA 94
Q+++ + Y H+ V HRDLKP N+L+ G +KI+D G + + + ++ L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 95 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129
T Y APE+L + +A D+W+ G I L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 7 IYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
I ++ E+ G+L + + + L ++ + Q+ + + S+ HRDL N+L
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------------APEVLNDKGYD 112
L ++KI DFGL ++ + D NYV APE + + Y
Sbjct: 174 LTHGKIVKICDFGL---ARDIMNDS---------NYVVKGNARLPVKWMAPESIFNCVYT 221
Query: 113 GRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKRI 169
SDVWS G++L+ + + G P+ + + + K+ + + + P + ++K
Sbjct: 222 FE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTC 280
Query: 170 LDPNPDTRMTISQM 183
D +P R T Q+
Sbjct: 281 WDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 35/125 (28%), Positives = 59/125 (47%), Gaps = 7/125 (5%)
Query: 9 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
IV E++ G L + KH G+L + L + + Y G H+ L +L++S
Sbjct: 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS 142
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPN--YVAPEVLNDKGYDGRASDVWSCGVIL 125
V KIS F Q+ + + + T G + APE + + ASDVWS G+++
Sbjct: 143 DLVCKISGFRRL---QEDKSEAIYTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVM 198
Query: 126 FVLMA 130
+ +M+
Sbjct: 199 WEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 41/212 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFHRDLK 59
YI++E ++GG+L + + ++L++ +D Y HRDL
Sbjct: 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133
Query: 60 PENLLLDSYG-----VLKISDFGL-----SAISQQVREDGLLHTACGTPNYVAPEVLNDK 109
N L+ G V+KI DFGL + + +GLL ++APE L D
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV-----RWMAPESLLD- 187
Query: 110 GYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKR 168
G SDVWS GV+++ +L G P+ N + ++G +
Sbjct: 188 GKFTTQSDVWSFGVLMWEILTLGQQPYPALN-----------NQEVLQHVTAGGR----- 231
Query: 169 ILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 200
L + I Q++ + W + + P FD+
Sbjct: 232 -LQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ----QLINAVDYCHSRGVFHRDLKP 60
+ + ++ + + G L D + +H K++ +Y Q+ ++Y R + HRDL
Sbjct: 81 STVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVLNDKGYDGRASDV 118
N+L+ + +KI+DFGL+ + ++ H G P ++A E + + Y SDV
Sbjct: 138 RNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDV 194
Query: 119 WSCGVILFVLMA-GFLPFD 136
WS GV ++ LM G P+D
Sbjct: 195 WSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 31/177 (17%)
Query: 29 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRED 88
L D+ R+ Q+ +D+ S+ HRD+ N+LL V KI DFGL ++ + D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL---ARDIMND 265
Query: 89 GLLHTACGTPNYV------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 135
NYV APE + D Y + SDVWS G++L+ + + G P+
Sbjct: 266 S---------NYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPY 315
Query: 136 DESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDE 187
+ + + K+ + + S P + ++K + P R T ISQ+++ +
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 96 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 155
GTP+Y+APE+L K + G A D W+ GV LF + G PF++ +++ I D P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 20/143 (13%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRY-FQQLIN-AVD------YCHSRGVFHRDLK 59
+I+LE + GG+L + R + + + L+ A D Y HRD+
Sbjct: 85 FILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA 143
Query: 60 PENLLLDSYG---VLKISDFGLSA---ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
N LL G V KI+DFG++ + R+ G A ++ PE D G
Sbjct: 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLPIKWMPPEAFLD-GIFT 199
Query: 114 RASDVWSCGVILFVLMA-GFLPF 135
+DVWS GV+L+ + + G++P+
Sbjct: 200 SKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 5/135 (3%)
Query: 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ + +V + + G L D + ++ R+ + + Q+ + Y + HRDL N+
Sbjct: 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV 140
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCG 122
L+ S +KI+DFGL+ + + E P ++A E + + + SDVWS G
Sbjct: 141 LVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYG 198
Query: 123 VILFVLMA-GFLPFD 136
V ++ LM G P+D
Sbjct: 199 VTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 4/124 (3%)
Query: 9 IVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+V + G L D + +H L + Q+ + Y + HR+L N+LL S
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGVILF 126
+++I+DFG++ + + ++ TP ++A E + Y SDVWS GV ++
Sbjct: 145 DSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVW 202
Query: 127 VLMA 130
+M+
Sbjct: 203 EMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 3/120 (2%)
Query: 9 IVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+V+E GG L + K + Q+ + Y + HRDL N+LL +
Sbjct: 71 LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVWSCGVILF 126
KISDFGLS +A P + APE +N + + R SDVWS G+ ++
Sbjct: 131 QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 28/161 (17%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ + + S+ HRDL N+LL + KI DFGL ++ +R D N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIRNDS---------N 269
Query: 100 YV------------APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 146
YV APE + + Y SDVWS G++L+ + + G P+ + + + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 147 ICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
+ + + P S ++K D +P R T Q+++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 2/98 (2%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ + Y R + HRDL N+L+ S +KI+DFGL+ + + ++
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 100 YVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFD 136
++A E ++ + + SDVWS GV ++ LM G P+D
Sbjct: 177 WMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 97
Q+ +++ S+ HRDL N+LL ++KI DFGL ++ + D + T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL---ARDIMHDSNYVSKGSTFL 301
Query: 98 -PNYVAPEVLNDKGYDGRASDVWSCGVILF 126
++APE + D Y SDVWS G++L+
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLW 330
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 9 IVLEFIDGGEL-----FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+VLEF G+L ++ ++D +R ++ + + + H H DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTAC-GTP-NYVAPEVLNDKGYD------GRA 115
L + +KI D+GL+ +Q ED + C P ++APE++ +G D +
Sbjct: 132 QLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189
Query: 116 SDVWSCGVILFVLM-AGFLPF-DESNLMALYRKICRADFSCP 155
S++WS GV ++ L A P+ D S+ L + + D P
Sbjct: 190 SNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 34/127 (26%), Positives = 54/127 (42%), Gaps = 13/127 (10%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ ++Y S HRDL N L+ +KISDFGLS + +
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191
Query: 100 YVAPEVLNDKGYDGR---ASDVWSCGVILFVLMA-GFLPF-----DESNLMALYRKICRA 150
++ PE + G+ SD+WS GV+L+ + + G P+ E M R++
Sbjct: 192 WMPPEAI----LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC 247
Query: 151 DFSCPSW 157
CP+
Sbjct: 248 PEDCPAR 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-- 97
Q+ N +++ S+ HRDL N+L+ ++KI DFGL ++ + D + T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGL---ARDIMRDSNYISKGSTFL 303
Query: 98 P-NYVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMAL-YRKICRA-DFS 153
P ++APE + + Y SDVWS G++L+ + G P+ E + Y I R +
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQML 184
P+ S +++++ + + R SQ++
Sbjct: 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 18/39 (46%), Positives = 26/39 (66%)
Query: 39 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77
+Q++ + H G+ HRD+KPENLL+ G +KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 36 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 95
R+ + + ++Y S+ HRDL N +L+ + ++DFGL S+++ C
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL---SKKIYSGDYYRQGC 173
Query: 96 GTP---NYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129
+ ++A E L D Y SDVW+ GV ++ +M
Sbjct: 174 ASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 12/103 (11%)
Query: 42 INAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY- 100
+ ++Y H G HR++K ++L+ G++ +S GLS + VR P +
Sbjct: 111 LRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 101 ------VAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPF 135
++PE+L GY+ + SD++S G+ L G +PF
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVK-SDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 17/125 (13%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL-----SAISQQVREDGLLHTA 94
Q+ ++Y S H+DL N+L+ +KISD GL SA +V+ LL
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI- 190
Query: 95 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLP---FDESNLMALYRKICRA 150
++ PE + + SD+WS GV+L+ + + G P F ++ + RK R
Sbjct: 191 ----RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQ 243
Query: 151 DFSCP 155
C
Sbjct: 244 LLPCS 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 20/136 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGV 53
+ +V E++ G+L + HG L + + QQ+ + Y S+
Sbjct: 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF 141
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHTACGTPNYVAPEVLNDKG 110
HRDL N L+ ++KI DFG+S + R G HT ++ PE + +
Sbjct: 142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI-RWMPPESIMYRK 198
Query: 111 YDGRASDVWSCGVILF 126
+ SDVWS GV+L+
Sbjct: 199 FTTE-SDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 24/79 (30%), Positives = 38/79 (48%), Gaps = 5/79 (6%)
Query: 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68
IV+E+I+G L D I E +++ V HS G+ H DL N++L
Sbjct: 76 IVMEYIEGEPLKDLINS----NGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGG 131
Query: 69 GVLKISDFGLSAISQQVRE 87
+ I DFGL+ S+ + +
Sbjct: 132 KIYLI-DFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 45 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS--AISQQVREDGLLHTACGTPNYVA 102
++Y +R HRDL N +L + ++DFGLS S G A ++A
Sbjct: 126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKMPVKWIA 183
Query: 103 PEVLNDKGYDGRASDVWSCGVILFVLM 129
E L D+ Y + SDVW+ GV ++ +
Sbjct: 184 IESLADRVYTSK-SDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 13/78 (16%)
Query: 9 IVLEFIDGGEL--FDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +E+IDG ++ + G L E R + +QL+ G FH D P N
Sbjct: 243 LTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-------DGFFHADPHPGN 295
Query: 63 LLLDSYGVLKISDFGLSA 80
+L+ S G + + DFG+
Sbjct: 296 ILVRSDGRIVLLDFGIVG 313
|
Length = 517 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 35/124 (28%), Positives = 56/124 (45%), Gaps = 7/124 (5%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ +++ S V H+DL N+L+ +KISD GL L+ +
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191
Query: 100 YVAPEVLNDKGYDGRASDVWSCGVILF-VLMAGFLPF-DESNL----MALYRKICRADFS 153
+++PE + G SD+WS GV+L+ V G P+ SN M R++
Sbjct: 192 WMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDD 250
Query: 154 CPSW 157
CP+W
Sbjct: 251 CPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---ISQQVREDGLLHTACG 96
Q+ + + Y S+ HRDL N L+ + ++KI DFG+S + R G HT
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTMLP 188
Query: 97 TPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
++ PE + + + SDVWS GVIL+
Sbjct: 189 I-RWMPPESIMYRKFTTE-SDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 39 QQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-----AISQQVREDGLLHT 93
+Q+ + Y R HRDL N L+ V+KI+DFGLS A + E+ +
Sbjct: 137 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPI 196
Query: 94 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPF 135
++ PE + Y SDVW+ GV+L+ + + G P+
Sbjct: 197 -----RWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 8/82 (9%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQL--INAVDYCHSRGVFHRDLK 59
S Y+++E+I+G L + KED A + + L ++ + + H DL
Sbjct: 63 ESDGWSYLLMEWIEGETLDEV---SEEEKEDIAEQLAELLAKLHQLP---LLVLCHGDLH 116
Query: 60 PENLLLDSYGVLKISDFGLSAI 81
P N+L+D +L I D+ +
Sbjct: 117 PGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 18/56 (32%), Positives = 28/56 (50%)
Query: 24 AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79
+ G L + + Q+ + + Y S+ HRDL N L+ V+KI DFG+S
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 36 RYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA--ISQQVREDGLLHT 93
++ + + ++Y S+ HRDL N +L+ + ++DFGLS + G +
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI-- 173
Query: 94 ACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
A ++A E L D+ Y + SDVWS GV ++
Sbjct: 174 AKMPVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.98 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.66 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.64 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.61 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.6 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.48 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.43 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.4 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.37 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.36 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.34 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.05 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.81 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.81 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.54 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.52 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.44 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.16 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 98.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.07 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.01 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.81 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.78 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.76 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.29 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.74 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.73 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.28 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.2 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.85 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.8 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.32 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.51 | |
| PLN02236 | 344 | choline kinase | 93.31 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.22 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.15 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.04 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.86 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.48 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.33 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.53 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.9 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.03 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 88.39 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 88.12 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 86.56 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 86.37 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-52 Score=400.52 Aligned_cols=189 Identities=63% Similarity=1.118 Sum_probs=181.7
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEecCCc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLS 79 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DFGla 79 (361)
+++++++|+|||||.||+|+++|...+++.|.+++.+|+||++||+|||++||+||||||||||+|.+ +++||+|||++
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 46788999999999999999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 158 (361)
.... ..+..+.+.||||.|+|||++.+.+ |++.++|||||||+||.|++|..||++.+...++.+|.++.+.+|.|+
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 8764 3456789999999999999999988 999999999999999999999999999999999999999999999999
Q ss_pred -CHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 159 -SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 159 -s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
|+++.+|+++||.+||.+|+|+.+|++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=406.20 Aligned_cols=191 Identities=47% Similarity=0.891 Sum_probs=183.4
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++++.++|+|+||++||+||+++...|+++|.+++++|+||+.|+.|||..+|+|||+||+|+|||.++++||+|||+|.
T Consensus 81 we~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 81 WENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred eccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
+-. ++..+.+.||+|+|.|||++.+.+|+|.++||||||||||.||+|.+||++.+...++.++.++.|.+|..+|+
T Consensus 161 Le~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~ 237 (786)
T KOG0588|consen 161 LEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISS 237 (786)
T ss_pred ccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCH
Confidence 643 45678999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
++++||++||+.||++|+|.+||++|||++....
T Consensus 238 eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 238 EAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999999999999987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=374.81 Aligned_cols=189 Identities=42% Similarity=0.796 Sum_probs=169.8
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC---CCEEEEecC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFG 77 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~---~~lKl~DFG 77 (361)
|+.....||||||++||+|++++..++.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ -.+||+|||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 35567789999999999999999999999999999999999999999999999999999999999766 679999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCC--CCCchhhhhhhhHHHhHhcCCCCCCcccHHH-HHHHHhhcCCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKICRADFSC 154 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~--~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~ 154 (361)
||.+.. ......|.||||.|+|||++.+.++ ++.++|+||+||+||.+|+|.+||.+..... +.++|.++.+.+
T Consensus 325 lAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 325 LAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred hhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 998754 4567889999999999999987764 4568999999999999999999998866554 888888887765
Q ss_pred --CCC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 --PSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 --~~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.| +|+++.+||..||..||++|||++|+|+||||+..
T Consensus 402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 345 89999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=382.25 Aligned_cols=196 Identities=38% Similarity=0.719 Sum_probs=184.6
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
||+++++|||+|+|..|+|..+++..+.++|.+|+.|++||+.||.|||+++|+|||||..||||+++.++||+|||||+
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceee
Confidence 68999999999999999999999988899999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
..... +....|.||||.|+||||+...++ +..+||||+||++|.||.|++||+..+..+.|.+|...++.+|..+|.
T Consensus 167 ~le~~--~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 167 QLEYD--GERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSA 243 (592)
T ss_pred eecCc--ccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCH
Confidence 87642 345678999999999999998887 499999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCCCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~~ 199 (361)
++++||.+||++||.+|||+++||.|+||+.++.|...+
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 999999999999999999999999999998887765443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=346.42 Aligned_cols=184 Identities=41% Similarity=0.828 Sum_probs=174.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
-+.+++||||||++||+|++++++.++++|..|+.|+.||+.||+|||+++|++||+||||||+|.+|.+||+|||+|..
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 35679999999999999999999999999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.. +...+.||||.|+|||++..++|. .++|+||+||++|||++|.+||.+.+...+|.+|+.+...+|+.++++
T Consensus 194 v~-----~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~ 267 (355)
T KOG0616|consen 194 VS-----GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD 267 (355)
T ss_pred ec-----CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH
Confidence 42 336789999999999999999996 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+++||+++|+.|-.+|. ...+|..||||+.
T Consensus 268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 99999999999999994 4789999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=353.35 Aligned_cols=188 Identities=39% Similarity=0.803 Sum_probs=174.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.|+.++|||+||+.||+|+.+|++.+.++|+.|+.|+.+|+.||.|||++||+||||||||||||.+|+++|+||||++
T Consensus 94 FQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 94 FQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred cccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFS 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s 159 (361)
..-. .+....+.|||+.|||||++.+.+|+ .++|+||+||++|+||+|.+||.+.+....+++|..+.. ..|..++
T Consensus 174 ~~~~--~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls 250 (357)
T KOG0598|consen 174 EDLK--DGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS 250 (357)
T ss_pred hccc--CCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC
Confidence 5432 33456779999999999999999997 899999999999999999999999999999999999884 4455599
Q ss_pred HHHHHHHHHccCCCcCCCC----CHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRM----TISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~----t~~eil~h~~f~~ 191 (361)
+++++||+++|..||.+|. .+.+|.+||||..
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 9999999999999999996 6899999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=357.43 Aligned_cols=190 Identities=38% Similarity=0.702 Sum_probs=175.4
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+..++|+|+||+++|+|.++|.+.|.|+|..++.|+.||+.||+|||++|||||||||||||||++|++||+|||-|.
T Consensus 143 FQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 143 FQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccc
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccC-----------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh
Q 018052 81 ISQQVRED-----------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR 149 (361)
Q Consensus 81 ~~~~~~~~-----------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~ 149 (361)
.+...... ....+..||..|++||++..... +..+|+|+||||||.|++|.+||.+.+.--++++|..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 76532221 11245789999999999987655 5899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 150 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 150 ~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+.+|+.+++.+.+||+++|..||++|+|+.+|.+||||..
T Consensus 302 l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 302 LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999999999985
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=325.25 Aligned_cols=188 Identities=38% Similarity=0.734 Sum_probs=171.7
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++|.+-+|+|+|+|+.|+|+|++.....++|..++++++||+.|++|||.++|+||||||+|||+|++.++||+|||+|+
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 47888999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCC-----CCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC-
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC- 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~-----~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~- 154 (361)
... ++..+...||||+|+|||.+.+.-| ++..+|+||||||+|.||+|.+||......-+++.|..+.+++
T Consensus 172 ~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 172 QLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred ccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 654 4556889999999999999865322 2578999999999999999999999888888888898887654
Q ss_pred -CCC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 155 -PSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 155 -~~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
|.| +|...++||.+||+.||.+|+|+.|+|.||||..
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 667 7999999999999999999999999999999953
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=313.70 Aligned_cols=187 Identities=39% Similarity=0.798 Sum_probs=169.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
.+....|||+|+++||+|+.-|....-++|..+-.+++||+.+|.|||.+||+|||+||+|+|+- ....+||+|||+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence 45678899999999999998887767799999999999999999999999999999999999994 345699999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
|...+ .+.....+.|||.|+|||++...+| +.++|||+||||||.||.|.+||.+.+...+|+.|..+.+.+|+
T Consensus 160 Ai~l~---~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 160 AIEVN---DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred EEEeC---CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 97654 3455677899999999999998887 49999999999999999999999999999999999998776654
Q ss_pred C--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 ~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
| +++++++|+++||..||++|+|+.|+|+|||+.+.
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 4 89999999999999999999999999999999853
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=330.43 Aligned_cols=186 Identities=32% Similarity=0.575 Sum_probs=167.4
Q ss_pred cCc-EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKT-KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~-~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++. .++|+||||+||+|.+.+...++++|....+++.++++||.|||+ ++|+||||||+|||++..|.+||||||.|.
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 344 599999999999999999998999999999999999999999995 899999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-----cHHHHHHHHhhcC-CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKICRAD-FSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~ 154 (361)
..-. +...+..||..|||||-+.+..|. .++||||||+.++|+.+|+.||... +.-+++..|+.+. ...
T Consensus 228 ~lvn----S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l 302 (364)
T KOG0581|consen 228 ILVN----SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL 302 (364)
T ss_pred Hhhh----hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC
Confidence 6533 356789999999999999998885 8899999999999999999999874 5667788888754 456
Q ss_pred CCC-CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 155 PSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 155 ~~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|.. +|+++++|+..||++||.+|+|+.|+++|||+++..
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 665 999999999999999999999999999999999743
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=337.51 Aligned_cols=189 Identities=37% Similarity=0.682 Sum_probs=167.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.++.++||||||++|||+..+|.+.+.|+|++++.|+.+++.|++.+|..|++||||||+|+|||..|++||+||||++
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 56889999999999999999999999999999999999999999999999999999999999999999999999999995
Q ss_pred ccccc--------------------ccCC-------------------------ccccccCCCccccccccccCCCCCCc
Q 018052 81 ISQQV--------------------REDG-------------------------LLHTACGTPNYVAPEVLNDKGYDGRA 115 (361)
Q Consensus 81 ~~~~~--------------------~~~~-------------------------~~~~~~gt~~y~APEv~~~~~~~~~~ 115 (361)
..... ..+. ......|||.|+||||+.+.+|. ..
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~ 368 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KE 368 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-cc
Confidence 42210 0000 01234699999999999999985 99
Q ss_pred hhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCCCCC--CCHHHHHHHHHccCCCcCCCCC---HHHHHhCcc
Q 018052 116 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW--FSSGAKKLIKRILDPNPDTRMT---ISQMLEDEW 188 (361)
Q Consensus 116 ~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~ 188 (361)
+|+||+|||+||||.|.+||.+.+..+.+++|.+-. +.+|.. +++++.+||.+||. ||.+|.. ++||..|||
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF 447 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence 999999999999999999999999999999987643 555654 78999999999999 9999985 999999999
Q ss_pred ccc
Q 018052 189 FKK 191 (361)
Q Consensus 189 f~~ 191 (361)
|+.
T Consensus 448 F~~ 450 (550)
T KOG0605|consen 448 FKG 450 (550)
T ss_pred ccc
Confidence 985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.26 Aligned_cols=187 Identities=32% Similarity=0.661 Sum_probs=173.1
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.|++++|+||||+.||++. .+++.+.++|..|+.|++.++.||+|||++||+|||||.+|||||.+|.+||+||||++
T Consensus 438 fQT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 57899999999999999944 45556789999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
-. ...+....|.||||.|+|||++.+..|. .++|+||+||+||+||.|+.||.+.+.++++..|...+..+|.|+|.
T Consensus 517 e~--m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ 593 (694)
T KOG0694|consen 517 EG--MGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK 593 (694)
T ss_pred cc--CCCCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence 42 3344567899999999999999998886 99999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
++.++++++|..||.+|.. +++|..||||+.
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999999999986 588999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=324.25 Aligned_cols=190 Identities=44% Similarity=0.796 Sum_probs=178.4
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|+.++++.|||||+.||+|+|||.+.+.++|.+++.+|+||++|+.|||.++|+|||||.+|||+|.++++||+||||+.
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhh
Confidence 68899999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.+.. ...+.++||+|-|.+||++.+.+|.|..+|.||+||+||.|+.|..||++.+...+.++|.++.+.-|.. +.
T Consensus 202 ly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PS 277 (668)
T KOG0611|consen 202 LYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PS 277 (668)
T ss_pred hhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-Cc
Confidence 7653 4568899999999999999999999999999999999999999999999999999999999988776654 67
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
++.-||+.||..||.+|.|+++|..|=|..=++.
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence 8999999999999999999999999988875553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.27 Aligned_cols=188 Identities=36% Similarity=0.673 Sum_probs=171.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC------CCEEEEe
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY------GVLKISD 75 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~------~~lKl~D 75 (361)
++++.+|||||||+||||.++|+..++++|..++.+++||+.||++||+++|+||||||+||||+.. -.+||+|
T Consensus 79 ~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 79 EDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred ecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 4678999999999999999999999999999999999999999999999999999999999999865 4599999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--- 152 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 152 (361)
||+|+... +.....+.||||.|||||++....|+ .++|+||+|+|||+|++|+.||+..+..+++..+.++..
T Consensus 159 FGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 159 FGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP 234 (429)
T ss_pred cchhhhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC
Confidence 99998765 45678899999999999999888898 789999999999999999999999999999988776643
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+.++++...+|+...|..+|..|.+..+.+.|++.....
T Consensus 235 ~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 33456888899999999999999999999999999887543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.38 Aligned_cols=188 Identities=34% Similarity=0.588 Sum_probs=161.3
Q ss_pred EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla~~~~ 83 (361)
.++++|||++||+|.+++.+.+ +++|..++.|.+|+++||+|||++||+||||||+|||++. +|.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 6999999999999999999987 7999999999999999999999999999999999999999 7999999999987654
Q ss_pred c-cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhcC--CCCCCCCC
Q 018052 84 Q-VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSWFS 159 (361)
Q Consensus 84 ~-~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~s 159 (361)
. ...........|||.|||||++......+.++||||+||++.+|+||..||.+ ....+....+.... ..+|.++|
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 3 11122234578999999999998633444599999999999999999999988 45455444444333 46788899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+++++||.+||..||++|||++++|+|||.+...
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999999999998643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.31 Aligned_cols=193 Identities=39% Similarity=0.747 Sum_probs=168.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DF 76 (361)
..+..+.+|||.++||+||+.|+.++. ++|.+|..+++||..|+.|||+.+|+||||||||+|... +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 456788999999999999999998774 999999999999999999999999999999999999964 557999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc----HHHHHHHHhhcCC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADF 152 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~ 152 (361)
|+|..... ...+.+.|-||.|+|||++....|+ ..+|+||+||++|.||+|.+||-... ...+..+|..+.+
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 99976442 3457889999999999999888887 89999999999999999999996533 2355677777776
Q ss_pred CCC--CC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCCC
Q 018052 153 SCP--SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 198 (361)
Q Consensus 153 ~~~--~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~ 198 (361)
.+| .| +|+.++++|+++|..+|.+|+|+.+++.|||+.....-+..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 665 45 79999999999999999999999999999999876554443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=322.85 Aligned_cols=192 Identities=36% Similarity=0.666 Sum_probs=171.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+++|||+|||..|.+.. ...+.. +++.+|+.|+++++.||+|||.+||+||||||+|+||+++|.+||+|||.+..+
T Consensus 182 s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEF 260 (576)
T ss_pred cCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeec
Confidence 468999999999999854 344455 999999999999999999999999999999999999999999999999999766
Q ss_pred cccc---cCCccccccCCCcccccccccc---CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC
Q 018052 83 QQVR---EDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 156 (361)
Q Consensus 83 ~~~~---~~~~~~~~~gt~~y~APEv~~~---~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 156 (361)
.... .+..+....|||.|+|||.+.+ ..|.+.+.||||+||.||.|+-|+.||.+....+++.+|.+....+|.
T Consensus 261 ~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~ 340 (576)
T KOG0585|consen 261 PQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE 340 (576)
T ss_pred ccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCC
Confidence 3321 2234556789999999999887 567899999999999999999999999999999999999999888887
Q ss_pred C--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 157 W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 157 ~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
. +.+.+++||.+||.+||.+|+++.+|..|||.......+
T Consensus 341 ~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 341 NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 6 789999999999999999999999999999999876544
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=320.44 Aligned_cols=192 Identities=40% Similarity=0.781 Sum_probs=179.6
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE-ecCCCEEEEecCC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGL 78 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl-d~~~~lKl~DFGl 78 (361)
+++.+++|||+|+-+||+|+|+|.++ .++.|+.+++||.||+.|+.|||..+|+||||||+|+.+ ..-|-+||.|||+
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccc
Confidence 46889999999999999999999876 479999999999999999999999999999999999877 4678999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF 158 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 158 (361)
+..+. ++..+.+.||+..|-|||++.+..|+++++||||+|||||-|++|++||...+..+.+-.|+...+..|..+
T Consensus 166 SNkf~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshv 242 (864)
T KOG4717|consen 166 SNKFQ---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHV 242 (864)
T ss_pred cccCC---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhh
Confidence 87654 456789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
|.+.++||..||..||++|.|.++|..|+|++..-.+
T Consensus 243 S~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 243 SKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999999999999976544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=322.90 Aligned_cols=189 Identities=33% Similarity=0.623 Sum_probs=178.4
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
||+..++|+|+|||.| +|+.+++.++.++|+.++.+..|+++||.|||+++|+|||+||.|||++..|.+|+||||+|+
T Consensus 70 fEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 70 FETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhh
Confidence 6899999999999988 999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.+.. ....+....|||.|||||+..+.+|+ ..+|+||+|||+|||++|++||-..+..++.+.|.......|...|.
T Consensus 149 ~m~~--~t~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~ 225 (808)
T KOG0597|consen 149 AMST--NTSVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASS 225 (808)
T ss_pred hccc--CceeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccH
Confidence 7654 33456778999999999999999997 89999999999999999999999999999999999999989999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+.+|++.+|.+||.+|+|+.+++.|||++...
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 999999999999999999999999999998654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=316.09 Aligned_cols=189 Identities=34% Similarity=0.546 Sum_probs=165.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+....+|+|||||+. +|++.+...+ .|+|..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||||+
T Consensus 80 d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 80 DNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred ccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence 344599999999976 9999998765 59999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
-.... ...+.+..|.+|.|||++...+|++.++||||+|||++|+.+-++.|.|.+..+...+|+.-
T Consensus 159 ev~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 65443 34677889999999999999999999999999999999999999999999888777776531
Q ss_pred ---------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 151 ---------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 151 ---------~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
++.+| +..++++.+||.+||.+||.+|||+.|+|+||||+.+..
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 22222 226889999999999999999999999999999997643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.19 Aligned_cols=187 Identities=37% Similarity=0.687 Sum_probs=169.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 65 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..|. .++||||+||++|+|++|..||...+....+..+......+|..++++
T Consensus 145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 221 (323)
T cd05571 145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE 221 (323)
T ss_pred ccc--CCCcccceecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 221 12233457899999999999887775 899999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||++||..||++|| ++.++++||||..
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=321.33 Aligned_cols=185 Identities=30% Similarity=0.599 Sum_probs=161.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
++.+|+||||++||+|.|.+.. ..++|.+++.++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 3689999999999999998876 569999999999999999999999999999999999999999999999999998665
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhc--CCCCCCCCCH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRA--DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~--~~~~~~~~s~ 160 (361)
... ....+..|||.|||||+...+.| |.++||||||++.+||+-|++||-..+.- ++|.-..++ ....|..+|+
T Consensus 421 ~~~--~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 421 EEQ--SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccc--CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 432 24567899999999999998888 59999999999999999999999855544 444433333 3455677999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++|+.+||..||.+|+++.|+|+||||+..
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999999643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=317.69 Aligned_cols=187 Identities=44% Similarity=0.797 Sum_probs=170.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC----CCEEEEec
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKISDF 76 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~----~~lKl~DF 76 (361)
|++++.+|+|||+|.||+|++.|.+. .++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++||
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 47888999999999999999999987 59999999999999999999999999999999999999643 57999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC--
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-- 154 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-- 154 (361)
|+|..... .....+.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+....+..+..+++.+
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 99987654 4567899999999999999988885 89999999999999999999999999888888888886644
Q ss_pred CCC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 PSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.| +|..+.++|++||..||.+|+|+.++|+|||++..
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 445 79999999999999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=299.94 Aligned_cols=175 Identities=35% Similarity=0.651 Sum_probs=159.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEecCCCCCcEEEecCCCEEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS--RG--VFHRDLKPENLLLDSYGVLKIS 74 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~--~g--i~HrDiKp~NiLld~~~~lKl~ 74 (361)
++.-++||||||.+|||...|+. ...++|..+++|+.||+.||..||+ .. |+||||||.||+|+.+|++||+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 44558999999999999998874 3469999999999999999999999 34 9999999999999999999999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS- 153 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~- 153 (361)
||||++.+... ....++..|||.||+||++.+.+|+ .++||||+||++|||++-+.||.+.+..++.++|.+++++
T Consensus 171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 99999887642 3456778999999999999999997 8999999999999999999999999999999999999886
Q ss_pred CC-CCCCHHHHHHHHHccCCCcCCCCCH
Q 018052 154 CP-SWFSSGAKKLIKRILDPNPDTRMTI 180 (361)
Q Consensus 154 ~~-~~~s~~~~~Li~~~L~~dP~~R~t~ 180 (361)
+| ..+|.++..||..|+.+||..||+.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 56 4689999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.28 Aligned_cols=186 Identities=38% Similarity=0.751 Sum_probs=174.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
-+...+|+++||+.+|+|+..++ +..+++|..+..|++|++.||.|||..+|+||||||+|+|++..|.+||+|||.+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 46789999999999999999999 5568999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 159 (361)
.... .+...+.|||.-|.|||...+..++ ..+|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|+.++
T Consensus 172 V~~p----~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is 246 (281)
T KOG0580|consen 172 VHAP----SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTIS 246 (281)
T ss_pred eecC----CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccC
Confidence 7643 3445789999999999999999998 8999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.++.+||.+||..+|.+|.+..|++.|||+...
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999999998753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=313.75 Aligned_cols=187 Identities=33% Similarity=0.676 Sum_probs=169.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.+
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 146 GIF--NGKTTSTFCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQD 222 (320)
T ss_pred cCc--CCCcccccccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 321 12233456899999999999877665 789999999999999999999999998888988888888889999999
Q ss_pred HHHHHHHccCCCcCCCCCH------HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 191 (361)
+.+||++||..||.+||++ +++++||||+.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=302.55 Aligned_cols=188 Identities=37% Similarity=0.710 Sum_probs=175.5
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+.+++|+||||+.||+|+-++.+...++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+||||+.
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence 46789999999999999999999988899999999999999999999999999999999999999999999999999985
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
- ....+....+.||||.|+|||++....| +.++|+|.+||++|+|++|++||...+-..++..|...+..+|..+|+
T Consensus 317 E--~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~ 393 (516)
T KOG0690|consen 317 E--EIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSP 393 (516)
T ss_pred h--cccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCH
Confidence 3 2333456788999999999999999888 499999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+++.|+..+|..||++|.. +.||.+|+||..
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999999999985 889999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=314.40 Aligned_cols=184 Identities=38% Similarity=0.780 Sum_probs=169.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||+.||+|.+++...+.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 88 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 88 QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 35678999999999999999999988999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+..+...+|.+++..
T Consensus 168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 241 (329)
T PTZ00263 168 VPD-----RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGR 241 (329)
T ss_pred cCC-----CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHH
Confidence 422 12356899999999999887775 899999999999999999999999888888888888888899999999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|++ +++++.||||..
T Consensus 242 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 242 ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999999999997 899999999985
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=312.53 Aligned_cols=187 Identities=33% Similarity=0.656 Sum_probs=170.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 66 ~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 66 QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..|. .++||||+||++|+|++|..||...+....+..+.......|.+++.+
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 222 (321)
T cd05591 146 GIL--NGVTTTTFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKE 222 (321)
T ss_pred ccc--CCccccccccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 322 22234457899999999999877775 889999999999999999999999998899999988888889999999
Q ss_pred HHHHHHHccCCCcCCCC-------CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-------TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-------t~~eil~h~~f~~ 191 (361)
+.+||.+||..||++|+ +++++++||||..
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=310.77 Aligned_cols=188 Identities=38% Similarity=0.733 Sum_probs=169.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+++++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 63 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 63 QSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred ecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+......+|..++++
T Consensus 143 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (312)
T cd05585 143 NMK--DDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD 219 (312)
T ss_pred Ccc--CCCccccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHH
Confidence 322 12233457899999999999887775 889999999999999999999999888888888888888888899999
Q ss_pred HHHHHHHccCCCcCCCC---CHHHHHhCcccccC
Q 018052 162 AKKLIKRILDPNPDTRM---TISQMLEDEWFKKG 192 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~~ 192 (361)
+.+||.+||..||.+|| ++.+++.||||...
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999999997 58999999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=311.53 Aligned_cols=187 Identities=31% Similarity=0.656 Sum_probs=168.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+||||+.||+|.+++...+++++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 66 QTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|.+++.+
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (316)
T cd05620 146 NVF--GDNRASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222 (316)
T ss_pred ccc--CCCceeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 221 12234567899999999999887775 889999999999999999999999888888888877777888999999
Q ss_pred HHHHHHHccCCCcCCCCCH-HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI-SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~-~eil~h~~f~~ 191 (361)
+.+||++||..||++||++ +++++||||+.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 9999999999999999998 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=304.97 Aligned_cols=190 Identities=32% Similarity=0.548 Sum_probs=167.7
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
|++.+.+|+|||||+||+|....+++ +.++++.|+.|+.+++.||+|||-.||++||||||||||-++|++-|+||.|
T Consensus 146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence 57889999999999999999988875 4799999999999999999999999999999999999999999999999999
Q ss_pred ccccc-------c--------------------------ccc---------------------CCccccccCCCcccccc
Q 018052 79 SAISQ-------Q--------------------------VRE---------------------DGLLHTACGTPNYVAPE 104 (361)
Q Consensus 79 a~~~~-------~--------------------------~~~---------------------~~~~~~~~gt~~y~APE 104 (361)
+.... . ... +.......||-.|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 74310 0 000 00112346899999999
Q ss_pred ccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--CCCHHHHHHHHHccCCCcCCCCC---
Q 018052 105 VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMT--- 179 (361)
Q Consensus 105 v~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t--- 179 (361)
++.+.+.. .++|+|++||++||||.|..||.+.+..+.+.++......+|. .++..+++||+++|.+||++|+.
T Consensus 306 vI~G~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r 384 (459)
T KOG0610|consen 306 VIRGEGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR 384 (459)
T ss_pred eeecCCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc
Confidence 99999885 8999999999999999999999999999999999988877775 47899999999999999999998
Q ss_pred -HHHHHhCccccc
Q 018052 180 -ISQMLEDEWFKK 191 (361)
Q Consensus 180 -~~eil~h~~f~~ 191 (361)
++||.+||||+.
T Consensus 385 GA~eIK~HpFF~g 397 (459)
T KOG0610|consen 385 GAAEIKRHPFFEG 397 (459)
T ss_pred chHHhhcCccccC
Confidence 999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=306.35 Aligned_cols=184 Identities=34% Similarity=0.714 Sum_probs=168.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 71 HDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred ccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..+++.
T Consensus 151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (291)
T cd05612 151 LRD-----RTWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY 224 (291)
T ss_pred ccC-----CcccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHH
Confidence 432 12356899999999999887765 899999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||++||..||.+|++ ++++++||||+.
T Consensus 225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=311.30 Aligned_cols=187 Identities=37% Similarity=0.698 Sum_probs=168.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 65 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 65 QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred EcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 45678999999999999999999888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+......+|..++++
T Consensus 145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 221 (328)
T cd05593 145 GIT--DAATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSAD 221 (328)
T ss_pred CCC--cccccccccCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHH
Confidence 221 12233457899999999999877764 899999999999999999999998888888888877788888899999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||++||..||++|+ ++.++++||||..
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.86 Aligned_cols=187 Identities=32% Similarity=0.640 Sum_probs=168.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 71 QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+.......|..++++
T Consensus 151 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T cd05587 151 NIF--GGKTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (324)
T ss_pred cCC--CCCceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 221 12234457899999999999887775 889999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCCH-----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~-----~eil~h~~f~~ 191 (361)
+.+++.+||..||.+|++. +++++||||..
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=310.17 Aligned_cols=187 Identities=34% Similarity=0.554 Sum_probs=163.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|||+|||+. ||.-++... ..|++.+++.|++||+.||+|||++||+|||||.+|||||.+|++||+|||||+++
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 4689999999987 999888874 48999999999999999999999999999999999999999999999999999976
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC----------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---------- 152 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------- 152 (361)
.... ...++...-|.+|.|||++.+..-++.++|+||+||||.||++|++.|.+.+..+.+.+|.+.-.
T Consensus 269 ~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 5433 23466778899999999999988888999999999999999999999999998888777654210
Q ss_pred CCC-------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 SCP-------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ~~~-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+| ..+++.+.+|+..||..||.+|.|+.++|+|+||+..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 111 0167889999999999999999999999999999543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.04 Aligned_cols=184 Identities=33% Similarity=0.671 Sum_probs=168.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||+.||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..+...+|..+++.
T Consensus 181 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 254 (340)
T PTZ00426 181 VDT-----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254 (340)
T ss_pred cCC-----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 422 23457899999999999876664 899999999999999999999999888888888888888889999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.++|++||..||.+|+ |++++++||||..
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999996 8999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=295.25 Aligned_cols=186 Identities=26% Similarity=0.512 Sum_probs=158.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+.++++|+|||+. ++.+.++.. .+++++.++.|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+
T Consensus 71 rrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 71 RRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred HhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhH
Confidence 457899999999987 666666654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
.... ++...+.+..|.+|.|||.+.+...+|.++||||+||++.||++|.+-|++.+..+.+..|...
T Consensus 150 ~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 150 TLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred hhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 7654 4556778899999999999998666789999999999999999999999998766655444321
Q ss_pred ----C-----CCCC------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 151 ----D-----FSCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 151 ----~-----~~~~------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+ ..+| +.++.-+.+|+++||..||.+|++.+|++.|+||.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1 0111 12567788999999999999999999999999994
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=307.84 Aligned_cols=187 Identities=36% Similarity=0.693 Sum_probs=168.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 65 ~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 45678999999999999999998888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+....+..+.......|..++++
T Consensus 145 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 221 (323)
T cd05595 145 GIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 221 (323)
T ss_pred ccC--CCCccccccCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 221 12223456899999999999877775 899999999999999999999999888888888877778888889999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|+ ++.++++||||..
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 99999999999999998 8999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=306.92 Aligned_cols=187 Identities=33% Similarity=0.701 Sum_probs=167.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 66 QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+.......|.+++.+
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05592 146 NMNG--EGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKE 222 (316)
T ss_pred CCCC--CCccccccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 3221 2234467899999999999887765 889999999999999999999999888888888877777788899999
Q ss_pred HHHHHHHccCCCcCCCCCH-HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI-SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~-~eil~h~~f~~ 191 (361)
+.+||.+||..||.+||++ .++++||||..
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 9999999999999999986 48889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.43 Aligned_cols=188 Identities=35% Similarity=0.669 Sum_probs=166.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 66 QTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC-CCCH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-WFSS 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~ 160 (361)
... ........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+..+....|. .+++
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 223 (330)
T cd05586 146 NLT--DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223 (330)
T ss_pred CCC--CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 321 1223456789999999999876554458999999999999999999999998888888888777766665 4799
Q ss_pred HHHHHHHHccCCCcCCCC----CHHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRM----TISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~----t~~eil~h~~f~~ 191 (361)
++.+||++||..||.+|| ++.++++||||..
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=307.50 Aligned_cols=187 Identities=32% Similarity=0.633 Sum_probs=169.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 71 QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred ecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+......+|..++.+
T Consensus 151 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 227 (323)
T cd05616 151 NMW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227 (323)
T ss_pred cCC--CCCccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHH
Confidence 321 12233457899999999999887775 899999999999999999999999988888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+|+.+||..||.+|++ ..++++||||..
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999999998 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.89 Aligned_cols=187 Identities=37% Similarity=0.704 Sum_probs=167.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++.
T Consensus 65 ~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 65 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 4567899999999999999999888889999999999999999999997 799999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+......+|..+++
T Consensus 145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 221 (325)
T cd05594 145 EGIK--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP 221 (325)
T ss_pred ecCC--CCcccccccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 4321 12233456899999999999877775 89999999999999999999999988888888887778888888999
Q ss_pred HHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
++.+||.+||..||++|+ ++.++++||||..
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 999999999999999997 8999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=306.08 Aligned_cols=188 Identities=35% Similarity=0.687 Sum_probs=169.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+||||++||+|.+++...+.++++.+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 70 QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred ecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 45678999999999999999999888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..+....|+.+++.
T Consensus 150 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (323)
T cd05584 150 SIH--EGTVTHTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226 (323)
T ss_pred ccc--CCCcccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 322 12233457899999999999877664 899999999999999999999999888888888888888889999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCcccccC
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 192 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 192 (361)
+.+||.+||..||++|| +++++++||||...
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.05 Aligned_cols=191 Identities=43% Similarity=0.831 Sum_probs=181.8
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++++..+|+||||+.||++++++.+++++.+..++.+|.|+++|++|||+++|+|||||.+||||+.+.++||+|||++.
T Consensus 124 ~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 124 IETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.+. ....+.+.||+|+|.|||++.+..|++..+|+||+|++||.|+.|.+||++.+...+..+...+.+..|-.++.
T Consensus 204 ~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 204 FFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSC 280 (596)
T ss_pred eec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeec
Confidence 775 35568899999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+..+||+++|..+|.+|+++++|++|.|...+..
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999999999999986553
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=306.29 Aligned_cols=189 Identities=34% Similarity=0.632 Sum_probs=163.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 45678999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhhcCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~ 157 (361)
..... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||... ........+.......|..
T Consensus 155 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd05614 155 FLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233 (332)
T ss_pred ccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 43221 122345689999999999987654568999999999999999999999642 2344555566666677778
Q ss_pred CCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+++.+.+||.+||..||++|| +++++++||||+.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999999 8899999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=298.12 Aligned_cols=191 Identities=30% Similarity=0.486 Sum_probs=161.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
=+.+|+|+|+|+. +|...|+.+..++++.++.+++|++.||.|+|+.||+|||+||.|+|++.+..+||+|||||+...
T Consensus 98 f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 3579999999954 999999887779999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR-------------- 149 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 149 (361)
........+.+.-|.+|.|||++.....++.++||||+|||+.|||+|++-|.|.+....+..|..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 433345567788999999999987666556999999999999999999999998776555443321
Q ss_pred ---------cCCCCC--------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 150 ---------ADFSCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 150 ---------~~~~~~--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....|
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111111 2368999999999999999999999999999999865443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.10 Aligned_cols=188 Identities=33% Similarity=0.654 Sum_probs=174.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.|-+++|+||||+.||+|...|++-|++.|..|..|+..|+-||-+||++||++||||.+|+|+|.+|++||+|||++.
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
- ..-.+....+.||||.|+|||++.-.+| +.++|+||+||+||+||+|++||++.+..+++..|...+..+|..+|.
T Consensus 499 E--ni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSk 575 (683)
T KOG0696|consen 499 E--NIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSK 575 (683)
T ss_pred c--cccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccH
Confidence 3 2233445678999999999999988777 599999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
++.++++.+|...|.+|.. -.+|.+||||..
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999999999986 468999999984
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=304.75 Aligned_cols=187 Identities=30% Similarity=0.656 Sum_probs=167.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+||||++||+|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 66 QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 35678999999999999999998878899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+.......|.+++.+
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05619 146 NML--GDAKTCTFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTRE 222 (316)
T ss_pred CCC--CCCceeeecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 221 12233456899999999999887775 899999999999999999999999888888887777777788899999
Q ss_pred HHHHHHHccCCCcCCCCCHH-HHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~-eil~h~~f~~ 191 (361)
+.+||.+||..||++||++. ++++||||..
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 99999999999999999996 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=306.22 Aligned_cols=187 Identities=32% Similarity=0.649 Sum_probs=162.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 66 QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 45678999999999999999998888999999999999999999999999999999999999999999999999999863
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---------cHHHHHHHHhhcCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---------NLMALYRKICRADF 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~ 152 (361)
... ......+.+||+.|+|||++.+..++ .++|+||+||++|+|++|..||+.. .....+..+.....
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (329)
T cd05588 146 GIR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222 (329)
T ss_pred ccc--CCCccccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC
Confidence 211 22234567899999999999887775 8999999999999999999999631 12234555666777
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCC------HHHHHhCccccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 191 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~eil~h~~f~~ 191 (361)
..|.+++.++.+||++||..||.+|+| ++++++||||..
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 888899999999999999999999997 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=304.44 Aligned_cols=187 Identities=35% Similarity=0.709 Sum_probs=169.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|+||||++||+|.+++...+++++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 66 QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 45778999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++|+||+||++|+|++|..||.+.+....+..+.......|..++.+
T Consensus 146 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 146 GIL--GGVTTSTFCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred cCc--CCCcccceecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHH
Confidence 221 12223456899999999999887775 899999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCCH-----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~-----~eil~h~~f~~ 191 (361)
+.+||++||..||++|||+ .+++.||||+.
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=305.63 Aligned_cols=187 Identities=33% Similarity=0.633 Sum_probs=168.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 66 QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+.......++.+++.
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (323)
T cd05575 146 GIE--HSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVS 222 (323)
T ss_pred ccc--CCCccccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 321 12233456899999999999887775 789999999999999999999999888888888888877788888999
Q ss_pred HHHHHHHccCCCcCCCCCH----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~----~eil~h~~f~~ 191 (361)
+.+||++||..||.+||++ .++++||||..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=308.93 Aligned_cols=188 Identities=34% Similarity=0.634 Sum_probs=159.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+|||||+||+|.+++.+.+++++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 71 QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred ecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999865
Q ss_pred cccccc---------------------------------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhH
Q 018052 82 SQQVRE---------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVL 128 (361)
Q Consensus 82 ~~~~~~---------------------------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~l 128 (361)
...... .......+||+.|+|||++.+..|+ .++||||+||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHH
Confidence 321100 0012346899999999999887776 899999999999999
Q ss_pred hcCCCCCCcccHHHHHHHHhhc--CCCCCCC--CCHHHHHHHHHccCCCcC---CCCCHHHHHhCccccc
Q 018052 129 MAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD---TRMTISQMLEDEWFKK 191 (361)
Q Consensus 129 l~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~--~s~~~~~Li~~~L~~dP~---~R~t~~eil~h~~f~~ 191 (361)
++|..||.+.+..+.+.++... ...+|++ +++++.+||.+|+. +|. .||+++||++||||+.
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 9999999998888888877653 3444543 68999999999775 444 4689999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=303.80 Aligned_cols=187 Identities=32% Similarity=0.643 Sum_probs=168.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 71 QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++|+||+||++|+|++|..||.+.+....+..+.......|..++.+
T Consensus 151 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 227 (323)
T cd05615 151 HMV--DGVTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (323)
T ss_pred cCC--CCccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 321 11223456799999999999887775 899999999999999999999999888888888888888888899999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+++.+||..+|.+|++ ..++++||||..
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999999999999997 579999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.62 Aligned_cols=186 Identities=31% Similarity=0.603 Sum_probs=166.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|+||||++||+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 456789999999999999988865 5799999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+.......|..++++
T Consensus 151 ~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 227 (324)
T cd05589 151 GMG--FGDRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSRE 227 (324)
T ss_pred CCC--CCCcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 221 12233467899999999999877664 889999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|| ++.++++||||+.
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 99999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=302.76 Aligned_cols=187 Identities=33% Similarity=0.661 Sum_probs=162.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|..++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 66 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 35678999999999999999998888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc---------ccHHHHHHHHhhcCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---------SNLMALYRKICRADF 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~ 152 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.. ......+..+.....
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 222 (329)
T cd05618 146 GLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222 (329)
T ss_pred ccC--CCCccccccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC
Confidence 321 12233467899999999999887775 899999999999999999999952 112234555666677
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCC------HHHHHhCccccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 191 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~eil~h~~f~~ 191 (361)
..|..++..+.+||.+||..||++||| ++++++||||+.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 788889999999999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=279.64 Aligned_cols=192 Identities=33% Similarity=0.476 Sum_probs=164.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
|..++.+-+|+||++. +|...|+... .++..+++.|+.|++.||+|||++.|+||||||+|+|++++|.+||+|||+|
T Consensus 70 F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 70 FPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred ccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccch
Confidence 4567889999999987 9999998754 6999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------- 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------- 152 (361)
+.+.... .......-|.+|.|||++.+...++..+||||.|||+.||+.|.+-|.+.+..+....|.+.-.
T Consensus 149 r~f~~p~--~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPN--RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCC--cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 9876533 3344447899999999999888788999999999999999999999999888777766654211
Q ss_pred ---------------CCCC------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 153 ---------------SCPS------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 153 ---------------~~~~------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
+.|+ -.++++.+|+.+||..||.+|+|+.|+++|+||+....|
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 1111 146788999999999999999999999999999975443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=303.00 Aligned_cols=187 Identities=35% Similarity=0.692 Sum_probs=168.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 68 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 68 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 45678999999999999999998888899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+.......|..++++
T Consensus 148 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~ 224 (318)
T cd05582 148 SIDH--EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPE 224 (318)
T ss_pred cCCC--CCceecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 4321 1233457899999999999877764 889999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||++||+.||.+||| +.+++.||||..
T Consensus 225 ~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 225 AQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.79 Aligned_cols=187 Identities=32% Similarity=0.659 Sum_probs=162.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 66 QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 35678999999999999999998888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-------cHHHHHHHHhhcCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-------NLMALYRKICRADFSC 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~ 154 (361)
... ......+.+||+.|+|||++.+..++ .++||||+||++|+|++|..||... .....+..+.......
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (327)
T cd05617 146 GLG--PGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222 (327)
T ss_pred ccC--CCCceecccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC
Confidence 221 12234567899999999999887775 8999999999999999999999532 2234555566666778
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCC------HHHHHhCccccc
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t------~~eil~h~~f~~ 191 (361)
|..++..+.++|.+||..||++|++ +++++.||||..
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 8889999999999999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.40 Aligned_cols=189 Identities=28% Similarity=0.397 Sum_probs=163.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+-+++|||||||+. ||...+..-+ +|.+.+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||||+.
T Consensus 148 ~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred ccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhh
Confidence 34679999999987 9999998765 899999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 151 (361)
.... -...+...-|.+|.|||++.+...+++++|+||+|||+.+|+++.+-|.+.+..+...+|.+.-
T Consensus 227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 6543 2335566789999999999988877899999999999999999999999988887777765310
Q ss_pred ---------CCCCC-----------C--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 152 ---------FSCPS-----------W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 152 ---------~~~~~-----------~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..++. + +++...+|++.+|..||.+|+|+.|+|+|.||.....
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 11111 1 4588899999999999999999999999999998544
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.74 Aligned_cols=187 Identities=34% Similarity=0.658 Sum_probs=167.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 66 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+.......++.++..
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (325)
T cd05602 146 NIE--HNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS 222 (325)
T ss_pred ccc--CCCCcccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHH
Confidence 321 22234567899999999999887775 889999999999999999999999888888888877777777789999
Q ss_pred HHHHHHHccCCCcCCCCCHH----HHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTIS----QMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~----eil~h~~f~~ 191 (361)
+.++|.+||..||.+|+++. ++++|+||..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999999865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.51 Aligned_cols=187 Identities=33% Similarity=0.624 Sum_probs=167.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 66 QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 35678999999999999999998888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+....+..+.......|+..+..
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 222 (321)
T cd05603 146 GVE--PEETTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222 (321)
T ss_pred CCC--CCCccccccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 321 22234457899999999999887775 789999999999999999999999888888888888878888889999
Q ss_pred HHHHHHHccCCCcCCCCCH----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~----~eil~h~~f~~ 191 (361)
+.++|.+||..||.+|+++ .++++|+||..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 9999999999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.38 Aligned_cols=187 Identities=33% Similarity=0.616 Sum_probs=167.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 66 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 66 QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred ecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+..+.+..+.......++..+..
T Consensus 146 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (325)
T cd05604 146 GIA--QSDTTTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLT 222 (325)
T ss_pred CCC--CCCCcccccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHH
Confidence 221 12233467899999999999887775 789999999999999999999999888888888887777777788999
Q ss_pred HHHHHHHccCCCcCCCCCH----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~----~eil~h~~f~~ 191 (361)
+.++|++||..+|.+||++ .++++||||..
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999976 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=300.26 Aligned_cols=187 Identities=33% Similarity=0.558 Sum_probs=166.7
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
|+|++.+|+||.+|+||||.-+|.+.+ +++|..++.|+.+|+.||++||+.+|++||+||+|||+|++|+++|+|.||
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 689999999999999999999998877 899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~ 154 (361)
|.-.... .....+.||.+|||||++.+..|+ ..+|+||+||++|+|+.|.-||..... .++-+.+......+
T Consensus 334 Avei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 334 AVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred EEecCCC---CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 9865432 234566999999999999988876 899999999999999999999975432 24445556666778
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
|..+|+++++|.+.+|..||++|.. ++++.+||||+.
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 8889999999999999999999985 789999999996
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=300.61 Aligned_cols=185 Identities=34% Similarity=0.617 Sum_probs=162.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 71 QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC---
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS--- 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--- 156 (361)
... .....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+... ....|.
T Consensus 151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 224 (333)
T cd05600 151 IVT-----YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD 224 (333)
T ss_pred ccc-----ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc
Confidence 432 33467899999999999887765 8999999999999999999999988877776665432 122232
Q ss_pred ---CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 ---WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 ---~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 358999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=293.47 Aligned_cols=186 Identities=28% Similarity=0.496 Sum_probs=157.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+.+.+|+||||++||+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred ccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 3567899999999999999887643 36999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH----HHHHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~ 155 (361)
..... ........||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+.. .....+.......+
T Consensus 150 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05631 150 VQIPE---GETVRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS 225 (285)
T ss_pred EEcCC---CCeecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC
Confidence 75422 1223456799999999999887775 8899999999999999999999875432 23333334445566
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
..+++++.+||++||..||.+||| ++++++||||..
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 678999999999999999999997 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=301.90 Aligned_cols=188 Identities=35% Similarity=0.670 Sum_probs=163.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 71 QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred ecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccc---------------------------cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC
Q 018052 82 SQQVR---------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP 134 (361)
Q Consensus 82 ~~~~~---------------------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P 134 (361)
..... .........||+.|+|||++.+..+. .++||||+||++|+|++|..|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCC
Confidence 44322 00123456799999999999887765 899999999999999999999
Q ss_pred CCcccHHHHHHHHhh--cCCCCCCC--CCHHHHHHHHHccCCCcCCCCC-HHHHHhCccccc
Q 018052 135 FDESNLMALYRKICR--ADFSCPSW--FSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 191 (361)
Q Consensus 135 f~~~~~~~~~~~i~~--~~~~~~~~--~s~~~~~Li~~~L~~dP~~R~t-~~eil~h~~f~~ 191 (361)
|.+.+....+.++.. .....|.. +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 230 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 230 FYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 999887777777765 44444443 59999999999997 9999999 999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.46 Aligned_cols=186 Identities=30% Similarity=0.468 Sum_probs=151.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....+|+||||++++.|..+....+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 70 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 70 RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred ecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 45678999999999987766655556799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 151 (361)
..... ........||+.|+|||++.+..++ .++|+||+||++|+|++|.+||.+.+..+....+....
T Consensus 150 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 150 LSEGS-NANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccc-cccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 43221 1223356799999999999887775 89999999999999999999998765443322221100
Q ss_pred ---------CCCC-------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 ---------FSCP-------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 ---------~~~~-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
...| ..+|.++.+||++||..||++|||++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0011 1267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=303.36 Aligned_cols=188 Identities=36% Similarity=0.687 Sum_probs=160.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 71 QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred EcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 46788999999999999999999888999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccC------------------------------------CccccccCCCccccccccccCCCCCCchhhhhhhhHH
Q 018052 82 SQQVRED------------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125 (361)
Q Consensus 82 ~~~~~~~------------------------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil 125 (361)
....... ....+.+||+.|+|||++.+..|. .++||||+||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHH
Confidence 3221100 011235799999999999887775 899999999999
Q ss_pred HhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHccCCCcCCCCC---HHHHHhCccccc
Q 018052 126 FVLMAGFLPFDESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 191 (361)
Q Consensus 126 ~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 191 (361)
|+|++|..||.+.+....+..+... ....|. .+++++.+||++||. +|.+|++ +.++++||||+.
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999988877777766543 233443 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.23 Aligned_cols=190 Identities=36% Similarity=0.613 Sum_probs=169.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+..++||||||++||||...+.+.++++|+.|++|+..|+.||.-+|+.|+|||||||+|||||..|++||+|||.+.
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 46788999999999999999999998899999999999999999999999999999999999999999999999999876
Q ss_pred cccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~ 154 (361)
.+...+ ........|||-|++||++.. ++.+|..+|+||+||++|+|+.|..||...+..+.|.+|.+. .+.+
T Consensus 224 km~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 224 KMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred hcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 544221 123456789999999999852 356789999999999999999999999999999999999876 6778
Q ss_pred C--CCCCHHHHHHHHHccCCCcCCCCC---HHHHHhCcccccC
Q 018052 155 P--SWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~--~~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~~ 192 (361)
| ..+|+++++||++++.. |..|.. +++|..||||...
T Consensus 303 P~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 303 PDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred CcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCC
Confidence 8 45899999999998875 889998 9999999999853
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=304.63 Aligned_cols=188 Identities=35% Similarity=0.640 Sum_probs=158.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 71 QDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 35678999999999999999998888899999999999999999999999999999999999999999999999999753
Q ss_pred ccccc---------------------------------------------cCCccccccCCCccccccccccCCCCCCch
Q 018052 82 SQQVR---------------------------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRAS 116 (361)
Q Consensus 82 ~~~~~---------------------------------------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~ 116 (361)
+.... ......+.+||+.|+|||++.+.+|+ .++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-Cee
Confidence 21100 00011245799999999999888876 899
Q ss_pred hhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHccCCCcCCCCC---HHHHHhCccc
Q 018052 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWF 189 (361)
Q Consensus 117 DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f 189 (361)
||||+||++|+|++|..||.+.+..+...++... ....|. .+++++.+||.+|+ .+|.+|++ ++++++||||
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF 308 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence 9999999999999999999988776666655442 233343 47999999999986 59999997 9999999999
Q ss_pred cc
Q 018052 190 KK 191 (361)
Q Consensus 190 ~~ 191 (361)
+.
T Consensus 309 ~~ 310 (382)
T cd05625 309 KT 310 (382)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=303.43 Aligned_cols=188 Identities=34% Similarity=0.663 Sum_probs=160.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 71 QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999864
Q ss_pred cccccc---------------------------------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhH
Q 018052 82 SQQVRE---------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVL 128 (361)
Q Consensus 82 ~~~~~~---------------------------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~l 128 (361)
...... .....+.+||+.|+|||++.+..|. .++||||+||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-Ccceeccccceeeec
Confidence 321100 0112245899999999999888776 899999999999999
Q ss_pred hcCCCCCCcccHHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHccCCCcCCCC---CHHHHHhCccccc
Q 018052 129 MAGFLPFDESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 191 (361)
Q Consensus 129 l~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 191 (361)
++|..||.+.+....+.++... ...+|+ .+++++.+||.+|+. ||.+|+ +++++++||||+.
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9999999998888777776642 233444 378999999999874 999998 4899999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=293.27 Aligned_cols=191 Identities=33% Similarity=0.543 Sum_probs=161.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++.+|+||.||.+|++++.|...- +++|..+..++++++.||.|||.+|-+|||||+.||||+++|.+||+|||.+.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 4678999999999999999998753 69999999999999999999999999999999999999999999999999987
Q ss_pred cccccccC-C-ccccccCCCccccccccc--cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC
Q 018052 81 ISQQVRED-G-LLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 156 (361)
Q Consensus 81 ~~~~~~~~-~-~~~~~~gt~~y~APEv~~--~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 156 (361)
.....+.. . .+.+..|||+|||||++. ..+|+ .++||||+||...||.+|..||....++..+..-.++..+.+.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 65443221 1 125679999999999943 34676 8999999999999999999999998877666554455443221
Q ss_pred ----------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 157 ----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 157 ----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
-++..++.+|..||..||.+|||++++|+|+||+....
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 15778999999999999999999999999999997543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.99 Aligned_cols=189 Identities=33% Similarity=0.570 Sum_probs=157.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..++|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 71 QDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999754
Q ss_pred cccccc---------------------------------------------CCccccccCCCccccccccccCCCCCCch
Q 018052 82 SQQVRE---------------------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRAS 116 (361)
Q Consensus 82 ~~~~~~---------------------------------------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~ 116 (361)
...... .....+.+||+.|+|||++.+..|. .++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-Ccc
Confidence 311000 0011346899999999999887775 899
Q ss_pred hhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCCCCCC--CCCHHHHHHHHHcc--CCCcCCCCCHHHHHhCcccc
Q 018052 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPS--WFSSGAKKLIKRIL--DPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 117 DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~Li~~~L--~~dP~~R~t~~eil~h~~f~ 190 (361)
||||+||++|+|++|..||...+..+...++.. .....|. .+++++.+||.+|| ..+|..|+|+++++.||||+
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~ 309 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence 999999999999999999988776666555543 2334444 47999999999965 45566699999999999997
Q ss_pred c
Q 018052 191 K 191 (361)
Q Consensus 191 ~ 191 (361)
.
T Consensus 310 ~ 310 (381)
T cd05626 310 E 310 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=303.59 Aligned_cols=188 Identities=33% Similarity=0.640 Sum_probs=158.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 71 QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred EcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999863
Q ss_pred ccccccC---------------------------------------------CccccccCCCccccccccccCCCCCCch
Q 018052 82 SQQVRED---------------------------------------------GLLHTACGTPNYVAPEVLNDKGYDGRAS 116 (361)
Q Consensus 82 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~ 116 (361)
+...... ......+||+.|+|||++.+..|. .++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-Cce
Confidence 2110000 000135799999999999887775 899
Q ss_pred hhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHccCCCcCCC---CCHHHHHhCccc
Q 018052 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWF 189 (361)
Q Consensus 117 DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f 189 (361)
||||+||++|+|++|..||.+.+..+.+..+... ...+|. .++.++.+||.+||. +|.+| +|+.+++.||||
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence 9999999999999999999988877777766542 344444 378999999999997 67765 599999999999
Q ss_pred cc
Q 018052 190 KK 191 (361)
Q Consensus 190 ~~ 191 (361)
+.
T Consensus 309 ~~ 310 (377)
T cd05629 309 RG 310 (377)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=298.76 Aligned_cols=188 Identities=34% Similarity=0.572 Sum_probs=159.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+||||++||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 71 QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred ecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 3567899999999999999999876 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FS 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~ 153 (361)
....... ......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+....+.++.... ..
T Consensus 151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 229 (330)
T cd05601 151 RLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229 (330)
T ss_pred ECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC
Confidence 5432211 12234579999999999863 2233588999999999999999999999887777777665432 22
Q ss_pred CC--CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 154 CP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 154 ~~--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+| +.+++++.+||++||. +|.+|||+++++.||||..
T Consensus 230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 23 3578999999999998 9999999999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.47 Aligned_cols=187 Identities=30% Similarity=0.522 Sum_probs=158.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.++..+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 63 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg 142 (280)
T cd05608 63 QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLG 142 (280)
T ss_pred cCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 456789999999999999887743 3469999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhhcCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFS 153 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~ 153 (361)
++...... ........||+.|+|||++.+..++ .++|+||+||++|+|++|..||...+. ......+......
T Consensus 143 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 219 (280)
T cd05608 143 LAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219 (280)
T ss_pred cceecCCC--CccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC
Confidence 98654322 1223456799999999999887775 889999999999999999999976432 2333444444555
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
.|..+++.+.+++.+||+.||++|| |++++++||||+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 6677899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.00 Aligned_cols=187 Identities=36% Similarity=0.690 Sum_probs=175.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+...+||.||-|-||+|+..+...+.|++..++.|+..+++|++|||++||++|||||+|+++|.+|-+||.|||+|.
T Consensus 489 frd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 489 FRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHH
Confidence 35677899999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~ 158 (361)
.... +....+.||||.|+|||++..++.+ .++|.||+||++||||+|.+||.+.+++..|..|.++ ...+|..+
T Consensus 569 ki~~---g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 569 KIGS---GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred Hhcc---CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccccc
Confidence 6543 4567899999999999999999998 8999999999999999999999999999999999887 45788899
Q ss_pred CHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+..+.+||+++...+|.+|.. +.+|.+|.||..
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999999999999986 899999999974
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=289.77 Aligned_cols=185 Identities=26% Similarity=0.476 Sum_probs=151.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||+.| +|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 73 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred cCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCccee
Confidence 356789999999975 9999887654 58999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 151 (361)
..... ........||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 152 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 54321 1223456789999999998765444589999999999999999999998876655444332110
Q ss_pred ----------CCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 ----------FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 ----------~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+| +.+++++.+||++||..||.+|||++|+++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=300.71 Aligned_cols=188 Identities=36% Similarity=0.613 Sum_probs=161.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 456789999999999999998865 4699999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 156 (361)
..... .......+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||.+.+....+.++.... ..+|.
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 192 MDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred ccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 43211 11224568999999999986532 34589999999999999999999999988888888876543 44454
Q ss_pred --CCCHHHHHHHHHccCCCcCC--CCCHHHHHhCccccc
Q 018052 157 --WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 191 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 191 (361)
.+|.++.+||++||..+|.+ |+|++++++||||+.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 47999999999999999988 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.35 Aligned_cols=189 Identities=35% Similarity=0.618 Sum_probs=159.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+|||||+||+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 456789999999999999999875 4699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 156 (361)
..... .....+.+||+.|+|||++.+.+ +.+.++|+||+||++|+|++|..||.+.+....+.++.... ...|.
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 43211 11234678999999999987543 34589999999999999999999999988887887776532 44444
Q ss_pred --CCCHHHHHHHHHccCCCcCC--CCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~~ 192 (361)
.++..+.+++.+||..+|.+ |+|+.++++||||+..
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 46999999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.99 Aligned_cols=188 Identities=35% Similarity=0.622 Sum_probs=158.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 71 QDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 45778999999999999999999888899999999999999999999999999999999999999999999999999753
Q ss_pred cccccc-----------------------------------------CCccccccCCCccccccccccCCCCCCchhhhh
Q 018052 82 SQQVRE-----------------------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120 (361)
Q Consensus 82 ~~~~~~-----------------------------------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS 120 (361)
+..... .......+||+.|+|||++.+..+. .++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeee
Confidence 211000 0011245799999999999887775 8999999
Q ss_pred hhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC--CCCHHHHHHHHHccCCCcCCCC---CHHHHHhCccccc
Q 018052 121 CGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS--WFSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 191 (361)
Q Consensus 121 ~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 191 (361)
+||++|+|++|..||.+.+..+....+... ....|. .+++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999999999999988776665555432 223333 47899999999976 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.27 Aligned_cols=188 Identities=27% Similarity=0.498 Sum_probs=149.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||+. |+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 73 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 73 HTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred ecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 45678999999996 5888877654 579999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhhc--C------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRA--D------ 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~~--~------ 151 (361)
.... ........+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+... .
T Consensus 152 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 152 AKSV--PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred eccC--CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 4322 122234567899999999987655555899999999999999999999987432 2222222110 0
Q ss_pred -------------CC--CCC---------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 -------------FS--CPS---------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 -------------~~--~~~---------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+. .|. .+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 000 135678999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.01 Aligned_cols=189 Identities=34% Similarity=0.602 Sum_probs=164.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.+..++|+||||++||+|.+++.. ...+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 135 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 135 KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 456789999999999999987754 3469999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPS 156 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~ 156 (361)
+|.............+.+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+..+.. +.|.
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 293 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC 293 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 99765432222234567899999999999887765 899999999999999999999999888887777766554 3455
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.++.++.+||.+||..||++|||+.+++.|+|++.
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 68999999999999999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=283.56 Aligned_cols=187 Identities=29% Similarity=0.486 Sum_probs=159.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
...+|+|+||++. +|..++.... +++...++.+++||+.||+|||++||+||||||+|||+++.|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 3589999999976 9999998755 6888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------- 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 150 (361)
....- +......-.+|.+|.|||++.+..+++..+||||+|||+.+|++++.-|.+.+..+....|.+.
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85542 2333566789999999999999877789999999999999999999999998877776666431
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 151 ---------DFSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 151 ---------~~~~~~~------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...++.| .+++..+|+.+||..+|.+|+|+..+++||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1122222 235788999999999999999999999999998753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.37 Aligned_cols=185 Identities=35% Similarity=0.593 Sum_probs=170.6
Q ss_pred CcE-EEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 4 KTK-IYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~-~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++. +||||+||+||+|.+.|.+.. -++|+.+..||.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|.
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhh
Confidence 444 999999999999999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFS 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 159 (361)
.... ......+..|||.|+.||++.+.+|. .++||||+||++|+|++-+++|.+.+...+..+|.++. .+.|..++
T Consensus 155 ~l~~--~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys 231 (426)
T KOG0589|consen 155 ILNP--EDSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYS 231 (426)
T ss_pred hcCC--chhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcccc
Confidence 7654 22366789999999999999999996 99999999999999999999999999999999999887 56788899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+++.||+.||..+|..||++.++|.+|....
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999999999987763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=291.04 Aligned_cols=186 Identities=30% Similarity=0.471 Sum_probs=150.1
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|||||. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 46899999995 69999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccc-CCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh------------
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------ 149 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~------------ 149 (361)
... ........||+.|+|||++.+ ..+ +.++||||+||++|+|++|..||.+.+.......+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 112245679999999999865 344 4899999999999999999999987654332211100
Q ss_pred --------------cCCCC-----CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 150 --------------ADFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 150 --------------~~~~~-----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..... -+.+++.+.++|.+||..||++|||++++++||||+..
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 01357889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.19 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=149.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCC-------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYG------------- 69 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~------------- 69 (361)
..++|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++..+
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 35799999998 78999999988899999999999999999999998 5999999999999998766
Q ss_pred ---CEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH
Q 018052 70 ---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 146 (361)
Q Consensus 70 ---~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~ 146 (361)
.+||+|||++.... ......+||+.|+|||++.+..|. .++||||+||++|+|++|++||++.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 123457899999999999888775 899999999999999999999987665443332
Q ss_pred HhhcCCCCC-----------------------C-------------------CCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 147 ICRADFSCP-----------------------S-------------------WFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 147 i~~~~~~~~-----------------------~-------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
+......+| + ..++.+.+||.+||..||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 211100000 0 0134577999999999999999999999
Q ss_pred hCcccccCC
Q 018052 185 EDEWFKKGY 193 (361)
Q Consensus 185 ~h~~f~~~~ 193 (361)
+||||.+.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998744
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=300.87 Aligned_cols=179 Identities=36% Similarity=0.632 Sum_probs=158.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE-ecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL-DSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl-d~~~~lKl~DFGla~ 80 (361)
++..++|+|||++.||.|.+.|.....+. .++..|++||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+.
T Consensus 386 ~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 386 EDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred cCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 46678999999999999999998866555 7888999999999999999999999999999999 599999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhcCCCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~s 159 (361)
..... ..+.|-|..|+|||++...+|+ .++||||+|++||+||+|..||.... ..++...+..+.++ .++|
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS 536 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVS 536 (612)
T ss_pred hCchh-----hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccC
Confidence 54321 4566888999999999988887 89999999999999999999997644 44777776665555 7899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.++++||++||+.||.+|+++.+++.||||
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 999999999999999999999999999999
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.78 Aligned_cols=185 Identities=33% Similarity=0.565 Sum_probs=162.8
Q ss_pred EEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 478999999999999988653 3689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCCCH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSS 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 160 (361)
...........+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+..+.. ..|+.+++
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISP 271 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 5433223334567899999999999887775 899999999999999999999999888877777665543 45677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
++.+|+.+||..||.+|||+.++++|||++.
T Consensus 272 ~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.60 Aligned_cols=186 Identities=30% Similarity=0.532 Sum_probs=163.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|++||||.||++.+.++..+.++|..+..++++++.||.|||.++.+|||||+.|||+..+|.+|++|||.|....
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 46789999999999999999988778999999999999999999999999999999999999999999999999997665
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCCCHHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGA 162 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 162 (361)
.... ...+..|||.||||||+.+.+|+ .++|||||||+.++|++|.+||.+..++.....|-+... .+...+|+.+
T Consensus 163 ~~~~--rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~ 239 (467)
T KOG0201|consen 163 NTVK--RRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPF 239 (467)
T ss_pred chhh--ccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHH
Confidence 4332 23788999999999999988887 899999999999999999999998777655444433322 2223589999
Q ss_pred HHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 163 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++|+..||+.||+.|||+.++|+|+|++..
T Consensus 240 kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 240 KEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 999999999999999999999999999973
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=283.38 Aligned_cols=181 Identities=30% Similarity=0.428 Sum_probs=152.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||+. |+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 457999999996 5999988753 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--------- 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------- 152 (361)
.... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+..+.+..+.....
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 4321 233456799999999999877765 789999999999999999999998776666555432110
Q ss_pred ------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 ------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 ------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
...+.+++.+.+|+.+||..||++|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0012367788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=276.30 Aligned_cols=194 Identities=33% Similarity=0.646 Sum_probs=166.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFG 77 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFG 77 (361)
|++.+++|||||-+.||.|...|+++..|+|.+|..+.++|+.||.|||.+||+|||+||+|||-.... .+|||||.
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccc
Confidence 688999999999999999999999999999999999999999999999999999999999999996554 58999999
Q ss_pred Cccccccccc-----CCccccccCCCccccccccc----cCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---------
Q 018052 78 LSAISQQVRE-----DGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESN--------- 139 (361)
Q Consensus 78 la~~~~~~~~-----~~~~~~~~gt~~y~APEv~~----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--------- 139 (361)
|+........ ...+.+.||+..|||||+.. ...++...+|.||+|||||.||+|++||.+.-
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 8754332111 23456789999999999853 22344489999999999999999999996421
Q ss_pred ------HHHHHHHHhhcCCCCCC--C--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 140 ------LMALYRKICRADFSCPS--W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 140 ------~~~~~~~i~~~~~~~~~--~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
...++..|..+.+.+|. | +|.++++||..+|..|+.+|.++.++++|||++....
T Consensus 305 e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 34677888888888885 4 8999999999999999999999999999999987543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.65 Aligned_cols=189 Identities=35% Similarity=0.607 Sum_probs=158.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+|||||+||+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 356789999999999999999875 4699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCCC-
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCP- 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~- 155 (361)
..... .....+.+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||.+.+....+.++.... ..+|
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 43211 11234578999999999987543 34589999999999999999999999988888888876542 3334
Q ss_pred -CCCCHHHHHHHHHccCCCcCC--CCCHHHHHhCcccccC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~~ 192 (361)
..++..+.+||.+||..++.+ |++++++++||||+..
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 358999999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.53 Aligned_cols=177 Identities=30% Similarity=0.505 Sum_probs=154.5
Q ss_pred EEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCCCcEEEecCC-CEEEEecCCccc
Q 018052 6 KIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDSYG-VLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~g-i~HrDiKp~NiLld~~~-~lKl~DFGla~~ 81 (361)
.+++||||+++|+|.+++.. .+.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 68999999999999999988 578999999999999999999999999 99999999999999998 999999999976
Q ss_pred ccccccCCccccccCCCccccccccc--cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~--~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~ 157 (361)
..... .......||+.|||||++. +..|+ .++||||+||++|+|+||..||.+....+....+.. .....|..
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 54321 2233368999999999999 55776 999999999999999999999999877655555442 24455667
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+++.+..|+..||..||..||++.+|+.
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 8999999999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.49 Aligned_cols=187 Identities=30% Similarity=0.518 Sum_probs=160.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++...+|+||||+.||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 67 ~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 67 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 45678999999999999999998888899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHhhcCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~ 158 (361)
.... .....+|+..|+|||++.+....+.++||||+||++|+|++|..||.+. ................|..+
T Consensus 147 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (278)
T cd05606 147 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222 (278)
T ss_pred cCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC
Confidence 4321 2235679999999999875433348899999999999999999999875 33333344444455666668
Q ss_pred CHHHHHHHHHccCCCcCCCC-----CHHHHHhCcccccC
Q 018052 159 SSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 192 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 192 (361)
+..+.+++.+||..+|.+|| ++.++++||||+..
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.28 Aligned_cols=183 Identities=27% Similarity=0.376 Sum_probs=148.8
Q ss_pred EEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCcc
Q 018052 6 KIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSA 80 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~ 80 (361)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 57799999975 7776664 345799999999999999999999999999999999999999665 69999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
.... .......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+.++...
T Consensus 220 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 220 NLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 5432 122345678999999999876554468999999999999999999999887655444333211
Q ss_pred -------CC------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 -------DF------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 -------~~------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.. .+|...++++.+||.+||..||.+|||+.|+++||||...
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00 1233467899999999999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=286.84 Aligned_cols=186 Identities=26% Similarity=0.470 Sum_probs=154.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 74 SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (331)
T ss_pred ECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence 4578999999999999999999888899999999999999999999986 699999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh-------------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC------------- 148 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~------------- 148 (361)
... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..++...+.
T Consensus 154 ~~~----~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 154 LID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc----cccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 422 223456799999999999887765 89999999999999999999997665443322111
Q ss_pred ---------------------------------hcCC-CC-CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 149 ---------------------------------RADF-SC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 149 ---------------------------------~~~~-~~-~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.... .. ...+++++.+||.+||..||++|||+.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000 00 112678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=287.79 Aligned_cols=189 Identities=32% Similarity=0.598 Sum_probs=157.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+||||++||+|.+++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred ecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 456789999999999999999987 4679999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~ 154 (361)
...... .......+||+.|+|||++.+ ....+.++||||+||++|+|++|..||...+....+.++.... ...
T Consensus 151 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 151 KLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 229 (332)
T ss_pred ecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC
Confidence 432211 112234689999999999862 2334589999999999999999999999988888887776543 233
Q ss_pred CC---CCCHHHHHHHHHccCCCcCC--CCCHHHHHhCccccc
Q 018052 155 PS---WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~---~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 191 (361)
|. .+++++.+||++||..+|.+ |++++++++||||..
T Consensus 230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 33 46899999999999765444 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=280.24 Aligned_cols=185 Identities=32% Similarity=0.539 Sum_probs=155.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+..|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 68 TPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred cCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 46689999999999999999998888999999999999999999999999999999999999999999999999998644
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---HHHHHHHHhhcCCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s 159 (361)
... ......||+.|+|||.+......+.++|+||+||++|+|++|..||.... ...............|..++
T Consensus 148 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd05633 148 SKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223 (279)
T ss_pred ccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccC
Confidence 321 12345799999999998643333488999999999999999999997532 22222222233445667789
Q ss_pred HHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+++.++|.+||..||++|+ |+.++++||||+.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=285.91 Aligned_cols=189 Identities=33% Similarity=0.614 Sum_probs=156.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++..++|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 456789999999999999999986 4579999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~ 154 (361)
....... ......+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+..+.+..+.... +..
T Consensus 151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 151 RLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229 (331)
T ss_pred ecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccC
Confidence 5432111 11223579999999999863 2334578999999999999999999999888777777765432 333
Q ss_pred C---CCCCHHHHHHHHHccCCCcC--CCCCHHHHHhCccccc
Q 018052 155 P---SWFSSGAKKLIKRILDPNPD--TRMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~---~~~s~~~~~Li~~~L~~dP~--~R~t~~eil~h~~f~~ 191 (361)
| ..+++++.+||++||..+++ .|+++.++++||||..
T Consensus 230 ~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 230 PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 3 24799999999999866444 3889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=279.25 Aligned_cols=186 Identities=27% Similarity=0.519 Sum_probs=157.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred cCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 4567899999999999999888654 36999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHH----HHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~ 155 (361)
..... .......+|++.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.... ...+.......+
T Consensus 150 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05605 150 VEIPE---GETIRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS 225 (285)
T ss_pred eecCC---CCccccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC
Confidence 65432 1222456799999999999876664 789999999999999999999987654332 222333344556
Q ss_pred CCCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
..++..+.+||.+||..||++|| +++++++||||..
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 66899999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=272.08 Aligned_cols=187 Identities=31% Similarity=0.555 Sum_probs=159.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++..
T Consensus 74 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 74 RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred ccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 45678999999999999999999888899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCC
Q 018052 82 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~ 158 (361)
....... .......|++.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+... ....|..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccC
Confidence 4322111 111345788999999999887654 8999999999999999999999876665554444332 34456678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+..+.++|++||..+|.+|||+.++++||||
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=269.58 Aligned_cols=183 Identities=27% Similarity=0.587 Sum_probs=158.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||++|++|.+++... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~ 151 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV 151 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEE
Confidence 34689999999999999998763 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCCCH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSS 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 160 (361)
.... ........|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..+.. ..+..+++
T Consensus 152 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08223 152 LENQ--CDMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228 (257)
T ss_pred eccc--CCccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCH
Confidence 5321 2233456789999999999877665 789999999999999999999998777666655555443 34556889
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.+.+++.+||+.||.+|||+.++++||||
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.20 Aligned_cols=185 Identities=25% Similarity=0.415 Sum_probs=143.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE----ecCCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGV 70 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl----d~~~~ 70 (361)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~ 150 (317)
T cd07868 72 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 150 (317)
T ss_pred CcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCc
Confidence 467899999995 4898887632 258999999999999999999999999999999999999 45678
Q ss_pred EEEEecCCcccccccc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---------
Q 018052 71 LKISDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL--------- 140 (361)
Q Consensus 71 lKl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~--------- 140 (361)
+||+|||+|....... ........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.....
T Consensus 151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07868 151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 230 (317)
T ss_pred EEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccccc
Confidence 9999999997653321 112234568999999999998765556899999999999999999999964321
Q ss_pred HHHHHHHhhc----------------------------CCCC----------CCCCCHHHHHHHHHccCCCcCCCCCHHH
Q 018052 141 MALYRKICRA----------------------------DFSC----------PSWFSSGAKKLIKRILDPNPDTRMTISQ 182 (361)
Q Consensus 141 ~~~~~~i~~~----------------------------~~~~----------~~~~s~~~~~Li~~~L~~dP~~R~t~~e 182 (361)
...+..+... .... ....+.++.+||++||..||.+|||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e 310 (317)
T cd07868 231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence 0111111100 0000 0113567889999999999999999999
Q ss_pred HHhCccc
Q 018052 183 MLEDEWF 189 (361)
Q Consensus 183 il~h~~f 189 (361)
+++||||
T Consensus 311 ~l~hp~f 317 (317)
T cd07868 311 AMQDPYF 317 (317)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=286.81 Aligned_cols=184 Identities=28% Similarity=0.483 Sum_probs=149.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 3568999999975 78777754 48899999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-----------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----------- 152 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 152 (361)
. ........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+.++.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 1223456799999999999887775 799999999999999999999988765554444322100
Q ss_pred -----------C---------CC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 153 -----------S---------CP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 153 -----------~---------~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
. ++ ...+..+++||.+||..||.+|||+.++|+||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 0 00 012467899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.41 Aligned_cols=185 Identities=30% Similarity=0.510 Sum_probs=153.7
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 7999999996 589999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh----------------
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR---------------- 149 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------- 149 (361)
.........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 157 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 -ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred -ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 112233456899999999988765556899999999999999999999988765544433321
Q ss_pred -------cCC---------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 150 -------ADF---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 150 -------~~~---------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
... ......++++.+||.+||..||.+|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1122357889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.50 Aligned_cols=188 Identities=22% Similarity=0.344 Sum_probs=149.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+...|+|||++. ++|..++....++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 4678899999995 699999988888999999999999999999999999999999999999999999999999998643
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-------HHHHHHHH--------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKI-------- 147 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-------~~~~~~~i-------- 147 (361)
.... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.. .......+
T Consensus 233 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 233 VDIN-ANKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred cccc-ccccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 2211 1223456899999999999887764 89999999999999999998764321 01111111
Q ss_pred ------------------hhcC----CCCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 148 ------------------CRAD----FSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 148 ------------------~~~~----~~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.... ...|.| ++.++.+||.+||..||.+|||+.|+|+||||+...
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 1110 011112 456889999999999999999999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.24 Aligned_cols=186 Identities=28% Similarity=0.489 Sum_probs=158.1
Q ss_pred EEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEecCCcc
Q 018052 6 KIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSA 80 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DFGla~ 80 (361)
.+.+||||++. +|.+.+.. +.+++.-.++.|..||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|.
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 45589999987 99998884 5679999999999999999999999999999999999999965 999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
......+ ..++..|..|.|||.+.+...++.+.||||+||++.||+.|++-|.|.+..+....|.+.
T Consensus 175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 7654333 356778999999999998887789999999999999999999999998877666554321
Q ss_pred -------CCCCC-----C-------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 151 -------DFSCP-----S-------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 151 -------~~~~~-----~-------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
++.+| + ..++++.+|+.++|..+|.+|.++.|++.||||.....+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111 2 258999999999999999999999999999999875443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=275.72 Aligned_cols=186 Identities=28% Similarity=0.491 Sum_probs=154.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+++.++|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 63 ~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~ 142 (277)
T cd05607 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142 (277)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceee
Confidence 46778999999999999998886543 5889999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~ 155 (361)
...... .......||+.|+|||++.+..++ .++|+||+||++|+|++|..||..... ..............+
T Consensus 143 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (277)
T cd05607 143 VELKDG---KTITQRAGTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE 218 (277)
T ss_pred eecCCC---ceeeccCCCCCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc
Confidence 654321 122345799999999999887764 899999999999999999999976432 233333333333322
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCH----HHHHhCccccc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 191 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~----~eil~h~~f~~ 191 (361)
..+++++.+||.+||+.||.+||++ ++++.||||+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 3579999999999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=279.60 Aligned_cols=189 Identities=25% Similarity=0.484 Sum_probs=153.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++..|+||||+.+ +|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred eeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccce
Confidence 356789999999975 8888877644 58999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
..... ........+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVP--TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCC--ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 53321 122234578999999999876554468999999999999999999999876655443332210
Q ss_pred ---------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 151 ---------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 151 ---------~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
....| +.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23678999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=276.01 Aligned_cols=181 Identities=30% Similarity=0.449 Sum_probs=150.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||+.+ +|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 4568999999975 899888764 3589999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 151 (361)
.... .......||+.|+|||++.+..+. .++||||+||++|+|++|.+||.+.+....+.++....
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 158 YSCQ---MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccCc---ccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 4321 223446789999999999877664 89999999999999999999998776655544432210
Q ss_pred --------C---------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 --------F---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 --------~---------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+ ...+.++..+.+||.+||..||++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112357788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.88 Aligned_cols=189 Identities=33% Similarity=0.582 Sum_probs=157.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 71 ~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~ 150 (331)
T cd05624 71 QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL 150 (331)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEecccee
Confidence 456789999999999999999987 4679999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccC----CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~----~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~ 154 (361)
....... ......+||+.|+|||++.+. +..+.++||||+||++|+|++|..||...+..+.+.++.... +..
T Consensus 151 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 151 KMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 229 (331)
T ss_pred eccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccC
Confidence 5432111 112346799999999998652 223578999999999999999999999888777777776533 333
Q ss_pred CC---CCCHHHHHHHHHccCCCcCC--CCCHHHHHhCccccc
Q 018052 155 PS---WFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~---~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 191 (361)
|. .+++++.+||.+||..++++ |++++++++||||+.
T Consensus 230 p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 230 PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 43 36899999999999876654 578999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.80 Aligned_cols=184 Identities=29% Similarity=0.535 Sum_probs=148.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 468999999976 67776643 489999999999999999999999999999999999999999999999999864322
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh---------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--------------- 149 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------- 149 (361)
........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+..
T Consensus 176 ---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 176 ---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 2223456789999999999887775 789999999999999999999987654433222111
Q ss_pred -------cCCC---------CCC-----------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 150 -------ADFS---------CPS-----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 150 -------~~~~---------~~~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.... ++. ..++.+.+||.+||..||++|||+.|+++||||...+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 0000 111 135778999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=275.79 Aligned_cols=183 Identities=40% Similarity=0.795 Sum_probs=165.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||+|.||+++.+|.+||+|||++...
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 46789999999999999999998889999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 162 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 162 (361)
... ....+|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+....+..+..+....|..++..+
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 225 (290)
T cd05580 152 KGR-----TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225 (290)
T ss_pred CCC-----CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHH
Confidence 321 3456799999999998776654 7899999999999999999999988877777777777778888899999
Q ss_pred HHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 163 KKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
.++|.+||..||.+|+ +++++++||||..
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 9999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.44 Aligned_cols=182 Identities=27% Similarity=0.497 Sum_probs=154.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~~ 81 (361)
..+.+|+||||++||+|.+++...+.++++++..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++..
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 4568999999999999999998878899999999999999999999999999999999999999988 999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH----HHHHHhhcCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~ 157 (361)
... .....|++.|+|||++.+..+. .++|+||+|+++|+|++|..||....... .+..........++.
T Consensus 160 ~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T PHA03390 160 IGT------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN 232 (267)
T ss_pred cCC------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence 422 1234689999999999887775 78999999999999999999997543322 122112333345556
Q ss_pred CCHHHHHHHHHccCCCcCCCCC-HHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t-~~eil~h~~f~~ 191 (361)
+++.+.+||.+||+.+|.+||+ ++++++||||+.
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 8999999999999999999996 699999999963
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=280.67 Aligned_cols=183 Identities=26% Similarity=0.449 Sum_probs=150.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|++||++ |++|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4689999998 779988775 45799999999999999999999999999999999999999999999999999875422
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------- 151 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 151 (361)
......||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+....
T Consensus 171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 23456799999999998775555689999999999999999999998766554443332110
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 152 ----------FSCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 152 ----------~~~~--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
...+ ...++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0001 124667889999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=283.44 Aligned_cols=186 Identities=32% Similarity=0.531 Sum_probs=150.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....+|+||||++||+|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 142 ~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 142 DHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217 (353)
T ss_pred ccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence 456789999999999998643 3467888899999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH---HHHHHHh-hcCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKIC-RADFS 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~---~~~~~i~-~~~~~ 153 (361)
..... .......||+.|+|||++.. ..+.+.++||||+||++|+|++|..||...... .....+. .....
T Consensus 218 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
T PLN00034 218 LAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295 (353)
T ss_pred ccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC
Confidence 53221 12245679999999998743 345567899999999999999999999743322 2222222 22334
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+..++.++.+||.+||..||++|||+.|+++||||.+..
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 4556899999999999999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=284.26 Aligned_cols=184 Identities=27% Similarity=0.487 Sum_probs=148.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 3568999999976 77777754 48999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 150 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 150 (361)
. ........||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2223456799999999999887775 7899999999999999999999876654433322110
Q ss_pred ---------C-----CC---------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 151 ---------D-----FS---------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 151 ---------~-----~~---------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
. .. .+...+.++.+||.+||..||++|||+.|+++||||...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01113567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.24 Aligned_cols=188 Identities=25% Similarity=0.405 Sum_probs=151.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+|||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 157 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 157 WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred eCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 4568999999995 599999987788999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---HHHHHHHhh----------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICR---------- 149 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~---~~~~~~i~~---------- 149 (361)
.............||+.|+|||++.+..|. .++||||+||++|+|++|..||.+... ...+..+.+
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 432222223456799999999999887775 789999999999999999999965421 111111110
Q ss_pred -------------------cCCCCCC-----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 150 -------------------ADFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 150 -------------------~~~~~~~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+..|. .++.++.+||.+||..||.+|||+.++|.||||++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 246778899999999999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.67 Aligned_cols=186 Identities=28% Similarity=0.501 Sum_probs=153.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 5678999999999999999999888899999999999999999999985 799999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHH--------------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI-------------- 147 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i-------------- 147 (361)
... ......+||+.|+|||++.+..+. .++|+||+||++|+|++|..||...........+
T Consensus 154 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 154 LID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred hhh----hccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 422 122345799999999999876664 8899999999999999999999765443322111
Q ss_pred ------------------------------hhcC-CCCC-CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 148 ------------------------------CRAD-FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 148 ------------------------------~~~~-~~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.... ...+ ..++.++.+||.+||..||++|||+.+++.||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 0011 13578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=275.64 Aligned_cols=186 Identities=30% Similarity=0.517 Sum_probs=154.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+++.+|+||||++||+|.+++...+ ++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 35678999999999999999886543 5999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH---HHHHHH-hhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALYRKI-CRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~---~~~~~i-~~~~~~~~ 155 (361)
..... ........||+.|+|||++.+..+. .++|+||+||++|+|++|..||...... ...... .......+
T Consensus 150 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05630 150 VHVPE---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS 225 (285)
T ss_pred eecCC---CccccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC
Confidence 64322 1222345799999999999877765 8899999999999999999999864321 112211 11222345
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
..+++++.+|+++||..||.+||| ++++++||||+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 668899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=279.81 Aligned_cols=181 Identities=25% Similarity=0.406 Sum_probs=146.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC---------------------------------------------------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--------------------------------------------------------- 26 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--------------------------------------------------------- 26 (361)
...+|+||||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 34689999999999999998753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccc
Q 018052 27 -----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV 101 (361)
Q Consensus 27 -----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 101 (361)
.++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 237788899999999999999999999999999999999999999999999987542211111122344678899
Q ss_pred cccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHH-HHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCC
Q 018052 102 APEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRM 178 (361)
Q Consensus 102 APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~-~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~ 178 (361)
|||++.+..|+ .++||||+||++|+|++ |..||.+...... ...+..+ ....|..+++++.+|+.+||..||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999877775 89999999999999997 9999987554333 3333332 2344566889999999999999999999
Q ss_pred CHHHHHh
Q 018052 179 TISQMLE 185 (361)
Q Consensus 179 t~~eil~ 185 (361)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=268.41 Aligned_cols=183 Identities=36% Similarity=0.650 Sum_probs=159.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..
T Consensus 67 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 35678999999999999999998888899999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC----CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----PSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~ 157 (361)
... .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+....+..+....... +..
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF 219 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCccccc
Confidence 322 234568899999999887665 489999999999999999999999888777776665544332 234
Q ss_pred CCHHHHHHHHHccCCCcCCCC---CHHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRM---TISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~---t~~eil~h~~f~~ 191 (361)
+++++.++|.+||..+|++|| +++|++.||||++
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 789999999999999999999 5589999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=271.58 Aligned_cols=185 Identities=39% Similarity=0.697 Sum_probs=153.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+..+|+||||+.+++|.+++...+.+++.++..++.|++.||.+||++||+||||||+||++++++.++|+|||.+...
T Consensus 69 ~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 69 DDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp ESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 35789999999999999999997788999999999999999999999999999999999999999999999999998653
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---HHHHHHHHhhcCCCCCC---
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRADFSCPS--- 156 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~--- 156 (361)
. .........++|+.|.|||++......+.++|+||+|+++|+|++|..||...+ ......+........+.
T Consensus 149 ~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T PF00069_consen 149 S--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS 226 (260)
T ss_dssp T--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence 1 122344567889999999998733444589999999999999999999999873 33333333222111111
Q ss_pred -CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 157 -WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 157 -~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+..+.++|.+||..||++|||+.++++||||
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 124899999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=269.04 Aligned_cols=186 Identities=40% Similarity=0.767 Sum_probs=162.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+||||++||+|.+++.+...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 63 KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred EcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHHHh--hcCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKIC--RADFSCPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~i~--~~~~~~~~~ 157 (361)
..... .....+|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... ....+..+. ......|..
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY 218 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcc
Confidence 53321 22345789999999998776665 78999999999999999999998766 566666665 345566777
Q ss_pred CCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
.++++.++|.+||..+|.+||| +.|+++||||+.
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 7899999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=268.97 Aligned_cols=183 Identities=28% Similarity=0.422 Sum_probs=151.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35789999999999999998864 3689999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC--CC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SC 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~ 154 (361)
.... ........|++.|+|||++.+ ..| +.++|+||+||++|+|++|..||...........+..... ..
T Consensus 161 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred cccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 4321 122345679999999999863 234 4789999999999999999999987655544443333221 12
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+..++..+.+|+.+||..+|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 23468899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=267.90 Aligned_cols=188 Identities=32% Similarity=0.667 Sum_probs=169.0
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.|++++|+|.||++||+|.-.++++.+++|+.|+.|...|+.||.|||++||++||||.+|+|+|..|++|++|+|++.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 56889999999999999999999999999999999999999999999999999999999999999999999999999975
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc--------ccHHHHHHHHhhcCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE--------SNLMALYRKICRADF 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~ 152 (361)
- ...++....+.||||.|+|||++.+..| +..+|+|++||++++|++|+-||+- .+..-+++-|.....
T Consensus 400 e--~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 400 E--GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred c--CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 3 3445667789999999999999998877 6999999999999999999999963 223345666777788
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCC------HHHHHhCccccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMT------ISQMLEDEWFKK 191 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t------~~eil~h~~f~~ 191 (361)
..|..+|-.+..+++..|++||.+|.. +.++..|+||..
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 889999999999999999999999964 789999999973
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=267.52 Aligned_cols=186 Identities=28% Similarity=0.552 Sum_probs=157.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.....|+||||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 45688999999999999999998888999999999999999999999999999999999999999999999999998755
Q ss_pred ccccc----CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 83 QQVRE----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 83 ~~~~~----~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
..... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||.+.+.......+... ....|..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN 235 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcc
Confidence 42111 1112235689999999999877665 7899999999999999999999886655444443332 3345566
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++..+.++|++||..||.+||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 88999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=271.91 Aligned_cols=177 Identities=19% Similarity=0.248 Sum_probs=154.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++...
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL 173 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence 457899999999999999999888899999999999999999999985 8999999999999999999999999998754
Q ss_pred cccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWF 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~ 158 (361)
... .....||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+.+..+.+..+... ....|...
T Consensus 174 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (283)
T PHA02988 174 SSP-----PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDC 247 (283)
T ss_pred ccc-----cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcC
Confidence 321 124568999999999876 445 48999999999999999999999998888877776543 34555568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+.+|+.+||+.||++|||+.++++.
T Consensus 248 ~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 248 PLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999999999999863
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.94 Aligned_cols=184 Identities=34% Similarity=0.584 Sum_probs=159.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...|+||||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 70 DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred cCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 457899999999999999999874 578999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFS 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s 159 (361)
..... .......+|++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+...... .+..++
T Consensus 150 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08529 150 LLSDN--TNFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYS 226 (256)
T ss_pred eccCc--cchhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccC
Confidence 54332 1223445789999999999887765 7899999999999999999999988877777666655443 333578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.++.+++.+||..+|++||++.++++|||+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=283.43 Aligned_cols=186 Identities=32% Similarity=0.538 Sum_probs=163.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+++||..|||.||-+...+-.- ..+.+++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...
T Consensus 101 enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 101 ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc
Confidence 46899999999999988776654 47999999999999999999999999999999999999999999999999998653
Q ss_pred cccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC---C
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---C 154 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~ 154 (361)
.. .-....++.|||+|||||++. +.+|+ .++|||||||.|.+|..+.+|..+.+.+..+.+|.+...+ -
T Consensus 181 ~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 181 KS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hh--HHhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 32 112335688999999999864 55777 8999999999999999999999999999999888776543 3
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
|..++.++.+++.+||..||..||+++++++||||+..
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 66689999999999999999999999999999999853
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.21 Aligned_cols=186 Identities=31% Similarity=0.544 Sum_probs=156.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 45789999999999999999988888999999999999999999999999999999999999999999999999998654
Q ss_pred cccc----cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCC
Q 018052 83 QQVR----EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCP 155 (361)
Q Consensus 83 ~~~~----~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~ 155 (361)
.... .........|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+... ....+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence 2111 11122345789999999999877665 8899999999999999999999876554443333322 12345
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..++.++.++|++||..+|.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 5688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=267.43 Aligned_cols=188 Identities=31% Similarity=0.509 Sum_probs=156.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...|+||||++||+|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred eCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 45688999999999999988765 45799999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FS 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~ 153 (361)
.... ........|++.|+|||++.. ..+ +.++|+||+||++|+|++|..||...+.......+.... ..
T Consensus 153 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd06643 153 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA 229 (282)
T ss_pred cccc--ccccccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC
Confidence 3221 112334578999999999742 223 478999999999999999999998877666555554332 23
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.|..++.++.+||.+||..||.+|||++++++||||+...
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 3455789999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=267.31 Aligned_cols=183 Identities=30% Similarity=0.502 Sum_probs=151.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+||||+++|+|.+++...+.+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 45789999999999999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC----
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---- 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 155 (361)
... ........|++.|+|||++. ...+ +.++|+||+||++|+|++|..||...................+
T Consensus 157 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 157 TAT--IAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred cCc--ccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 321 11223457899999999874 2334 4799999999999999999999976544333333322322222
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
..++..+.++|.+||..+|++|||++++++|||
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 135788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.71 Aligned_cols=189 Identities=36% Similarity=0.702 Sum_probs=163.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++..+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++..
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred ecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 45678999999999999999999878899999999999999999999999999999999999999999999999999865
Q ss_pred cccccc------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC
Q 018052 82 SQQVRE------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 155 (361)
Q Consensus 82 ~~~~~~------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 155 (361)
...... ........+++.|+|||......+ +.++|+||+|+++|+|++|..||........+..+..+....|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 332111 112234568899999999877665 4889999999999999999999998888888777766666655
Q ss_pred CCC--CHHHHHHHHHccCCCcCCCCCH---HHHHhCccccc
Q 018052 156 SWF--SSGAKKLIKRILDPNPDTRMTI---SQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~--s~~~~~Li~~~L~~dP~~R~t~---~eil~h~~f~~ 191 (361)
... +..+.+++.+||..+|++|||+ .++++||||++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 554 8999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.74 Aligned_cols=191 Identities=28% Similarity=0.515 Sum_probs=159.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..+..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 90 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred cCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 45789999999999999998854 57999999999999999999999999999999999999999999999999998643
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s 159 (361)
... ........|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+....+..+.... ......++
T Consensus 169 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06658 169 SKE--VPKRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVS 245 (292)
T ss_pred ccc--cccCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccC
Confidence 321 1223446789999999999876665 78999999999999999999998876665555443321 12223468
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 197 (361)
..+.+++.+||..||.+|||++++++||||.....|..
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 89999999999999999999999999999997765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=268.39 Aligned_cols=189 Identities=33% Similarity=0.499 Sum_probs=158.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++..+|+||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred ecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccch
Confidence 3567899999999999999998764 469999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccC----CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDK----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FS 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~----~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~ 153 (361)
...... .......|++.|+|||++... ...+.++|+||+|+++|+|++|..||.+.+......++.... ..
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 152 KNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred hhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 543211 122345789999999997532 122468999999999999999999998877766666655442 23
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.|..++.++.++|.+||..+|.+|||+.++++||||...
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 355688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.08 Aligned_cols=189 Identities=35% Similarity=0.691 Sum_probs=159.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++..
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 71 ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 45678999999999999999998888899999999999999999999999999999999999999999999999999863
Q ss_pred ccccc-------------cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh
Q 018052 82 SQQVR-------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 148 (361)
Q Consensus 82 ~~~~~-------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~ 148 (361)
..... .........|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 11000 0001123468889999999887666 489999999999999999999999887777777766
Q ss_pred hcCCCCCC---CCCHHHHHHHHHccCCCcCCCCC---HHHHHhCccccc
Q 018052 149 RADFSCPS---WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 191 (361)
Q Consensus 149 ~~~~~~~~---~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 191 (361)
......|. .++.++.++|.+||..||++||+ +.++++||||..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred hcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 65443332 47899999999999999999998 799999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=271.39 Aligned_cols=188 Identities=24% Similarity=0.477 Sum_probs=152.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++..+|+||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 74 HTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred ecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 35678999999997 5999888764 468999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
..... ........+++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+...
T Consensus 153 ~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIP--TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCC--CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 53221 112234567899999999876555568999999999999999999999887655444332210
Q ss_pred ---------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---------~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
....| +.+++.+.+||.+||..||.+|||++++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 2367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=269.16 Aligned_cols=187 Identities=29% Similarity=0.532 Sum_probs=157.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+++.+|+||||+.||+|.+++... .++++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred ecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 4567899999999999999888653 36999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH----HHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY----RKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~ 155 (361)
..... ........|++.|+|||++.+..+. .++|+||+||++|+|++|..||.+....... ..+.......+
T Consensus 150 ~~~~~---~~~~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd05632 150 VKIPE---GESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS 225 (285)
T ss_pred eecCC---CCcccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC
Confidence 64322 1223456799999999999877665 7899999999999999999999876543322 22333344455
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCC-----HHHHHhCcccccC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKKG 192 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~~ 192 (361)
..+++++.+|+.+||..||++||| +.+++.|+||..-
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 668899999999999999999999 8999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=264.13 Aligned_cols=178 Identities=28% Similarity=0.496 Sum_probs=151.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++....++++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++..
T Consensus 55 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 55 VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 35678999999999999999998888899999999999999999999999999999999999999999999999998754
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......++..|+|||.+....+. .++|+||+|+++|+|++|..|+...... .. .......|.++++.
T Consensus 135 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~ 204 (237)
T cd05576 135 VED-----SCDGEAVENMYCAPEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEE 204 (237)
T ss_pred ccc-----ccccCCcCccccCCcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHH
Confidence 332 12345567889999998776664 7899999999999999999887643211 00 11234567889999
Q ss_pred HHHHHHHccCCCcCCCCCH-----HHHHhCccc
Q 018052 162 AKKLIKRILDPNPDTRMTI-----SQMLEDEWF 189 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~-----~eil~h~~f 189 (361)
+.+||.+||+.||++|||+ ++++.||||
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 9999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=279.26 Aligned_cols=187 Identities=30% Similarity=0.486 Sum_probs=152.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKE-DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e-~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+||||||-+- ||...+.+.....+ -.++.|.+|++.|+.++|.+||||.||||.|.|+-. |.+||+|||.|..
T Consensus 431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 431 TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 35789999999754 99999998776544 589999999999999999999999999999999976 8999999999987
Q ss_pred ccccccCCccccccCCCccccccccccCCCC----------CCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhc
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYD----------GRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~----------~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~ 150 (361)
.......-...+.+||+.||+||.+....+. ++++||||||||||+|+-|++||.... .-.-+..|...
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 6554444445678999999999998755443 678999999999999999999997643 44444555444
Q ss_pred C--CCCCCCCCH-HHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 D--FSCPSWFSS-GAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 ~--~~~~~~~s~-~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+ .++|..-+. ++.++++.||..||++|||+.++|+|||.+-
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2 244443232 3999999999999999999999999999875
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.72 Aligned_cols=186 Identities=28% Similarity=0.512 Sum_probs=154.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 69 ~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred eeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 3567899999999999999999988889999999999999999999998 589999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
.... ......+|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+...
T Consensus 149 ~~~~----~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 149 QLID----SMANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cccc----cccccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 4322 223456899999999998776654 7899999999999999999999765543332221110
Q ss_pred ---------------------------CCCCCC-CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---------------------------DFSCPS-WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---------------------------~~~~~~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
....|. .++.++.+|+.+||..+|++|||+.++++||||...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001111 257789999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=268.54 Aligned_cols=186 Identities=33% Similarity=0.558 Sum_probs=157.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
++...+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++
T Consensus 63 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~ 142 (277)
T cd05577 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA 142 (277)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcch
Confidence 45678999999999999999998766 7999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~ 155 (361)
..... ........++..|+|||++.+..+. .++|+||+||++|+|++|..||..... ..+...+.......|
T Consensus 143 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (277)
T cd05577 143 VELKG---GKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP 218 (277)
T ss_pred hhhcc---CCccccccCCCCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC
Confidence 65432 2223345678899999998876654 889999999999999999999976543 233333333445566
Q ss_pred CCCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
..+++.+.++|.+||..||.+|| ++.+++.||||..
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 66899999999999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=268.65 Aligned_cols=185 Identities=28% Similarity=0.482 Sum_probs=148.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+|+||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 69 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 69 HSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred ccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 356789999999975 88887765 4679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCC-CcccHHHHHHHHhhcC--------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD-------- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~-------- 151 (361)
..... ........+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+....+..+....
T Consensus 148 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 148 AFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred ccCCC--CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 54321 122334567899999999877555468999999999999999998875 4444444333322100
Q ss_pred -----------C----------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 -----------F----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 -----------~----------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+ ...+.+++++.+||.+||..||.+|||++++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=286.56 Aligned_cols=182 Identities=30% Similarity=0.430 Sum_probs=154.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC--CEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~--~lKl~DFGl 78 (361)
-++|+|||+|++.. +|.++|+.+. +++...++.+++||+.||.+||+.||||+|||||||||.+.+ .+||+|||.
T Consensus 259 fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 47899999999965 9999999875 699999999999999999999999999999999999996543 799999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------- 151 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------- 151 (361)
|+.... ...+++.+..|.|||++.+.+|+ .+.||||||||+.||++|.+.|.+.+..+.+..|...-
T Consensus 338 Sc~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 338 SCFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986532 23488999999999999999997 89999999999999999999999988777665543100
Q ss_pred ---------------------------------------------CCCCCC-----------CCHHHHHHHHHccCCCcC
Q 018052 152 ---------------------------------------------FSCPSW-----------FSSGAKKLIKRILDPNPD 175 (361)
Q Consensus 152 ---------------------------------------------~~~~~~-----------~s~~~~~Li~~~L~~dP~ 175 (361)
...|+. -...+.+||++||..||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 001100 113467999999999999
Q ss_pred CCCCHHHHHhCccccc
Q 018052 176 TRMTISQMLEDEWFKK 191 (361)
Q Consensus 176 ~R~t~~eil~h~~f~~ 191 (361)
+|+|..++|+||||+.
T Consensus 492 ~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTG 507 (586)
T ss_pred hcCCHHHHhcCccccc
Confidence 9999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=271.26 Aligned_cols=190 Identities=32% Similarity=0.576 Sum_probs=161.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
++...+|+||||+.|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred ecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchh
Confidence 3567899999999999999998764 46999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccC---------------------------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCC
Q 018052 80 AISQQVRED---------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF 132 (361)
Q Consensus 80 ~~~~~~~~~---------------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~ 132 (361)
......... .......||..|+|||++.+..+. .++||||+|+++|+|++|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCC
Confidence 643221100 011234688999999999877664 8999999999999999999
Q ss_pred CCCCcccHHHHHHHHhhcCCCCCCC--CCHHHHHHHHHccCCCcCCCCC----HHHHHhCcccccC
Q 018052 133 LPFDESNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMT----ISQMLEDEWFKKG 192 (361)
Q Consensus 133 ~Pf~~~~~~~~~~~i~~~~~~~~~~--~s~~~~~Li~~~L~~dP~~R~t----~~eil~h~~f~~~ 192 (361)
.||.+.+....+..+.......+.. ++..+.++|.+||..||++||| +++++.||||+..
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred CCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 9999888777777666555555444 6899999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=272.35 Aligned_cols=186 Identities=26% Similarity=0.417 Sum_probs=142.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE----ecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYG 69 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl----d~~~ 69 (361)
+...+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++
T Consensus 71 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 71 SDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred CCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC
Confidence 45688999999965 888877532 248899999999999999999999999999999999999 5678
Q ss_pred CEEEEecCCccccccccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-------
Q 018052 70 VLKISDFGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM------- 141 (361)
Q Consensus 70 ~lKl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~------- 141 (361)
.+||+|||+|........ ........||+.|+|||++.+....+.++||||+||++|+|++|.+||......
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~ 229 (317)
T cd07867 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229 (317)
T ss_pred cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence 999999999976543211 112345678999999999877555568999999999999999999999643211
Q ss_pred --HHHHHHhh----------------------------cCCC----------CCCCCCHHHHHHHHHccCCCcCCCCCHH
Q 018052 142 --ALYRKICR----------------------------ADFS----------CPSWFSSGAKKLIKRILDPNPDTRMTIS 181 (361)
Q Consensus 142 --~~~~~i~~----------------------------~~~~----------~~~~~s~~~~~Li~~~L~~dP~~R~t~~ 181 (361)
.....+.. .... .....+..+.+||.+||..||.+|||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 309 (317)
T cd07867 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence 00100000 0000 0011345688999999999999999999
Q ss_pred HHHhCccc
Q 018052 182 QMLEDEWF 189 (361)
Q Consensus 182 eil~h~~f 189 (361)
|+++||||
T Consensus 310 e~l~hp~f 317 (317)
T cd07867 310 QALQDPYF 317 (317)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=283.64 Aligned_cols=189 Identities=35% Similarity=0.632 Sum_probs=156.9
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+++.+|+||||++||++..++-+.+-|+|+.|++|+..|.+|+++.|..|++||||||+|||||.+|++||+||||++
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 56899999999999999999999998999999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc------------C----------------------------CccccccCCCccccccccccCCCCCCchhhhh
Q 018052 81 ISQQVRE------------D----------------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120 (361)
Q Consensus 81 ~~~~~~~------------~----------------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS 120 (361)
-+.-... + ...+...||+.|+|||++...+|. ..+|+||
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws 856 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWS 856 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhH
Confidence 6431110 0 012334699999999999999997 8999999
Q ss_pred hhhHHHhHhcCCCCCCcccHHHHHHHH--hhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCC---HHHHHhCccccc
Q 018052 121 CGVILFVLMAGFLPFDESNLMALYRKI--CRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKK 191 (361)
Q Consensus 121 ~Gvil~~ll~g~~Pf~~~~~~~~~~~i--~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~ 191 (361)
.|||||+|+.|++||-..+..+...++ ++. .+..-..+|.++.+||.++.. +++.|.. ++++..||||+.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 999999999999999776554333322 222 233334589999999998654 5888875 778999999985
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=266.33 Aligned_cols=183 Identities=28% Similarity=0.414 Sum_probs=150.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46889999999999999998763 3588999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-C-C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-S-C 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~-~ 154 (361)
.... ........|++.|+|||++.. ..+ +.++|+||+||++|+|++|..||...........+..... . .
T Consensus 171 ~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 171 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 4321 122345678999999998763 234 3789999999999999999999977654443333322211 1 1
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+..++.++.+||++||..||.+|||+.++++||||
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 22478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=266.65 Aligned_cols=185 Identities=28% Similarity=0.488 Sum_probs=147.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
.++..+|+||||+. |+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+
T Consensus 69 ~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 69 MQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred eeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccc
Confidence 35678999999997 5898887643 4699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------- 150 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 150 (361)
+...... ........+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 8654321 112233467899999999876554458899999999999999999999875543222211100
Q ss_pred ------------CC---------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ------------DF---------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ------------~~---------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.. .....+++++.+||++||..||.+|||+.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 0112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=266.13 Aligned_cols=186 Identities=28% Similarity=0.448 Sum_probs=151.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....+|+||||++++.|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 70 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (286)
T cd07847 70 RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI 149 (286)
T ss_pred eeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECcccccee
Confidence 35678999999999988888877777899999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 150 (361)
..... .......++..|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 150 LTGPG--DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred cCCCc--ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 43321 12234567899999999876554458999999999999999999999876544332222110
Q ss_pred --------CCCCC------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 --------DFSCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 --------~~~~~------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
....| +.++..+.+||.+||..+|++|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00001 1357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=265.73 Aligned_cols=183 Identities=21% Similarity=0.346 Sum_probs=155.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
.....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 345789999999999999999764 4578899999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
+++.+||+|||++................+++.|+|||.+.+..++ .++||||+||++|+|++ |..||.+.+..+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999998754322111223345678899999998877665 89999999999999998 999999888877777
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 766543 34456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=268.44 Aligned_cols=186 Identities=26% Similarity=0.514 Sum_probs=157.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+|+||++||+|.+++.. ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 45789999999999999998875 46999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... .......+|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+... ....|..++
T Consensus 166 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06655 166 TPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (296)
T ss_pred ccc--cccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence 321 1122345789999999998876664 7899999999999999999999887665444433322 223445578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+.+||++||..||.+|||+.+++.||||+..
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=269.29 Aligned_cols=186 Identities=27% Similarity=0.527 Sum_probs=155.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+.|+||||++||+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 88 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred eCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 45689999999999999999865 56899999999999999999999999999999999999999999999999998653
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+... ....+..++
T Consensus 167 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06654 167 TPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (296)
T ss_pred ccc--ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccC
Confidence 321 1122345789999999998876664 8999999999999999999999876654333222221 123345578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+.+||.+||..+|.+|||+.++++||||...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=263.26 Aligned_cols=185 Identities=30% Similarity=0.532 Sum_probs=154.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|++|||++|++|.+++...+.+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 46789999999999999999888889999999999999999999999999999999999999999999999999986543
Q ss_pred ccc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCCCCCCCCCH
Q 018052 84 QVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSS 160 (361)
Q Consensus 84 ~~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~ 160 (361)
... .........|+..|+|||.+.+..+. .++|+||+||++|+|++|..||...........+.. .....|..+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 211 11122345688999999999876664 789999999999999999999987655444433322 13345666889
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+.++| +||..+|++|||++++++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999999 56778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=267.22 Aligned_cols=192 Identities=31% Similarity=0.435 Sum_probs=156.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||+ +|+|.+++.... .+++..+..++.||++||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 73 ~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 73 HKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred cCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 457899999999 899999998766 799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--------- 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------- 152 (361)
..... .......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+..+.+.++.....
T Consensus 152 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 152 FGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred ccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 54321 1223345688999999886654456899999999999999999888887665554444332100
Q ss_pred --------------C-----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCC
Q 018052 153 --------------S-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197 (361)
Q Consensus 153 --------------~-----~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 197 (361)
. .....+..+.++|.+||..||++|||+.++++|+||++...+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01224678899999999999999999999999999998776554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=262.68 Aligned_cols=187 Identities=28% Similarity=0.515 Sum_probs=156.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+...|+||||++|++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++
T Consensus 70 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 467899999999999999999864 45899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CC-
Q 018052 80 AISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP- 155 (361)
Q Consensus 80 ~~~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~- 155 (361)
......... .......|++.|+|||++......+.++|+||+||++|+|++|..||...+....+.+....... .+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET 229 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCC
Confidence 765432221 12234578999999999877634458999999999999999999999887766555554443221 11
Q ss_pred ----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 156 ----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 156 ----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+++.+.+++.+||..||++|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1367889999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=272.72 Aligned_cols=188 Identities=23% Similarity=0.419 Sum_probs=147.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+++.+|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+.
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 70 ADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred ECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 467899999999999999999753 459999999999999999999999999999999999999999999999998653
Q ss_pred cccccccC-----CccccccCCCccccccccccC--CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC
Q 018052 81 ISQQVRED-----GLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS 153 (361)
Q Consensus 81 ~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~--~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 153 (361)
........ .......++..|+|||++.+. .| +.++||||+||++|+|++|..||..............+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 228 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcc
Confidence 32111110 011223577889999998753 34 48999999999999999999999865543332222111100
Q ss_pred ----------------------------------------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 154 ----------------------------------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 154 ----------------------------------------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
....+++.+.+||++||..||++|||++++++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0112467899999999999999999999999999
Q ss_pred cccc
Q 018052 188 WFKK 191 (361)
Q Consensus 188 ~f~~ 191 (361)
||+.
T Consensus 309 ~f~~ 312 (327)
T cd08227 309 FFKQ 312 (327)
T ss_pred hhhh
Confidence 9975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=265.14 Aligned_cols=186 Identities=32% Similarity=0.499 Sum_probs=154.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||++||+|..++.+ ...+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 45689999999999999887764 45799999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---S 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~ 153 (361)
.... ........+++.|+|||++.+ ..+ +.++|+||+||++|+|++|..||...+....+.++..... .
T Consensus 160 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 160 NVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred cccc--ccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 3221 112234568899999999853 223 4789999999999999999999988766655555543322 2
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+..++.++.++|.+||..+|++||+++++++||||..
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 34457889999999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=264.55 Aligned_cols=186 Identities=29% Similarity=0.484 Sum_probs=152.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||+ |++|.+++... ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 70 ~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 70 HGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred cCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 456889999999 99999998753 5699999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 151 (361)
...... .......|+..|+|||.+.+....+.++||||+|+++|+|++|.+||.+.+....+..+....
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 543221 223456789999999998766555689999999999999999999997766554443332210
Q ss_pred ---------CC-----------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 152 ---------FS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 152 ---------~~-----------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.. ..+..+..+.+||.+||..+|.+|||++++++||||.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0123468889999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=262.24 Aligned_cols=188 Identities=29% Similarity=0.526 Sum_probs=155.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC--
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS-- 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~-- 156 (361)
..............|+..|+|||++.... ..+.++|+||+|+++|+|++|..||...+.......+... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43322222234467899999999987654 2358899999999999999999999766555444333222 122222
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.++.++.++|.+||..+|.+|||++++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 358899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=263.27 Aligned_cols=187 Identities=36% Similarity=0.681 Sum_probs=164.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++++|||++..
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccC------------------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHH
Q 018052 82 SQQVRED------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL 143 (361)
Q Consensus 82 ~~~~~~~------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~ 143 (361)
....... .......|+..|+|||++....+ +.++|+||+|+++++|++|..||...+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 5432211 12233467899999999877655 4789999999999999999999998877777
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCH----HHHHhCccc
Q 018052 144 YRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI----SQMLEDEWF 189 (361)
Q Consensus 144 ~~~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~----~eil~h~~f 189 (361)
+..+.......|..+++.+.++|.+||+.+|.+|||+ .++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7777777777888889999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=307.83 Aligned_cols=190 Identities=32% Similarity=0.567 Sum_probs=162.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.++||.||||+||+|.+.++..+-.+|...+.|..|++.|+.|||++||+||||||+||+|+.+|-+|++|||.|...
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 35678999999999999999998777888899999999999999999999999999999999999999999999999765
Q ss_pred cccc--cCCccccccCCCccccccccccCCC--CCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhc-CCCCCC
Q 018052 83 QQVR--EDGLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRA-DFSCPS 156 (361)
Q Consensus 83 ~~~~--~~~~~~~~~gt~~y~APEv~~~~~~--~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~-~~~~~~ 156 (361)
.... -.+.+....|||.|||||++.+..- .+.++||||+||++.||+||+.||...+.. ++..++..+ ..+.|.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch
Confidence 4321 1234567889999999999986542 257899999999999999999999875433 444444444 567788
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+|++.+++|.+||..||++|.++.|+++|.|-+..
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 899999999999999999999999999999987654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=259.79 Aligned_cols=185 Identities=29% Similarity=0.632 Sum_probs=159.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+..+.|+||||++|++|.+++.... .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred cCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 45678999999999999999987643 5899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~ 158 (361)
....... .......|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+..+....+..+... .+..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08218 149 RVLNSTV--ELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY 225 (256)
T ss_pred eecCcch--hhhhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccC
Confidence 7543321 112334688999999998876654 7899999999999999999999888777777766655443 45568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+.++.++|.+||..+|.+||++.++++||||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=261.05 Aligned_cols=184 Identities=30% Similarity=0.593 Sum_probs=159.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+....|+||||+.|++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++..
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 70 QDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149 (258)
T ss_pred cCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence 45778999999999999999998877899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---HHHHHHHhhcCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRADFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 158 (361)
.... .......|+..|+|||++....+ +.++|+||+|+++|+|++|..||...+. ..............|..+
T Consensus 150 ~~~~---~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T cd05578 150 VTPD---TLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW 225 (258)
T ss_pred cCCC---ccccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccC
Confidence 4322 12345678999999999887665 4899999999999999999999987663 333333333455667778
Q ss_pred CHHHHHHHHHccCCCcCCCCCH--HHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTI--SQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~--~eil~h~~f 189 (361)
+..+.++|.+||..||.+||++ .++++||||
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 226 STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=264.51 Aligned_cols=188 Identities=27% Similarity=0.511 Sum_probs=159.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+.|+|+||++|++|.+++.. ++++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 87 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred cCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 45688999999999999999887 67999999999999999999999999999999999999999999999999987644
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC---CCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC---PSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s 159 (361)
.... .......|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+....... +..++
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 166 SKEV--PRRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred ccCC--cccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCC
Confidence 3211 122345689999999999877665 78999999999999999999998877666666555442221 22378
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+.+++++||..+|++|||+.++++||||++...
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 89999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=264.77 Aligned_cols=184 Identities=27% Similarity=0.414 Sum_probs=151.2
Q ss_pred cEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 478999999999999998763 4578999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCC----CCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGY----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FS 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~----~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~ 153 (361)
...... .......|++.|+|||++..... .+.++|+||+||++|+|++|..||...+.......+.... ..
T Consensus 177 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd06639 177 QLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254 (291)
T ss_pred hccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 543211 11234578999999999764321 2478999999999999999999998766554444443332 22
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+..++..+.+||.+||..+|.+||++.++++||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2444678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=263.68 Aligned_cols=180 Identities=32% Similarity=0.570 Sum_probs=148.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||+.| +|.+.+... +.+++..+..++.|++.||+|||+.|++||||||+||+++. +.+||+|||++....
T Consensus 73 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 73 GRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred CcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 689999999975 888888764 46899999999999999999999999999999999999999 999999999987543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 150 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 150 (361)
.. .......+++.|+|||.+....+.+.++|+||+||++|+|++|..||.+.+..+.+..+...
T Consensus 151 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 151 SK---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred cC---CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 22 12234568899999998766566568999999999999999999999887655544333211
Q ss_pred -----CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 -----DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 -----~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.+..| +.++.++.+||.+||.++|++|||+.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11111 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=263.43 Aligned_cols=183 Identities=30% Similarity=0.488 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+..+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence 45689999999999999999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCcccccccccc---CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC----
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---- 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~---~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 155 (361)
... ........|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...+.......+....+..+
T Consensus 157 ~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06646 157 TAT--IAKRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233 (267)
T ss_pred ccc--ccccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence 321 111234578999999998742 223 4789999999999999999999976554433333322222222
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
..++..+.+||++||..+|.+|||++++++|+|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 236789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=262.27 Aligned_cols=184 Identities=30% Similarity=0.447 Sum_probs=151.2
Q ss_pred CcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
...+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4568999999999999998865 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCC----CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKG----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--- 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~----~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 152 (361)
...... ........|++.|+|||++.... ..+.++||||+||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 654321 12234467899999999875422 224789999999999999999999987655554444443322
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2223367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=263.66 Aligned_cols=186 Identities=31% Similarity=0.522 Sum_probs=153.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++...|+||||++++.|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++++++.+||+|||++..
T Consensus 70 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 70 RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred ccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 45678999999999999988877767799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 150 (361)
..... .......++..|+|||++.+....+.++||||+|+++|+|++|.+||...+..+....+...
T Consensus 150 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 150 LAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred ccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 43321 22334568899999999876555568899999999999999999999876544433332210
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 --------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 --------~~~------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
... .++.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=259.46 Aligned_cols=183 Identities=30% Similarity=0.486 Sum_probs=153.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|++|||+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 71 ~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchh
Confidence 567899999999999999998876 6899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-----
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS----- 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----- 153 (361)
..... .......++..|+|||.+... .++ .++|+||+|+++|+|++|..||.+.+.......+....+.
T Consensus 151 ~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 151 LTATI--AKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK 227 (262)
T ss_pred hhhhh--hccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcccc
Confidence 43211 122345789999999998765 555 7899999999999999999999887655444433333222
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
.+..++.++.+++++||..+|..|||+.+++.|+|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 12235788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=262.47 Aligned_cols=189 Identities=26% Similarity=0.542 Sum_probs=156.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.....|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 45688999999999999999876 47999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCC-CCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSW-FSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~ 160 (361)
.... .......|++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+.......+.... ...+.. ++.
T Consensus 152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06917 152 NQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229 (277)
T ss_pred CCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence 4322 223345789999999998765444589999999999999999999998876554443332221 122222 678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
++.+++.+||..||++|||+.+++.|+||++...
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.88 Aligned_cols=183 Identities=27% Similarity=0.443 Sum_probs=157.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl 73 (361)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l 146 (262)
T cd00192 67 EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKI 146 (262)
T ss_pred CCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEE
Confidence 467899999999999999999885 67999999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-C
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-D 151 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~ 151 (361)
+|||.+................+++.|+|||.+....+ +.++||||+|+++|+|++ |..||...+.......+... .
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 225 (262)
T cd00192 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225 (262)
T ss_pred cccccccccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999876543221122344567889999999887665 489999999999999998 69999998877777776643 3
Q ss_pred CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 152 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 152 ~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
...|..+++++.+++.+||..+|++|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 45567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=258.94 Aligned_cols=184 Identities=29% Similarity=0.520 Sum_probs=154.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+++||+.|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..
T Consensus 69 ~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 45789999999999999999976 34689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~ 158 (361)
..... .......|+..|+|||++.+..++ .++||||+||++|+|++|..||...+.......+... ....+..+
T Consensus 149 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd06612 149 LTDTM--AKRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225 (256)
T ss_pred cccCc--cccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhc
Confidence 54321 122334588999999999877665 8899999999999999999999876655443333221 22334457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+..+.++|.+||..||++|||+.++++||||
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.20 Aligned_cols=188 Identities=28% Similarity=0.512 Sum_probs=155.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.....+|+||||++|++|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred ecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecC
Confidence 3567899999999999999888763 379999999999999999999997 599999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCC-----CCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH---Hhh
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK---ICR 149 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~-----~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~---i~~ 149 (361)
++..... .......|++.|+|||.+.+... .+.++|+||+||++|+|++|..||........+.. +..
T Consensus 149 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 224 (286)
T cd06622 149 VSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224 (286)
T ss_pred CcccccC----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh
Confidence 9865422 22345578999999999865432 24789999999999999999999976554443332 222
Q ss_pred c-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 150 A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 150 ~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
. ....|+.++.++.++|.+||..+|++||++.+++.||||....
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 2 2345556899999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=262.44 Aligned_cols=186 Identities=29% Similarity=0.530 Sum_probs=158.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+|+||++||+|.+++... ++++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++...
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 70 KGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred ECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 356899999999999999999865 8999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCC-CCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW-FSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~ 160 (361)
.... .......|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..... ..+.. +++
T Consensus 149 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (274)
T cd06609 149 TSTM--SKRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSK 225 (274)
T ss_pred cccc--cccccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCH
Confidence 4321 123345788999999999877754 899999999999999999999988766555554444322 23334 788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++.+++.+||..+|++|||++++++||||++.
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=255.81 Aligned_cols=185 Identities=41% Similarity=0.770 Sum_probs=165.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++..+|+||||+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 63 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 63 QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred ecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence 46788999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
..... .......|+..|+|||...+... +.++|+||+|+++|+|++|..||...+.......+.......|..++..
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPE 219 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 43321 12345678999999999877665 4789999999999999999999988877777777777777788888999
Q ss_pred HHHHHHHccCCCcCCCCCH---HHHHhCccc
Q 018052 162 AKKLIKRILDPNPDTRMTI---SQMLEDEWF 189 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~---~eil~h~~f 189 (361)
+.++|++||..||++|||+ .++++||||
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=276.34 Aligned_cols=157 Identities=27% Similarity=0.416 Sum_probs=126.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccc
Q 018052 28 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 107 (361)
Q Consensus 28 ~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~ 107 (361)
++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+..+++.|+|||++.
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence 47888999999999999999999999999999999999999999999999987543221111112234566799999998
Q ss_pred cCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 108 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 108 ~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
+..|+ .++||||+||++|+|++ |..||........+...... ....|.++++++.+++.+||..||.+|||+.+++
T Consensus 288 ~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 288 DCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred CCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 76665 89999999999999997 99999876544333333332 3345667899999999999999999999999997
Q ss_pred h
Q 018052 185 E 185 (361)
Q Consensus 185 ~ 185 (361)
+
T Consensus 367 ~ 367 (374)
T cd05106 367 Q 367 (374)
T ss_pred H
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=264.98 Aligned_cols=190 Identities=26% Similarity=0.531 Sum_probs=158.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.....|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 89 ~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 89 VGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred eCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 46789999999999999987755 57999999999999999999999999999999999999999999999999998644
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s 159 (361)
... .......+|++.|+|||++.+..+. .++|+||+||++|+|++|..||...+.......+.... ...+..++
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 168 SKD--VPKRKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKIS 244 (297)
T ss_pred ccc--cccccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCC
Confidence 321 1122446799999999999877664 88999999999999999999998776655555443322 12233468
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
..+.++|.+||..+|.+|||+.++++||||.+...+.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 8999999999999999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=260.84 Aligned_cols=188 Identities=29% Similarity=0.509 Sum_probs=154.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~ 80 (361)
....++|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.
T Consensus 73 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 73 CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred ccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 35678999999999999999999888899999999999999999999999999999999999998876 59999999986
Q ss_pred ccccccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHH---h--hcCCC
Q 018052 81 ISQQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI---C--RADFS 153 (361)
Q Consensus 81 ~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i---~--~~~~~ 153 (361)
....... ........||..|+|||++.+..+. .++|+||+|+++|+|++|..||...........+ . .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence 5443211 1112235688999999998876664 8899999999999999999999754432222221 1 12334
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.|..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 5566889999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=260.78 Aligned_cols=182 Identities=23% Similarity=0.338 Sum_probs=152.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~ 68 (361)
+....|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 4567999999999999999997643 47889999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHH
Q 018052 69 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 147 (361)
Q Consensus 69 ~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i 147 (361)
+.+||+|||++................+++.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999998643221111112233467889999999887765 78999999999999998 99999887777777776
Q ss_pred hhcCCC-CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 148 CRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 148 ~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+... .+..++..+.+++.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 655443 34568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=257.21 Aligned_cols=184 Identities=37% Similarity=0.630 Sum_probs=158.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCH-----SRGVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH-----~~gi~HrDiKp~NiLld~~~~lKl 73 (361)
.+..+|++|||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 34578999999999999999875 357999999999999999999999 889999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF- 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 152 (361)
+|||++....... .......|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+.....
T Consensus 152 ~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd08217 152 GDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228 (265)
T ss_pred ecccccccccCCc--ccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC
Confidence 9999987654322 113445789999999999876654 889999999999999999999998877666666655543
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..|..++..+.+++.+||..+|++|||+.++++|||+
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 3455688999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=265.47 Aligned_cols=188 Identities=29% Similarity=0.450 Sum_probs=153.8
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
+.+|+||||+.+ +|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 578999999975 888887753 579999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 150 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 150 (361)
... .......+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+.+..+...
T Consensus 160 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred Ccc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 321 11223346788999999876554458999999999999999999999887776665544321
Q ss_pred ------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 151 ------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 151 ------~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.+..+ .+.++.+.+||.+||..||++|||+.+++.||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 01111 2358889999999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=256.91 Aligned_cols=184 Identities=32% Similarity=0.567 Sum_probs=156.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 73 EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 45689999999999999999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~ 160 (361)
.... ......|++.|+|||.+......+.++|+||+|+++|+|++|..||...........+.. .....|..+++
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCH
Confidence 3321 234567899999999987655235889999999999999999999987664444433332 22344566889
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.+.+++.+||..+|.+|||+.+++.|||+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=262.45 Aligned_cols=182 Identities=23% Similarity=0.354 Sum_probs=152.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG 69 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~ 69 (361)
....+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 4567899999999999999997543 489999999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHh
Q 018052 70 VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC 148 (361)
Q Consensus 70 ~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~ 148 (361)
.+||+|||++................+++.|+|||++.+..+. .++|+||+||++|+|++ |..||...+.......+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754321111112233457789999998876664 89999999999999998 999999888777777776
Q ss_pred hcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 149 RADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 149 ~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.. ..+..++.++.+|+.+||..||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6543 344567899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=266.31 Aligned_cols=188 Identities=27% Similarity=0.520 Sum_probs=155.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+||||++||+|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 45689999999999999999865 56899999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||...+.......+... ....|..++
T Consensus 166 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06656 166 TPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242 (297)
T ss_pred cCC--ccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccC
Confidence 321 1223345789999999999876664 8899999999999999999999876543322222211 122345578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+.+|+.+||..+|.+|||+.++++||||+....
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 89999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=260.92 Aligned_cols=184 Identities=28% Similarity=0.457 Sum_probs=150.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 34679999999999999988753 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--- 150 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--- 150 (361)
+...... ........|++.|+|||++.. ..+ +.++|+||+||++|+|++|..||...+.......+...
T Consensus 171 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 171 SAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred eeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 8654321 112234578999999998753 224 47899999999999999999999876654443333222
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
....|..++..+.+||.+||..||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 122344467899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.56 Aligned_cols=187 Identities=24% Similarity=0.410 Sum_probs=147.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....|+|||++. |+|.+++... +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 231 ~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 231 VGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred ECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 3567899999995 6898888764 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc--------ccHHHHHHHHhhcC--
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE--------SNLMALYRKICRAD-- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~-- 151 (361)
.............+||+.|+|||++.+..++ .++||||+||++|+|++|..|+.. .....+.+.+....
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 5432222223356799999999999887775 889999999999999988755422 11122222222111
Q ss_pred ---------------------------CCCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 ---------------------------FSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ---------------------------~~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+.| ++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 011112 4568999999999999999999999999999974
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.49 Aligned_cols=184 Identities=24% Similarity=0.396 Sum_probs=143.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 128 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 128 SGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred eCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 4567899999995 588888765 45799999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC-CCcccH---------HHHHHHHhhc-
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNL---------MALYRKICRA- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P-f~~~~~---------~~~~~~i~~~- 150 (361)
... ........||+.|+|||++.+..|. .++||||+||++|+|+++..| |..... ...+..+...
T Consensus 207 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 207 PVV---APAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred ccc---CcccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 322 1223456799999999999887775 899999999999999985444 433211 0011111110
Q ss_pred ---CCCCC------------------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 ---DFSCP------------------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 ---~~~~~------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+| ..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00001 124667788999999999999999999999999974
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=255.58 Aligned_cols=185 Identities=31% Similarity=0.612 Sum_probs=160.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++
T Consensus 69 ~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcce
Confidence 3567899999999999999999875 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~ 158 (361)
....... .......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+..+....+..+.+. .+..+
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08221 149 KILGSEY--SMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY 225 (256)
T ss_pred EEccccc--ccccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 7543322 123456789999999998876654 7899999999999999999999988877777776655443 33457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+..+.++|.+||..+|.+|||+.++++|+|+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=260.87 Aligned_cols=182 Identities=29% Similarity=0.462 Sum_probs=146.8
Q ss_pred EEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla 79 (361)
.+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 48999999986 898887653 35899999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------- 151 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 151 (361)
...... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+.++....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 644221 1122334578899999988764444589999999999999999999998766555444332210
Q ss_pred ---------CCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 152 ---------FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 152 ---------~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
...+ +.+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0001 23678899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.48 Aligned_cols=184 Identities=30% Similarity=0.546 Sum_probs=154.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+...+|+|+||+.|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 457899999999999999999876 789999999999999999999999 999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-----cHHHHHHHHhhcC-CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKICRAD-FSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~ 154 (361)
...... .....|+..|+|||.+.+..+. .++|+||+|+++|+|++|..||... ...+....+.... ...
T Consensus 150 ~~~~~~----~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (265)
T cd06605 150 QLVNSL----AKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL 224 (265)
T ss_pred hhHHHH----hhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC
Confidence 543211 1226789999999999887665 8899999999999999999999754 2333444433332 223
Q ss_pred CCC-CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 155 PSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+.. ++.++.++|.+||..||++|||+.+++.||||+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 333 7889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.66 Aligned_cols=184 Identities=28% Similarity=0.506 Sum_probs=149.9
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
.+.|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 468999999965 898888654 99999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------- 151 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 151 (361)
........|++.|+|||.+.+..+. .++||||+||++|+|++|..||...+....+.++....
T Consensus 171 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 171 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred ---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 1223445789999999999887775 88999999999999999999998766544333322100
Q ss_pred ---------C--------------CC-------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 152 ---------F--------------SC-------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 152 ---------~--------------~~-------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
. .. +...++.+.+||.+||..||++|||+.|+|.||||+..+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00 11135568999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=257.70 Aligned_cols=184 Identities=30% Similarity=0.551 Sum_probs=153.4
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46899999999999999998878899999999999999999999999999999999999999999999999999875432
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCCCHH
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSG 161 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~ 161 (361)
... ........|+..|+|||.+.+..+. .++|+||+||++|+|++|..||...+........... ....|..++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 111 1122345689999999998876664 8899999999999999999999876554444433322 22345567888
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+.++|.+||. +|++|||++++++|||+.
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999999995 899999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=255.03 Aligned_cols=183 Identities=34% Similarity=0.585 Sum_probs=156.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla 79 (361)
.+..+|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 467899999999999999999864 3589999999999999999999999999999999999998654 5899999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 158 (361)
...... .......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+..... ..+..+
T Consensus 150 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd08220 150 KILSSK---SKAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY 225 (256)
T ss_pred eecCCC---ccccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCc
Confidence 754322 222345789999999999876654 789999999999999999999998877776666655433 455668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++++.+++.+||..+|++|||+.++++||||
T Consensus 226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 226 SPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=259.88 Aligned_cols=185 Identities=28% Similarity=0.465 Sum_probs=149.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+....|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++
T Consensus 69 ~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 69 HTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred ccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccch
Confidence 45678999999996 589988865 346899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------- 151 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 151 (361)
...... ........+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+......++....
T Consensus 148 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccC--ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 654321 1122344678899999998776655688999999999999999999998765443332221100
Q ss_pred ----------CCC-----------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 ----------FSC-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 ----------~~~-----------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+ .+.+++++.++|.+||..||++|||+.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 001 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.42 Aligned_cols=182 Identities=22% Similarity=0.353 Sum_probs=152.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
+....|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 4567899999999999999997643 388999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................|++.|+|||++.+..+. .++||||+||++|+|++ |..||...+..+...
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998654322111122334568899999998877665 78999999999999998 999998877777776
Q ss_pred HHhhcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 146 KICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 146 ~i~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+..+.. ..+..++..+.+++.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6655543 234457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.15 Aligned_cols=186 Identities=33% Similarity=0.549 Sum_probs=152.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+++.+|+||||++++.+...+.....+++..+..++.|++.||.|||++|++||||+|+||++++++.+||+|||++...
T Consensus 71 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred ECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 45789999999998777777766677999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc------------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 150 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 150 (361)
..... .......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+...
T Consensus 151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 43221 12344678899999999987734458999999999999999999999876554333222110
Q ss_pred ---------CC-----------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ---------DF-----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ---------~~-----------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.+ .++..++.++.+||++||..+|++|||++++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1223358889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=260.52 Aligned_cols=190 Identities=33% Similarity=0.603 Sum_probs=158.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....+|+||||++||+|.+++....++++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 34567899999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhhcCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~ 156 (361)
..... .......+|+..|+|||.+.+. ...+.++|+||+|+++|+|++|..||... ........+.....+.|.
T Consensus 155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 155 FHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred ccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence 43211 1223356789999999998653 23357899999999999999999999643 223444444445555666
Q ss_pred CCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCcccccC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKKG 192 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 192 (361)
.+++.+.+++++||..||++|| ++.+++.||||++.
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 7899999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=270.88 Aligned_cols=174 Identities=29% Similarity=0.473 Sum_probs=154.0
Q ss_pred EEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
-+|||||||+.|+|.++++. .+.+...+...++.||++|++||+++++|||||-..|||+++++.+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 49999999999999999997 3469999999999999999999999999999999999999999999999999998432
Q ss_pred ccccCCcccccc---CCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 84 QVREDGLLHTAC---GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 84 ~~~~~~~~~~~~---gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
. ....... -...|.|||.+....++ .++|||||||+||||+| |+.||.+.+..+..+.+.++ ..+.|..+
T Consensus 355 d----~~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C 429 (468)
T KOG0197|consen 355 D----DEYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC 429 (468)
T ss_pred C----CceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC
Confidence 1 1222222 23469999999888876 89999999999999998 99999999999999988776 57888899
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
|+++.+++..||..+|++|||++.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999999764
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=256.71 Aligned_cols=185 Identities=31% Similarity=0.536 Sum_probs=150.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGl 78 (361)
+.+.+|+|+||++|++|.+++... ..+ ++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 457899999999999999999865 455 88899999999999999999999999999999999986 67999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccHH--HHHHH-HhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRK-ICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~ 154 (361)
+...... ........|++.|+|||++.... ..+.++|+||+|+++|+|++|..||...... ..+.. ........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 156 SKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred heecccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 8654321 11223346899999999986543 2358899999999999999999999764322 22221 12223345
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
|..+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 66788999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=262.22 Aligned_cols=185 Identities=24% Similarity=0.413 Sum_probs=146.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....|+||||+.+ +|.+.+.... .+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 3567999999965 8888877643 7999999999999999999999999999999999999999999999999998755
Q ss_pred cccccC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---------
Q 018052 83 QQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------- 151 (361)
Q Consensus 83 ~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 151 (361)
...... .......++..|+|||.+.+....+.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 332211 122345678899999988665434578999999999999999999998766543332221100
Q ss_pred ----------CCCC-------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 ----------FSCP-------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 ----------~~~~-------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
...| ...+..+.+||.+||..||.+|||++++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0001 0135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=276.08 Aligned_cols=178 Identities=26% Similarity=0.480 Sum_probs=158.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|||||||..|-|...++....+.......|..+|+.|+.|||.+.|+|||||.=||||+.+..+||+|||-+.....
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999998865443
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCCCHHH
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSSGA 162 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~ 162 (361)
. ...-.+|||..|||||++...+.. .++|||||||+||+||||..||.+.+..++.--+-.. ..+.|..++..+
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence 2 334568999999999999988875 9999999999999999999999988776654333222 346677899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHHhC
Q 018052 163 KKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+-||+.||.-.|..||++.+||.|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHH
Confidence 999999999999999999999998
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=255.97 Aligned_cols=182 Identities=33% Similarity=0.619 Sum_probs=155.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.++..+|+||||++||+|.+++... ..++++.+..++.|++.||.|||++||+|+||||+||+++.++.++++|||++
T Consensus 68 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence 4567899999999999999988753 35899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~ 158 (361)
...... ........|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..+... .|..+
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (255)
T cd08219 148 RLLTSP--GAYACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHY 224 (255)
T ss_pred eeeccc--ccccccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 754332 1122345789999999998876664 8899999999999999999999988877777666655443 45568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+.+||.+||+.||.+|||+.+++.-
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 8999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=266.07 Aligned_cols=190 Identities=27% Similarity=0.415 Sum_probs=153.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+. |+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 457899999995 5999999887889999999999999999999999999999999999999999999999999986543
Q ss_pred cccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh------------
Q 018052 84 QVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------ 149 (361)
Q Consensus 84 ~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~------------ 149 (361)
.... ........|+..|+|||.+.+....+.++|+||+||++|+|++|..||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 2211 11223457899999999986644446899999999999999999999987654332221111
Q ss_pred -------------cCC-CC-----CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 150 -------------ADF-SC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 150 -------------~~~-~~-----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
... .. .+..++++.++|++||+.+|.+|||+.+++.||||.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 000 00 1236889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=260.78 Aligned_cols=182 Identities=29% Similarity=0.434 Sum_probs=150.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||+.+ +|.+.+.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 789999999975 9999887644 59999999999999999999999999999999999999999999999999987554
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 151 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 151 (361)
... .......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+..+.+.++....
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 222345678899999998765555689999999999999999999998776655544432110
Q ss_pred -------------------CCCCCC-CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 -------------------FSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 -------------------~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..++.. +++.+.+||++||..+|++|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=256.80 Aligned_cols=181 Identities=22% Similarity=0.317 Sum_probs=151.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++.++|+||||++||+|.+++... +.+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 467899999999999999998874 5799999999999999999999999999999999999999999999999998754
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..... ........++..|+|||++.+..+. .++||||+||++|++++ |..||.+.+..+....+..+ ..+.|..++
T Consensus 157 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05064 157 DKSEA-IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCP 234 (266)
T ss_pred ccccc-hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 32111 0111123456789999998877665 89999999999999775 99999988777776666544 334566688
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.+++.+||..+|.+|||+.+|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=254.53 Aligned_cols=182 Identities=24% Similarity=0.323 Sum_probs=152.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
....++||||+.+|+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++....
T Consensus 67 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 67 AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 34678999999999999999888889999999999999999999999999999999999999999999999999987543
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
..... .......+++.|+|||.+....+. .++|+||+||++|+|++ |..||...+.......+..+. ...|..+++
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 225 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPP 225 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 22111 011223446789999998765554 78999999999999998 999999877777766666543 355667899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.++|.+||+.||++||++++|.+.
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHHH
Confidence 99999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=254.29 Aligned_cols=187 Identities=32% Similarity=0.589 Sum_probs=154.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+|+||+++++|.+++...+.+++..+..++.|++.||.|||++||+|+||+|+||++++++.+||+|||++...
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 70 HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 46789999999999999999998778999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCC-c-cccccCCCccccccccccCC--CCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHh-hcCCCCCC
Q 018052 83 QQVREDG-L-LHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKIC-RADFSCPS 156 (361)
Q Consensus 83 ~~~~~~~-~-~~~~~gt~~y~APEv~~~~~--~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~-~~~~~~~~ 156 (361)
....... . .....+++.|+|||++.+.. ....++||||+|+++|+|++|..||..... ......+. ......|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 4322211 1 22467889999999987654 134889999999999999999999976532 22222222 22334455
Q ss_pred CC--CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 157 WF--SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 157 ~~--s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+. ++.+.++|.+||..+|.+|||+.+++.|||+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 54 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=257.77 Aligned_cols=183 Identities=18% Similarity=0.283 Sum_probs=150.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lK 72 (361)
.....|+||||+++|+|.+++.... .++...+..++.|++.||.|||+.|++||||||+||++++++.+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 4567899999999999999987532 256778899999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|+|||++................+++.|+|||++.+..++ .++||||+||++|+|++ |..||.+.+.......+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998643321111111223567889999999876664 88999999999999998 799999887777666655543
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 152 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 152 -~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
...+...+..+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=258.70 Aligned_cols=187 Identities=28% Similarity=0.503 Sum_probs=155.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+.+|+||||++||+|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.+|++|||++..
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 72 LKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 356789999999999999998865 5799999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
..... .......|+..|+|||.+.+..+. .++|+||+||++|+|++|..||...........+.... ...+..++.
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06642 151 LTDTQ--IKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227 (277)
T ss_pred ccCcc--hhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCH
Confidence 43211 112234688999999999877665 78999999999999999999998665544443332222 223334678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++.++|.+||..+|.+|||+.++++||||...
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 89999999999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=258.64 Aligned_cols=181 Identities=28% Similarity=0.477 Sum_probs=148.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+....++||||++||+|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 70 VENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred ECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 46788999999999999654 35889999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH-------HHHHHHHhhcCCC-C
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-------MALYRKICRADFS-C 154 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~-~ 154 (361)
.. ......+||+.|+|||++.+..+. .++|+||+|+++|+|++|..||..... ......+...... .
T Consensus 146 ~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 146 VN----SIAKTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred cc----ccccCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 22 223456899999999999877664 899999999999999999999965321 1222222222111 1
Q ss_pred -CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 -PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 -~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
....++++.+++.+||..+|.+||+++++++||||...
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 23478899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=265.50 Aligned_cols=189 Identities=30% Similarity=0.491 Sum_probs=150.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..++|+|+||+.+ +|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 3578999999965 88887754 579999999999999999999999999999999999999999999999999987543
Q ss_pred cccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh-------------
Q 018052 84 QVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------------- 149 (361)
Q Consensus 84 ~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~------------- 149 (361)
.... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 2211 11223467899999999876544445899999999999999999999977654332221110
Q ss_pred -----------cCC--C-----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 150 -----------ADF--S-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 150 -----------~~~--~-----~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
... . ..+..++++.++|.+||+.+|.+|||+.++++||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 0 01235788999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=270.33 Aligned_cols=158 Identities=25% Similarity=0.400 Sum_probs=126.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccc
Q 018052 28 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 107 (361)
Q Consensus 28 ~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~ 107 (361)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................++..|+|||++.
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 289 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhc
Confidence 46788899999999999999999999999999999999999999999999987543222111112234567799999998
Q ss_pred cCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHH-HHHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 108 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 108 ~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
+..+. .++||||+||++|+|++ |..||....... ....+..+ ....|...+.++.+||.+||..||++|||+.+++
T Consensus 290 ~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 368 (375)
T cd05104 290 NCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368 (375)
T ss_pred CCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 77765 89999999999999997 899998765443 33333332 2234556788999999999999999999999998
Q ss_pred hC
Q 018052 185 ED 186 (361)
Q Consensus 185 ~h 186 (361)
+.
T Consensus 369 ~~ 370 (375)
T cd05104 369 QL 370 (375)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=258.68 Aligned_cols=186 Identities=29% Similarity=0.521 Sum_probs=155.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++||+|.+++.. +++++.++..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 73 KGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred ECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 45789999999999999999875 57999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
... ........++..|+|||++.+..++ .++|+||+||++|+|++|..||.+.+.......+.... ...+..++.+
T Consensus 152 ~~~--~~~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06640 152 TDT--QIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228 (277)
T ss_pred cCC--ccccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHH
Confidence 321 1122334688899999998876664 88999999999999999999998776555444433222 2223346788
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+++.+||..+|++|||+.++++|+||...
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=258.66 Aligned_cols=188 Identities=19% Similarity=0.303 Sum_probs=153.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lK 72 (361)
+....|+||||++||+|.+++...+ ..+...+..++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 4567899999999999999997532 245678899999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|+|||++................++..|+|||.+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+..+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998643321111111223456789999998876664 89999999999999998 799999887777766665443
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh------Cccccc
Q 018052 152 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE------DEWFKK 191 (361)
Q Consensus 152 -~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~------h~~f~~ 191 (361)
...+...++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 3445567899999999999999999999999986 788763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.17 Aligned_cols=187 Identities=34% Similarity=0.531 Sum_probs=151.2
Q ss_pred CcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEecCCCCCcEEEec-----
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-------GVFHRDLKPENLLLDS----- 67 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~-------gi~HrDiKp~NiLld~----- 67 (361)
...+||||||+++|+|.++|.. .+.+++..++.++.||+.||.|||+. +|+||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999999875 25799999999999999999999985 4999999999999964
Q ss_pred ------------CCCEEEEecCCcccccccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhcCCCC
Q 018052 68 ------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLP 134 (361)
Q Consensus 68 ------------~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~g~~P 134 (361)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++|||||||+||+|++|..|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 34599999999875432 2233456799999999998643 2335899999999999999999999
Q ss_pred CCcccHH-HHHHHHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 135 FDESNLM-ALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 135 f~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|...+.. .+...+...........+.++.+||..||..+|.+|||+.|+|.|+|++...
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 9765443 3444333332222234789999999999999999999999999999998543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=256.06 Aligned_cols=180 Identities=22% Similarity=0.335 Sum_probs=150.0
Q ss_pred EEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887432 24889999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC-CCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF-SCPSW 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 157 (361)
................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||.+......+..+..+.. ..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 765332111111233567789999998877664 89999999999999998 8999988777777776665433 44566
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++..+.++|.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=258.45 Aligned_cols=190 Identities=32% Similarity=0.584 Sum_probs=157.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||+.||+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++..
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 45678999999999999999998877899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCccc----HHHHHHHHhhcCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~ 156 (361)
..... .......+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .......+.......|.
T Consensus 155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 155 FLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233 (288)
T ss_pred ccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence 43221 11223457899999999986543 23578999999999999999999996432 23344444555566677
Q ss_pred CCCHHHHHHHHHccCCCcCCCCC---HHHHHhCcccccC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMT---ISQMLEDEWFKKG 192 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t---~~eil~h~~f~~~ 192 (361)
.++.++.++|.+||..||++||| +.++++||||+..
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 78999999999999999999998 5677999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=261.57 Aligned_cols=182 Identities=20% Similarity=0.273 Sum_probs=144.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~Ni 63 (361)
+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Ni 169 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhhe
Confidence 4567899999999999999986532 357788999999999999999999999999999999
Q ss_pred EEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc--CCCCCCcccHH
Q 018052 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLM 141 (361)
Q Consensus 64 Lld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~--g~~Pf~~~~~~ 141 (361)
|++.++.+||+|||++................+++.|+|||++.+..+. .++||||+||++|+|++ +..||.+.+..
T Consensus 170 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 248 (304)
T cd05096 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTDE 248 (304)
T ss_pred EEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCCCCcCCHH
Confidence 9999999999999998754322111122334567889999998876664 89999999999999986 67888876655
Q ss_pred HHHHHHhh--------cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 142 ALYRKICR--------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 142 ~~~~~i~~--------~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+....+.. .....|+.++..+.+|+.+||..||++|||+.+|.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 249 QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 44433211 112234567899999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=254.02 Aligned_cols=186 Identities=34% Similarity=0.627 Sum_probs=158.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....|+||||++|++|.+++.....+++..+..++.|++.|++|||+ .|++||||+|+||+++.++.++|+|||++..
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 70 KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred cCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 457899999999999999999988889999999999999999999999 9999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHhhcC-CCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRAD-FSCPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~-~~~~~~ 157 (361)
..... .......++..|+|||.+....+ +.++|+||+|+++|+|++|..||... ...+....+.... ...+..
T Consensus 150 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 150 LENTL--DQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred cccCC--CcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 53321 12235568899999999877655 48999999999999999999999776 4445555544332 233444
Q ss_pred -CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 158 -FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 158 -~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
++..+.++|.+||..+|++|||+.++++|||++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 7899999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=273.62 Aligned_cols=185 Identities=35% Similarity=0.704 Sum_probs=160.1
Q ss_pred CCcCcEEEEEEecCCCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEe
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISD 75 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~D 75 (361)
+||++++|+|||-+.| +..+.|- +.++++|...+.++.||+.||.|||.+||+|+||||||+|+.+.. .+||||
T Consensus 632 ~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 632 FETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred ecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecc
Confidence 6899999999999976 6666554 357999999999999999999999999999999999999997554 599999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP 155 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 155 (361)
||+|++... .....+..|||.|+|||++..++|+ ..-|+||.|||+|.-|+|..||.+.. ++-.+|.+..|-+|
T Consensus 711 FGfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyP 784 (888)
T KOG4236|consen 711 FGFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYP 784 (888)
T ss_pred ccceeecch---hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccC
Confidence 999988654 2345678999999999999999998 88999999999999999999998643 34445556666555
Q ss_pred --CC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 --SW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 --~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+| +++++.+||..+|+..-.+|.|.++.+.|||++..
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 45 89999999999999999999999999999999863
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=264.66 Aligned_cols=184 Identities=27% Similarity=0.442 Sum_probs=152.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|+||+ |++|.+++.. .++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 4589999999 6799998875 5799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-----------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS----------- 153 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----------- 153 (361)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred -----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 1345578999999999876444568999999999999999999999877665544443221100
Q ss_pred --------------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 154 --------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 154 --------------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
....+++.+.+||.+||..||++|||+.++++||||.+...+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 011258899999999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=256.46 Aligned_cols=184 Identities=29% Similarity=0.477 Sum_probs=149.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+....|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.
T Consensus 69 ~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 69 SENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred cCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 4578999999995 69999988765 69999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 151 (361)
..... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+......++....
T Consensus 148 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVP--VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCC--ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 44221 1122334568899999988765444588999999999999999999998766543333222110
Q ss_pred --------------C------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 --------------F------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 --------------~------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
. ...+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 1123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=258.56 Aligned_cols=185 Identities=28% Similarity=0.515 Sum_probs=145.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++...|+||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 73 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred ecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccccc
Confidence 356789999999975 999988764 468999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhc---------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA--------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~--------- 150 (361)
..... ........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. ..+....+...
T Consensus 152 ~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 152 AKSVP--SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred ccCCC--CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 43211 1112234578899999998764434588999999999999999999997654 22222221110
Q ss_pred ----------C--CC---------CCCCCC--HHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ----------D--FS---------CPSWFS--SGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ----------~--~~---------~~~~~s--~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
. .. ..+.++ .++.+++.+||..+|.+|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00 001233 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=259.21 Aligned_cols=190 Identities=27% Similarity=0.525 Sum_probs=157.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..++.|+||||++|++|.+++.. ++++++.+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 88 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred eCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 45789999999999999987754 57999999999999999999999999999999999999999999999999987643
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
.... .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.+.......+... .......++
T Consensus 167 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 167 SKEV--PRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243 (292)
T ss_pred cccc--ccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCC
Confidence 3211 12234578999999999876665 47899999999999999999999877655544433322 222233478
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
+.+.+++.+||..+|.+||++.+++.||||.+...|+
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 8999999999999999999999999999999887554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=261.60 Aligned_cols=190 Identities=25% Similarity=0.443 Sum_probs=149.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.....|++|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+.
T Consensus 70 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~ 149 (314)
T cd08216 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSV 149 (314)
T ss_pred cCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccce
Confidence 467899999999999999999864 468999999999999999999999999999999999999999999999999886
Q ss_pred ccccccc-----CCccccccCCCccccccccccC--CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH-HHHhhcC-
Q 018052 81 ISQQVRE-----DGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKICRAD- 151 (361)
Q Consensus 81 ~~~~~~~-----~~~~~~~~gt~~y~APEv~~~~--~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~-~~i~~~~- 151 (361)
....... ........++..|+|||++.+. .| +.++|+||+||++|+|++|..||......... .++....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCc
Confidence 4321111 1112334578899999998653 34 47899999999999999999999865433322 2211000
Q ss_pred --------------------------------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 152 --------------------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 152 --------------------------------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...+..++.++.+|+.+||..||++|||+.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000112356788999999999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=251.74 Aligned_cols=184 Identities=38% Similarity=0.705 Sum_probs=159.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
.....|+|+||++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccc
Confidence 347899999999999999999864 6799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW 157 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 157 (361)
+....... ......+|++.|+|||.+.+..+. .++|+||+|+++++|++|..||...+............. ..|..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQ 226 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCC
Confidence 87654322 233456789999999998777664 789999999999999999999988877777666655433 34556
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++..+.+++.+||..+|++|||+.++++||||
T Consensus 227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 227 YSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 88999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=258.96 Aligned_cols=183 Identities=26% Similarity=0.435 Sum_probs=152.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----------------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 45678999999999999999964 24688999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||...+..+.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999998764432111111223356789999998776665 88999999999999997 999999887777776
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|...+..+.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 655443 34455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=256.26 Aligned_cols=183 Identities=21% Similarity=0.382 Sum_probs=149.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lK 72 (361)
+....|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 3456899999999999999997653 488999999999999999999999999999999999998765 599
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA- 150 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 150 (361)
|+|||++................+++.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+.......+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754221111111122335679999999877665 89999999999999997 99999987766666554433
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
....|..++..+.+++.+||..+|++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 344566789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.24 Aligned_cols=181 Identities=22% Similarity=0.336 Sum_probs=151.1
Q ss_pred cEEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
...++||||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 3579999999999999888542 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 156 (361)
+................++..|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8754332211112223456789999998776664 89999999999999998 99999887777777666544 344566
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.++..+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=264.34 Aligned_cols=182 Identities=25% Similarity=0.412 Sum_probs=147.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhC---------------------------------------------------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--------------------------------------------------------- 26 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--------------------------------------------------------- 26 (361)
...+|++|||++||+|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45789999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCcccc
Q 018052 27 ----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVA 102 (361)
Q Consensus 27 ----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 102 (361)
.++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999999999999999999999999999999999975432111111223445678999
Q ss_pred ccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHH-Hhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCC
Q 018052 103 PEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK-ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMT 179 (361)
Q Consensus 103 PEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t 179 (361)
||++.+..+. .++||||+||++|+|++ |..||.+....+.+.. +... ....|...++++.+++.+||+.+|++|||
T Consensus 244 PE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 9999887776 78999999999999997 9999987544333322 2222 22345567899999999999999999999
Q ss_pred HHHHHhC
Q 018052 180 ISQMLED 186 (361)
Q Consensus 180 ~~eil~h 186 (361)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=251.62 Aligned_cols=185 Identities=31% Similarity=0.631 Sum_probs=155.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC-EEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-LKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~-lKl~DFGl 78 (361)
.+...+|+|+||++|++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++++++. +||+|||.
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 69 QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence 45678999999999999999987644 4799999999999999999999999999999999999998864 69999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW 157 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 157 (361)
+...... ........|++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+..... ..++.
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd08225 149 ARQLNDS--MELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN 225 (257)
T ss_pred chhccCC--cccccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCC
Confidence 8765321 1122345689999999998776665 889999999999999999999988776666655544433 23445
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++.++.++|.+||..+|++|||+.+++.||||
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=255.16 Aligned_cols=182 Identities=19% Similarity=0.300 Sum_probs=152.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lK 72 (361)
+....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 4567899999999999999987532 367889999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA- 150 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 150 (361)
|+|||++................++..|+|||.+.+..+. .++||||+||++|+|++ |..||.+.+.....+.+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999998754332211222345578899999998776654 88999999999999998 99999887777766666543
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 151 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 151 ~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
....|..++..+.++|.+||..+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 34456668999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=251.31 Aligned_cols=182 Identities=29% Similarity=0.494 Sum_probs=147.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 64 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 64 QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred CCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcc
Confidence 4567899999999999999997654 689999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..............++..|+|||.+.+..+. .++|+||+||++|+|++ |..||...+.......+... ....|..++
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCP 222 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCC
Confidence 3221100001111234569999998876664 78999999999999997 99999876655554444332 334555678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.+|+.+||..+|++|||+.++++
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.42 Aligned_cols=183 Identities=19% Similarity=0.333 Sum_probs=151.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
+....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 456789999999999999998532 237888999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.++.+||+|||++................++..|+|||++.+..+. .++|+||+||++|+|++ |..||.+.+.....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999998754322211222344567789999998776664 89999999999999998 99999887766665
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+... ..+.+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 555433 344566689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.55 Aligned_cols=184 Identities=32% Similarity=0.573 Sum_probs=157.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++|++|.+++...+.++++.+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred eCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 45789999999999999999998888999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh-hcCCCCCCCCCHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC-RADFSCPSWFSSG 161 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~ 161 (361)
..... ......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......+.. ......|..++..
T Consensus 150 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd06627 150 NDVSK--DDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE 226 (254)
T ss_pred CCCcc--cccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHH
Confidence 43221 1344578999999999877664 488999999999999999999998766544443333 3334456668899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+.+++.+||..+|++|||+.+++.||||
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=263.90 Aligned_cols=185 Identities=30% Similarity=0.447 Sum_probs=151.4
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 45899999995 69999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------------- 150 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------- 150 (361)
.. .......++..|+|||.+......+.++|+||+||++|+|++|..||.+.+....+..+...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 22344578999999998875444568999999999999999999999876543322221100
Q ss_pred --------------CC---CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 --------------DF---SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 --------------~~---~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.. ...+.+++++.+||++||+.+|++|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0123478899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=249.99 Aligned_cols=184 Identities=34% Similarity=0.614 Sum_probs=156.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|+||++|++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.....
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 68999999999999999999887999999999999999999999999999999999999999999999999999876544
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhh--cCCCCCCCCCHH
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICR--ADFSCPSWFSSG 161 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~s~~ 161 (361)
...........++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+ .......+.. .....|..++..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEE 232 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHH
Confidence 322112345678999999999877665 489999999999999999999998765 2233333332 233456667899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+.++|.+||..||.+||++.+++.||||
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=256.16 Aligned_cols=184 Identities=30% Similarity=0.512 Sum_probs=150.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+....|+||||+.| +|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++
T Consensus 69 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 69 TENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred eCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 45678999999985 8988887543 5899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------- 151 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 151 (361)
...... ........+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+..+.+.++....
T Consensus 148 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIP--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCC--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 654321 1122345678999999998765555689999999999999999999998876655544432110
Q ss_pred ----------CC-----------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 152 ----------FS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 152 ----------~~-----------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 012357788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=259.34 Aligned_cols=187 Identities=28% Similarity=0.506 Sum_probs=160.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.+|+|||||-.|++.+.++.. ..++|+++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|...
T Consensus 100 ~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 100 HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence 45799999999999999998854 57999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... -....+..|||.|||||++..-+|+ .++||||+|+.-.+|..|++||.+..++....-|-.. .|.-|..+|
T Consensus 180 TDT--MAKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 180 TDT--MAKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhh--HHhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhh
Confidence 331 2234678999999999999999998 8999999999999999999999887665433222211 223344578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.++.+++++||..+|++|.|+.++++|||.++..
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999999999999999998753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=251.64 Aligned_cols=182 Identities=24% Similarity=0.403 Sum_probs=152.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
....+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 4567899999999999999987643 58999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
....... .......+++.|+|||.+.+..+. .++||||+||++|+|++ |..||.+.+..+.+..+... ....|..+
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (263)
T cd05052 153 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC 230 (263)
T ss_pred cccccee-eccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 5432111 111122345679999998877665 78999999999999998 99999988877777766543 34456668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.++.++|.+||..||++|||+.++++.
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=259.38 Aligned_cols=183 Identities=25% Similarity=0.431 Sum_probs=151.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+.+|+|.+++.... .++..++..++.|++.||+|||++|++||||||+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4567899999999999999997642 478899999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................+++.|+|||++.+..+. .++|+||+||++|+|++ |..||.+.+..+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999998654322111111122345789999998876664 88999999999999998 899998877777666
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 655443 34556688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=262.19 Aligned_cols=192 Identities=27% Similarity=0.391 Sum_probs=156.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+||||+. |+|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 91 EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 4568999999997 599999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cccc------------cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc
Q 018052 83 QQVR------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA 150 (361)
Q Consensus 83 ~~~~------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 150 (361)
.... .........+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+..+.+..+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~ 249 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 3110 0112233457889999999876555568999999999999999999999887766555443221
Q ss_pred C-------C---------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 151 D-------F---------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 151 ~-------~---------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
. + ...+..+..+.++|.+||..+|++|||+++++.||||+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 0 0 0012347889999999999999999999999999999876443
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=251.48 Aligned_cols=177 Identities=27% Similarity=0.474 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 4567899999999999999998654 48899999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
..... .....++..|+|||++.+..+. .++||||+||++|+|++ |..||...+..+....+... ....++.+
T Consensus 151 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05082 151 EASST-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 224 (256)
T ss_pred ecccc-----CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 43221 1234456789999998876665 78999999999999997 99999888777776666544 23345567
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+.+++.+||..+|++|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=257.81 Aligned_cols=183 Identities=23% Similarity=0.424 Sum_probs=153.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+.+|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 456789999999999999999764 2467788999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................+++.|+|||++.+..++ .++||||+|+++|+|++ |..||.+.+..+...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999998755432222222334567789999999877665 78999999999999998 889999888877777
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 665443 33455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=255.50 Aligned_cols=182 Identities=22% Similarity=0.343 Sum_probs=150.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG---------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~ 67 (361)
.....|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 4567899999999999999997643 4889999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHH
Q 018052 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 146 (361)
Q Consensus 68 ~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~ 146 (361)
++.+||+|||++................+++.|+|||.+.+..++ .++||||+||++|+|++ |.+||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999998644321111111233456789999998877765 88999999999999998 9999987766666655
Q ss_pred Hhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 147 ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 147 i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+... ....|..+++.+.+||.+||..||.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5443 33455668999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=258.65 Aligned_cols=183 Identities=25% Similarity=0.425 Sum_probs=151.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+.+|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 456789999999999999999763 2478889999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................+++.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998754322111112223345689999998876664 88999999999999998 899999888777777
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|..++.++.+|+.+||..+|++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 665543 34456678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=261.96 Aligned_cols=189 Identities=29% Similarity=0.422 Sum_probs=156.8
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+.+ +|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 77 ~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 77 NDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred cceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 479999999974 8999998877899999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC----------
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---------- 153 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 153 (361)
... ........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 221 012344568999999999987734458999999999999999999999887766655544331100
Q ss_pred ---------------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 154 ---------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 154 ---------------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+.+++++.+||.+||..+|.+|||+++++.||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11225788999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=272.18 Aligned_cols=182 Identities=24% Similarity=0.525 Sum_probs=161.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEe-cCCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld-~~~~lKl~DFGla~ 80 (361)
+..+.+|+|+++.|+|..|+.+.++++...++.|++||+.||.|||++. |+|||||.+||+|+ ..|.+||+|+|||+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 4568999999999999999999999999999999999999999999996 99999999999997 56899999999999
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhcCCC--CCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFS--CPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~--~~~~ 157 (361)
+.... ......|||.|||||++. ..|+ ..+||||||+++.||.|+..||.+ .+..++|+++..+..+ +..-
T Consensus 195 l~r~s----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 195 LLRKS----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred Hhhcc----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence 86542 334578999999999886 5677 899999999999999999999976 6778999998776432 1222
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
-.++++++|.+||.. .+.|+|+.|+|.||||...
T Consensus 269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 478999999999999 9999999999999999975
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=251.09 Aligned_cols=183 Identities=22% Similarity=0.431 Sum_probs=150.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
......|+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence 3456789999999999999999764 468999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
........ ......++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||...+..+....+... ....|...
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05059 149 YVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA 226 (256)
T ss_pred eccccccc-ccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 54321110 01111234579999999877665 78999999999999998 89999887766666665544 33455568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+.+++.+||..+|++|||+.++++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=251.98 Aligned_cols=183 Identities=22% Similarity=0.373 Sum_probs=152.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 456789999999999999999764 4799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..............+++.|+|||.+.+..+. .++|+||+|+++|+|++ |..||...........+... ..+.+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 5421111111223456789999998877665 78999999999999998 99999877766666666543 234455678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+.+|+.+||..+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=257.13 Aligned_cols=180 Identities=25% Similarity=0.390 Sum_probs=149.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG 153 (297)
T ss_pred cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence 4567899999999999999997642 488899999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++........ ......+..|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.+.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999853221100 1112234579999998877665 89999999999999997 999999888877777
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.... ...|..++.++.+|+.+||..+|.+|||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 765542 33455688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=256.12 Aligned_cols=184 Identities=27% Similarity=0.458 Sum_probs=143.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+. ++|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 74 TKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred cCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 4568999999996 577776654 35688999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhc----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRA---------- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~---------- 150 (361)
.... ........+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+.. +...++...
T Consensus 153 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 153 KSIP--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred cCCC--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 3321 112234567899999999876543457899999999999999999999765432 222221100
Q ss_pred ----------C-C--CCCC---------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ----------D-F--SCPS---------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ----------~-~--~~~~---------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
. . ..+. ..++++.+++.+||..||++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0000 025688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=254.68 Aligned_cols=184 Identities=18% Similarity=0.314 Sum_probs=154.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.++..+++++||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 3456789999999999999998632 347888999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
++++.+||+|||++................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||.+.+..+..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999998754322221222334567899999998776664 78999999999999998 89999988877777
Q ss_pred HHHhhcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..... ..|..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77766543 4466789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=255.07 Aligned_cols=186 Identities=28% Similarity=0.475 Sum_probs=153.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred cCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 457899999999999999999888889999999999999999999997 5899999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-----------HHHHHHhhc
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-----------ALYRKICRA 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-----------~~~~~i~~~ 150 (361)
... ......+|+..|+|||++.+..+. .++|+||+||++|+|++|..||...+.. +....+...
T Consensus 154 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 154 LIN----SIADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred hhh----hccCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 322 112345799999999998776554 7899999999999999999999864431 222333222
Q ss_pred C-CCCCCC-CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 151 D-FSCPSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 151 ~-~~~~~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
. ...+.. ++..+.+|+.+||..||.+|||+.++++|+||.+..
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 2 122222 678899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=253.72 Aligned_cols=180 Identities=20% Similarity=0.355 Sum_probs=149.2
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+++|||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 3568999999999999999764 569999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
............+++.|+|||.+.+..++ .++||||+||++|+|++ |..||...........+... ..+.+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 32111111223356789999999877775 89999999999999998 99999877666555544443 23445568899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHh
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.+++.+||..||+.|||+.+++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=260.75 Aligned_cols=188 Identities=27% Similarity=0.411 Sum_probs=150.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|++|||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 46899999996 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc------------
Q 018052 85 VRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 150 (361)
Q Consensus 85 ~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 150 (361)
... ........||+.|+|||++.+....+.++|+||+||++|+|++|.+||...+....+..+...
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 211 112234578999999998765433358999999999999999999999876543333221110
Q ss_pred -------------C---CC---CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 151 -------------D---FS---CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 151 -------------~---~~---~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
. .. ..+..+..+.+|+.+||..||.+|||+.+++.|||+.+.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 00 0112578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=251.62 Aligned_cols=177 Identities=21% Similarity=0.280 Sum_probs=145.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC--------EEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~--------lKl 73 (361)
.....|+||||+.+|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++. +|+
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 3467899999999999999998654 5899999999999999999999999999999999999987765 699
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhcCC
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRADF 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~ 152 (361)
+|||++..... .....+++.|+|||++.+....+.++||||+||++|+|++| ..||...+...... ......
T Consensus 150 ~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~ 222 (258)
T cd05078 150 SDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRH 222 (258)
T ss_pred cccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccc
Confidence 99998764321 23456889999999998755445899999999999999998 56766554443322 333445
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..|...+.++.+||.+||+.||++|||++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 5666677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=259.62 Aligned_cols=181 Identities=20% Similarity=0.360 Sum_probs=150.4
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...++|+||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 3568999999999999999874 368999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
............++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+....+....+... ..+.|+.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 239 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 32221112233456789999999877775 89999999999999997 99999887666554433332 33456678899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+++.+||..+|.+|||+.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=259.08 Aligned_cols=181 Identities=26% Similarity=0.410 Sum_probs=149.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.+...+|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 34567999999999999999997543 47899999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.++.+||+|||++....... ......++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.+..+.+
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999999985322110 0111234567999999877665 489999999999999998 99999887777766
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+... ....+..+++++.+|+.+||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665443 223444578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=255.14 Aligned_cols=187 Identities=28% Similarity=0.557 Sum_probs=157.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 4578999999999999999999876 899999999999999999999999999999999999999999999999998764
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---CCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 158 (361)
..... .......+++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..... ..+..+
T Consensus 166 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 166 LTKEK--SKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred hccch--hhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 43211 122344688899999998877665 889999999999999999999988766555544433322 122237
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.++.++|.+||..+|.+|||+.++++|+||++.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 8899999999999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=249.39 Aligned_cols=180 Identities=23% Similarity=0.337 Sum_probs=151.1
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
...|+||||+.+|+|.+++...+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 68 EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence 46799999999999999999888899999999999999999999999999999999999999999999999999875533
Q ss_pred cccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 85 VREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 85 ~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
..... ......++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+..+....+.... ...|..++..
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQE 226 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 21110 01111234679999998776664 89999999999999998 999998877776666654442 3456678899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHh
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.++|.+||..+|++|||+.++++
T Consensus 227 l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 227 IYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=258.20 Aligned_cols=185 Identities=29% Similarity=0.484 Sum_probs=149.4
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-----------
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----------- 67 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~----------- 67 (361)
|+-+.++|+|+|.+ |-++++++.+++ +++.+.++.+.+||+.+++|||+.+++|-||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 45578999999998 669999999865 6899999999999999999999999999999999999932
Q ss_pred ---------CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc
Q 018052 68 ---------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES 138 (361)
Q Consensus 68 ---------~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~ 138 (361)
+-.+||+|||.|+.... ...+...|..|.|||++.+-++. .++||||+||||+||.+|...|...
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred ccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccC
Confidence 34689999999976432 22567889999999999999996 9999999999999999999999765
Q ss_pred cHHH---HHHHHhh------------------cCCCCCCC----------------------CC---HHHHHHHHHccCC
Q 018052 139 NLMA---LYRKICR------------------ADFSCPSW----------------------FS---SGAKKLIKRILDP 172 (361)
Q Consensus 139 ~~~~---~~~~i~~------------------~~~~~~~~----------------------~s---~~~~~Li~~~L~~ 172 (361)
+..+ +.+.|.. +....|.. -+ .++.+||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 5333 3333221 00000000 01 2467999999999
Q ss_pred CcCCCCCHHHHHhCcccccC
Q 018052 173 NPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 173 dP~~R~t~~eil~h~~f~~~ 192 (361)
||.+|+|+.|+|.||||+..
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=259.80 Aligned_cols=187 Identities=32% Similarity=0.465 Sum_probs=151.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+.+ +|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 81 ~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 81 DKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred CceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 4478999999974 999998775 78999999999999999999999999999999999999999999999999987543
Q ss_pred ccccC---CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---------
Q 018052 84 QVRED---GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------- 151 (361)
Q Consensus 84 ~~~~~---~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 151 (361)
..... .......||+.|+|||++.+....+.++|+||+|+++|+|++|..||.+....+...++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 223345689999999988765555688999999999999999999998765444333221110
Q ss_pred ------------------C----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 ------------------F----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ------------------~----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ...+.++.++.++|.+||..||++|||+.++++|||++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112268889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=249.53 Aligned_cols=181 Identities=23% Similarity=0.335 Sum_probs=150.0
Q ss_pred cEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 67 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 67 EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 468999999999999999875 4579999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 84 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
...... ......+++.|+|||.+....++ .++||||+||++|+|++ |..||.+....+....+..+ ....|+..++
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPP 225 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 211111 11112335789999998776664 78999999999999996 99999887777766655543 3456677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.++|.+||..+|++||++.++.+.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=261.07 Aligned_cols=186 Identities=29% Similarity=0.460 Sum_probs=147.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||+. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++ .++.+|++|||++....
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~ 166 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecC
Confidence 46899999997 589888764 5799999999999999999999999999999999999997 45678999999987543
Q ss_pred cccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-----------
Q 018052 84 QVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD----------- 151 (361)
Q Consensus 84 ~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 151 (361)
.... ........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07854 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNEL 246 (342)
T ss_pred CccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2211 1112234678999999987654445589999999999999999999998765544433322110
Q ss_pred -----------C--------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 -----------F--------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 -----------~--------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ...+.++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 247 LNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0112467889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=248.85 Aligned_cols=182 Identities=27% Similarity=0.463 Sum_probs=151.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+..+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 69 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 3456789999999999999998753 468999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC-CCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF-SCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 158 (361)
....... .......++..|+|||++.+..+. .++|+||+|+++|+|++ |..||...+..+....+..+.. ..|...
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 149 YVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA 226 (256)
T ss_pred ccCCCce-eccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 5322111 111122345679999998876665 79999999999999999 9999998887777777665432 335557
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+.+++.+||..+|.+|||++++++
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=251.29 Aligned_cols=184 Identities=32% Similarity=0.470 Sum_probs=150.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.++...|+||||+ +|+|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 68 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 68 RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred hcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence 3467899999999 789999888764 7899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------- 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 150 (361)
...... .......|+..|+|||++.+....+.++|+||+|+++++|++|..||...+..+.+.++...
T Consensus 147 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSR---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCC---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 754321 12234568899999998865444458999999999999999999999876655444333210
Q ss_pred ----------CCC-----------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ----------DFS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ----------~~~-----------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
... ..+..+..+.++|++||..+|++|||+.|++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000 011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=248.41 Aligned_cols=192 Identities=28% Similarity=0.444 Sum_probs=154.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC----CCEEEE
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY----GVLKIS 74 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~----~~lKl~ 74 (361)
+.++||++||++. +|.+.|.-+. .++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.+||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 6789999999987 9999887542 58999999999999999999999999999999999999877 999999
Q ss_pred ecCCccccccccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---------HHHH
Q 018052 75 DFGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---------MALY 144 (361)
Q Consensus 75 DFGla~~~~~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~---------~~~~ 144 (361)
|||+|+.+...-. -.......-|.+|.|||.+.+...++.++|+||+|||+.|||+-.+-|.+... .+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998765332 22334456789999999999888778999999999999999998888854321 1222
Q ss_pred HHHhhc--C---------CCCCC--------------------C------CCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 145 RKICRA--D---------FSCPS--------------------W------FSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 145 ~~i~~~--~---------~~~~~--------------------~------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
.+|..- . -.+|. | -++.+.+|+.+||+.||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 222210 0 01111 1 255688999999999999999999999999
Q ss_pred ccccCCCCC
Q 018052 188 WFKKGYKPP 196 (361)
Q Consensus 188 ~f~~~~~~~ 196 (361)
||.....|+
T Consensus 339 yF~~d~lpp 347 (438)
T KOG0666|consen 339 YFTEDPLPP 347 (438)
T ss_pred ccccCCCCC
Confidence 999876654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=246.44 Aligned_cols=182 Identities=36% Similarity=0.600 Sum_probs=152.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.....|+++||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..
T Consensus 68 ~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 456789999999999999999876 5799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CC--CCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SC--PSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~ 158 (361)
...... .....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............. .. +..+
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW 223 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCccccc
Confidence 543211 345678999999999877665 4789999999999999999999988754444333332221 12 2224
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
+..+.++|.+||..||++|||+.++++|||
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 889999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=257.34 Aligned_cols=187 Identities=26% Similarity=0.511 Sum_probs=154.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.....|+|+||++||+|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 87 VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred eCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 35678999999999999999875 46899999999999999999999999999999999999999999999999988654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... ........|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+... .+..+..++
T Consensus 166 ~~~--~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd06647 166 TPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (293)
T ss_pred ccc--ccccccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccC
Confidence 322 1223345689999999998876664 7899999999999999999999876654433222211 122233467
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+.++|++||..+|.+||++.+++.|+||+...
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 8899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=252.10 Aligned_cols=180 Identities=26% Similarity=0.414 Sum_probs=148.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~ 146 (270)
T cd05047 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 146 (270)
T ss_pred cCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc
Confidence 3456899999999999999997543 478999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
+++.+||+|||++....... .....+.+..|+|||++....++ .++|+||+||++|+|++ |..||.+.+..+.+.
T Consensus 147 ~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 222 (270)
T cd05047 147 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222 (270)
T ss_pred CCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHH
Confidence 99999999999985322110 11122345679999998776664 89999999999999997 999998877777776
Q ss_pred HHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+... ....+..++.++.+|+.+||..||.+|||+.+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 223 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 66443 223445578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=256.49 Aligned_cols=186 Identities=25% Similarity=0.439 Sum_probs=148.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||+.+ +|...+.. ...+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 34578999999975 77777664 35799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccC---------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC
Q 018052 82 SQQVRED---------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF 152 (361)
Q Consensus 82 ~~~~~~~---------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 152 (361)
....... .......|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4322111 1112345788999999887654445889999999999999999999988776655554332100
Q ss_pred -----------------------CCC-------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 -----------------------SCP-------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 -----------------------~~~-------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..+ ..+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1134678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=258.40 Aligned_cols=184 Identities=28% Similarity=0.439 Sum_probs=143.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec----CCCEEEEe
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----YGVLKISD 75 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~----~~~lKl~D 75 (361)
..+|+||||+.+ +|.+.+... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 77 KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 689999999975 777766532 26899999999999999999999999999999999999999 99999999
Q ss_pred cCCccccccccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH---------HHH
Q 018052 76 FGLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------LYR 145 (361)
Q Consensus 76 FGla~~~~~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~---------~~~ 145 (361)
||++........ .......++|+.|+|||++.+....+.++|+||+||++|+|++|..||.+..... ...
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876543221 1122345789999999988765444589999999999999999999997543221 010
Q ss_pred HHhh--------------------------cCCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 146 KICR--------------------------ADFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 146 ~i~~--------------------------~~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
.+.. .....+ ...+..+.++|.+||..||++|||+.++++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 0000 000111 035678999999999999999999999999999
Q ss_pred c
Q 018052 189 F 189 (361)
Q Consensus 189 f 189 (361)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=254.14 Aligned_cols=186 Identities=28% Similarity=0.498 Sum_probs=148.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
....+|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 71 REGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred cCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 4567999999997 588777654 34689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhc-C
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA-D 151 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~-~ 151 (361)
++...... .......|+..|+|||.+.+ ..+ +.++|+||+||++|+|++|..||.... ..+....+... .
T Consensus 150 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd06617 150 ISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225 (283)
T ss_pred cccccccc---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC
Confidence 98754321 11223568899999998864 233 478999999999999999999997532 22222222222 2
Q ss_pred CCCC-CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 152 FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 152 ~~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...| ..+|.++.++|.+||..+|.+|||+.++++||||.+..
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 3333 24789999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=251.66 Aligned_cols=181 Identities=19% Similarity=0.344 Sum_probs=149.5
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...++++||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 4578999999999999999764 568999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
............++..|+|||.+.+..++ .++||||+||++|+|++ |..||.+.........+..+. ...+...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID 239 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence 22211122345577889999999876665 89999999999999998 999998876655544444333 2334456788
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+++.+||..||.+|||+.++++.
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=249.27 Aligned_cols=180 Identities=23% Similarity=0.415 Sum_probs=151.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence 456789999999999999999863 468999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...... .......++..|+|||++.+..+. .++|+||+|+++|+|++ |..||...+..+.+..+... ..+.|..+
T Consensus 153 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 153 LIKEDV--YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229 (261)
T ss_pred hcCCcc--ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCC
Confidence 543211 111233456789999998876664 78999999999999998 89999887777777666543 33455668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+.+++.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=253.18 Aligned_cols=184 Identities=34% Similarity=0.530 Sum_probs=149.5
Q ss_pred CcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..++|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence 4579999999999999887653 346899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-----cHHHHHHHHhhcC-CC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-----NLMALYRKICRAD-FS 153 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~ 153 (361)
...... ......++..|+|||.+.+..++ .++|+||+||++|+|++|..||... ...+....+.... ..
T Consensus 153 ~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 153 GELVNS----LAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred cccccc----ccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 643221 12245688899999998877775 7899999999999999999999765 2233333333211 11
Q ss_pred CC------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 CP------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 ~~------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+ ..+++.+.++|.+||..+|++|||+.|+++||||++.
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 11 1246789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=252.37 Aligned_cols=187 Identities=28% Similarity=0.522 Sum_probs=157.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.....|+||||+.||+|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 73 KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred eCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 45789999999999999998875 57999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
.... .......|+..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+.... ...+..++.+
T Consensus 152 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06641 152 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 228 (277)
T ss_pred ccch--hhhccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHH
Confidence 3211 112345688999999998776654 78999999999999999999998776655555443332 2344567899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+++.+||..+|.+||++.++++||||.+..
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=249.35 Aligned_cols=184 Identities=32% Similarity=0.541 Sum_probs=155.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 35689999999999999999987889999999999999999999999999999999999999999999999999987543
Q ss_pred cccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCCCCCH
Q 018052 84 QVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~ 160 (361)
.... ........|+..|+|||.+.+..++ .++|+||+||++|+|++|..||.+........++... ....|..+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 2211 1122345689999999999876654 7899999999999999999999877655544444332 2345677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.+.++|.+||. +|..|||+.+++.|||.
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=270.53 Aligned_cols=189 Identities=31% Similarity=0.537 Sum_probs=159.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRL--KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l--~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla 79 (361)
...+-|.||-++||+|.+.+... |++ .|.....|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||-+
T Consensus 644 nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 644 NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccc
Confidence 45677999999999999999875 567 7899999999999999999999999999999999996 6799999999988
Q ss_pred ccccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHH-HhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRK-ICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~-i~~~~~~~~ 155 (361)
...... .....+..||..|||||++-..+ -+|.++||||+||.+.||.||++||-+.. ...+++- ..+...+.|
T Consensus 724 KRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 724 KRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred hhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 654433 33456788999999999986432 24799999999999999999999997532 2333332 344566778
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+|.+++.+|.+|+.+||.+||++.++|++||++.+.+
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 889999999999999999999999999999999997743
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=248.39 Aligned_cols=183 Identities=31% Similarity=0.592 Sum_probs=154.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+....|+||||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence 45678999999999999988864 346999999999999999999999999999999999999975 6799999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW 157 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 157 (361)
+...... ........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..... ..+..
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd08222 152 SRLLMGS--CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET 228 (260)
T ss_pred eeecCCC--cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcch
Confidence 8654321 1223345689999999998776665 789999999999999999999987776666666554433 33455
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++.++.++|.+||..+|++||++.++++||||
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 78999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=253.46 Aligned_cols=187 Identities=29% Similarity=0.474 Sum_probs=148.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla 79 (361)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++. ++.+||+|||++
T Consensus 72 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 72 SEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 5678999999996 58888876544 3688899999999999999999999999999999999985 557999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------- 151 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------- 151 (361)
...... ........|++.|+|||++.+....+.++|+||+||++|+|++|..||...+..+...++....
T Consensus 151 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 151 RAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred cccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 643321 1122344678999999998765444589999999999999999999998766554444332100
Q ss_pred ------------C---C------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 ------------F---S------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ------------~---~------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. . ..+.+++.+.+++.+||+.+|++||++.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0 112367889999999999999999999999999999863
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=260.09 Aligned_cols=191 Identities=18% Similarity=0.331 Sum_probs=147.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..+..+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|||.+
T Consensus 69 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 69 TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred ecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 3567889999999999999998864 35899999999999999999999999999999999999999999999999865
Q ss_pred ccccccccCC-----ccccccCCCccccccccccCCC-CCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-
Q 018052 80 AISQQVREDG-----LLHTACGTPNYVAPEVLNDKGY-DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF- 152 (361)
Q Consensus 80 ~~~~~~~~~~-----~~~~~~gt~~y~APEv~~~~~~-~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 152 (361)
.......... ......++..|+|||++.+..+ .+.++||||+||++|+|++|..||.+...............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 3321111100 0111235677999999876422 35899999999999999999999987654433322211110
Q ss_pred ----------------------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 ----------------------------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 ----------------------------------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+..+++.+.+||++||..||++|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011246778999999999999999999999999
Q ss_pred cccccC
Q 018052 187 EWFKKG 192 (361)
Q Consensus 187 ~~f~~~ 192 (361)
|||...
T Consensus 309 ~~~~~~ 314 (328)
T cd08226 309 AFFKQV 314 (328)
T ss_pred HHHHHH
Confidence 999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=255.40 Aligned_cols=182 Identities=23% Similarity=0.375 Sum_probs=149.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
....+|+||||+.||+|.+++.... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.+|++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 3457899999999999999997643 38999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC--CCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~ 157 (361)
...............+++.|+|||.+.+..+. .++||||+||++|+|++ |..||......+.+.+..... ...+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54322111111223467789999998877665 89999999999999998 999998766555444433322 234556
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.++.+.+++.+||..+|++|||+.++++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=245.75 Aligned_cols=182 Identities=31% Similarity=0.557 Sum_probs=157.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+....|+||||++|++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred cCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 45789999999999999998876 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSW 157 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 157 (361)
+...... ......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+....+ ..+..
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchh
Confidence 8765432 23346689999999999877765 789999999999999999999998887766666555443 23445
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
++.++.+++.+||..+|.+|||+.++++||++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 78999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=248.20 Aligned_cols=181 Identities=23% Similarity=0.383 Sum_probs=150.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.....|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 4567899999999999999997654 68999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
........ ......++..|+|||++.+..++ .++|+||+|+++|+|++ |..||.+.+....+..+... ....+...
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05068 152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGC 229 (261)
T ss_pred EccCCccc-ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 65421111 11112234579999998876664 88999999999999999 99999987777766665443 23445567
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+.+++.+||..+|.+||++.++++
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=277.90 Aligned_cols=189 Identities=22% Similarity=0.329 Sum_probs=138.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR--------------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~N 62 (361)
....+|+||||+.+|+|.+++..... ..+..+..++.||+.||+|||++||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45689999999999999998875421 1234567899999999999999999999999999
Q ss_pred EEEec-CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCC---------------------CCchhhhh
Q 018052 63 LLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD---------------------GRASDVWS 120 (361)
Q Consensus 63 iLld~-~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~---------------------~~~~DiwS 120 (361)
||++. ++.+||+|||+|...... ........+||+.|+|||.+....+. +.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 689999999999754321 12233567899999999976432221 24569999
Q ss_pred hhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC---------------------CCCCCHHHHHHHHHccCCCcCCCCC
Q 018052 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSC---------------------PSWFSSGAKKLIKRILDPNPDTRMT 179 (361)
Q Consensus 121 ~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~s~~~~~Li~~~L~~dP~~R~t 179 (361)
+||+||+|+++..|++.. .......+....... ....+....+||.+||..||++|||
T Consensus 365 lGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999999999987776532 111111111111110 0111234558999999999999999
Q ss_pred HHHHHhCcccccCC
Q 018052 180 ISQMLEDEWFKKGY 193 (361)
Q Consensus 180 ~~eil~h~~f~~~~ 193 (361)
+.++|+||||+...
T Consensus 444 a~e~L~Hpff~~~~ 457 (566)
T PLN03225 444 AKAALAHPYFDREG 457 (566)
T ss_pred HHHHhCCcCcCCCC
Confidence 99999999998643
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=248.09 Aligned_cols=181 Identities=22% Similarity=0.389 Sum_probs=149.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+....|+||||++||+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 456789999999999999998753 468899999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
....... .......++..|+|||.+.+..+. .++|+||+||++|+|++ |..||.+.........+... ..+.+..+
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05072 152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC 229 (261)
T ss_pred ecCCCce-eccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6432111 111223456789999998776664 78999999999999998 99999887766666665543 22333457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.++.+++.+||..+|++|||++++.+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=253.65 Aligned_cols=182 Identities=20% Similarity=0.261 Sum_probs=149.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 71 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~l 71 (361)
....+|+||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCce
Confidence 3467899999999999999998765 68999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc--CCCCCCcccHHHHHHHHhh
Q 018052 72 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMALYRKICR 149 (361)
Q Consensus 72 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~--g~~Pf~~~~~~~~~~~i~~ 149 (361)
||+|||++................+++.|+|||.+.+..+. .++||||+||++|+|++ |..||...+....+.....
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05051 170 KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGH 248 (296)
T ss_pred EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHh
Confidence 99999998654322211222344567889999998776554 89999999999999987 7889987666655554432
Q ss_pred c--------CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 150 A--------DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 150 ~--------~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. ....+..++.++.+|+.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 249 FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 1 12334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=251.11 Aligned_cols=185 Identities=34% Similarity=0.533 Sum_probs=150.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++..+|+||||+.+ +|.+.+... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||.+.
T Consensus 68 ~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 68 RHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred ccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 356789999999975 888888763 579999999999999999999999999999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---------- 150 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------- 150 (361)
...... .......++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+.+.++...
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 554322 12233457889999999877634458999999999999999999999887665544433211
Q ss_pred ---------CCC-----------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 ---------DFS-----------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 ---------~~~-----------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
... ..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 012357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=247.89 Aligned_cols=182 Identities=25% Similarity=0.409 Sum_probs=150.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred cCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 345689999999999999999764 4689999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC-CCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF-SCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s 159 (361)
...... .......++..|+|||.+.+..+. .++|+||+||++|+|++ |..||...+..+....+..... ..+...+
T Consensus 150 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05113 150 VLDDEY-TSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLAS 227 (256)
T ss_pred cCCCce-eecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 432111 111122345679999999876665 78999999999999998 9999988777766666655432 2344578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+.+++.+||..+|.+|||+.+++.+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=249.03 Aligned_cols=177 Identities=20% Similarity=0.321 Sum_probs=143.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC-------EEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-------LKIS 74 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~-------lKl~ 74 (361)
++...|+||||+++|+|..++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +|++
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 355789999999999999888754 56999999999999999999999999999999999999987664 8999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHh-cCCCCCCcccHHHHHHHHhhcCCC
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKICRADFS 153 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~~ 153 (361)
|||++..... .....|+..|+|||.+......+.++||||+||++|+|+ .|..||......+.. ........
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~ 227 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM 227 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc
Confidence 9999854321 123467889999999875444458999999999999997 689999876544432 22333333
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.....+.++.+||.+||..||.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 333456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=247.31 Aligned_cols=179 Identities=26% Similarity=0.399 Sum_probs=149.0
Q ss_pred cEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 4579999999999999999763 35899999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
..... .......++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||.+.+..+....+... ..+.+...+.
T Consensus 153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05070 153 EDNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI 230 (260)
T ss_pred cCccc-ccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 32111 111122355679999998766654 79999999999999999 89999887777766666543 3445566789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.+|+.+||..+|++|||++++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=279.56 Aligned_cols=178 Identities=34% Similarity=0.565 Sum_probs=148.8
Q ss_pred cEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
-.++|.||||.||.|-|++.. +.+|+|.++++||.|+++||.+||... |+|||||-|||||+.+|+.||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 368899999999999999984 457999999999999999999999998 9999999999999999999999999986
Q ss_pred cccccccC--C--c---cccccCCCcccccccc---ccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc
Q 018052 81 ISQQVRED--G--L---LHTACGTPNYVAPEVL---NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA 150 (361)
Q Consensus 81 ~~~~~~~~--~--~---~~~~~gt~~y~APEv~---~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 150 (361)
-.-..... . . --...-|+.|+|||++ .+.+. +.|+|||+|||+||-|+-...||++.... .|..+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNG 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEec
Confidence 43221110 0 0 0123479999999986 34444 58999999999999999999999886443 35667
Q ss_pred CCCCCC--CCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 151 DFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 151 ~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
.|.+|+ .++..+.+||+.||++||.+||++.|++.+-
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 787776 5899999999999999999999999998753
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=273.05 Aligned_cols=188 Identities=25% Similarity=0.430 Sum_probs=143.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
.+....|+|+|++. ++|.+++.... ......++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DF 311 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDF 311 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeC
Confidence 35678899999995 58888775432 2446778899999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCC-CCCcc--cHHHHHHHHhhc---
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDES--NLMALYRKICRA--- 150 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~-Pf~~~--~~~~~~~~i~~~--- 150 (361)
|++....... .......+||+.|+|||++.+..|. .++||||+||++|+|++|.. ||... +....+.++...
T Consensus 312 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~ 389 (501)
T PHA03210 312 GTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSV 389 (501)
T ss_pred CCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhccc
Confidence 9997654321 1123356899999999999887775 89999999999999999875 44322 111111111110
Q ss_pred ---CCC---------------------CC-----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---DFS---------------------CP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---~~~---------------------~~-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.++ .+ ..++.++.++|.+||..||.+|||+.|+|.||||...
T Consensus 390 ~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 390 CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 000 00 0145677888999999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=251.84 Aligned_cols=182 Identities=24% Similarity=0.320 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDi 58 (361)
..+..|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 456789999999999999988642 24788899999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCc
Q 018052 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 137 (361)
Q Consensus 59 Kp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~ 137 (361)
||+|||+++++.+||+|||++...............+++..|+|||.+.+..++ .++||||+|+++|+|++ |..||.+
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999998754322211112234567789999998776665 88999999999999998 9999998
Q ss_pred ccHHHHHHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 138 SNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 138 ~~~~~~~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.....++..+... ....|..++.++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8777766655433 23445668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=257.72 Aligned_cols=181 Identities=27% Similarity=0.419 Sum_probs=149.5
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
.+|+||||+ |++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~- 170 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS- 170 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-
Confidence 579999999 7799888764 6799999999999999999999999999999999999999999999999999865322
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-------------
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------------- 152 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------- 152 (361)
......+++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+....+.++.....
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 171 ----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred ----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 123456789999999987644456899999999999999999999987665444433322110
Q ss_pred ------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 153 ------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 153 ------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...+.+++.+.++|.+||..||++|||+.+++.||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01134678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=245.23 Aligned_cols=180 Identities=27% Similarity=0.397 Sum_probs=151.1
Q ss_pred cEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...|+||||+++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 57899999999999999998764 6899999999999999999999999999999999999999999999999998765
Q ss_pred cccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc--CCCCCCCC
Q 018052 83 QQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA--DFSCPSWF 158 (361)
Q Consensus 83 ~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~ 158 (361)
...... .......++..|+|||.+.+..+. .++||||+||++|+|++ |..||...+..+....+... ....|..+
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEAC 226 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccC
Confidence 332111 111234577899999998877665 78999999999999998 99999887777766655432 23344557
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=250.30 Aligned_cols=183 Identities=30% Similarity=0.496 Sum_probs=149.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||+++ +|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||++++++.+||+|||++....
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 73 GSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred CcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 689999999975 899888765 579999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-----------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----------- 152 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 152 (361)
.... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....
T Consensus 152 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 152 KRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 3221 1223456788999999877654446899999999999999999999988766554444332100
Q ss_pred ------------CC-------CCC-CCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 ------------SC-------PSW-FSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 ------------~~-------~~~-~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.. ... .++.+.+++++||..+|.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=248.67 Aligned_cols=184 Identities=30% Similarity=0.514 Sum_probs=150.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..
T Consensus 69 ~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 69 TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred cCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 4578999999997 4999999876 5799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 150 (361)
..... .......++..|+|||.+.+....+.++|+||+||++|+|++|..||...+....+.++...
T Consensus 148 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPL--RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCc--cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 43321 12234456788999999876634458899999999999999999999887655444433210
Q ss_pred -------CCCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 151 -------DFSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 151 -------~~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
....+ +.++..+.++|++||..||++||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00111 1246789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=246.17 Aligned_cols=179 Identities=27% Similarity=0.417 Sum_probs=148.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...|+||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 45799999999999999997643 4889999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.... ........++..|+|||...+..+. .++|+||+|+++|+|++ |..||.+....+....+... ....+..++.
T Consensus 153 ~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05069 153 EDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230 (260)
T ss_pred cCCc-ccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 3211 1111223456789999998766654 89999999999999999 99999887776666665443 2334556789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.+++.+||..||.+||+++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=252.84 Aligned_cols=184 Identities=30% Similarity=0.534 Sum_probs=147.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+|+||+++ +|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+|||++...
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 4489999999986 777777653 46999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CC-------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DF------- 152 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~------- 152 (361)
..... .......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+..+... ..
T Consensus 167 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 167 NSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred cCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 33221 11223356788999998865544458899999999999999999999876655444333221 00
Q ss_pred --------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 --------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 --------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
.....++..+.+++.+||..||.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011257899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=248.36 Aligned_cols=182 Identities=20% Similarity=0.286 Sum_probs=141.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.....|+||||+++|+|.+++.... ..++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 66 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg 145 (269)
T cd05042 66 ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYG 145 (269)
T ss_pred CCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccc
Confidence 4567899999999999999997643 24678889999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccC------CCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhh-
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDK------GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR- 149 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~------~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~- 149 (361)
++................+++.|+|||++... ...+.++||||+||++|+|++ |..||......+.......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 98543211111111233456789999987532 223578999999999999998 8899987765555444332
Q ss_pred cCCC-----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 150 ADFS-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 150 ~~~~-----~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.... .+..++....+++..|+ .||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2222 22346788899999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=255.92 Aligned_cols=183 Identities=25% Similarity=0.425 Sum_probs=151.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+||||+.+|+|.+++.... .++...+..++.|++.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 3567899999999999999997532 367788899999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++................++..|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999998754332111112223345679999999877665 78999999999999998 899999888777777
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.... ...|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 665543 34455678999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=252.81 Aligned_cols=184 Identities=25% Similarity=0.406 Sum_probs=150.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+.| +|.+.+.. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 86 REHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred eCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 45678999999975 77777654 45799999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCC-CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSC-PSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~ 157 (361)
... .....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.... ... +..
T Consensus 165 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (307)
T cd06607 165 VSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238 (307)
T ss_pred cCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchh
Confidence 321 234568899999998742 2223478999999999999999999998876655444433222 222 223
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
++..+.++|.+||..+|++|||+.+++.||||....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 678999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=263.03 Aligned_cols=158 Identities=23% Similarity=0.379 Sum_probs=126.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccc
Q 018052 28 RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 107 (361)
Q Consensus 28 ~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~ 107 (361)
.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+++.|+|||++.
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence 37788889999999999999999999999999999999999999999999987543322211223345778899999998
Q ss_pred cCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHH-HHHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 108 DKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 108 ~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
+..+. .++||||+||++|+|++ |..||....... .+..+..+ ....+..++..+.+++.+||..||++|||+.++.
T Consensus 313 ~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 313 DNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred CCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 76664 89999999999999997 999998755443 33333332 2344556889999999999999999999999987
Q ss_pred hC
Q 018052 185 ED 186 (361)
Q Consensus 185 ~h 186 (361)
+.
T Consensus 392 ~~ 393 (400)
T cd05105 392 DI 393 (400)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=244.19 Aligned_cols=177 Identities=26% Similarity=0.467 Sum_probs=150.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 71 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccc
Confidence 3678899999999999999998765 69999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
..... .....++..|+|||.+....+. .++|+||+|+++|+|++ |..||...+..+....+... ....|..+
T Consensus 151 ~~~~~-----~~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 151 EASQG-----QDSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGC 224 (256)
T ss_pred ccccc-----cccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCC
Confidence 54221 1123345679999998766654 78999999999999997 99999888777766655443 33445668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+.++|.+||..+|++|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=245.83 Aligned_cols=180 Identities=24% Similarity=0.387 Sum_probs=149.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....|+||||+++|+|.+++... ..++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 34579999999999999999863 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
...... .......++..|+|||++.+..++ .++|+||+||++|+|++ |..||.+.........+... ....+..++
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 152 IEDNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 229 (262)
T ss_pred cccccc-ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccC
Confidence 432211 112234467789999998776664 89999999999999999 89999887766666665443 234455678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.+++.+||..||++|||+.++++
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=248.28 Aligned_cols=177 Identities=25% Similarity=0.352 Sum_probs=143.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-------CEEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-------VLKIS 74 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-------~lKl~ 74 (361)
+....|+||||++||+|..++.. .+++++..+..++.|++.||+|||++||+||||||+|||++..+ .+|++
T Consensus 87 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~ 166 (274)
T cd05076 87 RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLS 166 (274)
T ss_pred eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeec
Confidence 34578999999999999999875 46799999999999999999999999999999999999998654 38999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhH-hcCCCCCCcccHHHHHHHHhhcCCC
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVL-MAGFLPFDESNLMALYRKICRADFS 153 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~l-l~g~~Pf~~~~~~~~~~~i~~~~~~ 153 (361)
|||++..... .....+++.|+|||.+.+....+.++|+||+||++|+| ++|..||.......... .......
T Consensus 167 d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~ 239 (274)
T cd05076 167 DPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYEKKHR 239 (274)
T ss_pred CCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHHhccC
Confidence 9998753221 12345788999999887644445899999999999998 47999998765544322 2223334
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.|...++.+.++|.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 240 LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 455567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=238.72 Aligned_cols=192 Identities=23% Similarity=0.422 Sum_probs=158.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..+|+||.+|+. +|+-.+.+. .+++..+++++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||+|+.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 45679999999987 999998876 5899999999999999999999999999999999999999999999999999976
Q ss_pred ccccccC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCCC----
Q 018052 82 SQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADFS---- 153 (361)
Q Consensus 82 ~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~---- 153 (361)
+...... ...+.+.-|.+|.+||.+.+..-++.+.|||+.|||+.+|.+|.+-+.+.+.......|.. +...
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 6543221 1244566799999999998887778999999999999999999999988765544433321 1100
Q ss_pred ----------------CCC-------------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 154 ----------------CPS-------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 154 ----------------~~~-------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.|. .-++++.+|+.+||..||.+|+++++++.|.||.+...|
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 110 024578999999999999999999999999999876544
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=245.93 Aligned_cols=182 Identities=24% Similarity=0.386 Sum_probs=149.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-----C
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-----V 70 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-----~ 70 (361)
.....|+||||++||+|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 70 LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred CCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcc
Confidence 456789999999999999999742 3478899999999999999999999999999999999999888 8
Q ss_pred EEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhh
Q 018052 71 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICR 149 (361)
Q Consensus 71 lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~ 149 (361)
+|++|||++................++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+....+..
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 228 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc
Confidence 99999999865432211111223345788999999987666 489999999999999998 9999988776666655543
Q ss_pred c-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 150 A-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 150 ~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. ....+..++..+.++|.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 34455668899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=243.93 Aligned_cols=182 Identities=27% Similarity=0.412 Sum_probs=149.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+.|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 63 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred cCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 456789999999999999999764 4689999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..............++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||...........+... ....|...+
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCP 221 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 432111111112334567999999877665 489999999999999998 89999887766655555433 234455678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.+++.+||..+|.+|||+.++++
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=257.81 Aligned_cols=184 Identities=28% Similarity=0.443 Sum_probs=148.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|++++++ |++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4588999987 7899887765 4699999999999999999999999999999999999999999999999999865321
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------------ 152 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------ 152 (361)
......|++.|+|||++.+....+.++|+||+||++|+|++|..||...+.......+.....
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 223457899999999987644445889999999999999999999976654443332211100
Q ss_pred -----------CCC--------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 153 -----------SCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 153 -----------~~~--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
..| ...++++.+||.+||..||.+|||+.+++.||||++...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 000 1247889999999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=245.26 Aligned_cols=184 Identities=27% Similarity=0.492 Sum_probs=145.1
Q ss_pred CcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+++.||+|.. .+...+.. .++++|..+-++..-+++||.||..+ ||+|||+||+|||+|+.|++|+||||.|..
T Consensus 163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 3445566777632 33333333 35799999999999999999999965 799999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCC-CC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSC-PS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~-~~ 156 (361)
.-.. .......|.+.|||||-+.-. .|+ ..+||||+||.|++|.||+.||.+.+.+ +.+.++.+...+. |.
T Consensus 242 lvdS---kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 242 LVDS---KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred eecc---cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence 4321 122345799999999987532 455 7899999999999999999999985433 5556666544332 22
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+|+.+.+|+..||.+|+.+||...++|+|||+...
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 289999999999999999999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=244.81 Aligned_cols=182 Identities=23% Similarity=0.361 Sum_probs=147.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....|+||||+.+|+|.+++... ...++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 69 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 69 EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccc
Confidence 44688999999999999999764 35678888999999999999999999999999999999999999999999998643
Q ss_pred ccccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCC
Q 018052 83 QQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 158 (361)
Q Consensus 83 ~~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 158 (361)
..... ........+++.|+|||.+.+..+. .++||||+||++|+|++ |.+||...+..+....+..+. ...+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 22110 0111233467789999998776664 89999999999999999 577787776666665554443 3335557
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+.+++.+||..+|++||++.++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=249.11 Aligned_cols=182 Identities=22% Similarity=0.344 Sum_probs=149.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp 60 (361)
.....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 3467899999999999999997432 367888999999999999999999999999999
Q ss_pred CcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCccc
Q 018052 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN 139 (361)
Q Consensus 61 ~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~ 139 (361)
+||+++.++.+||+|||++................+++.|+|||++.+..+. .++|+||+||++|+|++ |..||.+.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998643221111111223456779999998877765 79999999999999997 889998877
Q ss_pred HHHHHHHHhhcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 140 LMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 140 ~~~~~~~i~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+....+..+.. ..|..++.++.+||.+||..+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777666655543 346668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.64 Aligned_cols=179 Identities=31% Similarity=0.461 Sum_probs=148.4
Q ss_pred EEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.+|++|||+.+ +|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 49999999975 8999887643 59999999999999999999999999999999999999999999999999986643
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-------C---
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-------S--- 153 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------~--- 153 (361)
.. .......+++.|+|||++.+..+. .++|+||+||++|+|++|.+||.+.+..+.+.++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 222344578999999999877664 789999999999999999999998776666555432100 0
Q ss_pred ------C-----------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 154 ------C-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 154 ------~-----------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+ .+.+++.+.++|.+||..||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=251.58 Aligned_cols=183 Identities=25% Similarity=0.422 Sum_probs=150.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+. |+|.+.+.. ...+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 92 KEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred eCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 4578999999996 578887765 45699999999999999999999999999999999999999999999999998753
Q ss_pred ccccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC--CCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~ 157 (361)
.. ......|+..|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.....+ ....
T Consensus 171 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
T cd06633 171 SS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244 (313)
T ss_pred cC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 21 1234578999999999742 222347899999999999999999999887665554444433221 1223
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++..+.+|+.+||+.+|.+||++.+++.||||...
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 67889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=227.33 Aligned_cols=188 Identities=31% Similarity=0.527 Sum_probs=157.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.|..++-+|+|||.. +|..+... +|.++.+.++.++.|++.||.|||++++.|||+||.|+|++.+|.+|++|||+|+
T Consensus 71 hsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 71 HSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhh
Confidence 477899999999965 88877664 5679999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHh-cCCCCCCcccHHHHHHHHhhcCC-------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKICRADF------- 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~------- 152 (361)
.+.- +-.....-.-|.+|.+|.++.+...+++..|+||.|||+.++. +|.+.|.+.+..+...+|...-.
T Consensus 150 afgi--pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCC--ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 6643 2223334456899999999999887789999999999999997 58888999998888887754210
Q ss_pred ----CC---------CC---C------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 ----SC---------PS---W------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ----~~---------~~---~------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.. |. | ++...++|++++|..+|.+|++++.+++||||...
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 01 11 1 23456799999999999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=242.06 Aligned_cols=182 Identities=28% Similarity=0.486 Sum_probs=150.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 63 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred cCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 456789999999999999998764 4689999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..... ........+++.|+|||++.+..+. .++||||+|+++|++++ |..||.+.........+... ....+..++
T Consensus 143 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (250)
T cd05085 143 EDDGI-YSSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCP 220 (250)
T ss_pred ccccc-cccCCCCCCcccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 32211 1111123446789999998776654 78999999999999998 99999887766665555443 234566688
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.97 Aligned_cols=185 Identities=25% Similarity=0.397 Sum_probs=144.9
Q ss_pred cCcEEEEEEecCCCCChHH---HHH--hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFD---KIA--KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~---~i~--~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
.+...|++|||+.+ +|.+ .+. ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+||
T Consensus 74 ~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 74 REGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred cCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeec
Confidence 35678999999864 5544 332 235799999999999999999999985 9999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccC--CCCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhhcCC-
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADF- 152 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~--~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~- 152 (361)
|++...... .......|++.|+|||++.+. ...+.++||||+||++|+|++|..||...+. ......+.....
T Consensus 153 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 153 GISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred chhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 998644321 122345689999999998766 2335899999999999999999999976542 122222222221
Q ss_pred CC----CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 153 SC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 153 ~~----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.. +..++.++.+||.+||..+|++|||+++++.||||..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 11 1237889999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=255.93 Aligned_cols=157 Identities=27% Similarity=0.431 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCcccccccccc
Q 018052 29 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 108 (361)
Q Consensus 29 l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~ 108 (361)
++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................+++.|+|||++.+
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence 67788899999999999999999999999999999999999999999999875432111111222345678999999887
Q ss_pred CCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHH-HHHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 109 KGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA-LYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 109 ~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+. .++||||+|+++|+|++ |..||....... ....+..+ ....|.+.++++.+++.+||..||++|||+.++++
T Consensus 256 ~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~ 334 (343)
T cd05103 256 RVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334 (343)
T ss_pred CCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7665 88999999999999996 999998754332 22222222 33456678899999999999999999999999998
Q ss_pred C
Q 018052 186 D 186 (361)
Q Consensus 186 h 186 (361)
|
T Consensus 335 ~ 335 (343)
T cd05103 335 H 335 (343)
T ss_pred H
Confidence 7
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=249.60 Aligned_cols=182 Identities=21% Similarity=0.254 Sum_probs=145.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV 70 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~ 70 (361)
....+|+||||+.|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT 167 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCc
Confidence 4567899999999999999986532 3678899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc--CCCCCCcccHHHHHHHHh
Q 018052 71 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMALYRKIC 148 (361)
Q Consensus 71 lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~--g~~Pf~~~~~~~~~~~i~ 148 (361)
+||+|||++................+++.|+|||++....+ +.++|+||+||++|+|++ |..||...+..+....+.
T Consensus 168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 246 (295)
T cd05097 168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246 (295)
T ss_pred EEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHH
Confidence 99999999865432211111222345678999999877666 489999999999999987 678998766555444332
Q ss_pred h--------cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 149 R--------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 149 ~--------~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. .....++.+++.+.+|+.+||..||++|||+++|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 247 EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 112234457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=245.25 Aligned_cols=182 Identities=18% Similarity=0.275 Sum_probs=142.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+...+|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 66 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 66 EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred CCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEeccccc
Confidence 4567899999999999999998642 366778889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCC------CCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~------~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
+...............+|++.|+|||++.... ..+.++||||+||++|+|++ |..||...+..+.+..+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 225 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc
Confidence 75322111111223467899999999875321 12468999999999999996 578998777666666543332
Q ss_pred -C-----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 -F-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 -~-----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. ..+..+++.+.+++..|| .+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1 223346888999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=245.08 Aligned_cols=180 Identities=32% Similarity=0.624 Sum_probs=148.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
.+...|+||||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~ 152 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchh
Confidence 45689999999999999998863 34689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH--HHHHHHHhhcCCC-C-
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL--MALYRKICRADFS-C- 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~- 154 (361)
+....... ......+|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||.+... ......+...... .
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08229 153 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 229 (267)
T ss_pred hhccccCC--cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCC
Confidence 87543221 223456789999999999877765 789999999999999999999975433 3344444333222 1
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+++.+.+++.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 2357889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=241.81 Aligned_cols=181 Identities=28% Similarity=0.437 Sum_probs=152.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+..|++|||++|++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 72 EEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred CCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCce
Confidence 45689999999999999999986554 9999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 158 (361)
......... .....+++.|+|||.+....+ +.++|+||+|+++|+|++ |..||...+.......+.... ...+...
T Consensus 152 ~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T smart00219 152 DLYDDDYYK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC 229 (258)
T ss_pred ecccccccc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 654321111 111236789999999866555 489999999999999998 899998877777777665543 3445668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=244.68 Aligned_cols=180 Identities=24% Similarity=0.370 Sum_probs=150.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 45789999999999999998744 58999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
.... .......+++.|+|||.+....+. .++||||+|+++|+|++ |..||.+.+..+....+..+ ....|..++..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 236 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 2211 111123345689999998776664 88999999999999986 99999888777666665544 34556678999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.++|.+||..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.93 Aligned_cols=181 Identities=34% Similarity=0.599 Sum_probs=147.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+....|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 45689999999999999988753 23589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHHHhhcCCC-C-
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICRADFS-C- 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~-~- 154 (361)
+....... .......|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+.....+ .
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08228 153 GRFFSSKT--TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP 229 (267)
T ss_pred ceeccchh--HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCC
Confidence 87643221 122345789999999998877765 78999999999999999999996543 23444444333221 2
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..++..+.+++.+||..+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 22467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.22 Aligned_cols=182 Identities=20% Similarity=0.244 Sum_probs=140.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
+...+|+||||++||+|.+++.... ..++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 66 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg 145 (269)
T cd05087 66 EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYG 145 (269)
T ss_pred CCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcc
Confidence 4567899999999999999987532 35677888999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCC------CCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHh-h
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKIC-R 149 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~------~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~-~ 149 (361)
++...............+|++.|+|||++.+.. ..+.++|+||+|+++|+|++ |..||......+...... .
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 146 LSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred ccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 986432211111122356788999999986432 12578999999999999996 999998766554433322 2
Q ss_pred cCCCC--C---CCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 150 ADFSC--P---SWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 150 ~~~~~--~---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..... | ...++.+.+++++|+ .+|.+|||+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 21211 1 135788899999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=245.47 Aligned_cols=180 Identities=19% Similarity=0.361 Sum_probs=151.2
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 5689999999999999999874 469999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
............++..|+|||.+....+. .++|+||+|+++|++++ |..||.+....+....+... ..+.|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 22111111222345689999998766665 78999999999999998 99999988777776666554 34556667899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHh
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.+++.+||..+|+.|||+.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=253.71 Aligned_cols=180 Identities=28% Similarity=0.443 Sum_probs=146.0
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+.+ +|...+. ..++++.+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 467999999964 7776653 4699999999999999999999999999999999999999999999999999864321
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------- 151 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 151 (361)
......|++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12345678999999998764444589999999999999999999998876554443322210
Q ss_pred ----------CCC--------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 ----------FSC--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ----------~~~--------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
... .+..++.+.+||.+||+.||.+|||+++++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 01356789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=242.69 Aligned_cols=180 Identities=34% Similarity=0.652 Sum_probs=148.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
.....|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccce
Confidence 45688999999999999998864 24589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHHHhhcCC-CCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICRADF-SCP 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~~ 155 (361)
+...... ........|++.|+|||.+.+..+. .++|+||+||++|+|++|..||.... ..+....+..+.. +.|
T Consensus 153 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 153 GRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred eeeccCC--CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC
Confidence 8654321 1223345789999999999877775 78999999999999999999996543 3344444433322 233
Q ss_pred C-CCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 156 S-WFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 156 ~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. .++..+.++|.+||..+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3 57889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=242.19 Aligned_cols=182 Identities=24% Similarity=0.419 Sum_probs=151.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||++||+|.+++... +.++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence 456789999999999999998764 4689999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 159 (361)
...... .......++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||...........+..+. ...|...+
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05112 150 VLDDQY-TSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLAS 227 (256)
T ss_pred cccCcc-cccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCC
Confidence 422111 111122345689999998876664 78999999999999998 999999887777776665442 23345578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+.+|+.+||..+|++|||+.+++++
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=242.77 Aligned_cols=174 Identities=20% Similarity=0.268 Sum_probs=141.7
Q ss_pred cEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-------CEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-------VLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-------~lKl~DF 76 (361)
...|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 45689999999999999998766 799999999999999999999999999999999999999888 8999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCCCC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFSC 154 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~ 154 (361)
|++..... .....++..|+|||++.+. ...+.++|+||+||++|+|++ |..||...+......... .....
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~ 225 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRL 225 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCC
Confidence 99875322 2234577889999998776 234589999999999999998 688887765333332222 22222
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
|......+.++|.+||..+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2223478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=243.70 Aligned_cols=182 Identities=22% Similarity=0.364 Sum_probs=149.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+++|+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 456789999999999999998764 5789999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCc-cccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCC
Q 018052 82 SQQVREDGL-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~-~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 158 (361)
......... ......++.|+|||++.+..++ .++|+||+||++|+|++ |..||...+.......+.... .+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 432211111 1112234579999998877664 89999999999999997 999998877777666665432 2233347
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=247.80 Aligned_cols=181 Identities=29% Similarity=0.516 Sum_probs=147.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+++|||||++|+|.+++... ..+++.....++.|++.||.|||+++++|+||+|.||++++++.+||+|||++..
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34589999999999999999986 6799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 159 (361)
..............+...|+|||.+....++ .++||||+|+++|+|++ |..||.+.+..+....+.... ...|..++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCP 231 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSB
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchh
Confidence 5221111122334567789999998876664 89999999999999999 789999888887777765443 34556689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.++|..||..||.+|||+.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=277.91 Aligned_cols=182 Identities=33% Similarity=0.600 Sum_probs=147.8
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRL-KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+||=||||+.-.|.+.|..+... ..+.++++|+||++||.|+|++||+||||||.||++|+++.+||+|||+|+...
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~ 748 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK 748 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence 5789999999986666777665444 478999999999999999999999999999999999999999999999998721
Q ss_pred ----------------ccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHH
Q 018052 84 ----------------QVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDE-SNLMAL 143 (361)
Q Consensus 84 ----------------~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~ 143 (361)
.....+..+...||.-|+|||++.+.. |+ .++||||+|||++||+. ||.- ......
T Consensus 749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn-~KiDmYSLGIVlFEM~y---PF~TsMERa~i 824 (1351)
T KOG1035|consen 749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN-SKIDMYSLGIVLFEMLY---PFGTSMERASI 824 (1351)
T ss_pred hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc-chhhhHHHHHHHHHHhc---cCCchHHHHHH
Confidence 011122455678999999999998776 55 89999999999999984 6653 333455
Q ss_pred HHHHhhcCCCCCCCC----CHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 144 YRKICRADFSCPSWF----SSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 144 ~~~i~~~~~~~~~~~----s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+..+..+..+.|+.+ -+....+|+.||+.||++|||+.|+|++.||.
T Consensus 825 L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 825 LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 666666666666322 24567899999999999999999999999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=248.40 Aligned_cols=182 Identities=19% Similarity=0.280 Sum_probs=144.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-----------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 71 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~l 71 (361)
....+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~ 169 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCE
Confidence 3567899999999999999987643 36677899999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc--CCCCCCcccHHHHHHHHhh
Q 018052 72 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA--GFLPFDESNLMALYRKICR 149 (361)
Q Consensus 72 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~--g~~Pf~~~~~~~~~~~i~~ 149 (361)
||+|||++................+++.|+|||...+..+ +.++|+||+||++|+|++ |..||...+..+.......
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05095 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248 (296)
T ss_pred EeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHH
Confidence 9999999875432111111122344678999998877666 489999999999999998 7899987665554433211
Q ss_pred --------cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 150 --------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 150 --------~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
...+.|..+++.+.+|+.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 122345567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=245.18 Aligned_cols=182 Identities=25% Similarity=0.363 Sum_probs=151.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG---------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl 73 (361)
.....|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+|+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 4467899999999999999998765 6899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 152 (361)
+|||++...... .........+++.|+|||.+.+..+. .++||||+|+++|+|++ |..||.+......+..+..+..
T Consensus 159 ~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 159 SLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred cccccccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 999998643211 11122334567789999998776654 78999999999999998 8899987766666666554433
Q ss_pred --CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 --SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 --~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 3345578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=246.15 Aligned_cols=180 Identities=26% Similarity=0.399 Sum_probs=143.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+++|+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||+++++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999976 469999999999999999999999999999999999999999999999999987543
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH--HHH------------HHHh
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALY------------RKIC 148 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~--~~~------------~~i~ 148 (361)
..... .......++..|+|||.+.+..++ .++||||+|+++|+|++|..||...... +.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 22111 111223456779999998776664 8999999999999999999998653211 111 0001
Q ss_pred -h-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 149 -R-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 149 -~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
. ...+.|..++..+.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 112335567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=242.61 Aligned_cols=180 Identities=23% Similarity=0.389 Sum_probs=149.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceee
Confidence 45689999999999999998753 3689999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..... ........++..|+|||++....+. .++||||+|+++|+|++ |.+||.+.+..+....+... ..+.+...+
T Consensus 152 ~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05067 152 IEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229 (260)
T ss_pred cCCCC-cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Confidence 43211 1111233456789999998776654 88999999999999998 99999887777666655443 234455578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.++.+++.+||..+|++|||+++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=242.23 Aligned_cols=181 Identities=26% Similarity=0.403 Sum_probs=150.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 4567899999999999999997643 68999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
....... .......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||.+.+.......+... ....|...
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05034 152 LIEDDEY-TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNC 229 (261)
T ss_pred eccchhh-hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 5432111 11112234568999999887665 488999999999999998 99999887777666666543 23445557
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.++.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=243.36 Aligned_cols=182 Identities=23% Similarity=0.388 Sum_probs=148.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||++||+|.+++... +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 456789999999999999998764 5689999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCcccccc---CCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCC
Q 018052 82 SQQVREDGLLHTAC---GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~---gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 156 (361)
.............. ++..|+|||.+.+..++ .++||||+||++|+|++ |..||...+..+....+... ..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence 43221111111111 24579999999877775 78999999999999886 99999887776666665432 223445
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 57889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=236.69 Aligned_cols=184 Identities=28% Similarity=0.459 Sum_probs=147.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~DF 76 (361)
.++..|++++|...|+|.+.|+.- ..++|.++..||.++++||++||+.. .+||||||.|||+.+.+.++++||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 456899999999999999998853 25999999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccccCCc-------cccccCCCccccccccccCCCC--CCchhhhhhhhHHHhHhcCCCCCCcccH--HHHHH
Q 018052 77 GLSAISQQVREDGL-------LHTACGTPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNL--MALYR 145 (361)
Q Consensus 77 Gla~~~~~~~~~~~-------~~~~~gt~~y~APEv~~~~~~~--~~~~DiwS~Gvil~~ll~g~~Pf~~~~~--~~~~~ 145 (361)
|.++...-.-.++. ...-..|.+|.|||.+.-+.+. +.++||||+||+||+|+-|.-||+..-. ..+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99875432111110 1123468999999998755432 5899999999999999999999964211 11112
Q ss_pred HHhhcCCCCCC--CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRADFSCPS--WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~~~~~~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.++.+++|. .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 23344555554 389999999999999999999999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=249.53 Aligned_cols=183 Identities=26% Similarity=0.406 Sum_probs=149.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+....|+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 4567899999996 588777654 44689999999999999999999999999999999999999999999999999864
Q ss_pred ccccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC--CCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~ 157 (361)
... .....|++.|+|||.+.+ ....+.++||||+||++|+|++|..||...+.......+...... .+..
T Consensus 165 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 165 MAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238 (308)
T ss_pred ecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccc
Confidence 321 234568899999999753 122347899999999999999999999876655444444333222 1234
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++..+.+||++||..+|.+||+++++++|||+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 78899999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=245.62 Aligned_cols=182 Identities=31% Similarity=0.524 Sum_probs=151.0
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|||||.+ +|...+.. .++-+.+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|....
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~- 169 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED- 169 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC-
Confidence 468999999976 99988884 48888999999999999999999999999999999999999999999999997432
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------- 151 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------- 151 (361)
.+-..+.+..|..|.|||++.+.+|. ..+||||+||++.+|++|..-|.+.+..+.+.++....
T Consensus 170 --~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 170 --TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred --cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 22345678899999999999999965 89999999999999999999998877666555442110
Q ss_pred --------------CC----CCCC-----------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 152 --------------FS----CPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 152 --------------~~----~~~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
++ +|.+ -+..+++|+.+||..||++|++++++|.|||++-++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 01 1111 134578999999999999999999999999998543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=244.91 Aligned_cols=181 Identities=24% Similarity=0.341 Sum_probs=149.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEe
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 75 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~D 75 (361)
....|+++||+.+|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999998753 3588999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCC
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFS 153 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~ 153 (361)
||++................++..|+|||++.+..+. .++||||+||++|++++ |..||...+..+....+... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998754321111111223456789999999876664 88999999999999998 99999987777766655443 223
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+..+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 44557899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=248.38 Aligned_cols=185 Identities=25% Similarity=0.407 Sum_probs=151.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+.+..|+||||+.| +|.+.+.. ..++++.++..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 96 REHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred eCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 45678999999975 78777654 45699999999999999999999999999999999999999999999999998764
Q ss_pred ccccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-C-CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-C-PSW 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~ 157 (361)
... .....|++.|+|||.+.. .+..+.++|+||+||++|+|++|..||...+.......+...... . +..
T Consensus 175 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd06635 175 ASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248 (317)
T ss_pred cCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCcc
Confidence 321 234578999999998742 222347899999999999999999999877665555554443322 2 234
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+++.+.+++.+||..+|.+|||+.++++|+|+.....
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 6888999999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=243.03 Aligned_cols=182 Identities=25% Similarity=0.414 Sum_probs=149.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+|++|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 456789999999999999999765 4689999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 82 SQQVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
........ ......++..|+|||.+.+..+. .++|+||+||++|++++ |..||.+.+..+....+... ..+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDC 234 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCC
Confidence 53321111 01112235689999999876664 89999999999999886 99999887766666665543 22334457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+.+++.+||..+|.+|||+.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=247.89 Aligned_cols=176 Identities=15% Similarity=0.220 Sum_probs=140.9
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 86 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~ 86 (361)
.|++||++. +++.+.+......++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 102 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~ 180 (294)
T PHA02882 102 RFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180 (294)
T ss_pred EEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCC
Confidence 478888874 4777777765567899999999999999999999999999999999999999999999999997653211
Q ss_pred c-----CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH-H--------HHHHHHhhcCC
Q 018052 87 E-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-M--------ALYRKICRADF 152 (361)
Q Consensus 87 ~-----~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~--------~~~~~i~~~~~ 152 (361)
. ........||+.|+|||++.+..|. .++||||+||++|+|++|.+||.+.+. . +....+..+..
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (294)
T PHA02882 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI 259 (294)
T ss_pred cccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh
Confidence 1 1112335799999999999887774 899999999999999999999987532 1 12233333333
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.. +..+..+.++++.|+..+|++||+++++++
T Consensus 260 ~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 260 KI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 33 345789999999999999999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=246.52 Aligned_cols=186 Identities=26% Similarity=0.482 Sum_probs=148.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+...+|+||||+. ++|.+.+.. .+.+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||++.
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 4668999999985 477776665 4579999999999999999999997 599999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhhcCC-CCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADF-SCP 155 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~~ 155 (361)
...... ......+++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||..... .+.+..+..... ..+
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06618 164 RLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240 (296)
T ss_pred hccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence 543211 122345788999999987543 124789999999999999999999976332 234444433322 222
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..++.++.+|+.+||..||.+|||++++++||||...
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 2368899999999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=239.26 Aligned_cols=175 Identities=25% Similarity=0.474 Sum_probs=147.1
Q ss_pred cEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...|+||||+.||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 35799999999999999998654 5899999999999999999999999999999999999999999999999998643
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
... ......+..|+|||.+.+..+. .++|+||+||++|+|++ |..||...+..+....+..+. ...+..++.
T Consensus 151 ~~~-----~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (254)
T cd05083 151 SMG-----VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224 (254)
T ss_pred ccc-----CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCH
Confidence 221 1223345689999998776664 78999999999999997 999999887776666655442 233445789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.+++.+||..+|..|||++++++
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=273.17 Aligned_cols=96 Identities=30% Similarity=0.575 Sum_probs=83.7
Q ss_pred cCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC---CCCHHHHHHHHHccC
Q 018052 95 CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS---WFSSGAKKLIKRILD 171 (361)
Q Consensus 95 ~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---~~s~~~~~Li~~~L~ 171 (361)
.||+.|+|||++.+..|. .++||||+||++|+|++|..||.+......+..+.......|. .++..+.+++.+||.
T Consensus 541 vGT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 541 LGTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT 619 (669)
T ss_pred eeCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 468999999999888774 8999999999999999999999998888888777665444332 467889999999999
Q ss_pred CCcCCCCCHHHHHhCccccc
Q 018052 172 PNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 172 ~dP~~R~t~~eil~h~~f~~ 191 (361)
.||.+|||+.++++||||..
T Consensus 620 ~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 620 MDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred cChhHCcCHHHHHhCHhhcC
Confidence 99999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=256.96 Aligned_cols=157 Identities=24% Similarity=0.360 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCcccccccccc
Q 018052 29 LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND 108 (361)
Q Consensus 29 l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~ 108 (361)
++...++.++.|++.||+|||+.||+||||||+|||+++++.+||+|||++................+++.|+|||.+.+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 56677889999999999999999999999999999999999999999999875432111111223457889999999987
Q ss_pred CCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHH-Hhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 109 KGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK-ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 109 ~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~-i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+. .++||||+||++|+|++ |..||......+.... +..+ ....|..++.++.+|+.+||..+|.+||++.+|++
T Consensus 316 ~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 316 NLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6664 88999999999999998 8999987554444333 3322 23456678999999999999999999999999986
Q ss_pred C
Q 018052 186 D 186 (361)
Q Consensus 186 h 186 (361)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=247.17 Aligned_cols=180 Identities=22% Similarity=0.356 Sum_probs=148.0
Q ss_pred EEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4679999999999999987754 689999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHHH
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGA 162 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~ 162 (361)
...........++..|+|||.+.+..+. .++||||+||++|+|++ |..||.+.........+... ....++..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 2221112234567789999998876664 88999999999999997 99999876655544443332 234455578899
Q ss_pred HHHHHHccCCCcCCCCCHHHHHhC
Q 018052 163 KKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+++.+||..+|.+||++.++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=243.54 Aligned_cols=182 Identities=26% Similarity=0.410 Sum_probs=143.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999999999999997654 5899999999999999999999999999999999999999999999999998754
Q ss_pred cccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---------------HHHHHHH
Q 018052 83 QQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------------LMALYRK 146 (361)
Q Consensus 83 ~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---------------~~~~~~~ 146 (361)
...... .......|+..|+|||++.+..+. .++||||+||++|+|+++..|+.... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 322111 112345677789999998876664 78999999999999999876653211 1111111
Q ss_pred Hhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 147 ICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 147 i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+ ..+.+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111 223345578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=261.24 Aligned_cols=183 Identities=26% Similarity=0.425 Sum_probs=156.0
Q ss_pred CcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+..|||||||-| +-.|.+.- ..++.|.++..+..+.+.||+|||+++-+|||||..|||++++|.+||+|||.|.+.
T Consensus 98 e~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 98 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred cchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 3567899999965 77777664 357999999999999999999999999999999999999999999999999998764
Q ss_pred cccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-CC-CC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CP-SW 157 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-~~ 157 (361)
. ...++.|||.||||||+. .+.|+ -++||||+||...+|.-.++|....+.+..+..|...+.+ ++ +.
T Consensus 177 ~------PAnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~e 249 (948)
T KOG0577|consen 177 A------PANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 249 (948)
T ss_pred C------chhcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCch
Confidence 3 346789999999999975 34576 5899999999999999999999888877666666554332 22 23
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+|..+++|+..||.+-|.+|||.+++|.|+|....-+
T Consensus 250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 6899999999999999999999999999999987644
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.27 Aligned_cols=185 Identities=27% Similarity=0.461 Sum_probs=148.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
....|+||||+ +++|.+.+.. .++++..+..++.|+++||.|||++||+||||||.||+++.++.+||+|||++....
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 45789999999 5689887764 568999999999999999999999999999999999999999999999999986432
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR-------------- 149 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------- 149 (361)
. ......+++.|+|||++.+....+.++|+||+||++|+|++|..||...+....+..+.+
T Consensus 160 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 P-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred C-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 1 223456788999999886644445899999999999999999999977654322211110
Q ss_pred ------------cCCCCC-----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 150 ------------ADFSCP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 150 ------------~~~~~~-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.....| +.+++.+.++|++||..+|++|||+++++.||||...-.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000111 2367899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=239.81 Aligned_cols=181 Identities=30% Similarity=0.573 Sum_probs=152.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
......|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 346789999999999999988743 3469999999999999999999996 68999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC-C
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-P 155 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~ 155 (361)
|++....... ......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+....... +
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence 9987543321 3345678999999999987665 589999999999999999999998877776666655544332 2
Q ss_pred C-CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 156 S-WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 156 ~-~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
. .+++.+.++|.+||..||++|||+.|+..+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 2 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=237.91 Aligned_cols=179 Identities=25% Similarity=0.413 Sum_probs=147.4
Q ss_pred cEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++..+.+||+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 5689999999999999999764 35788899999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
..... .......++..|+|||++....+ +.++|+||+||++|++++ |..||.+.+..+....+... ..+.+...+.
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05073 153 EDNEY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230 (260)
T ss_pred cCCCc-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCH
Confidence 32111 11122345677999999877655 478999999999999998 99999987776666655443 2233456789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=231.92 Aligned_cols=183 Identities=48% Similarity=0.845 Sum_probs=157.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+....++++||+.+++|.+++.....+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||++...
T Consensus 58 ~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 58 DEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred eCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 34688999999999999999988767999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhcCCCCCCC---C
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW---F 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~ 158 (361)
.... ......++..|+|||.+.+..++ .++|+||+|+++++|++|..||.. .+.......+.......+.. +
T Consensus 138 ~~~~---~~~~~~~~~~~~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 138 DPGG---LLTTFVGTPEYMAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred cccc---ccccccCCcCCCCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccC
Confidence 4321 33456789999999998876665 699999999999999999999987 55555555555444433222 7
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+.++.+++.+||..+|++||++.++++||||
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=238.33 Aligned_cols=179 Identities=22% Similarity=0.362 Sum_probs=147.5
Q ss_pred EEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 7 IYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++++||+.+|+|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 47899999999998887532 247899999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...............+++.|++||.+....++ .++||||+||++|+|++ |..||.+.+..+.+..+... ....+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC 240 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 54321111112233456789999998877665 78999999999999998 89999887777776665544 33455678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+.+++.+||..+|++|||+.+++++
T Consensus 241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=279.15 Aligned_cols=184 Identities=21% Similarity=0.281 Sum_probs=137.0
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC---------------
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--------------- 68 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~--------------- 68 (361)
..++++|||+ +++|.+++... ..+++.+++.+++||+.||+|||++||+||||||+||||+..
T Consensus 53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3578889988 56999999753 469999999999999999999999999999999999999654
Q ss_pred ----CCEEEEecCCccccccccc--------------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc
Q 018052 69 ----GVLKISDFGLSAISQQVRE--------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA 130 (361)
Q Consensus 69 ----~~lKl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~ 130 (361)
+.+|++|||++........ .......+||+.|+|||++.+..|. .++||||+||+||+|++
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~sDVwSlGviL~ELl~ 210 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSN-CASDVYRLGVLLFELFC 210 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCC-chhhhhhHHHHHHHHhh
Confidence 4555666666543211000 0001124689999999999888774 89999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhcCCC-CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 131 GFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 131 g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
|..|+..... ....+.....+ .+....+...+++.+||.++|.+|||+.|+++||||...
T Consensus 211 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 211 PVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred CCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 9988764321 11111111111 001124567789999999999999999999999999763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=238.97 Aligned_cols=182 Identities=26% Similarity=0.396 Sum_probs=141.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 45689999999999999999764 46899999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCcc-ccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH---------------HHHH
Q 018052 83 QQVREDGLL-HTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------------LYRK 146 (361)
Q Consensus 83 ~~~~~~~~~-~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~---------------~~~~ 146 (361)
......... ....++..|+|||++.+..+. .++||||+||++|+|++|..|+....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 322111011 112234569999998876664 89999999999999999877764332110 0011
Q ss_pred Hhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 147 ICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 147 i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+... ..+.+..++.++.+|+.+||..+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111 223345578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=257.52 Aligned_cols=181 Identities=24% Similarity=0.433 Sum_probs=151.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+..+.||+-+|+|.+|..+|+-. .+|+....+.|++|+++|+.|||.++|+|||||..||++.+++.+||+||||+++.
T Consensus 459 ~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 459 NPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred CCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 34558999999999999998754 47999999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-----C
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-----C 154 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~ 154 (361)
..-.....+....|...|||||++... +| +..+||||+||++|||++|.+||...+.++++-.+.++... .
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 554444556667789999999998643 34 58999999999999999999999976666665444444221 1
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
....+.++++|+..||..++++||.+.+||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1235679999999999999999999999986
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=268.86 Aligned_cols=183 Identities=23% Similarity=0.406 Sum_probs=142.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 71 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~l 71 (361)
+.+..|+||||++||+|.+++... .+++...+..++.|++.||+|||++||+||||||+|||++.+|.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCE
Confidence 456899999999999999988641 235566788999999999999999999999999999999999999
Q ss_pred EEEecCCccccccccc----------------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCC
Q 018052 72 KISDFGLSAISQQVRE----------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135 (361)
Q Consensus 72 Kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf 135 (361)
||+|||++........ .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCC
Confidence 9999999976521100 0011235799999999999887764 8999999999999999999999
Q ss_pred CcccHHHHHHHH-hhcCCC--CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 136 DESNLMALYRKI-CRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 136 ~~~~~~~~~~~i-~~~~~~--~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
...+........ ...... ....+++.+.+++.+||..||++|++..+.+.+
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 875544332221 111111 113478899999999999999999886665543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=252.40 Aligned_cols=188 Identities=22% Similarity=0.315 Sum_probs=140.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiK 59 (361)
+...|+||||+.+|+|.+++.... .+++..++.++.|++.||.|||++||+|||||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 457899999999999999886421 23567788999999999999999999999999
Q ss_pred CCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCC--------------------CC-CCchhh
Q 018052 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG--------------------YD-GRASDV 118 (361)
Q Consensus 60 p~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~--------------------~~-~~~~Di 118 (361)
|+|||++.++.+||+|||++........ .......+|+.|+|||++.... |. ....|+
T Consensus 337 p~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv 415 (507)
T PLN03224 337 PENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS 415 (507)
T ss_pred hHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch
Confidence 9999999999999999999865432111 1111223489999999875432 11 124799
Q ss_pred hhhhhHHHhHhcCCC-CCCcccH-----------HHHHHHHhhcCCCCC--CCCCHHHHHHHHHccCCCc---CCCCCHH
Q 018052 119 WSCGVILFVLMAGFL-PFDESNL-----------MALYRKICRADFSCP--SWFSSGAKKLIKRILDPNP---DTRMTIS 181 (361)
Q Consensus 119 wS~Gvil~~ll~g~~-Pf~~~~~-----------~~~~~~i~~~~~~~~--~~~s~~~~~Li~~~L~~dP---~~R~t~~ 181 (361)
||+||++|+|++|.. ||.+... ...++.+....+.++ ...++.+.+|+.+||..+| .+|+|++
T Consensus 416 wSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 416 YTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred hhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 999999999999875 7754211 111222222333333 3478999999999999866 6899999
Q ss_pred HHHhCcccccC
Q 018052 182 QMLEDEWFKKG 192 (361)
Q Consensus 182 eil~h~~f~~~ 192 (361)
|+|+||||...
T Consensus 496 eaL~Hp~f~~~ 506 (507)
T PLN03224 496 QALSHRFFLPE 506 (507)
T ss_pred HHhCCCCcCCC
Confidence 99999999643
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=235.82 Aligned_cols=181 Identities=24% Similarity=0.400 Sum_probs=144.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...|+||||++||+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 557899999999999999998754 6999999999999999999999999999999999999999999999999998765
Q ss_pred cccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH---------------HHHH
Q 018052 83 QQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA---------------LYRK 146 (361)
Q Consensus 83 ~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~---------------~~~~ 146 (361)
...... .......++..|+|||.+....+. .++|+||+|+++|+|++|..|+....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 421111 111123445679999998776664 78999999999999999999986532211 1111
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 147 ICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 147 i~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.. ...+.+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111 123334557889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=222.44 Aligned_cols=159 Identities=22% Similarity=0.280 Sum_probs=129.2
Q ss_pred CChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCcccccc
Q 018052 17 GELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 95 (361)
Q Consensus 17 g~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 95 (361)
|+|.+++... .++++.+++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 6999999874 46999999999999999999999999 999999999999999 999875432 1236
Q ss_pred CCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhhcCCC-------CCCCCCH--HHHHH
Q 018052 96 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFS-------CPSWFSS--GAKKL 165 (361)
Q Consensus 96 gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~-------~~~~~s~--~~~~L 165 (361)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||..... ...+..+...... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999888775 899999999999999999999976543 2333333222111 1112333 68999
Q ss_pred HHHccCCCcCCCCCHHHHHhCccccc
Q 018052 166 IKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 166 i~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
|.+||..+|.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=247.60 Aligned_cols=185 Identities=26% Similarity=0.459 Sum_probs=151.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEec
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDF 76 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DF 76 (361)
|..++|+|||+|-+.- +|.+.+.+-| +|....++.|.+||..||..|-..||+|.||||+|||+++. ..+|||||
T Consensus 503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 3457899999999854 9999988755 68899999999999999999999999999999999999864 56899999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC-
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP- 155 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~- 155 (361)
|.|..... ...+.+.-+..|.|||++.+.+|+ .+.|+||+||.||+|.||+..|++.+...++...+.....+|
T Consensus 582 GSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99875432 234455667789999999999998 899999999999999999999998776665543321111111
Q ss_pred ----------------------------------------C------------CC-------CHHHHHHHHHccCCCcCC
Q 018052 156 ----------------------------------------S------------WF-------SSGAKKLIKRILDPNPDT 176 (361)
Q Consensus 156 ----------------------------------------~------------~~-------s~~~~~Li~~~L~~dP~~ 176 (361)
| .+ -..+.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 01 134679999999999999
Q ss_pred CCCHHHHHhCccccc
Q 018052 177 RMTISQMLEDEWFKK 191 (361)
Q Consensus 177 R~t~~eil~h~~f~~ 191 (361)
|+|+.|+|.||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=253.52 Aligned_cols=186 Identities=28% Similarity=0.452 Sum_probs=160.5
Q ss_pred CcEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+|||||||.||+..|++.+ +.++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.+|++|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 5689999999999999999886 45799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccC-----CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-C--
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-S-- 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~-----~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~-- 153 (361)
... .-+...+..|||.|||||++.+. .|+ ..+|+||+||+..||-.|.+|+-+...+..+.+|-+... .
T Consensus 173 lds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 173 LDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 543 23345678899999999998754 354 678999999999999999999999887766666544322 1
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
-|..++.++.++|..||..|-.+||+..++|+|||.+.+
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 233478999999999999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=262.26 Aligned_cols=186 Identities=36% Similarity=0.598 Sum_probs=158.6
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 86 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~ 86 (361)
++-+||||++ +|+..+...+.+...++-.+++||+.||+|||+.||.|||+||+|++++.+|.+||+|||.+.++....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 3344999999 999999998899999999999999999999999999999999999999999999999999999887765
Q ss_pred cC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH-HHH-h-------hcCCCCC
Q 018052 87 ED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKI-C-------RADFSCP 155 (361)
Q Consensus 87 ~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~-~~i-~-------~~~~~~~ 155 (361)
.. ......+|+.+|+|||++.+..|++..+||||+||++..|.+|+.||......+.. ... . .+....-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 55 56678899999999999999999999999999999999999999999765443221 111 0 0111111
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..++...+.+|.+||++||.+|+|+++|++++||+...
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 22677889999999999999999999999999998653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=243.71 Aligned_cols=178 Identities=30% Similarity=0.479 Sum_probs=152.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.-+|+|||+|+||+|.+++++.+ .++..+...++.|.+.||+|||+++++||||-..|+|++.++.+||+|||||...
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 456899999999999999999987 4999999999999999999999999999999999999999999999999998653
Q ss_pred cccccCCcccccc-CCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC--CCCCCC
Q 018052 83 QQVREDGLLHTAC-GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPSWF 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~-gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~ 158 (361)
... ......+ -...|+|||.+....|+ .++||||+||++||+++ |..||.+....+...++....+ +.|...
T Consensus 313 ~~~---~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~ 388 (474)
T KOG0194|consen 313 SQY---VMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT 388 (474)
T ss_pred cce---eeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence 211 1111122 34579999999887665 89999999999999998 8889999999999998855443 445567
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+..+..++.+|+..+|++|||+.++.+
T Consensus 389 p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 389 PKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHHhccCChhhccCHHHHHH
Confidence 888999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=257.66 Aligned_cols=179 Identities=25% Similarity=0.453 Sum_probs=153.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC------C-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEec
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH------G-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~------~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
....+|++|||+||+|..+|++. . .++..+...++.|+++|..||++++++||||...|+||++...+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 45678999999999999999986 2 4889999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCccccccC--CCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHH-HhhcCC
Q 018052 77 GLSAISQQVREDGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK-ICRADF 152 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~g--t~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~-i~~~~~ 152 (361)
|||+..... +.....-.+ ...|||||.+....+. .++|||||||+|||+++ |..||.+.+..++..- ...+..
T Consensus 847 GlArDiy~~--~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 847 GLARDIYDK--DYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred chhHhhhhc--hheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 999833211 111111112 2479999999987775 89999999999999997 8999999888877774 445678
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..|.+++..+.+++..||..+|++||++..|++
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 889999999999999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=228.99 Aligned_cols=186 Identities=28% Similarity=0.502 Sum_probs=150.7
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
.+|+|+|++.. +|...|.....++.+.++-+++||+.||.|||+.||.||||||.|+|++++..+||||||+|+.....
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 46788899865 88888888788999999999999999999999999999999999999999999999999999876542
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh-----------------
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC----------------- 148 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~----------------- 148 (361)
.. ...+.-.-|-.|.|||++.+...++.++||||.|||+.|||..+..|...+..+.+..|.
T Consensus 210 ~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 22 122333457899999999988777899999999999999999999998766554443321
Q ss_pred ------hcCCCCCC-----------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 149 ------RADFSCPS-----------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 149 ------~~~~~~~~-----------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
++....|. .-..+...++.+||..||.+|++.++++.|++..++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11111221 1235678899999999999999999999999987653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=220.82 Aligned_cols=185 Identities=26% Similarity=0.447 Sum_probs=147.7
Q ss_pred cCcEEEEEEecCCCCChHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKI-----AKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i-----~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
++...||.||+|.- +|..+. .++.+++|...-.+..-.+.||.||-.. .|+|||+||+|||+|..|.+|||||
T Consensus 134 ~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 134 SEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred cCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 35678999999964 654322 1345799999999999999999999865 8999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccc--cCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhcCCC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADFS 153 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~--~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~ 153 (361)
|.+..... .-..+.-.|..+|||||-+. +.+|+ ..+|+||+||.|||+.||..|+.+-+ ..+....+..++++
T Consensus 213 GIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 213 GICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP 288 (361)
T ss_pred cchHhHHH---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC
Confidence 99864432 11123357889999999885 34576 89999999999999999999998854 33445555555543
Q ss_pred CC---C---CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 CP---S---WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 ~~---~---~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.- . .++..+..+|..||.+|-+.||+..+++++||+...
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 21 1 278899999999999999999999999999999854
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=230.57 Aligned_cols=177 Identities=29% Similarity=0.424 Sum_probs=136.5
Q ss_pred EEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~g---i~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+||+||+++|+|.+++.... .+++....+|+.+++.||+|||... |+||||||+|||||++.+.||+|||+|.
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5899999999999999998765 7999999999999999999999864 9999999999999999999999999995
Q ss_pred cccccccCCccccc-cCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc------HHHHHHH-HhhcC-
Q 018052 81 ISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRK-ICRAD- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~-~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~------~~~~~~~-i~~~~- 151 (361)
..... .....+. .||.+|+|||++..... +.++||||+||+|.||++|+.|.+... ..+.... +..+.
T Consensus 226 ~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 226 LGPEG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cCCcc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 43221 2222233 89999999999876444 489999999999999999998887432 1221111 11111
Q ss_pred -----CCCC-CCCC--HH---HHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 -----FSCP-SWFS--SG---AKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 -----~~~~-~~~s--~~---~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+. ..++ .+ +..+..+|+..+|..||++.|+++
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 23 345678999999999999999754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=228.49 Aligned_cols=189 Identities=32% Similarity=0.506 Sum_probs=155.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
.+.+|-|+|||+|.+|.-++..+.-++|.+|+.++-||+.||.||.... |+|-||||.|||+- ..|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 4678999999999999999999999999999999999999999999874 99999999999994 568899999999
Q ss_pred cccccccccC---C--ccccccCCCccccccccc-c--CCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHH--H
Q 018052 79 SAISQQVRED---G--LLHTACGTPNYVAPEVLN-D--KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRK--I 147 (361)
Q Consensus 79 a~~~~~~~~~---~--~~~~~~gt~~y~APEv~~-~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~--i 147 (361)
+.++.....+ + ......||.+|++||.+. + .+..+.++||||+|||+|..+-|+-||.... ..+++.. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 9987654332 1 223467999999999764 2 3344689999999999999999999997543 3333322 2
Q ss_pred h-hcCCCCC--CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 148 C-RADFSCP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 148 ~-~~~~~~~--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ..+..+| +.+++++.++|++||.+.-++|+...++..||+|.-.
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2 2234444 5689999999999999999999999999999998743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=243.82 Aligned_cols=181 Identities=24% Similarity=0.381 Sum_probs=153.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------R----LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------~----l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~ 68 (361)
.++-+|||+|||..|||.+++.... . ++..+...++.||+.|++||-++.++||||-..|+|+.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 3567899999999999999987532 2 7788999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHH
Q 018052 69 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 147 (361)
Q Consensus 69 ~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i 147 (361)
-.+||+||||++..-............-...|||||-+.-..|. +++||||+||+|||+++ |..||.+.+..+..+.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 99999999998743211110111111224579999999888886 89999999999999997 99999999999998888
Q ss_pred hhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 148 CRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 148 ~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
..+. .+.|...+.++.+|+..||+.+|++||++.||-
T Consensus 719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 7764 678899999999999999999999999999983
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=246.10 Aligned_cols=185 Identities=29% Similarity=0.451 Sum_probs=144.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC---CCH-HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---C--CCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR---LKE-DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---Y--GVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~---l~e-~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~--~~lKl 73 (361)
++..+||.+|+|.. +|.+++...+. ... ...+..+.|+++||++||+.+|+||||||.||||+. + ..++|
T Consensus 574 d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 574 DRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred CCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEe
Confidence 56789999999976 99999998521 111 456888999999999999999999999999999976 3 46899
Q ss_pred EecCCcccccccc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhcC
Q 018052 74 SDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 74 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~ 151 (361)
+|||++....... .-....+..||-+|+|||++...... .++||+|+||++|+.++| ..||.+.-..+. .|..++
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~ 729 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGN 729 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCc
Confidence 9999997654322 12235567899999999999876554 799999999999998886 999987543322 233343
Q ss_pred CCC---CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 FSC---PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ~~~---~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+.. .+.-..++.+||.+||+++|..||++.++|.||+|=.
T Consensus 730 ~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 730 YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 322 1111128999999999999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=210.29 Aligned_cols=179 Identities=25% Similarity=0.485 Sum_probs=140.7
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAISQQV 85 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla~~~~~~ 85 (361)
--+|+||+++-+..... ..++...++.|+.||+.||.|||++||.|||+||.|+++|. .-.++|+|+|||.+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 35788999886654443 34888999999999999999999999999999999999994 56799999999986543
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCC-cccHHHHHHHHh-------------hc-
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKIC-------------RA- 150 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~-~~~~~~~~~~i~-------------~~- 150 (361)
.....-+..+..|--||.+..-+++..+-|+||+||+|..|+..+.||- +.+..+.+-+|. +.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2334556678889999999887766789999999999999999988874 333322222221 10
Q ss_pred ------------CCCCCCC-----------CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 ------------DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 ------------~~~~~~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+-.+| .++++.+|+.++|..|..+|+|+.|++.||||..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111122 4799999999999999999999999999999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=233.69 Aligned_cols=177 Identities=25% Similarity=0.458 Sum_probs=152.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..-+|||||+++.|+|..+++.+. .++......|..||+.||.|||+...+||||-..|||+.+...+|++||||++..
T Consensus 462 e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 462 EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 456899999999999999999765 6999999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCccccccC--CCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 83 QQVREDGLLHTACG--TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~g--t~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
... ...+...| ...|||||.+.-+.+. .++|||.|||++||++. |.-||.+....+..-.+.++ ..++|+.+
T Consensus 542 ed~---~yYkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC 617 (974)
T KOG4257|consen 542 EDD---AYYKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC 617 (974)
T ss_pred ccc---chhhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence 542 22222223 3469999999877775 89999999999999875 99999998777777666666 57889999
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
++.+..|+.+||+.+|.+||++.+|.
T Consensus 618 Pp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 618 PPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ChHHHHHHHHHhccCcccCCcHHHHH
Confidence 99999999999999999999987764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=235.74 Aligned_cols=170 Identities=28% Similarity=0.488 Sum_probs=134.8
Q ss_pred EEEEEEecCCCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe----cCCCEEEEecCC
Q 018052 6 KIYIVLEFIDGGELFDKIAKH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD----SYGVLKISDFGL 78 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~---~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld----~~~~lKl~DFGl 78 (361)
.-.+|||||.||||+..+... .+++|.+.+.++.++..|+.|||++||+||||||+||++- ..-..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 346899999999999999753 4799999999999999999999999999999999999993 333589999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-----HHHHHHHHhh----
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKICR---- 149 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-----~~~~~~~i~~---- 149 (361)
|+-... +....+..||+.|.|||++....+++..+|.||+||++|+..||..||-... ..-.+..+.+
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 976543 4567889999999999999865666789999999999999999999995321 1122222211
Q ss_pred ----------------cCCCCCCCCCHHH----HHHHHHccCCCcCCCC
Q 018052 150 ----------------ADFSCPSWFSSGA----KKLIKRILDPNPDTRM 178 (361)
Q Consensus 150 ----------------~~~~~~~~~s~~~----~~Li~~~L~~dP~~R~ 178 (361)
..++.|...++.+ ...+..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1233444455444 4577889999999998
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=222.09 Aligned_cols=176 Identities=24% Similarity=0.442 Sum_probs=150.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.-+|||+|||..|+|.+|+.+-. -++.-....++.||.+|++||..++++||||-..|+|+.++..+|++||||++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 45899999999999999998754 3666777788899999999999999999999999999999999999999999876
Q ss_pred cccccCCccccccC---CCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 83 QQVREDGLLHTACG---TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 83 ~~~~~~~~~~~~~g---t~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
... ..+.-.| ...|.|||-+.-..+. .++|||+|||+||++.| |--||.+.+..+.|..+.++ ...-|..
T Consensus 416 tgD----TYTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 416 TGD----TYTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred cCC----ceecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC
Confidence 431 1222223 4579999998766664 89999999999999987 89999999999999877655 4566888
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+++....|++.||+++|++||+++||-+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 9999999999999999999999998743
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=215.17 Aligned_cols=187 Identities=29% Similarity=0.493 Sum_probs=143.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla~ 80 (361)
..++++.+||||.+.-+..++... ++-.+++.|++.++.||.++|.+||+||||||.|+|.+ ..+.-.|+|||||.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 356789999999999887777665 77899999999999999999999999999999999997 56778999999997
Q ss_pred ccccc---------------c----------------cCCc-----------cccccCCCccccccccccCCCCCCchhh
Q 018052 81 ISQQV---------------R----------------EDGL-----------LHTACGTPNYVAPEVLNDKGYDGRASDV 118 (361)
Q Consensus 81 ~~~~~---------------~----------------~~~~-----------~~~~~gt~~y~APEv~~~~~~~~~~~Di 118 (361)
..... . +.+. ...+.|||+|.|||++..-+-.++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21000 0 0000 1124599999999999887777889999
Q ss_pred hhhhhHHHhHhcCCCCCCcccH-----HHHH--------HH---------Hhh-cC-------------------CCCC-
Q 018052 119 WSCGVILFVLMAGFLPFDESNL-----MALY--------RK---------ICR-AD-------------------FSCP- 155 (361)
Q Consensus 119 wS~Gvil~~ll~g~~Pf~~~~~-----~~~~--------~~---------i~~-~~-------------------~~~~- 155 (361)
||+|||+..++++..||-.... .++. ++ ++. .+ .+..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999843210 1100 00 000 00 0000
Q ss_pred ---------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 ---------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 ---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..++..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 114568899999999999999999999999999983
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=231.14 Aligned_cols=180 Identities=27% Similarity=0.482 Sum_probs=150.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~ 67 (361)
+..+++|+|||..|+|.+++...+ .++..+...+..||+.|++||++..++||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 567999999999999999998765 3888999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCccccccCCC--ccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCccc-HHHH
Q 018052 68 YGVLKISDFGLSAISQQVREDGLLHTACGTP--NYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESN-LMAL 143 (361)
Q Consensus 68 ~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~--~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~-~~~~ 143 (361)
+..+||+|||+|+......... .....|+. .|||||.+....|. .++||||+||+|||+++ |..||.+.. ..++
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999997433211110 01122223 49999999986665 89999999999999987 899999855 5566
Q ss_pred HHHHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 144 YRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 144 ~~~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+..+. ...|.++++++.++++.||+.+|++||++.++.+
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 76666664 4778889999999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=231.33 Aligned_cols=179 Identities=23% Similarity=0.412 Sum_probs=156.6
Q ss_pred EEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
-+-||.|||++|+|..+++. ++.|+..+..-+++.|+.|+.||-+.|.+||||-..|||++.+-.+|++||||+++.+.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 46689999999999999986 46799999999999999999999999999999999999999999999999999997765
Q ss_pred cccCCccccccCC--CccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 85 VREDGLLHTACGT--PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 85 ~~~~~~~~~~~gt--~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.. .....+..|- ..|.|||.+..+.+. .++||||+||++||.++ |..||-+.+..+..+.|..+ ..+.|..++.
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 43 2333444443 469999999988886 79999999999999876 99999999999998888765 4566667999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.+|+..||++|-..||+++||+.+
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=215.57 Aligned_cols=62 Identities=32% Similarity=0.595 Sum_probs=57.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLL 65 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLl 65 (361)
...|+|||+|+. |.+|..+|... .+++...++.+++|++.||.|||.. ||+|-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 356999999999 88999999875 4799999999999999999999976 99999999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=246.56 Aligned_cols=173 Identities=23% Similarity=0.332 Sum_probs=132.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH---SRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH---~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+....|+||||++||+|.+++.. +++..+..++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 45678999999999999999964 899999999999999999999 6699999999999999999988876 6654
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-----HHHHHHHHhhc----
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-----LMALYRKICRA---- 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~---- 150 (361)
..... .....||+.|+|||++.+..|. .++||||+||++|||++|+.||+... ...........
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchh
Confidence 33211 1234688999999999887775 89999999999999999999996421 11111110000
Q ss_pred ---CCCC------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 ---DFSC------PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ---~~~~------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+... +.....++.+++.+||..||++|||+.|+++.
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000 00112346789999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=223.96 Aligned_cols=187 Identities=28% Similarity=0.472 Sum_probs=159.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.++|++||||.||+|.+.-+-.+.++|.++....+..+.||.|||++|-+|||||-.|||+++.|.+|++|||.+...
T Consensus 83 r~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence 35689999999999999998887889999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC---
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS--- 156 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--- 156 (361)
... -.....+.|||.|||||+.. ..+|. ..+|||++|+.-.++---++|..+...+.......+..+..|.
T Consensus 163 tat--i~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 163 TAT--IAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD 239 (829)
T ss_pred hhh--hhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence 321 12345678999999999853 44565 8999999999999998888887777666666656666665543
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++.+.+|++.+|..+|++|||++.+|+|||....
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 368999999999999999999999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=193.71 Aligned_cols=142 Identities=31% Similarity=0.605 Sum_probs=115.6
Q ss_pred cCcEEEEEEecCCCCChHH----HHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFD----KIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~----~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
....+|+.||.|.. +|.. .+..++.++|...-+++.-++.||.|||++ .|+|||+||+|||++.+|.+|+||||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 34579999999965 7754 344567899999999999999999999987 79999999999999999999999999
Q ss_pred CcccccccccCCcccc-ccCCCccccccccc----cCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhc
Q 018052 78 LSAISQQVREDGLLHT-ACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRA 150 (361)
Q Consensus 78 la~~~~~~~~~~~~~~-~~gt~~y~APEv~~----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~ 150 (361)
.+.... ++...+ ..|..+|+|||.+. ..+|+ -++||||+|+.+.||.+++.||+. .+.-+.++++...
T Consensus 195 IsG~L~----dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 195 ISGYLV----DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cceeeh----hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 987543 233334 57889999999874 33565 899999999999999999999975 3444555555543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=199.02 Aligned_cols=186 Identities=28% Similarity=0.489 Sum_probs=142.3
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cCCCEEEEecCC
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGL 78 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld--~~~~lKl~DFGl 78 (361)
|+|-+.++++||||+.|+|.+-+.. .++.|.....++.|+++|++|||+++++|||||.+||||- +.-.+|+||||+
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 4567788899999999999998876 5699999999999999999999999999999999999994 334799999999
Q ss_pred cccccccccCCccccccCCCccccccccccCC---C-CCCchhhhhhhhHHHhHhcCCCCCCcccHHH----HHHHHh-h
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKG---Y-DGRASDVWSCGVILFVLMAGFLPFDESNLMA----LYRKIC-R 149 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~-~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~----~~~~i~-~ 149 (361)
+... +.......-+-.|-|||++.... + -....|+|.+||++|.+|+|.+||.....++ .+.++. +
T Consensus 170 t~k~-----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 170 TRKV-----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred cccc-----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 7643 22333344566899999764322 1 1367899999999999999999997543221 222222 2
Q ss_pred cCCCCCC---CCCHHHHHHHHHccCCCcCCC---CCHHHHHhCcccccC
Q 018052 150 ADFSCPS---WFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKKG 192 (361)
Q Consensus 150 ~~~~~~~---~~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f~~~ 192 (361)
.....|. .+|+.+..+.++-|.++|++| .++......-|....
T Consensus 245 k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 245 KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 2333443 379999999999999999999 455556666776643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=220.54 Aligned_cols=184 Identities=28% Similarity=0.408 Sum_probs=155.5
Q ss_pred EEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.+-||||+|++|+|.+.+.+. ..|-......|+.||+.|+.||.+++.|||||-..|+|+-....+||+||||.+-..
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 456899999999999999873 357788899999999999999999999999999999999999999999999987654
Q ss_pred ccccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 84 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
...... +.....-...|.|||.+....+. .++|+|++||.+|||++ |+.||.+.+...+++++-.+ ..+-|..+++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 322111 11112234579999999988886 89999999999999998 79999999999999988754 4677888999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+.+++..||..+|.+|||+..|.+.-+..
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999999997655444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=215.85 Aligned_cols=181 Identities=22% Similarity=0.289 Sum_probs=145.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+-++|||||++.|+|.+++.++. ...-....+++.||++|++||.+.+++||||.+.|||+|.++++||+|||+|+.
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 456899999999999999999874 335566778999999999999999999999999999999999999999999974
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHh--cCCCCCCcccHHHHHHHHhhc--------C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM--AGFLPFDESNLMALYRKICRA--------D 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll--~g~~Pf~~~~~~~~~~~i~~~--------~ 151 (361)
.-............-...|||||.+....+. .++|+|++|+.+||++ +...||...+.++..+....- .
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence 3221111111112234679999998877775 8999999999999874 679999988777766654321 2
Q ss_pred CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 ~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.|+-++.++.+|+.+||..+-++|||++++-.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 3456778999999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=215.55 Aligned_cols=132 Identities=34% Similarity=0.653 Sum_probs=122.5
Q ss_pred CCcCcEEEEEEecC-CCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 1 MASKTKIYIVLEFI-DGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 1 ~~s~~~~~lV~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
||+...+||+||-- +|-+||++|.-..+++|.++..+|+|++.|+++||++||+|||||-||+.++.+|.+||+|||.|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 68899999999975 57799999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 136 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~ 136 (361)
...+ .+......||..|.|||++.+.+|-|.+.|||++||+||.++-..-||-
T Consensus 718 a~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7654 3556788999999999999999999999999999999999998888874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=185.62 Aligned_cols=151 Identities=46% Similarity=0.838 Sum_probs=131.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla~~ 81 (361)
....+++|||+.|++|.+++... ..++...+..++.+++.++.+||++|++|+||+|.||+++. .+.++|+|||.+..
T Consensus 63 ~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 63 ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 46789999999999999999875 47999999999999999999999999999999999999999 89999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
...... ......++..|++||.+......+.+.|+|++|+++++| ..
T Consensus 143 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~ 189 (215)
T cd00180 143 LTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PE 189 (215)
T ss_pred ccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HH
Confidence 533211 133456788999999987752445889999999999998 67
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
+.+++.+||..+|++||++.++++|+
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 88999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=218.26 Aligned_cols=178 Identities=35% Similarity=0.666 Sum_probs=161.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.++.++|+++++..||+|+..+.+...+.+...+.|...++.+++++|+.||+|||+|++||+++.+|++|+.|||++.
T Consensus 66 fqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglsk 145 (612)
T KOG0603|consen 66 FQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSK 145 (612)
T ss_pred eccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhh
Confidence 46889999999999999999999988899999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
..-.. ...|||..|||||++. ++. ..+|.||+|++.++|++|..||.+ +....|.+..+..|..++.
T Consensus 146 e~v~~------~~~cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 146 EAVKE------KIACGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSA 212 (612)
T ss_pred HhHhh------hhcccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhH
Confidence 54321 1229999999999998 443 788999999999999999999988 6777788888999999999
Q ss_pred HHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
.+++++..++..+|..|.- ..++++|++|+.
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 9999999999999999975 589999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=198.40 Aligned_cols=180 Identities=24% Similarity=0.501 Sum_probs=141.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEecCCCEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~--------gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
+.+|||.+|-+.|+|+|++.. ..++.+.+.+++.-+++||++||.. .|+|||||..|||+..+|..-|+|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 589999999999999999998 6799999999999999999999963 3999999999999999999999999
Q ss_pred CCccccccccc--CCccccccCCCccccccccccCC----CC-CCchhhhhhhhHHHhHhc-----C-----CCCCCc--
Q 018052 77 GLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKG----YD-GRASDVWSCGVILFVLMA-----G-----FLPFDE-- 137 (361)
Q Consensus 77 Gla~~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~----~~-~~~~DiwS~Gvil~~ll~-----g-----~~Pf~~-- 137 (361)
|||........ +-..+..+||..|||||++...- +. -..+||||+|.++||+.. | ++||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99976544321 23456789999999999985431 11 146899999999999864 2 678853
Q ss_pred ---ccHHHHHHHHhhc--CCCCCC-CCCHH----HHHHHHHccCCCcCCCCCHHHHHh
Q 018052 138 ---SNLMALYRKICRA--DFSCPS-WFSSG----AKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 138 ---~~~~~~~~~i~~~--~~~~~~-~~s~~----~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+++.+-++-. ..+.|. |-+.+ +..|++.||..||.-|.|+-.|.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 5555555544432 334443 44433 346899999999999999887754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=199.64 Aligned_cols=179 Identities=25% Similarity=0.389 Sum_probs=142.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCCCCcEEEecCCCEEEE
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLLDSYGVLKIS 74 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~---------gi~HrDiKp~NiLld~~~~lKl~ 74 (361)
+..++||+||-+.|+|.+++.. ..++.....+++.-++.||+|||+. .|+|||||..|||+.++++.-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 5579999999999999999987 4699999999999999999999973 49999999999999999999999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCC-----CCchhhhhhhhHHHhHhcC------------CCCCC-
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG------------FLPFD- 136 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~-----~~~~DiwS~Gvil~~ll~g------------~~Pf~- 136 (361)
|||||..+....+.+......||..|||||++.+.-.- -...||||+|.+||||++. ++||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999988776666777778999999999998764321 1368999999999999863 23443
Q ss_pred ----cccHHHHHHHHhh--cCCCCCC-C----CCHHHHHHHHHccCCCcCCCCCHHHH
Q 018052 137 ----ESNLMALYRKICR--ADFSCPS-W----FSSGAKKLIKRILDPNPDTRMTISQM 183 (361)
Q Consensus 137 ----~~~~~~~~~~i~~--~~~~~~~-~----~s~~~~~Li~~~L~~dP~~R~t~~ei 183 (361)
.++.+++...... ....+|. | .-..+.+.+..||+.||+.|+|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2334444443332 3333443 2 23567889999999999999997544
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=208.75 Aligned_cols=178 Identities=23% Similarity=0.374 Sum_probs=154.1
Q ss_pred EEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
+-||++|+++|.|.++++.+. .+.......|..||++|+.|||.++++||||-..|+|+.+...+||.|||+|......
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 557899999999999998764 7999999999999999999999999999999999999999999999999999876554
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHHHH
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAK 163 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 163 (361)
...-......-.+.|+|=|.+....|. .++||||+||.+||++| |..|+++....++-..+..+ ..+.|+..+.++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 333222223335679999999888886 89999999999999998 99999998888777666555 4778899999999
Q ss_pred HHHHHccCCCcCCCCCHHHHHh
Q 018052 164 KLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 164 ~Li~~~L~~dP~~R~t~~eil~ 185 (361)
-++.+||..|+..||++.++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999988754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=180.16 Aligned_cols=149 Identities=44% Similarity=0.758 Sum_probs=124.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....|+++||+.+++|.+++..... +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++...
T Consensus 69 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 69 PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 4678999999999999999988766 899999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCcccccccc-ccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccH-HHHHHHHhhcCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNL-MALYRKICRADFSC 154 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~-~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~-~~~~~~i~~~~~~~ 154 (361)
..... .......++..|++||.+ ....+. .++|+|++|+++++|++|+.||.. .+. ..+.+.+..+....
T Consensus 149 ~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 149 HRDLA-ALLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred cCccc-ccccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 43221 123456788899999998 444554 689999999999999999999987 444 46667666655433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=188.12 Aligned_cols=181 Identities=22% Similarity=0.284 Sum_probs=149.7
Q ss_pred CcEEEEEEecCCCCChHHHHH-----hC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEe
Q 018052 4 KTKIYIVLEFIDGGELFDKIA-----KH---GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 75 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~-----~~---~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~D 75 (361)
...-++++.+..-|+|..++. .. ..++..+...++.|+..|++|||++||+|.||-..|++||+.-.+||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 345577888888899999887 11 1377788889999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCC
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFS 153 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~ 153 (361)
=.|++..........-..-.....||+||.+....|. .++|+|||||+||||++ |+.|+.+.++.++..-+..+ ...
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla 518 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA 518 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence 9998754322211111112235579999999988886 89999999999999987 99999999888887776665 456
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.|-+++.++..++..||...|++||+++|+..
T Consensus 519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 67889999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-24 Score=214.65 Aligned_cols=342 Identities=25% Similarity=0.384 Sum_probs=231.4
Q ss_pred cCcEEEEEEecCCCCChHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecCC-CEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKI-AKHG-RLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYG-VLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~ql~~gl~~lH-~~gi~HrDiKp~NiLld~~~-~lKl~DFGl 78 (361)
+....++++||+.||++++.+ ..+. ..+...+..++.|+..|+.|+| ..++.||||||+|.+++..+ ++|++|||+
T Consensus 92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 92 SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchh
Confidence 456788999999999999999 7666 7899999999999999999999 99999999999999999999 999999999
Q ss_pred cccccc-cccCCccccccC-CCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH-HHHhhc--CCC
Q 018052 79 SAISQQ-VREDGLLHTACG-TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKICRA--DFS 153 (361)
Q Consensus 79 a~~~~~-~~~~~~~~~~~g-t~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~-~~i~~~--~~~ 153 (361)
|+.+.. .+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||......... ..+... .+.
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 998877 556667788899 999999999998889999999999999999999999999876544322 222211 222
Q ss_pred CCCC--CCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc-CCCCCCCC-cccccCcchhh-----------hhh-cccc
Q 018052 154 CPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK-GYKPPHFD-KEEEVNLDDVD-----------AIF-NDSK 217 (361)
Q Consensus 154 ~~~~--~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~-~~~~~~~~-~~~~~~~~~~~-----------~~~-~~~~ 217 (361)
..+| ++..+.+++.++|..+|..|.+.+++..+||+.. ........ ........... .+. ....
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~ 331 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAY 331 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccceeeeccc
Confidence 3333 7889999999999999999999999999999987 11100000 00000000000 000 0000
Q ss_pred c--------cccccccCCC-C----CCCh---h-h-hh-------ccCCCCCCccc------------hhhh-ccccccc
Q 018052 218 E--------NLVTEKKEKP-V----SMNA---F-E-LI-------SRTKSFSLENL------------FEKQ-TGLVKRE 259 (361)
Q Consensus 218 ~--------~~~~~~~~~~-~----~~~~---~-~-~i-------~~~~~~~~~~~------------~~~~-~~~~~~~ 259 (361)
. ......+... . .... + . ++ ++++......+ .+.- .++....
T Consensus 332 g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~ 411 (601)
T KOG0590|consen 332 GSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLV 411 (601)
T ss_pred CceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHH
Confidence 0 0000000000 0 0000 0 0 00 00111100000 0000 1233455
Q ss_pred ce--eeeCCChhHHHHHHH---HHhcccCcEEEe-cCceeEEeeccCCCCCceE----EEEEEEEEeCC---eEEEEEEe
Q 018052 260 TR--FTSQRPPNEIMSKIE---EAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLS----VATEVFEVAPT---LHIVEVRK 326 (361)
Q Consensus 260 tr--f~s~~~~~~i~~~l~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~----~~~~i~~~~~~---~~~vdf~~ 326 (361)
++ |.+..++...++.|. +.+..+|+.-+. +...+.+.. +|.|. +..++|.++.+ ...+++..
T Consensus 412 ~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~-----~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~g 486 (601)
T KOG0590|consen 412 MSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE-----NGILKIIDFGAASVFRYPWEKNIHESSGIVG 486 (601)
T ss_pred hcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec-----CCceEEeecCcceeeccCcchhhhhhcCccc
Confidence 66 899999999999999 667788887654 222222211 11222 35677888765 56799999
Q ss_pred cCC-------CchhHHHHHHHHHhcccccc
Q 018052 327 TGG-------DTLEFHKFYKKFSSGLKDVV 349 (361)
Q Consensus 327 ~~G-------d~le~~~~~~~l~~~l~div 349 (361)
+++ ++.||+.++..+-..--+.+
T Consensus 487 S~pY~apE~~~~~~ydpr~vDiwS~~ii~~ 516 (601)
T KOG0590|consen 487 SDPYLAPEVLTGKEYDPRAVDVWSCGIIYI 516 (601)
T ss_pred CCcCcCcccccccccCcchhhhhhccceEE
Confidence 999 99999999998888744444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=178.80 Aligned_cols=189 Identities=37% Similarity=0.653 Sum_probs=153.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla 79 (361)
....+++++|+.|++|.+.+.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 344799999999999998887765 799999999999999999999999999999999999999988 6999999998
Q ss_pred ccccccccC----CccccccCCCccccccccccC--CCCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhh
Q 018052 80 AISQQVRED----GLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICR 149 (361)
Q Consensus 80 ~~~~~~~~~----~~~~~~~gt~~y~APEv~~~~--~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~ 149 (361)
......... ......+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 754432221 134678899999999999874 4556899999999999999999999887653 455554444
Q ss_pred cCCC-CCCCCC--------HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 150 ADFS-CPSWFS--------SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 150 ~~~~-~~~~~s--------~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.... ...... ..+.+++.+++..+|..|.+..+...++|....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 4433 222221 478899999999999999999999988766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=205.64 Aligned_cols=150 Identities=36% Similarity=0.684 Sum_probs=128.2
Q ss_pred HHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccccc-----C--------CccccccCCCccccccccc
Q 018052 41 LINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-----D--------GLLHTACGTPNYVAPEVLN 107 (361)
Q Consensus 41 l~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~-----~--------~~~~~~~gt~~y~APEv~~ 107 (361)
++.+++|+|+.||+|||+||+|++|+.-|.+|+.|||++...-.... + -.-...||||.|.||||+.
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 37899999999999999999999999999999999999864211100 0 0113459999999999999
Q ss_pred cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCC---CCHHHHHHHHHccCCCcCCCC---CHH
Q 018052 108 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW---FSSGAKKLIKRILDPNPDTRM---TIS 181 (361)
Q Consensus 108 ~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~s~~~~~Li~~~L~~dP~~R~---t~~ 181 (361)
..+| |.++|+|++|+|+|+++.|..||.+.+.++++..+.......|.. ++++++++|.++|+.+|..|. .+-
T Consensus 232 rqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 232 RQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 9888 699999999999999999999999999999999887766655543 689999999999999999995 477
Q ss_pred HHHhCccccc
Q 018052 182 QMLEDEWFKK 191 (361)
Q Consensus 182 eil~h~~f~~ 191 (361)
++.+|+||+.
T Consensus 311 evk~h~ff~~ 320 (1205)
T KOG0606|consen 311 EVKQHGFFQL 320 (1205)
T ss_pred hhhhccceee
Confidence 8899999985
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-20 Score=180.14 Aligned_cols=178 Identities=25% Similarity=0.410 Sum_probs=136.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..+|+.|++|+-++|.++|.+.. ..+....+.++.|+..|++| +|.+|||+||.||+...++.+||.|||+.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46899999999999999997543 35667899999999999999 9999999999999999999999999999875
Q ss_pred ccccc----cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCCCCCC
Q 018052 82 SQQVR----EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFSCPS 156 (361)
Q Consensus 82 ~~~~~----~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 156 (361)
..... .........||..||+||.+.+..|. .++||||||+||++|+. =..++.. ...+..+..+.++...
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH
Confidence 44332 11123456799999999999998886 99999999999999986 2222221 1222222223222111
Q ss_pred CC-CHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 157 WF-SSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 157 ~~-s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
+. -+....|+.+||.+.|.+||++.+.--|+|.
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 21 2456689999999999999988887777764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=162.96 Aligned_cols=176 Identities=23% Similarity=0.350 Sum_probs=132.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cCC--CEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYG--VLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld--~~~--~lKl~DFGl 78 (361)
....+|+||.-... +|.+++..+ ..+....+-++.|+++|+.|||.+||.|||+|.+|||+. +++ .+.|+|||.
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 35689999999866 999988763 467778888999999999999999999999999999993 333 589999997
Q ss_pred ccccccc----ccCCccccccCCCccccccccccCC-----CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHH--
Q 018052 79 SAISQQV----REDGLLHTACGTPNYVAPEVLNDKG-----YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI-- 147 (361)
Q Consensus 79 a~~~~~~----~~~~~~~~~~gt~~y~APEv~~~~~-----~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i-- 147 (361)
+---... .-.+..-...|...-||||+....+ .+-.++|.|++|-+-||++...-||.+...+.+-...
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 6321110 0111223456888999999976443 1225899999999999999999999774433221111
Q ss_pred hhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCH
Q 018052 148 CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180 (361)
Q Consensus 148 ~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~ 180 (361)
...-...|..+++.+++|+..+|+.||++|++.
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 122345677789999999999999999999984
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-19 Score=162.97 Aligned_cols=159 Identities=30% Similarity=0.426 Sum_probs=104.5
Q ss_pred EEEEEecCCCCChHHHHHh---CCCC---CHHHHHH-HHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 7 IYIVLEFIDGGELFDKIAK---HGRL---KEDEARR-YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~---~~~l---~e~~~~~-~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+++|+-+.+ +|.+.+.- .... ....|+. +..|++..+++||++|++|+||||+|++++.+|.++|+||+..
T Consensus 114 ~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 4788898855 88877552 2222 1223433 3489999999999999999999999999999999999999865
Q ss_pred ccccccccCCccccccCCCccccccccccC--------CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDK--------GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~--------~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
...+. .......+..|.+||..... .+ +.+.|.|++|+++|.|.+|..||+.......... .
T Consensus 193 ~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~ 262 (288)
T PF14531_consen 193 VRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----D 262 (288)
T ss_dssp EETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----G
T ss_pred eecCc-----eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHHccCCCCCCCccccccc----c
Confidence 43222 11113345779999987543 23 4788999999999999999999986543322111 2
Q ss_pred C-CCCCCCCHHHHHHHHHccCCCcCCC
Q 018052 152 F-SCPSWFSSGAKKLIKRILDPNPDTR 177 (361)
Q Consensus 152 ~-~~~~~~s~~~~~Li~~~L~~dP~~R 177 (361)
+ .+. .+++..+.||+++|+.||.+|
T Consensus 263 f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 263 FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2 233 688999999999999999988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-17 Score=158.84 Aligned_cols=182 Identities=25% Similarity=0.338 Sum_probs=138.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-----CCEEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISD 75 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-----~~lKl~D 75 (361)
+...-||||+++ |-+|.+..... ++++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 345679999998 88999987543 579999999999999999999999999999999999999765 4699999
Q ss_pred cCCcccccccccCC-------c-cccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH---HHH
Q 018052 76 FGLSAISQQVREDG-------L-LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---ALY 144 (361)
Q Consensus 76 FGla~~~~~~~~~~-------~-~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~---~~~ 144 (361)
||+|..+......+ . .....||..|.++....+... +...|+||++-++.+|+.|.+||...... ..+
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 99998433211111 1 123459999999998877665 58999999999999999999999775532 222
Q ss_pred HHHhhcCCC--CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~~~~--~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+....... .....+.++..+...+-..+...+|....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222222111 223345677777777777899999998887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-19 Score=181.65 Aligned_cols=171 Identities=26% Similarity=0.398 Sum_probs=128.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc-
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ- 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~- 83 (361)
.--|||=+|+.. +|+|.+....-+..-+-+.++.||+.||..||..||+|+|||.||||++.-+-+.|+||..-+..-
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence 334677778865 999999887778888899999999999999999999999999999999999999999997543211
Q ss_pred -ccccCC---ccccccCCCccccccccccCC-C---------CCCchhhhhhhhHHHhHhc-CCCCCCccc---------
Q 018052 84 -QVREDG---LLHTACGTPNYVAPEVLNDKG-Y---------DGRASDVWSCGVILFVLMA-GFLPFDESN--------- 139 (361)
Q Consensus 84 -~~~~~~---~~~~~~gt~~y~APEv~~~~~-~---------~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~--------- 139 (361)
..++.. ...|...-..|+|||-+.... + -.++-||||+||++.||++ |++||.-..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 111111 112233345799999876422 1 1357899999999999976 789885321
Q ss_pred --HHHHHHHHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 140 --LMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 140 --~~~~~~~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
....+++| -+..+++||..|++.||++|.++++.|+-
T Consensus 253 ~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11222222 14578999999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=161.84 Aligned_cols=181 Identities=22% Similarity=0.376 Sum_probs=140.0
Q ss_pred cEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-EecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGV-FHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi-~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..+++|.+||.-|+|.|.+.. ...++.-....++++++.|+.|+|+..| +|+.+++.|+++|..-.+|++|||+....
T Consensus 20 ~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 20 PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccc
Confidence 678999999999999999987 3468888888899999999999998876 99999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCC------CCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhh-cC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYD------GRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICR-AD 151 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~------~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~-~~ 151 (361)
.............-...|.|||.+...... +.++|+||+|++++++++...||+.. +..++..++.. +.
T Consensus 100 ~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~ 179 (484)
T KOG1023|consen 100 EETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGS 179 (484)
T ss_pred cccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCC
Confidence 321111111222234579999998765322 45789999999999999999999762 22345555555 32
Q ss_pred CCCCCC------CCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 FSCPSW------FSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 ~~~~~~------~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+.+. ..+++..+++.||..+|..||+++++..
T Consensus 180 ~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 180 NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 222222 3456889999999999999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.5e-18 Score=161.71 Aligned_cols=98 Identities=23% Similarity=0.287 Sum_probs=78.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDi-Kp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.+.|+|||||+|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|....
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 35799999999999973 221 11 1568899999999999999999999 9999999999999999999998765
Q ss_pred ccccCCc------cccccCCCccccccccccC
Q 018052 84 QVREDGL------LHTACGTPNYVAPEVLNDK 109 (361)
Q Consensus 84 ~~~~~~~------~~~~~gt~~y~APEv~~~~ 109 (361)
..+.... ..+.++++.|+|||.+...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 4332222 2467899999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.7e-17 Score=145.43 Aligned_cols=173 Identities=23% Similarity=0.362 Sum_probs=141.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEE--ec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKIS--DF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~--DF 76 (361)
++.++.+|..||+.|+|+..+.++.. ++..++.+++.+++.|++|||+.. |----+....+++|++-+.+|+ |-
T Consensus 258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 56788999999999999999998654 678899999999999999999975 4444788999999998877764 43
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCC--CCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhh--cCC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR--ADF 152 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~--~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~ 152 (361)
-++. + .....-+|.|++||.++.++-+ -.++|+|||+|++|+|.|...||.+-+.++.-.++.- -..
T Consensus 338 kfsf--q-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv 408 (448)
T KOG0195|consen 338 KFSF--Q-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV 408 (448)
T ss_pred eeee--e-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence 2221 1 1123347899999999877654 3589999999999999999999999888776655532 356
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHH
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil 184 (361)
..|+.++.....|+.-|++.||.+||.++.|+
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 78999999999999999999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=139.99 Aligned_cols=75 Identities=29% Similarity=0.354 Sum_probs=67.1
Q ss_pred EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~l-H~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
||||||++|+++...+...+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++|+|||+|....
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 89999999988876655567899999999999999999999 699999999999999998 4889999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=139.65 Aligned_cols=125 Identities=18% Similarity=0.197 Sum_probs=93.3
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC-CCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL-KPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDi-Kp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..|++|||+.|.+|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++.+|.++|+|||+|.....
T Consensus 72 ~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred CEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 46999999999999754322 1 2357899999999999999999999 79999999999999999999985443
Q ss_pred cccC-Cc----------cccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCc
Q 018052 85 VRED-GL----------LHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDE 137 (361)
Q Consensus 85 ~~~~-~~----------~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~ 137 (361)
.... .. ......++.|++|+--.-.. ..-...++++.|.-+|.++|+..|+-+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2210 00 11234688899997532211 111456888999999999999888744
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-16 Score=136.12 Aligned_cols=75 Identities=25% Similarity=0.316 Sum_probs=66.5
Q ss_pred EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
||||||++|+++........++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.++|+|||+|....
T Consensus 93 ~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 93 VLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 8999999998665544445678999999999999999999999 9999999999999999 7999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-15 Score=131.84 Aligned_cols=175 Identities=23% Similarity=0.339 Sum_probs=132.0
Q ss_pred CcEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGla 79 (361)
+..-.||||+. |-+|.+... -..+++...+.-++.|++.-++|+|.++++||||||+|.|.. ....+.++|||||
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 44557999998 778877654 245699999999999999999999999999999999999995 3456999999999
Q ss_pred ccccccccCC-----ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHhhcC
Q 018052 80 AISQQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRAD 151 (361)
Q Consensus 80 ~~~~~~~~~~-----~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 151 (361)
.......... .-....||..|.+--...+... +..-|+=|+|.+|.++..|.+||.+. +..+.+++|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 8765443321 2234568999988665544333 47789999999999999999999874 3456677776665
Q ss_pred CCCCC-----CCCHHHHHHHHHccCCCcCCCCCH
Q 018052 152 FSCPS-----WFSSGAKKLIKRILDPNPDTRMTI 180 (361)
Q Consensus 152 ~~~~~-----~~s~~~~~Li~~~L~~dP~~R~t~ 180 (361)
.+.|. .+|.++.-.+.-|-..--++-|..
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 55443 367777777777765555555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-16 Score=160.97 Aligned_cols=189 Identities=31% Similarity=0.538 Sum_probs=161.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.++..+++++|+.||+|...++..+..+++-++.++..+..+++|||+..+.|||++|.|+|...+|..+++|||.....
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999843211
Q ss_pred ccc----------------------c-----cC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCC
Q 018052 83 QQV----------------------R-----ED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL 133 (361)
Q Consensus 83 ~~~----------------------~-----~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~ 133 (361)
... . .+ .......||+.|.|||...+... +..+|+|+.|+++++.++|.+
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCC
Confidence 100 0 00 11233468999999999988766 488999999999999999999
Q ss_pred CCCcccHHHHHHHHhhcCCCCCC---CCCHHHHHHHHHccCCCcCCCCCHH---HHHhCcccccC
Q 018052 134 PFDESNLMALYRKICRADFSCPS---WFSSGAKKLIKRILDPNPDTRMTIS---QMLEDEWFKKG 192 (361)
Q Consensus 134 Pf~~~~~~~~~~~i~~~~~~~~~---~~s~~~~~Li~~~L~~dP~~R~t~~---eil~h~~f~~~ 192 (361)
||+.......++.+.+...+.|. ..+.++++++..+|..+|.+|..+. +.-.|++|+..
T Consensus 1034 p~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred CCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 99999999999988877766554 3789999999999999999999887 88999999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-16 Score=139.46 Aligned_cols=101 Identities=20% Similarity=0.358 Sum_probs=77.8
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
...||||||++|.+|.+... ++++ ...+++.+|..||+.|++|||+||+||+++.+| ++|+|||.+.....
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred CCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence 45899999999999987632 3432 456999999999999999999999999999988 99999998754321
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHh
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLM 129 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll 129 (361)
... . ..+...+.|+ .++|+||+|+.+..+.
T Consensus 187 ~~a----~----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKA----K----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhh----H----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 110 0 1134455676 8899999999887653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.5e-15 Score=134.35 Aligned_cols=170 Identities=21% Similarity=0.349 Sum_probs=126.6
Q ss_pred EEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-----CCEEEEecCCccc
Q 018052 8 YIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-----GVLKISDFGLSAI 81 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-----~~lKl~DFGla~~ 81 (361)
.||||+. |-+|.|+.. -+.+|+...+.-++.|++.-++|+|++.+|.|||||+|.||... ..+.|+|||+|..
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 4799998 777776554 24579999999999999999999999999999999999999644 3589999999987
Q ss_pred ccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc---ccHHHHHHHHhhcCCC
Q 018052 82 SQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFS 153 (361)
Q Consensus 82 ~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~ 153 (361)
....... +......||..||+=-...++.. +..-|+=|+|-+++++|.|.+||.+ .+..+-|++|-.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 6543221 22345679999999887777665 4788999999999999999999987 5566777777554333
Q ss_pred CC-----CCCCHHHHHHHHHccCCCcCCCCC
Q 018052 154 CP-----SWFSSGAKKLIKRILDPNPDTRMT 179 (361)
Q Consensus 154 ~~-----~~~s~~~~~Li~~~L~~dP~~R~t 179 (361)
.| ..++.++..-++-.-..+-.+-|.
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 32 125555555544443344444444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-15 Score=155.49 Aligned_cols=167 Identities=20% Similarity=0.303 Sum_probs=132.8
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-------cCCCEEEEecCC
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-------SYGVLKISDFGL 78 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-------~~~~lKl~DFGl 78 (361)
.-++|+||.+.|+|.+++...+.+++..+..+..|++.-|+.||..||||+||||+|+||. ..-.++|+|||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 4579999999999999999888999999999999999999999999999999999999993 344699999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-----CC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-----FS 153 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-----~~ 153 (361)
|--+.-...+..+...++|-.+-.+|+..++++. ..+|.|.++-+++.||.|+.- + ...+. ..
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~ 915 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTN 915 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceecccc
Confidence 9766655555577888999999999999999996 899999999999999988541 1 11221 11
Q ss_pred CCCCCCHH-HHHHHHHccCCCcCCCCCHHHHH
Q 018052 154 CPSWFSSG-AKKLIKRILDPNPDTRMTISQML 184 (361)
Q Consensus 154 ~~~~~s~~-~~~Li~~~L~~dP~~R~t~~eil 184 (361)
++.++..+ ..+++..+|+.|-..=|.+.++.
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 33333333 34688888885544445555553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=5e-14 Score=128.26 Aligned_cols=75 Identities=25% Similarity=0.356 Sum_probs=66.6
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g-i~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..|+||||+.|++|.........+.+..+..++.|++.+|.+||++| |+||||||+||+++ ++.++|+|||+|..
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 35899999999888776655566777788999999999999999999 99999999999999 88999999998764
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.7e-13 Score=96.44 Aligned_cols=62 Identities=56% Similarity=0.883 Sum_probs=49.1
Q ss_pred CCCCCChhhhhccCCCCCCccchhhhcc-cccccceeeeCCChhHHHHHHHHHhcccCcEEEe
Q 018052 227 KPVSMNAFELISRTKSFSLENLFEKQTG-LVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK 288 (361)
Q Consensus 227 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~ 288 (361)
+|..+|||++|++|+++||++||+.... .+++.+||+|..|++.|+++||++++.+|+.|++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3668899999999999999999987554 4678999999999999999999999999999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.7e-13 Score=118.44 Aligned_cols=71 Identities=21% Similarity=0.306 Sum_probs=57.8
Q ss_pred EEE-EEEec--CCCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcEecCCCCCcEEEec----CCCEEEEecC
Q 018052 6 KIY-IVLEF--IDGGELFDKIAKHGRLKEDEARRYFQQLINAV-DYCHSRGVFHRDLKPENLLLDS----YGVLKISDFG 77 (361)
Q Consensus 6 ~~~-lV~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl-~~lH~~gi~HrDiKp~NiLld~----~~~lKl~DFG 77 (361)
.+| +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 334 78999 667999999976 457766 46688888888 9999999999999999999974 3379999954
Q ss_pred Cc
Q 018052 78 LS 79 (361)
Q Consensus 78 la 79 (361)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.8e-12 Score=115.37 Aligned_cols=73 Identities=33% Similarity=0.536 Sum_probs=65.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..++||||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 4567899999999999999876432 7889999999999999999999999999999999 78999999998764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=118.12 Aligned_cols=69 Identities=30% Similarity=0.548 Sum_probs=60.3
Q ss_pred EEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 8 YIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 8 ~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++||||++| ++|.+++.. ..+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 599999997 689888765 4566553 57899999999999999999999999999999999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=116.29 Aligned_cols=73 Identities=22% Similarity=0.405 Sum_probs=62.7
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||++|++|...... ..+..++.+++.++.++|+.||+||||||+||++++++.++|+|||++....
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 345899999999998765331 3567788999999999999999999999999999999999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=114.21 Aligned_cols=69 Identities=29% Similarity=0.476 Sum_probs=61.5
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+..++||||++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 456899999999999988765321 7899999999999999999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.9e-12 Score=128.01 Aligned_cols=69 Identities=28% Similarity=0.445 Sum_probs=62.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....|+||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+|..
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 345789999999999999875 457789999999999999999999999999999 678999999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-11 Score=112.88 Aligned_cols=185 Identities=16% Similarity=0.291 Sum_probs=127.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEe
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISD 75 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~D 75 (361)
+.+.++.++.||+..|+|..++++. ..+....-.+|+.||++||.|||+-. |+|+++..+.|++..+|-+|+.-
T Consensus 142 ~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~ 221 (458)
T KOG1266|consen 142 EEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGS 221 (458)
T ss_pred ccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecc
Confidence 4677899999999999999998863 35888889999999999999999885 99999999999999999888753
Q ss_pred cCCccccccccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC-CCcccHHHHHHHHhhcCC
Q 018052 76 FGLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICRADF 152 (361)
Q Consensus 76 FGla~~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P-f~~~~~~~~~~~i~~~~~ 152 (361)
--.......... ........|-++|.|||.=..... ..++|||++|....+|..|..- -...+....-..+.+..+
T Consensus 222 ~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~ 300 (458)
T KOG1266|consen 222 VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII 300 (458)
T ss_pred cCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee
Confidence 211111100000 001112246788999996443333 3689999999999999877543 333222211112211111
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
... ..--++++.+||...|..||++.+++.||..-
T Consensus 301 ~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 301 GLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred ecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 111 11234689999999999999999999998643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-11 Score=107.59 Aligned_cols=74 Identities=24% Similarity=0.414 Sum_probs=59.7
Q ss_pred EEEEEEecCCCCChHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 6 KIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..|+||||++||.+.. .+... ... ..++.++.|++.++.++|. .||+||||||+||+++ ++.++++|||.|...
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 4589999999964432 12111 111 6789999999999999999 9999999999999999 899999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-11 Score=121.64 Aligned_cols=187 Identities=20% Similarity=0.241 Sum_probs=140.0
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCcEecCCCCCcEEEecC-CCEEEE
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLIN----AVDYCHSRGVFHRDLKPENLLLDSY-GVLKIS 74 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~----gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~ 74 (361)
+++.+..|+-+|+|. .+|..+...-.. +++..++.++.+... ||..+|+.+++|-|+||+||++..+ ...+++
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 467889999999994 699988887655 899999999999999 9999999999999999999999998 899999
Q ss_pred ecCCcccccccccCCc---cccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC
Q 018052 75 DFGLSAISQQVREDGL---LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 75 DFGla~~~~~~~~~~~---~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|||+........-... ....-|...|++||+..+. .+...|++++|.+..+-.+|..++...-.. .+..+....
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~ 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc
Confidence 9999866543321111 1122577889999998753 358899999999999887775554322000 000000000
Q ss_pred --CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 --FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 --~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+-...+..+...+..|++.+|..|++.+.++.|++...
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0111123566677999999999999999999999998873
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-11 Score=121.17 Aligned_cols=156 Identities=21% Similarity=0.337 Sum_probs=115.6
Q ss_pred HHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccccccccc-----CC--ccccccCCCcccccccccc
Q 018052 37 YFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVRE-----DG--LLHTACGTPNYVAPEVLND 108 (361)
Q Consensus 37 ~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~-----~~--~~~~~~gt~~y~APEv~~~ 108 (361)
=+.+...|+.|+|.. +++|++|.|++|.++.+|.+||+.|+++........ .. ...-......|.|||++.+
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345666899999976 899999999999999999999999998764432111 00 0001123457999999987
Q ss_pred CCCCCCchhhhhhhhHHHhHh-cCCCCCCcccHHHHHHHH----hhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHH
Q 018052 109 KGYDGRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKI----CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQM 183 (361)
Q Consensus 109 ~~~~~~~~DiwS~Gvil~~ll-~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~ei 183 (361)
. ..+.++|++|+||++|.+. .|..-+...+....+..- ..+.+..+..+++++++-+.++|..++..||++.++
T Consensus 184 ~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 T-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred c-cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 4 4458999999999999998 555555554333332221 112334456789999999999999999999999999
Q ss_pred HhCcccccCC
Q 018052 184 LEDEWFKKGY 193 (361)
Q Consensus 184 l~h~~f~~~~ 193 (361)
+..|||....
T Consensus 263 ~~~~ff~D~~ 272 (700)
T KOG2137|consen 263 LSIPFFSDPG 272 (700)
T ss_pred hcccccCCch
Confidence 9999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-10 Score=100.72 Aligned_cols=78 Identities=21% Similarity=0.313 Sum_probs=62.2
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYC-HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~l-H~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
.-+|||||+.|+.+....-++..++++.+..++.|++.++..| |..||+|+||+|.|||++ +|.+.|+|||.|....+
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 3478999997755533222334567777888899999999999 899999999999999997 47899999998865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.1e-10 Score=93.38 Aligned_cols=71 Identities=28% Similarity=0.439 Sum_probs=61.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~---gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+..|++|||+.|+++... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.+.
T Consensus 65 ~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 65 DGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred CCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 3568999999999877654 5566777899999999999985 69999999999999999999999999875
Q ss_pred c
Q 018052 81 I 81 (361)
Q Consensus 81 ~ 81 (361)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.93 E-value=2e-09 Score=106.57 Aligned_cols=75 Identities=27% Similarity=0.397 Sum_probs=58.7
Q ss_pred EEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLIN-AVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~-gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.-+|||||++|++|.+..... ...+ ...++.+++. .+..+|..|++|+|+||.||+++.+|.++++|||++....
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 357999999999998876532 1222 2345555555 4678899999999999999999999999999999986553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.8e-10 Score=109.66 Aligned_cols=177 Identities=23% Similarity=0.231 Sum_probs=130.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DFGla~~~~ 83 (361)
.+.|+=.|||+|+++...+.-...+++...++...|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 4567888999999887766544568999999999999999999999999999999999999876 889999999886321
Q ss_pred ccccCCccccccCCCcc-ccccccccCCCCCCchhhhhhhhHHHhHhcCC-CCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNY-VAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y-~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~-~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
-. ......++..| .+|.......+ ..++|++|+|.-+.+..+|. .++.+. .+..+..+.....+..+..
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~-~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPH-LSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred ee----cccccccccccccchhhcccccc-ccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHh
Confidence 10 00111223334 24444444444 58999999999999988875 333332 1223344445555555588
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+..+.+.++.+++..|+.+.++..|.=|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 88999999999999999999998876554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.8e-09 Score=91.26 Aligned_cols=65 Identities=29% Similarity=0.482 Sum_probs=53.9
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGV-----FHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi-----~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
-++||||++|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 66 ~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 66 GVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 4799999999887643 11224467899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-08 Score=93.76 Aligned_cols=76 Identities=21% Similarity=0.188 Sum_probs=65.1
Q ss_pred cEEEEEEecCCCC-ChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-------CCCEEEE
Q 018052 5 TKIYIVLEFIDGG-ELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-------YGVLKIS 74 (361)
Q Consensus 5 ~~~~lV~E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-------~~~lKl~ 74 (361)
..-|+|||+++|- +|.+++.. ....++.....++.++...+.-||..||+|+|+++.|||++. ++.+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3568999999875 78888764 345677788899999999999999999999999999999985 4679999
Q ss_pred ecCCcc
Q 018052 75 DFGLSA 80 (361)
Q Consensus 75 DFGla~ 80 (361)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999774
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.2e-09 Score=105.35 Aligned_cols=70 Identities=26% Similarity=0.414 Sum_probs=56.3
Q ss_pred EEEEEecCCCCChHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEec
Q 018052 7 IYIVLEFIDGGELFDK--IAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDF 76 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DF 76 (361)
-+|||||++|+.|.+. +...+ .+.+..+..++.|++ ..|++|+|+||.||+++.+| .++++||
T Consensus 236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 4599999999999774 33333 356666777777775 48999999999999999888 9999999
Q ss_pred CCccccc
Q 018052 77 GLSAISQ 83 (361)
Q Consensus 77 Gla~~~~ 83 (361)
|++....
T Consensus 309 Givg~l~ 315 (537)
T PRK04750 309 GIVGSLN 315 (537)
T ss_pred ceEEECC
Confidence 9986543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=87.59 Aligned_cols=69 Identities=28% Similarity=0.476 Sum_probs=57.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..-.|+|||++|-.|.+.+... . ..+++.+=.-+.-||..||+|+||.++||++...+ +.++||||+..
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 4556999999998888888765 2 45566666677889999999999999999998755 99999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.3e-08 Score=97.63 Aligned_cols=122 Identities=16% Similarity=0.287 Sum_probs=90.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++..++|+|+|-+ --|..++.+. +...+..-+.||+.||.|||+ .+++|++|.-..++++..|..||++|.++.
T Consensus 79 e~~~~~ylvTErV--~Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 79 EEEGTLYLVTERV--RPLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred cccCceEEEeecc--ccHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 5677999999998 4677777764 366777779999999999985 579999999999999999999999998875
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL 133 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~ 133 (361)
....... ......---.|..|+.+.... -..|.|.|||++++++.|..
T Consensus 154 ~~~~~~~--~~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 154 KASGFNA--PAKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccccCCc--ccccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCccc
Confidence 4433221 111111122466666553322 34799999999999999833
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.8e-08 Score=88.53 Aligned_cols=76 Identities=24% Similarity=0.482 Sum_probs=67.6
Q ss_pred EEEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecCCccc
Q 018052 6 KIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFGla~~ 81 (361)
.-|+|+|+++|- +|.+++......+......++.++...+.-||.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 458999999984 7999988755578888899999999999999999999999999999999887 899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.1e-07 Score=86.39 Aligned_cols=171 Identities=17% Similarity=0.213 Sum_probs=118.1
Q ss_pred EEEEEecCCCCChHH-HHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 7 IYIVLEFIDGGELFD-KIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~-~i~~~------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+-+.|..+.|..=-. +.... .....+.+.+..+.|+.+.+-||..|..-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 678888888753322 22221 12667889999999999999999999999999999999999999999985432
Q ss_pred ccccccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHH----HHHH-HHh
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLM----ALYR-KIC 148 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~----~~~~-~i~ 148 (361)
.+. ..+.......|.+.|.+||.-. +..-+ ...|.|.+|+++++||.| +.||.+.... .-++ .|.
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~-~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERT-ANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCC-ccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 221 1233344556899999999754 22222 567999999999998876 9999753210 0011 111
Q ss_pred hc-----------CCCCC---CC--CCHHHHHHHHHccCC--CcCCCCCHH
Q 018052 149 RA-----------DFSCP---SW--FSSGAKKLIKRILDP--NPDTRMTIS 181 (361)
Q Consensus 149 ~~-----------~~~~~---~~--~s~~~~~Li~~~L~~--dP~~R~t~~ 181 (361)
.+ ..+.| +| +++++..|..+|+.. ++.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 11 11112 22 678999999999875 367899964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.8e-08 Score=84.23 Aligned_cols=72 Identities=29% Similarity=0.441 Sum_probs=50.5
Q ss_pred EEEEecCC--CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 8 YIVLEFID--GGELFDKIAKHGRLKEDEARRYFQQLINAVDY-CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 8 ~lV~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~-lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+|||||+. |..+...... .++.+....++.+++..+.. +|..||+|+|+.+.|||++++ .+.|+|||.|...
T Consensus 82 ~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred EEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 69999998 6555433222 23356677888888886665 579999999999999999986 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.2e-07 Score=78.84 Aligned_cols=76 Identities=33% Similarity=0.430 Sum_probs=59.9
Q ss_pred EEEEEEecCCC-CChHHHHHhCC-CCCHHH-HHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEEecCCc
Q 018052 6 KIYIVLEFIDG-GELFDKIAKHG-RLKEDE-ARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~g-g~L~~~i~~~~-~l~e~~-~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~DFGla 79 (361)
.=+|+|||++| -++.+++.... .-.++. ...+++++=+.+.-||.++|+|+||..+||++..+|+ +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34689999987 47778877643 222333 3788899999999999999999999999999976653 579999998
Q ss_pred cc
Q 018052 80 AI 81 (361)
Q Consensus 80 ~~ 81 (361)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.7e-07 Score=80.60 Aligned_cols=66 Identities=29% Similarity=0.538 Sum_probs=52.5
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+|||||++|.+|.+... ++++ +...+.+++.-+|..|++|+|.+|.|++++.++ ++++||+...
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 4568999999988866432 3432 445677789999999999999999999998655 9999998643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-06 Score=77.11 Aligned_cols=75 Identities=27% Similarity=0.457 Sum_probs=60.9
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS----------------------------------- 50 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~----------------------------------- 50 (361)
..|+||||++|+++.+.+.. ..+++++...++.+++.+|..||+
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 56899999999988775532 457777888888888888888884
Q ss_pred ---------------------CCcEecCCCCCcEEEec--CCCEEEEecCCccc
Q 018052 51 ---------------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAI 81 (361)
Q Consensus 51 ---------------------~gi~HrDiKp~NiLld~--~~~lKl~DFGla~~ 81 (361)
..++|+|++|.||+++. .+.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.16 E-value=3e-05 Score=76.22 Aligned_cols=155 Identities=19% Similarity=0.285 Sum_probs=113.2
Q ss_pred CcEEEEEEecCCC-CChHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 018052 4 KTKIYIVLEFIDG-GELFDKIAK---------------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67 (361)
Q Consensus 4 ~~~~~lV~E~~~g-g~L~~~i~~---------------~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~ 67 (361)
...+++|++|.++ ++|.++--. +.+.+|...|.|+.||..||.++|+.|..-+=|.|.+||++.
T Consensus 349 D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G 428 (655)
T KOG3741|consen 349 DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG 428 (655)
T ss_pred cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC
Confidence 3578999999975 577664321 124678999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC-CCcccHHHH-HH
Q 018052 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMAL-YR 145 (361)
Q Consensus 68 ~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P-f~~~~~~~~-~~ 145 (361)
+..++|+-.|...+..... . |.+.+. .+-|.-.+|.++..|.+|..- +........ ..
T Consensus 429 ~~RIriS~C~i~Dvl~~d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~ 488 (655)
T KOG3741|consen 429 KMRIRISGCGIMDVLQEDP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT 488 (655)
T ss_pred cceEEEecccceeeecCCC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHH
Confidence 8889998888765433211 1 122222 355888999999999998542 211111111 22
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+ ...+|.++++++.-+...++.+ -++.+++.+
T Consensus 489 ~I-------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 RI-------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred Hh-------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 22 2346889999999999999987 689998876
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.7e-06 Score=54.04 Aligned_cols=43 Identities=19% Similarity=0.346 Sum_probs=38.0
Q ss_pred CceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHHHHHHHhccc
Q 018052 304 GQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYKKFSSGLK 346 (361)
Q Consensus 304 ~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~~l~~~l~ 346 (361)
..+.|.+||+++. .+++.|+|+|.+||...|+++|.+|...|+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~ 46 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR 46 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence 4588999999998 899999999999999999999999988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.7e-05 Score=70.43 Aligned_cols=75 Identities=17% Similarity=0.165 Sum_probs=63.4
Q ss_pred EEEEEEecCCC-CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC--EEEEecCCcc
Q 018052 6 KIYIVLEFIDG-GELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLSA 80 (361)
Q Consensus 6 ~~~lV~E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~--lKl~DFGla~ 80 (361)
.-+||+|-+.| -+|.+++.+. .+.++..-..++.++...+.-||+.|+.|+|+-+.||+++.+|. ++++||.-+.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 46899997753 5888888663 35677788899999999999999999999999999999987777 9999998553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.1e-05 Score=83.71 Aligned_cols=172 Identities=21% Similarity=0.269 Sum_probs=122.2
Q ss_pred EEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCC---cEEEecCCCEEEE--ecCCccccc
Q 018052 9 IVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE---NLLLDSYGVLKIS--DFGLSAISQ 83 (361)
Q Consensus 9 lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~---NiLld~~~~lKl~--DFGla~~~~ 83 (361)
+..|+|.+-++.+.++.-+.++...++.+..++++||.|+|+....|.-+... +--.+..+...++ ||+.+....
T Consensus 263 v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred HHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCC
Confidence 44678889999999999899999999999999999999999996555555444 3444566677777 888765443
Q ss_pred ccccCCccccccCCCccccccccccCCCC-CCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 162 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~-~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 162 (361)
.... .....-+..+.|||......+. +...|+|.+|..+..+..|..+-...-... .+. +.....+.
T Consensus 343 d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~---~~l------~~~~~~~~ 410 (1351)
T KOG1035|consen 343 DNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV---SLL------DVLSTSEL 410 (1351)
T ss_pred Cccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh---hhh------ccccchhh
Confidence 3221 2233346678899887665554 234699999999999988765432211111 111 11111267
Q ss_pred HHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 163 KKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++.+|+..++++|+++.+++.|+|.+..
T Consensus 411 ~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 788999999999999999999999997743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.4e-07 Score=95.97 Aligned_cols=184 Identities=19% Similarity=0.100 Sum_probs=131.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEEecCCCEEEE
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKIS 74 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~g-----i~HrDiKp~NiLld~~~~lKl~ 74 (361)
....|.+++||.+|.+++.|-++- .+.+.-+....++.+.+..-+|++. .+|+++|+-|.+|..+-++|+.
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 345678899999999999988652 3556666666777788888888762 6999999999999999999999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CC
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FS 153 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~ 153 (361)
++|+.++..+ .........++|.|++|++...-.+. .+.|+|..|+.+|.+..|..+|-......+...+.++. +.
T Consensus 1383 k~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~s 1459 (2724)
T KOG1826|consen 1383 KGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFS 1459 (2724)
T ss_pred ccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccc
Confidence 9999884322 12233456788999999998877775 45999999999999999988875544433333333332 23
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+.-.|.++......+|...-..||.-...+.-+.|.
T Consensus 1460 Ie~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1460 IEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred ccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 3333455555555556666666777766666554443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.9e-05 Score=70.09 Aligned_cols=71 Identities=25% Similarity=0.488 Sum_probs=57.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.-.+||||++|-.|... +++.+.+..++..|+.-+.-+-..||+|+|+.+-||+++++|.+.++||--+.
T Consensus 180 nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 180 NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 455799999999777432 23456667777777777777778999999999999999999999999997654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00015 Score=65.53 Aligned_cols=77 Identities=23% Similarity=0.294 Sum_probs=57.9
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
-.|||||+....+---.-.+.++..+++..+..+++..+.-|-. .|++|+||..-|||+. +|.+.|+|||-|....+
T Consensus 141 nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 35899999442110000112345555899999999999998887 8999999999999999 78999999998865543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00023 Score=71.60 Aligned_cols=70 Identities=30% Similarity=0.537 Sum_probs=52.9
Q ss_pred cEEEEEEecCCCCChHHH--HHhCCCCCH-----HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 5 TKIYIVLEFIDGGELFDK--IAKHGRLKE-----DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~--i~~~~~l~e-----~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
+.-.|+|||++|-.+.+. +.. .+++. .-+..++.|++ ..|++|.|.+|.||+++.+|.+-+.|||
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-------~dgffHaDpHpGNi~v~~~g~i~~lDfG 310 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-------RDGFFHADPHPGNILVRSDGRIVLLDFG 310 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH-------hcCccccCCCccceEEecCCcEEEEcCc
Confidence 345699999999988876 444 34553 33444444443 4899999999999999999999999999
Q ss_pred Ccccc
Q 018052 78 LSAIS 82 (361)
Q Consensus 78 la~~~ 82 (361)
+....
T Consensus 311 i~g~l 315 (517)
T COG0661 311 IVGRL 315 (517)
T ss_pred ceecC
Confidence 87544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.25 E-value=5e-05 Score=76.40 Aligned_cols=179 Identities=19% Similarity=0.185 Sum_probs=117.4
Q ss_pred CcEEEEEEecCCCC-ChHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGG-ELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg-~L~~~i-~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+++|+|+.+| +....+ ...-.+.+-+.....+.-..+++++|+.-=+||| ||+..+ +..|..||+.+..
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcc
Confidence 34677888998877 221111 1111244445555566677899999998778998 888766 7799999998765
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--CCC---CC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSC---PS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~---~~ 156 (361)
.... ..-.+..+|+.++|||+.....++ ...|.|+.|+--.++--|.+|-..+.. ....+..+. +.. ..
T Consensus 381 L~~~---~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~a 454 (829)
T KOG0576|consen 381 LTRT---MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSA 454 (829)
T ss_pred cCcc---cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhh
Confidence 4332 134567899999999999888887 678999999977777777666543110 000000000 000 11
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|-+..-.++...|+..-|..|++...++.|.+|....
T Consensus 455 w~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 455 WSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 2111222467789999999999999999999998653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.002 Score=58.19 Aligned_cols=28 Identities=25% Similarity=0.304 Sum_probs=25.3
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0028 Score=56.38 Aligned_cols=30 Identities=40% Similarity=0.592 Sum_probs=21.1
Q ss_pred CCcEecCCCCCcEEEe-cCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLD-SYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld-~~~~lKl~DFGla~ 80 (361)
..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0034 Score=55.04 Aligned_cols=74 Identities=18% Similarity=0.328 Sum_probs=59.2
Q ss_pred EEEEecCCCCChHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 8 YIVLEFIDGGELFDK---IAKHGRLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~gl~~lH~~---gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++|.||...+++... +.+-..-++....+++.+++..+++++.. .+.-.|++|+|+-++++|++|++|......
T Consensus 32 ~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 32 FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 568999987766421 11112367889999999999999999973 478889999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0041 Score=56.50 Aligned_cols=29 Identities=24% Similarity=0.204 Sum_probs=26.0
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++|+|+.|.|||+++++...|+||+.|.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999997778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0051 Score=62.07 Aligned_cols=75 Identities=25% Similarity=0.425 Sum_probs=52.5
Q ss_pred cEEEEEEecCCCCChHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec----CCCEEEEecCC
Q 018052 5 TKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS----YGVLKISDFGL 78 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~--~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~----~~~lKl~DFGl 78 (361)
+.-.|+||||+|..+.| .|.+. +++...+...+.+.. ++-+=..|++|.|-+|.||++.. ++.+.+-|||+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 35679999999987754 45543 466554443333322 22333578999999999999983 67899999999
Q ss_pred cccc
Q 018052 79 SAIS 82 (361)
Q Consensus 79 a~~~ 82 (361)
....
T Consensus 352 ~~~i 355 (538)
T KOG1235|consen 352 YAVI 355 (538)
T ss_pred cccc
Confidence 7654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.004 Score=58.67 Aligned_cols=68 Identities=18% Similarity=0.350 Sum_probs=54.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
++-++|||++.|-.|...-+ ...+..+...++.-+--|..+|++|+|..--||++++++.++++||--
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 46789999999977754311 224455667777778889999999999999999999999999999964
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.022 Score=56.83 Aligned_cols=81 Identities=22% Similarity=0.186 Sum_probs=58.9
Q ss_pred CchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC------------CCCHHHHHHHHHccCCCcCCCCCHH
Q 018052 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS------------WFSSGAKKLIKRILDPNPDTRMTIS 181 (361)
Q Consensus 114 ~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------~~s~~~~~Li~~~L~~dP~~R~t~~ 181 (361)
+++||||+|.++.++..|..-|......+....+.+.....-. ..+.-..++..+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 4899999999999999988777665544444433322111100 1355667899999999999999999
Q ss_pred HHHhCcccccCCC
Q 018052 182 QMLEDEWFKKGYK 194 (361)
Q Consensus 182 eil~h~~f~~~~~ 194 (361)
++.+++-|.....
T Consensus 190 ~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 190 ELSKRCSFTEVYK 202 (725)
T ss_pred HHhcCccHHHHHh
Confidence 9999999887643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.054 Score=47.89 Aligned_cols=73 Identities=29% Similarity=0.439 Sum_probs=51.0
Q ss_pred CcCcEEEEEEecCCC--C----ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CE
Q 018052 2 ASKTKIYIVLEFIDG--G----ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VL 71 (361)
Q Consensus 2 ~s~~~~~lV~E~~~g--g----~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~l 71 (361)
+|..-.-+|+|.+.. | +|.+++.+ +.+++ .... .+-.-.+||-+++|+.+|++|.||++...+ .+
T Consensus 87 eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~l 161 (199)
T PF10707_consen 87 ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRL 161 (199)
T ss_pred ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEE
Confidence 466667788888743 2 67888855 45766 3333 334446788899999999999999996432 58
Q ss_pred EEEe-cCCc
Q 018052 72 KISD-FGLS 79 (361)
Q Consensus 72 Kl~D-FGla 79 (361)
.|+| ||-.
T Consensus 162 vlIDG~G~~ 170 (199)
T PF10707_consen 162 VLIDGLGEK 170 (199)
T ss_pred EEEeCCCCc
Confidence 8888 6644
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.025 Score=60.77 Aligned_cols=31 Identities=32% Similarity=0.639 Sum_probs=25.3
Q ss_pred CcEecCCCCCcEEEecC-C-CEEEEecCCcccc
Q 018052 52 GVFHRDLKPENLLLDSY-G-VLKISDFGLSAIS 82 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~-~-~lKl~DFGla~~~ 82 (361)
.++|+|++|.|+|++.+ + ..-|.||++++.-
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 49999999999999853 3 3579999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.03 Score=53.71 Aligned_cols=70 Identities=26% Similarity=0.421 Sum_probs=53.6
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..|++|++- |+.|. .+.. -..+++..++.+.+.-+.-+..+ ..-|||+...||||+ +|++.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is-~ik~---~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPIS-IIKA---DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceee-eeec---ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 567777774 44543 2322 34678888888888877777655 589999999999999 89999999999873
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.042 Score=52.13 Aligned_cols=31 Identities=26% Similarity=0.479 Sum_probs=28.2
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.++|+|+.+.|++++..+.+=|.||+++.+-
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 4899999999999999999999999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.033 Score=52.51 Aligned_cols=30 Identities=43% Similarity=0.710 Sum_probs=27.0
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|+++.|++++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.02 Score=51.72 Aligned_cols=30 Identities=37% Similarity=0.557 Sum_probs=25.5
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++|+|+.|.|+|+++.+..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 589999999999998766567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.03 Score=50.39 Aligned_cols=29 Identities=21% Similarity=0.374 Sum_probs=26.2
Q ss_pred CcEecCCCCCcEEEec-CCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDS-YGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~-~~~lKl~DFGla~ 80 (361)
+++|+|+.|.|||+++ ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.06 Score=50.54 Aligned_cols=29 Identities=31% Similarity=0.544 Sum_probs=25.4
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999998 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.054 Score=51.22 Aligned_cols=30 Identities=33% Similarity=0.537 Sum_probs=25.9
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.|++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976656899999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.056 Score=50.70 Aligned_cols=29 Identities=31% Similarity=0.383 Sum_probs=26.3
Q ss_pred CcEecCCCCCcEEEecC----CCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSY----GVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~----~~lKl~DFGla~ 80 (361)
+++|+|+.|.|||++++ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.032 Score=48.74 Aligned_cols=28 Identities=25% Similarity=0.455 Sum_probs=25.3
Q ss_pred cEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 53 VFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 53 i~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+|+|+.|.|++++++| ++++||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998877 99999999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.066 Score=49.97 Aligned_cols=30 Identities=37% Similarity=0.585 Sum_probs=26.6
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|+.|.|+|+++++...|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999997777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.11 Score=48.15 Aligned_cols=48 Identities=29% Similarity=0.431 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHHHHHHHC--CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 34 ARRYFQQLINAVDYCHSR--GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 34 ~~~~~~ql~~gl~~lH~~--gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..+..+-.++.-.|.. -++|.|+.|+|++.++.|.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 333444555555555544 489999999999999999999999988764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.057 Score=49.40 Aligned_cols=29 Identities=28% Similarity=0.466 Sum_probs=25.8
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++|+|+.|.||++++++ +.++||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.1 Score=50.13 Aligned_cols=30 Identities=27% Similarity=0.538 Sum_probs=26.1
Q ss_pred CcEecCCCCCcEEEec-CCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDS-YGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~-~~~lKl~DFGla~~ 81 (361)
.++|+|+++.|||+++ ++.+.++||..|..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986 47899999998753
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.099 Score=49.55 Aligned_cols=75 Identities=20% Similarity=0.265 Sum_probs=44.5
Q ss_pred EEEEecCCC--CChHH-HHHhCCCCC-HHHHHHHHHHHHHHHHHHH----HCCcEecCCCCCcEEEecCC----------
Q 018052 8 YIVLEFIDG--GELFD-KIAKHGRLK-EDEARRYFQQLINAVDYCH----SRGVFHRDLKPENLLLDSYG---------- 69 (361)
Q Consensus 8 ~lV~E~~~g--g~L~~-~i~~~~~l~-e~~~~~~~~ql~~gl~~lH----~~gi~HrDiKp~NiLld~~~---------- 69 (361)
.+|++++.. ..+.. .+.+.|-.+ .+-++.++.|++.-.-.+- ..+.+|-||||+|||+-+..
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 330 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDA 330 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCe
Confidence 366776533 23332 233333222 3457777888876543342 23689999999999994322
Q ss_pred --------CEEEEecCCcccc
Q 018052 70 --------VLKISDFGLSAIS 82 (361)
Q Consensus 70 --------~lKl~DFGla~~~ 82 (361)
.++|.||.+|.+.
T Consensus 331 ~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 331 TYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred EEEeccchhhhhcccCHHHHc
Confidence 3566677776553
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.054 Score=48.05 Aligned_cols=30 Identities=33% Similarity=0.600 Sum_probs=21.6
Q ss_pred CcEecCCCCCcEEE-ecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLL-DSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLl-d~~~~lKl~DFGla~~ 81 (361)
.++|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.04 E-value=0.081 Score=47.47 Aligned_cols=37 Identities=32% Similarity=0.511 Sum_probs=32.0
Q ss_pred HHHHHHHHHC--CcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 42 INAVDYCHSR--GVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 42 ~~gl~~lH~~--gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+.+|.-.|+. +.+|+|-.|+||+-|+.|.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 4567788843 699999999999999999999999874
|
The function of this family is unknown. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.86 E-value=0.091 Score=50.00 Aligned_cols=75 Identities=19% Similarity=0.226 Sum_probs=44.1
Q ss_pred EEEecCCC--CChHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHH----HCCcEecCCCCCcEEEecC------------
Q 018052 9 IVLEFIDG--GELFDKIAKHGRL--KEDEARRYFQQLINAVDYCH----SRGVFHRDLKPENLLLDSY------------ 68 (361)
Q Consensus 9 lV~E~~~g--g~L~~~i~~~~~l--~e~~~~~~~~ql~~gl~~lH----~~gi~HrDiKp~NiLld~~------------ 68 (361)
+|++++.+ ..+.......-++ -.+-++.++.|++.-.--+- ..+.+|-||||+|||+-+.
T Consensus 248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~ 327 (434)
T PF05445_consen 248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN 327 (434)
T ss_pred EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence 67777643 2333333222222 23456777778754331121 3468999999999999332
Q ss_pred ------CCEEEEecCCccccc
Q 018052 69 ------GVLKISDFGLSAISQ 83 (361)
Q Consensus 69 ------~~lKl~DFGla~~~~ 83 (361)
-.+++-||.+|.+.+
T Consensus 328 ~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 328 YVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred EEecccceeeecccCHHHhcc
Confidence 246778888886543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.26 Score=43.35 Aligned_cols=30 Identities=27% Similarity=0.335 Sum_probs=25.1
Q ss_pred CCcEecCCCCCcEEEecCC-----CEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYG-----VLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~-----~lKl~DFGla~ 80 (361)
..++|||+.+.|+++..++ .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4589999999999997544 58999999764
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.19 Score=47.37 Aligned_cols=29 Identities=17% Similarity=0.154 Sum_probs=27.0
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+++|+|+.+.|+|+++++.+-++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.11 Score=48.42 Aligned_cols=30 Identities=23% Similarity=0.422 Sum_probs=25.3
Q ss_pred CcEecCCCCCcEEEecCCC-EEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGV-LKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~-lKl~DFGla~~ 81 (361)
.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.28 E-value=0.28 Score=43.40 Aligned_cols=56 Identities=29% Similarity=0.385 Sum_probs=41.5
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..-||.||++... .+... -+.++.+-+..+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 151 ~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 151 IRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 3457778776643 23333 3456777788899999999999999987 4589999964
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.03 E-value=0.21 Score=47.69 Aligned_cols=28 Identities=32% Similarity=0.526 Sum_probs=25.2
Q ss_pred cEecCCCCCcEEEecCCC-EEEEecCCcc
Q 018052 53 VFHRDLKPENLLLDSYGV-LKISDFGLSA 80 (361)
Q Consensus 53 i~HrDiKp~NiLld~~~~-lKl~DFGla~ 80 (361)
+||+|+.|.||+++.+.. ..++|||-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998875 8999999653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.68 Score=43.54 Aligned_cols=26 Identities=19% Similarity=0.290 Sum_probs=19.7
Q ss_pred CcEecCCCCCcEEEecC-CC-EEEEecC
Q 018052 52 GVFHRDLKPENLLLDSY-GV-LKISDFG 77 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~-~~-lKl~DFG 77 (361)
.++|+|+.|.|++++.. +. +-|.|..
T Consensus 194 sLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred eeEeCCCCcccEEECCCCCceEEEECch
Confidence 47999999999999865 33 5566654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.90 E-value=0.5 Score=45.16 Aligned_cols=29 Identities=34% Similarity=0.487 Sum_probs=25.4
Q ss_pred cEecCCCCCcEEEec-CCCEEEEecCCccc
Q 018052 53 VFHRDLKPENLLLDS-YGVLKISDFGLSAI 81 (361)
Q Consensus 53 i~HrDiKp~NiLld~-~~~lKl~DFGla~~ 81 (361)
.+|.|+.|.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975 57899999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.03 E-value=1 Score=42.83 Aligned_cols=28 Identities=21% Similarity=0.170 Sum_probs=23.6
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|+.|.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 3 57899999754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.39 E-value=0.64 Score=51.27 Aligned_cols=31 Identities=29% Similarity=0.439 Sum_probs=26.3
Q ss_pred CCcEecCCCCCcEEEecCC--CEE-EEecCCccc
Q 018052 51 RGVFHRDLKPENLLLDSYG--VLK-ISDFGLSAI 81 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~--~lK-l~DFGla~~ 81 (361)
++++|.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=88.12 E-value=0.73 Score=44.61 Aligned_cols=74 Identities=27% Similarity=0.319 Sum_probs=55.9
Q ss_pred EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.|||+++-+..--.-.-++..++...+..+.+|++.-+.-|-. .+++|.||.--|+|+-+ |.+.|+|-+-|.-.
T Consensus 240 VLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 240 VLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred eEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEEEccccccC
Confidence 6899999432111111134568888999999999998887765 48999999999999865 88999999877543
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.56 E-value=0.76 Score=50.52 Aligned_cols=31 Identities=23% Similarity=0.234 Sum_probs=25.5
Q ss_pred CCcEecCCCCCcEEEecC--CC---EEEEecCCccc
Q 018052 51 RGVFHRDLKPENLLLDSY--GV---LKISDFGLSAI 81 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~--~~---lKl~DFGla~~ 81 (361)
.|++|.|+.+.|||++.+ +. .-|+|||-+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 589999999999999865 33 37999998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=86.37 E-value=1.4 Score=38.34 Aligned_cols=69 Identities=22% Similarity=0.270 Sum_probs=47.6
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC-CCcEEEecCCCEEEEecCCccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK-PENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiK-p~NiLld~~~~lKl~DFGla~~ 81 (361)
..++.|||+.|-+|.+.-... + +.-+..+++.---|-..||-|..|. |...++-.++.+-|+||..|+.
T Consensus 86 ~~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 86 EDFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 345679999998887654321 2 2233445555556677899999986 5666666666999999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 361 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-50 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-50 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-50 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-50 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-50 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-49 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-49 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-49 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-49 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-47 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-46 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-45 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-45 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-45 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-45 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-45 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-44 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-43 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-43 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-40 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-40 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-40 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-39 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-39 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-38 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-38 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-38 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-38 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-38 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-38 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-38 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-37 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-37 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-37 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-37 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-37 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-36 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-36 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-36 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-36 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-36 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-36 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-36 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-36 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-36 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-36 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-36 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-36 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-36 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-36 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-36 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-36 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-36 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-36 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-36 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-36 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-36 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-36 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-35 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-35 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-35 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-35 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-35 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-35 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-35 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-35 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-35 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-35 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-35 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-35 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-35 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-35 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-35 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-35 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-35 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-34 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-34 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-34 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-33 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-33 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-33 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-33 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-33 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-33 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-33 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-33 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-33 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-33 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-33 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-33 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-33 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-33 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-33 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-33 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-32 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-32 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 1e-32 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-32 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-32 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-32 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-32 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-32 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-32 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-32 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-32 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-32 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-32 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-32 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-32 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-32 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-32 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-32 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-32 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-32 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-32 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-32 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-32 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-32 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-32 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-32 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-32 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-32 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-32 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-32 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-32 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-32 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-32 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-32 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-32 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-32 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-32 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-32 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-32 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-32 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-32 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-32 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-32 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-32 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-31 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-31 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-31 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-31 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-31 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-31 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-31 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-31 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-31 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-31 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-30 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-30 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-30 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-30 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-30 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-29 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-29 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-29 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-28 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-28 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-28 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-28 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-28 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-28 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-28 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-28 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-27 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-27 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-27 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-27 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-27 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-27 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-27 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-27 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-27 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-27 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-27 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-27 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-27 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-27 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-26 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-26 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-25 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-25 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-25 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-25 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-23 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-21 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-20 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-20 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-20 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-14 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-05 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-148
Identities = 113/394 (28%), Positives = 195/394 (49%), Gaps = 63/394 (15%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+++ + I++V+E++ GGELFD I K+GRL E E+RR FQQ+++ VDYCH V HRDLKP
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV++ + Y G D+WS
Sbjct: 145 ENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
GVIL+ L+ G LPFD+ ++ L++KIC F P + + L+K +L +P R TI
Sbjct: 202 SGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATI 261
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVD--------------------AIFNDSKEN- 219
+ E EWFK+ F ++ + +D ++N + ++
Sbjct: 262 KDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDP 321
Query: 220 -------LVTEKKEKPVSMNAFELISRTKSFSLEN------------------------- 247
++ ++ + + + S SF ++
Sbjct: 322 LAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLD 381
Query: 248 ----LFEKQTGLVKRE--TRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN-YKMKLQGDKT 300
K G+ K + SQ PN+IM+++ A K L + + N Y ++++
Sbjct: 382 ELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNP 441
Query: 301 GRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEF 334
++ ++++V ++++ R + LE
Sbjct: 442 VTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-129
Identities = 78/197 (39%), Positives = 109/197 (55%), Gaps = 3/197 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H G+ HRD+KP
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L + + DVWS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 121 CGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTR 177
CG++L ++AG LP+D+ S+ Y W S L+ +IL NP R
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253
Query: 178 MTISQMLEDEWFKKGYK 194
+TI + +D W+ K K
Sbjct: 254 ITIPDIKKDRWYNKPLK 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-129
Identities = 91/198 (45%), Positives = 131/198 (66%), Gaps = 3/198 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+++ T ++V+E++ GGELFD I KHGR++E EARR FQQ+++AVDYCH V HRDLKP
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD++ KI+DFGLS + + + L T+CG+PNY APEV++ + Y G D+WS
Sbjct: 140 ENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CGVIL+ L+ G LPFD+ ++ L++KI F P + + L+ +L +P R TI
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATI 256
Query: 181 SQMLEDEWFKKGYKPPHF 198
+ E EWFK+ F
Sbjct: 257 KDIREHEWFKQDLPSYLF 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-128
Identities = 78/222 (35%), Positives = 109/222 (49%), Gaps = 3/222 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H G+ HRD+KP
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD LKISDFGL+ + + + LL+ CGT YVAPE+L + + DVWS
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 193
Query: 121 CGVILFVLMAGFLPFDE-SNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTR 177
CG++L ++AG LP+D+ S+ Y W S L+ +IL NP R
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253
Query: 178 MTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKEN 219
+TI + +D W+ K K
Sbjct: 254 ITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQ 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-128
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 4/212 (1%)
Query: 2 ASKTKIYIVLEFIDGG--ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
K K+Y+V+E+ G E+ D + R +A YF QLI+ ++Y HS+G+ H+D+K
Sbjct: 78 EEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIK 136
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND-KGYDGRASDV 118
P NLLL + G LKIS G++ D T+ G+P + PE+ N + G D+
Sbjct: 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
WS GV L+ + G PF+ N+ L+ I + ++ P L+K +L+ P R
Sbjct: 197 WSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRF 256
Query: 179 TISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD 210
+I Q+ + WF+K + P + D D
Sbjct: 257 SIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-128
Identities = 90/274 (32%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ + T + I++E+ GGEL+++I GR EDEAR +FQQL++ V YCHS + HRDLK
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 61 ENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
EN LLD LKI DFG S S + GTP Y+APEVL + YDG+ +DV
Sbjct: 145 ENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADV 201
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRK----ICRADFSCPS--WFSSGAKKLIKRILDP 172
WSCGV L+V++ G PF++ YRK I +S P S LI RI
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVA 261
Query: 173 NPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV-NLDDVDAIFNDSKENL-VTEKKEKPVS 230
+P TR++I ++ WF K ++ + + + + + P
Sbjct: 262 DPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAV 321
Query: 231 MNAFELISRTKSFSLENLFEKQTGLVKRETRFTS 264
N T + L++ + + E S
Sbjct: 322 RNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDS 353
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-127
Identities = 96/250 (38%), Positives = 143/250 (57%), Gaps = 13/250 (5%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ + T I +V+E+ GGELFD I + R+ EDE RR+FQQ+I A++YCH + HRDLKP
Sbjct: 78 ITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD +KI+DFGLS I + + L T+CG+PNY APEV+N K Y G DVWS
Sbjct: 137 ENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
CG++L+V++ G LPFD+ + L++K+ + P + S GA+ LI+R++ +P R+TI
Sbjct: 194 CGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITI 253
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVN-------LDDVDAIFNDSKENLVT--EKKEKPVSM 231
++ D WF EE + + S++ +V E
Sbjct: 254 QEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALRSDENNEVK 313
Query: 232 NAFELISRTK 241
A+ L+ +
Sbjct: 314 EAYNLLHENQ 323
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-122
Identities = 72/198 (36%), Positives = 105/198 (53%), Gaps = 3/198 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+++VLE L + + L E EAR Y +Q++ Y H V HRDLK
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 143
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
NL L+ +KI DFGL+ + + CGTPNY+APEVL+ KG+ DVWS
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWS 200
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
G I++ L+ G PF+ S L Y +I + ++S P + A LI+++L +P R TI
Sbjct: 201 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 260
Query: 181 SQMLEDEWFKKGYKPPHF 198
+++L DE+F GY P
Sbjct: 261 NELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-121
Identities = 72/196 (36%), Positives = 105/196 (53%), Gaps = 3/196 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+++VLE L + + L E EAR Y +Q++ Y H V HRDLK
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKL 169
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
NL L+ +KI DFGL+ + + CGTPNY+APEVL+ KG+ DVWS
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWS 226
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
G I++ L+ G PF+ S L Y +I + ++S P + A LI+++L +P R TI
Sbjct: 227 IGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTI 286
Query: 181 SQMLEDEWFKKGYKPP 196
+++L DE+F GY P
Sbjct: 287 NELLNDEFFTSGYIPA 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-119
Identities = 68/194 (35%), Positives = 109/194 (56%), Gaps = 7/194 (3%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ +Y+V E ++ G + + + L ED+AR YFQ LI ++Y H + + HRD+KP
Sbjct: 108 PNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVW 119
NLL+ G +KI+DFG+S + D LL GTP ++APE L++ K + G+A DVW
Sbjct: 167 NLLVGEDGHIKIADFGVSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTR 177
+ GV L+ + G PF + +M L+ KI P + K LI R+LD NP++R
Sbjct: 225 AMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284
Query: 178 MTISQMLEDEWFKK 191
+ + ++ W +
Sbjct: 285 IVVPEIKLHPWVTR 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-119
Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 4/201 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+Y+VLE GE+ + E+EAR + Q+I + Y HS G+ HRDL
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLT 139
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
NLLL +KI+DFGL+ + +T CGTPNY++PE+ + G SDVW
Sbjct: 140 LSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSAH-GLESDVW 196
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
S G + + L+ G PFD + K+ AD+ PS+ S AK LI ++L NP R++
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLS 256
Query: 180 ISQMLEDEWFKKGYKPPHFDK 200
+S +L+ + + D+
Sbjct: 257 LSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-119
Identities = 90/226 (39%), Positives = 131/226 (57%), Gaps = 3/226 (1%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ ++ +Y+++E+ GGE+FD + HGR+KE EAR F+Q+++AV YCH + + HRDLK
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLLD+ +KI+DFG S + G L CG P Y APE+ K YDG DVWS
Sbjct: 143 ENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
GVIL+ L++G LPFD NL L ++ R + P + S+ + L+KR L NP R T+
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTL 259
Query: 181 SQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 226
Q+++D W G++ E LD D D + ++E
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEE 305
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-117
Identities = 72/205 (35%), Positives = 115/205 (56%), Gaps = 8/205 (3%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ +IY++LEF GEL+ ++ KHGR E + + ++L +A+ YCH R V HRD+KP
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKP 142
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLL+ G LKI+DFG S + +R T CGT +Y+ PE++ K +D + D+W
Sbjct: 143 ENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKV-DLWC 197
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
GV+ + + G PFD + +R+I D P + S G+K LI ++L +P R+ +
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPL 257
Query: 181 SQMLEDEWFKKGYK---PPHFDKEE 202
++E W K + PP + +
Sbjct: 258 KGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-115
Identities = 70/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
T++Y++LE+ G ++ ++ K + E Y +L NA+ YCHS+ V HRD+KP
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENLLL S G LKI+DFG S + R CGT +Y+ PE++ + +D + D+WS
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKV-DLWS 192
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
GV+ + + G PF+ + Y++I R +F+ P + + GA+ LI R+L NP R +
Sbjct: 193 LGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPML 252
Query: 181 SQMLEDEWFKKGYKPPHFDKEEE 203
++LE W P + +E
Sbjct: 253 REVLEHPWITANSSKPSNCQNKE 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 332 bits (852), Expect = e-113
Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 11/239 (4%)
Query: 1 MASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++ +V+E G +LF I +H RL E A F+QL++AV Y + + HRD+K
Sbjct: 98 FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIK 157
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
EN+++ +K+ DFG +A + L +T CGT Y APEVL Y G ++W
Sbjct: 158 DENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMW 214
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
S GV L+ L+ PF E + A P S L+ +L P P+ R T
Sbjct: 215 SLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTT 268
Query: 180 ISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFELIS 238
+ +++ D W + + EE ++ ++ + L + A EL
Sbjct: 269 LEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAAS-LEMGNRSLSDVAQAQELCG 326
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-112
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 1 MASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++ +VLE + +LFD I + G L E +R +F Q++ A+ +CHSRGV HRD+K
Sbjct: 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIK 166
Query: 60 PENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
EN+L+D G K+ DFG A+ D GT Y PE ++ Y + V
Sbjct: 167 DENILIDLRRGCAKLIDFGSGALLH----DEPYTDFDGTRVYSPPEWISRHQYHALPATV 222
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
WS G++L+ ++ G +PF+ ++I A+ P+ S LI+R L P P +R
Sbjct: 223 WSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP 276
Query: 179 TISQMLEDEWFKKGYKPPHFDKEEE 203
++ ++L D W + + + +
Sbjct: 277 SLEEILLDPWMQTPAEDVPLNPSKG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-110
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 1 MASKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++LE + +LFD I + G L+E+ AR +F Q++ AV +CH+ GV HRD+K
Sbjct: 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK 176
Query: 60 PENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
EN+L+D G LK+ DFG A+ + D + GT Y PE + Y GR++ V
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
WS G++L+ ++ G +PF+ +I R SS + LI+ L P R
Sbjct: 233 WSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 286
Query: 179 TISQMLEDEWFKKGYKPPHFDKEEEVNLDD 208
T ++ W + P + +L
Sbjct: 287 TFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-102
Identities = 52/234 (22%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLK--------EDEARRYFQQLINAVDYCHS-R 51
+ + ++YI+ E+++ + L + + ++N+ Y H+ +
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG- 110
+ HRD+KP N+L+D G +K+SDFG S D + + GT ++ PE +++
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFGESEY----MVDKKIKGSRGTYEFMPPEFFSNESS 227
Query: 111 YDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCP-------------- 155
Y+G D+WS G+ L+V+ +PF + +L+ L+ I + P
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287
Query: 156 -----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
++ S+ +K L NP R+T L+ EW + +E+
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKEL 341
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 1e-88
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ K+ ++I +E+ + G L+D I + DE R F+Q++ A+ Y HS+G+ HRDLK
Sbjct: 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLK 143
Query: 60 PENLLLDSYGVLKISDFGLSAISQQ------------VREDGLLHTACGTPNYVAPEVLN 107
P N+ +D +KI DFGL+ + L +A GT YVA EVL+
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 108 DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF----SSGAK 163
G+ D++S G+I F ++ + + +K+ P F K
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
Query: 164 KLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDK 200
K+I+ ++D +P+ R +L W ++ +
Sbjct: 262 KIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 4e-85
Identities = 84/204 (41%), Positives = 114/204 (55%), Gaps = 13/204 (6%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y H G+ HRDLKPEN+L
Sbjct: 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146
Query: 65 LDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVW 119
L S ++KI+DFG S I + E L+ T CGTP Y+APEVL G RA D W
Sbjct: 147 LSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 120 SCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWF--SSGAKKLIKRILDPNP 174
S GVILF+ ++G+ PF + ++L +I +F W S A L+K++L +P
Sbjct: 204 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 175 DTRMTISQMLEDEWFKKGYKPPHF 198
R T + L W + F
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKF 287
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-82
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ T ++V + + GELFD + + L E E R+ + L+ + H + HRDLKPEN
Sbjct: 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL------NDKGYDGRAS 116
+LLD +K++DFG S + L CGTP+Y+APE++ N GY G+
Sbjct: 155 ILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEV 210
Query: 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDP 172
D+WS GVI++ L+AG PF M + R I F P W +S K L+ R L
Sbjct: 211 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270
Query: 173 NPDTRMTISQMLEDEWFKKGYKP--PHF 198
P R T + L +F++ HF
Sbjct: 271 QPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-82
Identities = 83/197 (42%), Positives = 113/197 (57%), Gaps = 13/197 (6%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
YIVLE ++GGELFDK+ + RLKE + YF Q++ AV Y H G+ HRDLKPEN+L
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271
Query: 65 LDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVW 119
L S ++KI+DFG S I + E L+ T CGTP Y+APEVL G RA D W
Sbjct: 272 LSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 120 SCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSWF--SSGAKKLIKRILDPNP 174
S GVILF+ ++G+ PF + ++L +I +F W S A L+K++L +P
Sbjct: 329 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 175 DTRMTISQMLEDEWFKK 191
R T + L W +
Sbjct: 389 KARFTTEEALRHPWLQD 405
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 4e-82
Identities = 76/199 (38%), Positives = 110/199 (55%), Gaps = 14/199 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S + +++V + + GELFD + + L E E R + L+ AV + H+ + HRDLKPEN
Sbjct: 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL------NDKGYDGRAS 116
+LLD +++SDFG S + L CGTP Y+APE+L GY G+
Sbjct: 231 ILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEV 286
Query: 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDP 172
D+W+CGVILF L+AG PF + + R I FS P W SS K LI R+L
Sbjct: 287 DLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQV 346
Query: 173 NPDTRMTISQMLEDEWFKK 191
+P+ R+T Q L+ +F++
Sbjct: 347 DPEARLTAEQALQHPFFER 365
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 5e-81
Identities = 74/211 (35%), Positives = 114/211 (54%), Gaps = 12/211 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G+ HR+LKPEN
Sbjct: 76 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 135
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LLL S +K++DFGL+ V + H GTP Y++PEVL Y + D+W
Sbjct: 136 LLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIW 191
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
+CGVIL++L+ G+ PF + + LY +I D+ P W + AK LI +L NP
Sbjct: 192 ACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPK 251
Query: 176 TRMTISQMLEDEWFKKGYK-PPHFDKEEEVN 205
R+T Q L+ W + +++ V+
Sbjct: 252 KRITADQALKVPWICNRERVASAIHRQDTVD 282
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 258 bits (659), Expect = 2e-80
Identities = 63/366 (17%), Positives = 123/366 (33%), Gaps = 47/366 (12%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRD 57
+A + +E+ +GG+L + + LKE R + +A+ Y H + HRD
Sbjct: 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRD 146
Query: 58 LKPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 114
LKPEN++L + KI D G + + + L GT Y+APE+L K Y
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 115 ASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFSCPSWF--------------- 158
D WS G + F + GF PF + + K+ +
Sbjct: 204 V-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPT 262
Query: 159 --------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVD 210
+ ++ ++ +L + R T Q F+ + + +
Sbjct: 263 PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL---------DSILSLKLL 313
Query: 211 AIFNDSKENLVTEKKEKPVSMNAF-ELISRTKSFSLEN-LFEKQTGLVKRETRFTSQRPP 268
++ N + T + ++ + + E + +GL + +Q
Sbjct: 314 SVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQYVI 373
Query: 269 NEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTG 328
+ + + L F + + SV+ + + L +R+
Sbjct: 374 DCTVIDGRQGEGDLIFLFDNRK--TVYEPQISLPAHPESVSIVLQDPKRPLTYTHLRRVW 431
Query: 329 GDTLEF 334
G +
Sbjct: 432 GQIWQT 437
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 6e-80
Identities = 76/201 (37%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
T IY+V+E GGELF+++ +E +A R + +++AV YCH V HRDLKPEN
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPEN 136
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
L + LK+ DFGL+A + ++ T GTP YV+P+VL Y G D W
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-GLY-GPECDEW 191
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GV+++VL+ G+ PF + KI F W S A+ LI+R+L +P
Sbjct: 192 SAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPK 251
Query: 176 TRMTISQMLEDEWFKKGYKPP 196
R+T Q LE EWF+K
Sbjct: 252 QRITSLQALEHEWFEKQLSSS 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 9e-80
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ IY+V+E +L + K + E + Y++ ++ AV H G+ H DLKP N
Sbjct: 99 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 157
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD---------- 112
L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 113 GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSWFSSGAKKLIKRI 169
SDVWS G IL+ + G PF + N ++ I + P + ++K
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 276
Query: 170 LDPNPDTRMTISQMLEDEWFKKGYKP 195
L +P R++I ++L + + P
Sbjct: 277 LKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-78
Identities = 73/209 (34%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ Y+V + + GGELF+ I E +A QQ++ ++ YCHS G+ HR+LKPEN
Sbjct: 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LLL S +K++DFGL+ V + H GTP Y++PEVL Y + D+W
Sbjct: 159 LLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIW 214
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
+CGVIL++L+ G+ PF + + LY +I D+ P W + AK LI +L NP
Sbjct: 215 ACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPK 274
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
R+T Q L+ W + ++
Sbjct: 275 KRITADQALKVPWICNRERVASAIHRQDT 303
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-78
Identities = 81/202 (40%), Positives = 112/202 (55%), Gaps = 12/202 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S T Y+V++ + GGELFD+I + G E +A QQ+++AV Y H G+ HRDLKPEN
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LL + + I+DFGLS + ++G++ TACGTP YVAPEVL K Y +A D W
Sbjct: 137 LLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQKPY-SKAVDCW 191
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVI ++L+ G+ PF E L+ KI +F P W S AK I +L+ +P+
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251
Query: 176 TRMTISQMLEDEWFKKGYKPPH 197
R T + L W
Sbjct: 252 ERYTCEKALSHPWIDGNTALHR 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 5e-78
Identities = 66/200 (33%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+YIV+E +GGEL ++I A+ L E +Q++NA+ Y HS+ V H+DL
Sbjct: 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150
Query: 59 KPENLLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 115
KPEN+L + +KI DFGL+ + + D A GT Y+APEV +
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFK-RDV-TFK 205
Query: 116 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWF---SSGAKKLIKRILDP 172
D+WS GV+++ L+ G LPF ++L + +K + + + A L+K++L
Sbjct: 206 CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK 265
Query: 173 NPDTRMTISQMLEDEWFKKG 192
+P+ R + +Q+L EWFK+
Sbjct: 266 DPERRPSAAQVLHHEWFKQA 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 6e-78
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 21/272 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ IY+V+E +L + K + E + Y++ ++ AV H G+ H DLKP N
Sbjct: 80 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 138
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD---------- 112
L+ G+LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 139 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 197
Query: 113 GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSWFSSGAKKLIKRI 169
SDVWS G IL+ + G PF + N ++ I + P + ++K
Sbjct: 198 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 257
Query: 170 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPV 229
L +P R++I ++L + + P ++ + +++ + LV +
Sbjct: 258 LKRDPKQRISIPELLAHPYVQIQTHPV--NQMAKGTTEEMKYVLG----QLVGLNSPNSI 311
Query: 230 SMNAFELISRTKSFSLENLFEKQTGLVKRETR 261
A L N +T KR +
Sbjct: 312 LKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-77
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 21/272 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ IY+V+E +L + K + E + Y++ ++ AV H G+ H DLKP N
Sbjct: 127 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD---------- 112
L+ G+LK+ DFG++ Q + + G NY+ PE + D
Sbjct: 186 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244
Query: 113 GRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD--FSCPSWFSSGAKKLIKRI 169
SDVWS G IL+ + G PF + N ++ I + P + ++K
Sbjct: 245 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304
Query: 170 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPV 229
L +P R++I ++L + + P ++ + +++ + LV +
Sbjct: 305 LKRDPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTEEMKYVLG----QLVGLNSPNSI 358
Query: 230 SMNAFELISRTKSFSLENLFEKQTGLVKRETR 261
A L N +T KR +
Sbjct: 359 LKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK 390
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-77
Identities = 76/196 (38%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ YIV E GGELFD+I K R E +A R +Q+ + + Y H + HRDLKPEN
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+LL+S +KI DFGLS +++ + GT Y+APEVL Y DVW
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-GTY-DEKCDVW 206
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVIL++L++G PF N + +++ F P W S AK LI+++L +P
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 176 TRMTISQMLEDEWFKK 191
R+T +Q LE W +K
Sbjct: 267 LRITATQCLEHPWIQK 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 3e-76
Identities = 81/197 (41%), Positives = 112/197 (56%), Gaps = 12/197 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ T+I +VLE + GGELFD+I + G E +A +Q++ AV Y H G+ HRDLKPEN
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LL + LKI+DFGLS I V L+ T CGTP Y APE+L Y G D+W
Sbjct: 179 LLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMW 234
Query: 120 SCGVILFVLMAGFLPF-DESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNP 174
S G+I ++L+ GF PF DE ++R+I F P W S AK L+++++ +P
Sbjct: 235 SVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDP 294
Query: 175 DTRMTISQMLEDEWFKK 191
R+T Q L+ W
Sbjct: 295 KKRLTTFQALQHPWVTG 311
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 14/213 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+Y+V E + GGEL DKI + E EA + V+Y H++GV HRDLKP N
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSN 146
Query: 63 LLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
+L + ++I DFG + + E+GLL T C T N+VAPEVL +GYD A D+
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLERQGYD-AACDI 203
Query: 119 WSCGVILFVLMAGFLPFD---ESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILD 171
WS GV+L+ ++ G+ PF + + +I S W S AK L+ ++L
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLH 263
Query: 172 PNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
+P R+T + +L W + P + +
Sbjct: 264 VDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 4e-75
Identities = 74/209 (35%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ Y++ + + GGELF+ I E +A QQ++ AV +CH GV HR+LKPEN
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPEN 140
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LLL S +K++DFGL+ + E GTP Y++PEVL Y G+ D+W
Sbjct: 141 LLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLW 197
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
+CGVIL++L+ G+ PF + + LY++I DF P W + AK LI ++L NP
Sbjct: 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
R+T ++ L+ W +E
Sbjct: 258 KRITAAEALKHPWISHRSTVASCMHRQET 286
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 2e-74
Identities = 72/197 (36%), Positives = 109/197 (55%), Gaps = 12/197 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+KT + ++LE + GGELFD +A+ L EDEA ++ +Q+++ V Y HS+ + H DLKPEN
Sbjct: 79 NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138
Query: 63 LLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
++L V +K+ DFG++ + GTP +VAPE++N + G +D+
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADM 194
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNP 174
WS GVI ++L++G PF I DF + S AK I+R+L +P
Sbjct: 195 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDP 254
Query: 175 DTRMTISQMLEDEWFKK 191
RMTI+Q LE W K
Sbjct: 255 KRRMTIAQSLEHSWIKA 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 8e-74
Identities = 72/208 (34%), Positives = 115/208 (55%), Gaps = 17/208 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++V+E ++GGELF++I K E EA ++L++AV + H GV HRDLKPEN
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136
Query: 63 LLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LL +KI DFG + + ++ L T C T +Y APE+LN GYD + D+W
Sbjct: 137 LLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 120 SCGVILFVLMAGFLPFDESN-------LMALYRKICRA--DFSCPSW--FSSGAKKLIKR 168
S GVIL+ +++G +PF + + + +KI + F +W S AK LI+
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 169 ILDPNPDTRMTISQMLEDEWFKKGYKPP 196
+L +P+ R+ +S + +EW + G +
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-73
Identities = 70/206 (33%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLK----EDEARRYFQQLINAVDYCHSRGVFHRDL 58
S +Y+V EF+DG +L +I K E A Y +Q++ A+ YCH + HRD+
Sbjct: 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDV 156
Query: 59 KPENLLLDSYG---VLKISDFGLSAISQQVREDG-LLHTACGTPNYVAPEVLNDKGYDGR 114
KP +LL S +K+ FG++ Q+ E G + GTP+++APEV+ + Y G+
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAPEVVKREPY-GK 212
Query: 115 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRIL 170
DVW CGVILF+L++G LPF + L+ I + + W S AK L++R+L
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESAKDLVRRML 271
Query: 171 DPNPDTRMTISQMLEDEWFKKGYKPP 196
+P R+T+ + L W K+ +
Sbjct: 272 MLDPAERITVYEALNHPWLKERDRYA 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-73
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H++ + H DLKPEN
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145
Query: 63 LLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
++L +K+ DFGL+ + + GTP +VAPE++N + G +D+
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADM 201
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNP 174
WS GVI ++L++G PF I DF + S AK I+++L
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKET 261
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
R+TI + L W + E V
Sbjct: 262 RKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 5e-73
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIA--KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ ++I ++LE+ GGE+F + E++ R +Q++ V Y H + H DLKP
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159
Query: 61 ENLLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 117
+N+LL G +KI DFG+S + L GTP Y+APE+LN A+D
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNYDPI-TTATD 215
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPN 173
+W+ G+I ++L+ PF + Y I + D+S ++ S A I+ +L N
Sbjct: 216 MWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKN 275
Query: 174 PDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD 207
P+ R T L W ++ F EE +
Sbjct: 276 PEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 5e-73
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y HS + H DLKPEN
Sbjct: 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144
Query: 63 LLLDSY----GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
++L +KI DFGL+ + GTP +VAPE++N + G +D+
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADM 200
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNP 174
WS GVI ++L++G PF + +F + S+ AK I+R+L +P
Sbjct: 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFDKEEE 203
RMTI L+ W K ++
Sbjct: 261 KKRMTIQDSLQHPWIKPKDTQQALSRKAS 289
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-72
Identities = 78/229 (34%), Positives = 119/229 (51%), Gaps = 18/229 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K + I++E ++GGELF +I + G E EA + + A+ + HS + HRD+KP
Sbjct: 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156
Query: 61 ENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASD 117
ENLL S VLK++DFG + + L T C TP YVAPEVL + YD ++ D
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYD-KSCD 211
Query: 118 VWSCGVILFVLMAGFLPF----DESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRI 169
+WS GVI+++L+ GF PF ++ + R+I F P W S AK+LI+ +
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL 271
Query: 170 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKE 218
L +P R+TI+Q + W + P L + +++ KE
Sbjct: 272 LKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-72
Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 27/282 (9%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVDYCHSRGVFHRDL 58
A + + IV+E +DGGELF +I G E EA + + A+ Y HS + HRD+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187
Query: 59 KPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 115
KPENLL S +LK++DFG +++ L T C TP YVAPEVL + YD ++
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGF---AKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KS 243
Query: 116 SDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRA--DFSCPSW--FSSGAKKLIK 167
D+WS GVI+++L+ G+ PF ++ +A + +I +F P W S K LI+
Sbjct: 244 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 168 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEK 227
+L P RMTI++ + W + K P + L + + + KE+
Sbjct: 304 NLLKTEPTQRMTITEFMNHPWIMQSTKVP------QTPLHTSRVL--KEDKERWEDVKEE 355
Query: 228 PVSMNAFELISRTKSFSLENLFE-KQTGLVKRETRFTSQRPP 268
S A + + ++ + + L+KR + +
Sbjct: 356 MTSALATMRVDY-EQIKIKKIEDASNPLLLKRRKKARALEAA 396
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 3e-72
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++T + ++LE + GGELFD +A+ L E+EA + +Q+++ V+Y H++ + H DLKPEN
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145
Query: 63 LLLDS----YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
++L +K+ DFGL+ + + GTP +VAPE++N + G +D+
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADM 201
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNP 174
WS GVI ++L++G PF I DF + S AK I+++L
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKET 261
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
R+TI + L W + E V
Sbjct: 262 RKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-72
Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR---------------------------------- 28
+ I +V+E GG L DK+
Sbjct: 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFR 158
Query: 29 ------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGLSA 80
+E +Q+ +A+ Y H++G+ HRD+KPEN L + +K+ DFGLS
Sbjct: 159 ESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSK 218
Query: 81 I--SQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLPFDE 137
E + T GTP +VAPEVLN G D WS GV+L +L+ G +PF
Sbjct: 219 EFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278
Query: 138 SNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
N ++ F P++ S A+ L+ +L+ N D R + L+ W +
Sbjct: 279 VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 6e-72
Identities = 76/196 (38%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ YIV E GGELFD+I K R E +A R +Q+ + + Y H + HRDLKPEN
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPEN 151
Query: 63 LLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+LL+S +KI DFGLS +++ + GT Y+APEVL Y DVW
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-GTY-DEKCDVW 206
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVIL++L++G PF N + +++ F P W S AK LI+++L +P
Sbjct: 207 SAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 176 TRMTISQMLEDEWFKK 191
R+T +Q LE W +K
Sbjct: 267 LRITATQCLEHPWIQK 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 73/202 (36%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K Y+V EF +GGELF++I + E +A +Q+++ + Y H + HRD+KPEN
Sbjct: 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176
Query: 63 LLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+LL++ +KI DFGLS+ +D L GT Y+APEVL K Y DVW
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPEVLK-KKY-NEKCDVW 231
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
SCGVI+++L+ G+ PF N + +K+ + F W S AK+LIK +L + +
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 176 TRMTISQMLEDEWFKKGYKPPH 197
R T + L W KK +
Sbjct: 292 KRCTAEEALNSRWIKKYANNIN 313
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 9e-71
Identities = 82/257 (31%), Positives = 131/257 (50%), Gaps = 18/257 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K Y+V E GGELFD+I R E +A R +Q+++ + Y H + HRDLKPEN
Sbjct: 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 156
Query: 63 LLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LLL+S ++I DFGLS + GT Y+APEVL+ Y DVW
Sbjct: 157 LLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVLH-GTY-DEKCDVW 211
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVIL++L++G PF+ +N + +K+ + F P W S AK LI+++L P
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 271
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEK-KEKPVSMNAF 234
R++ L+ EW + + ++ V++ +D + ++ T+K + +
Sbjct: 272 MRISARDALDHEWIQT-----YTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGS 326
Query: 235 ELISRTKSFSLENLFEK 251
+L S+ ++ L +F K
Sbjct: 327 KLTSQDETKELTAIFHK 343
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-71
Identities = 31/186 (16%), Positives = 66/186 (35%), Gaps = 20/186 (10%)
Query: 16 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 75
G L + H L + Q+I + H G+ H L+P +++LD G + ++
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVIL 125
F DG + + + PE+ + + D W+ G+++
Sbjct: 250 FEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
+ + LP + + I F + L++ L + R+ Q +E
Sbjct: 304 YWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 186 DEWFKK 191
+++
Sbjct: 360 TPEYEQ 365
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 1e-70
Identities = 92/297 (30%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K Y+V+E GGELFD+I + E +A +Q+++ V Y H + HRDLKPEN
Sbjct: 107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN 166
Query: 63 LLLDS---YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LLL+S ++KI DFGLSA+ + GT Y+APEVL K Y DVW
Sbjct: 167 LLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-KKY-DEKCDVW 221
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVILF+L+AG+ PF + RK+ + F P W S GAK LIK++L +
Sbjct: 222 SIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQ 281
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAI--FNDSK-----------ENLVT 222
R++ Q LE W K+ E + ++ + F +S+ L +
Sbjct: 282 RRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTS 341
Query: 223 EKKEKPVSMNAFELISRTKS--FSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEE 277
+ +E + F I + + L + G K + +I S+++
Sbjct: 342 Q-EETKELTDIFRHIDKNGDGQLDRQELID---GYSKLSGEEVAVFDLPQIESEVDA 394
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-70
Identities = 42/240 (17%), Positives = 79/240 (32%), Gaps = 48/240 (20%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ +++EF G L+ + + L E E + ++ +++ G+ HR++K
Sbjct: 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 60 PENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--------N 107
P N++ D V K++DFG + + +D + GT Y+ P++ +
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 108 DKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSC--------- 154
K Y D+WS GV + G LPF + KI S
Sbjct: 197 QKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255
Query: 155 ----------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 198
++ IL+ + + Q + H
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHH 315
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 5e-70
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS + H D++PE
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 62 NLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ + +KI +FG ++Q++ P Y APEV A+D+W
Sbjct: 132 NIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMW 187
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S G +++VL++G PF + I A F ++ S A + R+L
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247
Query: 176 TRMTISQMLEDEWFKKGYKPP 196
+RMT S+ L+ W K+ +
Sbjct: 248 SRMTASEALQHPWLKQKIERV 268
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-69
Identities = 49/289 (16%), Positives = 96/289 (33%), Gaps = 49/289 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ +++EF G L+ + + L E E + ++ +++ G+ HR++K
Sbjct: 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK 139
Query: 60 PENLLL----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--------N 107
P N++ D V K++DFG + + +D + GT Y+ P++ +
Sbjct: 140 PGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYERAVLRKDH 196
Query: 108 DKGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALYRKICRADFS---------- 153
K Y G D+WS GV + G LPF + KI S
Sbjct: 197 QKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAE 255
Query: 154 ---------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF 198
++ IL+ + + Q + H
Sbjct: 256 NGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHV 315
Query: 199 DKEEEVNLDDVDAIFNDSKENLVTE-KKEKPVSMNAFELISRTKSFSLE 246
+++ + ++ K+ + + ELI + LE
Sbjct: 316 FSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLE 364
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-68
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ + Y+V E + GG + I K E EA Q + +A+D+ H++G+ HRDLKPEN
Sbjct: 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 63 LLLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPNYVAPEVLN-----DK 109
+L + +KI DF L + L T CG+ Y+APEV+
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS 201
Query: 110 GYDGRASDVWSCGVILFVLMAGFLPFDESNL---------------MALYRKICRADFSC 154
YD R D+WS GVIL++L++G+ PF L+ I +
Sbjct: 202 IYDKRC-DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 155 PS--W--FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192
P W S AK LI ++L + R++ +Q+L+ W +
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 5e-68
Identities = 72/292 (24%), Positives = 122/292 (41%), Gaps = 22/292 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ ++ EF+ GGELF+K+ +H ++ EDEA Y +Q+ + + H H DLKPE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284
Query: 62 NLLLDSYGV--LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ + LK+ DFGL + + + GT + APEV K G +D+W
Sbjct: 285 NIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMW 340
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GV+ ++L++G PF N R + + ++ S K I+++L +P+
Sbjct: 341 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 400
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFE 235
TRMTI Q LE W G P + ++++ T+ P +
Sbjct: 401 TRMTIHQALEHPWLTPGNAPGRDSQIPSSRY-------TKIRDSIKTKYDAWPEPLPPLG 453
Query: 236 LISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVR 287
IS S + R+ + + K G +
Sbjct: 454 RISNYSSLRK----HRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSAN 501
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-68
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
SK I +V+E++DGGELFD+I + L E + + +Q+ + + H + H DLKPE
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 62 NLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N+L + +KI DFGL +++ + L GTP ++APEV+N +D+W
Sbjct: 217 NILCVNRDAKQIKIIDFGL---ARRYKPREKLKVNFGTPEFLAPEVVNYDFV-SFPTDMW 272
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
S GVI ++L++G PF N I D + S AK+ I ++L
Sbjct: 273 SVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVN 205
R++ S+ L+ W +++ N
Sbjct: 333 WRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-67
Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K ++ ++LEF+ GGELFD+IA ++ E E Y +Q + + H + H D+KPE
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 62 NLLLDSYG--VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ ++ +KI DFGL+ + D ++ T + APE+++ + G +D+W
Sbjct: 179 NIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMW 234
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPSW--FSSGAKKLIKRILDPNPD 175
+ GV+ +VL++G PF + + + + R +F ++ S AK IK +L P
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFE 235
R+T+ LE W K + N ++ + + + P A
Sbjct: 295 KRLTVHDALEHPWLKGDHSNLTSRIPSSRY--------NKIRQKIKEKYADWPAPQPA-- 344
Query: 236 LISRTKSFSLENLFEKQTGLVKRET 260
I R +FS Q +
Sbjct: 345 -IGRIANFSSLRKHRPQEYQIYDSY 368
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-66
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRG-----V 53
+ T +YIV+E+ +GG+L I K + L E+ R QL A+ CH R V
Sbjct: 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRDLKP N+ LD +K+ DFGL+ I + T GTP Y++PE +N Y+
Sbjct: 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDP 172
+ SD+WS G +L+ L A PF + L KI F P +S ++I R+L+
Sbjct: 196 K-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 254
Query: 173 NPDTRMTISQMLEDEWFKKGYKPPH 197
R ++ ++LE+ + + H
Sbjct: 255 KDYHRPSVEEILENPLILEHHHHHH 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-65
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 9/207 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+YIV+++ +GG+LF +I K +ED+ +F Q+ A+ + H R + HRD+K
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
+N+ L G +++ DFG++ + L GTP Y++PE+ +K Y+ SD+W+
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN-NKSDIWA 210
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMT 179
G +L+ L F+ ++ L KI F +S + L+ ++ NP R +
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 180 ISQMLEDEWFKKG---YKPPHFDKEEE 203
++ +LE + K + P EE
Sbjct: 271 VNSILEKGFIAKRIEKFLSPQLIAEEF 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-64
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKI--AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++I +EF D G L I + +L + A F+Q+ VDY HS+ + +RDLKP
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKP 150
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+ L +KI DFGL ++ DG + GT Y++PE ++ + Y + D+++
Sbjct: 151 SNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYA 206
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
G+IL L+ E++ + + F K L++++L P+ R
Sbjct: 207 LGLILAELLHVCDTAFETS--KFFTDLRDGII--SDIFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 181 SQMLEDEWFKK 191
S++L K
Sbjct: 263 SEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 16/210 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKI----AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+K + +++L F G L+++I K L ED+ + ++ H++G HRDL
Sbjct: 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160
Query: 59 KPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLHTACGTPNYVAPEVLNDKGY 111
KP N+LL G + D G S+Q T +Y APE+ + + +
Sbjct: 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH 220
Query: 112 D--GRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRADFSCPSW--FSSGAKKLI 166
+DVWS G +L+ +M G P+D + S P SS +L+
Sbjct: 221 CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLL 280
Query: 167 KRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
++ +P R I +L + P
Sbjct: 281 NSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-64
Identities = 57/175 (32%), Positives = 99/175 (56%), Gaps = 1/175 (0%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K+Y L + GEL I K G E R Y ++++A++Y H +G+ HRDLKPEN
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 160
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL+ ++I+DFG + + + ++ GT YV+PE+L +K ++SD+W+ G
Sbjct: 161 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALG 219
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR 177
I++ L+AG PF N +++KI + ++ P F A+ L++++L + R
Sbjct: 220 CIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-63
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRG--VFH 55
+ +++L + G+L + + K G L D + F Q AV + H + + H
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161
Query: 56 RDLKPENLLLDSYGVLKISDFGLSAI-------SQQVREDGLLH---TACGTPNYVAPEV 105
RDLK ENLLL + G +K+ DFG + S + L+ T TP Y PE+
Sbjct: 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI 221
Query: 106 LN--DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--FSSG 161
++ G D+W+ G IL++L PF++ + I +S P +
Sbjct: 222 IDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTV 277
Query: 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197
LI+ +L NP+ R++I++++ + +
Sbjct: 278 FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-60
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 17/208 (8%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLK---EDEARRYFQQLINAVDYCHSRGVFHRDLK 59
K +YI ++ L D + ++ F Q+ AV++ HS+G+ HRDLK
Sbjct: 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145
Query: 60 PENLLLDSYGVLKISDFGLSAI----------SQQVREDGLLHTACGTPNYVAPEVLNDK 109
P N+ V+K+ DFGL + GT Y++PE ++
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205
Query: 110 GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWFSSGAKKLIKR 168
Y D++S G+ILF L+ F + + + F + +++
Sbjct: 206 SYS-HKVDIFSLGLILFELLYPF--STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD 262
Query: 169 ILDPNPDTRMTISQMLEDEWFKKGYKPP 196
+L P+P R ++E+ F+ P
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-60
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++ IVLE D G+L I + + E +YF QL +A+++ HSR V HRD+K
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK 163
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
P N+ + + GV+K+ D GL + H+ GTP Y++PE +++ GY+ SD+W
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIW 220
Query: 120 SCGVILFVLMAGFLPF--DESNLMALYRKICRADFSC--PSWFSSGAKKLIKRILDPNPD 175
S G +L+ + A PF D+ NL +L +KI + D+ +S ++L+ ++P+P+
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEE 202
R ++ + + +
Sbjct: 281 KRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 14/212 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ YI +E L + + K E QQ + + + HS + HRDLKP
Sbjct: 89 DRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147
Query: 62 NLLLDSYG-----VLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYD--G 113
N+L+ ISDFGL ++ GT ++APE+L++ +
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207
Query: 114 RASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFSCPSWF---SSGAKKLIKRI 169
D++S G + + +++ G PF +S + C A++LI+++
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM 267
Query: 170 LDPNPDTRMTISQMLEDEWFKKGYKPPHFDKE 201
+ +P R + +L+ +F K F ++
Sbjct: 268 IAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 61/246 (24%), Positives = 94/246 (38%), Gaps = 44/246 (17%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFH 55
+ +YI LE L D + KE +Q+ + V + HS + H
Sbjct: 80 TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIH 138
Query: 56 RDLKPENLLLDSYGV-------------LKISDFGLSAI--SQQVREDGLLHTACGTPNY 100
RDLKP+N+L+ + + ISDFGL S Q L+ GT +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 101 VAPEVLNDKGYD------GRASDVWSCGVILFVLM-AGFLPFDESNLMALYRKICRADFS 153
APE+L + R+ D++S G + + ++ G PF + I R FS
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--ESNIIRGIFS 256
Query: 154 CPSW-------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF-----DKE 201
+ A LI +++D +P R T ++L F K F D+
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRL 316
Query: 202 EEVNLD 207
E N D
Sbjct: 317 EIENRD 322
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-59
Identities = 78/247 (31%), Positives = 130/247 (52%), Gaps = 40/247 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+I++++++I+GGELF + K R A+ Y ++ A++Y HS+ + +RDLKPEN
Sbjct: 77 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 136
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +KI+DFG + + +T CGTP+Y+APEV++ K Y ++ D WS G
Sbjct: 137 ILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFG 190
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++++ ++AG+ PF +SN M Y KI A+ P +F+ K L+ R++ + R+ Q
Sbjct: 191 ILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 183 MLEDE-----WFK---------KGYKPP-------------HFDK--EEEVNL-----DD 208
++ WFK + + P FDK EE++N D
Sbjct: 251 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDP 310
Query: 209 VDAIFND 215
+F D
Sbjct: 311 YADLFRD 317
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-59
Identities = 74/244 (30%), Positives = 120/244 (49%), Gaps = 37/244 (15%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS + +RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
LL+D G ++++DFG + R G T CGTP +APE++ KGY +A D W+ G
Sbjct: 172 LLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALG 225
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+++ + AG+ PF + +Y KI PS FSS K L++ +L + R +
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285
Query: 183 MLEDE-----WFK---------KGYKPP------------HFDK--EEEVNL---DDVDA 211
++ WF + + P +FD EEE+ + +
Sbjct: 286 NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGK 345
Query: 212 IFND 215
F +
Sbjct: 346 EFTE 349
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-59
Identities = 70/235 (29%), Positives = 108/235 (45%), Gaps = 38/235 (16%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLK--EDEARRYFQQLINAVDYCHSRGVFHRDL 58
A + + IV+E +DGGELF +I G E EA + + A+ Y HS + HRD+
Sbjct: 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 143
Query: 59 KPENLLLDSYG---VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 115
KPENLL S +LK++DFG A E + YD ++
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGF-----------------------AKETTG-EKYD-KS 178
Query: 116 SDVWSCGVILFVLMAGFLPFDESNLMA----LYRKICRA--DFSCPSW--FSSGAKKLIK 167
D+WS GVI+++L+ G+ PF ++ +A + +I +F P W S K LI+
Sbjct: 179 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238
Query: 168 RILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVT 222
+L P RMTI++ + W + K P L + + D KE + +
Sbjct: 239 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTS 293
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-59
Identities = 31/180 (17%), Positives = 63/180 (35%), Gaps = 9/180 (5%)
Query: 16 GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 75
G L + H L + Q+I + H G+ H L+P +++LD G + ++
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD----GRASDVWSCGVILFVLMAG 131
F + + P A +L + A D W+ G+ ++ +
Sbjct: 255 FEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 132 FLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
LP + + I F + L++ L + R+ Q +E +++
Sbjct: 314 DLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-58
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 10/190 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+Y+ E G L G L E + Y + + A+ + HS+G+ H D+KP N
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+ L G K+ DFGL ++ G G P Y+APE+L Y A+DV+S G
Sbjct: 188 IFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SYG-TAADVFSLG 242
Query: 123 VILFVLMAGF-LPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+ + + LP L + +F + SS + ++ +L+P+P R T
Sbjct: 243 LTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRATAE 300
Query: 182 QMLEDEWFKK 191
+L ++
Sbjct: 301 ALLALPVLRQ 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 34/201 (16%), Positives = 62/201 (30%), Gaps = 21/201 (10%)
Query: 7 IYIVLEFIDG-----GELFDKIAKHGRLKEDEARRYF-QQLINAVDYCHSRGVFHRDLKP 60
+++ D + + A QLI S+G+ H P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVW 119
+NL + G L + D + + Y E LN A + W
Sbjct: 223 DNLFIMPDGRLMLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAW 277
Query: 120 SCGVILFVLMAGFLPFDESN--LMALYRKICRA-------DFSCPSWFSSGAKKLIKRIL 170
G+ ++ + FLPF + +++ F + K LI R L
Sbjct: 278 QLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337
Query: 171 DPNPDTRMTISQMLEDEWFKK 191
+ + R+ + +E F +
Sbjct: 338 NFDRRRRLLPLEAMETPEFLQ 358
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-57
Identities = 70/225 (31%), Positives = 121/225 (53%), Gaps = 29/225 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++ K+Y++L+F+ GG+LF +++K E++ + Y +L A+D+ HS G+ +RDLKPEN
Sbjct: 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +K++DFGLS + + + ++ CGT Y+APEV+N +G+ +++D WS G
Sbjct: 157 ILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFG 213
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V++F ++ G LPF + I +A P + S A+ L++ + NP R+
Sbjct: 214 VLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGP 273
Query: 183 MLEDE-----WFK---------KGYKPP------------HFDKE 201
+E +F + PP +FD E
Sbjct: 274 DGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPE 318
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 7e-57
Identities = 67/225 (29%), Positives = 116/225 (51%), Gaps = 29/225 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+Y++LE++ GGELF ++ + G ED A Y ++ A+ + H +G+ +RDLKPEN
Sbjct: 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
++L+ G +K++DFGL + + + + HT CGT Y+APE+L G+ RA D WS G
Sbjct: 152 IMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLG 208
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
+++ ++ G PF N KI + + P + + A+ L+K++L N +R+
Sbjct: 209 ALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGP 268
Query: 183 MLEDE-----WFK---------KGYKPP------------HFDKE 201
E +F+ + +PP FD +
Sbjct: 269 GDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSK 313
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 5e-56
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDE---ARRYFQQLINAVDYCHSRGVFHRDLKP 60
K +YI ++ L D + + L++ E F Q+ AV++ HS+G+ HRDLKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVRED----------GLLHTACGTPNYVAPEVLNDKG 110
N+ V+K+ DFGL Q E+ GT Y++PE ++
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 111 YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRI 169
Y D++S G+ILF L+ F E + + + F + +++ +
Sbjct: 253 YS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDM 309
Query: 170 LDPNPDTRMTISQMLEDEWFKK 191
L P+P R + ++E+ F+
Sbjct: 310 LSPSPTERPEATDIIENAIFEN 331
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-55
Identities = 77/250 (30%), Positives = 120/250 (48%), Gaps = 32/250 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V +RD+K EN
Sbjct: 76 THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
L+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y GRA D W G
Sbjct: 136 LMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLG 192
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+++ +M G LPF + L+ I + P S AK L+ +L +P R+
Sbjct: 193 VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 183 MLEDE-----WFK---------KGYKPP------------HFDKE---EEVNLDDVDAIF 213
E +F K PP +FD E + + + D
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYD 312
Query: 214 NDSKENLVTE 223
+ L
Sbjct: 313 SLGLLELDQR 322
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-55
Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+Y VL++I+GGELF + + E AR Y ++ +A+ Y HS + +RDLKPEN
Sbjct: 110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G + ++DFGL + + + T CGTP Y+APEVL+ + Y R D W G
Sbjct: 170 ILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLG 226
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
+L+ ++ G PF N +Y I ++ A+ L++ +L + R+
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286
Query: 183 MLED----EWFK---------KGYKPP------------HFDKE 201
+ +F K PP HFD E
Sbjct: 287 DFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPE 330
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-55
Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 30/226 (13%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +++ V+EF++GG+L I K R E AR Y ++I+A+ + H +G+ +RDLK +N
Sbjct: 95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G K++DFG+ + + T CGTP+Y+APE+L + Y G A D W+ G
Sbjct: 155 VLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMG 211
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TIS 181
V+L+ ++ G PF+ N L+ I + P+W A ++K + NP R+ +++
Sbjct: 212 VLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLT 271
Query: 182 QMLEDE-----WFK---------KGYKPP------------HFDKE 201
Q E +FK + +PP +FD +
Sbjct: 272 QGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPD 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-55
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+E+++GG+L I + A Y ++I + + HS+G+ +RDLK +N
Sbjct: 89 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 148
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +KI+DFG+ + + D +T CGTP+Y+APE+L + Y + D WS G
Sbjct: 149 ILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFG 205
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-TIS 181
V+L+ ++ G PF + L+ I + P W AK L+ ++ P+ R+
Sbjct: 206 VLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 265
Query: 182 QMLEDEWFK---------KGYKPP------------HFDKE 201
+ + F+ K PP +FDKE
Sbjct: 266 DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKE 306
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-55
Identities = 64/224 (28%), Positives = 118/224 (52%), Gaps = 28/224 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++Y V+E+++GG+L I + GR KE A Y ++ + + S+G+ +RDLK +N
Sbjct: 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D W+ G
Sbjct: 152 VMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFG 208
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+L+ ++AG PF+ + L++ I + + P S A + K ++ +P R+
Sbjct: 209 VLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP 268
Query: 183 MLEDE-----WFK---------KGYKPP-----------HFDKE 201
E + +F+ K +PP +FD+
Sbjct: 269 EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRNAENFDRF 312
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-55
Identities = 60/233 (25%), Positives = 114/233 (48%), Gaps = 31/233 (13%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ +++V++ + GG+L + ++ KE+ + + +L+ A+DY ++ + HRD+KP+N
Sbjct: 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVW 119
+LLD +G + I+DF ++A+ + + + T GT Y+APE+ + + GY A D W
Sbjct: 146 ILLDEHGHVHITDFNIAAM---LPRETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWW 201
Query: 120 SCGVILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
S GV + L+ G P+ ++ + + PS +S L+K++L+PNPD
Sbjct: 202 SLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQ 261
Query: 177 RM-TISQMLEDEWFK---------KGYKPP--------HFDKE---EEVNLDD 208
R +S + + K P + D EE+ L+
Sbjct: 262 RFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELEEMILES 314
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-55
Identities = 60/133 (45%), Positives = 94/133 (70%)
Query: 226 EKPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFN 285
E P+ MNAFE+I+ ++ +L LF+++ VKR+TRF S+R P+EI++ IE A +GF
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 286 VRKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGL 345
N+K +L+G + + GQL+V E++EVAP+L +V+VRK G+TLE+HKFYKK S L
Sbjct: 62 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121
Query: 346 KDVVWQAEENKEE 358
++++W+A E +
Sbjct: 122 ENIIWRATEGIPK 134
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-53
Identities = 62/184 (33%), Positives = 106/184 (57%), Gaps = 12/184 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG+ +RDLK +N
Sbjct: 81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 140
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y G + D W+ G
Sbjct: 141 VLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALG 197
Query: 123 VILFVLMAGFLPFDESNLMA---------LYRKICRADFSCPSWFSSGAKKLIKRILDPN 173
V++F +MAG PFD L++ I P S A ++K L+ +
Sbjct: 198 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD 257
Query: 174 PDTR 177
P R
Sbjct: 258 PKER 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-52
Identities = 62/181 (34%), Positives = 112/181 (61%), Gaps = 8/181 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++TK++++L++I+GGELF +++ R E E + Y +++ A+++ H G+ +RD+K EN
Sbjct: 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL--NDKGYDGRASDVWS 120
+LLDS G + ++DFGLS E + CGT Y+AP+++ D G+ +A D WS
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWS 247
Query: 121 CGVILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
GV+++ L+ G PF ++++ + R+I +++ P S+ AK LI+R+L +P
Sbjct: 248 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKK 307
Query: 177 R 177
R
Sbjct: 308 R 308
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 62/184 (33%), Positives = 106/184 (57%), Gaps = 12/184 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++++ V+E+++GG+L + + +L E+ AR Y ++ A++Y H RG+ +RDLK +N
Sbjct: 124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G +K++D+G+ + +R T CGTPNY+APE+L + Y G + D W+ G
Sbjct: 184 VLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALG 240
Query: 123 VILFVLMAGFLPFDESNLMA---------LYRKICRADFSCPSWFSSGAKKLIKRILDPN 173
V++F +MAG PFD L++ I P S A ++K L+ +
Sbjct: 241 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD 300
Query: 174 PDTR 177
P R
Sbjct: 301 PKER 304
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 64/224 (28%), Positives = 118/224 (52%), Gaps = 28/224 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++Y V+E+++GG+L I + GR KE A Y ++ + + S+G+ +RDLK +N
Sbjct: 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
++LDS G +KI+DFG+ + + + T CGTP+Y+APE++ + Y G++ D W+ G
Sbjct: 473 VMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFG 529
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+L+ ++AG PF+ + L++ I + + P S A + K ++ +P R+
Sbjct: 530 VLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP 589
Query: 183 MLEDE-----WFK---------KGYKPP-----------HFDKE 201
E + +F+ K +PP +FD+
Sbjct: 590 EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRNAENFDRF 633
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 76/226 (33%), Positives = 115/226 (50%), Gaps = 30/226 (13%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPE 61
+ ++ V+E+ +GGELF +++ ED AR Y ++++A+DY HS + V +RDLK E
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
NL+LD G +KI+DFGL + +++ + T CGTP Y+APEVL D Y GRA D W
Sbjct: 279 NLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGL 335
Query: 122 GVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
GV+++ +M G LPF + L+ I + P AK L+ +L +P R+
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGG 395
Query: 182 QMLEDE-----WFK---------KGYKPP------------HFDKE 201
E +F K PP +FD+E
Sbjct: 396 SEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEE 441
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-50
Identities = 30/212 (14%), Positives = 72/212 (33%), Gaps = 26/212 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-----LKEDEARRYFQQLINAVDYCHSRGVFHRD 57
+ +V E G L + I + + + + +++ ++ H + H D
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGD 197
Query: 58 LKPENLLL-----------DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 106
+KP+N +L D L + D G S + + + C T + E+L
Sbjct: 198 IKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257
Query: 107 NDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRADFSCPSWFSSGAKKL 165
++K ++ D + ++ ++ G ++ + R W +
Sbjct: 258 SNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW-----NEF 311
Query: 166 IKRILDPNPDTRMTISQMLE---DEWFKKGYK 194
+L+ + +L + F++ Y
Sbjct: 312 FHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 67/237 (28%), Positives = 109/237 (45%), Gaps = 40/237 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ +Y+V+E+ GG+L ++K G R+ + AR Y +++ A+D H G HRD+KP+
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNYVAPEVLNDKGYD------G 113
N+LLD G ++++DFG ++R DG + A GTP+Y++PE+L G G
Sbjct: 192 NILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPS---WFSSGAKKLIKR 168
D W+ GV + + G PF + Y KI + S P A+ I+R
Sbjct: 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308
Query: 169 ILDPNPDTRMT---ISQMLEDEWFK-------KGYKPP------------HFDKEEE 203
+L P+TR+ +F + PP +FD E+
Sbjct: 309 LLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVED 364
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 58/250 (23%), Positives = 105/250 (42%), Gaps = 42/250 (16%)
Query: 3 SKTKIYIVLEFIDGGELF----DKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+KT + +V+ ++GG++ + + +E A Y Q+++ +++ H R + +RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
KPEN+LLD G ++ISD GL+ + GTP ++APE+L + Y + D
Sbjct: 316 KPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDY 372
Query: 119 WSCGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSWFSSGAKKLIKRILDPNP 174
++ GV L+ ++A PF L +++ + P FS +K + +L +P
Sbjct: 373 FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDP 432
Query: 175 DTRMTISQMLEDE-----WFK---------KGYKPP-----------------HFDKEEE 203
+ R+ D F+ PP F +
Sbjct: 433 EKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKG 492
Query: 204 VNLDDVDAIF 213
V + D F
Sbjct: 493 VAFEKADTEF 502
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-49
Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 40/236 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+Y+V+++ GG+L ++K RL E+ AR Y +++ A+D H HRD+KP+
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNYVAPEVLNDK-----GYDGR 114
N+L+D G ++++DFG ++ EDG + A GTP+Y++PE+L Y G
Sbjct: 205 NILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GP 260
Query: 115 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSCPSW---FSSGAKKLIKRI 169
D WS GV ++ ++ G PF +L+ Y KI + F P+ S AK LI+R+
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320
Query: 170 LDPNPDTRMT---ISQMLEDEWFK-------KGYKPP------------HFDKEEE 203
+ R+ I + +F + + P +FD +++
Sbjct: 321 ICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDD 375
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-48
Identities = 73/234 (31%), Positives = 117/234 (50%), Gaps = 38/234 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+Y+V+E++ GG+L + + + E AR Y +++ A+D HS G HRD+KP+N
Sbjct: 140 DDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 198
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLL--HTACGTPNYVAPEVLNDKGYD---GRASD 117
+LLD G LK++DFG ++ ++G++ TA GTP+Y++PEVL +G D GR D
Sbjct: 199 MLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKI--CRADFSCPS--WFSSGAKKLIKRILDPN 173
WS GV L+ ++ G PF +L+ Y KI + + P S AK LI L +
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-D 314
Query: 174 PDTRMT---ISQMLEDEWFK---------KGYKPP------------HFDKEEE 203
+ R+ + ++ +FK + P +FD EE
Sbjct: 315 REVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEE 368
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 65/244 (26%), Positives = 110/244 (45%), Gaps = 40/244 (16%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+ +L+ ++GG+L +++HG E + R Y ++I +++ H+R V +RDLKP N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD +G ++ISD GL+ H + GT Y+APEVL ++D +S G
Sbjct: 323 ILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 378
Query: 123 VILFVLMAGFLPF---DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
+LF L+ G PF + + R P FS + L++ +L + + R+
Sbjct: 379 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 438
Query: 180 ISQMLEDE-----WFK---------KGYKPP-----------------HFDKE--EEVNL 206
E +F+ + Y PP FD+E + + L
Sbjct: 439 CLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKL 498
Query: 207 DDVD 210
D D
Sbjct: 499 LDSD 502
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+K + +VL ++GG+L I G+ E A Y ++ ++ H + +RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
EN+LLD +G ++ISD GL + V E + GT Y+APEV+ ++ Y + D W+
Sbjct: 315 ENILLDDHGHIRISDLGL---AVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWA 370
Query: 121 CGVILFVLMAGFLPFDESNLMA----LYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
G +L+ ++AG PF + + R + FS A+ L ++L +P
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 177 RMTISQMLEDE-----WFK---------KGYKPPHFDKEEEVNLDDV 209
R+ E FK +PP + + DV
Sbjct: 431 RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDV 477
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-45
Identities = 39/213 (18%), Positives = 76/213 (35%), Gaps = 35/213 (16%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ I E+ +GG L D I+++ R KE E + Q+ + Y HS + H D+K
Sbjct: 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIK 142
Query: 60 PENLLLDSYGVL-------------------KISDFGLSAISQQVREDGLLHTACGTPNY 100
P N+ + + KI D G V G +
Sbjct: 143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRISSPQVEEGDSRF 196
Query: 101 VAPEVLN-DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-CPSWF 158
+A EVL + + +D+++ + + + +I + P
Sbjct: 197 LANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVL 252
Query: 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
S +L+K ++ P+P+ R + +++
Sbjct: 253 SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-44
Identities = 30/127 (23%), Positives = 54/127 (42%), Gaps = 7/127 (5%)
Query: 227 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNV 286
MNAF++IS + F+L LF R RF S ++ ++EE V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 287 -RKGNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYK-KFSSG 344
+K + MK++G +KG ++ E+ ++ L ++EVRK +
Sbjct: 61 AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
Query: 345 LKDVVWQ 351
++V +
Sbjct: 117 FVELVHE 123
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 48/195 (24%), Positives = 80/195 (41%), Gaps = 8/195 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ I +E ++GG L I + G L ED A Y Q + ++Y H+R + H D+K +N
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180
Query: 63 LLLDSYGVL-KISDFGLSAI---SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
+LL S G + DFG + + GT ++APEV+ K D D+
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDI 239
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPD 175
WS ++ ++ G P+ + L KI P + + I+ L P
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 176 TRMTISQMLEDEWFK 190
R + ++
Sbjct: 300 HRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEA--RRYFQQLINAVDYCHSRGVFHRDLK 59
I I +E + GG L + +K G LK++E Y +Q++ + Y H + HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 60 PENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN--DKGYDGRAS 116
+N+L+++Y GVLKISDFG S + T GT Y+APE+++ +GY G+A+
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGY-GKAA 206
Query: 117 DVWSCGVILFVLMAGFLPF-DESNLMALYRKICRADFS--CPSWFSSGAKKLIKRILDPN 173
D+WS G + + G PF + A K+ P S+ AK I + +P+
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266
Query: 174 PDTRMTISQMLEDEWFKKGYK 194
PD R + +L DE+ K K
Sbjct: 267 PDKRACANDLLVDEFLKVSSK 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 47/195 (24%), Positives = 91/195 (46%), Gaps = 12/195 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKP 60
K I +V E + G L + + +K R + +Q++ + + H+R + HRDLK
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159
Query: 61 ENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+N+ + G +KI D GL+ + + GTP ++APE+ + YD + DV+
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYD-ESVDVY 213
Query: 120 SCGVILFVLMAGFLPF-DESNLMALYRKICRAD--FSCPSWFSSGAKKLIKRILDPNPDT 176
+ G+ + + P+ + N +YR++ S K++I+ + N D
Sbjct: 214 AFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDE 273
Query: 177 RMTISQMLEDEWFKK 191
R +I +L +F++
Sbjct: 274 RYSIKDLLNHAFFQE 288
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-37
Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 12/196 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ ++ IV ++ +G L+ + A + + + +Q +DY H++ + HRDLK
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD--GRASDVW 119
N+ L +KI DFGL+ + G+ ++APEV+ + + SDV+
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 120 SCGVILFVLMAGFLPFDE-SNLMALYRKICR-----ADFSCPSWFSSGAKKLIKRILDPN 173
+ G++L+ LM G LP+ +N + + R S K+L+ L
Sbjct: 210 AFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKK 269
Query: 174 PDTR---MTISQMLED 186
D R I +E+
Sbjct: 270 RDERPSFPRILAEIEE 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-35
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ---QLINAVDYCHSRG--VFHRDLKP 60
+ IV E++ G L+ + K G ++ + RR + ++Y H+R + HR+LK
Sbjct: 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
NLL+D +K+ DFGLS + + +A GTP ++APEVL D+ + SDV+S
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYS 224
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPNPDTR- 177
GVIL+ L P+ N + + P + +I+ P R
Sbjct: 225 FGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
Query: 178 --MTISQMLEDEWFKKGYKPPH 197
TI +L K PP+
Sbjct: 285 SFATIMDLLR-PLIKSAVPPPN 305
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENL 63
T ++I +E + K G + E + ++ A+ Y GV HRD+KP N+
Sbjct: 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-----NDKGYDGRASDV 118
LLD G +K+ DFG+S ++ +D + G Y+APE + YD R +DV
Sbjct: 157 LLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADV 212
Query: 119 WSCGVILFVLMAGFLPFDE-SNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNP 174
WS G+ L L G P+ + K+ + + FS + +K L +
Sbjct: 213 WSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDH 272
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFD 199
R +++LE + K+ Y+ D
Sbjct: 273 RKRPKYNKLLEHSFIKR-YETLEVD 296
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 34/225 (15%)
Query: 6 KIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ I+ G L+ + L ++ R+ Q+++ + Y H++G+ H+DLK +N+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162
Query: 65 LDSYGVLKISDFGLS---AISQQVREDGLLHTACGTPNYVAPEVL---------NDKGYD 112
D+ G + I+DFGL + Q R + L G ++APE++ + +
Sbjct: 163 YDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 113 GRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICR------ADFSCPSWFSSGAKKLI 166
+ SDV++ G I + L A PF A+ ++ + ++
Sbjct: 222 -KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEI----SDIL 276
Query: 167 KRILDPNPDTR---MTISQMLEDEWFKKGYK----PPHFDKEEEV 204
+ R + MLE K + P HF K E+
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEK--LPKRNRRLSHPGHFWKSAEL 319
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 55/187 (29%), Positives = 96/187 (51%), Gaps = 12/187 (6%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
Y+V+E+I+G L + I HG L D A + Q+++ + + H + HRD+KP+N+L+DS
Sbjct: 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
LKI DFG I++ + E L T GT Y +PE + D +D++S G++L
Sbjct: 147 NKTLKIFDFG---IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVL 202
Query: 126 FVLMAGFLPFD-ESNLMALYRKICRADFSCPSWFSSG----AKKLIKRILDPNPDTR-MT 179
+ ++ G PF+ E+ + + I + + + +I R + + R T
Sbjct: 203 YEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262
Query: 180 ISQMLED 186
I +M +D
Sbjct: 263 IQEMKDD 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 40/196 (20%), Positives = 80/196 (40%), Gaps = 26/196 (13%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD------YCHSRG--VFHRD 57
++ ++ G L++ + + D+++ + A+D + H+ +
Sbjct: 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGMAFLHTLEPLIPRHA 138
Query: 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG--RA 115
L ++++D +IS + Q P +VAPE L K D R+
Sbjct: 139 LNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRS 191
Query: 116 SDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDPN 173
+D+WS V+L+ L+ +PF + + M + K+ + P S KL+K ++ +
Sbjct: 192 ADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNED 251
Query: 174 PDTR---MTISQMLED 186
P R I +LE
Sbjct: 252 PAKRPKFDMIVPILEK 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 56/242 (23%), Positives = 95/242 (39%), Gaps = 57/242 (23%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K ++++V E+ D D+ + + E + Q + AV++CH HRD+KP
Sbjct: 73 RKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKP 130
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV------APEVL-NDKGYD 112
EN+L+ + V+K+ DFG + ++ + + V +PE+L D Y
Sbjct: 131 ENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYRSPELLVGDTQY- 180
Query: 113 GRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA-------------------D 151
G DVW+ G + L++G P S++ LY I +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGK-SDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 152 FSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
P S A L+K L +P R+T Q+L +F+ +
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298
Query: 200 KE 201
KE
Sbjct: 299 KE 300
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
++++++EF+ GG L D I RL E++ + ++ A+ Y H++GV HRD+K +++
Sbjct: 114 GEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LL G +K+SDFG A Q ++ + GTP ++APEV++ Y D+WS G
Sbjct: 173 LLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYATEV-DIWSLG- 228
Query: 124 ILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRM 178
I+ + M P F +S + A+ R + + S + ++R+L +P R
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
Query: 179 TISQMLEDEWFKKGYKP 195
T ++L+ + + P
Sbjct: 288 TAQELLDHPFLLQTGLP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 27/202 (13%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLI---NAVDYCHSR---GVFH 55
A + +V+E+ +GG L++ + L A + V Y HS + H
Sbjct: 69 ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 56 RDLKPENLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 114
RDLKP NLLL + VLKI DFG + Q + G+ ++APEV Y
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYS-E 182
Query: 115 ASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADF------SCPSWFSSGAKKLIK 167
DV+S G+IL+ ++ PFDE + P + L+
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI----ESLMT 238
Query: 168 RILDPNPDTR---MTISQMLED 186
R +P R I +++
Sbjct: 239 RCWSKDPSQRPSMEEIVKIMTH 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 36/131 (27%), Positives = 66/131 (50%), Gaps = 6/131 (4%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
Y+ + I+G +L + + G L A +Q+ +A+D H+ G HRD+KPEN+L+ +
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 68 YGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+ DFG I+ ++ L GT Y+APE ++ R +D+++ +L
Sbjct: 170 DDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVL 225
Query: 126 FVLMAGFLPFD 136
+ + G P+
Sbjct: 226 YECLTGSPPYQ 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 20/181 (11%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
YIV+E++ G L +L EA Y +++ A+ Y HS G+ + DLKPEN++L
Sbjct: 160 YIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217
Query: 68 YGVLKISDFGL-SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
+ K+ D G S I+ G GTP + APE++ + A+D+++ G L
Sbjct: 218 EQL-KLIDLGAVSRINS----FG---YLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLA 267
Query: 127 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTR-MTISQMLE 185
L + + L + L++R +DP+P R T +M
Sbjct: 268 ALTLDLPTRNGRYVDGLPEDD--PVLKTYDSYGR----LLRRAIDPDPRQRFTTAEEMSA 321
Query: 186 D 186
Sbjct: 322 Q 322
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 57/242 (23%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K + Y+V EF+D + + L ++Y Q+IN + +CHS + HRD+KP
Sbjct: 95 KKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV------APEVL-NDKGYD 112
EN+L+ GV+K+ DFG + ++ + + V APE+L D Y
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----DEVATRWYRAPELLVGDVKY- 202
Query: 113 GRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA-------------------D 151
G+A DVW+ G ++ + G P D S++ LY I
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGD-SDIDQLY-HIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 152 FSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
P S L K+ L +PD R +++L ++F+ F
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320
Query: 200 KE 201
+E
Sbjct: 321 QE 322
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
YIV+E++DG L D + G + A A+++ H G+ HRD+KP N+++ +
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTAC--GTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+K+ DFG+ A + + + TA GT Y++PE D R SDV+S G +L
Sbjct: 152 TNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVL 209
Query: 126 FVLMAGFLPFD-ESNLMALYRKICRADFSCPSWFSSG----AKKLIKRILDPNPDTR-MT 179
+ ++ G PF +S + Y+ + R D PS G ++ + L NP+ R T
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 180 ISQMLED 186
++M D
Sbjct: 269 AAEMRAD 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
++++V+E++ GG L D + + E + ++ + A+++ HS V HRD+K +N+
Sbjct: 89 GDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LL G +K++DFG A Q E T GTP ++APEV+ K Y + D+WS G
Sbjct: 148 LLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV-DIWSLG- 203
Query: 124 ILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTRM 178
I+ + M P +E+ L ALY I P S+ + + R L+ + + R
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYL-IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 262
Query: 179 TISQMLEDEWFKKGYKP 195
+ ++L+ ++ K
Sbjct: 263 SAKELLQHQFLKIAKPL 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 32/206 (15%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
++ + E+I GG L I + + + + + + Y HS + HRDL N L
Sbjct: 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140
Query: 65 LDSYGVLKISDFGLSAI------------SQQVREDGLLHTACGTPNYVAPEVLNDKGYD 112
+ + ++DFGL+ + S + + +T G P ++APE++N + YD
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 113 GRASDVWSCGVILFVLMAGFLPFDESNLM---------ALYRKICRADFSCPSWFSSGAK 163
DV+S G++L ++ + + C + CP F
Sbjct: 201 -EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN--CPPSFF---- 253
Query: 164 KLIKRILDPNPDTR---MTISQMLED 186
+ R D +P+ R + + LE
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 4 KTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
T ++IV+E+ G + D I ++ L EDE Q + ++Y H HRD+K N
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN 155
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL++ G K++DFG++ Q +T GTP ++APEV+ + GY+ A D+WS G
Sbjct: 156 ILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA-DIWSLG 212
Query: 123 VILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNPDTR 177
I + MA P D + A++ I F P +S +K+ L +P+ R
Sbjct: 213 -ITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
Query: 178 MTISQMLEDEWFKKGYKP 195
T +Q+L+ + +
Sbjct: 271 ATATQLLQHPFVRSAKGV 288
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPEN 62
+ +V+EF GG L ++ R+ D + Q+ ++Y H + HRDLK N
Sbjct: 80 NLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138
Query: 63 LLLDSYG--------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR 114
+L+ +LKI+DFGL+ + +A G ++APEV+ + +
Sbjct: 139 ILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRASMFS-K 193
Query: 115 ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFSSGAKKLIKRILDP 172
SDVWS GV+L+ L+ G +PF + +A+ + PS KL++ +P
Sbjct: 194 GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNP 253
Query: 173 NPDTR---MTISQMLED 186
+P +R I L
Sbjct: 254 DPHSRPSFTNILDQLTT 270
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 51/240 (21%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG-VFHRDLKPENL 63
+I I +E +DGG L + K GR+ E + +I + Y + + HRD+KP N+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L++S G +K+ DFG+S D + ++ GT +Y++PE L Y + SD+WS G+
Sbjct: 164 LVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGL 218
Query: 124 ILFVLMAGFLPFDESNLMALYRKICRADFSCPSW-------------------------- 157
L + G P + L +
Sbjct: 219 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIF 278
Query: 158 ------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
FS + + + L NP R + Q++ + K+ D
Sbjct: 279 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR-SDAEEVD 337
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 5 TKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHS-RGVFHRDL 58
++I +E +D DK K + ED + ++ A+++ HS V HRD+
Sbjct: 79 GDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV----LNDKGYDGR 114
KP N+L+++ G +K+ DFG+S + +D G Y+APE LN KGY +
Sbjct: 137 KPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVK 193
Query: 115 ASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD--FSCPSWFSSGAKKLIKRILD 171
SD+WS G+ + L P+ +++ FS+ + L
Sbjct: 194 -SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLK 252
Query: 172 PNPDTRMTISQMLEDEWFKK 191
N R T ++++ +F
Sbjct: 253 KNSKERPTYPELMQHPFFTL 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 59/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
TK++I++E++ GG D + + G L E + ++++ +DY HS HRD+K N+
Sbjct: 92 DTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LL +G +K++DFG++ Q +T GTP ++APEV+ YD +A D+WS G+
Sbjct: 151 LLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA-DIWSLGI 207
Query: 124 ILFVLMAGFLPFDESNLM-ALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDTRM 178
L G P E + M L+ I + + P +S K+ ++ L+ P R
Sbjct: 208 TAIELARGEPPHSELHPMKVLF-LIPKNN---PPTLEGNYSKPLKEFVEACLNKEPSFRP 263
Query: 179 TISQMLEDEWFKKGYKPPHFDKE 201
T ++L+ ++ + K + E
Sbjct: 264 TAKELLKHKFILRNAKKTSYLTE 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 43/202 (21%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRG--VFHRDL 58
+V+EF+ G+L+ ++ +K R + ++Y ++ + HRDL
Sbjct: 91 LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150
Query: 59 KPENLLLDSYG-----VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG--Y 111
+ N+ L S K++DFGLS S + G ++APE + + Y
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESY 205
Query: 112 DGRASDVWSCGVILFVLMAGFLPFDESNL--MALYRKICRADF--SCPSWFSSGAKKLIK 167
+D +S +IL+ ++ G PFDE + + I + P + +I+
Sbjct: 206 T-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIE 264
Query: 168 RILDPNPDTR---MTISQMLED 186
+P R I + L +
Sbjct: 265 LCWSGDPKKRPHFSYIVKELSE 286
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 58/238 (24%)
Query: 1 MASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+TK+ +V E +D DK+ + G + + + QL+ +D+ HS V HRDL
Sbjct: 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----------YVAPEVLND 108
KP+N+L+ S G +K++DFGL+ R Y APEVL
Sbjct: 147 KPQNILVTSSGQIKLADFGLA------R-------IYSFQMALTSVVVTLWYRAPEVLLQ 193
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA---------------- 150
Y D+WS G I + S++ L KI
Sbjct: 194 SSY-ATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLG-KILDVIGLPGEEDWPRDVALP 250
Query: 151 DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197
+ S K L+ + L NP R++ L +F+ +
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 53/237 (22%), Positives = 83/237 (35%), Gaps = 58/237 (24%)
Query: 1 MASKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+ K+ +V E +D DK G L + + +Q + +D+ H+ + HRDL
Sbjct: 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGLDFLHANCIVHRDL 146
Query: 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN----------YVAPEVLND 108
KPEN+L+ S G +K++DFGL+ R Y APEVL
Sbjct: 147 KPENILVTSGGTVKLADFGLA------R-------IYSYQMALTPVVVTLWYRAPEVLLQ 193
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA---------------- 150
Y D+WS G I + + S L KI
Sbjct: 194 STY-ATPVDMWSVGCIFAEMFRRKPLFCGN-SEADQLG-KIFDLIGLPPEDDWPRDVSLP 250
Query: 151 DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
+ P +L+ +L NP R++ + L+ + K P
Sbjct: 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAK------HGRLKEDEARRYFQQLINAVDYCHS-RGVFH 55
+ +I +E + FDK K + E+ + + A+++ + H
Sbjct: 92 REGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIH 149
Query: 56 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL----NDKGY 111
RD+KP N+LLD G +K+ DFG+S Q V A G Y+APE + + +GY
Sbjct: 150 RDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDA-GCRPYMAPERIDPSASRQGY 206
Query: 112 DGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRAD-----FSCPSWFSSGAKKL 165
D R SDVWS G+ L+ L G P+ + N + ++ + D S FS
Sbjct: 207 DVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINF 265
Query: 166 IKRILDPNPDTRMTISQMLEDEWFKK 191
+ L + R ++L+ +
Sbjct: 266 VNLCLTKDESKRPKYKELLKHPFILM 291
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K++I++EF GG + + + L E + + +Q++ A+++ HS+ + HRDLK N
Sbjct: 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-----LNDKGYDGRASD 117
+L+ G ++++DFG+SA + ++ + GTP ++APEV + D YD +A D
Sbjct: 148 VLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA-D 204
Query: 118 VWSCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDP 172
+WS G I + MA P + + + L KI ++D PS +S + +K LD
Sbjct: 205 IWSLG-ITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDK 262
Query: 173 NPDTRMTISQMLEDEWFKKGYKP 195
NP+TR + +Q+LE +
Sbjct: 263 NPETRPSAAQLLEHPFVSSITSN 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 63/239 (26%), Positives = 94/239 (39%), Gaps = 62/239 (25%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K+ I +V +F++ + L + Y + ++Y H + HRDLKP
Sbjct: 83 HKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVL-ND 108
NLLLD GVLK++DFGL+ + G+PN Y APE+L
Sbjct: 141 NNLLLDENGVLKLADFGLA-------------KSFGSPNRAYTHQVVTRWYRAPELLFGA 187
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA----------DFSC-- 154
+ Y G D+W+ G IL L+ FLP D S+L L +I D
Sbjct: 188 RMY-GVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLT-RIFETLGTPTEEQWPDMCSLP 244
Query: 155 -----PSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197
S+ LI+ + NP R+T +Q L+ ++F P
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 58/243 (23%), Positives = 92/243 (37%), Gaps = 66/243 (27%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+++++ E+ + +L + K+ + + + QLIN V++CHSR HRDLKP+N
Sbjct: 104 HNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN 162
Query: 63 LLLDSY-----GVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVL 106
LLL VLKI DFGL+ R A G P Y PE+L
Sbjct: 163 LLLSVSDASETPVLKIGDFGLA------R-------AFGIPIRQFTHEIITLWYRPPEIL 209
Query: 107 -NDKGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA------------- 150
+ Y + D+WS I ++ P D S + L+ KI
Sbjct: 210 LGSRHY-STSVDIWSIACIWAEMLMKTPLFPGD-SEIDQLF-KIFEVLGLPDDTTWPGVT 266
Query: 151 ---DFS--------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193
D+ + L+ +L+ +P R++ LE +F
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
Query: 194 KPP 196
P
Sbjct: 327 FDP 329
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 66/233 (28%), Positives = 96/233 (41%), Gaps = 63/233 (27%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+K ++ +V E +D +L D G L+ A+ + QL+N + YCH R V HRDLKP
Sbjct: 71 TKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVL-ND 108
+NLL++ G LKI+DFGL+ R A G P Y AP+VL
Sbjct: 129 QNLLINREGELKIADFGLA------R-------AFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA---------------- 150
K Y D+WS G I ++ G P S L +I R
Sbjct: 176 KKY-STTIDIWSVGCIFAEMVNGTPLFPGV-SEADQLM-RIFRILGTPNSKNWPNVTELP 232
Query: 151 DFSC--PSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
+ + L+ ++L +P+ R+T Q LE +FK
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 64/234 (27%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
S+ + +V EF++ ++ D+ L++ + + Y QL+ V +CH + HRDLKP
Sbjct: 90 SERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVL-ND 108
+NLL++S G LK++DFGL+ R A G P Y AP+VL
Sbjct: 148 QNLLINSDGALKLADFGLA------R-------AFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA---------------- 150
K Y + D+WS G I ++ G P ++ L KI
Sbjct: 195 KKY-STSVDIWSIGCIFAEMITGKPLFPGV-TDDDQLP-KIFSILGTPNPREWPQVQELP 251
Query: 151 ---DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
+ + F L+ +L +P+ R++ + +FK
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
S K+ +V EF D + FD +G L + + + QL+ + +CHSR V HRDLKP
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKP 129
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN-----YVAPEVL-NDKGYDG 113
+NLL++ G LK+++FGL+ A VR C + Y P+VL K Y
Sbjct: 130 QNLLINRNGELKLANFGLARAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLY-S 180
Query: 114 RASDVWSCGVILFVLMAGFLPF--DESNLMALYRKICRA----------------DFSC- 154
+ D+WS G I L P L +I R D+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 155 PSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
P + ++ + L++ +L NP R++ + L+ +F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 55/242 (22%), Positives = 89/242 (36%), Gaps = 59/242 (24%)
Query: 3 SKTKIYIVLEFIDGG-----ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRD 57
++ K+ +V EF+D + L+ + + + QL+ + +CH + HRD
Sbjct: 74 TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRD 133
Query: 58 LKPENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN-----YVAPEVL-NDKG 110
LKP+NLL++ G LK+ DFGL+ A V + Y AP+VL +
Sbjct: 134 LKPQNLLINKRGQLKLGDFGLARAFGIPVN--------TFSSEVVTLWYRAPDVLMGSRT 185
Query: 111 YDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA----------------DF 152
Y + D+WSCG IL ++ G P ++ L I +
Sbjct: 186 Y-STSIDIWSCGCILAEMITGKPLFPGT-NDEEQLK-LIFDIMGTPNESLWPSVTKLPKY 242
Query: 153 ------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194
+ +L NPD R++ Q L WF + Y
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302
Query: 195 PP 196
Sbjct: 303 HA 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 49/241 (20%), Positives = 87/241 (36%), Gaps = 64/241 (26%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ + +V E++D + D + + + QL+ + YCH + V HRDLKP
Sbjct: 71 TEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-----------YVAPEVL-ND 108
+NLL++ G LK++DFGL+ R A P Y P++L
Sbjct: 129 QNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYRKICRA---------------- 150
Y D+W G I + + G P + L+ I R
Sbjct: 176 TDY-STQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLH-FIFRILGTPTEETWPGILSNE 232
Query: 151 ---DFSCPSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
++ P + S L+ ++L R++ ++ +F +
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292
Query: 197 H 197
H
Sbjct: 293 H 293
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 5 TKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++V+EF G + D K K LKE+ ++++ + + H V HRD+K +N
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 159
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-----NDKGYDGRASD 117
+LL +K+ DFG+SA Q R G +T GTP ++APEV+ D YD ++ D
Sbjct: 160 VLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS-D 216
Query: 118 VWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSC--PSWFSSGAKKLIKRILDPNP 174
+WS G+ + G P + + M AL+ I R +S + I+ L N
Sbjct: 217 LWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKKWSKKFQSFIESCLVKNH 275
Query: 175 DTRMTISQMLEDEWFKKGYKPPHFDKE 201
R Q+++ + + +
Sbjct: 276 SQRPATEQLMKHPFIRDQPNERQVRIQ 302
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 42/226 (18%)
Query: 3 SKTKIYIVLEFIDG--GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K IY+V +F + L + E +R Q L+N + Y H + HRD+K
Sbjct: 95 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152
Query: 61 ENLLLDSYGVLKISDFGLS-AISQQVREDGLLHTAC-GTPNYVAPEVL-NDKGYDGRASD 117
N+L+ GVLK++DFGL+ A S +T T Y PE+L ++ Y G D
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY-GPPID 211
Query: 118 VWSCGVI---LFV---LMAG----------F----------------LP-FDESNLMALY 144
+W G I ++ +M G +++ L+
Sbjct: 212 LWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQ 271
Query: 145 RKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
++ + A LI ++L +P R+ L ++F
Sbjct: 272 KRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 4 KTKIYIVLEFIDGGELFD--------KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFH 55
K ++++V++ + GG + D K G L E ++++ ++Y H G H
Sbjct: 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144
Query: 56 RDLKPENLLLDSYGVLKISDFGLSA-ISQQVREDGLL--HTACGTPNYVAPEVL-NDKGY 111
RD+K N+LL G ++I+DFG+SA ++ T GTP ++APEV+ +GY
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY 204
Query: 112 DGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYR---------KICRADFSCPSWFSSG 161
D +A D+WS G+ L G P+ + M L + D +
Sbjct: 205 DFKA-DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
+K+I L +P+ R T +++L ++F+K
Sbjct: 264 FRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 43/224 (19%), Positives = 86/224 (38%), Gaps = 46/224 (20%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVF 54
S T+++++ + + G L+D + L R + + + + H +
Sbjct: 77 SSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 55 HRDLKPENLLLDSYGVLKISDFGLSAI--SQQVREDGLLHTACGTPNYVAPEVLNDKGYD 112
HRDLK +N+L+ G I+D GL+ + + D + GT Y+APEVL++
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 113 G-----RASDVWSCGVILFVLMAGF----------LPFDESN-----LMALYRKICR--- 149
+ D+W+ G++L+ + PF + + + +C
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 150 --------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
+ + KL+K NP R+T ++ +
Sbjct: 256 RPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ ++V+E+ G L+E E + + Y HS + HRD+K N+
Sbjct: 126 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185
Query: 64 LLDSYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEV---LNDKGYDGRASDVW 119
LL G++K+ DFG ++ ++ ++ GTP ++APEV +++ YDG+ DVW
Sbjct: 186 LLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKV-DVW 237
Query: 120 SCGVILFVLMAGFLP--FDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNP 174
S G I + +A P F+ + + ALY I + + W S + + L P
Sbjct: 238 SLG-ITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNFVDSCLQKIP 294
Query: 175 DTRMTISQMLEDEWFKKGYKP 195
R T +L+ + + P
Sbjct: 295 QDRPTSEVLLKHRFVLRERPP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 46/244 (18%), Positives = 84/244 (34%), Gaps = 56/244 (22%)
Query: 3 SKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ ++++V F+ G D + E Q ++ A+DY H G HR +K
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156
Query: 61 ENLLLDSYGVLKISDFGLSA-----ISQQVREDGLLHTACGTPNYVAPEVL--NDKGYDG 113
++L+ G + +S + +Q + +++PEVL N +GYD
Sbjct: 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 216
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKI------------------------- 147
++ D++S G+ L G +PF + L K+
Sbjct: 217 KS-DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275
Query: 148 --------------------CRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187
FS +++ L NPD R + S +L
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
Query: 188 WFKK 191
+FK+
Sbjct: 336 FFKQ 339
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-24
Identities = 65/264 (24%), Positives = 98/264 (37%), Gaps = 54/264 (20%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YI+ E + D ++ L +D + + Q + AV H V HRDLKP NLL
Sbjct: 89 VYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTP--NYV------APEV-LNDKGYDGRA 115
++S LK+ DFGL+ I + D T + +V APEV L Y RA
Sbjct: 145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS-RA 203
Query: 116 SDVWSCGVILFVLMAG---F-----------------LPFDESNLMAL-----------Y 144
DVWSCG IL L F P +++L +
Sbjct: 204 MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL 263
Query: 145 RKICRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEE 202
A P + L++R+L +P R+T + LE + + + P +E
Sbjct: 264 PMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP----NDE 318
Query: 203 EVNLDDVDAIFNDSKENLVTEKKE 226
+ F K+
Sbjct: 319 PEGEPIPPSFFEFDHYKEALTTKD 342
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 48/225 (21%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVF 54
S T++Y++ ++ + G L+D + L + ++ + + H+ +
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164
Query: 55 HRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGTPNYVAPEVL------ 106
HRDLK +N+L+ G I+D GL+ D +T GT Y+ PEVL
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 107 NDKGYDGRASDVWSCGVIL----------FVLMAGFLPFDE-----SNLMALYRKICR-- 149
N A D++S G+IL ++ LP+ + + + +C
Sbjct: 225 NHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 150 ---------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
+ C KL+ NP +R+T ++ +
Sbjct: 284 LRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTALRVKK 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 43/223 (19%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF-------- 54
+ T++++V ++ + G LFD + ++ + + + + + + H V
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 55 HRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKG-- 110
HRDLK +N+L+ G I+D GL+ + D + GT Y+APEVL+D
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 111 ----YDGRASDVWSCGVILFVLMAGF----------LPFDE-----SNLMALYRKICR-- 149
RA D+++ G++ + + LP+ + ++ + + +C
Sbjct: 230 KHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 150 -------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
SC + K+++ N R+T ++ +
Sbjct: 289 LRPNIPNRWQSCEAL--RVMAKIMRECWYANGAARLTALRIKK 329
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 64/261 (24%), Positives = 101/261 (38%), Gaps = 62/261 (23%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58
+ + +VL+++ E ++A+H L + Y QL ++ Y HS G+ HRD+
Sbjct: 125 EVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDI 182
Query: 59 KPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPN--YV------APEV-LND 108
KP+NLLLD VLK+ DFG + + G PN Y+ APE+
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAKQLVR-----------GEPNVSYICSRYYRAPELIFGA 231
Query: 109 KGYDGRASDVWSCGVILFVLMAG---FLPFDESNLMALYRKIC--------------RAD 151
Y + DVWS G +L L+ G F + + K+ +
Sbjct: 232 TDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290
Query: 152 FSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD 199
F P A L R+L+ P R+T + +F + P
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP---- 346
Query: 200 KEEEVNLDDVDAIFNDSKENL 220
+ N D A+FN + + L
Sbjct: 347 NVKLPNGRDTPALFNFTTQEL 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 40/224 (17%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV E+++ D + + G L E+ AR + QL+ + Y HS V HRDLKP NL
Sbjct: 97 VYIVQEYMET----DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152
Query: 65 LDSYG-VLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSC 121
+++ VLKI DFGL+ + G L T Y +P + L+ Y +A D+W+
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT-KAIDMWAA 211
Query: 122 GVILFVLMAGFLPF-------------------DESNLMALYRKICRADFSCPSW----- 157
G I ++ G F E + L I + +
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL 271
Query: 158 ------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195
S A +++IL +P R+T + L + P
Sbjct: 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-23
Identities = 37/135 (27%), Positives = 70/135 (51%), Gaps = 10/135 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S+T + E ++ + L + + R Y +++ A+DYCHS G+ HRD+KP N
Sbjct: 105 SRTPALVF-EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160
Query: 63 LLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-NDKGYDGRASDVWS 120
+++D + L++ D+GL+ +E + + + PE+L + + YD + D+WS
Sbjct: 161 VMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYD-YSLDMWS 216
Query: 121 CGVILFVLMAGFLPF 135
G +L ++ PF
Sbjct: 217 LGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 48/254 (18%), Positives = 92/254 (36%), Gaps = 62/254 (24%)
Query: 3 SKTKIYIVLEF--------IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVF 54
+ K++++ ++ I K +L + Q+++ + Y H+ V
Sbjct: 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150
Query: 55 HRDLKPENLLLDSY----GVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVL-ND 108
HRDLKP N+L+ G +KI+D G + + ++ L T Y APE+L
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210
Query: 109 KGYDGRASDVWSCGVILFVLMAG--FLPFDESNLMALYR-------KICRA--------- 150
+ Y +A D+W+ G I L+ + ++ +I
Sbjct: 211 RHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW 269
Query: 151 -------DFSC--PSW--------------------FSSGAKKLIKRILDPNPDTRMTIS 181
+ S + S A L++++L +P R+T
Sbjct: 270 EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329
Query: 182 QMLEDEWFKKGYKP 195
Q ++D +F + P
Sbjct: 330 QAMQDPYFLEDPLP 343
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 64/253 (25%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
Y+V+ F+ D K+ KH +L ED + Q++ + Y H+ G+ HRDLKP NL
Sbjct: 105 FYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 160
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------APEV-LNDKGYDGRASD 117
++ LKI DFGL+ R+ T YV APEV LN Y + D
Sbjct: 161 VNEDCELKILDFGLA------RQADSEMT-----GYVVTRWYRAPEVILNWMRYT-QTVD 208
Query: 118 VWSCGVILFVLMAG--------------------------FLPFDES----NLMALYRKI 147
+WS G I+ ++ G F+ +S N M ++
Sbjct: 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268
Query: 148 CRADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP------PHFD 199
+ DF+ + S A L++++L + + R+T + L +F+ + +D
Sbjct: 269 EKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 327
Query: 200 KEEEVNLDDVDAI 212
+ +D
Sbjct: 328 DSFDDVDRTLDEW 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 66/263 (25%), Positives = 103/263 (39%), Gaps = 64/263 (24%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-----GRLKEDEARRYFQQLINAVDYCHSRGVFHRD 57
+ + +VLE++ E + ++H + + Y QL+ ++ Y HS G+ HRD
Sbjct: 109 DEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 58 LKPENLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPN--YV------APEV-LN 107
+KP+NLLLD GVLK+ DFG + I PN Y+ APE+
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----------PNVSYICSRYYRAPELIFG 215
Query: 108 DKGYDGRASDVWSCGVILFVLMAGFLPFD-ESNLMALYRKICR----------------- 149
Y D+WS G ++ LM G F ES + L I +
Sbjct: 216 ATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE-IIKVLGTPSREQIKTMNPNY 273
Query: 150 ADFSCPSW------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197
+ P A LI R+L+ P R+T + L +F +
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG-- 331
Query: 198 FDKEEEVNLDDVDAIFNDSKENL 220
+ N ++ +FN +KE L
Sbjct: 332 --EARMPNGRELPPLFNWTKEEL 352
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 55/261 (21%), Positives = 100/261 (38%), Gaps = 47/261 (18%)
Query: 7 IYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ +++E++ + K+ K + + Y QL AV + HS G+ HRD+KP+
Sbjct: 113 LNVIMEYVP--DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 62 NLLLDSY-GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVW 119
NLL++S LK+ DFG + + + + C + Y APE+ L Y + D+W
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLW 226
Query: 120 SCGVILFVLMAGFLPF---DESNLMALYRKIC--------------RADFSCPSW----F 158
S G + L+ G F + + +I + P+ +
Sbjct: 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW 286
Query: 159 S--------SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD--- 207
S A L+++IL PD R+ + + +F + + N
Sbjct: 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGV 346
Query: 208 --DVDAIFNDSKENLVTEKKE 226
++ +FN S L
Sbjct: 347 NQNIPQLFNFSPYELSIIPGN 367
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 63/255 (24%), Positives = 103/255 (40%), Gaps = 61/255 (23%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+YIV + ++ D K+ K L D + Q++ + Y HS V HRDLKP NLL
Sbjct: 105 VYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------APEV-LNDKGYDGRASD 117
L++ LKI DFGL+ ++ + T YV APE+ LN KGY ++ D
Sbjct: 161 LNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYRAPEIMLNSKGYT-KSID 214
Query: 118 VWSCGVILFVLMAG--------------------------FLPFDES----NLMALYRKI 147
+WS G IL +++ L + N +
Sbjct: 215 IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 148 CRADFSCPSWF---SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-------PH 197
+ ++ F S A L+ ++L NP R+ + Q L + ++ Y P
Sbjct: 275 NKVPWN--RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 332
Query: 198 FDKEEEVNLDDVDAI 212
F + E++ + +
Sbjct: 333 FKFDMELDDLPKEKL 347
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 42/221 (19%), Positives = 78/221 (35%), Gaps = 40/221 (18%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------G 52
++++ F + G L D + + + +E + + + Y H
Sbjct: 93 VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151
Query: 53 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYD 112
+ HRD+K +N+LL + I+DFGL+ + + G H GT Y+APEVL
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
Query: 113 G----RASDVWSCGVIL--------------------FVLMAGFLPFDESNLMALYRKIC 148
D+++ G++L F G P E + K
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271
Query: 149 RADFSCPSWFSSGAKKLIKRIL----DPNPDTRMTISQMLE 185
R W ++ + D + + R++ + E
Sbjct: 272 RPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 62/252 (24%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+Y+V + D I K +L +D + Q++ + Y HS + HRDLKP NL
Sbjct: 109 VYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 164
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------APEV-LNDKGYDGRASD 117
++ LKI DFGL+ R T YV APE+ LN Y+ + D
Sbjct: 165 VNEDCELKILDFGLA------RHTADEMT-----GYVATRWYRAPEIMLNWMHYN-QTVD 212
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICR------ADF--------------SCPSW 157
+WS G I+ L+ G F ++ + + I R A+ S
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272
Query: 158 -----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP------PHFDK 200
+ A L++++L + D R+T +Q L +F + + P +D+
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ 332
Query: 201 EEEVNLDDVDAI 212
E +D
Sbjct: 333 SLESRDLLIDEW 344
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 64/330 (19%), Positives = 120/330 (36%), Gaps = 63/330 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E +D L I L + Q++ + + HS G+ HRDLKP N+++
Sbjct: 142 VYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S LKI DFGL ++ ++ T Y APEV+ GY D+WS G I+
Sbjct: 199 SDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMG 254
Query: 127 VLMAGFLPFDESNLMALYRKIC-----------------------------RADFS---- 153
++ + F + + + K+ F
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314
Query: 154 ---------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
+S A+ L+ ++L +P R+++ L+ + Y P + E
Sbjct: 315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP---AEVEAP 371
Query: 205 NLDDVDAIFNDS-------KENLVTE----KKEKPVSMNAFELISRTKSFSLENLFEKQT 253
D ++ KE + E +++ + + + + +
Sbjct: 372 PPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSS 431
Query: 254 GLVKRETRFTSQRPPNEIMSKIEEAAKPLG 283
+ + T Q ++ S +E +A PLG
Sbjct: 432 SVNDISSMSTDQTLASDTDSSLEASAGPLG 461
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-22
Identities = 29/189 (15%), Positives = 50/189 (26%), Gaps = 43/189 (22%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+V E+I GG L + A R Q L A D H GV P + +
Sbjct: 107 LVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI 164
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 127
G + ++ + D+ G L+
Sbjct: 165 DGDVVLAYPA----------------------TMPDA--------NPQDDIRGIGASLYA 194
Query: 128 LMAGFLPFDESN----LMALYRKICRADFSCPSWFSSGA----KKLIKRILDPNPDTR-- 177
L+ P E+ L R P+ + R + + R
Sbjct: 195 LLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
Query: 178 MTISQMLED 186
T+ +++
Sbjct: 254 STLLNLMQQ 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 55/253 (21%), Positives = 98/253 (38%), Gaps = 52/253 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+YIV+E +D L I L + Q++ + + HS G+ HRDLKP N+++
Sbjct: 105 VYIVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
S LKI DFGL ++ ++ T Y APEV+ GY D+WS G I+
Sbjct: 162 SDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMG 217
Query: 127 VLMAGFLPFDESNLMALYRKIC-------------------------------------- 148
++ G + F ++ + + K+
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277
Query: 149 ----RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEV 204
AD +S A+ L+ ++L + R+++ + L+ + Y P + E
Sbjct: 278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP---SEAEAP 334
Query: 205 NLDDVDAIFNDSK 217
D ++ +
Sbjct: 335 PPKIPDKQLDERE 347
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 57/290 (19%), Positives = 104/290 (35%), Gaps = 80/290 (27%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHRDLKPENL 63
+Y+V ++++ D + + L E ++Y QLI + Y HS G+ HRD+KP N+
Sbjct: 86 VYLVFDYMET----DLHAVIRANIL-EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNI 140
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN-------------YV------APE 104
LL++ +K++DFGLS +R N YV APE
Sbjct: 141 LLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200
Query: 105 V-LNDKGYDGRASDVWSCGVILFVLMAG---F---------------------------- 132
+ L Y + D+WS G IL ++ G F
Sbjct: 201 ILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQ 259
Query: 133 ----------------LPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDT 176
+ + K + + + A L+ ++L NP+
Sbjct: 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319
Query: 177 RMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKE 226
R++ + L+ + + P EE + ND+ ++ + + +
Sbjct: 320 RISANDALKHPFVSIFHNP----NEEPNCDHIITIPINDNVKHSIDDYRN 365
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 28/146 (19%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
++Y+VLE D + L E + L+ V Y HS G+ HRDLKP N L+
Sbjct: 131 ELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
Query: 66 DSYGVLKISDFGLS-AISQQVREDGLLHTACGTPN------------------YV----- 101
+ +K+ DFGL+ + + L + + +V
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249
Query: 102 -APEV-LNDKGYDGRASDVWSCGVIL 125
APE+ L + Y A DVWS G I
Sbjct: 250 RAPELILLQENYT-EAIDVWSIGCIF 274
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 63/252 (25%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
Y+V+ F+ +L + + E++ + Q++ + Y HS GV HRDLKP NL ++
Sbjct: 104 FYLVMPFMQT-DLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------APEV-LNDKGYDGRASDVW 119
LKI DFGL+ R T YV APEV L+ Y+ + D+W
Sbjct: 161 EDCELKILDFGLA------RHADAEMT-----GYVVTRWYRAPEVILSWMHYN-QTVDIW 208
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKIC------------------------------R 149
S G I+ ++ G F + + +I R
Sbjct: 209 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268
Query: 150 ADFS--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD 207
DF+ P S A L++++L+ + D R+T +Q L +F+ P D EEE
Sbjct: 269 KDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALTHPFFE-----PFRDPEEE---T 319
Query: 208 DVDAIFNDSKEN 219
+ F+DS E+
Sbjct: 320 EAQQPFDDSLEH 331
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 49/246 (19%), Positives = 89/246 (36%), Gaps = 45/246 (18%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHRDLKPENLLL 65
+Y+V E + +L I + + +YF ++ + H GV HRDL P N+LL
Sbjct: 109 LYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL 167
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRASDVWSCGVI 124
+ I DF L +++ D Y APE+ + KG+ + D+WS G +
Sbjct: 168 ADNNDITICDFNL---AREDTADANKTHYVTHRWYRAPELVMQFKGFT-KLVDMWSAGCV 223
Query: 125 LFVLMAG--------------------------FLPFDESNLMALYRKICRADFSCPSWF 158
+ + + S Y + ++ +W
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT 283
Query: 159 ------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP------PHFDKEEEVNL 206
A LI ++L+ NP R++ Q L +F+ + P + ++
Sbjct: 284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESV 343
Query: 207 DDVDAI 212
DV +
Sbjct: 344 TDVYDM 349
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 29/149 (19%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQ-QLINAVDYCHSRGVFHRDLKPENL 63
+YIVLE D D K+ K +E + L+ ++ H G+ HRDLKP N
Sbjct: 105 LYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP--------------NYV------AP 103
LL+ +K+ DFGL+ ++ +++ ++V AP
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 104 EV-LNDKGYDGRASDVWSCGVILFVLMAG 131
E+ L + Y ++ D+WS G I L+
Sbjct: 221 ELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-20
Identities = 50/231 (21%), Positives = 84/231 (36%), Gaps = 50/231 (21%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS---------RGV 53
+ + +V+E+ G L ++ H + R + + Y H+ +
Sbjct: 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLS------AISQQVREDGLLHTACGTPNYVAPEVL- 106
HRDL N+L+ + G ISDFGLS + + ED + GT Y+APEVL
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201
Query: 107 -----NDKGYDGRASDVWSCGVIL----------------------FVLMAGFLPFDESN 139
D + D+++ G+I F G P E
Sbjct: 202 GAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM 261
Query: 140 LMALYRKICRADFSCPSWFSSGA-----KKLIKRILDPNPDTRMTISQMLE 185
+ + R+ R F +W + K+ I+ D + + R+T E
Sbjct: 262 QVLVSREKQRPKFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 49/264 (18%), Positives = 92/264 (34%), Gaps = 52/264 (19%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHG-----RLKEDEARRYFQQLINAVDYCH--SRGVFHRD 57
+ +V+E++ + + ++ + + QLI ++ H S V HRD
Sbjct: 99 IYLNVVMEYVP--DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 58 LKPENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEV-LNDKGYDGRA 115
+KP N+L++ + G LK+ DFG + + C + Y APE+ ++ Y A
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYIC-SRYYRAPELIFGNQHYT-TA 212
Query: 116 SDVWSCGVILFVLMAG--------------------------FLPFDESNLMALY-RKIC 148
D+WS G I +M G L + +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK 272
Query: 149 RADFS-----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEE 203
+S + A L+ +L P+ RM + L +F + + P +
Sbjct: 273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP----ATKL 328
Query: 204 VNLDDVD-AIFNDSKENLVTEKKE 226
N D+ +F + +
Sbjct: 329 PNNKDLPEDLFRFLPNEIEVMSEA 352
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 46/241 (19%), Positives = 87/241 (36%), Gaps = 64/241 (26%)
Query: 9 IVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLL 65
+V E + G L K +H + ++ +QL+ +DY H R G+ H D+KPEN+L+
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165
Query: 66 D------SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
+ + +KI+D G + D + T Y +PEVL + +D+W
Sbjct: 166 EIVDSPENLIQIKIADLGNAC-----WYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIW 219
Query: 120 SCGVILFVLMAGFLPFD---------ESNLMALYRKIC---------RADFSCPSWFSSG 161
S ++F L+ G F+ + + +A ++ ++ + S G
Sbjct: 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279
Query: 162 AKK------------------------------LIKRILDPNPDTRMTISQMLEDEWFKK 191
+ + +L +P R ++ W K
Sbjct: 280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
Query: 192 G 192
Sbjct: 340 T 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 53/194 (27%), Positives = 79/194 (40%), Gaps = 23/194 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
IYIV+E + GG+ + G L+ + ++Y S+ HRDL N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNY----VAPEVLNDKGYDGRASDVWSC 121
VLKISDFG+S + DG+ + G APE LN Y SDVWS
Sbjct: 247 TEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSF 301
Query: 122 GVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKKLIKRILDPNPD 175
G++L+ G P+ + + + CP +L+++ P
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV----FRLMEQCWAYEPG 357
Query: 176 TR---MTISQMLED 186
R TI Q L+
Sbjct: 358 QRPSFSTIYQELQS 371
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 37/114 (32%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 35 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGLLH 92
R++ ++ +D H + H DLKPEN+LL G +K+ DFG S Q ++
Sbjct: 203 RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VY 257
Query: 93 TACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL 143
T + Y APEV+ Y D+WS G IL L+ G+ DE + +A
Sbjct: 258 TYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 35/150 (23%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ + ++ + + G L D + +H + + Q+ ++Y R + HRDL
Sbjct: 87 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDV 118
N+L+ + +KI+DFGL ++ + + + A G P ++A E + + Y SDV
Sbjct: 147 NVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH-QSDV 202
Query: 119 WSCGVILF-VLMAGFLPFDESNLMALYRKI 147
WS GV ++ ++ G P+D + +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 21/197 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
S+ IYIV E++ G L D + L+ + Q+ + + Y HRDL+
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKGYDGRASDV 118
N+L+ V K++DFGL ++ + ++ P + APE + SDV
Sbjct: 309 ANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDV 364
Query: 119 WSCGVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKKLIKRILDP 172
WS G++L + G +P+ + ++ R CP L+ +
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCWRK 420
Query: 173 NPDTR---MTISQMLED 186
P+ R + LED
Sbjct: 421 EPEERPTFEYLQAFLED 437
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 23/194 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
YI+ EF+ G L D + + R + Q+ +A++Y + HR+L N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSC 121
+ ++K++DFGLS ++ G + APE L + SDVW+
Sbjct: 351 VGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAF 405
Query: 122 GVILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKKLIKRILDPNPD 175
GV+L+ + G P+ +L +Y + + CP +L++ NP
Sbjct: 406 GVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV----YELMRACWQWNPS 461
Query: 176 TR---MTISQMLED 186
R I Q E
Sbjct: 462 DRPSFAEIHQAFET 475
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 50/224 (22%), Positives = 79/224 (35%), Gaps = 69/224 (30%)
Query: 35 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISD 75
R+ Q+ +V++ HS + H DLKPEN+L +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
FG SA +D T T +Y APEV+ G+ + DVWS G IL GF F
Sbjct: 181 FG-SAT----YDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234
Query: 136 ---DESNLMA------------LYRKICRADF---------------------------- 152
D +A + +K + +
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 153 -SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195
LI+++L+ +P R+T+ + L+ +F K
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 46/225 (20%), Positives = 77/225 (34%), Gaps = 69/225 (30%)
Query: 35 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-------------------LKISD 75
R QL +A+ + H + H DLKPEN+L + ++++D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135
FG SA + T T +Y PEV+ + G+ + DVWS G ILF GF F
Sbjct: 186 FG-SAT----FDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLF 239
Query: 136 ---DESNLMAL-----------------------------------------YRKICRAD 151
+ + + K ++
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 152 FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
S L++R+L+ +P R+T+++ L +F
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 21/193 (10%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
IYIV E++ G L D + L+ + Q+ + + Y HRDL+ N+L
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGT-P-NYVAPEVLNDKGYDGRASDVWSCG 122
+ V K++DFGL ++ + ++ P + APE + SDVWS G
Sbjct: 396 VGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFG 451
Query: 123 VILF-VLMAGFLPFDESNLMALYRKICR-----ADFSCPSWFSSGAKKLIKRILDPNPDT 176
++L + G +P+ + ++ R CP L+ + P+
Sbjct: 452 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDLMCQCWRKEPEE 507
Query: 177 R---MTISQMLED 186
R + LED
Sbjct: 508 RPTFEYLQAFLED 520
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 38/142 (26%), Positives = 59/142 (41%), Gaps = 17/142 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+V+E + G L + ++ +K+ Q+ + Y HRDL N
Sbjct: 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 147
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACG--------TPNYVAPEVLNDKGYDGR 114
+LL + KISDFGLS + +R D + A APE +N +
Sbjct: 148 VLLVTQHYAKISDFGLS---KALRADENYYKAQTHGKWPVKWY----APECINYYKFSS- 199
Query: 115 ASDVWSCGVILF-VLMAGFLPF 135
SDVWS GV+++ G P+
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPY 221
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 42/222 (18%), Positives = 76/222 (34%), Gaps = 67/222 (30%)
Query: 35 RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHT- 93
+ Y +++ A++Y + H DLKPEN+LLD K + + +
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 94 ---------ACGTPNYV----------APEVLNDKGYDGRASDVWSCGVILFVLMAGFLP 134
A +Y APEV+ + G+D +SD+WS G +L L G L
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLL 258
Query: 135 F---DESNLMAL---------YRKICRADFSCPSW-FSSGAKKL---------------- 165
F + +A+ + A + S + KL
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 166 -----------------IKRILDPNPDTRMTISQMLEDEWFK 190
+ IL +P R + +++L+ ++ +
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
IV E+++ G L + H G+ + + + + Y G HRDL N+L+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCG 122
DS V K+SDFGLS + + + +T G + APE + + + ASDVWS G
Sbjct: 185 DSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFG 241
Query: 123 VILF-VLMAGFLPF 135
V+++ VL G P+
Sbjct: 242 VVMWEVLAYGERPY 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K +YIV E++ G L D + GR L D ++ + A++Y HRDL
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDVW 119
N+L+ V K+SDFGL+ + ++ G L P + APE L +K + SDVW
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKFST-KSDVW 370
Query: 120 SCGVILF-VLMAGFLPFDESNLMALYRKICR 149
S G++L+ + G +P+ L + ++ +
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 10/134 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
IYIV E+I G L + + HG+ L+ + + + + S HRDL N L+
Sbjct: 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDVWSCG 122
D +K+SDFG++ + D ++ GT P + APEV + Y SDVW+ G
Sbjct: 138 DRDLCVKVSDFGMT----RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS-KSDVWAFG 192
Query: 123 VILF-VLMAGFLPF 135
++++ V G +P+
Sbjct: 193 ILMWEVFSLGKMPY 206
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K +YIV E++ G L D + GR L D ++ + A++Y HRDL
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASD 117
N+L+ V K+SDFGL+ + ++ G L P V APE L +K + SD
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALREKKFS-TKSD 196
Query: 118 VWSCGVILF-VLMAGFLPFDESNLMALYRKI 147
VWS G++L+ + G +P+ L + ++
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 43/137 (31%), Positives = 59/137 (43%), Gaps = 10/137 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +V E G L D++ KH G RY Q+ + Y S+ HRDL NLLL
Sbjct: 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 154
Query: 66 DSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSC 121
+ ++KI DFGL A+ Q D APE L + + ASD W
Sbjct: 155 ATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMF 210
Query: 122 GVILF-VLMAGFLPFDE 137
GV L+ + G P+
Sbjct: 211 GVTLWEMFTYGQEPWIG 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 3 SKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ IYI+ E+++ G L D K +L ++ Q+ + + R HRDL+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASD 117
N+L+ KI+DFGL+ ++ ED G P + APE +N + SD
Sbjct: 138 ANILVSDTLSCKIADFGLA----RLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSD 192
Query: 118 VWSCGVILF-VLMAGFLPF 135
VWS G++L ++ G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ I+ E+++ G L + + G + + + + Y + HRDL N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCG 122
+S V K+SDFGLS + + E +T G + APE ++ + + ASDVWS G
Sbjct: 181 NSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFG 237
Query: 123 VILF-VLMAGFLPF 135
++++ V+ G P+
Sbjct: 238 IVMWEVMTYGERPY 251
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 35/150 (23%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ + ++ + + G L D + +H + + Q+ ++Y R + HRDL
Sbjct: 87 LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 146
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDV 118
N+L+ + +KI+DFGL ++ + + + A G P ++A E + + Y SDV
Sbjct: 147 NVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDV 202
Query: 119 WSCGVILF-VLMAGFLPFDESNLMALYRKI 147
WS GV ++ ++ G P+D + +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 40/127 (31%), Positives = 68/127 (53%), Gaps = 15/127 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +++E++ G L D + KH R+ + +Y Q+ ++Y ++ HRDL N+L+
Sbjct: 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147
Query: 66 DSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDV 118
++ +KI DFGL+ + Q +V+E G P + APE L + + ASDV
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------PIFWYAPESLTESKFS-VASDV 200
Query: 119 WSCGVIL 125
WS GV+L
Sbjct: 201 WSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 40/127 (31%), Positives = 68/127 (53%), Gaps = 15/127 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +++E++ G L D + KH R+ + +Y Q+ ++Y ++ HRDL N+L+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178
Query: 66 DSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDV 118
++ +KI DFGL+ + Q +V+E G P + APE L + + ASDV
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYAPESLTESKFS-VASDV 231
Query: 119 WSCGVIL 125
WS GV+L
Sbjct: 232 WSFGVVL 238
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 15/127 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
I +++EF+ G L + + K+ ++ + +Y Q+ +DY SR HRDL N+L+
Sbjct: 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 159
Query: 66 DSYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDV 118
+S +KI DFGL+ AI V++D P + APE L + ASDV
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYAPECLMQSKFY-IASDV 212
Query: 119 WSCGVIL 125
WS GV L
Sbjct: 213 WSFGVTL 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 45/128 (35%), Positives = 69/128 (53%), Gaps = 19/128 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+ +V+E++ G L D + +H + + + QQ+ + Y H++ HRDL N+LLD
Sbjct: 110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168
Query: 67 SYGVLKISDFGLS-AISQ-----QVREDGLLHTACGTPNYV---APEVLNDKGYDGRASD 117
+ ++KI DFGL+ A+ + +VREDG P V APE L + + ASD
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWYAPECLKEYKFY-YASD 219
Query: 118 VWSCGVIL 125
VWS GV L
Sbjct: 220 VWSFGVTL 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ IV E+++ G L + KH + + + + + + Y G HRDL N+L+
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCG 122
+S V K+SDFGL + + E +T G + +PE + + + ASDVWS G
Sbjct: 181 NSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYG 237
Query: 123 VILF-VLMAGFLPF 135
++L+ V+ G P+
Sbjct: 238 IVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-14
Identities = 37/135 (27%), Positives = 60/135 (44%), Gaps = 11/135 (8%)
Query: 7 IYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
YI+ EF+ G L D + + Q+ +A++Y + HRDL N L
Sbjct: 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDVWSC 121
+ ++K++DFGLS ++ G P + APE L + SDVW+
Sbjct: 144 VGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAF 198
Query: 122 GVILF-VLMAGFLPF 135
GV+L+ + G P+
Sbjct: 199 GVLLWEIATYGMSPY 213
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 13/116 (11%)
Query: 35 RRYFQQLINAVDYCHSR--GVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDGL 90
R++ QQ+ A+ + + + H DLKPEN+LL + +KI DFG S+ +
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSC----QLGQR 214
Query: 91 LHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF---DESNLMAL 143
++ + Y +PEVL YD A D+WS G IL + G F +E + M
Sbjct: 215 IYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNK 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
I +V EF++ G L D + G + + + Y V HRDL N L+
Sbjct: 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDVWSCG 122
V+K+SDFG++ + D ++ GT P + +PEV + Y SDVWS G
Sbjct: 138 GENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFG 192
Query: 123 VILF-VLMAGFLPF 135
V+++ V G +P+
Sbjct: 193 VLMWEVFSEGKIPY 206
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 36/134 (26%), Positives = 55/134 (41%), Gaps = 8/134 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +V+E GG L + + Q+ + Y + HR+L N+LL
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASDVWSCG 122
+ KISDFGLS +D + APE +N + + SDVWS G
Sbjct: 470 VNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYG 526
Query: 123 VILF-VLMAGFLPF 135
V ++ L G P+
Sbjct: 527 VTMWEALSYGQKPY 540
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 38/134 (28%), Positives = 56/134 (41%), Gaps = 8/134 (5%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +V+E GG L + + Q+ + Y + HRDL N+LL
Sbjct: 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL 143
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDVWSCG 122
+ KISDFGLS +D P + APE +N + + SDVWS G
Sbjct: 144 VNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYG 200
Query: 123 VILF-VLMAGFLPF 135
V ++ L G P+
Sbjct: 201 VTMWEALSYGQKPY 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 45/127 (35%), Positives = 66/127 (51%), Gaps = 15/127 (11%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+ +V+E++ G L D + +H RL Y Q+ ++Y SR HRDL N+L+
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV 160
Query: 66 DSYGVLKISDFGLS-AISQQ-----VREDGLLHTACGTP-NYVAPEVLNDKGYDGRASDV 118
+S +KI+DFGL+ + VRE G P + APE L+D + R SDV
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIFWYAPESLSDNIFS-RQSDV 213
Query: 119 WSCGVIL 125
WS GV+L
Sbjct: 214 WSFGVVL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 10/138 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ ++I++E GEL + L Y QL A+ Y S+ HRD+
Sbjct: 86 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 145
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDV 118
N+L+ S +K+ DFGLS + ED + A P ++APE +N + + ASDV
Sbjct: 146 NVLVSSNDCVKLGDFGLS----RYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDV 200
Query: 119 WSCGVILF-VLMAGFLPF 135
W GV ++ +LM G PF
Sbjct: 201 WMFGVCMWEILMHGVKPF 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 3 SKTKIYIVLEFIDGGELFD--KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+K IYI+ EF+ G L D K + + + + Q+ + + R HRDL+
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRASD 117
N+L+ + V KI+DFGL+ +V ED G + APE +N + SD
Sbjct: 313 ANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSD 367
Query: 118 VWSCGVILF-VLMAGFLPF 135
VWS G++L ++ G +P+
Sbjct: 368 VWSFGILLMEIVTYGRIPY 386
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 43/265 (16%), Positives = 73/265 (27%), Gaps = 106/265 (40%)
Query: 25 KHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLL------------------ 65
+ L ++ QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 66 -------------------------------DSYGVLKISDFGLSAISQQVREDGLLHTA 94
+KI+D G + + T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTE 252
Query: 95 CGTPN-YVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK------- 146
Y + EVL GY+ +D+WS + F L G F+ + R
Sbjct: 253 DIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI 311
Query: 147 -----------ICRADFSCPSWFSSGAKK------------------------------L 165
I +S + G K
Sbjct: 312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF 371
Query: 166 IKRILDPNPDTRMTISQMLEDEWFK 190
+ +L+ P+ R T ++ L W
Sbjct: 372 LLPMLELIPEKRATAAECLRHPWLN 396
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ +I++E GEL + ++ LK Y Q+ A+ Y S HRD+
Sbjct: 83 EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR 142
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDV 118
N+L+ S +K+ DFGLS + ED + A T P +++PE +N + + ASDV
Sbjct: 143 NILVASPECVKLGDFGLS----RYIEDEDYYKASVTRLPIKWMSPESINFRRFTT-ASDV 197
Query: 119 WSCGVILF-VLMAGFLPF 135
W V ++ +L G PF
Sbjct: 198 WMFAVCMWEILSFGKQPF 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 21/156 (13%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFH 55
+ + +V +++ G L D +++ Q L+N V Y G+ H
Sbjct: 85 PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVH 138
Query: 56 RDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYD 112
R+L N+LL S ++++DFG+ + + D P ++A E ++ Y
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGV---ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 113 GRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKI 147
SDVWS GV ++ ++ G P+ L + +
Sbjct: 196 H-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 39/114 (34%), Positives = 54/114 (47%), Gaps = 35/114 (30%)
Query: 47 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA---------ISQQVREDGLLHTACGT 97
Y H+R + HRD+K N+LLD V KI+DFG+S +S V+ GT
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK---------GT 204
Query: 98 PNYVAPE-----VLNDKGYDGRASDVWSCGVILFVLMAG------FLPFDESNL 140
Y+ PE L +K SDV+S GV+LF ++ LP + NL
Sbjct: 205 LGYIDPEYFIKGRLTEK------SDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 38/134 (28%), Positives = 70/134 (52%), Gaps = 10/134 (7%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
I+I+ E++ G L + + + R + + + + A++Y S+ HRDL N L+
Sbjct: 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153
Query: 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGT--P-NYVAPEVLNDKGYDGRASDVWSCG 122
+ GV+K+SDFGLS + D ++ G+ P + PEVL + SD+W+ G
Sbjct: 154 NDQGVVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFG 208
Query: 123 VILF-VLMAGFLPF 135
V+++ + G +P+
Sbjct: 209 VLMWEIYSLGKMPY 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ ++I++E GEL + L Y QL A+ Y S+ HRD+
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG-TP-NYVAPEVLNDKGYDGRASDVW 119
N+L+ S +K+ DFGL S+ + + + G P ++APE +N + + ASDVW
Sbjct: 521 NVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVW 576
Query: 120 SCGVILF-VLMAGFLPF 135
GV ++ +LM G PF
Sbjct: 577 MFGVCMWEILMHGVKPF 593
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 8e-12
Identities = 37/144 (25%), Positives = 56/144 (38%), Gaps = 44/144 (30%)
Query: 47 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGL---------SAISQQVREDGLLHTACGT 97
+ H HRD+K N+LLD KISDFGL + ++ ++ GT
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV---------GT 198
Query: 98 PNYVAPE----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICR 149
Y+APE + K SD++S GV+L ++ G DE L+
Sbjct: 199 TAYMAPEALRGEITPK------SDIYSFGVVLLEIITGLPAVDEHREPQLLL-------- 244
Query: 150 ADFSCPSWFSSGAKKLIKRILDPN 173
D +K I+ +D
Sbjct: 245 -DIKEEIEDE---EKTIEDYIDKK 264
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 21/145 (14%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
S+ +VL ++ G+L + I + + Q+ + Y S+ HRDL
Sbjct: 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAAR 157
Query: 62 NLLLDSYGVLKISDFGLS-------AISQQVREDGLLHTACGTPNYV---APEVLNDKGY 111
N +LD +K++DFGL+ S + L P V A E L + +
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P--VKWMALESLQTQKF 209
Query: 112 DGRASDVWSCGVILF-VLMAGFLPF 135
SDVWS GV+L+ ++ G P+
Sbjct: 210 T-TKSDVWSFGVLLWELMTRGAPPY 233
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 41/150 (27%), Positives = 59/150 (39%), Gaps = 26/150 (17%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVF 54
++L F+ G+L + R+ E+ Q L+ VD Y SR
Sbjct: 101 GRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI 159
Query: 55 HRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---APEVL 106
HRDL N +L + ++DFGLS I L P V A E L
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL------P--VKWLALESL 211
Query: 107 NDKGYDGRASDVWSCGVILF-VLMAGFLPF 135
D Y SDVW+ GV ++ ++ G P+
Sbjct: 212 ADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 46/141 (32%), Positives = 62/141 (43%), Gaps = 30/141 (21%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRY---------FQQLIN-AVD------YCHS 50
+Y+ +E+ G L D + K L+ D A QQL++ A D Y
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ--QVREDGLLHTACGTPNYV---APEV 105
+ HRDL N+L+ V KI+DFGLS + + G L P V A E
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL------P--VRWMAIES 212
Query: 106 LNDKGYDGRASDVWSCGVILF 126
LN Y SDVWS GV+L+
Sbjct: 213 LNYSVYT-TNSDVWSYGVLLW 232
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 21/145 (14%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
S+ +VL ++ G+L + I + + Q+ + + S+ HRDL
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221
Query: 62 NLLLDSYGVLKISDFGLS-------AISQQVREDGLLHTACGTPNYV---APEVLNDKGY 111
N +LD +K++DFGL+ S + L P V A E L + +
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL------P--VKWMALESLQTQKF 273
Query: 112 DGRASDVWSCGVILF-VLMAGFLPF 135
SDVWS GV+L+ ++ G P+
Sbjct: 274 T-TKSDVWSFGVLLWELMTRGAPPY 297
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 21/141 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+++L ++ G+L I R + + Q+ ++Y + HRDL N +L
Sbjct: 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157
Query: 66 DSYGVLKISDFGLS-------AISQQVREDGLLHTACGTPNYV---APEVLNDKGYDGRA 115
D +K++DFGL+ S Q L P V A E L +
Sbjct: 158 DESFTVKVADFGLARDILDREYYSVQQHRHARL------P--VKWTALESLQTYRFT-TK 208
Query: 116 SDVWSCGVILF-VLMAGFLPF 135
SDVWS GV+L+ +L G P+
Sbjct: 209 SDVWSFGVLLWELLTRGAPPY 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 43/150 (28%)
Query: 7 IYIVLEFIDGGEL-----------FDKIAKHGRLKEDEARRYFQQLI-------NAVDYC 48
++ E+ G+L +++DE + L+ + +
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161
Query: 49 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV------- 101
S+ HRDL N+LL + KI DFGL ++ ++ D NYV
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIKNDS---------NYVVKGNARL 209
Query: 102 -----APEVLNDKGYDGRASDVWSCGVILF 126
APE + + Y SDVWS G+ L+
Sbjct: 210 PVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 39/146 (26%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRY-------FQQLIN-AVD------YCHSRG 52
+ ++ E+ G+L + + + R+ E + + L++ + + S+
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 53 VFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV----------- 101
HRD+ N+LL + V KI DFGL ++ + D NY+
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMND---------SNYIVKGNARLPVKW 232
Query: 102 -APEVLNDKGYDGRASDVWSCGVILF 126
APE + D Y SDVWS G++L+
Sbjct: 233 MAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 38/135 (28%), Positives = 54/135 (40%), Gaps = 25/135 (18%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFHRDL 58
K ++L F+ G+L + RL+ Q L+ VD Y +R HRDL
Sbjct: 115 KPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173
Query: 59 KPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---APEVLNDKG 110
N +L + ++DFGLS I + P V A E L D+
Sbjct: 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM------P--VKWIAIESLADRV 225
Query: 111 YDGRASDVWSCGVIL 125
Y SDVW+ GV +
Sbjct: 226 YT-SKSDVWAFGVTM 239
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 30/146 (20%), Positives = 52/146 (35%), Gaps = 30/146 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+V EF+ G L + K+ + +QL A+ + + H ++ +N+LL
Sbjct: 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146
Query: 66 DSYG--------VLKISDFGLSAISQQVREDGLLHTACGTPNY-------VAPEVLNDKG 110
+K+SD G+ S V + V PE + +
Sbjct: 147 IREEDRKTGNPPFIKLSDPGI---SITVLPK----------DILQERIPWVPPECIENPK 193
Query: 111 YDGRASDVWSCGVILF-VLMAGFLPF 135
A+D WS G L+ + G P
Sbjct: 194 NLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 46 DYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLH--TA-CGTPNYVA 102
D+C + + HRD+K N+LLD + DFGL+ + + H TA GT ++A
Sbjct: 149 DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIGHIA 203
Query: 103 PE-----VLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 140
PE ++K +DV+ GV+L L+ G FD + L
Sbjct: 204 PEYLSTGKSSEK------TDVFGYGVMLLELITGQRAFDLARL 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 34/137 (24%), Positives = 53/137 (38%), Gaps = 27/137 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFHRDLK 59
+I++E + GG+L + + + L++ A D Y HRD+
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167
Query: 60 PENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---APEVLND 108
N LL G V KI DFG++ I + +L P V PE +
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML------P--VKWMPPEAFME 219
Query: 109 KGYDGRASDVWSCGVIL 125
+ +D WS GV+L
Sbjct: 220 GIFTS-KTDTWSFGVLL 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-09
Identities = 18/78 (23%), Positives = 31/78 (39%), Gaps = 2/78 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPE 61
+++IVLEF GG +++ A+ QL ++ + HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191
Query: 62 NLLLDSYGVLKISDFGLS 79
N+LL + K+
Sbjct: 192 NVLLKKTSLKKLHYTLNG 209
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 35/137 (25%), Positives = 55/137 (40%), Gaps = 27/137 (19%)
Query: 7 IYIVLEFIDGGELFD---KIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFHR 56
+++E + G+L + A ++I A + Y ++ HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162
Query: 57 DLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---APEVLND 108
DL N ++ +KI DFG++ I + GLL P V +PE L D
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------P--VRWMSPESLKD 214
Query: 109 KGYDGRASDVWSCGVIL 125
+ SDVWS GV+L
Sbjct: 215 GVFT-TYSDVWSFGVVL 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 27/137 (19%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSRGVFHRDLK 59
+I+LE + GG+L + + + L++ A D Y HRD+
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208
Query: 60 PENLLLDSYG---VLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---APEVLND 108
N LL G V KI DFG++ I + +L P V PE +
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML------P--VKWMPPEAFME 260
Query: 109 KGYDGRASDVWSCGVIL 125
+ +D WS GV+L
Sbjct: 261 GIFTS-KTDTWSFGVLL 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 41/144 (28%), Positives = 62/144 (43%), Gaps = 33/144 (22%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+Y+++E+ G L + + E + + L++ A Y S
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
+ HRDL N+L+ V+KI+DFGL+ I +G L P V A
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL------P--VKWMA 261
Query: 103 PEVLNDKGYDGRASDVWSCGVILF 126
PE L D+ Y SDVWS GV+L+
Sbjct: 262 PEALFDRIYT-HQSDVWSFGVLLW 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 33/144 (22%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+Y+++E+ G L + + + E + F+ L++ Y S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
+ HRDL N+L+ V+KI+DFGL+ I+ +G L P V A
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL------P--VKWMA 227
Query: 103 PEVLNDKGYDGRASDVWSCGVILF 126
PE L D+ Y SDVWS GV+++
Sbjct: 228 PEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 25/99 (25%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ +++ SR HRDL N+LL V+KI DFGL ++ + +D P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL---ARDIYKD---------PD 248
Query: 100 YV------------APEVLNDKGYDGRASDVWSCGVILF 126
YV APE + D+ Y + SDVWS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLW 286
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 40/144 (27%), Positives = 58/144 (40%), Gaps = 33/144 (22%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+ +++EF G L K + + LI + + S
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
R HRDL N+LL V+KI DFGL+ I + + D L P + A
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL------P--LKWMA 218
Query: 103 PEVLNDKGYDGRASDVWSCGVILF 126
PE + D+ Y SDVWS GV+L+
Sbjct: 219 PETIFDRVYT-IQSDVWSFGVLLW 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 36/143 (25%), Positives = 60/143 (41%), Gaps = 33/143 (23%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+ +V E++ G+L I G+ ++ + Q+++ A Y S
Sbjct: 92 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
+ HRDL N L+ + ++KI DFG+S + V +L P +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML------P--IRWMP 203
Query: 103 PEVLNDKGYDGRASDVWSCGVIL 125
PE + + + SDVWS GVIL
Sbjct: 204 PESIMYRKFT-TESDVWSFGVIL 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 33/144 (22%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+Y+++E+ G L + + + E + F+ L++ Y S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
+ HRDL N+L+ V+KI+DFGL+ I+ +G L P V A
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL------P--VKWMA 273
Query: 103 PEVLNDKGYDGRASDVWSCGVILF 126
PE L D+ Y SDVWS GV+++
Sbjct: 274 PEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 36/127 (28%), Positives = 58/127 (45%), Gaps = 22/127 (17%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---R 86
QLI+ ++Y HS+ + +RD+KPEN L+ G V+ I DF L+ +++ R
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 87 EDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMA 142
E L GT Y++ + G + R D+ + G + + G LP L
Sbjct: 173 EHKSL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227
Query: 143 LYRKICR 149
Y+KI
Sbjct: 228 RYQKIGD 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 35/122 (28%), Positives = 50/122 (40%), Gaps = 14/122 (11%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQVREDGLL 91
Q+IN V++ HS+ HRD+KP+N L+ + I DFGL+ + Q
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 92 HTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALYRKI 147
GT Y + V G + R D+ S G +L + G LP Y KI
Sbjct: 171 KNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
Query: 148 CR 149
Sbjct: 229 SE 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 28/127 (22%), Positives = 53/127 (41%), Gaps = 22/127 (17%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYG-----VLKISDFGLS-----AISQQV---R 86
Q++ V H + + +RD+KP+N L+ ++ + DFG+ +++Q R
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 87 EDGLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMA 142
E L GT Y++ + G + R D+ + G + + G LP +
Sbjct: 174 EKKNL---SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228
Query: 143 LYRKICR 149
Y +I
Sbjct: 229 KYERIGE 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 20/125 (16%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLS-----AISQQ---VRED 88
Q+I+ ++Y HS+ HRD+KP+N L+ ++ I DFGL+ A + Q RE+
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 89 GLLHTACGTPNYVAPEVLNDKGYD-GRASDVWSCGVILFVLMAGFLP---FDESNLMALY 144
L GT Y + + G + R D+ S G +L G LP + Y
Sbjct: 173 KNL---TGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227
Query: 145 RKICR 149
+I
Sbjct: 228 ERISE 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 29/143 (20%), Positives = 53/143 (37%), Gaps = 33/143 (23%)
Query: 7 IYIVLEFIDGGELFD---------KIAKHGRLKEDEARRYFQQLIN-AVD------YCHS 50
+ ++ + G+L + + + ++ ++ Y S
Sbjct: 87 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146
Query: 51 RGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---A 102
V H+DL N+L+ +KISD GL + + + LL P + A
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL------P--IRWMA 198
Query: 103 PEVLNDKGYDGRASDVWSCGVIL 125
PE + + SD+WS GV+L
Sbjct: 199 PEAIMYGKFS-IDSDIWSYGVVL 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 40/155 (25%), Positives = 61/155 (39%), Gaps = 48/155 (30%)
Query: 7 IYIVLEFIDGGEL----------------FDKIAKHGRLKEDEARRYFQQLIN-AVD--- 46
IY++ E+ G+L + K +ED F+ L+ A
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 47 ---YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYV-- 101
+ + HRDL N+L+ V+KI DFGL ++ + D NYV
Sbjct: 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---ARDIMSDS---------NYVVR 231
Query: 102 ----------APEVLNDKGYDGRASDVWSCGVILF 126
APE L + Y + SDVWS G++L+
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 22/109 (20%), Positives = 43/109 (39%), Gaps = 22/109 (20%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS----------AISQQVRE 87
++++ ++Y H H D+K NLLL+ + + + D+GL+ A +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA--DP 217
Query: 88 DGLLHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 134
GT + + ++ G R D+ G + + G LP
Sbjct: 218 KRCH---DGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 40/152 (26%), Positives = 56/152 (36%), Gaps = 41/152 (26%)
Query: 7 IYIVLEFIDGGEL-----------------FDKIAKHGRLKEDEARRYFQQLIN-AVD-- 46
+ +++E+ G L DE LI+ A
Sbjct: 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQIS 160
Query: 47 ----YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGT 97
Y + HRDL N+L+ +KISDFGLS + ++ R G +
Sbjct: 161 QGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI------ 214
Query: 98 PNYV---APEVLNDKGYDGRASDVWSCGVILF 126
P V A E L D Y SDVWS GV+L+
Sbjct: 215 P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 22/106 (20%), Positives = 47/106 (44%), Gaps = 16/106 (15%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGLSAI----SQQV--RED-GL 90
+L++A+++ H H ++ EN+ + + + ++ +G + + V E
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226
Query: 91 LHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 134
H G +++ ++ KG R SD+ S G + + GFLP
Sbjct: 227 PHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLS------AISQQVRED-GL 90
++++ ++Y H H D+K NLLL + + ++D+GLS +Q +E+
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 91 LHTACGTPNYVAPEVLND-KGYD-GRASDVWSCGVILFVLMAGFLP 134
H GT + + L+ KG R SDV G + + G LP
Sbjct: 219 GHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 37/142 (26%), Positives = 52/142 (36%), Gaps = 32/142 (22%)
Query: 7 IYIVLEFIDGGEL--------FDKIAKHGRLKEDEARRYFQQLIN-AVD------YCHSR 51
+ +V E++ G+L D G QL+ A Y
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 52 GVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGTPNYV---AP 103
HRDL N L+ V+KI DFG+S I V +L P + P
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML------P--IRWMPP 229
Query: 104 EVLNDKGYDGRASDVWSCGVIL 125
E + + + SDVWS GV+L
Sbjct: 230 ESILYRKFT-TESDVWSFGVVL 250
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-07
Identities = 16/86 (18%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 263 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 320
TS PN++M +I + + K + + + + EV ++ +L+
Sbjct: 34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLN 93
Query: 321 IVEVRKTGGDTLEFHKFYKKFSSGLK 346
V ++ G ++ F K ++ LK
Sbjct: 94 GVRFKRISGTSIAFKNIASKIANELK 119
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 33/151 (21%), Positives = 51/151 (33%), Gaps = 41/151 (27%)
Query: 7 IYIVLEFIDGGEL-----------------FDKIAKHGRLKEDEARRYFQQLIN-AVD-- 46
+ ++ E++ G+L D + + + A
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 47 ----YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS-AISQQ----VREDGLLHTACGT 97
Y R HRDL N L+ V+KI+DFGLS I + +
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI------ 238
Query: 98 PNYV---APEVLNDKGYDGRASDVWSCGVIL 125
P + PE + Y SDVW+ GV+L
Sbjct: 239 P--IRWMPPESIFYNRYT-TESDVWAYGVVL 266
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 70/510 (13%), Positives = 134/510 (26%), Gaps = 192/510 (37%)
Query: 9 IVLEFIDGGE------LFDKIAKHGRLKEDEARRYFQQ---LINAVD----YCHSRGVFH 55
+V +F++ L I R R Y +Q L N Y SR +
Sbjct: 78 MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137
Query: 56 -------RDLKPENLL-----------------LDSYGVLKISDFG---LSAISQQVRED 88
+L+P + SY V DF L+ + +
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN-LKNCNSPE 196
Query: 89 GL---LHTACG--TPNYVAP-------------------EVLNDKGYDGRA----SDVWS 120
+ L PN+ + +L K Y+ +V +
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE-NCLLVLLNVQN 255
Query: 121 ----------CGVIL------------------FVLMAGFLPFDESNLMALYRKICRADF 152
C ++L L + + +L K
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK------ 309
Query: 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE---WFKKGYKPPHFDKEEEV----- 204
+ + L + +L NP I++ + D W +K + DK +
Sbjct: 310 ----YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW--DNWKHVNCDKLTTIIESSL 363
Query: 205 -NLDDVD--------AIFNDSKENLVTEKKEKPVSMNAFELI----SRTKSFSLENLFEK 251
L+ + ++F S + LI ++ + N K
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPS----A------HIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 252 QTGLVKRETRFTSQ--------RPPNEIMSK-----IEEAAKPLGFNVRKGNYKMKLQGD 298
+ + K+ T + E ++ P F+ + + D
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD---SDDLIPPYLD 470
Query: 299 K-----TGRKGQLSVA--TEVFEVAPTLHI------VEVRKTG---------GDTLEFHK 336
+ G L E + + + ++R +TL+ K
Sbjct: 471 QYFYSHIGH--HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528
Query: 337 FYKKF-----------SSGLKDVVWQAEEN 355
FYK + + + D + + EEN
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 1e-04
Identities = 36/238 (15%), Positives = 71/238 (29%), Gaps = 70/238 (29%)
Query: 29 LKEDEARRYFQQLINAVDYCHSRGVFHRDLK-PENLL------LDSYGVLKISD--FGLS 79
L+ E R+ F +L VF P LL + V+ + + S
Sbjct: 366 LEPAEYRKMFDRL----------SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 80 AISQQVRE------DGLLHTACGTPNYVAPEVLNDK---GYDG-RASDVWSC------GV 123
+ +Q +E L N A L+ Y+ + D
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYA---LHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 124 ILFVL---MAGFLPFDESNLM-ALY-------RKICRADFSCPSWFSSGA--------KK 164
+ + + L ++ +KI +W +SG+ K
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH---DSTAWNASGSILNTLQQLKF 529
Query: 165 LIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNL------DDVDAIFNDS 216
I D +P ++ +L+ F + + + +L + +AIF ++
Sbjct: 530 YKPYICDNDPKYERLVNAILD---FLPKIE-ENLICSKYTDLLRIALMAEDEAIFEEA 583
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.83 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.68 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.46 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.28 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.23 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.95 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.84 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.71 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.54 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.52 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.51 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.44 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.39 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.27 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.68 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.47 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 88.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 87.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.0 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 84.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.74 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.88 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=403.58 Aligned_cols=190 Identities=31% Similarity=0.613 Sum_probs=177.0
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+++++++|||||||+||+|+++|.+.++++|.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 101 ~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 101 FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 180 (311)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence 35788999999999999999999998999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
............+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+++.++.+..+.+|..+|+
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 259 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP 259 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCH
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCH
Confidence 76544444556788999999999999988885 89999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHH------HHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQ------MLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~e------il~h~~f~~ 191 (361)
++++||.+||..||++|||++| |++||||+.
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999887 688999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=390.45 Aligned_cols=187 Identities=49% Similarity=0.926 Sum_probs=166.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++++++|+||||| +|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 83 ~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 83 KSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred EECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence 5778999999999 679999999999999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .....+.|||+.|+|||++.+..|++.++||||+||++|+|++|..||.+.+...++..+..+.+.+|.++|++
T Consensus 162 ~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (275)
T 3hyh_A 162 MTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG 238 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred cCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 433 23446789999999999999999888899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+||.+||..||++|||++|+++||||+..
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=392.20 Aligned_cols=187 Identities=35% Similarity=0.697 Sum_probs=172.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++++++|||||||+||+|+++|.+.+++++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+++.++.+..+.+|..+|++
T Consensus 176 ~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 252 (304)
T 3ubd_A 176 SID--HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252 (304)
T ss_dssp -------CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccC--CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHH
Confidence 432 22345678999999999999988886 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||.+||..||++||| ++|+++||||+.
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999999999998 589999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=401.16 Aligned_cols=330 Identities=35% Similarity=0.653 Sum_probs=247.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|..
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .....+.|||+.|+|||++.+..|.+.++||||+||++|+|++|..||.+.+....+.++..+.+..|.+++++
T Consensus 166 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 242 (476)
T 2y94_A 166 MSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPS 242 (476)
T ss_dssp CCT---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHH
T ss_pred ccc---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHH
Confidence 532 23456789999999999999888877899999999999999999999999998899999998888889999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCCCCcccccCcc--hh---hhh---hcccccccc----c-------
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLD--DV---DAI---FNDSKENLV----T------- 222 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~~~~~~~~~~--~~---~~~---~~~~~~~~~----~------- 222 (361)
+.+||++||..||.+|||+.++++||||+.......++........ +. ... +....+... .
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 322 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPL 322 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHH
Confidence 9999999999999999999999999999976432222111000000 00 000 000000000 0
Q ss_pred --------cccCCCCCCChh---------------------hhhc----cCCC--CCCccch-----hhhccccccccee
Q 018052 223 --------EKKEKPVSMNAF---------------------ELIS----RTKS--FSLENLF-----EKQTGLVKRETRF 262 (361)
Q Consensus 223 --------~~~~~~~~~~~~---------------------~~i~----~~~~--~~~~~~~-----~~~~~~~~~~trf 262 (361)
...........+ ..+. .+.. ..+.... ...+...++.+++
T Consensus 323 ~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi 402 (476)
T 2y94_A 323 AVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGI 402 (476)
T ss_dssp ----------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESE
T ss_pred HHHHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecC
Confidence 000000000000 0000 0000 0011000 0012345778999
Q ss_pred eeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCCchhH
Q 018052 263 TSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLEF 334 (361)
Q Consensus 263 ~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le~ 334 (361)
.|..+|.+||..|.+|++.+|+.|+. +.+.++++...+.....+.|.+++|+++++.+||||++..|+.++|
T Consensus 403 ~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 403 RSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp EECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred ccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999999999999999999986 6788888765444455678999999999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=392.88 Aligned_cols=189 Identities=26% Similarity=0.490 Sum_probs=169.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|||||||+||+|.+++.+ +++++.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 141 ~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 141 LVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 467899999999999999999976 6799999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---CCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 158 (361)
... ......+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+.+..+..... ..+..+
T Consensus 220 ~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 296 (346)
T 4fih_A 220 VSK--EVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 296 (346)
T ss_dssp CCS--SSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGS
T ss_pred cCC--CCCcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccC
Confidence 543 22345678999999999999988885 899999999999999999999999988888888766532 223458
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
|+++.+||.+||..||++|||++|+|+||||++...
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=390.49 Aligned_cols=189 Identities=28% Similarity=0.597 Sum_probs=170.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
++++.+|||||||+||+|+++|...+ .++|.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 93 ~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 46789999999999999999997543 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-CCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWF 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 158 (361)
+..... .....+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+++.++..+.+ ..+..+
T Consensus 173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T 4b9d_A 173 RVLNST--VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY 249 (350)
T ss_dssp SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeecCC--cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccC
Confidence 865432 1234567999999999999998886 899999999999999999999999999999999888766 355679
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|+++.+||.+||..||++|||++|+|+||||++..
T Consensus 250 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999999999999998653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=392.47 Aligned_cols=189 Identities=26% Similarity=0.500 Sum_probs=169.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|||||||+||+|.+++.. +++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|..
T Consensus 218 ~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 218 LVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence 467899999999999999999875 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~ 158 (361)
... ......+.|||+.|||||++.+..|+ .++||||+||++|+|++|.+||.+.+..+.+..+.... ...+..+
T Consensus 297 ~~~--~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 373 (423)
T 4fie_A 297 VSK--EVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV 373 (423)
T ss_dssp CCS--SCCCBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSS
T ss_pred CCC--CCccccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccC
Confidence 543 22345678999999999999988885 89999999999999999999999998888888876653 2334568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
|+++.+||.+||..||++|||++|+|+||||++...
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 999999999999999999999999999999997643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=370.54 Aligned_cols=183 Identities=26% Similarity=0.533 Sum_probs=159.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEec-CCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDS-YGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~-~~~lKl~DFGla~ 80 (361)
+..+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 4579999999999999999999899999999999999999999999999 999999999999984 7999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-cHHHHHHHHhhcCC--CCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRADF--SCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~~~~ 157 (361)
... .....+.||||.|+|||++.+ +|+ .++||||+||++|+|++|..||.+. +...++..+..+.. ..+..
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 532 234567899999999999875 565 8999999999999999999999764 45566666655433 23455
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.++++.+||.+||..||++|||++|+++||||++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 78999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=379.59 Aligned_cols=191 Identities=27% Similarity=0.387 Sum_probs=164.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~ 80 (361)
.+++.+|||||||+||+|.++|.+.+++++.+++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|.
T Consensus 120 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 46789999999999999999999989999999999999999999999999999999999999999998 59999999998
Q ss_pred cccccccCC---ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---CC
Q 018052 81 ISQQVREDG---LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SC 154 (361)
Q Consensus 81 ~~~~~~~~~---~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~ 154 (361)
......... ...+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+++.++..... ..
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 278 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGS
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhc
Confidence 654322111 22346899999999999998886 899999999999999999999998877777777766553 35
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHH-------------HhCcccccCC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQM-------------LEDEWFKKGY 193 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~ei-------------l~h~~f~~~~ 193 (361)
|+.+|+++.+||.+||..||.+|||+.|+ ++|||+.+..
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 67899999999999999999999999998 4688887543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=375.80 Aligned_cols=191 Identities=27% Similarity=0.387 Sum_probs=164.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..++|||||||. |+|+++|...+++++.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 34578999999996 68999999989999999999999999999999999999999999999999999999999999976
Q ss_pred cccc--ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC-----
Q 018052 82 SQQV--REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----- 154 (361)
Q Consensus 82 ~~~~--~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----- 154 (361)
.... .......+.|||+.|+|||++.+..|++.++||||+||++|+|++|.+||.+.+..+.+..|.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 123345678999999999999887777899999999999999999999999998888777765432111
Q ss_pred ---------------C-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 155 ---------------P-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 155 ---------------~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
| +.+|+++.+||.+||..||++|||++|+|+||||++..
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 1 23689999999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=393.14 Aligned_cols=187 Identities=30% Similarity=0.528 Sum_probs=169.0
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
|.+++++|||||||+||+|+++|.+.++++|..++.|++||+.||+|||++||+||||||+||||+.+|++||+|||+|.
T Consensus 261 f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 261 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceee
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHhhcCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKICRADFSCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~ 157 (361)
.... ....+.||||.|+|||++.+...++.++||||+||++|+|++|.+||.+. +...++..+......+|..
T Consensus 341 ~~~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~ 416 (689)
T 3v5w_A 341 DFSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416 (689)
T ss_dssp ECSS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT
T ss_pred ecCC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc
Confidence 6532 23467899999999999975433458999999999999999999999764 3446677778888889999
Q ss_pred CCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+|+++.+||.+||..||.+|++ ++||++||||+.
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999998 799999999985
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.74 Aligned_cols=187 Identities=29% Similarity=0.505 Sum_probs=150.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DFGla~ 80 (361)
++++++|||||||+||+|.+++. ++++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 46789999999999999999984 59999999999999999999999999999999999999976 899999999997
Q ss_pred cccccc--------------------------cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC
Q 018052 81 ISQQVR--------------------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP 134 (361)
Q Consensus 81 ~~~~~~--------------------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P 134 (361)
...... ......+.|||+.|+|||++.+.++++.++||||+||++|+|++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 543211 112235678999999999998877667999999999999999999999
Q ss_pred CCc-ccHHHHHHHHhh--------------------------------------cCC----------------CCCCCCC
Q 018052 135 FDE-SNLMALYRKICR--------------------------------------ADF----------------SCPSWFS 159 (361)
Q Consensus 135 f~~-~~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s 159 (361)
|.. .+..+.+..+.. ... .....+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 954 333333322211 000 0112378
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+++.+||++||..||++|||++|+|+||||++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=346.31 Aligned_cols=183 Identities=23% Similarity=0.418 Sum_probs=148.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++.+|||||||+||+|.+++... +++++.++..++.|++.||+|||++||+||||||+|||+++++++||+|||+|..
T Consensus 102 ~~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 102 TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp CSSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred ECCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 356789999999999999999764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------ 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------ 152 (361)
...........+.+||+.|||||++.+. .| +.++||||+||+||+|++|..||.+.+.......+.....
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 6543333445678999999999998643 34 4899999999999999999999988665544433333222
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..+++++.+|+.+||..||++|||+.|++++
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2345689999999999999999999999998765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.84 Aligned_cols=191 Identities=35% Similarity=0.642 Sum_probs=171.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC--CCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY--GVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~--~~lKl~DFGl 78 (361)
+++.++|||||||+||+|+++|.. .+++++.+++.|++||+.||+|||++||+||||||+|||++.+ |.+||+|||+
T Consensus 224 ~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp ECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred EECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 577899999999999999999975 4689999999999999999999999999999999999999854 8999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
|..... .....+.|||+.|+|||++.+.+|. .++||||+||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 304 a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 379 (573)
T 3uto_A 304 TAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 379 (573)
T ss_dssp CEECCT---TSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG
T ss_pred eeEccC---CCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc
Confidence 986542 3445678999999999999998885 899999999999999999999999999999999888776554
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
..+|+++.+||.+||..||.+|||+.|+|+||||+....+.
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 35899999999999999999999999999999999765543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=347.85 Aligned_cols=187 Identities=22% Similarity=0.347 Sum_probs=164.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY 68 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~ 68 (361)
.+++.+|||||||+||+|.++|...+ .+++.++..++.|++.||+|||+++|+||||||+|||++++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 35678999999999999999997643 69999999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHH
Q 018052 69 GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKI 147 (361)
Q Consensus 69 ~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i 147 (361)
+.+||+|||+|+..............+||+.|+|||++.+..|+ .++||||+||++|||+| |..||.+.+..++...+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999765433222223346799999999999988886 89999999999999998 89999999988888888
Q ss_pred hhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 148 CRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 148 ~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+. .+.|..+|+++.+||.+||+.||++|||+.++ ++|+++
T Consensus 244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 7765 46778899999999999999999999999999 456653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=347.72 Aligned_cols=183 Identities=27% Similarity=0.469 Sum_probs=143.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCC---CHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRL---KEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+..+|||||||+||+|.+++...+.+ ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 34689999999999999999987654 456789999999999999999999999999999999999999999999998
Q ss_pred cccccccC----------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhh
Q 018052 81 ISQQVRED----------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICR 149 (361)
Q Consensus 81 ~~~~~~~~----------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~ 149 (361)
........ ....+.|||+.|+|||++.+..|+ .++||||+||++|+|++ ||..... ......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~ 242 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN 242 (299)
T ss_dssp -------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc
Confidence 65432211 123457899999999999988886 89999999999999996 8865432 233344433
Q ss_pred cCCCCCC---CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 150 ADFSCPS---WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 150 ~~~~~~~---~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.. .|+ ..++.+.+||.+||..||++|||+.|+++||||+.-
T Consensus 243 ~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 243 LK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp TC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred CC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 33 332 246778899999999999999999999999999853
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=344.35 Aligned_cols=184 Identities=21% Similarity=0.316 Sum_probs=155.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH---------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
.+...+|||||||+||+|.+++... +++++.++..++.|++.||+|||+++|+||||||+|||++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 3567899999999999999999764 3589999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
+++.+||+|||+|+..............+||+.|+|||++.+..|+ .++||||+||++|||+| |+.||.+.+..+...
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999865443333334567899999999999988886 89999999999999998 899999988888888
Q ss_pred HHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+ ....|..+++++.+|+.+||..||++|||+.||+++
T Consensus 272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 87765 466788899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=339.72 Aligned_cols=189 Identities=44% Similarity=0.843 Sum_probs=176.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++||+|.+++...+++++.+++.++.|++.||+|||++||+||||||+|||++.++++||+|||+|..
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 46778999999999999999999888999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+.......+..+.+..|.+++++
T Consensus 164 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 164 FTV---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp GSS---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCC---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 432 33456789999999999999888887899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+||++||..||.+|||++|+++||||+...
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.03 Aligned_cols=183 Identities=21% Similarity=0.338 Sum_probs=162.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
++..+|||||||+||+|.++|... ..+++.++..++.|++.||+|||+++|+||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 456789999999999999999753 3589999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
+++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||+||||+| |..||.+.+..++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865443333345567899999999999988875 89999999999999998 899999999888888
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+. .+.|..+++++.+|+.+||..||++|||+.||+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 877654 45677899999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=346.84 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=157.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
+.+.+|||||||+||+|.++|... ..+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 345799999999999999999753 3489999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHH-HHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM-ALY 144 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~-~~~ 144 (361)
+++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||+||||+| |..||.+.+.. .+.
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999865432222234467899999999999988886 89999999999999998 99999886543 444
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..+ ....|..+++++.+||.+||..||++|||+.||++|
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 444443 456788899999999999999999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=341.59 Aligned_cols=187 Identities=34% Similarity=0.678 Sum_probs=168.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+|||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 45778999999999999999999988999999999999999999999999999999999999999999999999999874
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.|||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+......+|.+++++
T Consensus 174 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 250 (353)
T 3txo_A 174 GIC--NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc--CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 322 22334578999999999999887775 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCH------HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 191 (361)
+.+||++||..||.+||++ +++++||||+.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 9999999999999999998 89999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=332.18 Aligned_cols=187 Identities=36% Similarity=0.693 Sum_probs=171.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 45678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+......+|..++++
T Consensus 155 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T 1o6l_A 155 GIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp SCC--TTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc--CCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 322 22345678999999999999887775 899999999999999999999999998899999888888899999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|| ++.++++||||+.
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999999999999 9999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=335.36 Aligned_cols=187 Identities=31% Similarity=0.649 Sum_probs=172.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 46789999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+......+|.+++++
T Consensus 168 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (345)
T 1xjd_A 168 NML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244 (345)
T ss_dssp CCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc--CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHH
Confidence 322 12234678999999999999887775 899999999999999999999999999999999988888899999999
Q ss_pred HHHHHHHccCCCcCCCCCHH-HHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~-eil~h~~f~~ 191 (361)
+.+||.+||..||.+||++. ++++||||+.
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 99999999999999999998 9999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.37 Aligned_cols=187 Identities=31% Similarity=0.621 Sum_probs=171.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 45679999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.|||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+++..+......+|..++++
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 247 (353)
T 2i0e_A 171 NIW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247 (353)
T ss_dssp CCC--TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc--CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 322 22235578999999999999888775 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+||+ +.++++||||+.
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 999999999999999994 799999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=325.84 Aligned_cols=184 Identities=36% Similarity=0.773 Sum_probs=171.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 35678999999999999999999988999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+.++......+|+.++++
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 229 (318)
T 1fot_A 156 VPD-----VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229 (318)
T ss_dssp CSS-----CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCC-----ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 432 23567999999999999887775 899999999999999999999999999999999999888899999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|| +++++++||||+.
T Consensus 230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999999999 9999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=334.77 Aligned_cols=187 Identities=33% Similarity=0.654 Sum_probs=167.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+|||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 46789999999999999999999888999999999999999999999999999999999999999999999999999974
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---------cHHHHHHHHhhcCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---------NLMALYRKICRADF 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~ 152 (361)
... ......+.|||+.|+|||++.+..|. .++||||+||++|+|++|..||... ....++..+.....
T Consensus 203 ~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 203 GLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp CCC--TTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred ccc--CCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 222 23345678999999999999988775 8999999999999999999999632 23456777888888
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCH------HHHHhCccccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 191 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 191 (361)
.+|..+++++.+||++||..||.+||++ ++|++||||+.
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999999999984 89999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.49 Aligned_cols=188 Identities=31% Similarity=0.624 Sum_probs=174.2
Q ss_pred CCcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 1 ~~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+.+++||||||++||+|.+++...+++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 411 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp CBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 35678999999999999999999998899999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.... ......+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+++..+......+|..+++
T Consensus 491 ~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 567 (674)
T 3pfq_A 491 ENIW--DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 567 (674)
T ss_dssp ECCC--TTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCH
T ss_pred cccc--CCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 5322 22345678999999999999888875 89999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCH-----HHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMTI-----SQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~-----~eil~h~~f~~ 191 (361)
++.+||++||..||.+||++ ++|++||||+.
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999999999997 99999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=332.61 Aligned_cols=188 Identities=47% Similarity=0.920 Sum_probs=169.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+||||+ +|+|.+++...+++++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 4677899999999 789999999888999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .....+.+||+.|+|||++.+..|.+.++||||+||++|+|++|..||.+......+.++....+..|..+|++
T Consensus 158 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 158 MTD---GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234 (336)
T ss_dssp TTT---SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHH
T ss_pred ccC---CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHH
Confidence 533 23456779999999999999888877899999999999999999999998776666666666677788889999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+||++||..||.+|||++|+++||||+...
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=327.40 Aligned_cols=184 Identities=35% Similarity=0.738 Sum_probs=171.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..++|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+..+...+|..++++
T Consensus 191 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 264 (350)
T 1rdq_E 191 VKG-----RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264 (350)
T ss_dssp CSS-----CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHH
T ss_pred ccC-----CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 432 23467899999999999887775 899999999999999999999999999999999999988899999999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+||+ ++++++||||+.
T Consensus 265 ~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999999999998 999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=329.84 Aligned_cols=187 Identities=34% Similarity=0.642 Sum_probs=171.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 45679999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.|||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+......+|+.++++
T Consensus 189 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 265 (373)
T 2r5t_A 189 NIE--HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNS 265 (373)
T ss_dssp GBC--CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHH
T ss_pred ccc--CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Confidence 322 22345678999999999999887775 899999999999999999999999999999999998888889999999
Q ss_pred HHHHHHHccCCCcCCCCCH----HHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTI----SQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~----~eil~h~~f~~ 191 (361)
+.+||.+||..||.+||++ .++++||||+.
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999999986 69999999974
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.24 Aligned_cols=186 Identities=33% Similarity=0.604 Sum_probs=168.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DFG 77 (361)
++...+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 46778999999999999999999888999999999999999999999999999999999999998877 79999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC--
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-- 155 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 155 (361)
++..... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 165 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 165 LAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp SCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred CceEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 9976543 2234567899999999999887775 899999999999999999999999998888888888776665
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 458999999999999999999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=326.14 Aligned_cols=187 Identities=33% Similarity=0.658 Sum_probs=166.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 45779999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc---------ccHHHHHHHHhhcCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---------SNLMALYRKICRADF 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~ 152 (361)
... ......+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.. ......+..+.....
T Consensus 160 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 160 GLR--PGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp SCC--TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred ccC--CCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 322 22335677999999999999887774 899999999999999999999975 234456677777888
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCH------HHHHhCccccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTI------SQMLEDEWFKK 191 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~------~eil~h~~f~~ 191 (361)
.+|..+++++.+||.+||..||.+||++ +++++||||+.
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 8899999999999999999999999995 89999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.49 Aligned_cols=187 Identities=34% Similarity=0.675 Sum_probs=166.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ........+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+....+..+.......|+.++++
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 247 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 322 12234567899999999999887774 899999999999999999999999998888888888888899999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|| ++.++++||||+.
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 99999999999999999 8999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.96 Aligned_cols=187 Identities=36% Similarity=0.721 Sum_probs=168.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
.+++.+|+|||||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 46788999999999999999999989999999999999999999999999999999999999998 467899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
|...... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+..+.+.+|.
T Consensus 160 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 160 AIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eEEecCC--CceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 9765432 2234567899999999999887775 8999999999999999999999999999999888887665543
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+++++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 47999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=331.71 Aligned_cols=187 Identities=36% Similarity=0.699 Sum_probs=170.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|.
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 3567899999999999999999988899999999999999999999998 999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.... ........+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+......+|..+++
T Consensus 298 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 374 (446)
T 4ejn_A 298 EGIK--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374 (446)
T ss_dssp TTCC-------CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred eccC--CCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 5322 22334568999999999999887775 89999999999999999999999999999999998888889999999
Q ss_pred HHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 161 GAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
++.+||.+||..||.+|| |++|+++||||+.
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999999999 9999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=319.73 Aligned_cols=193 Identities=39% Similarity=0.702 Sum_probs=165.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+..|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp ECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC--CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--SWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~ 158 (361)
.............+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+.. ..+..+.......+ ..+
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGS
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccC
Confidence 554333344557799999999999988887668899999999999999999999875543 33333333333333 348
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
++.+.+||.+||..||.+|||+.|+++||||+....
T Consensus 235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 999999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.02 Aligned_cols=186 Identities=26% Similarity=0.525 Sum_probs=162.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+||||++||+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 88 VGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 467899999999999999999874 6999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s 159 (361)
... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+.......+... ....|..++
T Consensus 167 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 167 TPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp CST--TCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred CCc--ccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 432 2234567899999999999887775 8999999999999999999999987776655544432 334456789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=318.17 Aligned_cols=187 Identities=28% Similarity=0.539 Sum_probs=167.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec--CCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~--~~~lKl~DFGl 78 (361)
++.+.+|+|||||+||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred ecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 35678999999999999999998754 7999999999999999999999999999999999999987 78999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
+..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......++
T Consensus 151 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 151 ARQLKP---GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CEECCT---TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CeECCC---CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence 976532 233456789999999999987655 4899999999999999999999999988888888888776655
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+|+++.+||.+||..||.+|||+.|+++||||+..
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 3589999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=328.33 Aligned_cols=189 Identities=32% Similarity=0.597 Sum_probs=163.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+..++|+|||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 467889999999999999999987 4689999999999999999999999999999999999999999999999999996
Q ss_pred cccccccCCccccccCCCcccccccccc----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSC 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~ 154 (361)
...... .......+||+.|+|||++.. ...++.++||||+||++|+|++|..||.+.+..+.+.++... .+.+
T Consensus 224 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 224 KLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp ECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 543211 112345789999999999872 233358999999999999999999999999988888887643 3455
Q ss_pred CCC---CCHHHHHHHHHccCCCcCC--CCCHHHHHhCccccc
Q 018052 155 PSW---FSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~~~---~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 191 (361)
|.. +|+++.+||++||..+|++ |++++|+++||||+.
T Consensus 303 p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 303 PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 543 8999999999999998888 999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=321.49 Aligned_cols=186 Identities=29% Similarity=0.602 Sum_probs=166.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 45678999999999999999999988999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCc---ccHHHHHHHHhhcCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSCP 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~ 155 (361)
... .....+.+||+.|+|||++.+. +| +.++||||+||++|+|++|..||.. ......+..+......+|
T Consensus 165 ~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p 240 (384)
T 4fr4_A 165 LPR---ETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240 (384)
T ss_dssp CCT---TCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC
T ss_pred ccC---CCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC
Confidence 432 3345678999999999998743 34 5899999999999999999999974 345566677777788889
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCC-HHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMT-ISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t-~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+||+ ++++++||||+.
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999999999999999999998 999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=327.16 Aligned_cols=188 Identities=36% Similarity=0.610 Sum_probs=164.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..++|+|||||+||+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 467889999999999999999976 5799999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCC---CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCC-
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG---YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCP- 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~---~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~- 155 (361)
..... .....+.+||+.|+|||++.+.+ +++.++||||+||++|+|++|..||.+.+....+.++... ...+|
T Consensus 218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 43221 11234679999999999997655 2358999999999999999999999999988888888654 23444
Q ss_pred -CCCCHHHHHHHHHccCCCcCC--CCCHHHHHhCccccc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDT--RMTISQMLEDEWFKK 191 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~--R~t~~eil~h~~f~~ 191 (361)
..+|+++.+||++||..+|.+ |++++||++||||+.
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 468999999999999999998 999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.14 Aligned_cols=186 Identities=38% Similarity=0.755 Sum_probs=166.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFGl 78 (361)
.+.+.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 35678999999999999999999888999999999999999999999999999999999999998654 599999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
+..... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+....+..+..+.+.+|.
T Consensus 178 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 253 (362)
T 2bdw_A 178 AIEVND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 253 (362)
T ss_dssp CBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred ceEecC---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 976542 2234567899999999999887775 8999999999999999999999999888888888877665543
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 37999999999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=318.89 Aligned_cols=188 Identities=37% Similarity=0.701 Sum_probs=164.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-C---CEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-G---VLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~---~lKl~DFG 77 (361)
.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+... + .+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 4567899999999999999999998899999999999999999999999999999999999998533 3 49999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc---ccHHHHHHHHhhcCCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE---SNLMALYRKICRADFSC 154 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~ 154 (361)
++...... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+ .+..+++..+..+.+..
T Consensus 166 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 242 (342)
T 2qr7_A 166 FAKQLRAE--NGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242 (342)
T ss_dssp TCEECBCT--TCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC
T ss_pred CcccCcCC--CCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc
Confidence 99764332 2345678999999999999877775 799999999999999999999976 45667777777776655
Q ss_pred C----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 P----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+ ..+|+++.+||++||..||++|||+.++++||||...
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4 3589999999999999999999999999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=312.95 Aligned_cols=186 Identities=37% Similarity=0.627 Sum_probs=166.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DFG 77 (361)
.++..+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 35678999999999999999999888999999999999999999999999999999999999999888 89999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC--
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-- 155 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 155 (361)
++..... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+....+.......+
T Consensus 164 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (326)
T 2y0a_A 164 LAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239 (326)
T ss_dssp TCEECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred CCeECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc
Confidence 9976532 2234567899999999999877765 899999999999999999999999888888777776665554
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 357899999999999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.93 Aligned_cols=190 Identities=43% Similarity=0.785 Sum_probs=154.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC--EEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~--lKl~DFGla 79 (361)
.++.++|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred eeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 356789999999999999999998889999999999999999999999999999999999999987776 999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc----HHHHHHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN----LMALYRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~ 155 (361)
..... .......+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+ .......+.......|
T Consensus 166 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 166 KSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC
T ss_pred ccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC
Confidence 64322 2233456899999999999888887666999999999999999999998743 3455555655665555
Q ss_pred C--CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 156 S--WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 156 ~--~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
. .+++++.+||.+||..||.+|||+.|+++||||.+...
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 5 47999999999999999999999999999999987543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.51 Aligned_cols=187 Identities=39% Similarity=0.730 Sum_probs=153.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEecCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGL 78 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DFGl 78 (361)
+.++|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567999999999999999998754 5999999999999999999999999999999999999997 78999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH----HHHHHHhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~ 154 (361)
+..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+.. .....+..+.+.+
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 211 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred ccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 975432 2234578999999999999887775 8999999999999999999999765432 2344455555444
Q ss_pred C----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 155 P----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 155 ~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
| ..+++++.+||++||..||.+|||+.++++||||.....
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 3 348999999999999999999999999999999987544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.50 Aligned_cols=188 Identities=36% Similarity=0.735 Sum_probs=167.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++...+++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999998854
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+....+..+.......|..++++
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T 3fdn_A 159 APS----SRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233 (279)
T ss_dssp C------------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred CCc----ccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHH
Confidence 322 223456899999999999876664 899999999999999999999999998888888888888899999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+.+||.+||..||.+|||+.|+++||||+....
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=314.09 Aligned_cols=190 Identities=38% Similarity=0.727 Sum_probs=146.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFGl 78 (361)
.+...+|+||||++||+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred EcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 35678999999999999999999988999999999999999999999999999999999999998766 899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-------HHHHHHHHhhcC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-------LMALYRKICRAD 151 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~ 151 (361)
+...... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+ ..+....+..+.
T Consensus 156 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 156 ARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp CEECCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred ceecCCC--CCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 9754322 2234567899999999999887775 89999999999999999999997643 356677777776
Q ss_pred CCCCC----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 152 FSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 152 ~~~~~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+..+. .+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 66553 47999999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.52 Aligned_cols=187 Identities=32% Similarity=0.590 Sum_probs=161.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+++|+|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|.
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 46788999999999999999998754 79999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCcccccccccc-------CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--C
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND-------KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--D 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~-------~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~ 151 (361)
...... .......+||+.|+|||++.. ..| +.++||||+||++|+|++|..||.+.+..+.+.++... .
T Consensus 211 ~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 211 KLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp ECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred eccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 543211 112335799999999999873 334 58999999999999999999999999888888887653 2
Q ss_pred CCCC---CCCCHHHHHHHHHccCCCcCCC---CCHHHHHhCccccc
Q 018052 152 FSCP---SWFSSGAKKLIKRILDPNPDTR---MTISQMLEDEWFKK 191 (361)
Q Consensus 152 ~~~~---~~~s~~~~~Li~~~L~~dP~~R---~t~~eil~h~~f~~ 191 (361)
...| ..+|+++.+||++||. +|.+| ++++++++||||+.
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 3344 4689999999999999 99998 59999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=304.79 Aligned_cols=188 Identities=28% Similarity=0.477 Sum_probs=154.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+||||+.| +|.+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|.
T Consensus 71 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 71 HSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 356789999999987 5555554 46789999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCC-CCcccHHHHHHHHhhcC--------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLP-FDESNLMALYRKICRAD-------- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~P-f~~~~~~~~~~~i~~~~-------- 151 (361)
.... ........+||+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+....+....
T Consensus 150 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 150 AFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCS--CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ecCC--ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 6532 223345678999999999998777556999999999999999988777 56666666555543210
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 ---------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ---------------------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
....+.+++++.+||++||..||++|||++|+++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01122368899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.87 Aligned_cols=187 Identities=28% Similarity=0.504 Sum_probs=166.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.+++++|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 4678899999999999999999864 369999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhhcCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFS 153 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~ 153 (361)
++...... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+. ....+...+......
T Consensus 335 la~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 335 LAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411 (543)
T ss_dssp TCEECCTT--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC
T ss_pred eeeeccCC--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC
Confidence 99764332 1223456999999999999887775 8999999999999999999999864 356777778888888
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+|..+++++.+||++||..||.+||+ ++++++||||+.
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 88999999999999999999999996 589999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.47 Aligned_cols=181 Identities=20% Similarity=0.362 Sum_probs=140.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEecCCCEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~--------gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
..+|||||||+||+|.+++.. .+++++.+..++.|++.||+|||++ +|+||||||+|||+|.++++||+||
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 478999999999999999986 5699999999999999999999987 9999999999999999999999999
Q ss_pred CCccccccccc--CCccccccCCCccccccccccCCC-----CCCchhhhhhhhHHHhHhcCCCCCCc------------
Q 018052 77 GLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDE------------ 137 (361)
Q Consensus 77 Gla~~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~~-----~~~~~DiwS~Gvil~~ll~g~~Pf~~------------ 137 (361)
|+|........ .....+.+||+.|+|||++.+... ++.++||||+||+||||++|.+||..
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99976543221 112345689999999999875421 23689999999999999999776532
Q ss_pred ---ccHHHHHHHHhhcCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 138 ---SNLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 138 ---~~~~~~~~~i~~~~~--~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.........+..... ..|.. .+..+.+|+.+||..||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122334443333322 23322 12467899999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=302.37 Aligned_cols=190 Identities=47% Similarity=0.899 Sum_probs=163.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... .......+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+....+..+.......|..++.+
T Consensus 161 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (276)
T 2h6d_A 161 MSD---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCC---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHH
Confidence 432 22234568999999999998877766899999999999999999999999888888888888888888889999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+.+||.+||..||.+|||+.++++||||++...
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 999999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=305.90 Aligned_cols=185 Identities=36% Similarity=0.694 Sum_probs=161.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||++||+|.+++. .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 110 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 110 EDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp SSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccc
Confidence 568999999999999988653 4679999999999999999999999999999999999999999999999999997653
Q ss_pred ccccCCccccccCCCccccccccccCCC--CCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC--CCCC
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--SWFS 159 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~--~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~s 159 (361)
.. .......+||+.|+|||++.+... .+.++||||+||++|+|++|..||.+.+.......+.......| +.++
T Consensus 189 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (298)
T 2zv2_A 189 GS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIA 266 (298)
T ss_dssp SS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCC
T ss_pred cc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccC
Confidence 31 223455789999999999876542 45789999999999999999999999888877777766655544 4589
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+++.+||.+||..||.+|||+.|+++||||++
T Consensus 267 ~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 267 EDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=330.95 Aligned_cols=186 Identities=30% Similarity=0.521 Sum_probs=165.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+++++|+||||++||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 46789999999999999999998755 4999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhhcCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCP 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~ 155 (361)
..... .....+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+. ....+...+......+|
T Consensus 334 ~~~~~---~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p 409 (576)
T 2acx_A 334 VHVPE---GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409 (576)
T ss_dssp EECCT---TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred eeccc---CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence 75432 2234567999999999999887775 8999999999999999999999875 34566667777777788
Q ss_pred CCCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
..+|+++.+||.+||..||.+|| +++|+++||||+.
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 88999999999999999999999 8999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=318.16 Aligned_cols=188 Identities=27% Similarity=0.429 Sum_probs=154.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+|||||. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 3457999999997 599998876 57999999999999999999999999999999999999999999999999999754
Q ss_pred ccc-------------------ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHH
Q 018052 83 QQV-------------------REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL 143 (361)
Q Consensus 83 ~~~-------------------~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~ 143 (361)
... .........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 0112345578999999999998755456899999999999999999999998887766
Q ss_pred HHHHhhcCC-----------------------------------------------CCCCCCCHHHHHHHHHccCCCcCC
Q 018052 144 YRKICRADF-----------------------------------------------SCPSWFSSGAKKLIKRILDPNPDT 176 (361)
Q Consensus 144 ~~~i~~~~~-----------------------------------------------~~~~~~s~~~~~Li~~~L~~dP~~ 176 (361)
+..+..... ..+..+++++.+||.+||..||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 665542100 011246889999999999999999
Q ss_pred CCCHHHHHhCcccccC
Q 018052 177 RMTISQMLEDEWFKKG 192 (361)
Q Consensus 177 R~t~~eil~h~~f~~~ 192 (361)
|||++|+++||||+..
T Consensus 320 R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 320 RISANDALKHPFVSIF 335 (388)
T ss_dssp SCCHHHHTTSTTTTTT
T ss_pred CCCHHHHhCCHHHHHh
Confidence 9999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.81 Aligned_cols=186 Identities=37% Similarity=0.762 Sum_probs=169.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 56789999999999999999998888999999999999999999999999999999999999999999999999998654
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGA 162 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 162 (361)
.. ......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+.......|+.++.++
T Consensus 165 ~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 2vgo_A 165 PS----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239 (284)
T ss_dssp SS----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred cc----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHH
Confidence 32 223456899999999999887765 8999999999999999999999998888888888888888889999999
Q ss_pred HHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 163 KKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 163 ~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+||.+||..||.+|||+.++++||||+...
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=312.52 Aligned_cols=186 Identities=35% Similarity=0.698 Sum_probs=159.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKIS 74 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~ 74 (361)
.+...+|+|||||+||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 3567899999999999999887643 35899999999999999999999999999999999999987665 9999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC 154 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 154 (361)
|||++...... .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+ ...+..+..+.+..
T Consensus 176 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 176 GFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp CCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred cCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99999765432 2224567899999999999887774 89999999999999999999998854 45566666665554
Q ss_pred C----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 155 P----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+ ..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 4 357999999999999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=307.60 Aligned_cols=188 Identities=27% Similarity=0.423 Sum_probs=154.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++..+|+||||++| +|.+.+... .++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 456789999999985 888887765 469999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCC-----
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFS----- 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~----- 153 (361)
..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+... ...
T Consensus 168 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 168 AFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp ETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 65321 223445689999999999877555568999999999999999999999876655444443221 000
Q ss_pred -----------------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 -----------------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 -----------------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+.+++++.+||.+||..||++|||+.|+++||||+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 012367899999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=304.99 Aligned_cols=190 Identities=28% Similarity=0.483 Sum_probs=159.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEe
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISD 75 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~D 75 (361)
.+++.+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 73 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 73 HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp CCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECc
Confidence 45678999999998 5999988753 3599999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--- 152 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 152 (361)
||++...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 152 fg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999765321 22344568999999999997655446899999999999999999999998877766655532100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 153 -------------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 153 -------------------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+..+++++.+||.+||..||.+|||+.|+++||||++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011246889999999999999999999999999999997554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=301.60 Aligned_cols=182 Identities=28% Similarity=0.422 Sum_probs=155.4
Q ss_pred EEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.+|+||||+. |+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 93 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 171 (308)
T 3g33_A 93 KVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171 (308)
T ss_dssp EEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTST
T ss_pred eEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccC
Confidence 6899999997 599999987654 9999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC----------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS---------- 153 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---------- 153 (361)
. .......+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+....+......
T Consensus 172 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 172 Y---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp T---CCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred C---CcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 2 2334567899999999999887775 8999999999999999999999998877776665432100
Q ss_pred -----------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 -----------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 -----------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+.+++.+.+||.+||..||++|||+.|+++||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012468899999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=297.92 Aligned_cols=186 Identities=41% Similarity=0.763 Sum_probs=166.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.+...+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~ 155 (277)
T 3f3z_A 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155 (277)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred ecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence 3567899999999999999999988899999999999999999999999999999999999999 8889999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
+..... .......+||+.|+|||++.+. + +.++||||+|+++|+|++|..||...+..+....+.......|.
T Consensus 156 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T 3f3z_A 156 AARFKP---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD 230 (277)
T ss_dssp CEECCT---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred ceeccC---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 876432 2334567899999999998654 4 58999999999999999999999998888888888887776664
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 579999999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.19 Aligned_cols=190 Identities=23% Similarity=0.405 Sum_probs=153.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 567899999999999999999876 679999999999999999999999999999999999999999999999999986
Q ss_pred ccccccc-----CCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC--
Q 018052 81 ISQQVRE-----DGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-- 151 (361)
Q Consensus 81 ~~~~~~~-----~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-- 151 (361)
....... .......+||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+.+.......+..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 4322111 112234589999999999987 345 489999999999999999999998755443332222111
Q ss_pred --------------------------------------------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 152 --------------------------------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 152 --------------------------------------------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
...+..+++++.+||.+||..||++|||+.|+++||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 112345789999999999999999999999999999
Q ss_pred ccccCC
Q 018052 188 WFKKGY 193 (361)
Q Consensus 188 ~f~~~~ 193 (361)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.86 Aligned_cols=192 Identities=38% Similarity=0.657 Sum_probs=172.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......+||+.|+|||++.+..+ +.++||||+|+++|+|++|..||...+..+.+..+.......|..+++.
T Consensus 165 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 2rku_A 165 VEYD--GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241 (294)
T ss_dssp CCST--TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred cccC--ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHH
Confidence 5322 122345689999999999987666 4899999999999999999999999888888888888888888899999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
+.+||.+||..||++|||++++++||||+....+.
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 99999999999999999999999999999876544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.53 Aligned_cols=190 Identities=33% Similarity=0.630 Sum_probs=155.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~DFGl 78 (361)
.+++.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 356789999999999999999998888999999999999999999999999999999999999998776 99999999
Q ss_pred ccccccccc-----CCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCccc---------
Q 018052 79 SAISQQVRE-----DGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESN--------- 139 (361)
Q Consensus 79 a~~~~~~~~-----~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--------- 139 (361)
+........ .......+||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 875432111 112345679999999999865 334 489999999999999999999997643
Q ss_pred ------HHHHHHHHhhcCCCCC----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 140 ------LMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 140 ------~~~~~~~i~~~~~~~~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
....+..+..+....| ..+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred ccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345566666666655 3579999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=307.05 Aligned_cols=193 Identities=37% Similarity=0.655 Sum_probs=173.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+||||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+..+.+..+.......|..+++.
T Consensus 191 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
T 2owb_A 191 VEYD--GERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267 (335)
T ss_dssp CCST--TCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred cccC--cccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHH
Confidence 5422 1223456899999999999877664 899999999999999999999999888888888888888888899999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPH 197 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 197 (361)
+.+||.+||..||.+|||+.++++||||+....+..
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence 999999999999999999999999999998765543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.64 Aligned_cols=188 Identities=31% Similarity=0.492 Sum_probs=153.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++.+|+||||+.| +|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp ECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred ccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 356789999999986 999988764 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CC------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DF------ 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~------ 152 (361)
..... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 149 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 149 AFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence 54321 122345689999999999976554568999999999999999999999987766665554321 00
Q ss_pred ---------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 ---------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ---------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+..+++++.+||.+||..||++|||+.|+++||||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0113478999999999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=313.64 Aligned_cols=188 Identities=31% Similarity=0.617 Sum_probs=164.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec--CCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~--~~~lKl~DFGl 78 (361)
.+...+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 118 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccc
Confidence 35678999999999999999998654 7999999999999999999999999999999999999974 57899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
|..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+....+.......+
T Consensus 198 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 198 ATKLNP---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CEECCT---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred ceecCC---CcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 976432 2334556899999999999887764 899999999999999999999999888888877776655443
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 34799999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=298.37 Aligned_cols=191 Identities=39% Similarity=0.705 Sum_probs=162.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+||||++||+|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 45788999999999999999988788999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC--CCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--SWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s 159 (361)
............+||+.|+|||++.+..+.+.++||||+|+++|+|++|..||...+.. ..+..+.......+ ..++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSC
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcC
Confidence 43333334456789999999999988777667899999999999999999999875543 23333333322222 3589
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+.+||.+||..||.+|||+.++++||||+...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.13 Aligned_cols=189 Identities=30% Similarity=0.386 Sum_probs=146.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 346799999998 5699999998889999999999999999999999999999999999999999999999999999765
Q ss_pred ccccc-------------------------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-------
Q 018052 83 QQVRE-------------------------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA------- 130 (361)
Q Consensus 83 ~~~~~-------------------------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~------- 130 (361)
..... .......+||+.|+|||++.....++.++||||+||++|+|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 42211 0134567899999999987544444589999999999999998
Q ss_pred ----CCCCCCcccH--------------------HHHHHHHhhc----------------------CC---------CCC
Q 018052 131 ----GFLPFDESNL--------------------MALYRKICRA----------------------DF---------SCP 155 (361)
Q Consensus 131 ----g~~Pf~~~~~--------------------~~~~~~i~~~----------------------~~---------~~~ 155 (361)
|.++|.+.+. .+.+..+... .+ ...
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6777766431 1111111100 00 011
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+..++++.+||++||..||++|||++|+|+||||+..
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 2358999999999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=302.58 Aligned_cols=186 Identities=33% Similarity=0.609 Sum_probs=165.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DFG 77 (361)
.+...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 35678999999999999999999888899999999999999999999999999999999999999888 79999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC--
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-- 155 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 155 (361)
++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+....+.......+
T Consensus 165 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 165 LAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp TCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred cceecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 9976543 2233556899999999999877764 899999999999999999999999888888887777665554
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 457899999999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=307.95 Aligned_cols=187 Identities=37% Similarity=0.690 Sum_probs=163.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+..|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccC-----CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC-
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP- 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~-----~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~- 155 (361)
... .......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.+.+.......+..+.+..+
T Consensus 250 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 250 LEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 542 2234567899999999998632 1235899999999999999999999998887777777776655443
Q ss_pred ---CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 ---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||+.++++||||++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 347899999999999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=296.10 Aligned_cols=187 Identities=38% Similarity=0.746 Sum_probs=165.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~DFGl 78 (361)
.+.+..|+||||++||+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 356788999999999999999998889999999999999999999999999999999999999987665 99999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
+..... ........||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+.......+.......|.
T Consensus 155 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T 3kk8_A 155 AIEVND---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230 (284)
T ss_dssp CEECCS---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eEEccc---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh
Confidence 975433 2233457899999999999887774 8999999999999999999999998888888887776655442
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+++++.+||.+||..||++|||+.|+++||||+..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 478999999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.62 Aligned_cols=187 Identities=26% Similarity=0.509 Sum_probs=162.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..+.+|+||||++||+|.+++.. .++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 113 ~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 113 VGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 45789999999999999998865 57999999999999999999999999999999999999999999999999998765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---CCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s 159 (361)
... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+..... ..+..++
T Consensus 192 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2c30_A 192 SKD--VPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268 (321)
T ss_dssp CSS--SCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred ccC--ccccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCC
Confidence 432 1223457899999999999877665 899999999999999999999998887777766655432 2233478
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+.+||.+||..||++|||+.++++||||....
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 9999999999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=308.12 Aligned_cols=188 Identities=33% Similarity=0.602 Sum_probs=162.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 46789999999999999999998889999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhcCCCCCCcc----cHHHHHHHHhhcCCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDES----NLMALYRKICRADFSCPSW 157 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~ 157 (361)
.... .......+||+.|+|||++.+. ...+.++||||+||++|+|++|..||... ....+...+.......|..
T Consensus 210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 1vzo_A 210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288 (355)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence 3221 1233457899999999998753 22358999999999999999999999643 3455666666677778888
Q ss_pred CCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+++.+.+||.+||..||.+|| |+.++++||||+.
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 999999999999999999999 9999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.28 Aligned_cols=188 Identities=35% Similarity=0.643 Sum_probs=141.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 3567899999999999999999875 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
...... ......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+.......|..++.
T Consensus 161 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (278)
T 3cok_A 161 QLKMPH--EKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237 (278)
T ss_dssp ECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCH
T ss_pred eccCCC--CcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCH
Confidence 654221 223456899999999999876664 89999999999999999999998877666666666666777888999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=311.19 Aligned_cols=186 Identities=33% Similarity=0.548 Sum_probs=163.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE--ecCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL--DSYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl--d~~~~lKl~DFGl 78 (361)
.+++.+|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 156 ~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 3567899999999999999988765 469999999999999999999999999999999999999 5677899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
+..... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+.+..+.......+
T Consensus 236 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 236 ARRYKP---REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp CEECCT---TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred ceecCC---ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 976543 223445689999999999977665 4899999999999999999999999888888888777655444
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 357999999999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=320.81 Aligned_cols=185 Identities=42% Similarity=0.732 Sum_probs=164.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC---CCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~---~~lKl~DFGl 78 (361)
.++..+|+|||||+||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 4567899999999999999999988899999999999999999999999999999999999999764 4599999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+.+..+..+.+.++.
T Consensus 186 a~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 260 (494)
T 3lij_A 186 SAVFEN---QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE 260 (494)
T ss_dssp CEECBT---TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred CeECCC---CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 976543 223456789999999999864 45 48999999999999999999999999998888888877665432
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+|+++.+||++||..||.+|||+.++++||||+.
T Consensus 261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 37999999999999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=307.38 Aligned_cols=188 Identities=39% Similarity=0.723 Sum_probs=153.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DFGl 78 (361)
.+...+|+||||++||+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred ecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 356789999999999999999998888999999999999999999999999999999999999975 89999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP-- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~-- 155 (361)
+..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.... ..+..+.......+
T Consensus 198 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 198 SKIVEH---QVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISP 273 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTT
T ss_pred ccccCc---ccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCc
Confidence 876432 2234567899999999999887764 8999999999999999999999775544 36666666554332
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..++.++.+||++||..||++|||+.++++||||+...
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 34789999999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=321.28 Aligned_cols=187 Identities=37% Similarity=0.686 Sum_probs=167.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFGl 78 (361)
+++..+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 45678999999999999999999888999999999999999999999999999999999999999876 699999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+....+..+.+.++
T Consensus 196 a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 196 SSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 976543 233456789999999999874 45 5899999999999999999999999999999998888776654
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+|+++.+||++||..||.+|||+.|+++||||++..
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 45899999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=305.37 Aligned_cols=192 Identities=25% Similarity=0.372 Sum_probs=158.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||+.| +|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 4679999999976 787777654 57999999999999999999999999999999999999999999999999999765
Q ss_pred cccc--cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCC---
Q 018052 83 QQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--- 157 (361)
Q Consensus 83 ~~~~--~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 157 (361)
.... ........+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+.......++.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 4221 12234567899999999998775555689999999999999999999999988776666554322111111
Q ss_pred -----------------------------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 158 -----------------------------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 158 -----------------------------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
.++.+.+||.+||..||++|||++|+++||||+....+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 267799999999999999999999999999998765443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=305.77 Aligned_cols=182 Identities=34% Similarity=0.556 Sum_probs=160.7
Q ss_pred CcCcEEEEEEecCCCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 3567899999999766 999999998899999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCH
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSS 160 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 160 (361)
.... .......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||..... ........|..+++
T Consensus 179 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCH
T ss_pred ECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCH
Confidence 6533 23345678999999999999888867899999999999999999999976432 23344556667899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++.+||.+||..||.+|||+.++++||||+..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=305.52 Aligned_cols=188 Identities=27% Similarity=0.417 Sum_probs=152.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-----cCCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-----SYGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-----~~~~lKl~DF 76 (361)
.+.+.+|+||||++| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 103 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 103 HHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred ecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 356789999999985 9999999988999999999999999999999999999999999999994 4555999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC--C-
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--S- 153 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~- 153 (361)
|+|...... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+..... .
T Consensus 182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 999765322 22345568899999999998766556999999999999999999999998877766655543210 0
Q ss_pred --------CCC-------------------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 --------CPS-------------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 --------~~~-------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+. .+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 011 167899999999999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.78 Aligned_cols=188 Identities=40% Similarity=0.697 Sum_probs=164.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
.+...+|+|||||.||+|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 35678999999999999999999888999999999999999999999999999999999999995 456799999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC--CC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~ 156 (361)
|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|..||.+.+..+.+..+..+.+.. |.
T Consensus 171 a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (486)
T 3mwu_A 171 STCFQQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245 (486)
T ss_dssp TTTBCC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred CeECCC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 976543 223456789999999999876 45 489999999999999999999999999888888887776543 33
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
.+|+++.+||.+||..||.+|||+.++++||||+....
T Consensus 246 ~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 37999999999999999999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=307.51 Aligned_cols=181 Identities=25% Similarity=0.443 Sum_probs=153.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-------------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS------------- 67 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~------------- 67 (361)
..+.+|+||||+ ||+|.+++.... ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 457899999999 899999998764 5999999999999999999999999999999999999975
Q ss_pred ------------CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCC
Q 018052 68 ------------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF 135 (361)
Q Consensus 68 ------------~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf 135 (361)
++.+||+|||+|..... .....+||+.|+|||++.+..|. .++||||+||++|+|++|..||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCC
Confidence 88999999999975332 23467899999999999988775 8999999999999999999999
Q ss_pred CcccHHHHHHHHhhcCCCCCC----------------------------------------------CCCHHHHHHHHHc
Q 018052 136 DESNLMALYRKICRADFSCPS----------------------------------------------WFSSGAKKLIKRI 169 (361)
Q Consensus 136 ~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~Li~~~ 169 (361)
.+.+..+....+.......|. ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 987776665554432222221 1236778999999
Q ss_pred cCCCcCCCCCHHHHHhCcccc
Q 018052 170 LDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 170 L~~dP~~R~t~~eil~h~~f~ 190 (361)
|..||.+|||+.|+|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999996
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=300.95 Aligned_cols=188 Identities=26% Similarity=0.428 Sum_probs=153.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 73 RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 46789999999999999999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc------------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 150 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 150 (361)
... .......+||+.|+|||++.+....+.++||||+|+++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 153 TGP--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCc--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 422 223445689999999999987555568999999999999999999999987766554433211
Q ss_pred ---------CCCCC----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---------DFSCP----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---------~~~~~----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+.+ +.+++++.+||.+||..||.+|||++|+++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 2478889999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.04 Aligned_cols=184 Identities=27% Similarity=0.478 Sum_probs=149.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+..++|+||||+.| +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 44689999999976 57777754 4999999999999999999999999999999999999999999999999999754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC---------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--------- 153 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------- 153 (361)
.. .......+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+.++......
T Consensus 215 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 215 GT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred CC---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 32 2335568999999999999988876 8999999999999999999999998877766665432100
Q ss_pred ------------------C----CCC-----------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 154 ------------------C----PSW-----------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 154 ------------------~----~~~-----------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+ |.. .++++.+||.+||..||++|||++|+|+||||+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0 000 146789999999999999999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.89 Aligned_cols=187 Identities=37% Similarity=0.679 Sum_probs=166.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.++..+|+|||||.||+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 4567899999999999999999998999999999999999999999999999999999999999 5678999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC--CC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~ 156 (361)
|..... .......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+.+ |.
T Consensus 176 a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 250 (484)
T 3nyv_A 176 STHFEA---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250 (484)
T ss_dssp HHHBCC---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG
T ss_pred eEEccc---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 875432 223456789999999999876 45 489999999999999999999999999888888888776544 33
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+|+++.+||++||..||.+|||+.++++||||+...
T Consensus 251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 3899999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=305.02 Aligned_cols=191 Identities=28% Similarity=0.500 Sum_probs=152.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+|||| .+|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred eCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 56789999995 5789999999989999999999999999999999999999999999999997 588999999999765
Q ss_pred cccccCCccccccCCCcccccccccc----------CCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhh--
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLND----------KGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICR-- 149 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~----------~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~-- 149 (361)
............+||+.|+|||++.+ ....+.++||||+||++|+|++|..||.+.. .......+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 44332223456789999999999864 1233589999999999999999999998743 3333333333
Q ss_pred cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 150 ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 150 ~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.....|...+.++.+||.+||..||.+|||+.++++||||+....+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence 2345667788999999999999999999999999999999975443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.59 Aligned_cols=189 Identities=24% Similarity=0.426 Sum_probs=153.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||+.| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 70 HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp ECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred eeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 356789999999975 9999888754 59999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC--------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-------- 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------- 152 (361)
..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 149 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 54321 22344568999999999988755556899999999999999999999999887766655543110
Q ss_pred -----------CC-----------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 153 -----------SC-----------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 153 -----------~~-----------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.. ++.+++++.+||.+||..||.+|||++|+++||||....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00 123678999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=295.73 Aligned_cols=191 Identities=32% Similarity=0.652 Sum_probs=166.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++..+|+||||+.+| |.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 456899999999886 7777765 3579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 159 (361)
...............||+.|+|||++.+.. +.+.++||||+|+++|+|++|..||.+.+....+..+.......|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG 237 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccC
Confidence 654333333445677999999999987643 3357899999999999999999999999888888888888888888899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+.+.+||.+||..||.+|||+.++++||||++...
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999999997654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=302.25 Aligned_cols=188 Identities=32% Similarity=0.562 Sum_probs=160.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DF 76 (361)
.+...+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 3567899999999999999998654 57999999999999999999999999999999999999987 789999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC-
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP- 155 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~- 155 (361)
|++...... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+.+..+.......+
T Consensus 179 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 179 GMSRKIGHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccccccCCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 999765332 223457899999999999877775 899999999999999999999999888887777766544333
Q ss_pred ---CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 ---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 34789999999999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=305.39 Aligned_cols=182 Identities=29% Similarity=0.434 Sum_probs=155.9
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+ |++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 4679999999 8899999886 6799999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC------------
Q 018052 85 VREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------------ 152 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------ 152 (361)
.....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.....
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 234578999999999988744445899999999999999999999998877666555432111
Q ss_pred -------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 153 -------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 153 -------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...+..++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11234689999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.04 Aligned_cols=190 Identities=27% Similarity=0.479 Sum_probs=155.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||| +.+|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 4567999999 56889999999988999999999999999999999999999999999999996 589999999999865
Q ss_pred cccccCCccccccCCCccccccccccC----------CCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhc-
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA- 150 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~----------~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~- 150 (361)
............+||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.. ....+..+...
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 433222234567899999999998652 233589999999999999999999998743 33444444433
Q ss_pred -CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 151 -DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 151 -~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
....|.+.+.++.+||.+||..||.+|||+.|+++||||+....
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 34567788999999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=311.19 Aligned_cols=188 Identities=29% Similarity=0.422 Sum_probs=146.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 67999999996 59999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred cccC--------------------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-----------CC
Q 018052 85 VRED--------------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-----------FL 133 (361)
Q Consensus 85 ~~~~--------------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-----------~~ 133 (361)
.... ......+||+.|+|||++.....++.++||||+||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2111 1246789999999999875555456899999999999999984 44
Q ss_pred CCCccc-----------------HHHHHHHHh------------------------hcCCCCC-------CCCCHHHHHH
Q 018052 134 PFDESN-----------------LMALYRKIC------------------------RADFSCP-------SWFSSGAKKL 165 (361)
Q Consensus 134 Pf~~~~-----------------~~~~~~~i~------------------------~~~~~~~-------~~~s~~~~~L 165 (361)
+|.+.+ ..+....+. ......+ +.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 444322 111111111 0011111 3479999999
Q ss_pred HHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 166 IKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 166 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|++||..||++|||++|+|+||||+.-.
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=293.12 Aligned_cols=185 Identities=35% Similarity=0.641 Sum_probs=154.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKIS 74 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~ 74 (361)
.+...+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 356789999999999999998854 3679999999999999999999999999999999999999 556889999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC 154 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 154 (361)
|||++..... .......+||+.|+|||++.+ .+ +.++||||+|+++|+|++|..||.+.+.......+.......
T Consensus 170 Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 170 DFGLAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eeecceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence 9999976443 223356789999999999864 44 489999999999999999999999988877777665544333
Q ss_pred C---CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 155 P---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 155 ~---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+ ..+++++.+||.+||..||++|||+.|+++||||++
T Consensus 245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 2 237899999999999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=296.60 Aligned_cols=187 Identities=42% Similarity=0.774 Sum_probs=165.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.+...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred ccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 3567899999999999999999888899999999999999999999999999999999999999 7889999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
+..... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+..+....+
T Consensus 156 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 156 SKMEQN----GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230 (304)
T ss_dssp TCCCCC----BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred ceecCC----CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 865332 233456799999999999887765 899999999999999999999999888888888777654433
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
..+++++.+||.+||..||.+|||+.++++||||+...
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 45789999999999999999999999999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.67 Aligned_cols=185 Identities=25% Similarity=0.393 Sum_probs=153.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC--EEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--LKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~--lKl~DFGl 78 (361)
.+.++|+||||+. |+|.+++.... ++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 4678999999996 59999998764 5999999999999999999999999999999999999999987 99999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------ 152 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------ 152 (361)
|.... ....+.+||+.|+|||++.+..|. .++||||+||++|+|++|.+||.+.+..+.+..+.....
T Consensus 249 a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 249 SCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 86532 224467899999999999888775 899999999999999999999998877665544432100
Q ss_pred --------------C---------------------------------------CCCCCCHHHHHHHHHccCCCcCCCCC
Q 018052 153 --------------S---------------------------------------CPSWFSSGAKKLIKRILDPNPDTRMT 179 (361)
Q Consensus 153 --------------~---------------------------------------~~~~~s~~~~~Li~~~L~~dP~~R~t 179 (361)
. .+...++.+.+||++||..||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 0 00113678999999999999999999
Q ss_pred HHHHHhCcccccCCC
Q 018052 180 ISQMLEDEWFKKGYK 194 (361)
Q Consensus 180 ~~eil~h~~f~~~~~ 194 (361)
+.|+|+||||++...
T Consensus 403 a~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 403 PGQALRHPWLRRRLP 417 (429)
T ss_dssp HHHHHTSTTTC----
T ss_pred HHHHhCChhhccCCC
Confidence 999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=299.29 Aligned_cols=183 Identities=29% Similarity=0.459 Sum_probs=153.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec------------
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS------------ 67 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~------------ 67 (361)
++..++|+||||+ +|+|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 3567899999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred -------CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH
Q 018052 68 -------YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL 140 (361)
Q Consensus 68 -------~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~ 140 (361)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 67899999999875322 23456899999999999887775 899999999999999999999988776
Q ss_pred HHHHHHHhhcCCCC--------------------------------------------CCCCCHHHHHHHHHccCCCcCC
Q 018052 141 MALYRKICRADFSC--------------------------------------------PSWFSSGAKKLIKRILDPNPDT 176 (361)
Q Consensus 141 ~~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~Li~~~L~~dP~~ 176 (361)
.+....+....... +...++.+.+||.+||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 55444332211111 1112467889999999999999
Q ss_pred CCCHHHHHhCccccc
Q 018052 177 RMTISQMLEDEWFKK 191 (361)
Q Consensus 177 R~t~~eil~h~~f~~ 191 (361)
|||+.|+++||||+.
T Consensus 320 Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 320 RITLREALKHPFFDL 334 (339)
T ss_dssp SCCHHHHTTSGGGGG
T ss_pred ccCHHHHhcCHHHHH
Confidence 999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=291.90 Aligned_cols=188 Identities=34% Similarity=0.611 Sum_probs=164.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 35678999999999999999999888899999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCcccccccccc-----CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC-
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLND-----KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP- 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~-----~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~- 155 (361)
... .......+||+.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+.......+
T Consensus 174 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 174 LDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred cCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 432 223456789999999999852 22235899999999999999999999998888877777776655443
Q ss_pred ---CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 ---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 2378999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=290.46 Aligned_cols=183 Identities=25% Similarity=0.519 Sum_probs=155.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEe-cCCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld-~~~~lKl~DFGla~ 80 (361)
+..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5679999999999999999998888999999999999999999999999 99999999999998 78999999999986
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhcCC--CCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRADF--SCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~--~~~~~ 157 (361)
.... ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.. ....+..+..... ..+..
T Consensus 181 ~~~~----~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 181 LKRA----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCCT----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred cccc----cccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 4332 23345689999999998874 34 589999999999999999999998744 4455554444322 23445
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.++++.+||.+||..||.+|||+.++++||||+..
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 78999999999999999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=290.31 Aligned_cols=185 Identities=37% Similarity=0.653 Sum_probs=161.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DFGl 78 (361)
++..+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 5678999999999999999999888899999999999999999999999999999999999998877 899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
+...... .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+..+....+.......+
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T 3bhy_A 159 AHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceeccCC---CcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh
Confidence 8754332 223456799999999999877664 899999999999999999999999888887777766655444
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 457899999999999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.96 Aligned_cols=181 Identities=20% Similarity=0.349 Sum_probs=150.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC----------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---------- 68 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~---------- 68 (361)
+++.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 467899999999999999999865 679999999999999999999999999999999999999844
Q ss_pred ---------CCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc
Q 018052 69 ---------GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN 139 (361)
Q Consensus 69 ---------~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~ 139 (361)
..+||+|||++..... ....+||+.|+|||++.+....+.++||||+||++|+|++|.+|+....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 4799999999875432 1234699999999999876455579999999999999999998876553
Q ss_pred HHHHHHHHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 140 LMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 140 ~~~~~~~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ...+.... ...|..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 236 ~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 236 Q---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp H---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred H---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3 22333333 34566789999999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=304.45 Aligned_cols=184 Identities=24% Similarity=0.379 Sum_probs=154.5
Q ss_pred CcEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGL 78 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGl 78 (361)
...+|+||||++| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~ 188 (383)
T 3eb0_A 110 NKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188 (383)
T ss_dssp CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCC
Confidence 4468999999985 7666554 457899999999999999999999999999999999999998 689999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------- 150 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 150 (361)
|..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus 189 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~ 265 (383)
T 3eb0_A 189 AKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265 (383)
T ss_dssp CEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 975432 223456788999999999887665568999999999999999999999988777666554321
Q ss_pred ---------CCC------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 ---------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 ---------~~~------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
... +|..+++++.+||.+||..||.+|||+.|+++||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 011 24457899999999999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=305.45 Aligned_cols=184 Identities=28% Similarity=0.416 Sum_probs=152.4
Q ss_pred cEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCc
Q 018052 5 TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 79 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla 79 (361)
..+|+||||+.++ |.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|
T Consensus 111 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 111 VFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 3588999999875 443332 356799999999999999999999999999999999999999 7999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------- 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 150 (361)
..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus 190 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 76532 222345688999999999977665568999999999999999999999988776655544321
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 --------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 --------~~~------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
... +++.+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 223478999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.01 Aligned_cols=180 Identities=26% Similarity=0.435 Sum_probs=148.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||+ +|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 467899999999 67999888764 4699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC--CCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--SCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s 159 (361)
... .......+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|+.+... +..+..... ..+..++
T Consensus 207 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 278 (311)
T 3p1a_A 207 LGT---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLS 278 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSC
T ss_pred ccc---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCC
Confidence 432 223345679999999999876 45 4899999999999999999766654332 222222221 1234589
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+++.+||.+||..||++|||+.++++||||++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=301.22 Aligned_cols=191 Identities=31% Similarity=0.544 Sum_probs=157.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh----------------------------------------CCCCCHHHHHHHHHHH
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK----------------------------------------HGRLKEDEARRYFQQL 41 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~ql 41 (361)
.+...+|+|||||+||+|.+++.. ...+++..++.++.|+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 356789999999999999998852 1124678899999999
Q ss_pred HHHHHHHHHCCcEecCCCCCcEEEecCC--CEEEEecCCcccccccccCC--ccccccCCCccccccccccC-CCCCCch
Q 018052 42 INAVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLSAISQQVREDG--LLHTACGTPNYVAPEVLNDK-GYDGRAS 116 (361)
Q Consensus 42 ~~gl~~lH~~gi~HrDiKp~NiLld~~~--~lKl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APEv~~~~-~~~~~~~ 116 (361)
+.||+|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999999998776 89999999997654322211 23467899999999998652 3335899
Q ss_pred hhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 117 DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
||||+||++|+|++|..||.+.+..+....+.......+. .+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999998888877777666544332 278999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=301.17 Aligned_cols=190 Identities=28% Similarity=0.395 Sum_probs=159.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++| +|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 82 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 82 GHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 356789999999986 8988887654 69999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS------- 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------- 153 (361)
.... ........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+......
T Consensus 161 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 6532 2233456789999999999976554568999999999999999999999998877776665432100
Q ss_pred ----C-----------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 154 ----C-----------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 154 ----~-----------------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
. ...+++++.+||.+||..||.+|||+.|+++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 0 0235789999999999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=301.11 Aligned_cols=188 Identities=28% Similarity=0.490 Sum_probs=156.4
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+||||+.| +|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 578999999975 99999876 5799999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC------------
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 151 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 151 (361)
... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 2234567899999999987665544689999999999999999999998876555544433210
Q ss_pred ----------CC---------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 152 ----------FS---------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 152 ----------~~---------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
.. .++.+++++.+||.+||..||.+|||+.|+++||||+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 00 11346899999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.69 Aligned_cols=187 Identities=29% Similarity=0.491 Sum_probs=153.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 46789999999999999998887888999999999999999999999999999999999999999999999999999754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc------------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------ 150 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 150 (361)
... .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 175 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 175 AAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 332 223455689999999999987645568999999999999999999999887765554433211
Q ss_pred -------CCCCC------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 -------DFSCP------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 -------~~~~~------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
....| +.+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 01111 246899999999999999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=305.73 Aligned_cols=192 Identities=26% Similarity=0.401 Sum_probs=144.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE----ecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH---------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYG 69 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl----d~~~ 69 (361)
+...+|+||||+.| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 46789999999975 888887632 249999999999999999999999999999999999999 7789
Q ss_pred CEEEEecCCcccccccc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-------
Q 018052 70 VLKISDFGLSAISQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM------- 141 (361)
Q Consensus 70 ~lKl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~------- 141 (361)
.+||+|||+|....... ........+||+.|+|||++.+..+++.++||||+||++|+|++|..||.+.+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 99999999998654321 1223456789999999999987665568999999999999999999999764431
Q ss_pred --HHHHHHhhc-CCC-CC------------------------------------CCCCHHHHHHHHHccCCCcCCCCCHH
Q 018052 142 --ALYRKICRA-DFS-CP------------------------------------SWFSSGAKKLIKRILDPNPDTRMTIS 181 (361)
Q Consensus 142 --~~~~~i~~~-~~~-~~------------------------------------~~~s~~~~~Li~~~L~~dP~~R~t~~ 181 (361)
+.+..+... ..+ .. ...++.+.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 222222211 000 00 01267889999999999999999999
Q ss_pred HHHhCcccccCCCC
Q 018052 182 QMLEDEWFKKGYKP 195 (361)
Q Consensus 182 eil~h~~f~~~~~~ 195 (361)
|+|+||||+....+
T Consensus 330 e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 330 QAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHTSGGGTSSSCC
T ss_pred HHhcChhhccCCCC
Confidence 99999999976543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=308.89 Aligned_cols=184 Identities=45% Similarity=0.806 Sum_probs=148.6
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lKl~DFGla~ 80 (361)
...+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 356899999999999999999888999999999999999999999999999999999999997654 49999999997
Q ss_pred cccccccCCccccccCCCcccccccccc---CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC-
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP- 155 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~---~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~- 155 (361)
.... .....+.+||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+.... .....+..+.+..+
T Consensus 291 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 291 ILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred ecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 6542 233456789999999999864 334 47999999999999999999999764332 34444445544433
Q ss_pred ---CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 ---~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||++|+++||||+.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 347999999999999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=300.48 Aligned_cols=186 Identities=26% Similarity=0.578 Sum_probs=163.0
Q ss_pred cCcEEEEEEecCCCCChHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDK------IAK--HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl 73 (361)
+.+.+|+||||++||+|.++ +.. ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl 193 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEE
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEE
Confidence 46789999999999999998 665 5679999999999999999999999 99999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhcCCCCCCcccH-HHHHHHHhhcC
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNL-MALYRKICRAD 151 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~ 151 (361)
+|||++...... ......||+.|+|||++.+. .+.+.++||||+||++|+|++|..||...+. .+....+....
T Consensus 194 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~ 269 (348)
T 2pml_X 194 SDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269 (348)
T ss_dssp CCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC
T ss_pred eccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 999998764322 34557899999999999877 4543489999999999999999999988766 67777777766
Q ss_pred CCCC-------------------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 FSCP-------------------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ~~~~-------------------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
...| ..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 6666 5689999999999999999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=297.97 Aligned_cols=183 Identities=26% Similarity=0.435 Sum_probs=151.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---------------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL--------------- 65 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl--------------- 65 (361)
...++|+||||+ +|+|.+++.... ++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence 457899999999 668888777654 69999999999999999999999999999999999999
Q ss_pred ----ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH
Q 018052 66 ----DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM 141 (361)
Q Consensus 66 ----d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~ 141 (361)
+.++.+||+|||++..... .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6789999999999975322 23456899999999999887775 8999999999999999999999987765
Q ss_pred HHHHHHhhcCCCCC--------------------------------------------CCCCHHHHHHHHHccCCCcCCC
Q 018052 142 ALYRKICRADFSCP--------------------------------------------SWFSSGAKKLIKRILDPNPDTR 177 (361)
Q Consensus 142 ~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~Li~~~L~~dP~~R 177 (361)
+....+.......| ...+.++.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 54443322111111 0123578899999999999999
Q ss_pred CCHHHHHhCcccccC
Q 018052 178 MTISQMLEDEWFKKG 192 (361)
Q Consensus 178 ~t~~eil~h~~f~~~ 192 (361)
||+.|+++||||+..
T Consensus 326 pt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 326 ITLAEALLHPFFAGL 340 (355)
T ss_dssp CCHHHHTTSGGGGGC
T ss_pred cCHHHHhcChhhcCC
Confidence 999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=309.75 Aligned_cols=173 Identities=14% Similarity=0.205 Sum_probs=145.4
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKE-------DEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.|+||||+ +|+|.+++...+++++ ..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence 89999999 6799999987666666 788889999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccC-----------CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDK-----------GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 148 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~-----------~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~ 148 (361)
.... ......+| +.|+|||++.+. .|+ .++||||+||++|+|++|..||.+.+.......+.
T Consensus 254 ~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 326 (377)
T 3byv_A 254 VRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF 326 (377)
T ss_dssp EETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC------CCSGGGG
T ss_pred eecC-----CcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh
Confidence 7432 23456788 999999999876 564 89999999999999999999998765444333322
Q ss_pred hcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 149 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 149 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 327 ----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 327 ----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred ----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 233568999999999999999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=296.26 Aligned_cols=186 Identities=25% Similarity=0.460 Sum_probs=153.9
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
..|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 46999999999999999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred cc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC----CCCCH
Q 018052 86 RE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSS 160 (361)
Q Consensus 86 ~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 160 (361)
.. .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+...............+ ..+++
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence 21 1223456799999999999887765 899999999999999999999999887776666555443332 34899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
++.+||.+||..||.+||+..+++.|+|++..
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 99999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=293.15 Aligned_cols=183 Identities=23% Similarity=0.429 Sum_probs=149.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~~~ 82 (361)
....|+||||+.|++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 5678999999999999998754 99999999999999999999999999999999999999777 8999999999754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-cHHHHHHH-------------Hh
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRK-------------IC 148 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-~~~~~~~~-------------i~ 148 (361)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|..||... +..+.... +.
T Consensus 182 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CC---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 32 223456789999999999987555568999999999999999999999432 22221111 11
Q ss_pred hcCCCC------------------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 149 RADFSC------------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 149 ~~~~~~------------------------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
...... +..+++++.+||.+||..||.+|||++|+++||||+.-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111111 11278999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=302.00 Aligned_cols=183 Identities=28% Similarity=0.471 Sum_probs=144.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+.| +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 3589999999975 7888886 459999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC---------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--------- 154 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 154 (361)
. .......+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234457899999999999887775 89999999999999999999999988776666654321100
Q ss_pred ----------CC-----------------C------CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 155 ----------PS-----------------W------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 155 ----------~~-----------------~------~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|. . .++++.+||.+||..||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0 146789999999999999999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.79 Aligned_cols=184 Identities=27% Similarity=0.396 Sum_probs=151.1
Q ss_pred cEEEEEEecCCCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC-CCEEEEecCCc
Q 018052 5 TKIYIVLEFIDGGELFDKIA----KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY-GVLKISDFGLS 79 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~-~~lKl~DFGla 79 (361)
..+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 357899999986 6666554 35679999999999999999999999999999999999999965 57899999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---------
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------- 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------- 150 (361)
..... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+.++...
T Consensus 205 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 75432 222345789999999999977644468999999999999999999999987766555444321
Q ss_pred --------CCCC------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 --------DFSC------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 --------~~~~------------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+.+ ++.+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 1112 23468999999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=301.40 Aligned_cols=183 Identities=27% Similarity=0.428 Sum_probs=142.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||+ |++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 35689999999 7899998876 679999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC------------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD------------ 151 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------ 151 (361)
. .....+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999998874445689999999999999999999999887766655543210
Q ss_pred -----------CCCC--------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 152 -----------FSCP--------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 152 -----------~~~~--------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
...+ +..++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0011 23578899999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=308.71 Aligned_cols=180 Identities=18% Similarity=0.213 Sum_probs=144.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG-RLKEDEA------RRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.++|+|||||+ |+|.+++...+ .+++... ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG 239 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGG
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecc
Confidence 56999999998 79999998743 3444444 4666999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH--HHHH-----Hh
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA--LYRK-----IC 148 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~--~~~~-----i~ 148 (361)
+|..... ......||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.+..... .+.. ..
T Consensus 240 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 313 (371)
T 3q60_A 240 ALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313 (371)
T ss_dssp GEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCC
T ss_pred eeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcc
Confidence 9875432 1224567799999999976 455 489999999999999999999998763221 1110 01
Q ss_pred hcCCCC--CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 149 RADFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 149 ~~~~~~--~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...... ++.+++.+.+||.+||..||++|||+.++++||||+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 112222 2468999999999999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.03 Aligned_cols=189 Identities=28% Similarity=0.444 Sum_probs=152.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~DF 76 (361)
.+...+|+||||++||+|.+++...+. +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 356678999999999999999987654 999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh--hcCCCC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC--RADFSC 154 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~--~~~~~~ 154 (361)
|++...... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+....+. ......
T Consensus 184 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 184 GLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred CCCcccccc--ccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 998754321 1223457899999999999887774 89999999999999999999999988777766553 345567
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHh--CcccccCC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE--DEWFKKGY 193 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~--h~~f~~~~ 193 (361)
|..+++++.+||.+||..||.+|||+.++++ +++++...
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 7889999999999999999999999999988 47766543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.98 Aligned_cols=185 Identities=29% Similarity=0.511 Sum_probs=154.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 4678999999999999999999888999999999999999999999996 999999999999999999999999999865
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH---------------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK--------------- 146 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~--------------- 146 (361)
.... .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..+....
T Consensus 182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 182 LIDS----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp HHHH----C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred cccc----cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 4321 23456899999999999887775 899999999999999999999987654433211
Q ss_pred ---------------------------HhhcCC-CCC-CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 147 ---------------------------ICRADF-SCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 147 ---------------------------i~~~~~-~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+..... ..+ ..++.++.+||.+||..||.+|||+.++++||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 111 2368899999999999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=302.17 Aligned_cols=183 Identities=31% Similarity=0.408 Sum_probs=151.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEEe--cCCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLD--SYGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH--~~gi~HrDiKp~NiLld--~~~~lKl~DF 76 (361)
.+.++|+||||+.| +|.+++... +++++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 45789999999965 999999875 46999999999999999999999 46999999999999994 5788999999
Q ss_pred CCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC--
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC-- 154 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-- 154 (361)
|+|..... .....+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+.......
T Consensus 206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99976432 23467899999999999888775 89999999999999999999999887776665554311000
Q ss_pred -----------------------------------CCC---------------------------CCHHHHHHHHHccCC
Q 018052 155 -----------------------------------PSW---------------------------FSSGAKKLIKRILDP 172 (361)
Q Consensus 155 -----------------------------------~~~---------------------------~s~~~~~Li~~~L~~ 172 (361)
|.+ .++++.+||.+||..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 013688999999999
Q ss_pred CcCCCCCHHHHHhCcccccC
Q 018052 173 NPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 173 dP~~R~t~~eil~h~~f~~~ 192 (361)
||++|||++|+|+||||++.
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.60 Aligned_cols=190 Identities=30% Similarity=0.413 Sum_probs=154.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
....+|+||||+. |+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 3478999999997 599999876 57999999999999999999999999999999999999999999999999999765
Q ss_pred cccccC--------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc----
Q 018052 83 QQVRED--------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---- 150 (361)
Q Consensus 83 ~~~~~~--------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---- 150 (361)
...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 422111 11234689999999998876444568999999999999999999999987766554433210
Q ss_pred --------------------CCC--------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 151 --------------------DFS--------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 151 --------------------~~~--------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
... .++.+++++.+||.+||..||++|||+.++++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 000 11357899999999999999999999999999999986543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=298.84 Aligned_cols=186 Identities=40% Similarity=0.750 Sum_probs=131.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEecCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGL 78 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DFGl 78 (361)
+..+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999998764 6999999999999999999999999999999999999976 45599999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHH----HHHHhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~ 154 (361)
+..... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+...... ...+.......
T Consensus 178 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 178 AKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ceeccc----cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 875432 233467899999999999776665 799999999999999999999977654433 22222222222
Q ss_pred C----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 155 P----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 155 ~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
+ ..+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 2 357999999999999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.20 Aligned_cols=182 Identities=34% Similarity=0.609 Sum_probs=160.3
Q ss_pred CcCcEEEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla 79 (361)
.+.+.+|+||||+.+ ++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 356789999999986 89999999888999999999999999999999999999999999999999 7899999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 159 (361)
..... ......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+ .+.......+..++
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~ 267 (320)
T 3a99_A 198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 267 (320)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence 76542 233456799999999999877776688999999999999999999997653 23345556677899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+++.+||.+||..||.+|||++++++||||+...
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.64 Aligned_cols=186 Identities=27% Similarity=0.435 Sum_probs=152.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 56899999999999999999865 4799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC--C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--C 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~ 154 (361)
.... .......+||+.|+|||++. +..+ +.++||||+||++|+|++|..||.+.+.......+...... .
T Consensus 179 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 2x7f_A 179 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 255 (326)
T ss_dssp --------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred cCcC--ccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCC
Confidence 4321 12234567999999999986 3334 48999999999999999999999887776665555444322 2
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 34579999999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=298.46 Aligned_cols=184 Identities=24% Similarity=0.427 Sum_probs=158.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.+...+|+||||++||+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 35667999999999999999998753 48899999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.+|.+||+|||+|................||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+..+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999765433222233445678899999999887775 89999999999999999 99999988877777
Q ss_pred HHHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..+. ...|..+++++.+||.+||..||.+|||+.|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665543 45667789999999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=288.75 Aligned_cols=187 Identities=29% Similarity=0.530 Sum_probs=160.5
Q ss_pred cCcEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++. ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 4568999999999999999997 456899999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---CCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~ 158 (361)
.... ........||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+.......+.... +..+..+
T Consensus 175 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T 3com_A 175 LTDT--MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251 (314)
T ss_dssp CBTT--BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred hhhh--ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence 4332 1223456799999999999887765 89999999999999999999998877665554443332 2334557
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.10 Aligned_cols=190 Identities=27% Similarity=0.520 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK--------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKIS 74 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~ 74 (361)
+++.+|+||||++||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEE
Confidence 45679999999999999999874 4569999999999999999999999999999999999999999999999
Q ss_pred ecCCcccccccc---cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC
Q 018052 75 DFGLSAISQQVR---EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 75 DFGla~~~~~~~---~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|||++....... ........+||+.|+|||++.+....+.++||||+||++|+|++|..||...+............
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999986543221 11223456799999999998763333589999999999999999999998766554443333222
Q ss_pred C----------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 152 F----------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 152 ~----------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ..+..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1 1223478899999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=288.96 Aligned_cols=187 Identities=35% Similarity=0.598 Sum_probs=161.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----GRLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~ql~~gl~~lH~~g-----i~HrDiKp~NiLld~~~~lKl 73 (361)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 356899999999999999998753 24999999999999999999999999 999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF- 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 152 (361)
+|||++...... .......+||+.|+|||++.+..++ .++||||+|+++|+|++|..||...+..+....+..+..
T Consensus 158 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 234 (279)
T 2w5a_A 158 GDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234 (279)
T ss_dssp CCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ecCchheeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc
Confidence 999998754321 1123356799999999999887765 899999999999999999999999888877777776655
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..|..+++++.+||.+||..||.+|||+.++++|+|+...
T Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 4566789999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.52 Aligned_cols=184 Identities=26% Similarity=0.465 Sum_probs=147.6
Q ss_pred cEEEEEEecCCCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGR---LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..+|+|||||+||+|.+++..... .++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 134 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 213 (332)
T 3qd2_B 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213 (332)
T ss_dssp CEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccc
Confidence 358999999999999999987653 56667999999999999999999999999999999999999999999999976
Q ss_pred cccccc----------CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC
Q 018052 82 SQQVRE----------DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 82 ~~~~~~----------~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
...... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..|+... ......+....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~ 290 (332)
T 3qd2_B 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLK 290 (332)
T ss_dssp CSCC--------------CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTC
T ss_pred cccchhhccccccccccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccC
Confidence 543211 1123456899999999999887775 8999999999999999987775332 22233333322
Q ss_pred CCC-CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 FSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ~~~-~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+. +...++++.+||.+||..||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 211 1235788899999999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.83 Aligned_cols=184 Identities=26% Similarity=0.468 Sum_probs=142.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
+++.+|+||||++| +|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 46689999999975 88776653 56899999999999999999999998 99999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCcccccccc----ccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-cHHHHHHHHhh-cC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVL----NDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICR-AD 151 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~----~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-~~~~~~~~i~~-~~ 151 (361)
++...... ......+||+.|+|||++ .+..+ +.++||||+||++|+|++|..||... ........... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 156 ISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred Cccccccc---ccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 98764332 223445799999999996 33334 58999999999999999999999863 33333333333 33
Q ss_pred CCCC-CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ~~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+ ..+++++.+||.+||..||++|||+.++++||||+.
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 3332 358999999999999999999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.93 Aligned_cols=182 Identities=26% Similarity=0.455 Sum_probs=146.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCC----------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYG---------- 69 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~---------- 69 (361)
+..++|+||||+ +|+|.+.+... +++++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456899999999 66777777654 4699999999999999999999999 999999999999999776
Q ss_pred ---------------------------------------CEEEEecCCcccccccccCCccccccCCCccccccccccCC
Q 018052 70 ---------------------------------------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKG 110 (361)
Q Consensus 70 ---------------------------------------~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~ 110 (361)
.+||+|||+|..... .....+||+.|+|||++.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCCC
Confidence 799999999976432 234568999999999998877
Q ss_pred CCCCchhhhhhhhHHHhHhcCCCCCCccc------HHHHHHHHhhc--C-------------------------------
Q 018052 111 YDGRASDVWSCGVILFVLMAGFLPFDESN------LMALYRKICRA--D------------------------------- 151 (361)
Q Consensus 111 ~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~------~~~~~~~i~~~--~------------------------------- 151 (361)
|. .++||||+||++|+|++|..||...+ .......+... .
T Consensus 270 ~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 YN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 75 89999999999999999999997543 12222221110 0
Q ss_pred ---------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 ---------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ---------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+..+...++.+.+||.+||..||++|||+.|+++||||+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0111123467889999999999999999999999999973
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=294.16 Aligned_cols=183 Identities=26% Similarity=0.426 Sum_probs=156.7
Q ss_pred cCcEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++.+|+||||+. |+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 4678999999997 58888775 456799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC--CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS--CPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~ 156 (361)
... ....+||+.|+|||++. ...| +.++||||+||++|+|++|..||.+.+.......+...... .+.
T Consensus 204 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 276 (348)
T 1u5q_A 204 MAP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 276 (348)
T ss_dssp SSS------BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred cCC------CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC
Confidence 432 23568999999999985 3344 48999999999999999999999988777666665554332 234
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+++.+.+||.+||..||++|||++++++||||....
T Consensus 277 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 5799999999999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=287.53 Aligned_cols=190 Identities=29% Similarity=0.439 Sum_probs=154.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla~~ 81 (361)
....+|+||||+. |+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~ 170 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccc
Confidence 4578999999997 599998864 6799999999999999999999999999999999999998 567999999999976
Q ss_pred ccccc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC--------
Q 018052 82 SQQVR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-------- 152 (361)
Q Consensus 82 ~~~~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------- 152 (361)
..... .........||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (320)
T 2i6l_A 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250 (320)
T ss_dssp C--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred cCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence 53221 122334567899999999987644446899999999999999999999998776665554432210
Q ss_pred ----------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 153 ----------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 153 ----------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..++.+++++.+||.+||..||.+|||+.++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 012347899999999999999999999999999999986443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=286.94 Aligned_cols=187 Identities=28% Similarity=0.531 Sum_probs=162.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||||++||+|.+++.. +++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceec
Confidence 45689999999999999999875 67999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
.... .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||...+.......+.... ...+..++..
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (303)
T 3a7i_A 170 TDTQ--IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 246 (303)
T ss_dssp BTTB--CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHH
T ss_pred Cccc--cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHH
Confidence 4321 223456899999999999887775 89999999999999999999999887776666555443 3445678999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+||.+||..||.+|||+.++++||||....
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.75 Aligned_cols=185 Identities=30% Similarity=0.430 Sum_probs=158.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
....+|+||||+. |+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 4568999999998 59999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-------C-
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD-------F- 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-------~- 152 (361)
..... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+..+....+.... +
T Consensus 169 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 169 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccCC---CCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 65422 234457899999999999877765 89999999999999999999999887776665554210 0
Q ss_pred -------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 -------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 -------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 1224578999999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=291.29 Aligned_cols=187 Identities=21% Similarity=0.317 Sum_probs=146.9
Q ss_pred EEEEEecCCCCChHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 7 IYIVLEFIDGGELFDKIAKHG------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~ 185 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence 499999999999999986533 59999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...............+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+.+..+... ....+..+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (323)
T 3qup_A 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPEC 264 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred cccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCcc
Confidence 65433222223345678899999999887765 89999999999999999 99999988777777766554 35567778
Q ss_pred CHHHHHHHHHccCCCcCCCCC-------HHHHHhCcccccCCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMT-------ISQMLEDEWFKKGYK 194 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t-------~~eil~h~~f~~~~~ 194 (361)
++++.+||.+||..||.+||| +++++.|||+.....
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 999999999999999999999 777889999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=293.09 Aligned_cols=185 Identities=25% Similarity=0.314 Sum_probs=152.4
Q ss_pred EEEEEEecCCCCChHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCCCcEEEec-CCCEEEEecCC
Q 018052 6 KIYIVLEFIDGGELFDK----IAKHGRLKEDEARRYFQQLINAVDYCH--SRGVFHRDLKPENLLLDS-YGVLKISDFGL 78 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~----i~~~~~l~e~~~~~~~~ql~~gl~~lH--~~gi~HrDiKp~NiLld~-~~~lKl~DFGl 78 (361)
.+|+||||+.| +|.+. +.....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 48899999987 54443 335567999999999999999999999 999999999999999996 89999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------ 152 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------ 152 (361)
|...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 179 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 179 AKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9765432 2334568999999999987766556999999999999999999999998877666655533100
Q ss_pred --------------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 153 --------------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 153 --------------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..+...++++.+||.+||..||.+|||+.|+++||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 011124678999999999999999999999999999997543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=289.03 Aligned_cols=187 Identities=32% Similarity=0.514 Sum_probs=155.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+.+.+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 45689999999999999998876 46799999999999999999999999999999999999999999999999998754
Q ss_pred ccccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---S 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~ 153 (361)
..... ......+||+.|+|||++. +..+ +.++||||+|+++|+|++|..||...+.......+..... .
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 167 NLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHHH--HC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ccccc--cccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC
Confidence 32211 1223467999999999984 3344 4899999999999999999999999887777666655543 2
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 345678999999999999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=283.77 Aligned_cols=187 Identities=32% Similarity=0.584 Sum_probs=148.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 3578999999999999999998654 688999999999999999999999999999999999999999999999999976
Q ss_pred ccccc------------cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHh
Q 018052 82 SQQVR------------EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKIC 148 (361)
Q Consensus 82 ~~~~~------------~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~ 148 (361)
..... ........+||+.|+|||++.+.+..+.++||||+||++|+|++ ||.. .+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~ 242 (303)
T 1zy4_A 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLR 242 (303)
T ss_dssp TTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred cccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcc
Confidence 43211 01223456799999999999876545689999999999999998 6653 33445555555
Q ss_pred hcCCCCCC----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 149 RADFSCPS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 149 ~~~~~~~~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
......|+ ..++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 54444443 356779999999999999999999999999999753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=293.59 Aligned_cols=187 Identities=24% Similarity=0.361 Sum_probs=148.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||+. |+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred cceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 457999999997 58888887654 7999999999999999999999999999999999999999999999999998643
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC-----------
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD----------- 151 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------- 151 (361)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 185 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (362)
T 3pg1_A 185 TA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHT
T ss_pred cc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhc
Confidence 32 2233456899999999998874445689999999999999999999999887666655543210
Q ss_pred -------------CC--------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 152 -------------FS--------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 152 -------------~~--------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
.. .++..++.+.+||.+||..||.+|||+.|+++||||+..+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp SCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 00 12346888999999999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=286.33 Aligned_cols=187 Identities=26% Similarity=0.463 Sum_probs=152.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++.+.+|+||||++||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 35678999999999999999999888999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC-----CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-----CPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~ 156 (361)
..... .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+......+....... .++
T Consensus 161 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 4eqm_A 161 LSETS-LTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCT
T ss_pred ccccc-ccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhccc
Confidence 54321 1223456899999999999887764 8899999999999999999999998877665554443322 235
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 5899999999999999999999666666666643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=290.38 Aligned_cols=183 Identities=45% Similarity=0.803 Sum_probs=153.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~DFGla~~ 81 (361)
..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 348999999999999999998889999999999999999999999999999999999999987665 99999999876
Q ss_pred ccccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC--
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP-- 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~-- 155 (361)
... .......+||+.|+|||++. ...+ +.++||||+||++|+|++|..||...... .....+..+....+
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 242 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch
Confidence 432 12234568999999999974 2334 58999999999999999999999764332 33333444444332
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 347899999999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=284.79 Aligned_cols=185 Identities=41% Similarity=0.695 Sum_probs=161.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC---CCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~---~~lKl~DFGla 79 (361)
+...+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred CCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 467899999999999999999888899999999999999999999999999999999999999764 46999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC----
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP---- 155 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 155 (361)
...... .......||+.|+|||++.+. + +.++||||+|+++|+|++|..||.+.+..+....+..+....+
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 172 TCFQQN---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp GTBCCC---SSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred eeecCC---CccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh
Confidence 765332 223445689999999998754 4 5899999999999999999999999888888877776654433
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 3479999999999999999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.31 Aligned_cols=188 Identities=20% Similarity=0.346 Sum_probs=161.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC---CEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG---VLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~---~lK 72 (361)
+....|+|||||+||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 4567899999999999999998643 589999999999999999999999999999999999999655 499
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|+|||+|................||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+..+....+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999754433333334456789999999999887775 89999999999999998 999999988888887776654
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 -~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+..+++.+.+||.+||..||.+|||+.+++++.|+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4556678999999999999999999999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.64 Aligned_cols=184 Identities=25% Similarity=0.437 Sum_probs=161.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.+...+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 35667899999999999999998754 49999999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.++.+||+|||+|................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999865443322334456778999999999887765 89999999999999999 99999998888887
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+... ....|..+++++.+||.+||..||++|||+.+++++
T Consensus 304 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777655 445667789999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=286.10 Aligned_cols=191 Identities=28% Similarity=0.499 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+...+|+||| +.+|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+++ +.+||+|||++...
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 4678999999 557899999999889999999999999999999999999999999999999975 89999999999765
Q ss_pred cccccCCccccccCCCccccccccccC----------CCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHhhc-
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDK----------GYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKICRA- 150 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~----------~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~~~- 150 (361)
............+||+.|+|||++.+. ...+.++||||+||++|+|++|..||.... .......+...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 433222233456899999999998652 233579999999999999999999998643 33333333332
Q ss_pred -CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 151 -DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 151 -~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
....|...+.++.+||.+||..||.+|||+.++++||||+....+
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 345566778999999999999999999999999999999975443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=287.39 Aligned_cols=181 Identities=34% Similarity=0.659 Sum_probs=156.8
Q ss_pred CcCcEEEEEEec-CCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe-cCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEF-IDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD-SYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld-~~~~lKl~DFGla 79 (361)
.+.+.+|+|||| +.||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 356788999999 78999999999888899999999999999999999999999999999999999 8899999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 159 (361)
..... ......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.... .+.......+..++
T Consensus 188 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~ 257 (312)
T 2iwi_A 188 ALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHVS 257 (312)
T ss_dssp EECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTSC
T ss_pred hhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccCC
Confidence 76543 223466799999999999877776568999999999999999999997643 23445666778899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+.+||.+||..||++|||+.++++||||+..
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 999999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=294.57 Aligned_cols=182 Identities=25% Similarity=0.398 Sum_probs=153.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCC-------------------------------------------------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGR------------------------------------------------------- 28 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~------------------------------------------------------- 28 (361)
...+|+|||||+||+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 3458999999999999999987543
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCccccccCC
Q 018052 29 -----------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGT 97 (361)
Q Consensus 29 -----------l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt 97 (361)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 899999999999999999999999999999999999999999999999999765332222234456789
Q ss_pred CccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHH-HHHHhh-cCCCCCCCCCHHHHHHHHHccCCCc
Q 018052 98 PNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMAL-YRKICR-ADFSCPSWFSSGAKKLIKRILDPNP 174 (361)
Q Consensus 98 ~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~-~~~i~~-~~~~~~~~~s~~~~~Li~~~L~~dP 174 (361)
+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+.... ...+.. .....|..+++++.++|.+||..||
T Consensus 259 ~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 337 (359)
T 3vhe_A 259 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 337 (359)
T ss_dssp GGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 999999999887775 89999999999999998 9999988654333 333333 2456677899999999999999999
Q ss_pred CCCCCHHHHHhC
Q 018052 175 DTRMTISQMLED 186 (361)
Q Consensus 175 ~~R~t~~eil~h 186 (361)
.+|||+.++++|
T Consensus 338 ~~Rps~~ell~~ 349 (359)
T 3vhe_A 338 SQRPTFSELVEH 349 (359)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=290.33 Aligned_cols=182 Identities=22% Similarity=0.377 Sum_probs=156.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
...+|+||||+.||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45689999999999999999875 57999999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.............||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+.......+... ....|..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 443333334556788899999999877765 89999999999999999 99999987777666666554 4556677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+||.+||..||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=286.20 Aligned_cols=184 Identities=23% Similarity=0.336 Sum_probs=157.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGR------------------------LKEDEARRYFQQLINAVDYCHSRGVFHRD 57 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~ql~~gl~~lH~~gi~HrD 57 (361)
.+.+.+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 346678999999999999999987543 89999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCC
Q 018052 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFD 136 (361)
Q Consensus 58 iKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~ 136 (361)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999755432222223345678899999999877665 89999999999999999 999999
Q ss_pred cccHHHHHHHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 137 ESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 137 ~~~~~~~~~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+.......+... ....|..+++++.+||.+||..||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88777766666554 345567789999999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.80 Aligned_cols=184 Identities=22% Similarity=0.321 Sum_probs=158.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH------------------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRD 57 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrD 57 (361)
.+.+.+|+||||++||+|.+++... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3467889999999999999999874 5699999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCC
Q 018052 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFD 136 (361)
Q Consensus 58 iKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~ 136 (361)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999765432222233456789999999999877765 89999999999999999 999999
Q ss_pred cccHHHHHHHHhhcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 137 ESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 137 ~~~~~~~~~~i~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+..+....+..+.. ..|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9888887777766543 5677889999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=293.15 Aligned_cols=183 Identities=23% Similarity=0.432 Sum_probs=146.9
Q ss_pred cEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEec------CCCEEEEe
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDS------YGVLKISD 75 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~------~~~lKl~D 75 (361)
..+|+||||+ ||+|.+++... +++++..++.++.||+.||+|||++ ||+||||||+|||++. .+.+||+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~D 181 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECC
T ss_pred ceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcc
Confidence 3789999999 88999999873 4699999999999999999999998 9999999999999954 34799999
Q ss_pred cCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH------HHHHHHHhh
Q 018052 76 FGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL------MALYRKICR 149 (361)
Q Consensus 76 FGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~------~~~~~~i~~ 149 (361)
||+|..... .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+. ......+..
T Consensus 182 fg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 182 LGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp CTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred cccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 999975432 23456899999999999887775 899999999999999999999986431 111211111
Q ss_pred ------------------------------------------cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 150 ------------------------------------------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 150 ------------------------------------------~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
....++...++++.+||.+||..||.+|||+.|+++||
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 11223333467888999999999999999999999999
Q ss_pred ccccCCC
Q 018052 188 WFKKGYK 194 (361)
Q Consensus 188 ~f~~~~~ 194 (361)
||+....
T Consensus 336 ~f~~~~~ 342 (373)
T 1q8y_A 336 WLKDTLG 342 (373)
T ss_dssp GGTTCTT
T ss_pred hhhcccC
Confidence 9997543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=280.40 Aligned_cols=188 Identities=31% Similarity=0.525 Sum_probs=154.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGl 78 (361)
....+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 4568999999999999999998752 4679999999999999999999999999999999999997 89999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccHH--HHHHH-HhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRK-ICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~--~~~~~-i~~~~~~~ 154 (361)
+...... ........||+.|+|||++.+.. ..+.++||||+|+++|+|++|..||...+.. ..... ........
T Consensus 170 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 170 SKRLAGI--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred ccccCCC--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccc
Confidence 8764332 12234567999999999987543 2358999999999999999999999764322 22221 22334456
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
|..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 77789999999999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.30 Aligned_cols=185 Identities=21% Similarity=0.325 Sum_probs=155.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiK 59 (361)
..+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 4567899999999999999998753 27999999999999999999999999999999
Q ss_pred CCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcc
Q 018052 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDES 138 (361)
Q Consensus 60 p~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~ 138 (361)
|+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999765433222233456688999999999877765 89999999999999998 99999886
Q ss_pred cHHHHHHHHhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 139 NLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 139 ~~~~~~~~i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
+....+...... ....|..+++++.+||.+||..||.+|||+.++++|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 654444443333 34456778999999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.73 Aligned_cols=179 Identities=28% Similarity=0.434 Sum_probs=147.7
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
.+|+||||+. |+|.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 3599999997 58988774 4599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-------------
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF------------- 152 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------------- 152 (361)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 234568999999999988744446899999999999999999999998876666555432100
Q ss_pred ----------C--------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 ----------S--------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ----------~--------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. .++.+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 123468999999999999999999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=277.94 Aligned_cols=183 Identities=23% Similarity=0.412 Sum_probs=158.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 3566799999999999999999764 469999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
....... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+..+....+... ....|..+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred ccccccc-ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence 5433211 122345678899999999877765 89999999999999999 99999998888888777665 34456678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+.+++.+||..||.+|||+.++++|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=277.18 Aligned_cols=183 Identities=25% Similarity=0.400 Sum_probs=157.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred ccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccce
Confidence 35667999999999999999998754 59999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 158 (361)
....... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+.... ...|...
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T 3sxs_A 153 YVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA 230 (268)
T ss_dssp ECCTTCE-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTS
T ss_pred ecchhhh-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcC
Confidence 5433211 122344567789999999877765 89999999999999999 999999988887777766554 3445668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+.+||.+||..||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=285.96 Aligned_cols=184 Identities=24% Similarity=0.356 Sum_probs=156.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 3456789999999999999999754 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 81 ISQQVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
......... ......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+... ....|..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCC
Confidence 654322111 22234567889999999877765 89999999999999999 99999998888887776655 4456677
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+.+||.+||..||.+|||+.++++.
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=287.02 Aligned_cols=180 Identities=23% Similarity=0.445 Sum_probs=146.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE----ecCCCEEEEec
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDF 76 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl----d~~~~lKl~DF 76 (361)
...+|+||||++||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 347899999999999999998654 39999999999999999999999999999999999999 78888999999
Q ss_pred CCcccccccccCCccccccCCCccccccccc--------cCCCCCCchhhhhhhhHHHhHhcCCCCCCc----ccHHHHH
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLN--------DKGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALY 144 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~--------~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~----~~~~~~~ 144 (361)
|+|..... .......+||+.|+|||++. +..+ +.++||||+||++|+|++|..||.. ....+..
T Consensus 161 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 161 GAARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp TTCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99976533 22344678999999999986 2344 5899999999999999999999963 2233444
Q ss_pred HHHhhcCC---------------------CCC----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 145 RKICRADF---------------------SCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 145 ~~i~~~~~---------------------~~~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
.++..+.. +.+ ..++..+.+||++||..||++|||++|+++||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 44443221 111 12346788999999999999999999999997
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=278.74 Aligned_cols=183 Identities=23% Similarity=0.406 Sum_probs=158.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+.+.+|+||||++||+|.+++.. .+++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccc
Confidence 356789999999999999999987 4679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~ 158 (361)
....... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+.... ...|...
T Consensus 169 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T 3gen_A 169 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246 (283)
T ss_dssp GBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred ccccccc-ccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcC
Confidence 5433211 122344578889999999877765 89999999999999998 999999988887777776653 4456678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+.+||.+||..||.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=279.04 Aligned_cols=181 Identities=24% Similarity=0.374 Sum_probs=145.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 456899999999999999998654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
..... .......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+... ....|+.+++
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 43211 122344578899999999877775 89999999999999996 99999987777666666554 3456778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.++|.+||..||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=285.40 Aligned_cols=181 Identities=20% Similarity=0.362 Sum_probs=153.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...++|+||+.+|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 3578999999999999999874 579999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
............||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+.......+... ....|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43332233445678899999999887775 89999999999999999 99999987776666555444 34566778999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+|+.+||..||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999886
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=286.35 Aligned_cols=179 Identities=28% Similarity=0.451 Sum_probs=147.7
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQV 85 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~ 85 (361)
.+|+||||+. |+|.+++. .++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 4699999997 59988774 3599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---------------
Q 018052 86 REDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--------------- 150 (361)
Q Consensus 86 ~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------- 150 (361)
.....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+.+..+...
T Consensus 179 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred ----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2345689999999999887444468999999999999999999999987766555443221
Q ss_pred ---------------C-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---------------D-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---------------~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
. ...++.+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 01223578999999999999999999999999999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=278.55 Aligned_cols=182 Identities=17% Similarity=0.251 Sum_probs=150.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC-----EEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~-----lKl~DF 76 (361)
.....|+||||+ ||+|.+++...+ ++++..+..++.|++.||+|||++||+||||||+|||++.++. +||+||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 456899999999 999999998754 5999999999999999999999999999999999999988776 999999
Q ss_pred CCcccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHh
Q 018052 77 GLSAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKIC 148 (361)
Q Consensus 77 Gla~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~ 148 (361)
|+|......... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+. +....+..+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 999765432221 123456899999999999887764 8999999999999999999999873 3344444433
Q ss_pred hcCC-----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 149 RADF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 149 ~~~~-----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.... ..+..+++++.+||.+||..||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2221 1224578999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=282.40 Aligned_cols=184 Identities=23% Similarity=0.361 Sum_probs=154.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~Ni 63 (361)
.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 34567899999999999999998754 489999999999999999999999999999999999
Q ss_pred EEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHH
Q 018052 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 142 (361)
Q Consensus 64 Lld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~ 142 (361)
|++.++.+||+|||++................||+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999765443322233445678899999999877665 89999999999999998 999998766444
Q ss_pred HHHHHhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 143 LYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 143 ~~~~i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
........ ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33333322 233456789999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=281.19 Aligned_cols=184 Identities=18% Similarity=0.285 Sum_probs=158.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVL 71 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~l 71 (361)
.+.+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 3566789999999999999998753 357999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc
Q 018052 72 KISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA 150 (361)
Q Consensus 72 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~ 150 (361)
||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999999755432222223345678999999999877665 89999999999999999 89999998888777776655
Q ss_pred C-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 D-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
. ...+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4 34566789999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=282.82 Aligned_cols=180 Identities=26% Similarity=0.412 Sum_probs=155.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
+.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 5678999999999999999998754 699999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||++...... .......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp GGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 9999999999998643221 122345678899999999876664 89999999999999998 999999988888887
Q ss_pred HHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+ ....|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77655 345566789999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=279.11 Aligned_cols=177 Identities=21% Similarity=0.275 Sum_probs=149.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC--------EEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV--------LKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~--------lKl 73 (361)
+.+..|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 45678999999999999999988664 999999999999999999999999999999999999999887 999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhcCC
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRADF 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~ 152 (361)
+|||++..... .....||+.|+|||++.+....+.++||||+||++|+|++| .+||...+...... ......
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~ 235 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH 235 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC
Confidence 99999864322 23456899999999998744446899999999999999995 56666555444333 344555
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..|...++++.+||.+||..||.+|||+.++++|
T Consensus 236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6667778999999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=282.82 Aligned_cols=184 Identities=24% Similarity=0.427 Sum_probs=157.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 34668899999999999999998754 38999999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.++.+||+|||++................+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999765432221222345678899999999876664 89999999999999999 99999998888777
Q ss_pred HHHhhcC-CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~~-~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+.... ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7766553 45566789999999999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=286.88 Aligned_cols=182 Identities=18% Similarity=0.242 Sum_probs=148.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC--CEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~--~lKl~DFGla~ 80 (361)
....+|+||||+ ||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~ 201 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCE
T ss_pred CCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCce
Confidence 367899999999 999999998877899999999999999999999999999999999999999887 99999999997
Q ss_pred ccccccc-----CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc--cHHHHHHHHhhcCCC
Q 018052 81 ISQQVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKICRADFS 153 (361)
Q Consensus 81 ~~~~~~~-----~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~ 153 (361)
....... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+. +..............
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 280 (345)
T 2v62_A 202 RYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE 280 (345)
T ss_dssp ESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT
T ss_pred ecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc
Confidence 6543221 1122456899999999999887664 8999999999999999999999652 222221111111111
Q ss_pred CC---------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 154 CP---------SWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 154 ~~---------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.| ..+++++.+||.+||..||++|||+.++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 281 LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11 2578999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=276.74 Aligned_cols=182 Identities=22% Similarity=0.292 Sum_probs=149.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.....|+||||+ ||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 356789999999 8999999984 4579999999999999999999999999999999999999 5889999999999
Q ss_pred cccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---HHHHHHHHhhc
Q 018052 79 SAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRA 150 (361)
Q Consensus 79 a~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---~~~~~~~i~~~ 150 (361)
+......... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+ ....+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 9765432221 123456899999999999887764 89999999999999999999998632 22233333222
Q ss_pred CCCC-----CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 DFSC-----PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ~~~~-----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.... +..+++++.+||.+||..||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 2222 25689999999999999999999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=282.60 Aligned_cols=182 Identities=25% Similarity=0.406 Sum_probs=153.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGR----------------LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~ 67 (361)
...+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3468999999999999999987654 899999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHH-HHHH
Q 018052 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLM-ALYR 145 (361)
Q Consensus 68 ~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~-~~~~ 145 (361)
++.+||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.... ....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999765432222223456789999999999887775 89999999999999998 99999876543 3333
Q ss_pred HHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+ ....|..+++.+.++|.+||..||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333 345677789999999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=290.39 Aligned_cols=183 Identities=27% Similarity=0.456 Sum_probs=154.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++..+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 4567899999999999999998654 699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..............+++.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..++
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 3221111111123356789999999877665 89999999999999998 99999988877766665544 456677789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+||.+||..||.+|||+.++++.
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999999999763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=282.20 Aligned_cols=181 Identities=20% Similarity=0.371 Sum_probs=149.0
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...++|+||+.+|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 3478999999999999999874 579999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
............||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+.......+... ....|..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 43333333445678899999999887775 89999999999999999 99999987777666665544 35567778999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+||.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=276.51 Aligned_cols=181 Identities=23% Similarity=0.323 Sum_probs=149.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.....|+||||+ ||+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 456889999999 9999999985 4579999999999999999999999999999999999999 8999999999999
Q ss_pred cccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---HHHHHHHhhc
Q 018052 79 SAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRA 150 (361)
Q Consensus 79 a~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~---~~~~~~i~~~ 150 (361)
+......... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+. ...+..+...
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 9765432221 123456899999999999887764 899999999999999999999976432 1222222222
Q ss_pred CCCCC-----CCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 151 DFSCP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 151 ~~~~~-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
....| ..+++++.+||.+||..||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 22222 457899999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=287.86 Aligned_cols=179 Identities=15% Similarity=0.232 Sum_probs=145.9
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cCCCEEEEecCCccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGLSAI 81 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld--~~~~lKl~DFGla~~ 81 (361)
..+||||||| ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|..
T Consensus 125 ~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~ 203 (364)
T 3op5_A 125 SYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203 (364)
T ss_dssp EEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEE
T ss_pred ceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCccee
Confidence 5689999999 99999999876 5799999999999999999999999999999999999999 899999999999976
Q ss_pred ccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh----hcC-
Q 018052 82 SQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC----RAD- 151 (361)
Q Consensus 82 ~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~----~~~- 151 (361)
....... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+......+.... ...
T Consensus 204 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3op5_A 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENI 282 (364)
T ss_dssp SSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCH
T ss_pred cccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhH
Confidence 5432221 112345699999999999887764 89999999999999999999998632221111100 000
Q ss_pred ------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 ------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 ------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.-.+..+++++.+|+..||..||.+|||+.++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 283 ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 0112457899999999999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.58 Aligned_cols=180 Identities=21% Similarity=0.318 Sum_probs=148.1
Q ss_pred EEEEEEecCCCCChHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 6 KIYIVLEFIDGGELFDKIAK------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 46999999999999999843 356999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
................+++.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+.......+..+ ....|..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED 273 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTT
T ss_pred eecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCcc
Confidence 765432222223345678899999999887765 89999999999999999 99999987777776666554 3455667
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 274 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=283.35 Aligned_cols=180 Identities=22% Similarity=0.301 Sum_probs=149.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC-----EEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV-----LKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~-----lKl~DF 76 (361)
+....|+||||+ ||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred cCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 456889999999 99999999873 67999999999999999999999999999999999999998887 999999
Q ss_pred CCcccccccccCC-----ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc---cHHHHHHHHh
Q 018052 77 GLSAISQQVREDG-----LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES---NLMALYRKIC 148 (361)
Q Consensus 77 Gla~~~~~~~~~~-----~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~---~~~~~~~~i~ 148 (361)
|+|.......... .....+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+. +..+.+..+.
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 9997654322111 13467899999999999887774 8999999999999999999999873 4445555554
Q ss_pred hcCCCCC-----CCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 149 RADFSCP-----SWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 149 ~~~~~~~-----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
......| ..++ ++.+||..||..||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3322222 1234 9999999999999999999998876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=277.47 Aligned_cols=183 Identities=26% Similarity=0.481 Sum_probs=139.6
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
....+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 345689999999999999999654 5699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccc---cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH-HHHHHhhcCCC----
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLN---DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-LYRKICRADFS---- 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~---~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~---- 153 (361)
.............+||+.|+|||++. +..+ +.++||||+|+++|+|++|..||.+.+... ....+......
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred cccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 54333333445678999999999986 3334 479999999999999999999998755443 33333333322
Q ss_pred -CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 154 -CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 154 -~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+++.+.+||.+||..||.+|||+.++++.
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 223578999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.24 Aligned_cols=183 Identities=22% Similarity=0.314 Sum_probs=156.8
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 4689999999999999999754 469999999999999999999999999999999999999999999999999997653
Q ss_pred cccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 84 QVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 84 ~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
.... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+..+....+..+. ...|..+++
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 240 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence 2211 1122334578999999999876665 89999999999999998 999999887777777665543 456778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
++.+||.+||..||.+|||+.+++++.+
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=283.81 Aligned_cols=184 Identities=21% Similarity=0.361 Sum_probs=153.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~ 67 (361)
.+...+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 3456789999999999999998753 35899999999999999999999999999999999999999
Q ss_pred CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHH
Q 018052 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRK 146 (361)
Q Consensus 68 ~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~ 146 (361)
++.+||+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999765433222223345678899999999877765 89999999999999998 9999987655444433
Q ss_pred Hhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 147 ICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 147 i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+... ....|...++.+.+||.+||..||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 3332 334566789999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=271.52 Aligned_cols=179 Identities=29% Similarity=0.538 Sum_probs=146.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCCCcEEEec--------CCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG---VFHRDLKPENLLLDS--------YGV 70 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g---i~HrDiKp~NiLld~--------~~~ 70 (361)
.+...+|+||||++||+|.+++. .+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred ecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 34667899999999999999886 468999999999999999999999999 999999999999986 788
Q ss_pred EEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc
Q 018052 71 LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA 150 (361)
Q Consensus 71 lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 150 (361)
+||+|||++...... ......||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+.......+...
T Consensus 155 ~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 155 LKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred eEEccCCcccccccc----cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 999999998754332 22356799999999999877665 8999999999999999999999988776666555444
Q ss_pred C--CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 D--FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ~--~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
. ...|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 3 45567789999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=281.87 Aligned_cols=188 Identities=19% Similarity=0.331 Sum_probs=158.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC---CCEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY---GVLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~---~~lK 72 (361)
+...+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 4567899999999999999998753 48999999999999999999999999999999999999844 4699
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA- 150 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~- 150 (361)
|+|||++................||+.|+|||++.+..+. .++||||+||++|+|++ |..||...+.......+...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999998754332222233445789999999999877765 89999999999999998 99999988877777766554
Q ss_pred CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 151 DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 151 ~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
....+..+++.+.+||.+||..||.+|||+.++++|.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 34456678999999999999999999999999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=274.74 Aligned_cols=182 Identities=21% Similarity=0.321 Sum_probs=155.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||++||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 45689999999999999999998889999999999999999999999999999999999999999999999999997653
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
..... .......||+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+..+....+.... ...|..+++
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32111 112234567899999999877665 89999999999999999 999999988877777665543 456677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.++|.+||..||.+|||+.++++.
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999763
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=276.34 Aligned_cols=184 Identities=27% Similarity=0.507 Sum_probs=143.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+.+.+|+||||+ ++.+...... .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 467899999999 5566555543 56799999999999999999999996 99999999999999999999999999986
Q ss_pred cccccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhcCCC-
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRADFS- 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~- 153 (361)
..... ......+||+.|+|||++. ...+ +.++||||+||++|+|++|..||.. .+.......+......
T Consensus 174 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 174 RLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp ----------------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred hccCC---ccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 54331 2234567999999999985 3334 4899999999999999999999987 3444555555544332
Q ss_pred CC--CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 154 CP--SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 154 ~~--~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.| ..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 22 347999999999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=270.79 Aligned_cols=182 Identities=23% Similarity=0.411 Sum_probs=156.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++..+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 456789999999999999999875 4699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+.......+..+ ....|..++
T Consensus 154 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 231 (267)
T 3t9t_A 154 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 231 (267)
T ss_dssp BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred ccccc-ccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCc
Confidence 43211 1122345678899999999877764 89999999999999999 89999998888777777665 334566689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+.+|+.+||..||.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=279.32 Aligned_cols=180 Identities=23% Similarity=0.400 Sum_probs=147.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++.. .+.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 46789999999999999999987 56799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccC------------CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH-----HH
Q 018052 82 SQQVRED------------GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA-----LY 144 (361)
Q Consensus 82 ~~~~~~~------------~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~-----~~ 144 (361)
....... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 5332111 111256899999999999887775 89999999999999999999986532110 00
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 145 RKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 145 ~~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.... ....|+.+++.+.+||.+||..||.+|||+.++++
T Consensus 237 ~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 237 RGFL--DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHH--HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccc--cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 11245678899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=292.88 Aligned_cols=188 Identities=24% Similarity=0.363 Sum_probs=142.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-----CCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-----YGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-----~~~lKl~DF 76 (361)
+...+|+|||||. |+|.+++.... .+.+..+..++.||+.||+|||++||+||||||+|||++. ...+||+||
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 4678999999996 59999998754 4666778899999999999999999999999999999953 235889999
Q ss_pred CCccccccccc-CCccccccCCCccccccccccC--CCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC
Q 018052 77 GLSAISQQVRE-DGLLHTACGTPNYVAPEVLNDK--GYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF 152 (361)
Q Consensus 77 Gla~~~~~~~~-~~~~~~~~gt~~y~APEv~~~~--~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~ 152 (361)
|+|........ .......+||+.|+|||++.+. ...+.++||||+||++|+|++ |..||...........+.....
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 247 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence 99976543211 1233457899999999998742 223478999999999999999 9999976554443332222222
Q ss_pred CC---CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 153 SC---PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 153 ~~---~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.. +...+..+.+||.+||..||.+|||+.++++||||..
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 11 1224566889999999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.92 Aligned_cols=187 Identities=28% Similarity=0.428 Sum_probs=139.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecC------
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLK-------EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSY------ 68 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~------ 68 (361)
.+...+|+|||||. |+|.+++...+... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 35678999999996 59999998765432 33457899999999999999999999999999999764
Q ss_pred -------CCEEEEecCCcccccccccC--CccccccCCCcccccccccc------CCCCCCchhhhhhhhHHHhHhc-CC
Q 018052 69 -------GVLKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLND------KGYDGRASDVWSCGVILFVLMA-GF 132 (361)
Q Consensus 69 -------~~lKl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APEv~~~------~~~~~~~~DiwS~Gvil~~ll~-g~ 132 (361)
+.+||+|||+|......... ......+||+.|+|||++.+ ....+.++||||+||++|+|++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 48999999999765432211 12345689999999999865 1234589999999999999998 99
Q ss_pred CCCCcccHHHHHHHHhhcCCCCCC-------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 133 LPFDESNLMALYRKICRADFSCPS-------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 133 ~Pf~~~~~~~~~~~i~~~~~~~~~-------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.||.+..... ..+.......+. .+++++.+||.+||..||.+|||+.++++||||..
T Consensus 238 ~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9997754333 222333322221 24578999999999999999999999999999963
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=268.35 Aligned_cols=175 Identities=19% Similarity=0.323 Sum_probs=152.7
Q ss_pred cEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 67899999999999999998765 4899999999999999999999999 9999999999999999999999999865
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCC--chhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--CCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR--ASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA--DFSCPS 156 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~--~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~ 156 (361)
... .....||+.|+|||++.+..+... ++||||+||++|+|++|..||.+.+.......+... ....|.
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred eec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 321 234578999999999987665432 799999999999999999999988877776665544 345667
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+++++.+||.+||..||.+|||+.++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 799999999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=273.65 Aligned_cols=184 Identities=23% Similarity=0.352 Sum_probs=153.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++...|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 3456789999999999999999864 468999999999999999999999999999999999999999999999999997
Q ss_pred ccccccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCC
Q 018052 81 ISQQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPS 156 (361)
Q Consensus 81 ~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 156 (361)
....... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |.+||.+.+..+....+.... ...|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 6543221 1223345688899999999877765 89999999999999999 678888776666655555543 34466
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+++.+.++|.+||..||.+|||+.++++.
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=279.65 Aligned_cols=182 Identities=21% Similarity=0.304 Sum_probs=144.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEecCCCCCcEEEecCCCEEE
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR----------GVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~----------gi~HrDiKp~NiLld~~~~lKl 73 (361)
...+|+|||||+||+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 3468999999999999999977 4699999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCC----CCCchhhhhhhhHHHhHhcCCCCCCccc----------
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGY----DGRASDVWSCGVILFVLMAGFLPFDESN---------- 139 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~----~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---------- 139 (361)
+|||+|...............+||+.|+|||++.+... .+.++||||+||++|+|++|..||.+..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976554333333455789999999999876322 2357899999999999999999996532
Q ss_pred ------HHHHHHHHhhcCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 140 ------LMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 140 ------~~~~~~~i~~~~~--~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.......+..... ..+.. .++++.+||.+||..||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222211 11111 23458999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.38 Aligned_cols=176 Identities=28% Similarity=0.492 Sum_probs=152.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+..+|+|||||+||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4479999999999999999987654 79999999999999999999999999999999999999999999999999874
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
... ......+++.|+|||++.+..++ .++||||+||++|+|++ |..||.+.+..+....+..+ ....|..++
T Consensus 339 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~ 412 (450)
T 1k9a_A 339 ASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred ccc-----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 322 12234678999999999887775 89999999999999998 99999987777666666554 456677899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.+.+||.+||..||.+|||+.++++
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=285.92 Aligned_cols=177 Identities=15% Similarity=0.239 Sum_probs=145.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec----------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---------- 67 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---------- 67 (361)
..+..|+|||||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 46788999999999999999974 457999999999999999999999999999999999999998
Q ss_pred -CCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH
Q 018052 68 -YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK 146 (361)
Q Consensus 68 -~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~ 146 (361)
++.+||+|||+|...............+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 899999999999765443344455678899999999999988775 89999999999999999999996543210
Q ss_pred HhhcCCCC-CCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 147 ICRADFSC-PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 147 i~~~~~~~-~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
......+ ..+.++...+++..||+.+|.+|++..+.+.
T Consensus 293 -~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 293 -CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 0011111 1245778899999999999999966444444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=278.10 Aligned_cols=184 Identities=22% Similarity=0.355 Sum_probs=151.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+...+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 3567899999999999999999865 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 81 ISQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 81 ~~~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
........ .......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCccc
Confidence 65432111 112234568899999999877765 89999999999999998 99999988887777776655 3455667
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=269.57 Aligned_cols=180 Identities=29% Similarity=0.459 Sum_probs=153.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 171 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhee
Confidence 45689999999999999999754 5799999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||... ......+... ..+..+++.
T Consensus 172 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~ 243 (284)
T 2a19_B 172 LKND---GKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--IISDIFDKK 243 (284)
T ss_dssp SSCC---SCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CCCTTSCHH
T ss_pred cccc---ccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cccccCCHH
Confidence 5432 223456799999999999887764 8999999999999999999988543 2233333332 345668999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+.+||.+||..||.+|||+.++++|.|.-.
T Consensus 244 ~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 244 EKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=271.80 Aligned_cols=180 Identities=23% Similarity=0.332 Sum_probs=150.6
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 4568999999999999999765 469999999999999999999999999999999999999999999999999987654
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
.... .......+|+.|+|||++.+..+. .++||||+|+++|+|++ |..||...+..+....+... ....|..+++.
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 3211 122345678899999999877765 89999999999999998 99999876655555555443 34556678999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+||.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=273.21 Aligned_cols=183 Identities=23% Similarity=0.399 Sum_probs=156.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+...+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 35677999999999999999998743 5999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
....... ........||+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+.......+... ....|..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 159 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp GTSCSSS-SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred eeccCCc-cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 7654221 1223345678899999999877765 89999999999999999 99999987776666665544 4456677
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+.+||.+||..||.+|||+.++++.
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=273.35 Aligned_cols=181 Identities=23% Similarity=0.379 Sum_probs=146.0
Q ss_pred cEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||++||+|.+++...+ ++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 45899999999999999998754 59999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH----------------HHHHH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----------------ALYRK 146 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~----------------~~~~~ 146 (361)
..... .......||+.|+|||++.+..+. .++||||+|+++|+|++|..||...... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 32211 122334577889999999887775 8999999999999999999998754322 11122
Q ss_pred Hh-hcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 147 IC-RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 147 i~-~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+. ....+.|..+++++.+||.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 22 22445677789999999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=279.48 Aligned_cols=181 Identities=16% Similarity=0.263 Sum_probs=149.1
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC--CEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG--VLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~--~lKl~DFGla 79 (361)
...+|+||||+ ||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a 208 (352)
T 2jii_A 130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208 (352)
T ss_dssp TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGC
T ss_pred CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcce
Confidence 57899999999 99999999986 6899999999999999999999999999999999999999998 9999999999
Q ss_pred ccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHH---Hhh
Q 018052 80 AISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRK---ICR 149 (361)
Q Consensus 80 ~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~---i~~ 149 (361)
......... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.. ....... +..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 287 (352)
T 2jii_A 209 FRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD 287 (352)
T ss_dssp BCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH
T ss_pred eeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccC
Confidence 765432211 122345899999999999887764 89999999999999999999998753 3322222 222
Q ss_pred cCCCCC------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 150 ADFSCP------SWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 150 ~~~~~~------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.....+ ..+++++.+||.+||..||.+|||+.++++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 288 KPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp SCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 222111 1368999999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=284.23 Aligned_cols=183 Identities=23% Similarity=0.362 Sum_probs=145.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++...|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 4567899999999999999998654 589999999999999999999999999999999999999999999999999975
Q ss_pred ccccccC--CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 82 SQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 82 ~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
....... .......+|+.|+|||++.+..+. .++||||+||++|+|++ |.+||.+.+..+....+..+ ....|..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~ 320 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 4322111 112345678899999999877775 89999999999999999 78899876655555555444 3445667
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+.++|.+||..||.+|||+.+++++
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=282.88 Aligned_cols=183 Identities=23% Similarity=0.373 Sum_probs=145.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++...+ .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 4567899999999999999998754 699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 82 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
....... .......+|+.|+|||++.+..+. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 5432111 111223457889999999887775 89999999999999998 99999988877777766554 34455668
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+.+||.+||..||.+|||+.++++.
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.44 Aligned_cols=184 Identities=23% Similarity=0.406 Sum_probs=132.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCCCcEEEecCCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-----HGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~ql~~gl~~lH~~-gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
+.+.+|+||||+.| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 46789999999986 88877763 56799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccCCccccccCCCccccccccc----cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcC
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLN----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRAD 151 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~ 151 (361)
|++...... ......+||+.|+|||++. +..+ +.++||||+||++|+|++|..||.+.+.. +....+..+.
T Consensus 171 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 171 GISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp SSSCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred CCceecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 998754321 1223457999999999983 4445 48999999999999999999999875422 2222222222
Q ss_pred C-CC----CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 F-SC----PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 ~-~~----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
. .. +..+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1 11 1347899999999999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.91 Aligned_cols=177 Identities=27% Similarity=0.485 Sum_probs=147.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
....+|+||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 165 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccc
Confidence 34578999999999999999987543 8999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
..... .....+++.|+|||++.+..+. .++||||+|+++|+|++ |..||...+..+....+..+ ....+..+
T Consensus 166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (278)
T 1byg_A 166 EASST-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239 (278)
T ss_dssp ---------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTC
T ss_pred ccccc-----ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccC
Confidence 54321 2344688999999999877665 89999999999999998 99999988777776666544 34566778
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++.+.++|.+||..||.+|||+.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=282.16 Aligned_cols=185 Identities=21% Similarity=0.305 Sum_probs=148.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
.+.+.+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 45678899999999999999987643 58999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH------HH-HHHhhc
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMA------LY-RKICRA 150 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~------~~-~~i~~~ 150 (361)
++...............+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+....+ .. ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99764433233334456799999999999877765 89999999999999999999997543211 10 111111
Q ss_pred CC------C----CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 151 DF------S----CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 151 ~~------~----~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
.. . .++..+..+.+++.+||..||++|||+.+++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 1 1112356788999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=290.38 Aligned_cols=180 Identities=25% Similarity=0.417 Sum_probs=154.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...+|+|||||+||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 456899999999999999998543 689999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
...... .......+|+.|+|||++....|. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..++
T Consensus 334 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 334 IEDNEY-TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp BCCHHH-HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred cCCCce-eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 532111 112234567889999999877765 89999999999999999 99999998888777776554 445677799
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+++.+||.+||..||.+|||+.++++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=272.72 Aligned_cols=182 Identities=25% Similarity=0.401 Sum_probs=143.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEEecCCCEEEEe
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKISD 75 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH--------~~gi~HrDiKp~NiLld~~~~lKl~D 75 (361)
...+|+||||++||+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 4578999999999999999964 57999999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccccccC--CccccccCCCccccccccccCCCC-----CCchhhhhhhhHHHhHhcC----------CCCCCcc
Q 018052 76 FGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFDES 138 (361)
Q Consensus 76 FGla~~~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~-----~~~~DiwS~Gvil~~ll~g----------~~Pf~~~ 138 (361)
||+|......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999754432211 112345899999999999776322 2589999999999999999 8888542
Q ss_pred c----HHHHHHHHhhcC---CCCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 139 N----LMALYRKICRAD---FSCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 139 ~----~~~~~~~i~~~~---~~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
. ............ ...|.. .++.+.+||.+||..||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1 122222222221 122211 34679999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=269.03 Aligned_cols=180 Identities=23% Similarity=0.399 Sum_probs=154.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+|+||||++||+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 346899999999999999987543 699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
...... .......+|+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+..+....+..+ ....+..++
T Consensus 159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T 1qpc_A 159 IEDNEY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (279)
T ss_dssp CSSSCE-ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccc-ccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccccc
Confidence 543211 122344578899999999876664 89999999999999999 99999988877777766554 344566789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.+.+||.+||..||.+|||+.++++
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=272.48 Aligned_cols=181 Identities=24% Similarity=0.402 Sum_probs=144.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred eCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 46789999999999999999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---CCCCCCC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF---SCPSWFS 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s 159 (361)
.... .......+||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+.+.......+..... ..++.++
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIP 262 (309)
T ss_dssp -------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCC
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCC
Confidence 3321 1223456799999999999877664 899999999999999999999998776655444433221 2345689
Q ss_pred HHHHHHHHHccCCCcCCCC-CHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRM-TISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~-t~~eil~ 185 (361)
+.+.+||.+||..||.+|| |++++++
T Consensus 263 ~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 263 VAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp THHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999999 7888775
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=271.25 Aligned_cols=180 Identities=26% Similarity=0.429 Sum_probs=149.0
Q ss_pred cEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 568999999999999999954 4579999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---------------HHHHHHHH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---------------LMALYRKI 147 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---------------~~~~~~~i 147 (361)
..... .......||+.|+|||++.+..+. .++||||+|+++|+|++|..|+.... .......+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 32211 223456788999999999887775 89999999999999999998864321 11222222
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 148 CR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 148 ~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.. .....|..+++.+.+||.+||..||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22 244567779999999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=291.89 Aligned_cols=174 Identities=17% Similarity=0.234 Sum_probs=145.4
Q ss_pred EEEEEEecCCCCChHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 6 KIYIVLEFIDGGELFDKIAK-------HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
.+|++|+++ +|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 468888887 5699998851 23478888999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCcccccccc----------ccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHh
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVL----------NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKIC 148 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~----------~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~ 148 (361)
+..... ...+.+| +.|+|||++ ....| +.++||||+||++|+|++|..||.+.+.......+.
T Consensus 258 a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~ 330 (413)
T 3dzo_A 258 LVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330 (413)
T ss_dssp CEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG
T ss_pred eeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH
Confidence 875432 2456788 999999998 33334 479999999999999999999998876544433332
Q ss_pred hcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 149 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 149 ~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
. ....+++++.+||.+||..||++|||+.++++||||+.
T Consensus 331 ~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 331 R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp S----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred h----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 2 23457899999999999999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=275.76 Aligned_cols=183 Identities=26% Similarity=0.414 Sum_probs=151.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 46789999999999999999987 35699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH---------------HHHH
Q 018052 82 SQQVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------------ALYR 145 (361)
Q Consensus 82 ~~~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~---------------~~~~ 145 (361)
....... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 5432211 122345688899999999877664 8999999999999999999999654432 2222
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.. .....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222 2345567789999999999999999999999999765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=277.78 Aligned_cols=190 Identities=24% Similarity=0.350 Sum_probs=141.8
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR---------GVFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~---------gi~HrDiKp~NiLld~~~~lKl 73 (361)
.+..+|+|||||+||+|.+++... +.++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 345789999999999999999764 469999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccccc------cCCccccccCCCccccccccccCC------CCCCchhhhhhhhHHHhHhcCCCCCCc-cc-
Q 018052 74 SDFGLSAISQQVR------EDGLLHTACGTPNYVAPEVLNDKG------YDGRASDVWSCGVILFVLMAGFLPFDE-SN- 139 (361)
Q Consensus 74 ~DFGla~~~~~~~------~~~~~~~~~gt~~y~APEv~~~~~------~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~- 139 (361)
+|||+|....... ........+||+.|+|||++.+.. ..+.++||||+||++|+|++|..||.. .+
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999997653211 112233568999999999987631 223689999999999999999766532 11
Q ss_pred ----------------HHHHHHHHhh--cCCCCCCC------CCHHHHHHHHHccCCCcCCCCCHHHHHh------Cccc
Q 018052 140 ----------------LMALYRKICR--ADFSCPSW------FSSGAKKLIKRILDPNPDTRMTISQMLE------DEWF 189 (361)
Q Consensus 140 ----------------~~~~~~~i~~--~~~~~~~~------~s~~~~~Li~~~L~~dP~~R~t~~eil~------h~~f 189 (361)
.......+.. ....+|.. .++.+.+||.+||..||++|||+.|+++ ++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 1111111111 11222322 3357999999999999999999999954 5666
Q ss_pred ccCC
Q 018052 190 KKGY 193 (361)
Q Consensus 190 ~~~~ 193 (361)
++..
T Consensus 322 ~~~~ 325 (336)
T 3g2f_A 322 RNKS 325 (336)
T ss_dssp C---
T ss_pred hccc
Confidence 6543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=267.86 Aligned_cols=180 Identities=21% Similarity=0.356 Sum_probs=151.3
Q ss_pred EEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..|+||||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 34999999999999999987 35699999999999999999999999999999999999999999999999999975433
Q ss_pred cc--cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 85 VR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 85 ~~--~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.. .........||+.|+|||++.+..+. .++||||+|+++|+|++ |.+||...+..+....+... ....|..+++
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence 21 11223456788999999999887765 89999999999999999 56667666666655555444 3455677899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.+||.+||..||.+|||+.++++.
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=299.36 Aligned_cols=181 Identities=22% Similarity=0.318 Sum_probs=154.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 45899999999999999999888999999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
... ........||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+..+....+..+ ....|..++++
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 600 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 221 1122334578899999999887775 89999999999999998 99999998888877777665 34567789999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+||.+||..||++|||+.++++.
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=273.94 Aligned_cols=181 Identities=24% Similarity=0.408 Sum_probs=142.7
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEecCCCCCcEEEecCCCEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------GVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~--------gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
..+|+||||++||+|.+++.. .++++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 689999999999999999976 4799999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccccccC--CccccccCCCccccccccccCCCCCC-----chhhhhhhhHHHhHhcC----------CCCCCcc-
Q 018052 77 GLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGR-----ASDVWSCGVILFVLMAG----------FLPFDES- 138 (361)
Q Consensus 77 Gla~~~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~~~-----~~DiwS~Gvil~~ll~g----------~~Pf~~~- 138 (361)
|+|......... ......+||+.|+|||++.+..+... ++||||+||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999654332211 11235689999999999987665532 38999999999999999 7777542
Q ss_pred ----cHHHHHHHHhhc--CCCCCC-----CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 139 ----NLMALYRKICRA--DFSCPS-----WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 139 ----~~~~~~~~i~~~--~~~~~~-----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
........+... ....|. .+++.+.+||.+||..||.+|||+.++++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 122222222221 122222 245678999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=271.27 Aligned_cols=169 Identities=36% Similarity=0.701 Sum_probs=137.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DFG 77 (361)
....+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 3668999999999999999998764 6999999999999999999999999999999999999998 7899999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH----HhhcCCC
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK----ICRADFS 153 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~----i~~~~~~ 153 (361)
+|.... +..| +.++||||+||++|+|++|..||.+.+....... +......
T Consensus 166 ~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 166 FAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp TCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred cccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 985321 1223 3789999999999999999999987654443221 1122223
Q ss_pred CC----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCCC
Q 018052 154 CP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196 (361)
Q Consensus 154 ~~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 196 (361)
.| ..+++++.+||.+||..||.+|||+.++++||||+.....+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 33 45799999999999999999999999999999998765433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=268.45 Aligned_cols=180 Identities=27% Similarity=0.409 Sum_probs=152.6
Q ss_pred EEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 6 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 478999999999999998864 5699999999999999999999999999999999999999999999999999876543
Q ss_pred cccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC--CCCCCCCCH
Q 018052 85 VRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSS 160 (361)
Q Consensus 85 ~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~ 160 (361)
.... .......+|+.|+|||++.+..+. .++||||+|+++|+|++ |..||.+.+..+....+.... ...+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2211 122345678899999999877665 89999999999999999 999999988888877776543 344567899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.++|.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=286.26 Aligned_cols=180 Identities=24% Similarity=0.376 Sum_probs=150.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 5689999999999999999753 46999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.... ........+|+.|+|||++....+. .++||||+||++|+|++ |..||.+.+..+....+..+ ..+.|..+++
T Consensus 331 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 331 EDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 408 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred CCCc-eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 3211 1122334578899999999877765 89999999999999999 99999998887777776554 3456778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.+||.+||..||++|||++++++.
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.82 Aligned_cols=182 Identities=23% Similarity=0.393 Sum_probs=155.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+...+|+|||||+||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 456789999999999999999864 359999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...... ........+++.|+|||++....|. .++||||+||++|+|++ |..||.+.+..+.+..+... ....|..+
T Consensus 367 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 367 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 444 (495)
T ss_dssp CCTTCC-EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eccCCc-eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 653211 1112334567899999999877765 89999999999999999 99999988777666665543 34567779
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+.+||.+||..||.+|||+.++++.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=264.38 Aligned_cols=174 Identities=24% Similarity=0.423 Sum_probs=144.9
Q ss_pred EEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCC-----EEEEecCCc
Q 018052 8 YIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGV-----LKISDFGLS 79 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~-----lKl~DFGla 79 (361)
|+||||++||+|.+.+.... .+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+|||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 79999999999999887654 7999999999999999999999999 999999999999988887 999999998
Q ss_pred ccccccccCCccccccCCCccccccccccC-CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHH--HHHHHhhc--CCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDK-GYDGRASDVWSCGVILFVLMAGFLPFDESNLMA--LYRKICRA--DFSC 154 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~-~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~--~~~~i~~~--~~~~ 154 (361)
.... ......+||+.|+|||++... ...+.++||||+||++|+|++|..||...+... ....+... ....
T Consensus 177 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 177 QQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251 (287)
T ss_dssp BCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred cccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence 6432 224457899999999998432 223579999999999999999999998654322 23333332 3455
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
|..+++.+.+||.+||..||.+|||+.++++.
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 67789999999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=271.02 Aligned_cols=183 Identities=22% Similarity=0.360 Sum_probs=149.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 4567999999999999999998755 699999999999999999999999999999999999998 68999999999875
Q ss_pred ccccc---cCCccccccCCCccccccccccC--------CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc
Q 018052 82 SQQVR---EDGLLHTACGTPNYVAPEVLNDK--------GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA 150 (361)
Q Consensus 82 ~~~~~---~~~~~~~~~gt~~y~APEv~~~~--------~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 150 (361)
..... .........||+.|+|||++.+. ...+.++||||+||++|+|++|..||...+.......+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 43211 12233445799999999998752 22357999999999999999999999998887777766555
Q ss_pred CCCC--CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 151 DFSC--PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 151 ~~~~--~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.... +..++.++.+||.+||..||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3322 22478899999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=270.40 Aligned_cols=184 Identities=25% Similarity=0.385 Sum_probs=147.1
Q ss_pred CcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4588999999999999999886 467999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCC-------ccccccCCCccccccccccCCC--CCCchhhhhhhhHHHhHhcCCCCCCcccHH--HHHHHHh
Q 018052 80 AISQQVREDG-------LLHTACGTPNYVAPEVLNDKGY--DGRASDVWSCGVILFVLMAGFLPFDESNLM--ALYRKIC 148 (361)
Q Consensus 80 ~~~~~~~~~~-------~~~~~~gt~~y~APEv~~~~~~--~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~--~~~~~i~ 148 (361)
.......... ......||+.|+|||++.+..+ .+.++||||+||++|+|++|..||...... .....+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 6543211110 1123568999999999875542 258999999999999999999999642111 1111111
Q ss_pred -hcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 149 -RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 149 -~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
....+.++.+++++.+||.+||..||.+|||+.+++++-
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 122334456899999999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=271.86 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=146.2
Q ss_pred cCcEEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+.+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 180 (307)
T 2nru_A 101 DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180 (307)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence 45678999999999999999874 346999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH----HHHHHHhhcCC---
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----ALYRKICRADF--- 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~--- 152 (361)
...............+||+.|+|||++.+. + +.++||||+|+++|+|++|..||.+.... .....+.....
T Consensus 181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (307)
T 2nru_A 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIE 258 (307)
T ss_dssp EECCSCSSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHH
T ss_pred cccccccccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhh
Confidence 765433222233456799999999998753 4 48999999999999999999999864432 22222211111
Q ss_pred --------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 153 --------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 153 --------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+...++.+.+++.+||..||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122245678899999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.33 Aligned_cols=186 Identities=21% Similarity=0.315 Sum_probs=154.0
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+|||||.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 4589999999999999999754 469999999999999999999999999999999999999999999999999997653
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
..... .......+|+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 566 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 22111 111233467899999999877775 89999999999999998 99999998888877777665 3466778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHH---hCccccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQML---EDEWFKK 191 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil---~h~~f~~ 191 (361)
++.+||.+||..||.+|||+.+++ ++.|+..
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999984 4455543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=266.09 Aligned_cols=175 Identities=28% Similarity=0.492 Sum_probs=141.2
Q ss_pred EEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCCCcEEEecCCC-EEEEecCC
Q 018052 6 KIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHS---RGVFHRDLKPENLLLDSYGV-LKISDFGL 78 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~---~gi~HrDiKp~NiLld~~~~-lKl~DFGl 78 (361)
..|+||||++||+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 4689999999999999998765 37899999999999999999999 89999999999999999887 79999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc--HHHHHHHHhh-cCCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN--LMALYRKICR-ADFSCP 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~--~~~~~~~i~~-~~~~~~ 155 (361)
+..... ......||+.|+|||++.+..+. .++||||+||++|+|++|..||.... .......+.. .....+
T Consensus 153 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
T 2eva_A 153 ACDIQT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred cccccc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence 865432 12345799999999999877765 89999999999999999999997543 2223222222 234455
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+++.+.+||.+||..||.+|||+.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=271.01 Aligned_cols=185 Identities=21% Similarity=0.296 Sum_probs=147.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCCCcEEEecCCCEEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----RLKEDEARRYFQQLINAVDYCHSR---GVFHRDLKPENLLLDSYGVLKIS 74 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~ql~~gl~~lH~~---gi~HrDiKp~NiLld~~~~lKl~ 74 (361)
.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 35677899999999999999998654 399999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH--------HHHHHH
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL--------MALYRK 146 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~--------~~~~~~ 146 (361)
|||++...... ........+||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......
T Consensus 177 Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 177 DFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred cCccccccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999765432 2223445679999999999987766 4899999999999999999999963211 111111
Q ss_pred Hhhc-C------C----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 147 ICRA-D------F----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 147 i~~~-~------~----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
.... . . ..+...++.+.+|+.+||..||.+|||+.++++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1110 0 0 011112467889999999999999999999999854
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=265.50 Aligned_cols=181 Identities=33% Similarity=0.618 Sum_probs=141.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 45689999999999999998874 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc--cHHHHHHHHhhcCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES--NLMALYRKICRADFSC-- 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~-- 154 (361)
+...... ........||+.|+|||++.+..+. .++||||+|+++|+|++|..||.+. +.......+....+..
T Consensus 183 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T 2wqm_A 183 GRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLP 259 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCC
T ss_pred eeeecCC--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCc
Confidence 8754332 1223456799999999999877765 8999999999999999999999764 3344555554444332
Q ss_pred CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 155 ~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+..+++++.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 24579999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=269.32 Aligned_cols=180 Identities=26% Similarity=0.392 Sum_probs=148.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+|+||||++||+|.+++... ++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 46899999999999999999764 59999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH---------------HHHHHH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM---------------ALYRKI 147 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~---------------~~~~~i 147 (361)
..... .......||+.|+|||++.+..+. .++||||+||++|+|++|..||...... .....+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 32111 123345688899999999887775 8999999999999999999999764322 111122
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 148 CR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 148 ~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.. .....+..+++++.+||.+||..||.+|||+.++++
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22 234556778999999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=282.44 Aligned_cols=181 Identities=22% Similarity=0.299 Sum_probs=149.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE---ecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL---DSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl---d~~~~lKl~DFGl 78 (361)
.....||||||+ ||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 356789999999 9999999985 4679999999999999999999999999999999999999 6899999999999
Q ss_pred cccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---HHHHHHHHhhc
Q 018052 79 SAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKICRA 150 (361)
Q Consensus 79 a~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---~~~~~~~i~~~ 150 (361)
|......... ......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.. ....+.++...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 9765432221 122367899999999999887775 89999999999999999999998743 33444433322
Q ss_pred CC-----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 151 DF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 151 ~~-----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.. ..+..+++++.+||.+||..||.+||++.+|++
T Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 232 KVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 122457899999999999999999999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=269.92 Aligned_cols=182 Identities=27% Similarity=0.450 Sum_probs=128.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEecCCCEEEEecC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK---HGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLDSYGVLKISDFG 77 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld~~~~lKl~DFG 77 (361)
....+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4557899999996 699888765 567999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccC----------CccccccCCCcccccccc---ccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH
Q 018052 78 LSAISQQVRED----------GLLHTACGTPNYVAPEVL---NDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY 144 (361)
Q Consensus 78 la~~~~~~~~~----------~~~~~~~gt~~y~APEv~---~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~ 144 (361)
++......... ......+||+.|+|||++ .+..+ +.++||||+||++|+|++|..||.+.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 99765432111 111256799999999998 34334 47999999999999999999999876554433
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcc
Q 018052 145 RKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEW 188 (361)
Q Consensus 145 ~~i~~~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~ 188 (361)
... .....+...+..+.+||.+||..||.+|||+.++++|-+
T Consensus 263 ~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 263 NGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred cCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 321 123334557888999999999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=292.49 Aligned_cols=181 Identities=24% Similarity=0.373 Sum_probs=153.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|...
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 456899999999999999998654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.... ........||+.|+|||++.+..|. .++||||+||++|+|++ |..||.+.+..+....+..+ ....|+.+++
T Consensus 542 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 542 EDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred CCCc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 3321 1122345678899999999877765 89999999999999997 99999998888877777655 3567788999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.+||.+||..||.+|||+.++++.
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=272.17 Aligned_cols=172 Identities=19% Similarity=0.278 Sum_probs=140.2
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecCC-------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYG------------- 69 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH-~~gi~HrDiKp~NiLld~~~------------- 69 (361)
...+|+|||||+||++.+.+.+ +.+++..++.++.||+.||+||| ++||+||||||+|||++.+|
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~ 212 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccc
Confidence 6899999999999988777754 67999999999999999999999 99999999999999999987
Q ss_pred -------CEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhH-HHhHhcCCCCCCcccH-
Q 018052 70 -------VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI-LFVLMAGFLPFDESNL- 140 (361)
Q Consensus 70 -------~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvi-l~~ll~g~~Pf~~~~~- 140 (361)
.+||+|||+|..... ...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+...
T Consensus 213 ~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~ 283 (336)
T 2vuw_A 213 TIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWL 283 (336)
T ss_dssp EEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH
T ss_pred cccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhh
Confidence 899999999976532 2458999999999998765 589999998777 7789999999965322
Q ss_pred HHHHHHHhhc-CCC--C----CCCCCHHHHHHHHHccCCCcCCCCCHHHHH-hCcccc
Q 018052 141 MALYRKICRA-DFS--C----PSWFSSGAKKLIKRILDPNPDTRMTISQML-EDEWFK 190 (361)
Q Consensus 141 ~~~~~~i~~~-~~~--~----~~~~s~~~~~Li~~~L~~dP~~R~t~~eil-~h~~f~ 190 (361)
......+... ... . ++.+++++.+||++||..| |+.|+| +||||+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 284 HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 2222233211 111 1 1136789999999999987 999999 999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=287.21 Aligned_cols=180 Identities=24% Similarity=0.377 Sum_probs=154.9
Q ss_pred cEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
..+|+|||||+||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 5689999999999999999753 46999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
..... .......++..|+|||++....|. .++||||+||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus 414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 414 EDNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp CCHHH-HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCce-ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32111 112234577899999999877765 89999999999999999 99999998887777776554 3456778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+.+||.+||..||++|||+.++++.
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=279.28 Aligned_cols=179 Identities=23% Similarity=0.446 Sum_probs=143.9
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE----ecCCCEEEEec
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL----DSYGVLKISDF 76 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl----d~~~~lKl~DF 76 (361)
...+|+|||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 347899999999999999998643 39999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCccccccCCCcccccccccc--------CCCCCCchhhhhhhhHHHhHhcCCCCCCc----ccHHHHH
Q 018052 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLND--------KGYDGRASDVWSCGVILFVLMAGFLPFDE----SNLMALY 144 (361)
Q Consensus 77 Gla~~~~~~~~~~~~~~~~gt~~y~APEv~~~--------~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~----~~~~~~~ 144 (361)
|+|...... ......+||+.|+|||++.+ ..| +.++||||+||++|+|++|..||.. ....+..
T Consensus 161 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 161 GAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCceEccCC---CccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 999765432 23345789999999999864 233 4789999999999999999999964 2233444
Q ss_pred HHHhhcCCC-------------------CC------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRADFS-------------------CP------SWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~~~~-------------------~~------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.++..+... .| ..++..+.+||++||..||++|||+.+++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 444433211 11 1134577899999999999999999998664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=264.90 Aligned_cols=180 Identities=23% Similarity=0.386 Sum_probs=147.4
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 4789999999999999999876 469999999999999999999999999999999999999999999999999997654
Q ss_pred ccccC-CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH----------------HHHHH
Q 018052 84 QVRED-GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM----------------ALYRK 146 (361)
Q Consensus 84 ~~~~~-~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~----------------~~~~~ 146 (361)
..... .......+++.|+|||++.+..+. .++||||+|+++|+|++|..||...... .+...
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 32211 112334678889999999877665 8999999999999999999998653211 11112
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 147 ICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 147 i~~-~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.. ...+.|..+++++.+||.+||..||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 221 234556778999999999999999999999999986
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=229.77 Aligned_cols=131 Identities=45% Similarity=0.846 Sum_probs=119.0
Q ss_pred CCCCCChhhhhccCCCCCCccchhhhcccccccceeeeCCChhHHHHHHHHHhcccCcEEEecCceeEEeeccCCCCCce
Q 018052 227 KPVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQL 306 (361)
Q Consensus 227 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 306 (361)
.|..+|||++|++|++++||+||+..+..++|+|||+|..|++.|+++|+++++++||.|+++++++++++..++++|.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46679999999999999999999775555789999999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEEeCCeEEEEEEecCCCchhHHHHHHHHHhccccccccccchhH
Q 018052 307 SVATEVFEVAPTLHIVEVRKTGGDTLEFHKFYKKFSSGLKDVVWQAEENKE 357 (361)
Q Consensus 307 ~~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~~~l~~~l~div~~~~~~~~ 357 (361)
++.+|||+|+|+++||||+|++||++||+++|++|++.|+||||++.+..+
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999999999999999999998665533
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.73 Aligned_cols=184 Identities=28% Similarity=0.432 Sum_probs=148.3
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC---EEEEecC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG---RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV---LKISDFG 77 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~---lKl~DFG 77 (361)
....|+|||||+||+|.+++.... ++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 667899999999999999998754 6999999999999999999999999999999999999997775 9999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHH---------H-
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRK---------I- 147 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~---------i- 147 (361)
++..... .......+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+......+.. +
T Consensus 170 ~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred ccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9976533 2234557899999999999887775 899999999999999999999976533221100 0
Q ss_pred ----hhcCC------CCC----CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 148 ----CRADF------SCP----SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 148 ----~~~~~------~~~----~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+.. +.| ..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00111 111 125678999999999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=263.33 Aligned_cols=181 Identities=21% Similarity=0.393 Sum_probs=144.9
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEecCCCCCcEEEecCCCEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCH--------SRGVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH--------~~gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
..+|+||||++||+|.+++.. .++++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 379999999999999999976 57999999999999999999999 899999999999999999999999999
Q ss_pred CCcccccccccC--CccccccCCCccccccccccCCCC-----CCchhhhhhhhHHHhHhcC----------CCCCCcc-
Q 018052 77 GLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYD-----GRASDVWSCGVILFVLMAG----------FLPFDES- 138 (361)
Q Consensus 77 Gla~~~~~~~~~--~~~~~~~gt~~y~APEv~~~~~~~-----~~~~DiwS~Gvil~~ll~g----------~~Pf~~~- 138 (361)
|++......... ......+||+.|+|||++.+.... +.++||||+||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999765432211 023456899999999998765322 1579999999999999999 7898653
Q ss_pred ----cHHHHHHHHhhcCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 139 ----NLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 139 ----~~~~~~~~i~~~~~--~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
........+..... ..|.. .+..+.+||.+||..||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23344444433222 22221 23578899999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=278.71 Aligned_cols=167 Identities=27% Similarity=0.418 Sum_probs=136.2
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 86 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~ 86 (361)
+||||||++||+|.+++.. ++++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~-- 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-- 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC--
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc--
Confidence 7999999999999988765 79999999999999999999999999999999999999984 899999999875432
Q ss_pred cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 018052 87 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLI 166 (361)
Q Consensus 87 ~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~Li 166 (361)
....+||+.|+|||++.+. + +.++||||+||++|+|++|..||.+....... ........++.+.+||
T Consensus 234 ----~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 234 ----FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLL 301 (681)
T ss_dssp ----CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHH
T ss_pred ----CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHHH
Confidence 1456899999999998764 3 58999999999999999999998763211000 0000011367899999
Q ss_pred HHccCCCcCCCCCHHHHHhCcccc
Q 018052 167 KRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 167 ~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.+||..||.+||+..+.+.|+|+.
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999998875
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=209.04 Aligned_cols=120 Identities=23% Similarity=0.372 Sum_probs=105.5
Q ss_pred CCCCChhhhhccCCCCCCccchhhhcccccccceeeeCCChhHHHHHHHHHhcccCcEEEecCceeEEeeccCCCCCceE
Q 018052 228 PVSMNAFELISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGNYKMKLQGDKTGRKGQLS 307 (361)
Q Consensus 228 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (361)
|..+|||++|++|+++|||+||+.. ...+|+|||+|..|++.|+++|+++++++||+|++++++ ++..++++|.|+
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~-~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l~ 78 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDA-RKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNFA 78 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGG-CSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTEE
T ss_pred cccccHHHHHHHCcCCCchHhcCcc-cccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccEE
Confidence 5679999999999999999999763 224779999999999999999999999999999987775 666688899999
Q ss_pred EEEEEEEEeCCeEEEEEEecCCCchhHHHHH-HHHHhcccccccc
Q 018052 308 VATEVFEVAPTLHIVEVRKTGGDTLEFHKFY-KKFSSGLKDVVWQ 351 (361)
Q Consensus 308 ~~~~i~~~~~~~~~vdf~~~~Gd~le~~~~~-~~l~~~l~div~~ 351 (361)
+.+|||+|+|+++||||+|++||++||++|| ++|++.|+||||.
T Consensus 79 v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 79 MVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999976 6899999999995
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-31 Score=267.39 Aligned_cols=169 Identities=15% Similarity=0.171 Sum_probs=116.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++...+|||||||+||+|.++|...+++++. .++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 312 ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 312 ENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp ECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCee
Confidence 5788999999999999999999998889875 4789999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .....+.+||+.|+|||++.+. + ..++|+||+|++++.|.++..|+. ..+.. .|.. ...
T Consensus 389 ~~~~--~~~~~t~vGTp~YmAPE~l~g~-~-~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~ 451 (569)
T 4azs_A 389 TPQD--CSWPTNLVQSFFVFVNELFAEN-K-SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWN 451 (569)
T ss_dssp CC-----CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCS
T ss_pred CCCC--CccccCceechhhccHHHhCCC-C-CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCc
Confidence 5432 2345678999999999999764 3 367999999999998877644331 11111 1111 112
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+..+...++..+|..|+.......++|..
T Consensus 452 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 452 FVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 44566667777777777666665666543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=235.25 Aligned_cols=151 Identities=18% Similarity=0.176 Sum_probs=122.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+.+|+||||++||+|.+++... ..+.++..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 467899999999999999999643 5667889999999999999999999999999999999999999998554
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHH---HHhhcCCC----CC
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYR---KICRADFS----CP 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----~~ 155 (361)
|++| + +.++||||+||++|+|++|..||.+.+...... +....... .+
T Consensus 175 -----------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -----------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229 (286)
T ss_dssp -----------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred -----------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence 2332 3 489999999999999999999998754322110 11111111 22
Q ss_pred CCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 156 ~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+.+++++.+||.+||..||.+| |+.++++.
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 4589999999999999999999 99999874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-22 Score=203.11 Aligned_cols=122 Identities=23% Similarity=0.298 Sum_probs=101.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
.++.|+|||||+||+|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|....
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 3456999999999999999876 6789999999999999999999999999999999 99999999998764
Q ss_pred ccccCC-----ccccccCCCcccccccccc--CCCCCCchhhhhhhhHHHhHhcCCCCCC
Q 018052 84 QVREDG-----LLHTACGTPNYVAPEVLND--KGYDGRASDVWSCGVILFVLMAGFLPFD 136 (361)
Q Consensus 84 ~~~~~~-----~~~~~~gt~~y~APEv~~~--~~~~~~~~DiwS~Gvil~~ll~g~~Pf~ 136 (361)
...... ...+.+||+.|+|||++.. .+|. ..+|+||..+-..+-..++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 322111 1246789999999999976 5564 67899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.6e-18 Score=156.47 Aligned_cols=80 Identities=24% Similarity=0.326 Sum_probs=68.8
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
+..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|.+||+|||+|..
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~--- 241 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--- 241 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE---
T ss_pred cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---
Confidence 35699999999999987 42 134567999999999999999999999999999999 99999999999852
Q ss_pred cccCCccccccCCCccccccccc
Q 018052 85 VREDGLLHTACGTPNYVAPEVLN 107 (361)
Q Consensus 85 ~~~~~~~~~~~gt~~y~APEv~~ 107 (361)
+..|.|||++.
T Consensus 242 ------------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ------------VGEEGWREILE 252 (282)
T ss_dssp ------------TTSTTHHHHHH
T ss_pred ------------CCCCCHHHHHH
Confidence 44678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=3.2e-14 Score=129.79 Aligned_cols=71 Identities=23% Similarity=0.322 Sum_probs=59.8
Q ss_pred EEEEEEecCCC-C----ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 6 KIYIVLEFIDG-G----ELFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 6 ~~~lV~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH-~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
..||||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|||++. .++|+|||+|
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a 216 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQA 216 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccc
Confidence 35799999932 3 67665433 345678899999999999999 999999999999999998 8999999998
Q ss_pred cc
Q 018052 80 AI 81 (361)
Q Consensus 80 ~~ 81 (361)
..
T Consensus 217 ~~ 218 (258)
T 1zth_A 217 VT 218 (258)
T ss_dssp EE
T ss_pred cc
Confidence 64
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.28 E-value=2.5e-11 Score=97.06 Aligned_cols=87 Identities=17% Similarity=0.291 Sum_probs=77.6
Q ss_pred ceeeeCCChhHHHHHHHHHhcccCcEEEec-CceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHH
Q 018052 260 TRFTSQRPPNEIMSKIEEAAKPLGFNVRKG-NYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKF 337 (361)
Q Consensus 260 trf~s~~~~~~i~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~ 337 (361)
...+|+.+|++|+.+|++|++.+|+.++.+ .|.+.+....+..++.+.|.+||+++. +++++|+|+|.+||.+.|+++
T Consensus 31 v~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~l 110 (120)
T 3ose_A 31 MKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 110 (120)
T ss_dssp CCCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHH
T ss_pred ecCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHH
Confidence 355899999999999999999999999875 588888876555667899999999996 899999999999999999999
Q ss_pred HHHHHhccc
Q 018052 338 YKKFSSGLK 346 (361)
Q Consensus 338 ~~~l~~~l~ 346 (361)
|.+|...|+
T Consensus 111 c~~il~~L~ 119 (120)
T 3ose_A 111 ASKIANELK 119 (120)
T ss_dssp HHHHHHHCC
T ss_pred HHHHHHHhc
Confidence 999988775
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-12 Score=122.85 Aligned_cols=68 Identities=18% Similarity=0.206 Sum_probs=57.7
Q ss_pred EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCC----------EEEEecC
Q 018052 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGV----------LKISDFG 77 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~----------lKl~DFG 77 (361)
+|||||++|++|.... ..+.+..++.||+.+|.|||++||+||||||.|||++++|. +.|+||+
T Consensus 187 ~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~ 260 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFP 260 (397)
T ss_dssp EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCT
T ss_pred eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeC
Confidence 6999999999886532 22356788999999999999999999999999999988773 8999999
Q ss_pred Cccc
Q 018052 78 LSAI 81 (361)
Q Consensus 78 la~~ 81 (361)
-+..
T Consensus 261 Q~V~ 264 (397)
T 4gyi_A 261 QMVS 264 (397)
T ss_dssp TCEE
T ss_pred Cccc
Confidence 7653
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.95 E-value=1.1e-09 Score=87.50 Aligned_cols=85 Identities=14% Similarity=0.221 Sum_probs=75.7
Q ss_pred eeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEecCCCchhHHHHHH
Q 018052 262 FTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHKFYK 339 (361)
Q Consensus 262 f~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~~~~ 339 (361)
.+|+.+|++|+..|.++++.+|+.++. +.|.+.+....+..+..+.|.+||+++. .+++.|+|+|.+||.+.|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 578899999999999999999999986 6788888765444566899999999994 78999999999999999999999
Q ss_pred HHHhccc
Q 018052 340 KFSSGLK 346 (361)
Q Consensus 340 ~l~~~l~ 346 (361)
+|...|+
T Consensus 113 ~IL~eLk 119 (126)
T 1v5s_A 113 KIANELK 119 (126)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9999887
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=2.3e-08 Score=77.16 Aligned_cols=89 Identities=18% Similarity=0.324 Sum_probs=76.3
Q ss_pred ccceeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCC------
Q 018052 258 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGD------ 330 (361)
Q Consensus 258 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd------ 330 (361)
..-...|...|.+||..|.+|++.+|+.|+. +.|.+++....+.....+.|.+++|++.++.+|+||++..||
T Consensus 8 W~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 8 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred ceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 3456788899999999999999999999986 579999886644344568899999999999999999999994
Q ss_pred --chhHHHHHHHHHhccc
Q 018052 331 --TLEFHKFYKKFSSGLK 346 (361)
Q Consensus 331 --~le~~~~~~~l~~~l~ 346 (361)
.++|-.+|.++-..|.
T Consensus 88 ~~~~~F~d~ca~li~~la 105 (106)
T 4eai_A 88 SHTIEFFEMCANLIKILA 105 (106)
T ss_dssp CHHHHHHHHHHHHHHHCC
T ss_pred cCcEeHHHHHHHHHHHHh
Confidence 8999999998876664
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.4e-07 Score=77.18 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=63.9
Q ss_pred cccceeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 018052 257 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 333 (361)
Q Consensus 257 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 333 (361)
+..-...|..+|.+||..|.+|++.+|+.||+ +.|.++++...+.....+.|.+++|++.++.|||||++..||+.|
T Consensus 4 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 4 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 44566778889999999999999999999987 679999987654333468899999999999999999999999744
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=4.5e-09 Score=97.52 Aligned_cols=126 Identities=21% Similarity=0.261 Sum_probs=84.8
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS------------------------------------ 50 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~------------------------------------ 50 (361)
-|+|||+++|..|.+.... .++.++...++.|+...+..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp SCEEEECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ceEEEcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 3789999999998765443 48888889999999999999996
Q ss_pred ----------------------CCcEecCCCCCcEEEec--CCCEEEEecCCcccccccccCCcccccc--CCC------
Q 018052 51 ----------------------RGVFHRDLKPENLLLDS--YGVLKISDFGLSAISQQVREDGLLHTAC--GTP------ 98 (361)
Q Consensus 51 ----------------------~gi~HrDiKp~NiLld~--~~~lKl~DFGla~~~~~~~~~~~~~~~~--gt~------ 98 (361)
..++|+|++|.||+++. .+.+.|+||+.+........-....... ..+
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence 13699999999999998 5668999999886532110000000000 000
Q ss_pred ----cccc-ccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc
Q 018052 99 ----NYVA-PEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE 137 (361)
Q Consensus 99 ----~y~A-PEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~ 137 (361)
.+.. |+...... .-.+.|++|.++|.+.+|..+|-.
T Consensus 249 l~~Y~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHTCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHcCCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1111 22221111 125899999999999999887743
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.5e-07 Score=75.71 Aligned_cols=77 Identities=17% Similarity=0.313 Sum_probs=64.7
Q ss_pred cccceeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 018052 257 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 333 (361)
Q Consensus 257 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 333 (361)
+..-...|..+|.+||..|.+|++.+|+.|++ +.|.++++...+.....+.|.+++|++.++.|||||++..||+.|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 56677889999999999999999999999987 679999987644333468899999999999999999999999876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.4e-08 Score=87.00 Aligned_cols=72 Identities=18% Similarity=0.201 Sum_probs=58.4
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------------------------------- 50 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~--------------------------------- 50 (361)
....|+||||++|.+|.+.+. +......++.++..+|..||+
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred CCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 457899999999999877531 223345788999999999998
Q ss_pred --------------------------CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 --------------------------RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 --------------------------~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..++|+|++|.|||+++.+.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876666799999764
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.51 E-value=8.3e-07 Score=70.27 Aligned_cols=76 Identities=17% Similarity=0.328 Sum_probs=61.1
Q ss_pred ccceeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 018052 258 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 333 (361)
Q Consensus 258 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 333 (361)
..-...|...|.+||..|.+|++.+|+.|++ +.|.++++.........+.+.+++|++.++.+|+||++..||-.|
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~ 84 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVE 84 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-----
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhh
Confidence 3445677888999999999999999999987 579999987655445568899999999999999999999999543
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=3.5e-07 Score=74.09 Aligned_cols=90 Identities=16% Similarity=0.200 Sum_probs=74.4
Q ss_pred cccceeeeCCChhHHHHHHHHHhcccCcEEEec----------CceeEEeeccCCC-----CCceEEEEEEEEEeCCeEE
Q 018052 257 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----------NYKMKLQGDKTGR-----KGQLSVATEVFEVAPTLHI 321 (361)
Q Consensus 257 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~ 321 (361)
+..-...|..+|.+||..|.+|++.+|+.|++. .|.++++...+.. ...+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 566778888999999999999999999999864 4788887653321 2357899999999999999
Q ss_pred EEEEecCCC---------------c----hhHHHHHHHHHhccc
Q 018052 322 VEVRKTGGD---------------T----LEFHKFYKKFSSGLK 346 (361)
Q Consensus 322 vdf~~~~Gd---------------~----le~~~~~~~l~~~l~ 346 (361)
|||++..|+ . ++|-.+|.+|...|+
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence 999999999 5 899999988876664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.42 E-value=1.8e-07 Score=88.63 Aligned_cols=74 Identities=20% Similarity=0.466 Sum_probs=61.8
Q ss_pred EEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 018052 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS----------------------------------- 50 (361)
Q Consensus 6 ~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~----------------------------------- 50 (361)
..|+||||++|..+.+.. -..+++.+...++.++...|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 478999999998875422 1347888899999999999999997
Q ss_pred -----------------------CCcEecCCCCCcEEEecCCC--EEEEecCCccc
Q 018052 51 -----------------------RGVFHRDLKPENLLLDSYGV--LKISDFGLSAI 81 (361)
Q Consensus 51 -----------------------~gi~HrDiKp~NiLld~~~~--lKl~DFGla~~ 81 (361)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997764 69999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.39 E-value=1.2e-07 Score=84.87 Aligned_cols=69 Identities=17% Similarity=0.237 Sum_probs=53.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG------------------------------- 52 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g------------------------------- 52 (361)
....|+||||++|.+|. .. ..+ ...++.++...|..||+..
T Consensus 87 ~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 87 AGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 34679999999998884 11 122 2356677778888888643
Q ss_pred ---------------------------cEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 53 ---------------------------VFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 53 ---------------------------i~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999887667799999875
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.27 E-value=4.9e-06 Score=69.54 Aligned_cols=89 Identities=19% Similarity=0.247 Sum_probs=72.8
Q ss_pred cccceeeeCCChhHHHHHHHHHhcccCcEEEec----CceeEEeeccCC---------CCCceEEEEEEEEEeCCeEEEE
Q 018052 257 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKG----NYKMKLQGDKTG---------RKGQLSVATEVFEVAPTLHIVE 323 (361)
Q Consensus 257 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~vd 323 (361)
+..-...|...|.+||..|.+|++.+|+.|++. .|.++++...+. ....+.|.+++|++.++.||||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 445567889999999999999999999999873 788888864221 1234889999999999999999
Q ss_pred EEecCC----------------------CchhHHHHHHHHHhccc
Q 018052 324 VRKTGG----------------------DTLEFHKFYKKFSSGLK 346 (361)
Q Consensus 324 f~~~~G----------------------d~le~~~~~~~l~~~l~ 346 (361)
|+ ..| ....|-.+|.+|--.|.
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa 173 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA 173 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence 99 788 77899999988876664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00012 Score=64.11 Aligned_cols=121 Identities=16% Similarity=0.121 Sum_probs=78.8
Q ss_pred ChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcccccccccCCcccccc
Q 018052 18 ELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTAC 95 (361)
Q Consensus 18 ~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~ 95 (361)
+|.+.+.. +.+++|++|+.++.|.+.+|.-+-. +.-..+=+-|..|++..+|++-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 67887775 4589999999999999999877622 2212334457999999999988764 2110 1
Q ss_pred CCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHHHHHHHHHccCC
Q 018052 96 GTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDP 172 (361)
Q Consensus 96 gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~Li~~~L~~ 172 (361)
....+.|||... .-.+.+.=|||+|+++|.-+--..|- .-+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 233677888763 22246789999999999776422211 12345899999999999866
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=9.3e-05 Score=68.45 Aligned_cols=75 Identities=25% Similarity=0.301 Sum_probs=55.8
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR--------------------------------- 51 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~--------------------------------- 51 (361)
..-|+||||++|..|.+.... .+++.+...+..|+...|..||+.
T Consensus 86 g~~~~v~e~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 86 GNPFVGYRKVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp SCEEEEEECCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred CceEEEEeccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 346899999999888764322 356666666677777776666643
Q ss_pred ---------------------------CcEecCCCCCcEEEec---CCCE-EEEecCCccc
Q 018052 52 ---------------------------GVFHRDLKPENLLLDS---YGVL-KISDFGLSAI 81 (361)
Q Consensus 52 ---------------------------gi~HrDiKp~NiLld~---~~~l-Kl~DFGla~~ 81 (361)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2499999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00022 Score=64.08 Aligned_cols=75 Identities=21% Similarity=0.292 Sum_probs=56.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR------------------------------- 51 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~------------------------------- 51 (361)
+...-|+|||+++|.++.+..... ......+..++...|..||+.
T Consensus 91 ~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (272)
T 4gkh_A 91 TPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD 166 (272)
T ss_dssp ETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred ECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence 345779999999998887765542 223345666777777777741
Q ss_pred ---------------------------CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 ---------------------------GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 ---------------------------gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++|+|+.|.|||++..+.+-|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00029 Score=66.20 Aligned_cols=31 Identities=16% Similarity=0.328 Sum_probs=26.0
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
..++|+|+.|.|||+++.+.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644579999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0038 Score=57.67 Aligned_cols=30 Identities=20% Similarity=0.271 Sum_probs=27.2
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.012 Score=53.61 Aligned_cols=28 Identities=32% Similarity=0.336 Sum_probs=24.7
Q ss_pred cEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 53 VFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 53 i~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++|+|+.|.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 799999999999 6677899999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.011 Score=56.93 Aligned_cols=32 Identities=16% Similarity=0.293 Sum_probs=27.8
Q ss_pred HHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 49 HSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 49 H~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 345799999999999998877 99999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.22 E-value=0.021 Score=54.26 Aligned_cols=29 Identities=17% Similarity=0.242 Sum_probs=24.8
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..++|+|+.|.|||++.+ .++++||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 468999999999999875 48999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.47 E-value=0.031 Score=51.19 Aligned_cols=30 Identities=27% Similarity=0.412 Sum_probs=25.9
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999987666899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.10 E-value=0.036 Score=51.18 Aligned_cols=31 Identities=26% Similarity=0.332 Sum_probs=26.9
Q ss_pred CCcEecCCCCCcEEEecC----CCEEEEecCCccc
Q 018052 51 RGVFHRDLKPENLLLDSY----GVLKISDFGLSAI 81 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~----~~lKl~DFGla~~ 81 (361)
..++|+|+.|.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 7899999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.35 E-value=0.082 Score=48.43 Aligned_cols=28 Identities=18% Similarity=0.062 Sum_probs=24.2
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
..++|+|++|.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 3589999999999998 4 89999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.25 E-value=0.17 Score=47.31 Aligned_cols=29 Identities=28% Similarity=0.442 Sum_probs=24.5
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++|+|++|.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999998655 89999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.86 E-value=0.13 Score=47.87 Aligned_cols=30 Identities=20% Similarity=0.335 Sum_probs=27.0
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 589999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.12 E-value=0.18 Score=49.02 Aligned_cols=15 Identities=27% Similarity=0.337 Sum_probs=14.1
Q ss_pred CcEecCCCCCcEEEe
Q 018052 52 GVFHRDLKPENLLLD 66 (361)
Q Consensus 52 gi~HrDiKp~NiLld 66 (361)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=88.86 E-value=0.14 Score=49.29 Aligned_cols=30 Identities=30% Similarity=0.416 Sum_probs=24.5
Q ss_pred CcEecCCCCCcEEEecC----------------------------CCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSY----------------------------GVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~----------------------------~~lKl~DFGla~~ 81 (361)
.++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 6789999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=87.97 E-value=0.23 Score=47.11 Aligned_cols=30 Identities=33% Similarity=0.413 Sum_probs=26.7
Q ss_pred CcEecCCCCCcEEEecC----CCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSY----GVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~----~~lKl~DFGla~~ 81 (361)
.++|+|+.+.|||++.+ +.+.++||..|..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 7899999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.70 E-value=0.34 Score=46.07 Aligned_cols=29 Identities=31% Similarity=0.422 Sum_probs=25.5
Q ss_pred cEecCCCCCcEEE------ecCCCEEEEecCCccc
Q 018052 53 VFHRDLKPENLLL------DSYGVLKISDFGLSAI 81 (361)
Q Consensus 53 i~HrDiKp~NiLl------d~~~~lKl~DFGla~~ 81 (361)
++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.74 E-value=0.51 Score=45.37 Aligned_cols=29 Identities=34% Similarity=0.528 Sum_probs=26.2
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++|+|+.+.||+ +.++.+.++||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 8889999999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.88 E-value=1.6 Score=37.91 Aligned_cols=71 Identities=18% Similarity=0.096 Sum_probs=52.7
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHHCCcEecCCCCCcEEEecCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVD-YCHSRGVFHRDLKPENLLLDSYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~-~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGl 78 (361)
+.+.+.+.++.=+++-=+..+.. ++..+-++++.+|+.... ++ ..-+|--+.|+||++|.++.++|.=.|+
T Consensus 59 ~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 59 SEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp CSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEE
T ss_pred eCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCC
Confidence 45566666666555544556644 788888888888877555 33 4457888999999999999999987775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 361 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-49 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-24 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 6e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-11 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-66
Identities = 68/189 (35%), Positives = 107/189 (56%), Gaps = 5/189 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
T++Y++LE+ G ++ ++ K + E Y +L NA+ YCHS+ V HRD+KPEN
Sbjct: 77 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
LLL S G LKI+DFG S + T CGT +Y+ PE++ + +D D+WS G
Sbjct: 137 LLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLG 191
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
V+ + + G PF+ + Y++I R +F+ P + + GA+ LI R+L NP R + +
Sbjct: 192 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 251
Query: 183 MLEDEWFKK 191
+LE W
Sbjct: 252 VLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-63
Identities = 78/194 (40%), Positives = 108/194 (55%), Gaps = 3/194 (1%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
Y+ LE+ GGELFD+I + E +A+R+F QL+ V Y H G+ HRD+KPENL
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
LLD LKISDFGL+ + + + LL+ CGT YVAPE+L + + DVWSCG+
Sbjct: 135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194
Query: 124 ILFVLMAGFLPFD-ESNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTRMTI 180
+L ++AG LP+D S+ Y W S L+ +IL NP R+TI
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 254
Query: 181 SQMLEDEWFKKGYK 194
+ +D W+ K K
Sbjct: 255 PDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-59
Identities = 59/189 (31%), Positives = 103/189 (54%), Gaps = 1/189 (0%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K+Y L + GEL I K G E R Y ++++A++Y H +G+ HRDLKPEN
Sbjct: 79 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL+ ++I+DFG + + + ++ GT YV+PE+L +K ++SD+W+ G
Sbjct: 139 ILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALG 197
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
I++ L+AG PF N +++KI + ++ P F A+ L++++L + R+ +
Sbjct: 198 CIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 183 MLEDEWFKK 191
M K
Sbjct: 258 MEGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 190 bits (483), Expect = 4e-59
Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ T ++V + + GELFD + + L E E R+ + L+ + H + HRDLKPEN
Sbjct: 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL-----NDKGYDGRASD 117
+LLD +K++DFG S Q+ L CGTP+Y+APE++ ++ G+ D
Sbjct: 141 ILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW--FSSGAKKLIKRILDPN 173
+WS GVI++ L+AG PF M + R I + F P W +S K L+ R L
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 257
Query: 174 PDTRMTISQMLEDEWFKK 191
P R T + L +F++
Sbjct: 258 PQKRYTAEEALAHPFFQQ 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-58
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 10/202 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR-LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ ++I++EF GG + + + R L E + + +Q ++A++Y H + HRDLK
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAG 139
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGR----ASD 117
N+L G +K++DFG+SA + R + GTP ++APEV+ + R +D
Sbjct: 140 NILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197
Query: 118 VWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---FSCPSWFSSGAKKLIKRILDPNP 174
VWS G+ L + P E N M + KI +++ + PS +SS K +K+ L+ N
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNV 257
Query: 175 DTRMTISQMLEDEWFKKGYKPP 196
D R T SQ+L+ + P
Sbjct: 258 DARWTTSQLLQHPFVTVDSNKP 279
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-57
Identities = 65/196 (33%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR----LKEDEARRYFQQLINAVDYCHSRG-----V 53
+ T +YIV+E+ +GG+L I K + L E+ R QL A+ CH R V
Sbjct: 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRDLKP N+ LD +K+ DFGL+ I + GTP Y++PE +N Y+
Sbjct: 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN- 192
Query: 114 RASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDP 172
SD+WS G +L+ L A PF + L KI F P +S ++I R+L+
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 252
Query: 173 NPDTRMTISQMLEDEW 188
R ++ ++LE+
Sbjct: 253 KDYHRPSVEEILENPL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (469), Expect = 4e-56
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ ++ EF+ GGELF+K+A +H ++ EDEA Y +Q+ + + H H DLKPE
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 153
Query: 62 NLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ + LK+ DFGL+A + + GT + APEV K G +D+W
Sbjct: 154 NIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMW 209
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADF----SCPSWFSSGAKKLIKRILDPNPD 175
S GV+ ++L++G PF N R + D+ S S S K I+++L +P+
Sbjct: 210 SVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269
Query: 176 TRMTISQMLEDEWFKKGYKPPH 197
TRMTI Q LE W G P
Sbjct: 270 TRMTIHQALEHPWLTPGNAPGR 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-55
Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPE 61
K I +V E + G L + + +K R + +Q++ + + H+R + HRDLK +
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 62 NLLLDS-YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+ + G +KI D GL+ + GTP ++APE+ +K YD + DV++
Sbjct: 144 NIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYA 197
Query: 121 CGVILFVLMAGFLPFDES-NLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTR 177
G+ + + P+ E N +YR++ S K++I+ + N D R
Sbjct: 198 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
Query: 178 MTISQMLEDEWFK 190
+I +L +F+
Sbjct: 258 YSIKDLLNHAFFQ 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 5e-55
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 12/223 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ ++V+E+ G L+E E + + Y HS + HRD+K N
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL---NDKGYDGRASDVW 119
+LL G++K+ DFG ++I ++ GTP ++APEV+ ++ YDG+ DVW
Sbjct: 146 ILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVW 198
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSW--FSSGAKKLIKRILDPNPDTR 177
S G+ L P N M+ I + + +S + + L P R
Sbjct: 199 SLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 178 MTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 220
T +L+ + + P + D V + N +
Sbjct: 259 PTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 301
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (460), Expect = 9e-55
Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 34/283 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
K ++ ++LEF+ GGELFD+IA ++ E E Y +Q + + H + H D+KPE
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 156
Query: 62 NLLLDSY--GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ ++ +KI DFGL + ++ D ++ T + APE+++ + +D+W
Sbjct: 157 NIMCETKKASSVKIIDFGL---ATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMW 212
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP----SWFSSGAKKLIKRILDPNPD 175
+ GV+ +VL++G PF + + + + R D+ S S AK IK +L P
Sbjct: 213 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 272
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFE 235
R+T+ LE W K + +N ++ + + + P A
Sbjct: 273 KRLTVHDALEHPWLKGDHSNLTSRIPSSR--------YNKIRQKIKEKYADWPAPQPA-- 322
Query: 236 LISRTKSFSLENLFEKQTGLVKRETRFTSQRPPNEIMSKIEEA 278
I R +FS R+ R + + + +EA
Sbjct: 323 -IGRIANFSSL-----------RKHRPQEYQIYDSYFDR-KEA 352
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-54
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++++V+E++ GG L D + + E + ++ + A+++ HS V HRD+K +N
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LL G +K++DFG A Q E T GTP ++APEV+ K Y D+WS G
Sbjct: 147 ILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLG 203
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
++ ++ G P+ N + I + P S+ + + R LD + + R +
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263
Query: 180 ISQMLEDEWFKKGYKPPH 197
++L+ ++ K
Sbjct: 264 AKELLQHQFLKIAKPLSS 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 7e-54
Identities = 79/232 (34%), Positives = 120/232 (51%), Gaps = 17/232 (7%)
Query: 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
A + + IV+E +DGGELF +I G E EA + + A+ Y HS + HRD+K
Sbjct: 79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVK 138
Query: 60 PENLLLDSY---GVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRAS 116
PENLL S +LK++DFG +++ L T C TP YVAPEVL + YD ++
Sbjct: 139 PENLLYTSKRPNAILKLTDFG---FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 194
Query: 117 DVWSCGVILFVLMAGFLPFDESNLMALYRKI------CRADFSCPSW--FSSGAKKLIKR 168
D+WS GVI+++L+ G+ PF ++ +A+ + + +F P W S K LI+
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 169 ILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENL 220
+L P RMTI++ + W + K P L + + D KE +
Sbjct: 255 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (443), Expect = 1e-52
Identities = 86/244 (35%), Positives = 127/244 (52%), Gaps = 22/244 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S +Y++++ + GGELFD+I + G E +A R Q+++AV Y H G+ HRDLKPEN
Sbjct: 78 SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137
Query: 63 LLL---DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
LL D + ISDFGLS + +L TACGTP YVAPEVL K Y +A D W
Sbjct: 138 LLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCW 193
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRAD--FSCPSW--FSSGAKKLIKRILDPNPD 175
S GVI ++L+ G+ PF + N L+ +I +A+ F P W S AK I+ +++ +P+
Sbjct: 194 SIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 253
Query: 176 TRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFNDSKENLVTEKKEKPVSMNAFE 235
R T Q L+ W + + K+N K ++ + NA
Sbjct: 254 KRFTCEQALQHPWIAGDTALDKNIHQS---------VSEQIKKNFAKSKWKQ--AFNATA 302
Query: 236 LISR 239
++
Sbjct: 303 VVRH 306
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-52
Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 9/192 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ ++ IV ++ +G L+ + + + + +Q +DY H++ + HRDLK
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN--DKGYDGRASDVW 119
N+ L +KI DFGL+ + + G+ ++APEV+ DK SDV+
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADF------SCPSWFSSGAKKLIKRILDPN 173
+ G++L+ LM G LP+ N + + S K+L+ L
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253
Query: 174 PDTRMTISQMLE 185
D R Q+L
Sbjct: 254 RDERPLFPQILA 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-52
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
S ++ ++ EFI G ++F++I L E E Y Q+ A+ + HS + H D++PE
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 62 NLLLDS--YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
N++ + +KI +FG ++Q++ P Y APEV A+D+W
Sbjct: 132 NIIYQTRRSSTIKIIEFGQ---ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMW 187
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIKRILDPNPD 175
S G +++VL++G PF + I A+++ S A + R+L
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERK 247
Query: 176 TRMTISQMLEDEWFKKGYKPP 196
+RMT S+ L+ W K+ +
Sbjct: 248 SRMTASEALQHPWLKQKIERV 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 5e-52
Identities = 69/242 (28%), Positives = 118/242 (48%), Gaps = 28/242 (11%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+K ++ V+E+++GG+L I + A Y ++I + + HS+G+ +RDLK +N
Sbjct: 74 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +KI+DFG+ + D +T CGTP+Y+APE+L + Y+ + D WS G
Sbjct: 134 ILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFG 190
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMTI-S 181
V+L+ ++ G PF + L+ I + P W AK L+ ++ P+ R+ +
Sbjct: 191 VLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
Query: 182 QMLEDEWFK---------KGYKPP------------HFDKE---EEVNLDDVDAIFNDSK 217
+ + F+ K PP +FDKE E+ L D +S
Sbjct: 251 DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSM 310
Query: 218 EN 219
+
Sbjct: 311 DQ 312
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-51
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSR-GVFHRDLKPE 61
S +I I +E +DGG L + K GR+ E + +I + Y + + HRD+KP
Sbjct: 75 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+L++S G +K+ DFG+S D + ++ GT +Y++PE L Y SD+WS
Sbjct: 135 NILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSM 189
Query: 122 GVILFVLMAGFLPF---DESNLMALYRKICRADFS------------------------- 153
G+ L + G P D L ++ D +
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249
Query: 154 ----------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
FS + + + L NP R + Q++ + K+
Sbjct: 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-51
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 1 MASKTKIYIVLEFIDGG-ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
++LE + +LFD I + G L+E+ AR +F Q++ AV +CH+ GV HRD+K
Sbjct: 78 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK 137
Query: 60 PENLLLD-SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
EN+L+D + G LK+ DFG A+ +D + GT Y PE + Y GR++ V
Sbjct: 138 DENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 193
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
WS G++L+ ++ G +PF+ +I R SS + LI+ L P R
Sbjct: 194 WSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP 247
Query: 179 TISQMLEDEWFKKGYKPPHFDKEEEVNL 206
T ++ W + P + E++L
Sbjct: 248 TFEEIQNHPWMQDVLLPQ---ETAEIHL 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 1e-49
Identities = 69/269 (25%), Positives = 123/269 (45%), Gaps = 25/269 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+ K+ +L+ ++GG+L +++HG E + R Y ++I +++ H+R V +RDLKP N
Sbjct: 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 137
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD +G ++ISD GL+ H + GT Y+APEVL ++D +S G
Sbjct: 138 ILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 193
Query: 123 VILFVLMAGFLPFDESN---LMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
+LF L+ G PF + + R P FS + L++ +L + + R+
Sbjct: 194 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253
Query: 180 -----ISQMLEDEWFK---------KGYKPPHFDKEEEVNLDDVDAIFN----DSKENLV 221
++ E +F+ + Y PP EVN D I + D+K +
Sbjct: 254 CLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKL 313
Query: 222 TEKKEKPVSMNAFELISRTKSFSLENLFE 250
+ ++ + R + E +F+
Sbjct: 314 LDSDQELYRNFPLTISERWQQEVAETVFD 342
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-48
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+KT + ++LE + GGELFD +A+ L E+EA + +Q++N V Y HS + H DLKPEN
Sbjct: 84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143
Query: 63 LLLDSYGV----LKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDV 118
++L V +KI DFGL + ++ GTP +VAPE++N + +D+
Sbjct: 144 IMLLDRNVPKPRIKIIDFGL---AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADM 199
Query: 119 WSCGVILFVLMAGFLPFDESNLMALYRKICRADFS----CPSWFSSGAKKLIKRILDPNP 174
WS GVI ++L++G PF + ++ S S+ AK I+R+L +P
Sbjct: 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 175 DTRMTISQMLEDEWFK---------KGYKPPHFD 199
RMTI L+ W K + P F+
Sbjct: 260 KKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 1e-46
Identities = 68/194 (35%), Positives = 115/194 (59%), Gaps = 11/194 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+I++++++I+GGELF + K R A+ Y ++ A++Y HS+ + +RDLKPEN
Sbjct: 75 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLD G +KI+DFG + V +T CGTP+Y+APEV++ K Y+ ++ D WS G
Sbjct: 135 ILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFG 188
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM---- 178
++++ ++AG+ PF +SN M Y KI A+ P +F+ K L+ R++ + R+
Sbjct: 189 ILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
Query: 179 -TISQMLEDEWFKK 191
+ WFK+
Sbjct: 249 NGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 68/195 (34%), Positives = 109/195 (55%), Gaps = 8/195 (4%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ ++ V+E+ +GGELF +++ E+ AR Y ++++A++Y HSR V +RD+K
Sbjct: 74 FQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
ENL+LD G +KI+DFGL + + + + T CGTP Y+APEVL D Y RA D W
Sbjct: 134 ENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWG 190
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-- 178
GV+++ +M G LPF + L+ I + P S AK L+ +L +P R+
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
Query: 179 ---TISQMLEDEWFK 190
+++E +F
Sbjct: 251 GPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 10/187 (5%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K +YIV E++ G L D + GR L D ++ + A++Y HRDL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+L+ V K+SDFGL+ + + T + APE L +K + SDVWS
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS-TKSDVWS 185
Query: 121 CGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G++L+ + + G +P+ L + ++ + P +++K + R
Sbjct: 186 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 245
Query: 179 TISQMLE 185
+ Q+ E
Sbjct: 246 SFLQLRE 252
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-46
Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 8/192 (4%)
Query: 6 KIYIVLEFIDGGELFDKI-AKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ +V+E GG L + K + Q+ + Y + HRDL N+L
Sbjct: 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141
Query: 65 LDSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L + KISDFGLS A+ + APE +N + + R SDVWS GV
Sbjct: 142 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGV 200
Query: 124 ILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
++ ++ G P+ + + I + CP L+ + R
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFL 260
Query: 182 ---QMLEDEWFK 190
Q + ++
Sbjct: 261 TVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-46
Identities = 41/191 (21%), Positives = 75/191 (39%), Gaps = 7/191 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65
+V+E + G L + ++ +K+ Q+ + Y HRDL N+LL
Sbjct: 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140
Query: 66 DSYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ KISDFGLS A+ + APE +N + + SDVWS GV+
Sbjct: 141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVL 199
Query: 125 LFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ + G P+ + + + + CP+ L+ + + R +
Sbjct: 200 MWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259
Query: 183 ---MLEDEWFK 190
L + ++
Sbjct: 260 VELRLRNYYYD 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 7e-46
Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 6/189 (3%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
YIV+E++DG L D + G + A A+++ H G+ HRD+KP N+++
Sbjct: 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145
Query: 67 SYGVLKISDFGLSA-ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+ +K+ DFG++ I+ GT Y++PE D R SDV+S G +L
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVL 204
Query: 126 FVLMAGFLPFDESNLMALYRKICRADFSCPS----WFSSGAKKLIKRILDPNPDTRMTIS 181
+ ++ G PF + +++ + R D PS S+ ++ + L NP+ R +
Sbjct: 205 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 264
Query: 182 QMLEDEWFK 190
+ + +
Sbjct: 265 AEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (388), Expect = 3e-44
Identities = 75/243 (30%), Positives = 122/243 (50%), Gaps = 35/243 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V+E++ GGE+F + + GR E AR Y Q++ +Y HS + +RDLKPENLL+D
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILF 126
G ++++DFG + R G T CGTP +APE++ KGY+ +A D W+ GV+++
Sbjct: 176 QQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIY 229
Query: 127 VLMAGFLPFDESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM-----TIS 181
+ AG+ PF + +Y KI PS FSS K L++ +L + R ++
Sbjct: 230 EMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 182 QMLEDEWFK---------KGYKPP------------HFDKEEEVNLDDVDAIFNDSKENL 220
+ +WF + + P +FD EE +++ N+
Sbjct: 290 DIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEE---EEIRVSINEKCGKE 346
Query: 221 VTE 223
TE
Sbjct: 347 FTE 349
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 3e-43
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 30/223 (13%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
K+ I +V +F++ L + Y + ++Y H + HRDLKP
Sbjct: 69 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
NLLLD GVLK++DFGL+ + T Y APE+L G D+W+
Sbjct: 129 NNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCP------------------------- 155
G IL L+ + + +I +
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 246
Query: 156 ---SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195
S LI+ + NP R+T +Q L+ ++F P
Sbjct: 247 HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-43
Identities = 40/209 (19%), Positives = 80/209 (38%), Gaps = 27/209 (12%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKH-----------------------GRLKEDEARRYFQ 39
IY++ E+ G+L + + L ++ +
Sbjct: 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 171
Query: 40 QLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPN 99
Q+ +++ + HRDL N+L+ V+KI DFGL+ + A
Sbjct: 172 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 231
Query: 100 YVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPS 156
++APE L + Y SDVWS G++L+ + + G P+ + A + K+ + F P
Sbjct: 232 WMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF 290
Query: 157 WFSSGAKKLIKRILDPNPDTRMTISQMLE 185
+ + +++ + R + +
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 7e-43
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 6/185 (3%)
Query: 6 KIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ +V E G L D++ KH G RY Q+ + Y S+ HRDL NLL
Sbjct: 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHT-ACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L + ++KI DFGL Q + ++ + APE L + + ASD W GV
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGV 202
Query: 124 ILFVLMA-GFLPFDESNLMALYRKICRAD--FSCPSWFSSGAKKLIKRILDPNPDTRMTI 180
L+ + G P+ N + KI + P ++ + P+ R T
Sbjct: 203 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262
Query: 181 SQMLE 185
+ +
Sbjct: 263 VALRD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 8e-43
Identities = 47/227 (20%), Positives = 75/227 (33%), Gaps = 34/227 (14%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
K IY+V +F + + E +R Q L+N + Y H + HRD+K N
Sbjct: 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAAN 147
Query: 63 LLLDSYGVLKISDFGLSAISQQVRED--GLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
+L+ GVLK++DFGL+ + T Y PE+L + G D+W
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS------------------------ 156
G I+ + + I + S
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267
Query: 157 --------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195
A LI ++L +P R+ L ++F P
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-43
Identities = 61/246 (24%), Positives = 95/246 (38%), Gaps = 35/246 (14%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+Y+V + K+ K L D + Q++ + Y HS V HRDLKP NLLL+
Sbjct: 86 VYLVTHLMGAD--LYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 143
Query: 67 SYGVLKISDFGLS-AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
+ LKI DFGL+ G L T Y APE++ + ++ D+WS G IL
Sbjct: 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203
Query: 126 FVLMAGFLPFDESNLMALYRKI--------------------CRADFSCPSW-------- 157
+++ F + + I S P
Sbjct: 204 AEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 263
Query: 158 ---FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIFN 214
S A L+ ++L NP R+ + Q L + ++ Y P E D++ + +
Sbjct: 264 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDME-LDD 322
Query: 215 DSKENL 220
KE L
Sbjct: 323 LPKEKL 328
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-42
Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 9/198 (4%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
IYIV E++ G L D + L+ + Q+ + + Y HRDL+ N+
Sbjct: 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144
Query: 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGV 123
L+ V K++DFGL+ + + E A + APE + SDVWS G+
Sbjct: 145 LVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGI 202
Query: 124 ILF-VLMAGFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTIS 181
+L + G +P+ + ++ R CP L+ + P+ R T
Sbjct: 203 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 262
Query: 182 QMLE--DEWFKKGYKPPH 197
+ +++F +P +
Sbjct: 263 YLQAFLEDYF-TSTEPQY 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-41
Identities = 56/256 (21%), Positives = 95/256 (37%), Gaps = 40/256 (15%)
Query: 7 IYIVLEFIDGG---ELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+ +VL+++ L + Y QL ++ Y HS G+ HRD+KP+NL
Sbjct: 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 64 LLDSYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
LLD VLK+ DFG ++Q+ + + Y APE++ + DVWS G
Sbjct: 154 LLDPDTAVLKLCDFGS---AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFSCPSW------------------------- 157
+L L+ G F + + +I + +
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 158 ----FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFDKEEEVNLDDVDAIF 213
A L R+L+ P R+T + +F + P + N D A+F
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV----KLPNGRDTPALF 326
Query: 214 NDSKENLVTEKKEKPV 229
N + + L + +
Sbjct: 327 NFTTQELSSNPPLATI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-41
Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
T Y+V+ F+ G K+ KH +L ED + Q++ + Y H+ G+ HRDLKP NL
Sbjct: 96 TDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
++ LKI DFGL+ + D + T Y APEV+ + + D+WS G I
Sbjct: 154 VNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFSCPSWF-------------------------- 158
+ ++ G F S+ + ++I + + P+ F
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 159 -----SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP---PHFDKEEEVNLDDVD 210
S A L++++L + + R+T + L +F+ + P K ++ + DDVD
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDD-SFDDVD 327
Query: 211 AIFNDSKENLVTE 223
++ K E
Sbjct: 328 RTLDEWKRVTYKE 340
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-41
Identities = 44/193 (22%), Positives = 85/193 (44%), Gaps = 8/193 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
++ IYI+ E+++ G L D + +L ++ Q+ + + R HRDL+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N+L+ KI+DFGL+ + + E A + APE +N + + SDVWS
Sbjct: 138 ANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWS 195
Query: 121 CGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G++L ++ G +P+ + + + R P +L++ P+ R
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
Query: 179 TISQMLE--DEWF 189
T + +++F
Sbjct: 256 TFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-41
Identities = 43/187 (22%), Positives = 80/187 (42%), Gaps = 5/187 (2%)
Query: 3 SKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ I+I+ E++ G L + + R + + + + A++Y S+ HRDL
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 129
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N L++ GV+K+SDFGLS E + + PEVL + + SD+W+
Sbjct: 130 NCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAF 187
Query: 122 GVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
GV+++ + + G +P++ I + P S ++ D R T
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247
Query: 180 ISQMLED 186
+L +
Sbjct: 248 FKILLSN 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-40
Identities = 49/228 (21%), Positives = 85/228 (37%), Gaps = 24/228 (10%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDY 47
+ +Y+ +E+ G L D + K L + + + +DY
Sbjct: 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142
Query: 48 CHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLN 107
+ HRDL N+L+ V KI+DFGL S+ ++A E LN
Sbjct: 143 LSQKQFIHRDLAARNILVGENYVAKIADFGL---SRGQEVYVKKTMGRLPVRWMAIESLN 199
Query: 108 DKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKL 165
Y SDVWS GV+L+ ++ G P+ LY K+ + P L
Sbjct: 200 YSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDL 258
Query: 166 IKRILDPNPDTRMTISQMLE--DEWFKKGYKPPHFDKEEEVNLDDVDA 211
+++ P R + +Q+L + ++ + E+ +D
Sbjct: 259 MRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDC 306
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-40
Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 9/198 (4%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
++TK++++L++I+GGELF +++ R E E + Y +++ A+++ H G+ +RD+K EN
Sbjct: 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+LLDS G + ++DFGLS + V +A D WS G
Sbjct: 160 ILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219
Query: 123 VILFVLMAGFLPF----DESNLMALYRKICRADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
V+++ L+ G PF ++++ + R+I +++ P S+ AK LI+R+L +P R+
Sbjct: 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
Query: 179 -----TISQMLEDEWFKK 191
++ E +F+K
Sbjct: 280 GCGPRDADEIKEHLFFQK 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 3e-40
Identities = 43/189 (22%), Positives = 78/189 (41%), Gaps = 7/189 (3%)
Query: 3 SKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
T + I+ EF++ G L G+ + + + + Y HRDL
Sbjct: 98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTA---CGTPNYVAPEVLNDKGYDGRASDV 118
N+L++S V K+SDFGLS + D +A + APE + + + SDV
Sbjct: 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDV 216
Query: 119 WSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDT 176
WS G++++ +M+ G P+ + + I + P S +L+ + +
Sbjct: 217 WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276
Query: 177 RMTISQMLE 185
R Q++
Sbjct: 277 RPKFGQIVN 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (356), Expect = 3e-40
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 31/220 (14%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ +K ++ +V E +D G L+ A+ + QL+N + YCH R V HRDLKP
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
+NLL++ G LKI+DFGL+ T Y AP+VL D+WS
Sbjct: 129 QNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 121 CGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS------------------------ 156
G I ++ G F + +I R + S
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPW 246
Query: 157 -----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191
L+ ++L +P+ R+T Q LE +FK+
Sbjct: 247 ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-40
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 1 MASKTKIYIVLEFID-GGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLK 59
+ ++ K+Y+V EF+ + F + + + Y QL+ + +CHS V HRDLK
Sbjct: 70 IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 60 PENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVW 119
P+NLL+++ G +K++DFGL+ T Y APE+L Y A D+W
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 120 SCGVILFVLMAGFLPFDESNLMALYRKICRA------------------DFSCPSW---- 157
S G I ++ F + + +I R S P W
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 158 -------FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP-PH 197
+ L+ ++L +P+ R++ L +F+ KP PH
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 32/215 (14%)
Query: 4 KTKIYIVLEFIDGGEL-FDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
+TK+ +V E +D + + + + QL+ +D+ HS V HRDLKP+N
Sbjct: 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
+L+ S G +K++DFGL+ I + T Y APEVL Y D+WS G
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYA-TPVDLWSVG 202
Query: 123 VILFVLMAGFLPFDESNLMALYRKICRADFS---------------------------CP 155
I + F S+ + KI
Sbjct: 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 262
Query: 156 SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
+ K L+ + L NP R++ L +F+
Sbjct: 263 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 1e-39
Identities = 40/211 (18%), Positives = 71/211 (33%), Gaps = 27/211 (12%)
Query: 1 MASKTKIYIVLEFIDGGELFDKIAKHGR------------------------LKEDEARR 36
A + ++ E++ G+L + + L E
Sbjct: 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144
Query: 37 YFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACG 96
+Q+ + Y R HRDL N L+ V+KI+DFGLS
Sbjct: 145 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 204
Query: 97 TPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFL-PFDESNLMALYRKICRADF-SC 154
++ PE + Y SDVW+ GV+L+ + + L P+ + + + +C
Sbjct: 205 PIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC 263
Query: 155 PSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185
P L++ P R + +
Sbjct: 264 PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 37/184 (20%), Positives = 79/184 (42%), Gaps = 4/184 (2%)
Query: 6 KIYIVLEFIDGGELFDKIAKHGRLK-EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+ ++ + + G L D + +H + Q+ ++Y R + HRDL N+L
Sbjct: 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ + +KI+DFGL+ + ++ ++A E + + Y SDVWS GV
Sbjct: 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVT 202
Query: 125 LFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMTISQ 182
++ LM G P+D + + + + P + ++ + + D+R +
Sbjct: 203 VWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRE 262
Query: 183 MLED 186
++ +
Sbjct: 263 LIIE 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-39
Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 5/187 (2%)
Query: 3 SKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
++ ++I++E GEL + L Y QL A+ Y S+ HRD+
Sbjct: 78 TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 137
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N+L+ S +K+ DFGLS + ++APE +N + + ASDVW
Sbjct: 138 NVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMF 195
Query: 122 GVILF-VLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTRMT 179
GV ++ +LM G PF + +I + P L+ + +P R
Sbjct: 196 GVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPR 255
Query: 180 ISQMLED 186
+++
Sbjct: 256 FTELKAQ 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-39
Identities = 46/202 (22%), Positives = 84/202 (41%), Gaps = 19/202 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVD 46
+Y+++E+ G L + + +L + Q+ ++
Sbjct: 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGME 149
Query: 47 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 106
Y S+ HRDL N+L+ V+KI+DFGL+ + ++APE L
Sbjct: 150 YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209
Query: 107 NDKGYDGRASDVWSCGVILF-VLMAGFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKK 164
D+ Y + SDVWS GV+L+ + G P+ + L++ + PS ++
Sbjct: 210 FDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM 268
Query: 165 LIKRILDPNPDTRMTISQMLED 186
+++ P R T Q++ED
Sbjct: 269 MMRDCWHAVPSQRPTFKQLVED 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-38
Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 5/186 (2%)
Query: 3 SKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ I +V EF++ G L D + G + + + Y V HRDL
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 130
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSC 121
N L+ V+K+SDFG++ + + +PEV + Y SDVWS
Sbjct: 131 NCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSF 188
Query: 122 GVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMT 179
GV+++ + + G +P++ + + I P S+ +++ P+ R
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA 248
Query: 180 ISQMLE 185
S++L
Sbjct: 249 FSRLLR 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-37
Identities = 41/218 (18%), Positives = 74/218 (33%), Gaps = 21/218 (9%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+V+E + + Q+I+ ++Y HS+ HRD+KP+N
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134
Query: 64 LLDSYG---VLKISDFGLSAI-----SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRA 115
L+ ++ I DFGL+ + Q GT Y + R
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RR 193
Query: 116 SDVWSCGVILFVLMAGFLPFD---ESNLMALYRKICRADFSCP-----SWFSSGAKKLIK 167
D+ S G +L G LP+ + Y +I S P + S +
Sbjct: 194 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 253
Query: 168 RILDPNPDTRMT---ISQMLEDEWFKKGYKPPH-FDKE 201
D + + Q+ + + ++G+ + FD
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 6e-37
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 8/208 (3%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR--LKEDEARRYFQQLINAVDYCHSRGVFHRDLKP 60
+ YI+ EF+ G L D + + R + Q+ +A++Y + HRDL
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 143
Query: 61 ENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWS 120
N L+ ++K++DFGLS + A + APE L + SDVW+
Sbjct: 144 RNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWA 201
Query: 121 CGVILF-VLMAGFLPFDESNLMALYRKICR-ADFSCPSWFSSGAKKLIKRILDPNPDTRM 178
GV+L+ + G P+ +L +Y + + P +L++ NP R
Sbjct: 202 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 261
Query: 179 TISQMLEDEWFKKGYKPPHFDKEEEVNL 206
+ +++ + F+ ++ E E L
Sbjct: 262 SFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-37
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPEN 62
S K+ +V EF D + +G L + + + QL+ + +CHSR V HRDLKP+N
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131
Query: 63 LLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCG 122
LL++ G LK+++FGL+ T Y P+VL + D+WS G
Sbjct: 132 LLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 123 VILFVLMAGFLP-FDESNLMALYRKICRADFSCPS------------------------- 156
I L P F +++ ++I R +
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 157 ----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPP 196
++ + L++ +L NP R++ + L+ +F + PP
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD-FCPP 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-36
Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 20/202 (9%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGR----------------LKEDEARRYFQQLINAVD 46
+ +++EF G L + L + Y Q+ ++
Sbjct: 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 148
Query: 47 YCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVL 106
+ SR HRDL N+LL V+KI DFGL+ + + A ++APE +
Sbjct: 149 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208
Query: 107 NDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRAD--FSCPSWFSSGAK 163
D+ Y SDVWS GV+L+ + + P+ + + + + P + +
Sbjct: 209 FDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 267
Query: 164 KLIKRILDPNPDTRMTISQMLE 185
+ + P R T S+++E
Sbjct: 268 QTMLDCWHGEPSQRPTFSELVE 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-36
Identities = 44/212 (20%), Positives = 88/212 (41%), Gaps = 9/212 (4%)
Query: 3 SKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
S+ +VL ++ G+L + + + + Q+ + + S+ HRDL
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 159
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHT--ACGTPNYVAPEVLNDKGYDGRASDVW 119
N +LD +K++DFGL+ D + + A ++A E L + + SDVW
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVW 218
Query: 120 SCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILDPNPDTR 177
S GV+L+ LM G P+ + N + + + P + +++ + P + R
Sbjct: 219 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
Query: 178 MTISQMLED-EWFKKGYKPPHFDKEEE--VNL 206
+ S+++ + H+ VN+
Sbjct: 279 PSFSELVSRISAIFSTFIGEHYVHVNATYVNV 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-36
Identities = 52/233 (22%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS 67
+ L G + I K +L +D + Q++ + Y HS + HRDLKP NL ++
Sbjct: 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156
Query: 68 YGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFV 127
LKI DFGL+ + T Y APE++ + + + D+WS G I+
Sbjct: 157 DCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 128 LMAGFLPFDESNLMALYRKICRADFSCPSWF----------------------------- 158
L+ G F ++ + + I R + +
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 159 --SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP------PHFDKEEE 203
+ A L++++L + D R+T +Q L +F + + P +D+ E
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFE 324
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-36
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 22/204 (10%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINA 44
++ E+ G+L + + + L ++ + Q+
Sbjct: 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157
Query: 45 VDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPE 104
+ + S+ HRDL N+LL + KI DFGL+ + + A ++APE
Sbjct: 158 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
Query: 105 VLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADFS--CPSWFSSG 161
+ + SDVWS G+ L+ L + G P+ + + + K+ + F P +
Sbjct: 218 SIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 162 AKKLIKRILDPNPDTRMTISQMLE 185
++K D +P R T Q+++
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-36
Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 5/187 (2%)
Query: 3 SKTKIYIVLEFIDGGELFD-KIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPE 61
+ I+ E+++ G L K G + + + + Y + HRDL
Sbjct: 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 139
Query: 62 NLLLDSYGVLKISDFGLSAISQQVREDGLLHTA-CGTPNYVAPEVLNDKGYDGRASDVWS 120
N+L++S V K+SDFGLS + + E + + APE ++ + + ASDVWS
Sbjct: 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWS 198
Query: 121 CGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRM 178
G++++ +M G P+ E + + + I P S +L+ + R
Sbjct: 199 FGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP 258
Query: 179 TISQMLE 185
+ ++
Sbjct: 259 KFADIVS 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (324), Expect = 2e-35
Identities = 30/218 (13%), Positives = 65/218 (29%), Gaps = 23/218 (10%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63
+V++ + + +Q++ V H + + +RD+KP+N
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 64 LLDSY-----GVLKISDFGLSAI-----SQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
L+ ++ + DFG+ ++Q GT Y++ +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS- 191
Query: 114 RASDVWSCGVILFVLMAG---FLPFDESNLMALYRKICRADFSCPSW-----FSSGAKKL 165
R D+ + G + + G + + Y +I S P F K
Sbjct: 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKY 251
Query: 166 IKRILDPNPDTR---MTISQMLEDEWFKKGYKPPH-FD 199
+ + D + + + FD
Sbjct: 252 MHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-35
Identities = 38/214 (17%), Positives = 79/214 (36%), Gaps = 15/214 (7%)
Query: 4 KTKIYIVLEFIDGGELFDKIAKHGR----------LKEDEARRYFQQLINAVDYCHSRGV 53
+++E + G+L + + + ++ + + Y ++
Sbjct: 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF 154
Query: 54 FHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDG 113
HRDL N ++ +KI DFG++ + +++PE L D +
Sbjct: 155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 214
Query: 114 RASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRAD-FSCPSWFSSGAKKLIKRILD 171
SDVWS GV+L+ + P+ + + R + P +L++
Sbjct: 215 Y-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQ 273
Query: 172 PNPDTRMTISQMLE--DEWFKKGYKPPHFDKEEE 203
NP R + +++ E + G++ F EE
Sbjct: 274 YNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 1e-34
Identities = 43/223 (19%), Positives = 84/223 (37%), Gaps = 45/223 (20%)
Query: 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66
+V E ++ + L + + R Y +++ A+DYCHS G+ HRD+KP N+++D
Sbjct: 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163
Query: 67 SYG-VLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVIL 125
L++ D+GL+ + + + PE+L D + D+WS G +L
Sbjct: 164 HEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 126 FVLMAGFLPF----DESNLMALYRKICRADFSC--------------------------- 154
++ PF D + + K+ +
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 155 -------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190
S A + ++L + +R+T + +E +F
Sbjct: 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-34
Identities = 38/220 (17%), Positives = 91/220 (41%), Gaps = 38/220 (17%)
Query: 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------RGVF 54
+ T++++V ++ + G LFD + ++ + + + + + + H +
Sbjct: 72 TWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 55 HRDLKPENLLLDSYGVLKISDFGLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDK--- 109
HRDLK +N+L+ G I+D GL+ + D + GT Y+APEVL+D
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 110 --GYDGRASDVWSCGVILFVLMAGFLPFD---------------ESNLMALYRKIC--RA 150
+ +D+++ G++ + + + ++ + + +C +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 151 DFSCPSWFSS-----GAKKLIKRILDPNPDTRMTISQMLE 185
+ P+ + S K+++ N R+T ++ +
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-31
Identities = 54/265 (20%), Positives = 100/265 (37%), Gaps = 53/265 (20%)
Query: 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLL 64
+Y+V+E +D L + Q++ + + HS G+ HRDLKP N++
Sbjct: 95 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 65 LDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVI 124
+ S LKI DFGL+ + ++ T Y APEV+ GY D+WS G I
Sbjct: 152 VKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCI 207
Query: 125 LFVLMAGFLPFDESNLMALYRKICRADFSCPSWF-------------------------- 158
+ ++ + F + + + K+ + F
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
Query: 159 ----------------SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHFD--- 199
+S A+ L+ ++L +P R+++ L+ + Y P +
Sbjct: 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327
Query: 200 -KEEEVNLDDVDAIFNDSKENLVTE 223
+ + LD+ + + KE + E
Sbjct: 328 PQIYDKQLDEREHTIEEWKELIYKE 352
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.7 bits (247), Expect = 3e-24
Identities = 38/252 (15%), Positives = 77/252 (30%), Gaps = 54/252 (21%)
Query: 19 LFDKIAKHGRLKEDEARRYFQQLINAVDYCH-SRGVFHRDLKPENLLLDSYG-VLKISDF 76
K +H + ++ +QL+ +DY H G+ H D+KPEN+L++ +
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 77 GLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFD 136
++ + D + T Y +PEVL + +D+WS ++F L+ G F+
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE 230
Query: 137 ESNLMALY------------------------------------------------RKIC 148
+ +
Sbjct: 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL 290
Query: 149 RADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKPPHF---DKEEEVN 205
+ + + +L +P R ++ W K D+E +
Sbjct: 291 TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
Query: 206 LDDVDAIFNDSK 217
D+ F + +
Sbjct: 351 GSDIPGWFEEVR 362
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 87.1 bits (216), Expect = 6e-22
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 263 TSQRPPNEIMSKIEEAAKPLGFNVR-KGNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLH 320
TS P+++M +I + + + + + + + EV ++ +L+
Sbjct: 16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLN 75
Query: 321 IVEVRKTGGDTLEFHKFYKKFSSGLK 346
V ++ G ++ F K ++ LK
Sbjct: 76 GVRFKRISGTSIAFKNIASKIANELK 101
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.6 bits (141), Expect = 8e-11
Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 15/101 (14%)
Query: 31 EDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVREDGL 90
+ ++ V + RG+ H DL N+L+ G+ I DF S + +
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREI 160
Query: 91 LHTACGTPNYVAPEVLND---KGYDGRASDVWSCGVILFVL 128
L + + Y D+ S I +L
Sbjct: 161 LERDV--------RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.63 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.47 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.59 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.14 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 82.46 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-51 Score=372.22 Aligned_cols=186 Identities=37% Similarity=0.751 Sum_probs=173.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 76 ~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 76 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred EECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeee
Confidence 46789999999999999999999988999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+.+..+.+..+..|..+|++
T Consensus 156 ~~~----~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 230 (263)
T d2j4za1 156 APS----SRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 230 (263)
T ss_dssp CCC----CCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred cCC----CcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH
Confidence 432 234567899999999999988875 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+||.+||..||++|||++|+++||||+..
T Consensus 231 ~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 231 ARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999999999999999853
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=374.41 Aligned_cols=192 Identities=39% Similarity=0.700 Sum_probs=166.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|||||||+||+|++++...+.+++.+++.++.||+.||+|||++||+||||||+|||++++|.+||+|||+|..
T Consensus 73 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 73 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence 45788999999999999999999888999999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH-HHHHHHhhcCCCCC--CCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM-ALYRKICRADFSCP--SWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~ 158 (361)
...........+.+||+.|+|||++.+..|++.++||||+||++|+|++|.+||...+.. ..+..+.......+ ..+
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGS
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccC
Confidence 654444445567899999999999998888778899999999999999999999875543 33333333333222 347
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
|+++.+||.+||..||++|||++|+++||||++..
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 233 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 99999999999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=371.16 Aligned_cols=189 Identities=31% Similarity=0.623 Sum_probs=169.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|..
T Consensus 78 ~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 78 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEeccccccee
Confidence 46789999999999999999999989999999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
...........+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+++.++.+..+.+|..+|++
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 236 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 236 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHH
T ss_pred cccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHH
Confidence 6544444455678999999999999988875 899999999999999999999999999999999999998999999999
Q ss_pred HHHHHHHccCCCcCCCCCHHH------HHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQ------MLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~e------il~h~~f~~ 191 (361)
+.+||++||..||++|||++| +++||||+.
T Consensus 237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 999999999999999999987 578888864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=371.97 Aligned_cols=187 Identities=36% Similarity=0.691 Sum_probs=174.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|+|||||+||+|.+++.+.+.++|+.++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ......+.|||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+++..+......+|..+|++
T Consensus 155 ~~~--~~~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 231 (337)
T d1o6la_ 155 GIS--DGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231 (337)
T ss_dssp SCC--TTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccc--CCcccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH
Confidence 432 22345678999999999999998885 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
+.+||++||++||.+|++ ++|+++||||+.
T Consensus 232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 999999999999999994 999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=362.40 Aligned_cols=187 Identities=27% Similarity=0.522 Sum_probs=164.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|||||||+||+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..
T Consensus 87 ~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 87 LVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 457889999999999999998876 5799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc---CCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA---DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~ 158 (361)
.... .......+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+....+... ....|..+
T Consensus 166 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T d1yhwa1 166 ITPE--QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242 (293)
T ss_dssp CCST--TCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGS
T ss_pred eccc--cccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccC
Confidence 5432 2334567899999999999988775 8999999999999999999999988776665555443 33445678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
|+++++||.+||..||.+|||++|+|+||||+..
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-48 Score=360.37 Aligned_cols=187 Identities=41% Similarity=0.785 Sum_probs=157.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
.+.+.+|||||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++ ++|.+||+|||+
T Consensus 77 ~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 77 ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence 46789999999999999999999988999999999999999999999999999999999999994 578999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
|..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+.......+
T Consensus 157 a~~~~~---~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (307)
T d1a06a_ 157 SKMEDP---GSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTT
T ss_pred eEEccC---CCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcc
Confidence 975432 2345678999999999999988885 899999999999999999999999988888888887765443
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+.+|+++.+||.+||..||++|||++|+++||||+..
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 4589999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-47 Score=358.98 Aligned_cols=184 Identities=36% Similarity=0.773 Sum_probs=172.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++.+|+|||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 74 ~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 74 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceE
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+.+.++..+....|+.+|++
T Consensus 154 ~~~-----~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 227 (316)
T d1fota_ 154 VPD-----VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 227 (316)
T ss_dssp CSS-----CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ecc-----ccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHH
Confidence 532 23568999999999999988886 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.++|.+||..||.+|+ |++++++||||+.
T Consensus 228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 99999999999999996 9999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=357.72 Aligned_cols=188 Identities=32% Similarity=0.514 Sum_probs=163.7
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++.+|||||||+||+|.+++.+ .+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.
T Consensus 79 ~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 457899999999999999998765 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccc-----cCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLN-----DKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--- 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~-----~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 152 (361)
..... .....+.+||+.|+|||++. +.+| +.++||||+||++|+|++|..||.+.+..+.+.++.....
T Consensus 159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred ccCCC--cccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 54332 12345678999999999984 3344 4899999999999999999999999888888777776643
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
..|..+|+++.+||.+||+.||++|||++|+++||||+..
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3345689999999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=359.27 Aligned_cols=187 Identities=31% Similarity=0.644 Sum_probs=173.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|||||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhh
Confidence 46789999999999999999999989999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
.... .......+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+..+++.++....+.+|.++|++
T Consensus 153 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 229 (320)
T d1xjda_ 153 NMLG--DAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229 (320)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cccc--cccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHH
Confidence 4332 2334567899999999999998886 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCCCHH-HHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRMTIS-QMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~-eil~h~~f~~ 191 (361)
+.+||++||..||.+|||+. ++++||||+.
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999999995 8999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=352.23 Aligned_cols=184 Identities=35% Similarity=0.612 Sum_probs=153.0
Q ss_pred cCcEEEEEEecCCCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEecCCCCCcEEEecCCCEEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK----HGRLKEDEARRYFQQLINAVDYCHSRG-----VFHRDLKPENLLLDSYGVLKI 73 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~ql~~gl~~lH~~g-----i~HrDiKp~NiLld~~~~lKl 73 (361)
+...+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 35679999999999999998864 457999999999999999999999976 999999999999999999999
Q ss_pred EecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-
Q 018052 74 SDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF- 152 (361)
Q Consensus 74 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~- 152 (361)
+|||+|...... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+++.++..+.+
T Consensus 156 ~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~ 232 (269)
T d2java1 156 GDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232 (269)
T ss_dssp CCHHHHHHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred eeccceeecccC--CCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999765432 2234568999999999999887775 899999999999999999999999999898888887765
Q ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccc
Q 018052 153 SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWF 189 (361)
Q Consensus 153 ~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f 189 (361)
..|..+|+++.+||.+||..||.+|||++|+++|||+
T Consensus 233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4566799999999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=348.09 Aligned_cols=181 Identities=27% Similarity=0.538 Sum_probs=157.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCCCcEEEe-cCCCEEEEecCCcc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRG--VFHRDLKPENLLLD-SYGVLKISDFGLSA 80 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~g--i~HrDiKp~NiLld-~~~~lKl~DFGla~ 80 (361)
+..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|.
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 5679999999999999999998889999999999999999999999999 99999999999996 57899999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcc-cHHHHHHHHhhcCC--CCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDES-NLMALYRKICRADF--SCPSW 157 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~--~~~~~ 157 (361)
... .....+.+||+.|+|||++.+ +|+ .++||||+||++|+|++|..||.+. +...++..+..+.. ..+..
T Consensus 164 ~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 164 LKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred ecc----CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCcc
Confidence 533 233457799999999999875 464 8999999999999999999999764 45566666655432 23345
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
.++++.+||.+||..||++|||++|+++||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 789999999999999999999999999999996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-47 Score=361.60 Aligned_cols=186 Identities=30% Similarity=0.527 Sum_probs=164.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+.+|+|||||+||+|.++|...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 46789999999999999999999989999999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccH---HHHHHHHhhcCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNL---MALYRKICRADFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 158 (361)
... ......+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+. ..+...+.......|..+
T Consensus 157 ~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (364)
T d1omwa3 157 FSK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232 (364)
T ss_dssp CSS----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSS
T ss_pred cCC----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCC
Confidence 543 2345678999999999997655446899999999999999999999986543 344455555566777889
Q ss_pred CHHHHHHHHHccCCCcCCCCC-----HHHHHhCccccc
Q 018052 159 SSGAKKLIKRILDPNPDTRMT-----ISQMLEDEWFKK 191 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t-----~~eil~h~~f~~ 191 (361)
|+++.+||.+||..||++||| ++|+++||||+.
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999999999999999 799999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=358.88 Aligned_cols=184 Identities=35% Similarity=0.738 Sum_probs=171.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+||||+.||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 111 ~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 45678999999999999999999989999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCCHH
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFSSG 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~ 161 (361)
... ...+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||.+.+....+.++.......|..+|++
T Consensus 191 ~~~-----~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 264 (350)
T d1rdqe_ 191 VKG-----RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD 264 (350)
T ss_dssp CSS-----CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHH
T ss_pred ccc-----ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHH
Confidence 532 23567899999999999988885 899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 162 AKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
+.+||++||..||.+|+ |++++++||||+.
T Consensus 265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999999999995 9999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-47 Score=359.55 Aligned_cols=190 Identities=35% Similarity=0.642 Sum_probs=169.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld--~~~~lKl~DFGl 78 (361)
.+++++|||||||+||+|.+++.. .+++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 93 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 467899999999999999999964 46799999999999999999999999999999999999996 468899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
|..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 173 a~~~~~---~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 248 (350)
T d1koaa2 173 TAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248 (350)
T ss_dssp CEECCT---TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG
T ss_pred heeccc---ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 976542 3345678999999999999988885 8999999999999999999999999999999988887765543
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
.+|+++.+||.+||..||++|||++|+|+||||+....+
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 489999999999999999999999999999999976543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-46 Score=346.82 Aligned_cols=187 Identities=34% Similarity=0.623 Sum_probs=167.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.++.++|||||||+||+|.++|...+++++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 57789999999999999999999989999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccC-----CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK-----GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~-----~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 156 (361)
... .......+||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.+..+....+..+....+.
T Consensus 160 ~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 160 LDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 543 2234567899999999998632 22357999999999999999999999999988888888877654433
Q ss_pred ----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 157 ----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 157 ----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.+|+++.+||.+||++||.+|||++|+++||||++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-46 Score=352.97 Aligned_cols=185 Identities=25% Similarity=0.389 Sum_probs=163.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|+|||||.||+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 85 ~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 85 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence 35789999999999999988888888999999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccC---CCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC--CC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDK---GYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC--PS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~---~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~ 156 (361)
... ....+||+.|+|||++.+. .| +.++||||+||++|+|++|..||.+.+..+.+..+....... +.
T Consensus 165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 165 MAP------ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp SSS------BCCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred cCC------CCccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 432 3457899999999998642 34 479999999999999999999999988887777776664432 34
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.+|+++.+||.+||..||.+|||++|+++||||.+..
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 5899999999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-46 Score=358.83 Aligned_cols=188 Identities=31% Similarity=0.614 Sum_probs=169.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe--cCCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD--SYGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld--~~~~lKl~DFGl 78 (361)
+++.++|||||||+||+|++++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 96 ~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccc
Confidence 56789999999999999999877654 699999999999999999999999999999999999998 678999999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC---
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP--- 155 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 155 (361)
|..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.+..+.+..+....+.+|
T Consensus 176 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 176 ATKLNP---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251 (352)
T ss_dssp CEECCT---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred ceecCC---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 976543 3445678999999999999888775 899999999999999999999999999999888888776554
Q ss_pred -CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 156 -SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 156 -~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
+.+|+++.+||.+||..||.+|||++|+|+||||+...
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 35899999999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=356.99 Aligned_cols=185 Identities=29% Similarity=0.507 Sum_probs=154.2
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++++|+|||||+||+|.+++.+.+++++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|.
T Consensus 74 ~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 74 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 4678999999999999999999988899999999999999999999997 499999999999999999999999999998
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH----------------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALY---------------- 144 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~---------------- 144 (361)
.... ....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.....
T Consensus 154 ~~~~----~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 154 QLID----SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HHHH----HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred ccCC----CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 6533 223567999999999999988876 8999999999999999999999765422110
Q ss_pred --------------------------HHHhhcC-CCCC-CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 145 --------------------------RKICRAD-FSCP-SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 145 --------------------------~~i~~~~-~~~~-~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..+.... ...| ..+|.++.+||.+||..||.+|||++|+|+||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000 0111 125889999999999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=347.76 Aligned_cols=186 Identities=37% Similarity=0.639 Sum_probs=168.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC----CEEEEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG----VLKISDFG 77 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~----~lKl~DFG 77 (361)
++++++|||||||+||+|.++|...+++++..++.++.|++.||+|||++||+||||||+|||++.+| .+|++|||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence 57789999999999999999999888999999999999999999999999999999999999998777 49999999
Q ss_pred CcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCC--
Q 018052 78 LSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCP-- 155 (361)
Q Consensus 78 la~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 155 (361)
+|..... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..||.+.+..+.+..+.......+
T Consensus 163 ~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 163 LAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238 (293)
T ss_dssp TCEECTT---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred hhhhcCC---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 9976543 233456789999999999988766 4899999999999999999999999999998888888766554
Q ss_pred --CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 156 --SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 156 --~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
+.+|+++.+||++||..||++|||++|+++||||+.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 458999999999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=342.67 Aligned_cols=181 Identities=34% Similarity=0.607 Sum_probs=162.3
Q ss_pred CcCcEEEEEEecCCC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-CCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDG-GELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-YGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-~~~lKl~DFGla 79 (361)
++++.+|+||||+.| +++.+++...+.+++++++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence 467899999999986 688899988889999999999999999999999999999999999999995 479999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPSWFS 159 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s 159 (361)
..... ....+.+||+.|+|||++.+..|++.++||||+||++|+|++|..||.+.+ .+..+...+++.+|
T Consensus 159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s 228 (273)
T d1xwsa_ 159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 228 (273)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCC
Confidence 75432 334578899999999999888887788999999999999999999998743 35567777888999
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
+++.+||++||..||++|||++|+++||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=352.47 Aligned_cols=188 Identities=38% Similarity=0.710 Sum_probs=159.5
Q ss_pred CcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec---CCCEEEEecCC
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS---YGVLKISDFGL 78 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~---~~~lKl~DFGl 78 (361)
+.++|||||||+||+|+++|... .++++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 56799999999999999999874 36999999999999999999999999999999999999985 56799999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHH----HHHHhhcCCCC
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMAL----YRKICRADFSC 154 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~ 154 (361)
|..... .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+.... ...+....+.+
T Consensus 161 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 161 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred eeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 976543 2334677999999999999988886 899999999999999999999987654333 33344445555
Q ss_pred CC----CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 155 PS----WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 155 ~~----~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
|. .+|+++.+||++||..||++|||+.|+++||||++....
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 43 379999999999999999999999999999999876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=346.17 Aligned_cols=191 Identities=27% Similarity=0.355 Sum_probs=162.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+++++|||||||.||++...+...+.+++.+++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 70 ~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 70 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccc
Confidence 46778999999999988887777777899999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCC--------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFS-------- 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-------- 153 (361)
.... .....+.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+.+.++.+....
T Consensus 150 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCC--cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 4432 233456789999999999876666668999999999999999999999998877777665432100
Q ss_pred ------------C--------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 154 ------------C--------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 154 ------------~--------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
. .+.+++++.+||.+||..||++|||++|+|+||||+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 0 1235789999999999999999999999999999986543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=348.31 Aligned_cols=187 Identities=28% Similarity=0.539 Sum_probs=168.6
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec--CCCEEEEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS--YGVLKISDFGL 78 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~--~~~lKl~DFGl 78 (361)
++++++|||||||+||+|+++|...+ ++++++++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+
T Consensus 71 ~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence 56789999999999999999998765 7999999999999999999999999999999999999985 45899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC--
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS-- 156 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-- 156 (361)
+..... .....+.+||+.|+|||++.+..|. .++||||+||++|+|++|..||.+.+..+.+..+.+..+.+|.
T Consensus 151 ~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T d1tkia_ 151 ARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CEECCT---TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred hhcccc---CCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh
Confidence 976432 2345667899999999999887775 8999999999999999999999999999999999888777654
Q ss_pred --CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 157 --WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 157 --~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.+|+++.+||.+||..||++|||++|+++||||++.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 589999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=340.39 Aligned_cols=184 Identities=21% Similarity=0.340 Sum_probs=159.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG-----------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDL 58 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDi 58 (361)
.+.+.+|+|||||+||+|.++|.... .+++..++.++.|++.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 45678999999999999999997642 4899999999999999999999999999999
Q ss_pred CCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCc
Q 018052 59 KPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDE 137 (361)
Q Consensus 59 Kp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~ 137 (361)
||+|||++.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999865544333334567889999999999887775 89999999999999997 8999988
Q ss_pred ccHHHHHHHHhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 138 SNLMALYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 138 ~~~~~~~~~i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+....+.++... ....|.++|+++.+||.+||+.||++|||++||++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7665555555444 345677899999999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=330.34 Aligned_cols=185 Identities=29% Similarity=0.388 Sum_probs=158.1
Q ss_pred cCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
...++|++||||.||.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 45689999999998877654443 45799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD---------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------- 151 (361)
... .....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+.+..+....
T Consensus 166 ~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 166 YSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 433 2335678899999999999988886 89999999999999999999999988777766654210
Q ss_pred -----------------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 -----------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 -----------------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+..+++.+.+||.+||..||++|||++|+|+||||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0122347899999999999999999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=330.39 Aligned_cols=184 Identities=25% Similarity=0.412 Sum_probs=148.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+|||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 74 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 74 TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp CSSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred eccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 456789999999999999999764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCccccccCCCccccccccccCC--CCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHH-HHHhhcCC-----C
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG--YDGRASDVWSCGVILFVLMAGFLPFDESNLMALY-RKICRADF-----S 153 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~--~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~-~~i~~~~~-----~ 153 (361)
...........+.+||+.|+|||++.... .++.++||||+||++|+|++|..||.+.+..... ..+..+.. .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh
Confidence 65443344456778999999999986432 2358999999999999999999999886654433 33333321 2
Q ss_pred CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 154 CPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 154 ~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+++++.+||.+||..||++|||+.+++++
T Consensus 234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 345689999999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=330.07 Aligned_cols=192 Identities=28% Similarity=0.446 Sum_probs=159.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAK-HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++++|+|||||.|+.+...... .+++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|.
T Consensus 71 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 71 HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence 467899999999976544333333 4579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcC---------
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRAD--------- 151 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------- 151 (361)
.... ........+||+.|+|||++....+.+.++||||+||++|+|++|..||.+.+..+...++....
T Consensus 151 ~~~~--~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 151 AFGV--PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp HHCC--CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred eccC--CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc
Confidence 5433 22345567899999999999888888899999999999999999999999887766655543210
Q ss_pred ---------CCCC-----------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCCC
Q 018052 152 ---------FSCP-----------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYKP 195 (361)
Q Consensus 152 ---------~~~~-----------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 195 (361)
...+ +.+|+++.+||++||..||++|||++|+++||||++-..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0011 1357899999999999999999999999999999876554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=327.55 Aligned_cols=185 Identities=22% Similarity=0.346 Sum_probs=159.9
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
+..|||||||+||+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 45799999999999999999988999999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCHH
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSSG 161 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 161 (361)
... ........||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+.+..++...+..+ ..+.|..+|++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 238 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 238 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 221 1122345799999999999887775 89999999999999997 89999998888888777665 45677889999
Q ss_pred HHHHHHHccCCCcCCCCCHHHH---HhCcccc
Q 018052 162 AKKLIKRILDPNPDTRMTISQM---LEDEWFK 190 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~ei---l~h~~f~ 190 (361)
+.+||.+||..||++|||+++| |+|+|+.
T Consensus 239 ~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999999998 4566653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=328.58 Aligned_cols=183 Identities=25% Similarity=0.380 Sum_probs=150.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
....+|+|||||+||+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 4567899999999999999997542 489999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHH-
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALY- 144 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~- 144 (361)
+++++||+|||+|.............+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+..+.+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999765544333344567899999999999887775 899999999999999986 5788776544333
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
..+..+ ....|..+++++.+||.+||..||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333333 456677899999999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=327.33 Aligned_cols=192 Identities=24% Similarity=0.316 Sum_probs=156.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
++.++|+|||||.++.+.........+++..++.+++|++.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 35679999999998777766666678999999999999999999999999999999999999999999999999999765
Q ss_pred cccc--cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCCCC----
Q 018052 83 QQVR--EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSCPS---- 156 (361)
Q Consensus 83 ~~~~--~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~---- 156 (361)
.... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......+.......++
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4322 1223455789999999999887655568999999999999999999999987776665554332111110
Q ss_pred ----------------------------CCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 157 ----------------------------WFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 157 ----------------------------~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
..++++.+||.+||..||++|||++|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 02677889999999999999999999999999996543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.8e-43 Score=324.26 Aligned_cols=188 Identities=31% Similarity=0.443 Sum_probs=157.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+++|++|||+.|+.+..+....+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|..
T Consensus 70 ~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp ECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccccee
Confidence 45678999999999888877777788999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC---------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF--------- 152 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------- 152 (361)
.... ........||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+..+.+.++.....
T Consensus 150 ~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 150 FGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccC--ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 5332 22234567999999999998877777999999999999999999999998877766655432100
Q ss_pred --------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 153 --------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 153 --------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
..++.+++++.+||++||..||++|||+.|+++||||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=324.68 Aligned_cols=185 Identities=22% Similarity=0.335 Sum_probs=161.4
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
+.+|+|||||+||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 4689999999999999998654 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 84 QVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 84 ~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.... .......+||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+.+..++...+..+ ....|+.+|+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 3221 1223456799999999999887775 89999999999999998 99999998888888777665 3567788999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHH---HhCcccc
Q 018052 161 GAKKLIKRILDPNPDTRMTISQM---LEDEWFK 190 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~ei---l~h~~f~ 190 (361)
++.+||.+||..||++|||+.+| |+|+|+.
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999888 6778875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=328.37 Aligned_cols=187 Identities=26% Similarity=0.365 Sum_probs=154.2
Q ss_pred cCcEEEEEEecCCCCChH---HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELF---DKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~---~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGl 78 (361)
+..++|||||||.+|.+. .+......+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence 345789999999876332 2334556899999999999999999999999999999999999999775 899999999
Q ss_pred cccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc--------
Q 018052 79 SAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA-------- 150 (361)
Q Consensus 79 a~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------- 150 (361)
|..... .....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..||...+..+.+..+.+.
T Consensus 170 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 170 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 876533 233456789999999999877666679999999999999999999999987776665554321
Q ss_pred ---------CCC------------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 151 ---------DFS------------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 151 ---------~~~------------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
... ..+.+++++.+||.+||..||++|||+.|+|+||||+.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 011 123468999999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=324.31 Aligned_cols=189 Identities=33% Similarity=0.600 Sum_probs=164.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++..+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCC-CCCCchhhhhhhhHHHhHhcCCCCCCcccH----HHHHHHHhhcCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKG-YDGRASDVWSCGVILFVLMAGFLPFDESNL----MALYRKICRADFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~-~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~ 156 (361)
.... ......+.+||+.|+|||.+.+.. +++.++||||+||+||+|++|..||.+.+. ..+...........|.
T Consensus 179 ~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 179 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 5432 223355678999999999987654 345799999999999999999999977543 3444445556677788
Q ss_pred CCCHHHHHHHHHccCCCcCCCC-----CHHHHHhCccccc
Q 018052 157 WFSSGAKKLIKRILDPNPDTRM-----TISQMLEDEWFKK 191 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~-----t~~eil~h~~f~~ 191 (361)
.+|+++.+||.+||.+||.+|| |++|+++||||+.
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 8999999999999999999999 5899999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-42 Score=321.51 Aligned_cols=183 Identities=23% Similarity=0.378 Sum_probs=149.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 467899999999999999988874 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCC---ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCC
Q 018052 82 SQQVREDG---LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPS 156 (361)
Q Consensus 82 ~~~~~~~~---~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~ 156 (361)
........ ......||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+.+..++...+..+ ..+.|.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 256 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 54322211 11234689999999999887775 89999999999999998 89999998888888877655 345667
Q ss_pred CCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 157 WFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 157 ~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+++++.+||.+||..||++|||+.|++++
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 789999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-42 Score=318.15 Aligned_cols=185 Identities=24% Similarity=0.451 Sum_probs=151.3
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|+|||||+||+|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||++.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 35899999999999999999989999999999999999999999999999999999999999999999999999865433
Q ss_pred cc-cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC----CCCCC
Q 018052 85 VR-EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC----PSWFS 159 (361)
Q Consensus 85 ~~-~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s 159 (361)
.. ......+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++....... ++.+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 22 22234567899999999999887775 89999999999999999999999988888877776655433 24589
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhCcccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLEDEWFK 190 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~ 190 (361)
+++.+||.+||.+||.+||+..+.+.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999544455677764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=318.60 Aligned_cols=186 Identities=23% Similarity=0.400 Sum_probs=159.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+.+|+|||||++|+|.+++.... ++++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+|..
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 456899999999999999776433 699999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
..... ........||+.|+|||++.+..|+ .++||||+||++|+|++| .+||...+..+....+..+ ....|..++
T Consensus 159 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (272)
T d1qpca_ 159 IEDNE-YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (272)
T ss_dssp CSSSC-EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCc-cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence 54321 1223456799999999999877775 899999999999999995 6667777777777777664 455677899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh--Cccccc
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE--DEWFKK 191 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~--h~~f~~ 191 (361)
+++.+||.+||..||++|||++++++ |+||+.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999999999988 788864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=313.88 Aligned_cols=182 Identities=23% Similarity=0.418 Sum_probs=149.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+++.+|+|||||++|+|.+++... ..++++.+..++.|++.||+|||++||+||||||+|||+|+++++||+|||+|..
T Consensus 71 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred cCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence 467899999999999999998765 4689999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCCC
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWFS 159 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 159 (361)
...... .......||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||...+..+.+..+..+ ....|..++
T Consensus 151 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 228 (263)
T d1sm2a_ 151 VLDDQY-TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred ccCCCc-eeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccC
Confidence 543221 223456799999999999988876 89999999999999998 57888888888888777665 345567789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++.+||.+||..||++|||++|+++|
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=320.43 Aligned_cols=188 Identities=28% Similarity=0.485 Sum_probs=153.9
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQ 84 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~ 84 (361)
..+|++|+ +.||+|++++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 84 ~~~~l~~~-~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 84 KDVYLVTH-LMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCEEEEEE-CCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEe-ecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 34566655 558999999976 4799999999999999999999999999999999999999999999999999976543
Q ss_pred ccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-------------
Q 018052 85 VRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA------------- 150 (361)
Q Consensus 85 ~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------- 150 (361)
... .......+||+.|+|||++....+++.++||||+||++|+|++|..||.+.+..+........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 322 223456789999999999876666679999999999999999999999887655444332110
Q ss_pred ------------CCC------CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 151 ------------DFS------CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 151 ------------~~~------~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
... ..+.+|+++.+||.+||..||.+|||++|+|+||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000 12346889999999999999999999999999999986544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=321.83 Aligned_cols=182 Identities=29% Similarity=0.442 Sum_probs=154.7
Q ss_pred CcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..++|+||||| |++|...+. .+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 44789999999 667777665 4689999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCC-----------
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADF----------- 152 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----------- 152 (361)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+....+..+.....
T Consensus 173 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2345678999999999998877777999999999999999999999998776655443322110
Q ss_pred --------------------CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccC
Q 018052 153 --------------------SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKG 192 (361)
Q Consensus 153 --------------------~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~ 192 (361)
.....+++++.+||.+||..||++|||++|+|+||||+.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1123478999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-41 Score=314.32 Aligned_cols=182 Identities=23% Similarity=0.367 Sum_probs=154.8
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH--GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
.+.+.+|+|||||++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence 3567899999999999999999764 46899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCC-CCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGF-LPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~-~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
....... ........||+.|+|||++.+..|+ .++||||+||++|+|++|. +||.+.+...++..+..+ ....|..
T Consensus 163 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (287)
T d1opja_ 163 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 240 (287)
T ss_dssp TTCCSSS-SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred eecCCCC-ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence 7654321 1222345689999999999888875 8999999999999999965 455666666666655443 4566778
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+|+++.+||.+||..||++|||++++++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=313.20 Aligned_cols=181 Identities=24% Similarity=0.374 Sum_probs=149.0
Q ss_pred CcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|...
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 46789999999999999987654 57999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~ 160 (361)
.... .......+||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||.+.+..+++..+..+. .+.|+.+|+
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 4321 2233456789999999999887776 89999999999999987 899999988888888877664 567788999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++.+||.+||..||++|||+.||++|
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=312.55 Aligned_cols=183 Identities=25% Similarity=0.431 Sum_probs=163.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG----------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLL 65 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLl 65 (361)
.++..+|+|||||+||+|.++|.... .+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 35677999999999999999997543 48999999999999999999999999999999999999
Q ss_pred ecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHH
Q 018052 66 DSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALY 144 (361)
Q Consensus 66 d~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~ 144 (361)
+.+|.+||+|||++...............+||+.|+|||++.+..|+ .++||||+||++|+|++ |.+||.+.+..+++
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999877655444445667899999999999888875 89999999999999998 79999998888888
Q ss_pred HHHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 145 RKICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 145 ~~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
..+..+ .+..|.++++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 777654 45677889999999999999999999999999987
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=305.99 Aligned_cols=183 Identities=23% Similarity=0.409 Sum_probs=161.3
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.+++.+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 69 ~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp CCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred eeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhe
Confidence 4567899999999999999987654 579999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 81 ISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...... .......+||+.|+|||++.+..|+ .++||||+||++|+|+| |..||.+.+..++..++..+ ....|...
T Consensus 149 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 149 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp BCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred eccCCC-ceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 654322 2223346799999999999988886 89999999999999998 89999999988888888765 34566778
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++++.+||.+||+.||++|||+++|++|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=307.56 Aligned_cols=188 Identities=27% Similarity=0.441 Sum_probs=159.0
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
.+...+|+|||++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|..
T Consensus 71 ~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 71 HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp ECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhc
Confidence 45778999999999999999999888999999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCC-CcccHHHHHHHHhhcC---------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPF-DESNLMALYRKICRAD--------- 151 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~--------- 151 (361)
.... ........+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+.+.++....
T Consensus 151 ~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 151 FGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccCC--CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 5432 223344568899999999988777679999999999999999999885 5555555555543210
Q ss_pred --------------------CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 152 --------------------FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 152 --------------------~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
...+..+++.+.+||++||..||++|||++|+|+||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0112336889999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-41 Score=317.04 Aligned_cols=182 Identities=26% Similarity=0.367 Sum_probs=151.0
Q ss_pred EEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccccccc
Q 018052 7 IYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQQVR 86 (361)
Q Consensus 7 ~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~~~~ 86 (361)
.++||+|+.||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 3455666779999998864 5799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhcCCCC------------
Q 018052 87 EDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRADFSC------------ 154 (361)
Q Consensus 87 ~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 154 (361)
...+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 34567899999999998887777899999999999999999999999887766655543321110
Q ss_pred -------------------CCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCCC
Q 018052 155 -------------------PSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGYK 194 (361)
Q Consensus 155 -------------------~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 194 (361)
...+++++.+||++||..||.+|||+.|+|+||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1236899999999999999999999999999999986543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-40 Score=312.84 Aligned_cols=183 Identities=23% Similarity=0.435 Sum_probs=148.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCC-CEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYG-VLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~-~lKl~DFGla~~ 81 (361)
....+|+|||||.+|+|.... +++++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 346799999999999997653 4699999999999999999999999999999999999999765 599999999976
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc-HHHHHHHHh------------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN-LMALYRKIC------------ 148 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~-~~~~~~~i~------------ 148 (361)
... .......+||+.|+|||++.+...++.++||||+||++|+|++|..||.... ..+....+.
T Consensus 180 ~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHP---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCT---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ccC---CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 543 2334567899999999998877666699999999999999999999996533 222111110
Q ss_pred -hcCC----------------------C--CCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhCccccc
Q 018052 149 -RADF----------------------S--CPSWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKK 191 (361)
Q Consensus 149 -~~~~----------------------~--~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~ 191 (361)
.... . ....+|+++.+||++||..||++|||++|+|+||||+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000 0 01126889999999999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=312.49 Aligned_cols=182 Identities=20% Similarity=0.359 Sum_probs=155.7
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
...+++|||+.+|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 4578999999999999988765 579999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcC-CCCCCCCCHH
Q 018052 84 QVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRAD-FSCPSWFSSG 161 (361)
Q Consensus 84 ~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 161 (361)
............||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||.+.+..++...+..+. .+.|+.++++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 241 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred cccccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence 43333333445789999999999888775 89999999999999998 899999888777777766654 5667789999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHHhCc
Q 018052 162 AKKLIKRILDPNPDTRMTISQMLEDE 187 (361)
Q Consensus 162 ~~~Li~~~L~~dP~~R~t~~eil~h~ 187 (361)
+.+||.+||..||.+|||+.|+++|.
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999883
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=305.66 Aligned_cols=186 Identities=24% Similarity=0.383 Sum_probs=153.9
Q ss_pred cEEEEEEecCCCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAK--HGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+.+|+|||||++|+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||+|.++.+||+|||+|...
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 458999999999999988764 357999999999999999999999999999999999999999999999999999765
Q ss_pred cccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhc-CCCCCCCCCH
Q 018052 83 QQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWFSS 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 160 (361)
.... .......+||+.|+|||++.+..++ .++||||+||++|+|++| .+|+.+.+..+.+..+..+ ..+.|..+++
T Consensus 164 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 164 EDNE-YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cCCC-ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence 3321 2233456799999999999887775 899999999999999995 5666777777777776654 4567788999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHHh--CcccccC
Q 018052 161 GAKKLIKRILDPNPDTRMTISQMLE--DEWFKKG 192 (361)
Q Consensus 161 ~~~~Li~~~L~~dP~~R~t~~eil~--h~~f~~~ 192 (361)
++.+||.+||+.||++|||++++++ ++||+..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999999987 7888754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-40 Score=307.26 Aligned_cols=183 Identities=21% Similarity=0.314 Sum_probs=158.5
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecC
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG------------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRD 57 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrD 57 (361)
.++..+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 35678899999999999999997532 388999999999999999999999999999
Q ss_pred CCCCcEEEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCC
Q 018052 58 LKPENLLLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFD 136 (361)
Q Consensus 58 iKp~NiLld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~ 136 (361)
|||+|||+|.++++||+|||+|.............+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999766544444445567899999999999988886 899999999999999998 47899
Q ss_pred cccHHHHHHHHhhcCC-CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 137 ESNLMALYRKICRADF-SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 137 ~~~~~~~~~~i~~~~~-~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+.+..+....+..+.. ..|..+++++.+||.+||..||++|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9888888888877654 456679999999999999999999999999965
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-40 Score=303.36 Aligned_cols=182 Identities=22% Similarity=0.345 Sum_probs=148.9
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
+...+|+|||||.+|+|.+.+... +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 567899999999999999988765 5799999999999999999999999999999999999999999999999999976
Q ss_pred cccccc-CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhc-CCCCCCCC
Q 018052 82 SQQVRE-DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 82 ~~~~~~-~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
...... .......+||+.|+|||++.+..|+ .++||||+||++|+|++| .+|+.+.+..+++..+..+ ..+.|..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhh
Confidence 543222 1123345789999999999887776 899999999999999985 5666667777777776654 34566678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
++++.+||.+||..||++|||+.+|++
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=313.55 Aligned_cols=185 Identities=27% Similarity=0.482 Sum_probs=143.9
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++.+++|+|||||.|| +.+.+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|++|||++..
T Consensus 92 ~~~~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 92 EEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp TTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred ccCceeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence 4568999999999764 555553 5699999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHHhhc-----------
Q 018052 82 SQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKICRA----------- 150 (361)
Q Consensus 82 ~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------- 150 (361)
... .......+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+......++...
T Consensus 169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccc---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 543 2334567899999999999887775 8999999999999999999999887766554443211
Q ss_pred -----------CCCC--------------C------CCCCHHHHHHHHHccCCCcCCCCCHHHHHhCcccccCC
Q 018052 151 -----------DFSC--------------P------SWFSSGAKKLIKRILDPNPDTRMTISQMLEDEWFKKGY 193 (361)
Q Consensus 151 -----------~~~~--------------~------~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h~~f~~~~ 193 (361)
.... + ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000 0 01356789999999999999999999999999998743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=304.20 Aligned_cols=180 Identities=26% Similarity=0.394 Sum_probs=157.4
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD 66 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld 66 (361)
+++.+|+|||||+||+|.++|... ..+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 467899999999999999999754 5699999999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHH
Q 018052 67 SYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYR 145 (361)
Q Consensus 67 ~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~ 145 (361)
.++.+||+|||+|...... ......+||+.|+|||.+.+..|+ .++||||+||++|+|++| .+||.+.+..+++.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999754432 223456799999999999888775 899999999999999996 56899999999888
Q ss_pred HHhhc-CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 146 KICRA-DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 146 ~i~~~-~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.+..+ ....|..+++++.+||.+||..||++|||+.+|++|
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87765 456677899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=300.91 Aligned_cols=180 Identities=27% Similarity=0.405 Sum_probs=153.9
Q ss_pred cEEEEEEecCCCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 5 TKIYIVLEFIDGGELFDKIAKH-GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
..+|+|||||++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 4679999999999999877654 469999999999999999999999999999999999999999999999999998764
Q ss_pred ccccCC-ccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhcCC--CCCCCCC
Q 018052 84 QVREDG-LLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRADF--SCPSWFS 159 (361)
Q Consensus 84 ~~~~~~-~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s 159 (361)
...... .....+||+.|+|||++.+..|+ .++||||+||++|+|++ |..||.+.+..+....+.+... +.|+.+|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 432222 23345688899999999887765 88999999999999998 8999999999988888876643 4456789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 160 SGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 160 ~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
+++.+||.+||..||++|||+++|++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-40 Score=299.01 Aligned_cols=179 Identities=26% Similarity=0.467 Sum_probs=151.1
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCc
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG--RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLS 79 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla 79 (361)
+++..+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++|++|||++
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccc
Confidence 34567899999999999999997653 5999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHHHHHHHhhc-CCCCCCC
Q 018052 80 AISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMALYRKICRA-DFSCPSW 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 157 (361)
..... ...+.++|+.|+|||++.+..|+ .++||||+||++|+|++ |.+||...+..++...+.++ ..+.|..
T Consensus 151 ~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~ 224 (262)
T d1byga_ 151 KEASS-----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 224 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred eecCC-----CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 75432 23456789999999999887775 89999999999999998 79999988888888877654 4567788
Q ss_pred CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 158 FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 158 ~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
+++++.+||.+||..||.+|||+.+++++
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=304.44 Aligned_cols=183 Identities=23% Similarity=0.370 Sum_probs=155.4
Q ss_pred CcCcEEEEEEecCCCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcE
Q 018052 2 ASKTKIYIVLEFIDGGELFDKIAKHG------------------RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENL 63 (361)
Q Consensus 2 ~s~~~~~lV~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~Ni 63 (361)
.++..+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 35667899999999999999997643 589999999999999999999999999999999999
Q ss_pred EEecCCCEEEEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhc-CCCCCCcccHHH
Q 018052 64 LLDSYGVLKISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMA-GFLPFDESNLMA 142 (361)
Q Consensus 64 Lld~~~~lKl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~-g~~Pf~~~~~~~ 142 (361)
|++.++.+|++|||++...............+||+.|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876544333344557899999999999877665 89999999999999998 677777766655
Q ss_pred HHHHHhhc--CCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 143 LYRKICRA--DFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 143 ~~~~i~~~--~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.+.++... ....|..+++++.+||.+||+.||++|||+++|++
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55444333 33455678999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=300.63 Aligned_cols=182 Identities=18% Similarity=0.276 Sum_probs=159.5
Q ss_pred cCcEEEEEEecCCCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEE
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKH----------GRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLK 72 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lK 72 (361)
.+..+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 456789999999999999988743 2468899999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcC-CCCCCcccHHHHHHHHhhcC
Q 018052 73 ISDFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAG-FLPFDESNLMALYRKICRAD 151 (361)
Q Consensus 73 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~ 151 (361)
|+|||+|...............+||+.|+|||.+.+..|+ .++||||+||++|+|++| .+||.+.+..+.+..+..+.
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999866544333334456799999999999887775 899999999999999998 68999999888888877654
Q ss_pred -CCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 152 -FSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 152 -~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
...|..+++.+.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4557789999999999999999999999999988
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-38 Score=292.57 Aligned_cols=182 Identities=21% Similarity=0.303 Sum_probs=150.8
Q ss_pred CcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCcccc
Q 018052 4 KTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAIS 82 (361)
Q Consensus 4 ~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~ 82 (361)
+..+|+|||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||++...
T Consensus 101 ~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 101 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 468999999999999999888654 5888899999999999999999999999999999999999999999999999765
Q ss_pred ccccc--CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCc-ccHHHHHHHHhhc-CCCCCCCC
Q 018052 83 QQVRE--DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDE-SNLMALYRKICRA-DFSCPSWF 158 (361)
Q Consensus 83 ~~~~~--~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~ 158 (361)
..... ........||+.|+|||++....++ .++||||+||++|+|++|..||.. .+..+....+..+ ....|.++
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTC
T ss_pred cccccccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccC
Confidence 43221 1223345789999999999887775 899999999999999997666654 4444555555444 44567789
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 159 SSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 159 s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
++++.+||.+||..||++|||+.||++|
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-38 Score=290.14 Aligned_cols=191 Identities=20% Similarity=0.276 Sum_probs=148.7
Q ss_pred cCcEEEEEEecCCCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEe---cCCCEEEEecCC
Q 018052 3 SKTKIYIVLEFIDGGELFDKIA-KHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLD---SYGVLKISDFGL 78 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld---~~~~lKl~DFGl 78 (361)
+.+..|+||||+. |+|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+
T Consensus 74 ~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 74 EGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred cCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence 4568899999994 56666555 456899999999999999999999999999999999999985 455799999999
Q ss_pred cccccccccC-----CccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHHHHHHHH---hhc
Q 018052 79 SAISQQVRED-----GLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLMALYRKI---CRA 150 (361)
Q Consensus 79 a~~~~~~~~~-----~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~~~~~~i---~~~ 150 (361)
|......... ....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|..||...........+ ...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 9876533221 223456899999999999988875 8999999999999999999999875544332221 111
Q ss_pred C--C---CCCCCCCHHHHHHHHHccCCCcCCCCCHHH---HHhCcccccCCCC
Q 018052 151 D--F---SCPSWFSSGAKKLIKRILDPNPDTRMTISQ---MLEDEWFKKGYKP 195 (361)
Q Consensus 151 ~--~---~~~~~~s~~~~~Li~~~L~~dP~~R~t~~e---il~h~~f~~~~~~ 195 (361)
. . ..+..+|+++.+||.+||..||.+||++++ +|+|+|.+.++..
T Consensus 232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 1 1 123458899999999999999999999874 5788887766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=283.98 Aligned_cols=181 Identities=20% Similarity=0.362 Sum_probs=140.2
Q ss_pred cEEEEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEecCCCCCcEEEecCCCEEEEec
Q 018052 5 TKIYIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHS--------RGVFHRDLKPENLLLDSYGVLKISDF 76 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~--------~gi~HrDiKp~NiLld~~~~lKl~DF 76 (361)
..+|+|||||++|+|.+++.+. +++++....++.|++.||+|||+ +||+||||||+|||++.+|.+||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 4789999999999999999874 69999999999999999999996 59999999999999999999999999
Q ss_pred CCccccccccc--CCccccccCCCccccccccccCCC-----CCCchhhhhhhhHHHhHhcCCCCCCcc-----------
Q 018052 77 GLSAISQQVRE--DGLLHTACGTPNYVAPEVLNDKGY-----DGRASDVWSCGVILFVLMAGFLPFDES----------- 138 (361)
Q Consensus 77 Gla~~~~~~~~--~~~~~~~~gt~~y~APEv~~~~~~-----~~~~~DiwS~Gvil~~ll~g~~Pf~~~----------- 138 (361)
|++........ .......+||+.|+|||++.+... .+.++||||+||++|+|++|..||...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 99986543221 123345789999999999875432 236899999999999999998877421
Q ss_pred ----cHHHHHHHHhhcCC--CCCCC-----CCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 139 ----NLMALYRKICRADF--SCPSW-----FSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 139 ----~~~~~~~~i~~~~~--~~~~~-----~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
.............. ..|.. ....+.+|+.+||..||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22223333322222 12221 12358899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-36 Score=279.04 Aligned_cols=181 Identities=17% Similarity=0.260 Sum_probs=147.3
Q ss_pred cCcEEEEEEecCCCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEec-----CCCEEEEec
Q 018052 3 SKTKIYIVLEFIDGGELFDKIAKHG-RLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDS-----YGVLKISDF 76 (361)
Q Consensus 3 s~~~~~lV~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~-----~~~lKl~DF 76 (361)
.....|+||||+ ||+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. .+.+||+||
T Consensus 72 ~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 72 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred cCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 467899999999 789999887654 6999999999999999999999999999999999999974 578999999
Q ss_pred CCccccccccc-----CCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCccc---HHHHHHHHh
Q 018052 77 GLSAISQQVRE-----DGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESN---LMALYRKIC 148 (361)
Q Consensus 77 Gla~~~~~~~~-----~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~---~~~~~~~i~ 148 (361)
|+|........ .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.+.. ....+.++.
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 99987543221 1234457899999999999988775 89999999999999999999997533 333333332
Q ss_pred hcCC-----CCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHh
Q 018052 149 RADF-----SCPSWFSSGAKKLIKRILDPNPDTRMTISQMLE 185 (361)
Q Consensus 149 ~~~~-----~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~ 185 (361)
.... ..++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 2111 123457899999999999999999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-34 Score=275.48 Aligned_cols=182 Identities=23% Similarity=0.399 Sum_probs=137.9
Q ss_pred cEEEEEEecCCCCChHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCCCcEEEecCCC------EEEE
Q 018052 5 TKIYIVLEFIDGGELFDK---IAKHGRLKEDEARRYFQQLINAVDYCHS-RGVFHRDLKPENLLLDSYGV------LKIS 74 (361)
Q Consensus 5 ~~~~lV~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~ql~~gl~~lH~-~gi~HrDiKp~NiLld~~~~------lKl~ 74 (361)
...+++|+++.++..... ......+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +|++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~ 174 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEe
Confidence 456677777765543322 2234579999999999999999999998 89999999999999987664 9999
Q ss_pred ecCCcccccccccCCccccccCCCccccccccccCCCCCCchhhhhhhhHHHhHhcCCCCCCcccHH------HHHHHHh
Q 018052 75 DFGLSAISQQVREDGLLHTACGTPNYVAPEVLNDKGYDGRASDVWSCGVILFVLMAGFLPFDESNLM------ALYRKIC 148 (361)
Q Consensus 75 DFGla~~~~~~~~~~~~~~~~gt~~y~APEv~~~~~~~~~~~DiwS~Gvil~~ll~g~~Pf~~~~~~------~~~~~i~ 148 (361)
|||.|..... .....+||+.|+|||++....|+ .++||||+||++++|++|+.||...+.. +......
T Consensus 175 dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 175 DLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp CCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 9999875432 23467899999999999988886 8999999999999999999999753321 1111000
Q ss_pred h------------------------------------------cCCCCCCCCCHHHHHHHHHccCCCcCCCCCHHHHHhC
Q 018052 149 R------------------------------------------ADFSCPSWFSSGAKKLIKRILDPNPDTRMTISQMLED 186 (361)
Q Consensus 149 ~------------------------------------------~~~~~~~~~s~~~~~Li~~~L~~dP~~R~t~~eil~h 186 (361)
. .....+...++++.+||.+||..||.+|||++|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0001111235778999999999999999999999999
Q ss_pred cccccC
Q 018052 187 EWFKKG 192 (361)
Q Consensus 187 ~~f~~~ 192 (361)
|||++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999953
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.63 E-value=1.2e-17 Score=143.61 Aligned_cols=68 Identities=28% Similarity=0.478 Sum_probs=58.8
Q ss_pred EEEEecCCCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCCCcEEEecCCCEEEEecCCccccc
Q 018052 8 YIVLEFIDGGELFDKIAKHGRLKEDEARRYFQQLINAVDYCHSRGVFHRDLKPENLLLDSYGVLKISDFGLSAISQ 83 (361)
Q Consensus 8 ~lV~E~~~gg~L~~~i~~~~~l~e~~~~~~~~ql~~gl~~lH~~gi~HrDiKp~NiLld~~~~lKl~DFGla~~~~ 83 (361)
+++|||++++.+. .+++..+..++.|++.||+|||++||+||||||+|||+++++ ++|+|||+|....
T Consensus 86 ~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 86 AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCC
Confidence 6899999886553 256677889999999999999999999999999999999755 8999999986543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.47 E-value=1.2e-13 Score=105.21 Aligned_cols=88 Identities=16% Similarity=0.260 Sum_probs=80.9
Q ss_pred cceeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEe-CCeEEEEEEecCCCchhHHH
Q 018052 259 ETRFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVA-PTLHIVEVRKTGGDTLEFHK 336 (361)
Q Consensus 259 ~trf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~vdf~~~~Gd~le~~~ 336 (361)
....+|+.+|++|+.+|++|++.+|+.+++ ++|.++.....+++++.+.|.+||+++. +++++|+|+|.+||.++|++
T Consensus 12 sv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~ 91 (102)
T d1ul7a_ 12 SMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKN 91 (102)
T ss_dssp CCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHH
T ss_pred eeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHH
Confidence 456789999999999999999999999976 4699999988888899999999999996 79999999999999999999
Q ss_pred HHHHHHhccc
Q 018052 337 FYKKFSSGLK 346 (361)
Q Consensus 337 ~~~~l~~~l~ 346 (361)
+|.+|...|+
T Consensus 92 l~~~il~~l~ 101 (102)
T d1ul7a_ 92 IASKIANELK 101 (102)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHhcc
Confidence 9999988775
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.59 E-value=1.1e-07 Score=75.09 Aligned_cols=73 Identities=18% Similarity=0.343 Sum_probs=63.5
Q ss_pred eeeeCCChhHHHHHHHHHhcccCcEEEe-cCceeEEeeccCCCCCceEEEEEEEEEeCCeEEEEEEecCCCchh
Q 018052 261 RFTSQRPPNEIMSKIEEAAKPLGFNVRK-GNYKMKLQGDKTGRKGQLSVATEVFEVAPTLHIVEVRKTGGDTLE 333 (361)
Q Consensus 261 rf~s~~~~~~i~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~vdf~~~~Gd~le 333 (361)
.+.|...|.+||..|.+|++.+|+.|++ +.|.++++.........+.+.+++|++.++.|||||++..|+-.|
T Consensus 4 GIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 4 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 4568889999999999999999999986 679999998866666788899999999999999999999998665
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.14 E-value=4.3e-06 Score=64.52 Aligned_cols=89 Identities=15% Similarity=0.230 Sum_probs=67.6
Q ss_pred ccceeeeCCChhHHHHHHHHHhcccCcEEEecC----------ceeEEeeccC-----CCCCceEEEEEEEEEeCCeEEE
Q 018052 258 RETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN----------YKMKLQGDKT-----GRKGQLSVATEVFEVAPTLHIV 322 (361)
Q Consensus 258 ~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~l~~~~~i~~~~~~~~~v 322 (361)
......|...|-+||..|.+|++.+|+.|++.+ +.|+++...+ .....+.+.+++|+++++.+||
T Consensus 3 WhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 3 WHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp CEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred ceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEE
Confidence 345677889999999999999999999998643 6788874322 2233577899999999999999
Q ss_pred EEE-----ecCC--------------CchhHHHHHHHHHhccc
Q 018052 323 EVR-----KTGG--------------DTLEFHKFYKKFSSGLK 346 (361)
Q Consensus 323 df~-----~~~G--------------d~le~~~~~~~l~~~l~ 346 (361)
||+ .+.| .+.+|-.+|.+|--.|.
T Consensus 83 DFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~ 125 (127)
T d2qrda1 83 DVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF 125 (127)
T ss_dssp EEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred EEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence 998 2222 24678888887766554
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.90 E-value=1.8e-05 Score=64.02 Aligned_cols=89 Identities=19% Similarity=0.244 Sum_probs=64.1
Q ss_pred cccceeeeCCChhHHHHHHHHHhcccCcEEEecC----ceeEEeeccCC---------CCCceEEEEEEEEEeCCeEEEE
Q 018052 257 KRETRFTSQRPPNEIMSKIEEAAKPLGFNVRKGN----YKMKLQGDKTG---------RKGQLSVATEVFEVAPTLHIVE 323 (361)
Q Consensus 257 ~~~trf~s~~~~~~i~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~vd 323 (361)
+......|..+|-+||..|.+|++.+|+.|++.+ +.++++...+. ....+.+.+++|+++++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 5677889999999999999999999999998643 78888754221 1234789999999999999999
Q ss_pred EEec-----CC----------------CchhHHHHHHHHHhcc
Q 018052 324 VRKT-----GG----------------DTLEFHKFYKKFSSGL 345 (361)
Q Consensus 324 f~~~-----~G----------------d~le~~~~~~~l~~~l 345 (361)
|+-. .| .+.+|-.+|.+|--.|
T Consensus 125 FK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qL 167 (171)
T d2qlva1 125 FKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMEL 167 (171)
T ss_dssp EEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHH
T ss_pred EecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHH
Confidence 9742 12 2366888887665544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.05 E-value=0.00019 Score=61.95 Aligned_cols=29 Identities=28% Similarity=0.306 Sum_probs=25.0
Q ss_pred cEecCCCCCcEEEecCCCEEEEecCCccc
Q 018052 53 VFHRDLKPENLLLDSYGVLKISDFGLSAI 81 (361)
Q Consensus 53 i~HrDiKp~NiLld~~~~lKl~DFGla~~ 81 (361)
++|+|+.|.|||+++++..-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 78999999999999866667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.97 E-value=0.0012 Score=56.49 Aligned_cols=28 Identities=21% Similarity=0.201 Sum_probs=24.8
Q ss_pred cEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 53 VFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 53 i~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
++|+|+.|.|||+++++..-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.65 E-value=0.0043 Score=57.03 Aligned_cols=28 Identities=18% Similarity=0.259 Sum_probs=24.7
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.++|+|+.|.|||+++++ ++|+||.+|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 489999999999998755 8999998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.36 E-value=0.0054 Score=54.15 Aligned_cols=30 Identities=27% Similarity=0.412 Sum_probs=26.9
Q ss_pred CCcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 51 RGVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 51 ~gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
.|++|+|+.++|++++.++..-|.||+.++
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999998877899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.80 E-value=0.045 Score=48.36 Aligned_cols=27 Identities=22% Similarity=0.251 Sum_probs=22.5
Q ss_pred CcEecCCCCCcEEEecCCCEEEEecCCcc
Q 018052 52 GVFHRDLKPENLLLDSYGVLKISDFGLSA 80 (361)
Q Consensus 52 gi~HrDiKp~NiLld~~~~lKl~DFGla~ 80 (361)
+++|+|+.|.|||+++ | ..++||+-++
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999974 4 4589999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=82.46 E-value=0.2 Score=45.12 Aligned_cols=15 Identities=40% Similarity=0.634 Sum_probs=13.3
Q ss_pred cEecCCCCCcEEEec
Q 018052 53 VFHRDLKPENLLLDS 67 (361)
Q Consensus 53 i~HrDiKp~NiLld~ 67 (361)
++|.|+.+.||++.+
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 589999999999854
|